0000926326-21-000007.txt : 20210224 0000926326-21-000007.hdr.sgml : 20210224 20210224160436 ACCESSION NUMBER: 0000926326-21-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 132 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210224 DATE AS OF CHANGE: 20210224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMNICELL, Inc CENTRAL INDEX KEY: 0000926326 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPUTERS [3571] IRS NUMBER: 943166458 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-33043 FILM NUMBER: 21673014 BUSINESS ADDRESS: STREET 1: 590 E. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6502516100 MAIL ADDRESS: STREET 1: 590 E. MIDDLEFIELD ROAD CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL INC /CA/ DATE OF NAME CHANGE: 20010625 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL COM /CA/ DATE OF NAME CHANGE: 20000419 FORMER COMPANY: FORMER CONFORMED NAME: OMNICELL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960807 10-K 1 omcl-20201231.htm 10-K omcl-20201231
FYFALSE20200000926326us-gaap:AccountingStandardsUpdate201613MemberP1YP1Yus-gaap:AccruedLiabilitiesCurrentus-gaap:AccruedLiabilitiesCurrent0.0102751P1YP1YP1Y3252500009263262020-01-012020-12-31iso4217:USD00009263262020-06-30xbrli:shares00009263262021-02-1700009263262020-12-3100009263262019-12-31iso4217:USDxbrli:shares0000926326us-gaap:ProductMember2020-01-012020-12-310000926326us-gaap:ProductMember2019-01-012019-12-310000926326us-gaap:ProductMember2018-01-012018-12-310000926326us-gaap:ServiceMember2020-01-012020-12-310000926326us-gaap:ServiceMember2019-01-012019-12-310000926326us-gaap:ServiceMember2018-01-012018-12-3100009263262019-01-012019-12-3100009263262018-01-012018-12-310000926326us-gaap:CommonStockMember2017-12-310000926326us-gaap:TreasuryStockMember2017-12-310000926326us-gaap:AdditionalPaidInCapitalMember2017-12-310000926326us-gaap:RetainedEarningsMember2017-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2017-12-3100009263262017-12-310000926326us-gaap:RetainedEarningsMember2018-01-012018-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-01-012018-12-310000926326us-gaap:CommonStockMember2018-01-012018-12-310000926326us-gaap:AdditionalPaidInCapitalMember2018-01-012018-12-310000926326us-gaap:CommonStockMember2018-12-310000926326us-gaap:TreasuryStockMember2018-12-310000926326us-gaap:AdditionalPaidInCapitalMember2018-12-310000926326us-gaap:RetainedEarningsMember2018-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-3100009263262018-12-310000926326us-gaap:RetainedEarningsMember2019-01-012019-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-12-310000926326us-gaap:CommonStockMember2019-01-012019-12-310000926326us-gaap:AdditionalPaidInCapitalMember2019-01-012019-12-310000926326us-gaap:CommonStockMember2019-12-310000926326us-gaap:TreasuryStockMember2019-12-310000926326us-gaap:AdditionalPaidInCapitalMember2019-12-310000926326us-gaap:RetainedEarningsMember2019-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000926326us-gaap:RetainedEarningsMember2020-01-012020-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-12-310000926326us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310000926326us-gaap:CommonStockMember2020-01-012020-12-310000926326us-gaap:TreasuryStockMember2020-01-012020-12-310000926326srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-12-310000926326srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember2019-12-310000926326us-gaap:CommonStockMember2020-12-310000926326us-gaap:TreasuryStockMember2020-12-310000926326us-gaap:AdditionalPaidInCapitalMember2020-12-310000926326us-gaap:RetainedEarningsMember2020-12-310000926326us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-31omcl:segmentxbrli:pure0000926326omcl:TenLargestGroupPurchasingOrganizationsGPOsMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310000926326srt:MinimumMember2020-01-012020-12-310000926326srt:MaximumMember2020-01-012020-12-310000926326omcl:LeaseReceivableMemberomcl:U.S.GovernmentHospitalsMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310000926326omcl:PrimarySupplierMember2020-12-310000926326omcl:PrimarySupplierMember2020-01-012020-12-310000926326omcl:PrimarySupplierMember2019-01-012019-12-310000926326omcl:PrimarySupplierMember2018-01-012018-12-310000926326us-gaap:ShippingAndHandlingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310000926326us-gaap:ShippingAndHandlingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000926326us-gaap:ShippingAndHandlingMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2018-01-012018-12-310000926326srt:MinimumMemberus-gaap:ComputerEquipmentMember2020-01-012020-12-310000926326srt:MaximumMemberus-gaap:ComputerEquipmentMember2020-01-012020-12-310000926326us-gaap:FurnitureAndFixturesMembersrt:MinimumMember2020-01-012020-12-310000926326us-gaap:FurnitureAndFixturesMembersrt:MaximumMember2020-01-012020-12-310000926326srt:MinimumMemberus-gaap:EquipmentMember2020-01-012020-12-310000926326srt:MaximumMemberus-gaap:EquipmentMember2020-01-012020-12-310000926326omcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember2020-01-012020-12-310000926326us-gaap:PropertyPlantAndEquipmentMemberomcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember2020-01-012020-12-310000926326us-gaap:PropertyPlantAndEquipmentMemberomcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember2019-01-012019-12-310000926326us-gaap:OtherAssetsMember2020-01-012020-12-310000926326us-gaap:OtherAssetsMember2019-01-012019-12-31omcl:reportingUnit0000926326omcl:A340BLinkBusinessMember2020-10-012020-10-010000926326omcl:A340BLinkBusinessMember2020-10-010000926326us-gaap:CustomerRelationshipsMemberomcl:A340BLinkBusinessMember2020-10-012020-10-010000926326us-gaap:TechnologyBasedIntangibleAssetsMemberomcl:A340BLinkBusinessMember2020-10-012020-10-010000926326us-gaap:TradeNamesMemberomcl:A340BLinkBusinessMember2020-10-012020-10-010000926326us-gaap:NoncompeteAgreementsMemberomcl:A340BLinkBusinessMember2020-10-012020-10-0100009263262020-10-012020-10-010000926326omcl:MeasurementInputRoyaltyRateMemberus-gaap:TechnologyBasedIntangibleAssetsMemberomcl:A340BLinkBusinessMember2020-10-010000926326us-gaap:TradeNamesMemberomcl:MeasurementInputRoyaltyRateMemberomcl:A340BLinkBusinessMember2020-10-010000926326us-gaap:MeasurementInputDiscountRateMemberomcl:A340BLinkBusinessMember2020-10-010000926326omcl:A340BLinkBusinessMember2020-01-012020-12-310000926326omcl:A340BLinkBusinessMember2020-10-012020-12-310000926326omcl:A340BLinkBusinessMember2019-01-012019-12-310000926326omcl:ConnectedDevicesSoftwareLicensesAndOtherMember2020-01-012020-12-310000926326omcl:ConnectedDevicesSoftwareLicensesAndOtherMember2019-01-012019-12-310000926326omcl:ConnectedDevicesSoftwareLicensesAndOtherMember2018-01-012018-12-310000926326omcl:TechnicalServicesMember2020-01-012020-12-310000926326omcl:TechnicalServicesMember2019-01-012019-12-310000926326omcl:TechnicalServicesMember2018-01-012018-12-310000926326omcl:ConsumablesMember2020-01-012020-12-310000926326omcl:ConsumablesMember2019-01-012019-12-310000926326omcl:ConsumablesMember2018-01-012018-12-310000926326omcl:HardwareAndSoftwareMember2020-01-012020-12-310000926326omcl:HardwareAndSoftwareMember2019-01-012019-12-310000926326omcl:HardwareAndSoftwareMember2018-01-012018-12-310000926326country:US2020-01-012020-12-310000926326country:US2019-01-012019-12-310000926326country:US2018-01-012018-12-310000926326us-gaap:NonUsMember2020-01-012020-12-310000926326us-gaap:NonUsMember2019-01-012019-12-310000926326us-gaap:NonUsMember2018-01-012018-12-310000926326us-gaap:RestrictedStockMember2020-01-012020-12-310000926326us-gaap:RestrictedStockMember2019-01-012019-12-310000926326us-gaap:RestrictedStockMember2018-01-012018-12-310000926326omcl:ConvertibleDebtSecuritiesAndWarrantsMember2020-01-012020-12-310000926326omcl:ConvertibleDebtSecuritiesAndWarrantsMember2019-01-012019-12-310000926326omcl:ConvertibleDebtSecuritiesAndWarrantsMember2018-01-012018-12-310000926326us-gaap:ConvertibleDebtMemberomcl:ConvertibleSeniorNotesMember2020-12-310000926326us-gaap:InterestRateSwapMember2016-06-300000926326us-gaap:InterestRateSwapMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-06-300000926326us-gaap:OtherCurrentAssetsMember2020-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310000926326us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-12-310000926326us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000926326us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-12-310000926326us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-12-310000926326us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000926326us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310000926326us-gaap:EquipmentMember2020-12-310000926326us-gaap:EquipmentMember2019-12-310000926326us-gaap:FurnitureAndFixturesMember2020-12-310000926326us-gaap:FurnitureAndFixturesMember2019-12-310000926326us-gaap:LeaseholdImprovementsMember2020-12-310000926326us-gaap:LeaseholdImprovementsMember2019-12-310000926326us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2020-12-310000926326us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2019-12-310000926326us-gaap:ConstructionInProgressMember2020-12-310000926326us-gaap:ConstructionInProgressMember2019-12-310000926326country:US2020-12-310000926326country:US2019-12-310000926326us-gaap:NonUsMember2020-12-310000926326us-gaap:NonUsMember2019-12-310000926326us-gaap:CustomerRelationshipsMember2020-12-310000926326us-gaap:CustomerRelationshipsMember2020-01-012020-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MinimumMember2020-01-012020-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MaximumMember2020-01-012020-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2020-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2020-01-012020-12-310000926326srt:MinimumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2020-01-012020-12-310000926326srt:MaximumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2020-01-012020-12-310000926326us-gaap:OrderOrProductionBacklogMember2020-12-310000926326us-gaap:OrderOrProductionBacklogMember2020-01-012020-12-310000926326us-gaap:TradeNamesMember2020-12-310000926326us-gaap:TradeNamesMember2020-01-012020-12-310000926326us-gaap:TradeNamesMembersrt:MinimumMember2020-01-012020-12-310000926326us-gaap:TradeNamesMembersrt:MaximumMember2020-01-012020-12-310000926326us-gaap:PatentsMember2020-12-310000926326us-gaap:PatentsMember2020-01-012020-12-310000926326us-gaap:PatentsMembersrt:MinimumMember2020-01-012020-12-310000926326us-gaap:PatentsMembersrt:MaximumMember2020-01-012020-12-310000926326us-gaap:NoncompeteAgreementsMember2020-12-310000926326us-gaap:NoncompeteAgreementsMember2020-01-012020-12-310000926326us-gaap:CustomerRelationshipsMember2019-12-310000926326us-gaap:CustomerRelationshipsMember2019-01-012019-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MinimumMember2019-01-012019-12-310000926326us-gaap:CustomerRelationshipsMembersrt:MaximumMember2019-01-012019-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2019-12-310000926326us-gaap:TechnologyBasedIntangibleAssetsMember2019-01-012019-12-310000926326srt:MinimumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-01-012019-12-310000926326srt:MaximumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2019-01-012019-12-310000926326us-gaap:OrderOrProductionBacklogMember2019-12-310000926326us-gaap:OrderOrProductionBacklogMember2019-01-012019-12-310000926326us-gaap:TradeNamesMember2019-12-310000926326us-gaap:TradeNamesMember2019-01-012019-12-310000926326us-gaap:TradeNamesMembersrt:MinimumMember2019-01-012019-12-310000926326us-gaap:TradeNamesMembersrt:MaximumMember2019-01-012019-12-310000926326us-gaap:PatentsMember2019-12-310000926326us-gaap:PatentsMember2019-01-012019-12-310000926326us-gaap:PatentsMembersrt:MinimumMember2019-01-012019-12-310000926326us-gaap:PatentsMembersrt:MaximumMember2019-01-012019-12-310000926326us-gaap:LineOfCreditMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMember2016-01-050000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326us-gaap:LetterOfCreditMemberomcl:WellsFargoBankNationalAssociationMember2016-01-050000926326omcl:WellsFargoBankNationalAssociationMemberus-gaap:BridgeLoanMember2016-01-050000926326us-gaap:LineOfCreditMembersrt:MinimumMemberomcl:CreditAgreementInterestRateOptionOneMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:CreditAgreementInterestRateOptionOneMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberus-gaap:FederalFundsEffectiveSwapRateMemberomcl:CreditAgreementInterestRateOptionTwoMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MinimumMemberomcl:CreditAgreementInterestRateOptionTwoMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberomcl:CreditAgreementInterestRateOptionTwoMemberomcl:WellsFargoBankNationalAssociationMemberus-gaap:SecuredDebtMemberus-gaap:LondonInterbankOfferedRateLIBORMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoBankNationalAssociationMember2016-01-052016-01-050000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberomcl:WellsFargoBankNationalAssociationMember2017-12-260000926326omcl:WellsFargoBankNationalAssociationMember2017-12-012017-12-310000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:RevolvingCreditFacilityMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:RevolvingCreditFacilityMember2019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberomcl:IncrementalLoanFacilityMember2019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:BridgeLoanMember2019-11-150000926326us-gaap:LineOfCreditMemberomcl:TermLoanFacilityMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MaximumMemberus-gaap:LondonInterbankOfferedRateLIBORMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberus-gaap:FederalFundsEffectiveSwapRateMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:LondonInterbankOfferedRateLIBORMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MinimumMemberomcl:LondonInterbankOfferingRateLIBORPlus100Member2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MaximumMemberomcl:LondonInterbankOfferingRateLIBORPlus100Member2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MinimumMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMembersrt:MaximumMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:RevolvingCreditFacilityMemberomcl:DebtInstrumentCovenantPeriod1Member2020-09-220000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMemberus-gaap:RevolvingCreditFacilityMemberomcl:DebtInstrumentCovenantPeriod2Member2020-09-220000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2019-11-152019-11-150000926326us-gaap:LineOfCreditMemberomcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember2020-09-222020-09-220000926326us-gaap:LineOfCreditMember2020-01-012020-12-310000926326us-gaap:LineOfCreditMember2019-01-012019-12-310000926326us-gaap:LineOfCreditMember2018-01-012018-12-310000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2019-12-310000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-01-012020-12-310000926326us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-12-310000926326us-gaap:LineOfCreditMember2019-12-310000926326us-gaap:LineOfCreditMember2020-12-310000926326us-gaap:ConvertibleDebtMemberomcl:ConvertibleSeniorNotesMember2020-09-250000926326us-gaap:ConvertibleDebtMemberomcl:ConvertibleSeniorNotesMember2020-09-252020-09-25omcl:day0000926326us-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:ConvertibleDebtMemberomcl:ConvertibleSeniorNotesMember2020-09-252020-09-250000926326us-gaap:ConvertibleDebtMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMemberomcl:ConvertibleSeniorNotesMember2020-09-252020-09-250000926326us-gaap:ConvertibleDebtMemberomcl:ConvertibleSeniorNotesMember2020-01-012020-12-310000926326omcl:ConvertibleNoteHedgeRightsMember2020-09-2500009263262020-09-252020-09-250000926326us-gaap:StockOptionMember2020-09-250000926326us-gaap:WarrantMember2020-09-250000926326srt:MinimumMember2020-12-310000926326srt:MaximumMember2020-12-310000926326us-gaap:AssetsLeasedToOthersMember2020-12-310000926326us-gaap:AssetsLeasedToOthersMember2019-12-310000926326us-gaap:AssetsLeasedToOthersMember2020-01-012020-12-310000926326us-gaap:AssetsLeasedToOthersMember2019-01-012019-12-310000926326us-gaap:AssetsLeasedToOthersMember2018-01-012018-12-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-12-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-01-012020-12-310000926326omcl:A2009PlanMember2020-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:EmployeeStockOptionMemberus-gaap:ShareBasedCompensationAwardTrancheOneMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedCompensationAwardTrancheOneMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:CostOfSalesMember2020-01-012020-12-310000926326us-gaap:CostOfSalesMember2019-01-012019-12-310000926326us-gaap:CostOfSalesMember2018-01-012018-12-310000926326us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-12-310000926326us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-12-310000926326us-gaap:ResearchAndDevelopmentExpenseMember2018-01-012018-12-310000926326us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-12-310000926326us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-12-310000926326us-gaap:SellingGeneralAndAdministrativeExpensesMember2018-01-012018-12-310000926326omcl:A2009PlanMember2020-01-012020-12-310000926326omcl:A2009PlanMember2019-01-012019-12-310000926326omcl:A2009PlanMember2018-01-012018-12-310000926326us-gaap:EmployeeStockOptionMember2020-01-012020-12-310000926326us-gaap:EmployeeStockOptionMember2019-01-012019-12-310000926326us-gaap:EmployeeStockOptionMember2018-01-012018-12-310000926326srt:MinimumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-01-012020-12-310000926326srt:MaximumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2020-01-012020-12-310000926326srt:MinimumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2019-01-012019-12-310000926326srt:MaximumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2019-01-012019-12-310000926326srt:MinimumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2018-01-012018-12-310000926326srt:MaximumMemberus-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2018-01-012018-12-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2019-01-012019-12-310000926326us-gaap:EmployeeStockMemberomcl:A1997EmployeeStockPurchasePlanMember2018-01-012018-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2020-12-310000926326us-gaap:EmployeeStockOptionMemberomcl:A2009PlanMember2018-01-012018-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2020-12-310000926326us-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2018-01-012018-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2020-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:RestrictedStockMemberomcl:A2009PlanMember2018-01-012018-12-310000926326srt:OfficerMemberus-gaap:PerformanceSharesMember2019-01-012019-12-310000926326srt:OfficerMemberus-gaap:PerformanceSharesMember2020-01-012020-12-310000926326us-gaap:PerformanceSharesMember2020-02-132020-02-130000926326us-gaap:PerformanceSharesMember2019-02-132019-02-130000926326us-gaap:PerformanceSharesMemberomcl:A2018PerformanceBasedRestrictedStockUnitsMember2019-03-052019-03-050000926326us-gaap:PerformanceSharesMemberomcl:A2018PerformanceBasedRestrictedStockUnitsMember2020-12-310000926326omcl:A2019PerformanceBasedRestrictedStockUnitsMemberus-gaap:PerformanceSharesMember2020-03-032020-03-030000926326omcl:A2019PerformanceBasedRestrictedStockUnitsMemberus-gaap:PerformanceSharesMember2020-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2019-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2020-01-012020-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2020-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2019-01-012019-12-310000926326us-gaap:PerformanceSharesMemberomcl:A2009PlanMember2018-01-012018-12-310000926326us-gaap:EmployeeStockOptionMember2020-12-310000926326omcl:RestrictedStockAwardsRSAsAndRestrictedStockUnitsRSUsMember2020-12-310000926326omcl:FuturegrantsandawardsMember2020-12-310000926326us-gaap:EmployeeStockMember2020-12-310000926326us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberomcl:OmnicellPlanMember2020-01-012020-12-310000926326us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberomcl:OmnicellPlanMember2019-01-012019-12-310000926326us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMemberomcl:OmnicellPlanMember2018-01-012018-12-310000926326us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:RestrictedStockUnitsRSUMemberomcl:A2009PlanMember2020-01-012020-12-310000926326omcl:A2016RepurchaseProgramMember2016-08-020000926326omcl:A2014ShareRepurchaseProgramMember2014-11-040000926326omcl:A2016and2014ShareRepurchaseProgramsMember2020-12-310000926326omcl:OneTimeStockRepurchaseSeptember2020Member2020-09-170000926326omcl:OneTimeStockRepurchaseSeptember2020Member2020-09-172020-09-170000926326omcl:A2016and2014ShareRepurchaseProgramsMember2018-01-012018-12-310000926326omcl:A2016and2014ShareRepurchaseProgramsMember2020-01-012020-12-310000926326omcl:A2016and2014ShareRepurchaseProgramsMember2019-01-012019-12-310000926326omcl:DistributionAgreementMember2017-11-032017-11-030000926326omcl:DistributionAgreementMember2018-01-012018-12-310000926326omcl:DistributionAgreementMember2018-12-310000926326omcl:DistributionAgreementMember2019-01-012019-12-310000926326omcl:DistributionAgreementMember2019-12-310000926326us-gaap:StateAndLocalJurisdictionMember2020-12-310000926326us-gaap:ForeignCountryMember2020-12-310000926326us-gaap:DomesticCountryMemberus-gaap:ResearchMember2020-12-310000926326us-gaap:StateAndLocalJurisdictionMemberus-gaap:ResearchMember2020-12-310000926326us-gaap:EmployeeSeveranceMemberomcl:Q1Q22020RestructuringPlanMember2020-01-012020-12-310000926326omcl:Q1Q22020RestructuringPlanMember2020-12-310000926326omcl:Q42018RestructuringPlanMember2018-01-012018-12-310000926326omcl:Q12018RestructuringPlanMemberMember2018-01-012018-12-310000926326us-gaap:AccountsReceivableMember2017-12-310000926326us-gaap:AccountsReceivableMember2018-01-012018-12-310000926326us-gaap:AccountsReceivableMember2018-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2017-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2018-01-012018-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2018-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2017-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2018-01-012018-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2018-12-310000926326us-gaap:AccountsReceivableMember2019-01-012019-12-310000926326us-gaap:AccountsReceivableMember2019-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2019-01-012019-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2019-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2019-01-012019-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2019-12-310000926326us-gaap:AccountsReceivableMember2020-01-012020-12-310000926326us-gaap:AccountsReceivableMember2020-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2020-01-012020-12-310000926326omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember2020-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2020-01-012020-12-310000926326omcl:NetInvestmentInSalesTypeLeasesMember2020-12-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________
FORM 10-K
(Mark One)
☒ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2020
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to
Commission File No. 000-33043
OMNICELL, INC.
(Exact name of registrant as specified in its charter)
Delaware94-3166458
(State or other jurisdiction of
incorporation or organization)		(IRS Employer
Identification No.)
590 East Middlefield Road
Mountain View, CA 94043
(Address of registrant’s principal executive offices, including zip code)

(650) 251-6100
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.001 par valueOMCLNASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ý    No o
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o    No ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer☒Accelerated filer☐Non-accelerated filer☐Smaller reporting company☐Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal controls over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ý

The aggregate market value of the registrant’s common stock, $0.001 par value, held by non-affiliates of the registrant as of June 30, 2020 was $3.0 billion (based upon the closing sales price of such stock as reported on the NASDAQ Global Select Market on such date) which excludes an aggregate of 571,294 shares of the registrant’s common stock held by officers, directors and affiliated stockholders. For purposes of determining whether a stockholder was an affiliate of the registrant at June 30, 2020, the registrant has assumed that a stockholder was an affiliate of the registrant at June 30, 2020 if such stockholder (i) beneficially owned 10% or more of the registrant’s common stock and/or (ii) was affiliated with an executive officer or director of the registrant at June 30, 2020. Exclusion of such shares should not be construed to indicate that any such person possesses the power, direct or indirect, to direct or cause the direction of the management or policies of the registrant or that such person is controlled by or under common control with the registrant.
As of February 17, 2021, there were 43,041,554 shares of the registrant’s common stock, $0.001 par value, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s definitive Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the United States Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Form 10-K are incorporated by reference in Part III, Items 10-14 of this Form 10-K.


OMNICELL, INC.
TABLE OF CONTENTS
Page
OTHER

3
FORWARD-LOOKING STATEMENTS AND FACTORS THAT MAY AFFECT FUTURE RESULTS
This annual report on Form 10-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act"). The forward-looking statements are contained throughout this report including in the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements include, but are not limited to, statements about:
•our expectations about the continuing impact of the ongoing global novel coronavirus (COVID-19) pandemic (including efforts to contain the spread of the pandemic) on our workforce and operations, as well as the continuing impacts on our customers and suppliers, and the anticipated continuing effects of the pandemic and associated containment measures on our business, financial condition, liquidity, and results of operations;
•our expectations regarding our future sales pipeline and product bookings;
•the extent and timing of future revenues, including the amounts of our current backlog;
•the size or growth of our market or market share;
•our beliefs about drivers of demand for our solutions, market opportunities in certain product categories, and continued expansion in these product categories, as well as our belief that our technology, services, and solutions within these categories position us well to address the needs of retail, acute, and post-acute pharmacy providers;
•our ability to acquire companies, businesses, products, or technologies on commercially reasonable terms and integrate such acquisitions effectively;
•our goal of advancing our platform with new product introductions annually;
•our ability to deliver on the autonomous pharmacy vision, as well as our plan to integrate our current offerings and technologies on a cloud infrastructure and invest in broadening our solutions across certain key areas as we execute on this vision;
•continued investment in the autonomous pharmacy vision, our beliefs about the anticipated benefits of such investments, and our expectations regarding continued growth in subscription and cloud-based offerings as we execute on this vision;
•our belief that our solutions and vision for fully autonomous medication management are strongly aligned with long-term trends in the healthcare market and well-positioned to address the evolving needs of the healthcare institutions;
•planned new products and services;
•the bookings, revenue, and margin opportunities presented by new products, emerging markets, and international markets;
•our ability to align our cost structure and headcount with our current business expectations;
•the outcome of any legal proceedings to which we are a party;
•the bookings, revenues, non-GAAP EBITDA, operating margin, or non-GAAP earnings per share goals we may set;
•our projected target long-term revenues and revenue growth rates, long-term non-GAAP operating margin targets, long-term non-GAAP EBITDA margin targets, and free cash flow conversion;
•our ability to protect our intellectual property and operate our business without infringing, misappropriating, or otherwise violating the intellectual property rights of others;
•the expected impacts of new accounting standards or changes to existing accounting standards;
•our expected future uses of cash, including our expected uses for the remaining proceeds of our convertible senior notes, and the sufficiency of our sources of funding; and
•our ability to generate cash from operations and our estimates regarding the sufficiency of our cash resources.
4
In some cases, you can identify forward-looking statements by terms such as “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “seeks,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would,” and variations of these terms and similar expressions. Forward-looking statements are based on our current expectations and assumptions, and are subject to known and unknown risks and uncertainties, which may cause our actual results, performance, or achievements to be materially different from those expressed or implied in the forward-looking statements. Such risks and uncertainties include those described throughout this annual report, including in Part I - Section 1A. “Risk Factors” and Part II - Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations" below. Given these risks and uncertainties, you should not place undue reliance on these forward-looking statements. You should carefully read this annual report and the documents that we reference in this annual report and have filed as exhibits, as well as other documents we file from time to time with the United States Securities and Exchange Commission, with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements in this annual report represent our estimates and assumptions only as of the date of this annual report. Except as required by law, we assume no obligation to update any forward-looking statements publicly, or to update the reasons actual results could differ materially from those expressed or implied in any forward-looking statements, even if new information becomes available in the future.
All references in this report to “Omnicell,” “our,” “us,” “we,” or the “Company” collectively refer to Omnicell, Inc., a Delaware corporation, and its subsidiaries. The term “Omnicell, Inc.” refers only to Omnicell, Inc., excluding its subsidiaries.
We own various registered and unregistered trademarks and service marks used in our business, some of which appear in this report. The most important of these marks include Omnicell® and the Omnicell logo. This report may also include the trademarks and service marks of other companies. Such trademarks and service marks are the marks of their respective owners.
5
PART I
ITEM 1.    BUSINESS
Overview
We are a leader in transforming the pharmacy care delivery model. Our medication management automation solutions and adherence tools empower healthcare systems and pharmacies to focus on clinical care, rather than administrative tasks. Our solutions support the vision of a fully autonomous pharmacy, a roadmap designed to improve operational efficiencies through a fully automated, medication management infrastructure. Our vision is to transform the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. We believe our connected devices, products, and solutions will help our customers harness the power of data and analytics, and deliver improved patient outcomes.
In 2019, several pharmacy leaders published a framework that validates the need for greater automation of pharmacy workflows and outlines the levels to progress towards the fully autonomous pharmacy. Through our medication management automation platform that spans the continuum of care, we are advancing the vision for the autonomous pharmacy. By delivering a combination of automation, intelligence, and advanced services, to be powered by a single, cloud-based platform, we believe we are helping to empower healthcare and pharmacy providers to increase healthcare value and improve patient outcomes.
omcl-20201231_g1.jpg
We believe our robust customer base and channel within the pharmacy automation market enable us to bring new solutions and innovations to market. Over 7,000 facilities worldwide use our automation and analytics solutions which are designed to improve pharmacy workflows, increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage our innovative medication adherence and population health solutions to improve patient engagement, and adherence to prescriptions and vaccine scheduling, helping to reduce costly hospital readmissions.
6
omcl-20201231_g2.jpg
We believe our broad portfolio of products and services, combined with innovation, align us with the long-term trends of the healthcare market to manage patients across the continuum of care while helping to control costs and improve patient outcomes.
Operating Segments
We manage our operations as a single segment for the purposes of assessing performance and making operating decisions. Our Chief Operating Decision Maker ("CODM") is our Chief Executive Officer. The CODM allocates resources and evaluates the performance of Omnicell at the consolidated level using information about our revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of Omnicell as one operating segment, which is the same as our reporting segment.
Business Strategy
We are committed to being the care provider’s most trusted partner and executing on the vision of the autonomous pharmacy by delivering automation, intelligence, and advanced services, powered by a single, cloud-based platform. We believe there are significant challenges in pharmacy practice including, but not limited to, medication errors, drug shortages, medication loss due to drug diversion, significant medication waste and expiration costs, a high level of manual steps in the medication management automation process, complexity around compliance requirements, high pharmacy employee turnover rates, hospitalizations from adverse drug events in outpatient settings, high variability in outcomes, and limited inventory visibility. We believe that these significant challenges in pharmacy practice drive the demand for increased digitization and virtualization, and that our solutions enable this and represent large opportunities in four market categories:
•Point of Care. As a market leader, we expect to continue expansion of this product category as customers increase use of our dispensing systems in more areas within their hospitals. In addition, we are early in the replacement, upgrade, and expansion cycle of our XT Series automated dispensing systems which we believe is a significant market opportunity and we expect to continue to focus on further penetrating markets through competitive conversions. We believe our current portfolio within the Point of Care market and new innovation and services will continue to drive improved outcomes and lower costs for our customers.
•Central Pharmacy. This market represents the beginning of the medication management process in acute care settings, and, we believe, the next big automation opportunity to replace manual and repetitive processes which are common in the pharmacy today. Manual processes are prone to significant errors, and products such as IVX Workflow, our IV sterile compounding solutions, and the XR2 Automated Central Pharmacy system automate
7
these manual processes and are designed to reduce the risk of error for our healthcare partners. We believe new products and innovations, including Omnicell One™, in the Central Pharmacy market create opportunities to replace prior generation Central Pharmacy robotics and carousels. The Central Pharmacy also represents an opportunity to provide technology-enabled services designed to reduce the administrative burden on the pharmacy and allow clinicians to operate at the top of their license.
•340B Software-Enabled Services. This market is targeted to covered entities participating in Section 340B of the Public Health Services Act. The act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients and results in a complex compliance environment. We believe that there are significant opportunities for health systems to improve participation benefits and maximize program savings through software-enabled services and solutions. Our Omnicell 340B platform of technology-enabled services includes split billing software, contract pharmacy administration, specialty contract pharmacy administration, and drug discount access solutions.
•Retail, Institutional, and Payer. We believe the Retail, Institutional, and Payer market represents a large opportunity as the majority of drugs are distributed in the non-acute sector. New technology and updated state board regulations are leading to innovation at traditional retail providers, which, combined with the move to value-based care, we believe will incentivize the market to adopt solutions to help providers and payers engage patients in new ways that lower the total cost of care. We believe adoption of our EnlivenHealth (formerly Population Health Solutions) portfolio of software products and services, along with medication adherence packaging, will increase adherence performance rates, increase prescription volume for our customers, and reduce hospital and emergency room visits due to improved adherence. As retail pharmacies play an increasingly vital role in population health following the onset of the COVID-19 pandemic, EnlivenHealth has extended solutions to assist with vaccination programs, testing protocols, and patient engagement efforts. There are three main areas of focus:
◦CareScheduler is an exclusive digital solution that automates the scheduling, reporting, and patient outreach for administering the COVID-19 vaccine and other vaccines and testing procedures.
◦Medication Synchronization is an appointment-based solution that aligns a patient's medications to a single refill date, designed to improve medication adherence and reduce hospital readmissions.
◦Medication Therapy Management is a platform that offers intuitive workflow with high-level decision support for efficiently completing CMS-compliant Comprehensive Medication Reviews using pharmacy claims data.
We believe our technology, services, and solutions within these market categories position us well to address the needs of retail, acute, and post-acute pharmacy providers.
8
omcl-20201231_g3.jpg
Environmental, Social, and Governance Initiatives
We view Omnicell as a company with a social mission: Our focus on reinventing the pharmacy care delivery model is designed to dramatically improve health outcomes and lower healthcare costs. Our teams are motivated by knowing that our work to improve medication management has a tangible, real-world impact on healthcare workers, patients, and communities.
We recognize that we are accountable not only to our customers and shareholders, but also to the global community. In December 2020, we published initial ESG disclosure and performance information, aligned to Sustainability Accounting Standards Board, Task Force on Climate-related Financial Disclosures, and Global Reporting Initiative guidelines. We are focused on innovating to drive sustainability across our business; ethically and responsibly sourcing materials by adhering to internationally-recognized Organisation for Economic Co-operation and Development guidance; and elevating our diversity and inclusion initiatives.
9
omcl-20201231_g4.jpg
Industry Background and Market
We believe our solutions support the vision for the fully autonomous pharmacy and are strongly aligned with trends in the healthcare market, and well positioned to address the evolving needs of healthcare institutions.
The healthcare industry continues to experience a significant degree of consolidation, with healthcare providers combining to create larger healthcare delivery organizations to achieve greater market power. We believe this trend has increased the market need for more integrated medication management automation solutions on a single platform to help improve patient and financial outcomes for both inpatient and outpatient settings. Our portfolio of connected devices, products, and services, combined with innovation, are designed with this objective in mind.
In addition, healthcare providers and facilities are affected by significant economic pressures. Annual prescription drug expenditures in the United States were approximately $508 billion in 2019, according to the IQVIA National Sales Perspective database. Also, based on a 2018 report by the Health Care Cost Institute, the largest growth in spending for professional services—defined as payments to physicians and other clinical care team members for services provided in physician offices and hospitals—occurred among administered drugs, which accounted for the biggest share, at 39%, of the total increase in professional services spending from 2014 to 2018. Rising costs of labor, prescription drugs, and new medical technology all contribute to increased spending. Governmental pressures surrounding healthcare reform and compliance have led to increased scrutiny of the cost and efficiency with which healthcare providers deliver their services. These factors, combined with continuing consolidation in the healthcare industry, have increased the need for the efficient delivery of healthcare in order to control costs, and have elevated the strategic importance of medication management and pharmacy automation across the continuum of care.
Furthermore, over time, complexities in medication management have increased along with the volume of patients and medications, but many manual processes are still used, resulting in inefficient tracking and delivery of medications and supplies. Many clinical staff are burdened with administrative tasks. According to a survey conducted by the American Society of Health-System Pharmacists in 2019, approximately 75% of pharmacist activities are non-clinical in nature. In addition, many existing healthcare information systems are unable to support the modernization of healthcare delivery processes or address mandated patient safety initiatives. These factors contribute to medical errors and unnecessary process costs across the healthcare sector including in medication management.
Legislation and industry guidelines, such as those issued by the U.S. Food and Drug Administration (the "FDA"), The Joint Commission, the U.S. Pharmacopeial Convention and the Institute for Safe Medication Practices in the areas of medication management—including storage, security, and labeling—have created an environment of increased patient safety awareness and regulatory control. Against this backdrop, healthcare organizations, desiring to improve quality and avoid
10
liability, have been driven to prioritize investments in capital equipment, including pharmacy automation, which is a standard of care, to improve patient safety. While the overall storage and security of medications in hospitals have improved, there had been an increased focus on controlled substance management in recent years, particularly in light of the opioid crisis in the United States. According to a research report published by the Butler Center for Research in 2015, studies in the United States have shown that 10% to 15% of healthcare professionals will misuse substances during their lifetime, with significantly higher levels of opioid abuse in particular. Joint Commission surveyors are seeking more documentation from hospitals demonstrating that their medication policies and procedures are adequate.
Medication non-adherence is widely recognized as a common and costly problem. Poor adherence results in increased hospital readmissions, deteriorated treatment outcomes, and avoidable healthcare costs. The estimated annual cost of prescription drug-related morbidity and mortality resulting from non-optimized medication therapy, including medication non-adherence, was $528 billion in 2016, according to a study published in the Annals of Pharmacotherapy in 2018. In addition, a 2017 study published in the Journal of the American Pharmacists Association found that medication issues are responsible for 26% of hospital readmissions. With more than 40 million Americans taking five or more maintenance medications routinely (based on statistics published by the National Center for Health Statistics in 2018), pharmacists need ways to support the arduous task of keeping patients compliant. According to a 2011 article by the World Health Organization, “although these medications are effective in combating disease, their full benefits are often not realized because approximately 50% of patients do not take their medications as prescribed.” Medication adherence can be improved through attitudinal and behavioral changes, which pharmacists can encourage and help facilitate by providing interventional support, including adherence tools such as blister cards, reminders, prescription synchronization, and patient engagement tools. We believe our EnlivenHealth portfolio has the potential to reduce hospitalizations and emergency department visits, and improve patient health by increasing medication adherence.
Government Regulation
Our operations are global and are affected by complex state, federal, and international laws and regulations. These laws and regulations relate to healthcare, privacy and security, product compliance, import, export, trade, healthcare fraud and abuse (including anti-kickback and false claims laws), environmental standards, anti-corruption, anti-bribery, labor and employment, as well as other areas.
We receive, store, and process personal information and other data from and about our customers, in addition to our employees and service providers, and our customers use our solutions to obtain and store personal information, including personal health information. As a result, we are subject to various laws and regulations related to privacy, data protection, and information security. In the United States, these include federal health information privacy laws (such as the Health Information Portability and Accountability Act of 1996 ("HIPAA"), various state and federal security breach notification laws, consumer protection laws, as well as state laws addressing privacy and security. Internationally, various foreign jurisdictions in which we operate have established, or are developing, their own data privacy and security legal framework with which we or our customers must comply, including the European Union’s General Data Protection Regulation (“GDPR”).
In addition, while the manufacture and sale of most of our current products are not regulated by the FDA or the Drug Enforcement Administration, through our acquisition of Aesynt Incorporated, we have both Class I and Class II, 510(k) exempt medical devices which are subject to FDA regulation and require compliance with the FDA Quality System Regulation as well as medical device reporting.
Furthermore, our operations are impacted by trade regulations in many countries that govern the import of raw materials and finished products, and we are also subject to laws and regulations that seek to prevent corruption and bribery in the marketplace (including the U.S. Foreign Corrupt Practices Act and the United Kingdom Bribery Act) as well as laws and regulations pertaining to healthcare fraud and abuse, including state and federal anti-kickback and false claims laws in the United States.
Since we manufacture and sell our products outside of the United States, certain products of a local nature and variations of product lines must also meet other local regulatory requirements. Additional risks are inherent in conducting business outside the United States, including more robust information governance and environmental regulations in the European Union, expropriation, nationalization, and other governmental action. Demand for many of our existing and new products is, and will continue to be, affected by the extent to which local regulatory requirements increase our risk and/or expense to do business in those countries.
Compliance with the laws and regulations applicable to our global operations is costly and requires sufficient resources to actively maintain various governance, risk, and compliance systems in several areas, including FDA, quality, information governance and security, and environmental, health and safety, to enable Omnicell to keep abreast of the constantly evolving
11
regulatory landscape both in the United States and abroad. Any failure to comply with these laws and regulations could result in a range of fines, penalties, and/or other sanctions.
Products and Services
omcl-20201231_g5.jpg
As we continue to execute on the vision of the autonomous pharmacy, we plan to integrate our current offerings and technologies on a cloud infrastructure, and invest in broadening our solutions across three key areas:
Automation
We provide a range of advanced automation, including robotics designed to digitize and streamline workflows and reduce human error in central pharmacy and clinical areas, and to support medication adherence initiatives in retail pharmacies. Our automation products and technology-enabled services include central pharmacy automation solutions for both dispensing and IV compounding systems, medication and supply dispensing systems at the point of care, as well as medication adherence solutions which are used by retail, community, and outpatient pharmacies to help improve patient engagement and adherence to prescriptions.
Point of Care
Our point of care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. Automated dispensing systems are an essential part of medication management because they safeguard medications - including controlled substances - and automatically track inventory. We strive to continually develop new innovations for our automated dispensing systems to close gaps in safety and help enable clinicians to spend less time managing medications and more time caring for patients.
Our XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital can be customized with various software and hardware options. Our interoperability solutions integrate our automated dispensing systems with key electronic health record systems to help streamline workflow and increase accuracy. We also offer specialized automated dispensing systems for the operating room.
Central Pharmacy
An efficient central pharmacy operation is vital to delivering exceptional patient care. With pharmacist and technician labor requirements increasing over the years, it is critical for pharmacies to find new ways of increasing productivity. Our broad medication management platform offers a range of automated hardware and software solutions. Our central pharmacy automation solutions are designed to empower healthcare providers to increase staff efficiency, reduce inventory costs, prevent
12
medication errors, improve compliance, and strengthen security of controlled substances. By automating manual, error-prone processes, our technology helps enable pharmacy staff to work more efficiently and directly contribute to clinical care.
Our central pharmacy automation solutions include: automated storage and retrieval systems, including our XR2 Automated Central Pharmacy System – an important building block of the autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.
Medication Adherence
Our medication adherence solutions are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.
We offer automated systems to aid pharmacies in more accurately and efficiently filling our multimed adherence packaging based on individual patient medication orders. These machines interface with pharmacy information systems to obtain prescription information for each patient receiving the medication blister cards. In addition to robotic automation, we offer software that guides the user through the manual filling process to streamline workflow and increase packing accuracy.
Our single dose automation solutions fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions. Our semi-automated filling equipment is designed specifically for the long-term care institutional pharmacy with enough order volume to warrant pre-packaging frequently-used medications. Our automated solutions interface with pharmacy information systems to obtain prescription information.
We also offer a wide range of medication blister card packaging and packaging supplies designed to enhance medication adherence in a variety of non-acute care settings. These products include multimed blister cards (adherence packaging) distributed by retail, community, and outpatient pharmacies to help patients manage their medication regimens at home. These cards organize multiple drugs into a single blister cavity for each dosing time, helping to make it easier for patients on complex regimens to comply with their therapy. For environments where a caregiver is present, institutional and retail pharmacies use our single dose blister cards, which provide up to 90-day doses of a specific single medication.
Other Automation Products and Services
Omnicell® Interface Software provides interface and integration between our medication-use products or our supply products and a healthcare facility’s in-house information management systems.
Customer service includes customer education and training, and post-installation technical support with phone support, on-site service, parts, and access to software upgrades. Product support is available through fixed-period service contracts and on a time and materials basis. On-site service is provided by our field service team.
Retail Pharmacy and Hospital Automation Outside the United States
Additional products sold outside the United States include robotic dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. For management of medical supplies, a specialized cabinet that uses radio frequency identification is also available.
Intelligence
Leveraging data analytics and predictive intelligence, we provide actionable insights to help customers better understand their medication usage and improve pharmacy supply chain management. We offer specialized services and analytics software designed to help healthcare facilities improve their bottom line and patient care by harnessing data from automation and other systems. Our Omnicell One (formerly Performance Center) solution, a technology-enabled service, combines a cloud-based predictive intelligence platform with expert services designed to drive enterprise improvements in medication inventory optimization, medication waste reduction, and drug diversion monitoring.
Our comprehensive 340B solution provides a combination of software, deep knowledge of the 340B program, and software-enabled services, to help deliver superior outcomes in both savings and compliance, optimizing the 340B program for eligible entities. The suite of offerings includes split billing software, contract pharmacy administration, specialty contract pharmacy administration, and drug discount access solutions.
EnlivenHealth™ offers a portfolio of medication management tools designed to help improve health outcomes. EnlivenHealth Patient Engagement is a web-based nexus of solutions designed to comprehensively support improvement in health outcomes related to medication use. EnlivenHealth Patient Engagement includes clinical solutions such as Medication Synchronization, Immunization and Scheduling, Targeted Patient Interventions, Medication Therapy Management, and Opioid Mitigation Solution, and patient communications such as hosted Interactive Voice Response (IVR), Outbound
13
Communications, and Mobile App, which enable tailoring of patient contact to individual preferences. Combined with advanced analytics to stratify populations and prioritize patient interventions, these solutions support improved performance for both pharmacies and health plans, helping them to succeed in value-based healthcare by driving health outcomes - better care, better health, and lower costs.
Technology-Enabled Services
We provide technology-enabled services that serve as an extension of pharmacy operations to support improved efficiency, regulatory compliance, and patient outcomes. Our technology-enabled services provide comprehensive, customer-centric, outcome-based adoption services to help ensure successful adoption of our technology.
Our Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs. Our Central Pharmacy Dispensing Service is a turnkey, full service central pharmacy automation solution designed to improve inventory control, compliance, safety, and efficiency through automation, supported by operational staff, maintenance, and optimization services.
We also offer Professional Services, as the introduction of new innovations within our health system customers has become increasingly complex, with greater organizational impacts. We view our customers as partners in the pursuit of better health outcomes for patients and improved satisfaction for the clinicians who serve them. Every engagement is an opportunity for us to help customers reach their clinical and business objectives.
Acquisitions
In addition to our own development, we have, from time to time, acquired businesses and technologies that expand our product lines and are a strategic fit for our business.
On October 1, 2020, we completed the acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The acquisition adds to our portfolio a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner.
Sales and Distribution
omcl-20201231_g6.jpg
We sell our solutions primarily in the United States. Approximately 89% of our revenue was generated in this market for the year ended December 31, 2020. Our sales force is organized by geographic region in the United States and Canada,
14
where our sales are primarily made direct to end-user customers with the exception of some distribution of medication adherence consumables. Outside the United States and Canada, we field direct sales employees in the United Kingdom, France, Germany, the United Arab Emirates, Belgium, and Australia. For other geographies, we generally sell through distributors and resellers. Our foreign operations are discussed in Note 3, Revenues, and Note 7, Property and Equipment, of the Notes to Consolidated Financial Statements and Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, of this annual report on Form 10-K. Our combined direct, corporate, and international distribution sales teams consisted of approximately 370 staff members as of December 31, 2020. Nearly all of our direct sales team members have hospital capital equipment, services, or clinical systems experience.
As of December 31, 2020, we have 145 long-term, sole-source agreements with the top 300 U.S. health systems. The sales cycle for our automation systems, from the initial sales meeting to completion of installation, can take in excess of 12 to 24 months. This is due in part to the relative cost of our systems and the number of people within each healthcare facility involved in the purchasing decision and installation process. To initiate the selling process, the sales representative generally targets the director of pharmacy, the director of nursing, the director of materials management, or other decision makers, and educates each group within the healthcare facility about the economic, safety, and compliance benefits of our solutions relative to competing methods of managing medications or medical and surgical supplies.
We contract with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. Pursuant to the terms of GPO agreements, each member contracts directly with us and can purchase our product at pre-negotiated contract terms and pricing. These GPO contracts are typically for multiple years with options to renew or extend for up to two years and some of which can be terminated by either party at any time. Our current most significant GPO contracts include Vizient, Inc., Premier Inc., and HealthTrust Purchasing Group. We also have a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease our products. Some of our contracts with these organizations are terminable at the convenience of either party. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During our fiscal year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.
We offer multi-year, non-cancelable lease payment terms to assist healthcare organizations in purchasing our systems by reducing their cash flow requirements. We sell the majority of our multi-year lease receivables to third-party leasing finance companies.
Our field operations representatives support our sales force by providing operational and clinical expertise prior to the close of a sale and during installation of our automation systems. This group assists the customer with the technical implementation of our automation systems, including configuring our systems to address the specific needs of each individual customer. After the systems are installed, on-site support is provided by our field service team and technical support group.
We offer telephone technical support through our technical support centers in Illinois, Florida, Pennsylvania, and North Carolina. Our support centers are staffed 24 hours a day, 365 days a year. We have found that a majority of our customers’ service issues can be addressed either over the phone or by our support center personnel using their remote diagnostics tools. In addition, we use remote dial-in software that monitors customer conditions on a daily basis. We offer a suite of remote monitoring features, which proactively monitors system status and alerts service personnel to potential problems before they lead to system failure.
In addition, our international team handles direct sales, installation, and service to healthcare facilities in the United Kingdom, France, and Germany, and to non-acute customers in Australia. Sales, installation, and service to healthcare facilities is handled through distribution partners in other parts of Europe, Asia, Australia, the Middle East, South Africa, and South America. Our products are available in a variety of languages including Traditional Chinese, Simplified Chinese, Japanese, Korean, French, Swedish, Dutch, Spanish, and German.
Manufacturing and Inventory
The manufacturing process for our automation products allows us to configure hardware and software in unique combinations to meet a wide variety of individual customer needs. The automation product manufacturing process primarily consists of the final assembly of components and testing of the completed product. Many of the sub-assemblies and components we use are provided by third-party contract manufacturers or other suppliers. A portion of these contract manufacturers and other suppliers are based in Asia. We and our partners test these sub-assemblies and perform inspections to assure the quality and reliability of our products. While many components of our systems are standardized and available from multiple sources, certain components or subsystems are fabricated by a sole supplier according to our specifications and schedule requirements,
15
or are only available from limited sources. Our medication adherence product manufacturing process consists of fabrication and assembly of equipment and mechanized process manufacturing of consumables. We rely on a limited number of suppliers for the raw material that are necessary in the production of our consumable medication packages.
Our arrangements with our contract manufacturers generally set forth quality, cost, and delivery requirements, as well as manufacturing process terms, such as continuity of supply, inventory management, capacity flexibility, quality and cost management, oversight of manufacturing, and conditions for the use of our intellectual property.
Our manufacturing organization procures components and schedules production based on the backlog of customer orders. Installation of equipment and software typically occurs between two weeks and twelve months after the initial order is received, depending upon the customer’s particular needs. We deploy a key operational strategy of operating with backlog levels that approximate the average installation cycle of our customers, which allows us to more efficiently manage our installation teams, improve production efficiencies, reduce inventory scrap, and lower shipping costs. Shipment of consumables typically occurs between one and four weeks after an order is received.
Competition
The markets in which we operate are intensely competitive. We compete directly with a number of companies in the medication management automations solutions market, as well as the medication adherence solutions market, on the basis of many factors, including price, quality, customer outcome and cost of operation, innovation, product features and capabilities, installation and service, reputation and brand recognition, size of installed base, range of solutions, distribution, and promotion. We expect continued and increased competition from current and future competitors in the markets in which we operate, and are affected by evolving and new technologies, changes in industry standards, and dynamic customer requirements.
We believe our products and services compare favorably with the offerings of our competitors, particularly with respect to proprietary technological advancements, system performance, system reliability, installation, applications training, service response time, and service repair quality.
Intellectual Property and Proprietary Technology
We rely on a combination of patents, trademarks, copyright and trade secret laws, confidentiality procedures, contractual restrictions, and licensing arrangements to protect our intellectual property rights.
We pursue patent protection in the United States and foreign jurisdictions for technology that we believe to be proprietary and that offers a potential competitive advantage for our products. Our issued patents expire on various dates between 2021 and 2038. We intend to seek and obtain additional United States and foreign patents on our technology.
All of our product software is subject to copyright protection under applicable United States and foreign copyright laws. We have also obtained United States and, for certain marks, foreign registrations of various marks, and we intend to seek and obtain additional registrations of our trademarks in the United States and foreign jurisdictions.
Trade secrets and other confidential information are also important to our business. We protect our trade secrets through a combination of contractual restrictions and confidentiality and licensing agreements.
Research and Development
Our research and development efforts begin with customer collaboration. The insight that we gain through this collaboration helps us to develop solutions to address the unmet needs and challenges faced by our customers. We continue to make significant investments in the vision of the autonomous pharmacy, in particular, in our cloud-based platform, in the further development of technology-enabled software and services, and in the evolution of our robotic automation capabilities, while continuing to enhance the other elements of our product and service portfolio. The results of our research and development efforts will further drive the advancement of our cloud-based offerings and amplify the vision of the autonomous pharmacy.
Human Capital Management
As of December 31, 2020, we had approximately 2,860 employees worldwide (with approximately 2,470 in the United States and Canada), excluding individuals who are classified as temporary or contractors. We regularly conduct employee engagement surveys, most recently via the Glint platform. Through continued investment in talent processes and acting on employee feedback, we have achieved an overall employee satisfaction (ESAT) score of 77, which exceeds the average score of similarly-sized companies identified by Glint that use the Glint platform by four points. We believe this reflects our positive employee relations and that Omnicell is viewed by our employees as a good place to work.
16
Compensation and Benefits
•We embrace a strong pay-for-performance total rewards philosophy that we believe is competitive, performance-based, and cost-effective. We offer market-competitive pay and a comprehensive benefits package.
•Our quarterly bonus program is designed to incentivize our employees to focus on work that will further our strategic priorities.
•We offer reward and recognition programs that embed our core values into our culture and everything we do, allowing for peer-to-peer recognition and motivating our employees to continually work to advance our mission, vision, and values.
Health and Wellness
We offer a comprehensive wellness program designed to promote a healthy lifestyle, including exercise challenges, on-site gym facilities, virtual workouts, and health coaching. In addition to making physical health a priority, we offer mental health counseling and resources, financial coaching, and Teladoc Health services.
Learning and Development
•Our Talent and Leadership development function plays a strategic role in helping us attract and retain talent. We strive to develop career growth capabilities while delivering a consistent learning experience irrespective of role, function, or location.
•We invest in our employees’ learning through robust training programs including Omnicell University, our Core Values in Action training, our New Employee Orientation and our Leading at Omnicell training.
•Our People Manager Talent Development curriculum creates one unique global Omnicell approach to talent development. It is designed to enable our organizational transformation by aligning how we lead across all levels.
Diversity, Equity, and Inclusion
Relationships Matter is one of our core values and that means we are people who care. We value the whole person, not just the work person. At Omnicell, we have always prohibited discrimination on the basis of any protected characteristic and make employment decisions on the basis of merit. We strive to create and maintain a positive, supportive, inclusive, and diverse work environment. Our different backgrounds, education, cultures, and experiences all contribute to the advancement of our business.
We realize we have an opportunity to take more action and that our journey to improve diversity, equity, and inclusion (“DEI”) at Omnicell will continue to evolve. A focus on understanding our related data will be critical to our success. With a continued commitment to DEI, we are taking the steps to build a truly diverse and inclusive culture and plan to create and launch a more comprehensive strategy that we anticipate publicizing in 2021.
Business under Government Contracts
A number of our U.S. government-owned or government-run hospital customers sign five-year leases, with payment terms that are subject to one-year government budget funding cycles. Failure of any of our U.S. government customers to receive their annual funding could impair our ability to sell to these customers, or to collect payments on our existing unsold leases. For additional information regarding these leases, see the section titled “Risk Factors” under Part I, Item 1A below.
Financing Practices Relating to Working Capital
We assist healthcare facilities in financing their cash outlay requirements for the purchase of our systems by offering multi-year, non-cancelable sales contracts. For additional information regarding these financing activities, refer to Note 1, Organization and Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K.
Product Backlog
Product backlog is the dollar amount of medication management automation solutions and adherence tools for which we have purchase orders from our customers and for which we believe the majority we will install, bill, and gain customer acceptance within one year. Due to industry practice that allows customers to change order configurations with limited advance notice prior to shipment and occasional customer changes in installation schedules, we do not believe that backlog as of any particular date is necessarily indicative of future sales. However, we do believe that backlog is an indication of a customer’s
17
willingness to install our solutions. Our product backlog was $924 million and $588 million as of December 31, 2020 and 2019, respectively.
Available Information
We file reports and other information with the United States Securities and Exchange Commission (“SEC”) including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy or information statements. Those reports and statements as well as all amendments to those documents filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are available (1) at the SEC’s Internet site (www.sec.gov) and (2) free of charge through our website as soon as reasonably practicable after electronic filing with, or furnishing to, the SEC. Our website address is www.omnicell.com. Information posted on or accessible through these websites is not incorporated by reference nor otherwise included in this report, and any references to these websites are intended to be inactive textual references only.
Information About Our Executive Officers
The following table sets forth certain information about our executive officers as of the date of this annual report on Form 10-K:
NameAgePosition
Randall A. Lipps63President, Chief Executive Officer, and Chairman of the Board of Directors
Dan S. Johnston57Executive Vice President and Chief Legal and Administrative Officer
Peter J. Kuipers49Executive Vice President and Chief Financial Officer
Scott P. Seidelmann45Executive Vice President and Chief Commercial Officer
Randall A. Lipps was named Chief Executive Officer and President of Omnicell in October 2002. Mr. Lipps has served as Chairman of the Board and a Director of Omnicell since founding Omnicell in September 1992. Mr. Lipps received both a B.S. in economics and a B.B.A. from Southern Methodist University.
Dan S. Johnston joined Omnicell in November 2003 as Vice President and General Counsel. In March 2012, Mr. Johnston was named Executive Vice President and General Counsel. In February 2015, Mr. Johnston was named Executive Vice President and Chief Legal and Administrative Officer. From April 1999 to November 2003, Mr. Johnston was Vice President and General Counsel at Be, Inc., a software company. From September 1994 to March 1999, Mr. Johnston was an attorney with the law firm Cooley LLP. Mr. Johnston received a B.S. in computer information systems from Humboldt State University and a J.D. from the Santa Clara University School of Law.
Peter J. Kuipers joined Omnicell in August 2015 as Executive Vice President and Chief Financial Officer. Prior to Omnicell, Mr. Kuipers served as Senior Vice President and Chief Financial Officer of Quantcast Corp., a global technology company that specializes in digital audience measurement and real-time advertising. From May 2013 to December 2014, Mr. Kuipers served as Executive Vice President and Chief Financial Officer of The Weather Company, a media and global technology leader operating The Weather Channel, weather.com, wunderground.com and its professional services division WSI. From September 2009 to April 2013, Mr. Kuipers served in various financial management positions at Yahoo! Inc., a global internet technology company, most recently as Vice President, Finance for the Americas region. Prior to Yahoo! Inc., Mr. Kuipers held financial leadership roles at Altera Corporation, General Electric Company, and Akzo Nobel. He started his career with Ernst & Young and worked in both the Netherlands and Seattle, Washington. Mr. Kuipers received a Master’s Degree in Economics and Business Administration from Maastricht University and is a Chartered Accountant in the Netherlands.
Scott P. Seidelmann joined Omnicell in April 2018 as Executive Vice President and Chief Commercial Officer. Prior to joining Omnicell, from January 2015 to August 2017, Mr. Seidelmann served as founder and Chief Executive Officer of Candescent Health, Inc., a cloud-based radiology workflow and analytics provider. From 2005 to 2014, Mr. Seidelmann served as co-founder and Chief Executive Officer of Radisphere, Inc., a national radiology practice, prior to its acquisition by Sheridan Healthcare. Earlier in his career, Mr. Seidelmann held positions with Merrill Lynch and Ericsson Venture Partners. Mr. Seidelmann received a B.A. from Cornell University.
ITEM 1A.    RISK FACTORS
We have identified the following risks and uncertainties that may have a material adverse effect on our business, financial condition or results of operations. Our business faces significant risks and the risks described below may not be the only risks we face. Additional risks not presently known to us or that we currently believe are immaterial may also significantly impair our business operations. If any of these risks occur, our business, results of operations, or financial condition could suffer and the market price of our common stock could decline.
18
In assessing these risks, you should also refer to other information contained in this annual report on Form 10-K, including the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our Consolidated Financial Statements and related Notes.
Risk Factors Related to our Business and Industry
We face risks related to adverse public health epidemics, including the ongoing global COVID-19 pandemic, which had an adverse effect on and, depending on the severity and duration of the pandemic, could continue to adversely affect our business, financial condition, and results of operations.
The continued spread of COVID-19, concerns over the pandemic, and related containment measures have adversely impacted our workforce and operations, as well as those of our customers and suppliers, and had an adverse effect on and, depending on the severity and duration of the ongoing COVID-19 pandemic, could continue to adversely affect our business, financial condition, and results of operations.
In response to the ongoing pandemic, the vast majority of our non-manufacturing and non-customer facing personnel continues to work from home. If significant or critical portions of our workforce are unable to work effectively as a result of the COVID-19 pandemic, including because of illness, quarantines, facility closures, ineffective remote work arrangements, or technology failures or limitations, our operations would be materially adversely impacted.
Demand for our solutions, many of which involve a significant initial financial commitment from our customers, is largely dependent on our customers’ financial strength and capital and operating budgets. As a result of the pandemic, health systems have faced financial pressures which we believe led our customers to delay or defer purchasing decisions and/or installations of our solutions during the first half of 2020. However, starting in the third quarter of 2020, we began to see our customers returning to pre-pandemic purchasing patterns consistent with long-term strategic investments. However, any future decisions by our customers to cancel, defer or delay capital expenditure projects, generally reduced capital expenditures by healthcare facilities, and financial losses sustained by health systems as a result of the COVID-19 pandemic, could again decrease demand for our products and related services, resulting in decreased revenue and lower revenue growth rates, which would adversely affect our operating results, perhaps materially.
In addition, although we have not experienced any material disruptions to our supply chain to date, any future prolonged disruption to our suppliers as a result of the COVID-19 pandemic and associated containment measures could significantly disrupt our supply chain and impact our ability to produce our products, which would negatively impact our sales and operating results.
Furthermore, the COVID-19 pandemic has significantly increased economic and demand uncertainty and has led to disruption and volatility in the global capital markets, which could increase the cost of capital and adversely impact access to capital not only for us, but also for our customers and suppliers. Weak economic conditions and inability to access capital in a timely manner, or at all, could reduce our customers’ demand for our products and services, which would adversely affect our operating results, perhaps materially.
The global COVID-19 pandemic continues to rapidly evolve, and the full extent to which COVID-19 will continue to impact our business, results of operations, and financial position will depend on future developments, which remain highly uncertain and cannot be predicted with confidence, such as the severity, resurgences, and duration of the outbreak, travel restrictions, business closures or disruptions, and the effectiveness of actions taken to contain and treat the disease, including the timeline for distribution of vaccinations.
To the extent the COVID-19 pandemic continues to adversely affect our business and financial results, it may also have the effect of heightening certain other risks described in this “Risk Factors” section, including, but not limited to, those relating to unfavorable economic and market conditions, our ability to develop new products or enhance existing products, the need to compete successfully against new product or service entrants, our need to generate sufficient cash flows to service our indebtedness, our tax rates, and our international operations.
Unfavorable economic and market conditions and a decreased demand in the capital equipment market could adversely affect our operating results.
Customer demand for our products is significantly linked to the strength of the economy. If decreases in demand for capital equipment caused by weak economic conditions and decreased corporate and government spending, any effects of fiscal budget balancing at the federal level, proposed legislative changes or other uncertainties in connection with the change in administration, deferrals or delays of capital equipment projects, longer timeframes for capital equipment purchasing decisions, or generally reduced expenditures for capital solutions occurs, we will experience decreased revenues and lower revenue growth rates, and our operating results could be materially and adversely affected.
19
We may fail to develop new solutions or enhance existing solutions to react to changes in technology and customer requirements in a timely and cost-effective manner, or our new or enhanced solutions may not achieve market acceptance.
We must develop new products or enhance existing products to react to evolving technologies and industry standards, and meet changing demands of our customers. This process can be time-consuming, costly, and complex, and usually requires us to accurately anticipate technological innovations and market trends. Our ability to fund product development and enhancements partially depends on our ability to generate revenues from our existing products.
New product and service developments, or product enhancements, may be late, have technical problems (including software defects, errors, or bugs), fail to meet customer or market specifications, not be competitive with other products using alternative technologies that offer comparable performance and functionality, or not be accepted in new or existing markets, which, in any case, could damage our reputation or otherwise harm our business, financial condition, and results of operations.
Our ability to execute successfully on our vision of a fully digitized and autonomous pharmacy depends on our ability to continue to develop and introduce new products or product enhancements, and integrate new products with existing offerings, in furtherance of this vision in a timely manner and on a cost-effective basis. If we fail to do so, we may be unable to achieve the vision of the autonomous pharmacy, we may not realize the anticipated benefits of our investments in support of this vision, and this could have a material adverse effect on our business, financial condition, and results of operations.
We operate in highly competitive markets, and we may be unable to compete successfully.
The markets in which we operate are intensely competitive. We expect continued and increased competition from current and future competitors, in the medication management automation solutions market and the medication adherence solutions market, many of which have significantly greater financial, technical, marketing, and other resources than we do.
The competitive challenges we face in the markets in which we operate include, but are not limited to, the following:
•current or future competitors may offer or have the ability to offer a broader range of solutions than us, develop alternative solutions that provide a better customer outcome or lower cost of operation, develop new features or capabilities for their products that could compete with ours, or devote greater resources to the development, promotion, and sale of their products than we do;
•competitive pressures could result in increased price competition for our products and services, fewer customer orders, and reduced gross margins;
•current and potential competitors may make strategic acquisitions or establish cooperative relationships among themselves or with third parties, including larger, more established healthcare supply companies, thereby increasing their ability to develop and offer a broader suite of products and services;
•our industry has recently experienced a significant degree of consolidation which could lead to competitors developing new business models that require us to adapt how we market, sell, or distribute our products;
•certain competitors have greater brand name recognition and a more extensive installed base than we do, and such advantages could be used to increase their market share;
•certain competitors may have existing business relationships with our current and potential customers, which may cause these customers to purchase competing products and services from these competitors; and
•our competitors may secure products and services from suppliers on more favorable terms or secure exclusive arrangements with suppliers or buyers that may impede the sales of our products and services.
If we fail to compete successfully against new entrants and established companies, it could materially adversely affect our business, financial condition, results of operations, and cash flows.
Any reduction in the demand for or adoption of our medication management automation solutions, medication packaging systems, or related services would reduce our revenues.
A significant portion of domestic and international healthcare facilities still use traditional approaches to medication and/or supply management in some form that do not include fully-automated methods of medication management. As a result, we must continuously educate existing and prospective customers about the advantages of our medication management automation solutions and medication packaging systems, which requires significant sales efforts and can cause longer sales cycles. Despite our significant efforts and extensive time commitments in sales to healthcare facilities, we cannot be assured that our efforts will result in sales to these customers.
20
In addition, our medication management automation solutions and our more complex automated packaging systems typically represent a sizable initial capital expenditure for healthcare organizations. Changes in the budgets of these organizations and the timing of spending under these budgets can have a significant effect on the demand for our medication management automation solutions, medication packaging systems, and related services. These budgets are often supported by cash flows that can be negatively affected by declining investment income and influenced by limited resources, increased operational and financing costs, macroeconomic conditions, and conflicting spending priorities among different departments. Any decrease in expenditures by healthcare facilities or increased financing costs (including as a result of the impacts of public health crises such as the ongoing COVID-19 pandemic) could decrease demand for our medication management automation solutions, medication packaging systems, and related services, and reduce our revenues.
Also, the continuing gradual transition to value-based reimbursement could shift more of the burden for financial risk onto healthcare provider organizations and could decrease utilization of healthcare per patient. Value-based reimbursement could also cause a shift in care from traditional venues, such as hospitals and clinics, to the home, and could impact our revenues.
We have incurred substantial debt, which could impair our flexibility and access to capital and adversely affect our financial position.
On November 15, 2019, we refinanced our existing senior secured credit facility pursuant to an amended and restated agreement with certain lenders, and Wells Fargo Bank, National Association, as administrative agent (as amended, the “A&R Credit Agreement”). The A&R Credit Agreement provides for a five-year revolving credit facility of $500.0 million and an uncommitted incremental loan facility of up to $250.0 million. As of December 31, 2020, there were no outstanding balances under the A&R Credit Agreement.
In addition, on September 25, 2020, we issued $575.0 million aggregate principal amount of 0.25% Convertible Senior Notes due 2025 (the “Notes”), pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between us and U.S. Bank National Association, as trustee. We used a portion of the proceeds from the issuance of the Notes to repay all outstanding borrowings under the revolving credit facility.
Our debt may limit our ability to borrow additional funds or use our existing cash flow for working capital, capital expenditures, acquisitions, or other general business purposes; limit our flexibility to plan for, or react to, changes in our business and industry; place us at a competitive disadvantage compared to our less leveraged competitors; and increase our vulnerability to the impact of adverse economic and industry conditions.
Our ability to make scheduled payments of the principal of, to pay interest on, or to refinance our indebtedness, including the Notes, depends on our future performance, which is subject to economic, financial, competitive, and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as borrowing more money, selling assets, restructuring debt, or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or do so on desirable terms, which could result in a default on our debt obligations. In addition, as more fully described below in the risk factor captioned "Covenants in our A&R Credit Agreement restrict our business and operations in many ways, and if we do not effectively manage our compliance with these covenants, our financial conditions and results of operations could be adversely affected," the A&R Credit Agreement includes customary restrictive covenants that impose operating and financial restrictions on us.
In addition, borrowings under the A&R Credit Agreement bear interest based on the London Interbank Offered Rate (“LIBOR”). LIBOR is the subject of recent national, international, and other regulatory guidance and proposals for reform. These reforms and other pressures may cause LIBOR to disappear entirely or to perform differently than in the past. The consequences of these developments cannot be entirely predicted, but could include an increase in the cost of borrowings under the A&R Credit Agreement and other financial contracts that we may enter into that are indexed to LIBOR.
The transition to selling more products which include a software as a service or solution as a service subscription presents a number of risks.
We currently offer our IV compounding robots, PakPlus-Rx service, and XR2 Automated Central Pharmacy System together with personnel to operate the equipment and expert services to optimize utilization through subscription agreements. We also offer Omnicell One (formerly Performance Center), EnlivenHealth Patient Engagement, 340B, and certain other products and solutions as a subscription and/or service. IVX Workflow also contains a payment stream as part of the license fees in its pricing structure. As we continue to execute on the autonomous pharmacy vision and grow subscription and cloud-based offerings, we may offer additional products and services on a subscription basis. The transition to selling more products and services on a subscription basis presents a number of risks. The shift requires an investment of technical, financial,
21
compliance, and sales resources, and we cannot guarantee that we will recoup the costs of such investments, or that these investments will improve our long-term growth and results of operations. If adoption of subscription solutions takes place faster than anticipated, the shift to subscription revenues will change the timing of revenue recognition and we may experience a temporary reduction of revenues. In addition, our cash flows may be impacted by the timing of invoicing of our subscription solutions. If any of our subscription solutions do not substantially meet customer requirements, contracts may be modified, causing a decline in revenue. Customers may elect not to renew their subscriptions upon expiration, or they may attempt to renegotiate pricing or other contractual terms at or prior to renewal on terms that are less favorable to us. In addition, since revenues are generally recognized over the term of the subscription, any decrease in customer purchases of our subscription-based products and services will not be fully reflected in our operating results until future periods, and it will also be more difficult for us to rapidly increase our revenues through additional subscription sales in any one period.
Delays in installations of our medication management automation solutions or our more complex medication packaging systems could harm our competitive position, results of operations, and financial condition.
The purchase of our medication management automation solutions or our more complex medication packaging systems is often part of a customer’s larger initiative to re-engineer its pharmacy and their distribution and materials management systems. The purchase of our systems often entails larger strategic purchases by customers that generally require more complex and stringent contractual requirements, involve a significant commitment of management attention and resources by prospective customers, and require the input and approval of many decision-makers. In addition, new product announcements can cause a delay in our customers’ decisions to purchase our products or convert pending orders for our older products to those of our newer products. For these and other reasons, the sales cycle associated with sales of our systems is often lengthy and subject to a number of delays over which we have little or no control. A delay in, or loss of, sales of these systems (including as a result of the impacts of public health crises such as the ongoing COVID-19 pandemic) could have an adverse effect upon our operating results and could harm our business.
In addition, and in part as a result of the complexities inherent in larger transactions, the time between the purchase and installation of our systems can generally range from two weeks to one year. Delays in installation can occur for reasons that are often outside of our control. We have also experienced fluctuations in our customer and transaction size mix, which makes our ability to forecast our product bookings more difficult. Because we recognize revenues for our medication management automation solutions and our more complex medication packaging systems only upon installation at a customer’s site, any delay in installation (including as a result of the impacts of public health crises such as the ongoing COVID-19 pandemic) will also cause a delay in the recognition of the revenues for those systems.
We are subject to laws, regulations, and other legal obligations related to privacy, data protection, and information security, and the costs of compliance with, and potential liability associated with, our actual or perceived failure to comply with such obligations could harm our business.
We receive, store, and process personal information and other data from and about customers, in addition to our employees and services providers. In addition, our customers use our solutions to obtain and store personal information, including personal health information. For example, our customers use our EnlivenHealth Patient Engagement platform to guide and track patient notes, interventions, and appointments, which involves the collection of personal health information of patients. Our handling of data is subject to a variety of laws and regulations by state, local, and foreign agencies, as well as contractual obligations and industry standards. Regulatory focus on data privacy and security concerns continues to increase globally, and laws and regulations concerning the collection, use, and disclosure of personal information are expanding and becoming more complex. In the United States, these include federal health information privacy laws (such as the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), discussed below), security breach notification laws, and consumer protection laws, as well as state laws addressing privacy and data security (such as the California Consumer Privacy Act of 2018 and the California Privacy Rights Act of 2020).
Internationally, various foreign jurisdictions in which we operate have established, or are developing, their own data privacy and security legal framework with which we or our customers must comply. In certain cases, these international laws and regulations are more restrictive than many regulations in the United States. For example, within the European Union, the General Data Protection Regulation (“GDPR”) imposes more stringent data protection requirements on U.S.-based companies, such as ours, which receive or process personal information from EU residents, and establishes greater penalties for non-compliance. Violations of the GDPR can result in penalties up to the greater of €20.0 million or 4% of global annual revenues, and may also lead to damages claims by data controllers and data subjects. Such penalties are in addition to any civil litigation claims by data controllers, customers, and data subjects.
In addition to government regulation, privacy advocates and industry groups may propose new and different self-regulatory standards that may legally or contractually apply to us, and other regulatory protections, such as Privacy Shield, may lose their applicability to our business as regulations and legal proceedings continue to evolve globally. We also expect that
22
there will continue to be new proposed laws, regulations, and industry standards relating to privacy, data protection, and information security, including in the United Kingdom, where we have business operations, as a result of Brexit. We cannot predict the scope of any such future laws, regulations, and standards that may be applicable to us, or how courts, agencies, or data protection authorities might interpret current ones. It is possible that these laws and other obligations may be interpreted and applied in a manner that is inconsistent with our existing data management practices or the functionality of our solutions.
Compliance with privacy, data protection, and information security laws, regulations, and other obligations is costly, and we may encounter difficulties, delays, or significant expenses in connection with our compliance, or because of our customers’ need to comply or our customers’ interpretation of their own legal requirements. In addition, any failure or perceived failure by us to comply with laws, regulations, policies, legal or contractual obligations, industry standards, or regulatory guidance relating to privacy or data security could result in governmental investigations and enforcement actions, litigation, fines and penalties, exposure to indemnification obligations or other liabilities, and adverse publicity, all of which could have an adverse effect on our reputation, as well as our business, financial condition, and results of operations. For example, as discussed further in the section entitled “Legal Proceedings” in Note 13, Commitments and Contingencies, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K, we are currently and have in the past been subject to certain class action lawsuits asserting, among other allegations, claims of violation of the Illinois Biometric Information Privacy Act.
If we experience a significant disruption in our information technology systems, breaches of data security, or cyber-attacks on our systems or solutions, our business could be adversely affected.
We rely on information technology (IT) systems to keep financial records and corporate records, communicate with staff and external parties, and operate other critical functions, including sales and manufacturing processes. We also utilize third-party cloud services in connection with our operations. Our IT systems and third-party cloud services are potentially vulnerable to disruption due to breakdown, malicious intrusion and computer viruses, public health crises such as the ongoing COVID-19 pandemic, other catastrophic events or environmental impact. Any prolonged system disruption in our IT systems or third-party cloud services could negatively impact the coordination of our sales, planning, and manufacturing activities, which could harm our business. In addition, in order to maximize our information technology efficiency, we have physically consolidated our primary corporate data and computer operations. This concentration, however, exposes us to a greater risk of disruption to our internal IT systems. Although we maintain offsite back-ups of our data, a disruption of operations at our facilities could materially disrupt our business if we are not capable of restoring function within an acceptable time frame.
Our IT systems and third-party cloud services are potentially vulnerable to cyber-attacks or other data security breaches, by employees or others, which may expose sensitive data to unauthorized persons. Such data security breaches could lead to the loss of trade secrets or other intellectual property, or to the public exposure of sensitive and confidential information of our employees, customers, suppliers, and others, any of which could have a material adverse effect on our business, financial condition, and results of operations. Moreover, a security breach or privacy violation that leads to disclosure or modification of, or prevents access to, patient information, including personally identifiable information or protected health information, could harm our reputation, result in litigation, compel us to comply with federal and/or state breach notification laws, subject us to mandatory corrective action, require us to verify the correctness of database contents, and otherwise subject us to liability under laws and regulations that protect personal data, resulting in increased costs or loss of revenues.
In addition, we sell certain solutions that receive, store, and process our customers’ data. For example, our Omnicell One (formerly Performance Center) solution combines a cloud-based predictive intelligence platform with expert services designed to monitor pharmacy operations and recommend opportunities to help improve efficiency, regulatory compliance, and patient outcomes. As another example, our EnlivenHealth Patient Engagement platform is a private cloud-based solution that supports improving patient adherence goals through a single web-based platform that hosts functionality to guide and track patient notes, interventions, and appointments. An effective attack on our solutions could disrupt the proper functioning of our solutions, allow unauthorized access to sensitive and confidential information of our customers (including protected health information), and disrupt our customers’ operations. Any of these events could cause our solutions to be perceived as having security vulnerabilities and reduce demand for our solutions, which could have a material adverse effect on our business, financial condition, and results of operations. These risks are likely to increase as we continue to grow our cloud-based offerings, including in support of the autonomous pharmacy vision, and as we receive, store, and process more of our customers’ data.
While we have implemented a number of security measures designed to protect our systems and data, including firewalls, antivirus and malware detection tools, patches, log monitors, routine back-ups, system audits, routine password modifications, and disaster recovery procedures, and have designed certain security features into our solutions, such measures may not be adequate or implemented properly to prevent or fully address the adverse effect of such events, and in some cases we may be unaware of an incident or its magnitude and effects as breaches and other inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm. Additionally, we use third-party cloud providers in
23
connection with certain of our cloud-based offerings or third-party providers to host our own data, in which case we rely on the processes, controls, and security such third parties have in place to protect the infrastructure. We also may acquire companies, products, services, and technologies and inherit such risks when we integrate these acquisitions within Omnicell.
Any failure to prevent such security breaches or privacy violations, or implement satisfactory remedial measures, could require us to expend significant resources to remediate any damage, disrupt our operations or the operations of our customers, damage our reputation, or expose us to a risk of financial loss, litigation, regulatory penalties, contractual indemnification obligations, or other liability.
We may fail to realize the potential benefits of acquired businesses, including the 340B Link Business, which could negatively affect our business, financial condition, and operating results.
We have in the past acquired businesses, and expect to continue to seek to acquire businesses, technologies, or products in the future. For example, we acquired Aesynt Incorporated ("Aesynt") and ateb, Inc. ("Ateb") in 2016, Dixie Drawl, LLC d/b/a InPharmics ("InPharmics") in 2017 and the 340B Link Business in October 2020. We cannot provide assurance that any acquisition or future transaction we complete will result in long-term benefits to us or our stockholders, or that we will be able to effectively integrate or manage the acquired businesses, including the 340B Link Business.
These transactions may involve significant challenges, uncertainties, and risks, including:
•difficulties in combining previously separate businesses into a single unit and the complexity of managing a more dispersed organization as sites are acquired;
•difficulties in right-sizing organizations and gaining synergies across acquired operations;
•complying with regulatory requirements, such as those of the FDA, that we were not previously subject to;
•failure to understand and compete effectively in markets in which we have limited previous experience;
•substantial costs and diversion of management’s attention when evaluating and negotiating such transactions and then integrating an acquired business, including any unforeseen delays and expenditures that may result;
•discovery, after completion of the acquisition, of liabilities assumed in acquisitions that are broader in scope and magnitude or are more difficult to manage than originally assumed;
•difficulties assimilating and retaining key personnel of an acquired business;
•failure to achieve anticipated benefits such as revenue enhancements and operational and cost efficiencies;
•difficulties in integrating newly-acquired products and solutions in our offerings, or inability or failure to expand product bookings and sales or effectively coordinate sales and marketing efforts of the combined company;
•inability to maintain business relationships with customers and suppliers of newly-acquired companies due to post-acquisition disruption; and
•inability or failure to successfully integrate financial reporting and information technology systems.
If we are not able to successfully integrate or manage the acquired businesses and their operations, or if there are delays in combining the businesses, the anticipated benefits of the acquisition may not be realized fully or at all or may take longer to realize than expected and our business, financial condition, and operating results may be negatively impacted.
If goodwill or other intangible assets that we recorded in connection with the Aesynt, Ateb, InPharmics, and 340B Link Business acquisitions, or other prior acquisitions, become impaired, we could be required to take significant charges against earnings.
In connection with the accounting for the Aesynt and Ateb acquisitions in 2016, the InPharmics acquisition in 2017, and the 340B Link Business acquisition in October 2020, we recorded a significant amount of goodwill and other intangible assets, and we maintain significant goodwill and other intangible assets relating to prior acquisitions, such as our acquisitions of MTS Medication Technologies, Inc., Avantec Healthcare Limited, and Mach4 Automatisierungstechnik GmbH. As of December 31, 2020, we had recorded approximately $666.0 million net, in goodwill and intangible assets, in connection with past acquisitions. Under U.S. generally accepted accounting principles, we must assess, at least annually and potentially more frequently, whether the value of goodwill and other indefinite-lived intangible assets has been impaired. Intangible assets subject to amortization will be assessed for impairment in the event of an impairment indicator. Any reduction or impairment of the value of goodwill or other intangible assets will result in a charge against earnings, which could materially adversely affect our results of operations and shareholders’ equity in future periods.
24
The healthcare industry is subject to legislative and regulatory changes, as well as financial constraints and consolidation, which could adversely affect the demand for our products and services.
The healthcare industry has faced, and will likely continue to face, significant financial constraints. U.S. government legislation and program rulemaking may cause customers to postpone purchases of our products due to reductions in federal healthcare program reimbursement rates and/or needed changes to their operations in order to meet the requirements of legislation or in anticipation of future rulemaking. Our automation solutions often involve a significant financial commitment from our customers and, as a result, our ability to grow our business is largely dependent on our customers’ capital and operating budgets. To the extent current or proposed legislation and program rules promote spending on other initiatives or healthcare providers’ spending declines or increases more slowly than we anticipate, demand for our products and services could decline.
Healthcare providers have consolidated to create larger healthcare delivery organizations in order to achieve economies of scale and/or greater market power. If this consolidation continues, it would increase the size of certain target customers, which could increase the cost, effort, and difficulty in selling our products to such customers, or could cause our existing or potential customers to begin utilizing our competitors’ products if such customers are acquired by healthcare providers that prefer our competitors’ products to ours. In addition, the resulting organizations could have greater bargaining power, which may lead to price erosion.
Government regulation of the healthcare industry could reduce demand for our products, or substantially increase the cost to produce our products.
The manufacture and sale of most of our current products are not regulated by the FDA, or the Drug Enforcement Administration (“DEA”). Through our acquisition of Aesynt, we have both Class I and Class II, 510(k) exempt medical devices which are subject to FDA regulation and require compliance with the FDA Quality System Regulation as well as medical device reporting. Additional products may be regulated in the future by the FDA, DEA, or other federal agencies due to future legislative and regulatory initiatives or reforms. Direct regulation of our business and products by the FDA, DEA, or other federal agencies could substantially increase the cost to produce our products and increase the time required to bring those products to market, reduce the demand for our products, and reduce our revenues. In addition, our customers include healthcare providers and facilities subject to regulation by the DEA, pharmacies subject to regulation by individual state boards of pharmacy and hospitals subject to accreditation by accrediting organizations approved by the Centers for Medicare & Medicaid Services, such as the Joint Commission, and the rules, regulations, and standards of such regulators and accrediting organizations. Any failure of our customers to comply with the applicable rules, regulations, and standards could reduce demand for our products and harm our competitive position, results of operations, and financial condition.
While we have implemented a Privacy and Use of Information Policy and adhere to established privacy principles, use of customer information guidelines, and related federal and state statutes, we cannot assure you that we will be in compliance with all federal and state healthcare information privacy and security laws that we are directly or indirectly subject to, including, without limitation, HIPAA. Under HIPAA, we are considered a “business associate” in relation to many of our customers that are covered entities, and, as such, most of these customers have required that we enter into written agreements governing the way we handle and safeguard certain patient health information we may encounter in providing our products and services, and may impose liability on us for failure to meet our contractual obligations. Further, pursuant to changes in HIPAA under the American Recovery and Reinvestment Act of 2009, we are covered under HIPAA similar to other covered entities and, in some cases, subject to the same civil and criminal penalties as a covered entity. A number of states and countries have also enacted privacy and security statutes and regulations that, in some cases, are more stringent than HIPAA and may also apply directly to us. If our past or present operations are found to violate any of these laws, we may be subject to fines, penalties, and other sanctions.
In addition, we cannot predict the potential impact of future privacy standards and other federal, state, and international privacy and security laws that may be enacted at any time on our customers or on Omnicell. These laws could restrict the ability of Omnicell and/or our customers to obtain, use, or disseminate patient information, which could reduce the demand for our products or force us to redesign our products in order to meet regulatory requirements.
Our international operations may subject us to additional risks that can adversely affect our operating results.
We currently have operations outside of the United States, including sales efforts centered in Canada, Europe, the Middle East, and the Asia-Pacific regions, and supply chain efforts in Asia. We intend to continue to expand our international operations, particularly in certain markets that we view as strategic, including the Middle East. Our international operations subject us to a variety of risks, including:
•our reliance on distributors for the sale of our medication management automation solutions outside the United States, Canada, the United Kingdom, France, and Germany;
25
•the difficulty of managing an organization operating in various countries;
•reduced protection for intellectual property rights in certain jurisdictions;
•the imposition of, or adverse changes in, international laws and regulations, including privacy and security, labor, import, export, trade, environmental standards, product compliance, tax, anti-bribery, and employment laws;
•fluctuations in currency exchange rates and difficulties in repatriating funds from certain countries;
•additional investment, coordination, and lead-time necessary to successfully interface our automation solutions with the existing information systems of our customers or potential customers outside of the United States;
•political unrest, terrorism, and other potential hostilities in areas in which we have facilities or operations; and
•epidemics, pandemics, or other major public health crises, such as the ongoing COVID-19 pandemic.
If we are unable to anticipate and address these risks properly, our business or operating results will be harmed.
Furthermore, changes in export or import regulation and other trade barriers and uncertainties may have an adverse effect on our business. For example, in recent years, the U.S. government advocated greater restrictions on trade generally and tariff increases on certain goods imported into the United States, particularly from China. We cannot predict what actions may ultimately be taken with respect to tariffs or trade relations between the United States and other countries (including China), what products may be subject to such actions, or what actions may be taken by the other countries in retaliation. The adoption and expansion of trade restrictions, the occurrence of a trade war, other governmental action related to tariffs or trade agreements or policies, or the related uncertainties, has the potential to adversely impact our supply chain and costs, which could, in turn, adversely affect our business, financial condition, and results of operations.
Covenants in our A&R Credit Agreement restrict our business and operations in many ways, and if we do not effectively manage our compliance with these covenants, our financial conditions and results of operations could be adversely affected.
The A&R Credit Agreement contains various customary covenants that limit our ability and/or our subsidiaries’ ability to, among other things, incur or assume liens or additional debt or provide guarantees in respect of obligations of other persons; issue redeemable preferred stock; pay dividends or distributions or redeem or repurchase capital stock; prepay, redeem, or repurchase certain debt; make loans, investments, acquisitions, and capital expenditures; enter into agreements that restrict distributions from our subsidiaries; sell assets and capital stock of our subsidiaries; enter into certain transactions with affiliates; and consolidate or merge with or into, or sell substantially all of our assets to, another person.
The A&R Credit Agreement also includes financial covenants requiring us (i) not to exceed a maximum consolidated secured net leverage ratio of 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020 and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter and (ii) to maintain a minimum interest coverage ratio of 3.00:1. Our ability to comply with these financial covenants may be affected by events beyond our control. Our failure to comply with any of the covenants under the A&R Credit Agreement could result in a default under the terms of the A&R Credit Agreement, which could permit the administrative agent or the lenders to declare all or part of any outstanding borrowings to be immediately due and payable, or to refuse to permit additional borrowings under the revolving credit facility, which could restrict our operations, particularly our ability to respond to changes in our business or to take specified actions to take advantage of certain business opportunities that may be presented to us. In addition, if we are unable to repay those amounts, the administrative agent and the lenders under the A&R Credit Agreement could proceed against the collateral granted to them to secure that debt, which would seriously harm our business.
Our success is dependent on our ability to recruit and retain skilled and motivated personnel.
Our success is highly dependent upon the continuing contributions of our key management, sales, technical, and engineering staff, and on our ability to attract, train, and retain highly-skilled and motivated personnel. As more of our products are installed in increasingly complex environments, greater technical expertise will be required. As our installed base of customers increases, we will require additional resources to meet increased demands on our customer service and support personnel. Furthermore, as we execute on the autonomous pharmacy vision and grow our cloud-based software as a service and solution as a service offerings, more specialized expertise will be required. Competition for such personnel can be intense, and we may not be successful in attracting and retaining qualified personnel. Competitors have in the past attempted, and may in the future attempt, to recruit our employees. In addition, since equity compensation is a key component of our employee compensation program, any failure to receive stockholder approval for future proposed increases to the number of shares reserved for issuance under our equity incentive plans could prevent us from granting equity compensation at competitive levels and make it more difficult to attract, retain, and motivate employees, including key employees of acquired businesses. Failure to attract and retain key personnel could harm our competitive position, results of operations, and financial condition.
26
Our failure to protect our intellectual property rights could negatively affect our ability to compete.
Our success depends in part on our ability to obtain patent protection for technology and processes, and our ability to preserve our trademarks, copyrights, and trade secrets. We have pursued patent protection in the United States and foreign jurisdictions for technology that we believe to be proprietary and for technology that offers us a potential competitive advantage for our products. We intend to continue to pursue such protection in the future. Our issued patents relate to various features of our medication management automation solutions and medication packaging systems. We cannot assure you that we will file any patent applications in the future and that any of our patent applications will result in issued patents, or that, if issued, such patents will provide significant protection for our technology and processes. Furthermore, we cannot assure you that others will not design around the patents we own. All of our system software is copyrighted and subject to the protection of applicable copyright laws. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our products or obtain and use information that we regard as proprietary, which could harm our competitive position.
If we are unable to maintain our relationships with group purchasing organizations (“GPOs”) or other similar organizations, we may have difficulty selling our products and services to customers represented by these organizations.
A number of GPOs have negotiated standard contracts for our products on behalf of their member healthcare organizations. Members of these GPOs may purchase under the terms of these contracts, which obligate us to pay the GPO a fee. We also have a Federal Supply Schedule contract with the Department of Veterans Affairs, allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease our products. These contracts enable us to more readily sell our products and services to customers represented by these organizations. Some of our contracts with these organizations are terminable at the convenience of either party. The loss of any of these relationships could impact the breadth of our customer base and could impair our ability to meet our revenue targets or increase our revenues. These organizations may not renew our contracts on similar terms, if at all, and they may choose to terminate our contracts before they expire, any of which could cause our revenues to decline.
If we are unable to meet the demands of, or maintain our relationships with, our institutional and retail pharmacy customers, our revenue from sales of medication packages and other consumables may decline.
Approximately 8% of our revenues during the year ended December 31, 2020 were generated from the sale of consumable medication packages, most of which are produced in our St. Petersburg, Florida facility on a continuous basis and are shipped out to fulfill the demands of our institutional and retail pharmacy customers domestically and abroad. The demands placed on institutional and retail pharmacies by their customers represent real time requirements of those customers. Our customer agreements for the sale of consumable medication packages are typically short-term in nature and typically do not impose volume commitments on the customer. If we are unable to supply quality packaging to our customers in a timely manner, they may use alternative methods of distributing medications to their customers, including consumable medication packaging sold by our competitors, and our revenues will decline. Any disruption in the production capabilities of our St. Petersburg facilities will adversely affect our ability to ship our consumable medication packages globally and would reduce our revenues.
In addition, the institutional pharmacy market consists of significant national suppliers of medications to non-acute care facilities, smaller regional suppliers, and very small local suppliers. If we are unable to maintain our relationships with the major institutional pharmacies we do business with, they may purchase consumable blister card components from alternative sources, or choose to use alternatives to blister cards for medication control, and our revenues would decline.
We depend on a limited number of suppliers for our products, and our business may suffer if we were required to change suppliers to obtain an adequate supply of components, equipment, and raw materials on a timely basis.
Although we generally use parts and components for our products with a high degree of modularity, certain components are presently available only from a single source or limited sources. We rely on a limited number of suppliers for the raw materials necessary to produce our consumable medication packages. While we have generally been able to obtain adequate supplies of all components and raw materials in a timely manner from existing sources, or where necessary, from alternative sources, we entered into relationships with new suppliers in connection with the launch of our XT Series products. We engage multiple single source third-party manufacturers to build several of our sub-assemblies. The risks associated with changing to alternative vendors, if necessary, for any of the numerous components used to manufacture our products could limit our ability to manufacture our products and harm our business. Due to our reliance on a few single source partners to build our hardware sub-assemblies and on a limited number of suppliers for the raw materials that are necessary in the production of our consumable medication packages, a reduction or interruption in supply from our partners or suppliers, or a significant increase in the price of one or more components could have an adverse impact on our business, results of operations, and financial condition. In certain circumstances, the failure of any of our suppliers or us to perform adequately could result in quality control issues affecting end users’ acceptance of our products, which could damage customer relationships and harm our business.
27
The United Kingdom’s withdrawal from the European Union (“Brexit”) could adversely affect us.
The United Kingdom (the “UK”) left the European Union (the “EU”) on January 31, 2020. The transition period provided for in the withdrawal agreement entered into by the UK and the EU ended on December 31, 2020 (the “Brexit Transition Period”). In December 2020, the UK and the EU agreed on a trade and cooperation agreement that will apply provisionally after the end of the transition period until it is ratified by the parties to the agreement. On December 31, 2020, the UK passed legislation giving effect to the trade and cooperation agreement, with the EU expected to formally adopt the agreement in early 2021. The trade and cooperation agreement covers the general objectives and framework of the relationship between the United Kingdom and the European Union, including as it relates to trade, transport, visas, judicial, law enforcement, and security matters, and provides for continued participation in community programs and mechanisms for dispute resolution. The effects of Brexit have been and are expected to continue to be far-reaching. Brexit and the perceptions as to its impact may adversely affect business activity and economic conditions in Europe and globally, continue to contribute to uncertainty regarding the regulation of data protection in the UK, disrupt the free movement of goods, services, and people between the UK and the EU, and lead to legal uncertainty and potentially divergent national laws and regulations for the UK. We are currently in the process of evaluating our own risks and uncertainty related to ascertaining what financial, trade, regulatory, and legal implications this new Brexit trade deal could have on our UK and European business operations. This uncertainty also includes the impact on our customers’ business operations and capital planning as well as the overall impact on the healthcare industry. We have not experienced any direct material financial impact since the 2016 referendum, and while we cannot predict its future implications, we do not currently expect Brexit and its related effects to have an adverse impact on our consolidated financial position and results of operations.
Our U.S. government lease agreements are subject to annual budget funding cycles and mandated unilateral changes, which may affect our ability to enter into such leases or to recognize revenues, and sell receivables based on these leases.
U.S. government customers that lease our equipment typically sign contracts with five-year payment terms that are subject to one-year government budget funding cycles. Further, the government has in certain circumstances mandated unilateral changes in its Federal Supply Services contract that could render our lease terms with the government less attractive. In our judgment and based on our history with these accounts, we believe these receivables are collectible. However, in the future, the failure of any of our U.S. government customers to receive their annual funding, or the government mandating changes to the Federal Supply Services contract could impair our ability to sell lease equipment to these customers or to sell our U.S. government receivables to third-party leasing companies. In addition, the ability to collect payments on unsold receivables could be impaired and may result in a write-down of our unsold receivables from U.S. government customers. The balance of our unsold leases to U.S. government customers was $23.8 million as of December 31, 2020.
If we fail to manage our inventory properly, our revenue, gross margin, and profitability could suffer.
Managing our inventory of components and finished products is a complex task. A number of factors, including, but not limited to, the need to maintain a significant inventory of certain components that are in short supply or that must be purchased in bulk to obtain favorable pricing, the general unpredictability of demand for specific products and customer requests for quick delivery schedules, may result in us maintaining large amounts of inventory. Other factors, including changes in market demand, customer requirements, and technology, may cause our inventory to become obsolete. Any excess or obsolete inventory could result in inventory write-downs, which in turn could harm our business and results of operations.
Intellectual property claims against us could harm our competitive position, results of operations, and financial condition.
We expect that developers of medication management automation solutions and medication packaging systems will be increasingly subject to infringement claims as the number of products and competitors in our industry grows and the functionality of products in different industry segments overlaps. In the future, third parties may claim that we have infringed upon, misappropriated, or otherwise violated their intellectual property rights with respect to current or future products. We do not carry special insurance that covers intellectual property infringement claims; however, such claims may be covered under our traditional insurance policies. These policies contain terms, conditions, and exclusions that make recovery for intellectual property infringement claims difficult to guarantee. Any infringement claims, with or without merit, could be time-consuming to defend, result in costly litigation, divert management’s attention and resources, cause product shipment delays or require us to enter into royalty or licensing agreements. These royalty or licensing agreements, if required, may not be available on terms acceptable to us, or at all, which could harm our competitive position, results of operations, and financial condition.
Product liability claims against us could harm our competitive position, results of operations, and financial condition.
Our products include medication management automation solutions and medication adherence products and services for healthcare systems and pharmacies. Despite the presence of healthcare and pharmacy professionals as intermediaries between our products and patients, if our products fail to provide accurate and timely information or operate as designed, customers, patients, or their family members could assert claims against us for product liability. Moreover, failure of health care
28
facility and pharmacy employees to use our products for their intended purposes could result in product liability claims against us. Litigation with respect to product liability claims, regardless of any outcome, could result in substantial cost to us, divert management’s attention from operations, and decrease market acceptance of our products. We possess a variety of insurance policies that include coverage for general commercial liability and technology errors and omissions liability. We attempt to mitigate these risks through contractual terms negotiated with our customers. However, these policies and protective contractual terms may not be adequate against product liability claims and in the past we have been subject to certain lawsuits asserting, among other allegations, claims of product liability. A successful claim brought against us, or any claim or product recall that results in negative publicity about us, could harm our competitive position, results of operations, and financial condition. Also, in the event that any of our products is defective, we may be required to recall or redesign those products.
We are dependent on technologies provided by third-party vendors, the loss of which could negatively and materially affect our ability to market, sell, or distribute our products.
Some of our products incorporate technologies owned by third parties that are licensed to us for use, modification, and distribution. For example, we entered into a reseller agreement with Kit Check, Inc. to offer Bluesight for Controlled Substances diversion prevention software to our customers. If we lose access to third-party technologies, such as our ability to distribute Bluesight for Controlled Substances, or we lose the ongoing rights to modify and distribute these technologies with our products, we will have to devote resources to independently develop, maintain, and support the technologies ourselves, pay increased license costs, or transition to another vendor. Any independent development, maintenance, or support of these technologies by us or the transition to alternative technologies could be costly, time consuming, and could delay our product releases and upgrade schedules. These factors could negatively and materially affect our ability to market, sell, or distribute our products.
Risks Related to Ownership of our Common Stock
The market price of our common stock may continue to be highly volatile.
Our common stock traded between $54.24 and $125.00 per share during the year ended December 31, 2020. The market price of our common stock has been and may continue to be highly volatile in response to various factors, many of which are beyond our control, including:
•actual or anticipated changes in our operating results, and whether our operating results or forecasts meet the expectations of securities analysts or investors;
•changes in the ratings of our common stock by securities analysts or changes in their earnings estimates;
•developments in our customer relationships;
•announcements by us or our competitors of technological innovations or new products;
•mergers, acquisitions, combinations, and other significant transactions involving us or our competitors;
•level of demand for our common stock, and actions by stockholders or short sellers of our common stock;
•epidemics, pandemics, or other major public health crises, such as the ongoing COVID-19 pandemic; or
•general economic and market conditions.
Furthermore, the stock market in general, and the market for technology companies in particular, have experienced extreme price and volume fluctuations. These broad market fluctuations may cause the market price of our common stock to decline irrespective of our performance. In addition, sales of substantial amounts of our common stock in the public market, or the perception that such sales could occur, could lower the market price of our common stock.
In addition, stockholders have initiated class action lawsuits against companies following periods of volatility in the market prices of these companies’ stock. For example, in July 2019, a putative class action lawsuit was filed against Omnicell and certain of our officers alleging that the defendants violated federal securities laws by making certain materially false and misleading statements. While this action was concluded in December 2019 following the lead plaintiff's voluntary dismissal as to all defendants, we may in the future be subject to other class action lawsuits, especially following periods of volatility in our stock price.
Our quarterly operating results may fluctuate and may cause our stock price to decline.
Our quarterly operating results may vary in the future. In addition to other factors discussed in this “Risk Factors” section, factors that may cause our quarterly operating results to fluctuate include, but are not limited to, the following:
29
•the size, product mix, and timing of orders for our products, and their installation and integration;
•our ability to successfully install our products on a timely basis and meet other contractual obligations necessary to recognize revenue;
•fluctuations in customer demand for our products, including due to changes in our customers’ budgets;
•our ability to control costs, including operating expenses, and continue cost reduction efforts;
•changes in pricing policies by us or our competitors;
•the number, timing, and significance of product enhancements and new product announcements by us or our competitors;
•the timing and significance of any acquisition or business development transactions that we may consider or negotiate and the revenues, costs, and earnings that may be associated with these transactions;
•the relative proportions of revenues we derive from products and services;
•our ability to generate cash from our accounts receivable on a timely basis;
•changes in, and our ability to successfully execute on, our business strategy; and
•macroeconomic and political conditions, including fluctuations in interest rates, tax increases, availability of credit markets, and trade and tariff actions.
Due to all of these factors, our quarterly revenues and operating results are difficult to predict and may fluctuate, which in turn may cause the market price of our stock to decline.
Raising additional capital may cause dilution to our existing stockholders, restrict our operations or harm our business, financial condition, and results of operations.
We may seek additional capital through a variety of means, including through private and public equity offerings and debt financings. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest will be diluted, and the terms may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take certain actions, such as incurring additional debt, making capital expenditures, entering into licensing arrangements, or declaring dividends. If we raise additional funds from third parties, we may have to relinquish valuable rights to our technologies, or grant licenses on terms that are not favorable to us.
If we are unable to raise additional funds through equity or debt financing when needed, our ability to market, sell, or distribute our products may be negatively impacted and could harm our business, financial condition, and results of operations.
Certain provisions in our charter documents and under Delaware law may delay or prevent an acquisition of us and limit our stockholders’ ability to obtain a favorable judicial forum for certain disputes.
Certain anti-takeover provisions of Delaware law and our charter documents may make a change in control of our Company more difficult, even if a change in control would be beneficial to the stockholders. Our certificate of incorporation provides that stockholders' meetings may only be called by our Board of Directors. Our bylaws provide that stockholders may not take action by written consent, and require that stockholders comply with advance notice procedures to nominate director candidates for election or to propose matters to be acted upon at a meeting of our stockholders. Delaware law also prohibits corporations from engaging in a business combination with any holders of 15% or more of their capital stock until the holder has held the stock for three years unless, among other possibilities, our Board of Directors approves the transaction. Our Board of Directors may use these provisions to prevent changes in the management and control of our Company. Also, under applicable Delaware law, our Board of Directors may adopt additional anti-takeover measures in the future including, without limitation, a stockholder rights plan.
In addition, our bylaws also establish the Delaware Court of Chancery as the exclusive forum for certain legal actions, including certain stockholder disputes, and establish the federal district courts of the United States of America as the exclusive forum for any action asserting a cause of action arising under the Securities Act of 1933, as amended, which exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or other employees.
30
Risk Factors Related to our Notes
Conversion of the Notes may dilute the ownership interest of our stockholders, depress the price of our common stock or, if the conditional conversion feature of the Notes is triggered, adversely affect our financial condition and operating results.
The Notes are convertible at the option of the holders on or after May 15, 2025 and, in certain circumstances, prior to May 15, 2025. The initial conversion rate for the Notes is 10.2751 shares of our common stock per $1,000 principal amount of Notes, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. The conversion of some or all of the Notes may dilute the ownership interests of our stockholders. Upon conversion of the Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock. If we elect to settle our conversion obligation in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling of our common stock by market participants because the conversion of the Notes could be used to satisfy short positions, or the anticipated conversion of the Notes into shares of our common stock could depress the price of our common stock.
Prior to May 15, 2025, if a circumstance that permits early conversion occurs, holders of the Notes will be entitled to convert their Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than paying cash in lieu of delivering any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.
The accounting method for convertible debt securities that may be settled in cash, such as the Notes, could have a material effect on our reported financial results.
Under Accounting Standards Codification ("ASC") 470-20, Debt with Conversion and Other Options, an entity must separately account for the liability and equity components of convertible debt instruments (such as the Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the Notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet at issuance, and the value of the equity component is treated as a discount for purposes of accounting for the debt component of the Notes. As a result, we are required to record a greater amount of non-cash interest expense as a result of the amortization of the discounted carrying value of the Notes to their face amount over the term of the Notes. We report larger net losses or lower net income in our financial results because ASC 470-20 requires interest to include both the amortization of the debt discount and the instrument’s coupon interest rate, which could adversely affect our reported or future financial results.
In addition, under certain circumstances, convertible debt instruments (such as the Notes) that may be settled entirely or partly in cash may be accounted for utilizing the treasury stock method for earnings per share purposes, the effect of which is that the shares issuable upon conversion of the Notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the Notes exceeds their principal amount. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot assure you that we will be eligible, or will continue to be eligible, to account for the Notes using the treasury stock method.
In August 2020, the FASB published an Accounting Standards Update ("ASU") 2020-06, which amends these accounting standards by reducing the number of accounting models for convertible instruments and limiting instances of separate accounting for the debt and equity or a derivative component of the convertible debt instruments. ASU 2020-06 also will no longer allow the use of the treasury stock method for convertible instruments and instead require application of the “if- converted” method. Under that method, diluted earnings per share will generally be calculated assuming that all of the Notes were converted solely into shares of common stock at the beginning of the reporting period, unless the result would be anti-dilutive, which could adversely affect our diluted earnings per share. These amendments will be effective for public companies for fiscal years beginning after December 15, 2021, with early adoption permitted, but no earlier than fiscal years beginning after December 15, 2020. The adoption of these amendments would have a material impact on our accounting for the Notes, which may impact our reported financial results.
The convertible note hedge and warrant transactions may affect the value of our common stock.
In connection with the offering of the Notes, we entered into convertible note hedge transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”). We also entered into warrant transactions with the option counterparties. The convertible note hedge transactions are expected generally to
31
reduce the potential dilution to our common stock upon any conversion of Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted Notes, as the case may be. However, the warrant transactions could separately have a dilutive effect on our common stock to the extent that the market price per share of our common stock exceeds the strike price of the warrants. In addition, the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions prior to the maturity of the Notes (and are likely to do so in connection with any conversion of the Notes or redemption or repurchase of the Notes), which could cause or avoid an increase or a decrease in the market price of our common stock.
We will also be subject to the risk that these option counterparties may default under the convertible note hedge transactions. Our exposure to the credit risk of the option counterparties will not be secured by any collateral. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under the convertible note hedge transactions with such option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.
General Risk Factors
Changes in our tax rates, exposure to additional tax liabilities, or the adoption of new tax legislation could adversely affect our business and financial condition.
We are subject to taxes in the United States and foreign jurisdictions. Our future effective tax rates could be affected by several factors, many of which are outside of our control, including: changes in the mix of earnings with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, changes in federal, state, and international tax laws or their interpretation, adjustments to income tax expense upon the finalization of tax returns, changes in tax attributes, or changes in accounting principles. We regularly assess the likelihood of adverse outcomes to determine the adequacy of our provision for taxes. We are also subject to examination of our income tax returns by the Internal Revenue Service and other tax authorities. There can be no assurance that the outcomes from these examinations will not materially adversely affect our financial condition and operating results. Forecasting our estimated annual effective tax rate is complex and subject to uncertainty, and there may be a material difference between the forecasted and the accrued effective tax rates, especially due to the volatility and uncertainty of global economic conditions resulting from the COVID-19 pandemic. Any increase in our effective tax rate would reduce our profitability.
Catastrophic events may disrupt our business and harm our operating results.
We rely on our network infrastructure, data centers, enterprise applications, and technology systems for the development, marketing, support, and sales of our products, and for the internal operation of our business. These systems are susceptible to disruption or failure in the event of a major earthquake, fire, flood, ice and snow storms, cyber-attack, terrorist attack, telecommunications failure, epidemic or pandemic (such as the ongoing COVID-19 pandemic), or other catastrophic event. Many of these systems are housed or supported in or around our corporate headquarters located in Northern California, near major earthquake faults, and where a significant portion of our research and development activities and other critical business operations take place. Other critical systems, including our manufacturing facilities for our consumable medication packages, are housed in St. Petersburg, Florida, in communities that have been subject to significant tropical storms. Disruptions to or the failure of any of these systems, and the resulting loss of critical data, which is not quickly recoverable by the effective execution of disaster recovery plans designed to reduce such disruption, could cause delays in our product development, prevent us from fulfilling our customers’ orders, and could severely affect our ability to conduct normal business operations, the result of which would adversely affect our operating results.
Failure to maintain effective internal control over financial reporting in accordance with Section 404 of the Sarbanes-Oxley Act of 2002 could cause our stock price to decline.
Section 404 of the Sarbanes-Oxley Act of 2002 and the related rules and regulations of the United States Securities and Exchange Commission (“SEC”) require annual management assessments of the effectiveness of our internal control over financial reporting, and a report by our independent registered public accounting firm attesting to the effectiveness of internal control. If we fail to maintain effective internal control over financial reporting, as such standards are modified, supplemented, or amended from time to time, we may not be able to ensure that we can conclude on an ongoing basis that we have effective internal control over financial reporting.
32
ITEM 1B.    UNRESOLVED STAFF COMMENTS
There are currently no unresolved issues with respect to any SEC staff’s written comments.
ITEM 2.    PROPERTIES
Our headquarters are located in a leased facility in Mountain View, California. The following is a list of our material leased facilities and their primary functions:
SiteMajor ActivityApproximate Square Footage
St. Petersburg, FloridaAdministration, marketing, research and development, sales, and manufacturing167,700
Cranberry Township, Pennsylvania Administration, marketing, research and development, sales, technical support, and training119,400
Warrendale, Pennsylvania Manufacturing and administration107,400
Mountain View, CaliforniaAdministration, marketing, and research and development 99,900
Raleigh, North CarolinaAdministration, sales, marketing, and research and development65,700
Irlam, United KingdomAdministration, sales, marketing, and distribution center61,000
Milpitas, CaliforniaManufacturing46,300
Waukegan, IllinoisTechnical services, support, training, and repair center38,500
Plano, TexasAdministration, sales, marketing, and research and development23,500
Bochum, GermanyAdministration, sales, marketing, distribution, and manufacturing center19,000
We also have smaller rented facilities in Strongsville, Ohio; Germany; France; Italy; the People’s Republic of China; the United Arab Emirates; Australia; and the United Kingdom.
We believe that these facilities are sufficient for our current operational needs and that suitable additional space will be available on commercially reasonable terms to accommodate expansion of our operations, if necessary.
For additional information regarding our obligations pursuant to operating leases, refer to Note 12, Lessee Leases, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K.
ITEM 3.    LEGAL PROCEEDINGS
Refer to the information set forth under “Legal Proceedings” in Note 13, Commitments and Contingencies, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
ITEM 4.    MINE SAFETY DISCLOSURES
Not applicable.
33
PART II
ITEM 5.    MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
Market for Our Common Stock
Our common stock is traded on the NASDAQ Global Select Market under the symbol “OMCL.”
Stockholders
There were 81 registered stockholders of record as of February 17, 2021. A substantially greater number of stockholders are beneficial holders, whose shares of record are held by banks, brokers, and other financial institutions.
Dividend Policy
We have never declared or paid any cash dividends on our common stock. We currently expect to retain any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends on our common stock in the foreseeable future.
Performance Graph
The following graph compares total stockholder returns for Omnicell’s common stock for the past five years to three indexes: the NASDAQ Composite Index, the NASDAQ Health Care Index, and the NASDAQ Health Services Index. The graph assumes $100 was invested in each of Omnicell’s common stock, the NASDAQ Composite Index, the NASDAQ Health Care Index, and the NASDAQ Health Services Index as of the market close on December 31, 2015. The total return for Omnicell’s common stock and for each index assumes the reinvestment of all dividends, although cash dividends have never been declared on Omnicell’s common stock, and is based on the returns of the component companies weighted according to their capitalization as of the end of each annual period.
The NASDAQ Composite Index tracks the aggregate price performance of equity securities traded on The NASDAQ Stock Market. The NASDAQ Health Care Index and NASDAQ Health Services Index tracks the aggregate price performance of health care and health services equity securities. Omnicell’s common stock is traded on The NASDAQ Global Select Market and is a component of both indexes. The stock price performance shown on the graph is based on historical results and is not necessarily indicative of future price performance.
34
COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN (1) (2)
Among Omnicell, Inc., the NASDAQ Composite Index, the NASDAQ Health Care Index, and
the NASDAQ Health Services Index
omcl-20201231_g7.jpg
_________________________________________________
(1)$100 invested on December 31, 2015 in stock or index, including reinvestment of dividends.
(2)This section is not deemed “soliciting material” or to be “filed” with the SEC and is not to be incorporated by reference into any filing of Omnicell, Inc. under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.
Year Ended December 31,
201520162017201820192020
Omnicell, Inc. $100.00 $109.07 $156.05 $197.04 $262.93 $386.16 
NASDAQ Composite100.00 108.87 141.13 137.12 187.44 271.64 
NASDAQ Health Care100.00 83.07 104.46 102.81 124.72 156.88 
NASDAQ Health Services100.00 78.91 90.89 108.53 151.08 242.42 
Stock Repurchase Program
On September 17, 2020, the Board of Directors authorized a one-time stock repurchase transaction providing for the repurchase of up to $75.0 million of our common stock in privately negotiated transactions concurrently with the issuance of the convertible senior notes, described in Note 10, Convertible Senior Notes, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K. In September 2020, we repurchased 749,300 shares of our common stock from purchasers of the convertible senior notes in the offering in privately negotiated transactions effected through one of the initial purchasers or its affiliate at an average price of $70.78 per share for an aggregate purchase price of approximately $53.0 million. There will be no further repurchases under this one-time authorization. There were no other repurchases of our outstanding common stock
35
during the year ended December 31, 2020, including under our current stock repurchase programs. Refer to Note 15, Stock Repurchase Program, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K for additional information.
Equity Offerings
For the year ended December 31, 2020, we did not sell any of our common stock under our Distribution Agreement. Refer to Note 16, Equity Offerings, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K for additional information.
ITEM 6.    SELECTED FINANCIAL DATA
The following selected consolidated financial data is derived from our Consolidated Financial Statements. This data should be read in conjunction with our Consolidated Financial Statements and related Notes included in this annual report on Form 10-K and with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations. Historical results may not be indicative of future results.
Year Ended December 31,
2020 (1)
20192018
2017 (2) (4)
2016 (3) (4)
(In thousands, except per share amounts)
Consolidated Statements of Operations Data
Total revenues$892,208 $897,027 $787,309 $712,714 $695,908 
Gross profit413,292 436,912 372,330 318,637 317,085 
Income from operations35,526 78,352 44,392 11,145 21,405 
Net income$32,194 $61,338 $37,729 $30,518 $9,756 
Net income per share:
Basic$0.76 $1.48 $0.96 $0.81 $0.27 
Diluted$0.74 $1.43 $0.93 $0.79 $0.26 
Shares Used in Per Share Calculations 
Basic42,583 41,462 39,242 37,483 36,156 
Diluted43,743 42,943 40,559 38,712 36,864 
December 31,
2020 (1)
20192018
2017 (2) (4)
2016 (3) (4)
(In thousands)
Consolidated Balance Sheet Data
Total assets$1,824,504 $1,240,810 $1,081,242 $1,016,362 $966,884 
Long-term debt (5)
467,201 50,000 135,417 194,917 245,731 
Total liabilities857,001 395,556 401,625 462,021 508,048 
Total stockholders’ equity$967,503 $845,254 $679,617 $554,341 $458,836 
__________________________________________________
(1)    Includes 340B Link Business financial results as of October 2020, the acquisition date.
(2)    Includes InPharmics financial results as of April 2017, the acquisition date.
(3)    Includes Aesynt and Ateb financial results as of the acquisition dates of January 2016 and December 2016, respectively.
(4)    As adjusted for full retrospective adoption of Accounting Standards Codification 606, Revenue from Contracts with Customers.
(5)    Consists of the revolving credit facility and convertible senior notes, net.
ITEM 7.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related Notes in this annual report on Form 10-K. This may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results and the timing of selected events could differ materially from those anticipated in these forward-looking statements as a result of several factors, including those set forth under
36
Item 1A “Risk Factors” and elsewhere in this annual report on Form 10-K. Unless otherwise stated, references in this report to particular years or quarters refer to our fiscal year and the associated quarters of those fiscal years.
We have elected to omit discussion of the earliest of the three years covered by the Consolidated Financial Statements presented. Such omitted discussion can be found under Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, located in our annual report on Form 10-K for the fiscal year ended December 31, 2019, filed with the SEC on February 26, 2020, for reference to discussion of the fiscal year ended December 31, 2018, the earliest of the three fiscal years presented.
OVERVIEW
Our Business
We are a leader in transforming the pharmacy care delivery model. Our medication management automation solutions and adherence tools empower healthcare systems and pharmacies to focus on clinical care, rather than administrative tasks. Our solutions support the vision of a fully autonomous pharmacy, a roadmap designed to improve operational efficiencies through a fully automated, medication management infrastructure. Our vision is to transform the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. We believe our connected devices, products, and solutions will help our customers harness the power of data and analytics, and deliver improved patient outcomes.
Over 7,000 facilities worldwide use our automation and analytics solutions which are designed to improve pharmacy workflows, increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. More than 50,000 institutional and retail pharmacies across North America and the United Kingdom leverage our innovative medication adherence and population health solutions to improve patient engagement, and adherence to prescriptions and vaccine scheduling, helping to reduce costly hospital readmissions. We sell our product and consumable solutions together with related service offerings. Revenues generated in the United States represented 89% of our total revenues for the year ended December 31, 2020.
Over the past several years, our business has expanded from a single-point solution to a platform of products and services that will help to further advance the vision of the autonomous pharmacy. This has resulted in larger deal sizes across multiple products, services, and implementations for customers and, we believe, more comprehensive, valuable, and enduring relationships.
We utilize product bookings as an indicator of the success of our business. Product bookings generally consist of all firm orders other than for technical services and other less significant items, as evidenced generally by a non-cancelable contract and purchase order for equipment and software products, and by a purchase order for consumables. The majority of connected devices and software license product bookings are installable within twelve months of booking, and are recorded as revenue upon customer acceptance of the installation or receipt of goods. Revenues from software-as-a-service (“SaaS”), subscription software, and technology-enabled services product bookings are recorded over the contractual term. Product bookings increased by 23%, from $813 million in 2019 to $1.002 billion in 2020, driven by the success of our growth strategies in our comprehensive platform and differentiated products, as well as expanding our customer portfolio.
In addition to product solution sales, we provide services to our customers. We provide installation planning and consulting as part of most product sales which is generally included in the initial price of the solution. To help assure the maximum availability of our systems, our customers typically purchase maintenance and support contracts in increments of one to five years. As a result of the growth of our installed base of customers and expanded service offerings, our service revenues have also grown.
37
The following table summarizes each revenue category:
Revenue Category
Revenue Type (1)
Income Statement Classification
Included in Product Bookings
Connected devices, software licenses, and other
High visibility/
Nonrecurring
Product
Yes (2)
Technical services
High visibility/
Recurring
Service
No
Consumables
High visibility/
Recurring
Product
Yes
SaaS, subscription software, and technology-enabled services
High visibility/
Recurring
Service
Yes
_________________________________________________
(1)     All revenue types are highly visible from long-term, sole-source agreements, backlog, or the recurring nature of the revenue stream.
(2)     Freight revenue and certain other insignificant revenue streams are not included in product bookings.
Our full-time headcount of approximately 2,860 on December 31, 2020, an increase of approximately 160 from December 31, 2019, reflects our efforts to grow our operations, while driving profitability and optimizing resource allocation.
Operating Segments
We manage our operations as a single segment for the purposes of assessing performance and making operating decisions. Our Chief Operating Decision Maker ("CODM") is our Chief Executive Officer. The CODM allocates resources and evaluates the performance of Omnicell at the consolidated level using information about our revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of Omnicell as one operating segment, which is the same as our reporting segment.
Strategy
We are committed to being the care provider’s most trusted partner and executing on the vision of the autonomous pharmacy by delivering automation, intelligence, and advanced services, powered by a single, cloud-based platform. We believe there are significant challenges in pharmacy practice including, but not limited to, medication errors, drug shortages, medication loss due to drug diversion, significant medication waste and expiration costs, a high level of manual steps in the medication management automation process, complexity around compliance requirements, high pharmacy employee turnover rates, hospitalizations from adverse drug events in outpatient settings, high variability in outcomes, and limited inventory visibility. We believe that these significant challenges in pharmacy practice drive the demand for increased digitization and virtualization, and that our solutions enable this and represent large opportunities in four market categories:
•Point of Care. As a market leader, we expect to continue expansion of this product category as customers increase use of our dispensing systems in more areas within their hospitals. In addition, we are early in the replacement, upgrade, and expansion cycle of our XT Series automated dispensing systems which we believe is a significant market opportunity and we expect to continue to focus on further penetrating markets through competitive conversions. We believe our current portfolio within the Point of Care market and new innovation and services will continue to drive improved outcomes and lower costs for our customers.
•Central Pharmacy. This market represents the beginning of the medication management process in acute care settings, and, we believe, the next big automation opportunity to replace manual and repetitive processes which are common in the pharmacy today. Manual processes are prone to significant errors, and products such as IVX Workflow, our IV sterile compounding solutions, and the XR2 Automated Central Pharmacy system automate these manual processes and are designed to reduce the risk of error for our healthcare partners. We believe new products and innovations, including Omnicell One, in the Central Pharmacy market create opportunities to replace prior generation Central Pharmacy robotics and carousels. The Central Pharmacy also represents an opportunity to provide technology-enabled services designed to reduce the administrative burden on the pharmacy and allow clinicians to operate at the top of their license.
•340B Software-Enabled Services. This market is targeted to covered entities participating in Section 340B of the Public Health Services Act. The act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients and results in a complex compliance environment. We believe that there are significant opportunities for health systems to improve participation benefits and maximize program savings through software-enabled services
38
and solutions. Our Omnicell 340B platform of technology-enabled services includes split billing software, contract pharmacy administration, specialty contract pharmacy administration, and drug discount access solutions.
•Retail, Institutional, and Payer. We believe the Retail, Institutional, and Payer market represents a large opportunity as the majority of drugs are distributed in the non-acute sector. New technology and updated state board regulations are leading to innovation at traditional retail providers, which, combined with the move to value-based care, we believe will incentivize the market to adopt solutions to help providers and payers engage patients in new ways that lower the total cost of care. We believe adoption of our EnlivenHealth (formerly Population Health Solutions) portfolio of software products and services, along with medication adherence packaging, will increase adherence performance rates, increase prescription volume for our customers, and reduce hospital and emergency room visits due to improved adherence. As retail pharmacies play an increasingly vital role in population health following the onset of the COVID-19 pandemic, EnlivenHealth has extended solutions to assist with vaccination programs, testing protocols, and patient engagement efforts. There are three main areas of focus:
◦CareScheduler is an exclusive digital solution that automates the scheduling, reporting, and patient outreach for administering the COVID-19 vaccine and other vaccines and testing procedures.
◦Medication Synchronization is an appointment-based solution that aligns a patient's medications to a single refill date, designed to improve medication adherence and reduce hospital readmissions.
◦Medication Therapy Management is a platform that offers intuitive workflow with high-level decision support for efficiently completing CMS-compliant Comprehensive Medication Reviews using pharmacy claims data.
We believe our technology, services, and solutions within these market categories position us well to address the needs of retail, acute, and post-acute pharmacy providers.
COVID-19 Update
Keeping in mind our role in the healthcare industry, we are continuing to closely monitor the COVID-19 pandemic. As a result of the COVID-19 pandemic, health systems have faced financial pressures which we believe led our customers to delay or defer purchasing decisions and/or implementation of our solutions during the first half of 2020. However, starting in the third quarter of 2020, we began to see our customers returning to pre-pandemic purchasing patterns consistent with long-term strategic investments. We believe that the challenges that our customers have faced during the COVID-19 pandemic, including the need for robust visibility throughout their pharmacy supply chains, have increased the strategic relevance of our products and services. Though we expect to continue to face challenges and opportunities brought on by the COVID-19 pandemic, we remain confident in the overall health of our business and in our ability to navigate through these unusual times.
Acquisitions
On October 1, 2020, we completed the acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC pursuant to the terms and conditions of the Equity Purchase Agreement, dated August 11, 2020, as amended, by and among the Company, PSGH, LLC, BW Apothecary Holdings, LLC, the sellers identified therein and the seller’s representative for total cash consideration of $225.0 million. The acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner. The results of the operations of the 340B Link Business have been included in our consolidated results of operations beginning October 1, 2020.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Our discussion and analysis of our financial condition and results of operations are based on our Consolidated Financial Statements, which have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The preparation of these financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of any contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. We regularly review our estimates and assumptions, which are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of certain assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates and assumptions. We believe the following critical accounting policies are affected by significant judgments and estimates used in the preparation of our Consolidated Financial Statements:
39
Revenue Recognition
We earn revenues from sales of our products and related services, which are sold in the healthcare industry, our principal market.
Prior to recognizing revenue, we identify the contract, performance obligations, and transaction price, and allocate the transaction price to the performance obligations. All identified contracts meet the following required criteria:
Parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of our contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order.
Entity can identify each party’s rights regarding the goods or services to be transferred. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following our standard business process and terms.
The entity can identify the payment terms for the goods or services to be transferred. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, our standard payment terms are net 30 day terms.
The contract has commercial substance (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). Our agreements are an exchange of cash for a combination of products and services which result in changes in the amount of our future cash flows.
It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. We perform a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected.
Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, we combine the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify our performance obligations, we consider all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, we consider an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of our sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services.
The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of our commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.
The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.
We recognize revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as we provide a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to our unsatisfied performance obligations are recorded as deferred revenues.
Revenues, contract assets, and contract liabilities are recorded net of associated taxes.
40
We often enter into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. Our change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.
In the normal course of business, we typically do not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. We establish provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to our Consolidated Financial Statements for any periods presented.
Lessor Leases
We determine if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price we charge for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, our products and services are not generally sold separately. We use an amount discounted from the list price as a best estimated selling price.
Sales-Type Leases
We enter into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. Our sales-type lease agreements do not contain any material residual value guarantees.
For sales-type leases, we recognize revenues for our hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. We recognize service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. We recognize interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.
We optimize cash flows by selling a majority of our non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. We have no obligation to the leasing company once the lease has been sold. Some of our sales-type leases, mostly those relating to U.S. government hospitals, are retained in-house.
Allowance for Credit Losses
We are exposed to credit losses primarily through sales of our products and services, as well as our sales-type leasing arrangements. We perform credit evaluations of our customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. We continue to monitor customers’ creditworthiness on an ongoing basis.
We maintain an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of our customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective (pool) basis by aggregating customer balances with similar risk characteristics. We also record a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to our financial position and results of operations.
Inventory
Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. We regularly monitor inventory quantities on hand and record write-downs for excess and obsolete inventories based on our estimate of demand for our products, potential obsolescence of
41
technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before we receive them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to us.
Software Development Costs
We capitalize certain software development costs in accordance with Accounting Standards Codification ("ASC") 985-20, Costs of Software to Be Sold, Leased, or Marketed, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. We establish technological feasibility when we complete a detail program design or a working model. We amortize development costs over the estimated lives of the related products, which is generally five years. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.
Lessee Leases
We determine if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of our lease contracts do not provide an implicit rate, we use our incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. We do not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. We elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.
Many of our operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that we operate. We review each of our lease options at a time required by the terms of the lease contract, and notify the lessor if we choose to exercise the lease renewal option. Until we are reasonably certain that we will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.
Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When we have made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.
Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (i.e. Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. 
Business Combinations
We use the acquisition method of accounting under the authoritative guidance on business combinations. Each acquired company’s operating results are included in our Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed.
Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements.
42
Goodwill and Acquired Intangible Assets
Goodwill
We review goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. We have one reporting unit, which is the same as our operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if we decide to bypass this option, we proceed to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of our reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, we will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.
To determine the reporting unit’s fair value under the quantitative approach, we use a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. We also consider our market capitalization on the date of the analysis to ensure the reasonableness of our reporting unit's fair value.
Intangible Assets
In connection with our acquisitions, we generally recognize assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from one to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.
We assess the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. Our cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of our intangible assets are subjective and are affected by changes to our business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of our assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on our operating results and financial condition.
Convertible Debt
We account for convertible debt and related transactions in accordance with ASC 470-20, Debt with Conversion and Other Options, ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. We evaluate convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.
Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance Sheets.
Valuation of Share-Based Compensation
We account for share-based compensation in accordance with ASC 718, Stock Compensation. We recognize compensation expense related to share-based compensation based on the grant date estimated fair value.
43
The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of our common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on our historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period.
The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period.
The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period.
Forfeiture rates are estimated based on our historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.
Accounting for Income Taxes
We record an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740, Income Taxes, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, we will incur a benefit or detriment on our income tax expense in the period of change. If we were to determine that all or part of the net deferred tax assets are not realizable in the future, we will record a valuation allowance that would be charged to earnings in the period such determination is made.
In accordance with ASC 740, we recognize the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on our financial condition and operating results.
Recently Issued Authoritative Guidance
Refer to Note 1, Organization and Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements in this annual report on Form 10-K for a description of recently issued accounting pronouncements, including the expected dates of adoption and estimated effects on our results of operations, financial position, and cash flows.
RESULTS OF OPERATIONS
Total Revenues
Year Ended December 31, Change in
20202019$%
(Dollars in thousands)
Product revenues$636,031 $659,602 $(23,571)(4)%
Percentage of total revenues71%74%
Services and other revenues256,177 237,425 18,752 8%
Percentage of total revenues29%26%
Total revenues$892,208 $897,027 $(4,819)(1)%
44
Product revenues represented 71% and 74% of total revenues for the years ended December 31, 2020 and 2019, respectively. Product revenues decreased by $23.6 million, primarily due to the impact of the COVID-19 pandemic as health systems were focusing resources on COVID-19 essential activities during the second and third quarters of 2020.
Services and other revenues represented 29% and 26% of total revenues for the years ended December 31, 2020 and 2019, respectively. Services and other revenues include revenues from technical services, SaaS, subscription software, and technology-enabled services, and other services. Services and other revenues increased by $18.8 million, primarily due to revenues of $10.2 million from the newly-acquired 340B Link Business, as well as continued growth in our installed customer base.
Our international sales represented 11% and 10% of total revenues for the years ended December 31, 2020 and 2019, respectively, and are expected to be affected by foreign currency exchange rate fluctuations. We are unable to predict the extent to which revenues in future periods will be impacted by changes in foreign currency exchange rates.
Our ability to continue to grow revenues is dependent on our ability to continue to obtain orders from customers, our ability to produce quality products and consumables to fulfill customer demand, the volume of installations we are able to complete, our ability to meet customer needs by providing a quality installation experience, and our flexibility in manpower allocations among customers to complete installations on a timely basis. The timing of our product revenues for equipment is primarily dependent on when our customers’ schedules allow for installations.
The effects of the COVID-19 pandemic have had an adverse impact on our revenues for the year ended December 31, 2020. During the first half of 2020, we experienced delays in implementations and lower product bookings compared to management’s expectations prior to the COVID-19 outbreak. Starting in the third quarter of 2020, we began to see our customers returning to pre-pandemic purchasing patterns consistent with long-term strategic investments. Future developments with respect to the COVID-19 pandemic remain uncertain and may impact future periods.
Cost of Revenues and Gross Profit
Cost of revenues is primarily comprised of three general categories: (i) standard product costs which account for the majority of the product cost of revenues that are provided to customers, and are inclusive of purchased material, labor to build the product and overhead costs associated with production; (ii) installation costs as we install our equipment at the customer site and include costs of the field installation personnel, including labor, travel expenses, and other expenses; and (iii) other costs, including variances in standard costs and overhead, scrap costs, rework, warranty, provisions for excess and obsolete inventory, and amortization of software development costs and intangibles.
Year Ended December 31,Change in
20202019$%
(Dollars in thousands)
Cost of revenues:
Cost of product revenues$354,004 $344,914 $9,090 3%
As a percentage of related revenues56%52%
Cost of services and other revenues124,912 115,201 9,711 8%
As a percentage of related revenues49%49%
Total cost of revenues$478,916 $460,115 $18,801 4%
As a percentage of total revenues54%51%
Gross profit$413,292 $436,912 $(23,620)(5)%
Gross margin46%49%
Cost of revenues for the year ended December 31, 2020 compared to the year ended December 31, 2019 increased by $18.8 million, of which $9.1 million was attributed to the increase in cost of product revenues and $9.7 million was attributed to the increase in cost of services and other revenues.
The increase in cost of product revenues is reflective of investments made to drive the customer experience and support expected annual revenue levels which were impacted by the COVID-19 pandemic. While product revenues decreased by $23.6 million for the year ended December 31, 2020 compared to the year ended December 31, 2019, cost of product revenues increased by $9.1 million primarily due to certain fixed costs, such as labor and overhead. The increase in cost of product revenues was also driven by an increase of $4.1 million of amortization of capitalized software development costs for
45
external use and an increase of $2.0 million in employee-related expenses related to restructuring initiatives, partially offset by cost-saving initiatives.
The increase in cost of services and other revenues was primarily driven by the increase in services and other revenues of $18.8 million, including incremental revenues from the newly-acquired 340B Link Business, for the year ended December 31, 2020 compared to the year ended December 31, 2019, as well as additional investments in our service business to support new product offerings, an increase of $1.4 million of amortization of capitalized software development costs for external use, and an increase of $0.6 million in employee-related expenses related to restructuring initiatives.
The overall decrease in gross margin primarily relates to lower revenues during the year ended December 31, 2020 due to the impact of the COVID-19 pandemic, employee-related expenses related to restructuring initiatives, and additional investments in our business, including increased amortization of capitalized software development costs for external use, partially offset by lower costs associated with cost-saving initiatives. Our gross profit for the year ended December 31, 2020 was $413.3 million compared to $436.9 million for the year ended December 31, 2019.
The effects of the COVID-19 pandemic have had an adverse impact on our cost of revenues and gross margins for the year ended December 31, 2020. Future developments with respect to the COVID-19 pandemic remain uncertain and may impact future periods.
Operating Expenses and Interest and Other Income (Expense), Net
Year Ended December 31,Change in
20202019$%
(Dollars in thousands)
Operating expenses:
Research and development$70,161 $68,644 $1,517 2%
As a percentage of total revenues8%8%
Selling, general, and administrative307,605 289,916 17,689 6%
As a percentage of total revenues34%32%
Total operating expenses$377,766 $358,560 $19,206 5%
As a percentage of total revenues42%40%
Interest and other income (expense), net$(6,177)$(4,419)$(1,758)40%
Research and Development. Research and development expenses increased by $1.5 million for the year ended December 31, 2020 compared to the year ended December 31, 2019. The increase was primarily attributed to an increase of $3.7 million in employee-related expenses related to restructuring initiatives as well as timing of projects, partially offset by lower consulting expenses and reduced travel costs.
Selling, General, and Administrative. Selling, general, and administrative expenses increased $17.7 million for the year ended December 31, 2020 compared to the year ended December 31, 2019, primarily due to overall growth of operations and increase in overall headcount. The increase was primarily due to an increase of $26.1 million in employee-related expenses primarily related to increased headcount, including the incremental headcount from the 340B Link Business acquisition, an increase of $3.7 million in employee-related expenses related to restructuring initiatives, and an increase of $6.5 million in acquisition-related expenses, partially offset by approximately $18.2 million of certain cost savings, including reduced travel, meetings, trade shows, and commission expenses.
In response to the COVID-19 pandemic, we implemented cost reduction initiatives in all aspects of our business and remain mindful of the uncertainty related to the pandemic.
Interest and Other Income (Expense), Net. Interest and other income (expense), net, changed by $1.8 million for the year ended December 31, 2020 compared to the year ended December 31, 2019, primarily driven by a $1.6 million increase in other expenses. The increase in other expenses is primarily due to $5.1 million of amortization of discount and interest expense incurred on our convertible senior notes issued in September 2020, partially offset by a decrease of $3.1 million in interest expense on our credit facilities as a result of a lower outstanding balances during the year ended December 31, 2020 as compared to the year ended December 31, 2019, as well as favorable foreign currency fluctuations during the period.
46
Provision for (Benefit from) Income Taxes
Year Ended December 31,Change in
20202019$%
(Dollars in thousands)
Provision for (benefit from) income taxes$(2,845)$12,595 $(15,440)(123)%
Effective tax rate on earnings(10)%17%
We recorded a benefit for income taxes of $2.8 million and had a negative effective tax rate of 10% for the year ended December 31, 2020 compared to an income tax expense of $12.6 million and an effective tax rate of 17% for the year ended December 31, 2019. The 2020 annual effective tax rate differed from the statutory tax rate of 21%, and resulted in a decrease as compared to the 2019 annual effective tax rate, primarily due to a favorable impact of the excess tax benefit from equity-based compensation and research and development credits, partially offset by an unfavorable impact from non-deductible compensation and equity charges.
Refer to Note 17, Income Taxes, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K for more details.
LIQUIDITY AND CAPITAL RESOURCES
We had cash and cash equivalents of $485.9 million at December 31, 2020, compared to $127.2 million at December 31, 2019. All of our cash and cash equivalents are invested in bank accounts and money market funds held in sweep accounts with major financial institutions.
Our cash position and working capital at December 31, 2020 and 2019 were as follows:
December 31,
20202019
(In thousands)
Cash$485,928 $127,210 
Working Capital$552,991 $246,242 
Our ratio of current assets to current liabilities was 3.0:1 at December 31, 2020 and 2.0:1 at December 31, 2019.
Sources of Cash
Credit Facilities
On January 5, 2016, we entered into a $400.0 million senior secured credit facility pursuant to a credit agreement with certain lenders, Wells Fargo Securities, LLC as sole lead arranger, and Wells Fargo Bank, National Association, as administrative agent (as subsequently amended as discussed below, the “Prior Credit Agreement”). The Prior Credit Agreement provided for a $200.0 million term loan facility (the “Prior Term Loan Facility”), and prior to the amendment discussed below, a $200.0 million revolving credit facility (the “Prior Revolving Credit Facility” and, together with the Prior Term Loan Facility, the “Prior Facilities”). In addition, the Prior Credit Agreement included a letter of credit sub-limit of up to $10.0 million and a swing line loan sub-limit of up to $10.0 million.
On April 11, 2017 and December 26, 2017, we entered into amendments to the Prior Credit Agreement. Under these amendments, the Prior Revolving Credit Facility was increased from $200.0 million to $315.0 million and certain other modifications were made.
On November 15, 2019, we refinanced the Prior Credit Agreement and entered into an Amended and Restated Credit Agreement (as subsequently amended, as discussed below, the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement replaced the Prior Credit Agreement and provides for (a) a five-year revolving credit facility of $500.0 million (the “Current Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million. In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. On November 15, 2019, the $80.0 million outstanding term loan balance under the Prior Facilities was transferred to the Current Revolving Credit Facility.
47
On September 22, 2020, the parties entered into an amendment (the “Amendment”) to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions described below, expand our flexibility to repurchase our common stock and make other restricted payments and replace the total net leverage covenant with a new secured net leverage covenant that requires us to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter.
As of December 31, 2020, there was no outstanding balance for the Current Revolving Credit Facility and we were in full compliance with all covenants. Refer to Note 9, Debt and Credit Agreements, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K. We expect to use future loans under the Current Revolving Credit Facility, if any, for working capital, potential acquisitions, and other general corporate purposes.
Convertible Senior Notes
On September 25, 2020, we completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. We received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted. Refer to Note 10, Convertible Senior Notes, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
We used approximately $49.3 million of the net proceeds from the offering to pay the cost of the convertible note hedge transactions (partially offset by proceeds to the Company from the sale of the warrant transactions), approximately $53.0 million of the net proceeds to repurchase shares of our common stock from purchasers of the Notes, $150.0 million of the net proceeds to pay down outstanding borrowings under the Current Revolving Credit Facility, and $225.0 million for the acquisition of the 340B Link Business. We intend to use the remainder of the net proceeds from this offering for working capital and other general corporate purposes, which may include potential acquisitions, strategic transactions, and potential future repurchases of our common stock.
Distribution Agreement
On November 3, 2017, we entered into a Distribution Agreement (the “Distribution Agreement”) with J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, and HSBC Securities (USA) Inc., as our sales agents, pursuant to which we may offer and sell from time to time through the sales agents up to $125.0 million maximum aggregate offering price of our common stock. Sales of the common stock pursuant to the Distribution Agreement may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the Nasdaq Stock Market, or sales made to or through a market maker other than on an exchange. The registration statement under which the shares that could have been sold pursuant to the Distribution Agreement expired on November 3, 2020 and, accordingly, no additional sales will be made pursuant to the Distribution Agreement.
For the year ended December 31, 2019, we received gross proceeds of $38.5 million from sales of our common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 460,000 shares of our common stock at an average price of approximately $83.81 per share.
For the year ended December 31, 2020, we did not sell any of our common stock under the Distribution Agreement.
Uses of Cash
Our future uses of cash are expected to be primarily for working capital, capital expenditures, and other contractual obligations. We also expect a continued use of cash for potential acquisitions and acquisition-related activities, as well as repurchases of our common stock.
Our stock repurchase programs have a total of $54.9 million remaining for future repurchases as of December 31, 2020, which may result in additional use of cash. Refer to Note 15, Stock Repurchase Program, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K. In September 2020, we repurchased 749,300 shares of our common stock from purchasers of the Notes in the offering in privately negotiated transactions effected through one of the initial purchasers or its affiliate at an average price of $70.78 per share for an aggregate purchase price of approximately $53.0 million. The repurchases were made concurrently with the issuance of the Notes. The repurchases were separately authorized by the Board of Directors, and did not impact the total remaining for future purchases under the previously authorized stock purchase programs. There were no stock repurchases during the years ended December 31, 2020 and 2019
48
including under our stock repurchase programs, other than the separately-authorized one-time stock repurchase concurrent with the offering of the Notes in September 2020.
Based on our current business plan and product backlog, we believe that our existing cash and cash equivalents, our anticipated cash flows from operations, cash generated from the exercise of employee stock options and purchases under our employee stock purchase plan, along with the availability of funds under the Current Revolving Credit Facility will be sufficient to meet our cash needs for working capital, capital expenditures, potential acquisitions, and other contractual obligations for at least the next twelve months. For periods beyond the next twelve months, we also anticipate that our net operating cash flows plus existing balances of cash and cash equivalents will suffice to fund the continued growth of our business.
We believe that our current financial position and resources will allow us to manage the anticipated impact of the COVID-19 pandemic on our business for the foreseeable future, including any potential changes in timing of revenue recognition or potential extensions in customer payments. However, the future impact of COVID-19 cannot be predicted with certainty and may increase our borrowing costs and other costs of capital and otherwise adversely affect our business, results of operations, financial condition, and liquidity.
Cash Flows
The following table summarizes, for the periods indicated, selected items in our Consolidated Statements of Cash Flows:
Year Ended December 31,
20202019
(In thousands)
Net cash provided by (used in):
Operating activities$185,870 $145,008 
Investing activities(279,866)(61,664)
Financing activities456,269 (23,479)
Effect of exchange rate changes on cash and cash equivalents437 153 
Net increase in cash and cash equivalents$362,710 $60,018 
Operating Activities
We expect cash from our operating activities to fluctuate in future periods as a result of a number of factors, including the timing of our billings and collections, our operating results, and the timing of other liability payments.
Net cash provided by operating activities was $185.9 million for 2020, primarily consisting of net income of $32.2 million adjusted for non-cash items of $116.4 million and changes in assets and liabilities of $37.3 million. The non-cash items primarily consisted of depreciation and amortization expense of $61.1 million, share-based compensation expense of $44.7 million, amortization of operating lease right-of-use assets of $10.5 million, amortization of debt issuance costs of $1.6 million, amortization of discount on convertible senior notes of $4.8 million, and a change in deferred income taxes of $6.5 million. Changes in assets and liabilities include cash inflows from (i) a decrease in accounts receivable and unbilled receivables of $36.8 million primarily due to higher collections in the fourth quarter of 2020, (ii) a decrease in inventories of $12.4 million primarily due to timing of shipments and a focus on supply chain efficiencies, (iii) an increase in accrued compensation of $11.6 million primarily due to an increase in accrued commissions, as well as timing of payroll, (iv) an increase in deferred revenues of $7.6 million primarily due to the timing of shipments in order to meet customers’ implementation schedules and recognition of revenues for products requiring installation, (v) an increase in other long-term liabilities of $7.5 million primarily due to the deferral of certain payroll taxes related to the CARES Act, and (vi) an increase in accrued liabilities of $4.4 million. These cash inflows were partially offset by (i) a decrease in operating lease liabilities of $9.5 million, (ii) an increase in prepaid commissions of $8.1 million primarily due to an increase in bookings, (iii) an increase in other long-term assets of $7.7 million primarily due to an increase in unbilled receivables, (iv) an increase in other current assets of $6.4 million, (v) a decrease in accounts payables of $6.3 million primarily due to an overall decrease in spending, as well as timing of payments, (vi) an increase in investment in sales-type leases of $2.9 million, and (vii) an increase in prepaid expenses of $2.1 million.
Net cash provided by operating activities was $145.0 million for 2019, primarily consisting of net income of $61.3 million adjusted for non-cash items of $99.5 million offset by changes in assets and liabilities of $15.8 million. The non-cash items primarily consisted of depreciation and amortization expense of $53.6 million, share-based compensation expense of $34.0 million, amortization of operating lease right-of-use assets of $10.6 million, amortization of debt issuance costs of
49
$2.2 million, and a change in deferred income taxes of $1.3 million. Changes in assets and liabilities include cash outflows from (i) an increase in accounts receivable and unbilled receivables of $21.5 million due to increased billings and the timing of billings and collections, (ii) a decrease in operating lease liabilities of $10.0 million, (iii) an increase in inventories of $8.1 million for inventory buildup in support of forecasted sales, (iv) an increase in investment in sales-type leases of $3.7 million, (v) an increase in prepaid commissions of $2.7 million, and (vi) an increase in other current assets of $2.0 million. These cash outflows were partially offset by (i) an increase in accounts payables of $7.9 million due to increased spending with vendors and increased consulting costs, (ii) an increase in other long-term liabilities of $6.0 million, (iii) an increase in deferred revenues of $5.4 million, (iv) a decrease in other long-term assets of $4.5 million, (v) an increase in accrued liabilities of $3.0 million, (vi) a decrease in prepaid expenses of $2.9 million, and (vii) an increase in accrued compensation of $2.5 million.
Investing Activities
Net cash used in investing activities was $279.9 million for 2020, which consisted of $225.0 million consideration paid for the acquisition of the 340B Link Business, capital expenditures of $22.8 million for property and equipment, and $32.0 million for costs of software development for external use.
Net cash used in investing activities was $61.7 million for 2019, which consisted of capital expenditures of $15.9 million for property and equipment, and $45.8 million for costs of software development for external use.
Financing Activities
Net cash provided by financing activities was $456.3 million for 2020, primarily due to proceeds of $559.7 million from the issuance of the Notes, net of issuance costs, proceeds of approximately $51.3 million from the sale of warrants in connection with the issuance of the Notes, $150.0 million of proceeds under the Current Revolving Credit Facility, $54.3 million in proceeds from employee stock option exercises and employee stock plan purchases, and a net increase in the customer funds balances of $4.0 million, partially offset by repayments of $200.0 million under the Current Revolving Credit Facility, $100.6 million for the purchase of the convertible note hedge in connection with the issuance of the Notes, $53.0 million for repurchases of our stock, $8.7 million in employees’ taxes paid related to restricted stock unit vesting, and payments for debt issuance costs related to the Current Revolving Credit Facility of $0.6 million.
Net cash used in financing activities was $23.5 million for 2019, primarily due to the repayment of $90.0 million of the Prior Facilities and the Current Revolving Credit Facility, $9.7 million in employees’ taxes paid related to restricted stock unit vesting, and payments of debt issuance costs of $2.3 million, partially offset by $40.7 million in proceeds from employee stock option exercises and employee stock plan purchases, and $37.8 million proceeds from sales of our common stock under the Distribution Agreement.
50
Contractual Obligations
Contractual obligations as of December 31, 2020 were as follows:
Payments Due by Period
Total20212022 - 20232024 - 20252026 and thereafter
(In thousands)
Operating leases (1)
$72,532 $15,290 $24,327 $15,493 $17,422 
Purchase obligations (2)
72,751 69,893 2,338 479 41 
Convertible senior notes (3)
582,148 1,398 2,875 577,875 — 
Total (4)
$727,431 $86,581 $29,540 $593,847 $17,463 
_________________________________________________
(1)Commitments under operating leases relate primarily to leased office buildings, data centers, office equipment, and vehicles. Refer to Note 12, Lessee Leases, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
(2)We purchase components from a variety of suppliers and use contract manufacturers to provide manufacturing services for our products. During the normal course of business, we issue purchase orders with estimates of our requirements several months ahead of the delivery dates. These amounts are associated with agreements that are enforceable and legally binding. The amounts under such contracts are included in the table above because we believe that cancellation of these contracts is unlikely and we expect to make future cash payments according to the contract terms or in similar amounts for similar materials.
(3)We issued convertible senior notes in September 2020 that are due in September 2025. The obligations presented above include both principal and interest for these notes. Although these notes mature in 2025, they may be converted into cash and shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity can result in repayment of the principal amounts sooner than the scheduled repayment as indicated in the table above. Refer to Note 10, Convertible Senior Notes, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
(4)Refer to Note 13, Commitments and Contingencies, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
Off-Balance Sheet Arrangements
As of December 31, 2020, we had no off-balance sheet arrangements as defined under Regulation S-K 303(a)(4) of the Exchange Act and the instructions thereto.
ITEM 7A.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to market risks related to fluctuations in foreign currency exchange rates and interest rates.
Foreign Currency Exchange Risk
We operate in foreign countries which expose us to market risk associated with foreign currency exchange rate fluctuations between the U.S. dollar and various foreign currencies, the most significant of which are the British Pound and the Euro. In order to manage foreign currency risk, at times we enter into foreign exchange forward contracts to mitigate risks associated with changes in spot exchange rates of mainly non-functional currency denominated assets or liabilities of our foreign subsidiaries. In general, the market risk related to these contracts is offset by corresponding gains and losses on the hedged transactions. By working only with major banks and closely monitoring current market conditions, we seek to limit the risk that counterparties to these contracts may be unable to perform. We do not enter into derivative contracts for trading purposes. As of December 31, 2020, we did not have any outstanding foreign exchange forward contracts.
Interest Rate Fluctuation Risk
We are exposed to interest rate risk through our borrowing activities. As of December 31, 2020, there was no outstanding balance under the A&R Credit Agreement, and the net carrying amount under our convertible senior notes was $467.2 million. Although our convertible senior notes are based on a fixed rate, changes in interest rates could impact the fair value of such notes. As of December 31, 2020, the fair market value of our convertible senior notes was $782.3 million. Refer to Note 10, Convertible Senior Notes, of the Notes to Consolidated Financial Statements included in this annual report on Form 10-K.
We have used interest rate swap agreements to protect against adverse fluctuations in interest rates by reducing our exposure to variability in cash flows relating to interest payments on a portion of our outstanding debt. Our interest rate swaps, which were designated as cash flow hedges, involved the receipt of variable amounts from counterparties in exchange for us
51
making fixed-rate payments over the life of the agreements. We do not hold or issue any derivative financial instruments for speculative trading purposes. As of December 31, 2020, we did not have any outstanding interest rate swap agreements. Our interest rate swap agreement matured during the second quarter of 2019.
ITEM 8.    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
The following tables presenting our unaudited quarterly results of operations should be read in conjunction with the Consolidated Financial Statements and related Notes included in Part IV, Item 15 of this annual report on Form 10-K and are incorporated by reference into this Item 8. We have prepared the unaudited information on the same basis as our audited Consolidated Financial Statements. Our operating results for any quarter are not necessarily indicative of results for any future quarters or for a full year.
SUPPLEMENTARY CONSOLIDATED FINANCIAL DATA (UNAUDITED)
Quarter Ended
December 31, 2020September 30, 2020June 30, 2020March 31, 2020
(In thousands, except per share data)
2020 Consolidated Statements of Operations Data
Total revenues$249,202 $213,699 $199,621 $229,686 
Gross profit123,654 96,791 83,225 109,622 
Income (loss) from operations20,214 10,152 (6,991)12,151 
Net income (loss)$16,377 $8,805 $(4,299)$11,311 
Net income (loss) per share:
Basic $0.39 $0.21 $(0.10)$0.27 
Diluted$0.37 $0.20 $(0.10)$0.26 
Quarter Ended
December 31, 2019September 30, 2019June 30, 2019March 31, 2019
(In thousands, except per share data)
2019 Consolidated Statements of Operations Data
Total revenues$248,292 $228,805 $217,413 $202,517 
Gross profit123,603 112,147 104,045 97,117 
Income from operations22,182 24,646 18,763 12,761 
Net income$22,095 $19,983 $15,976 $3,284 
Net income per share:
Basic $0.53 $0.48 $0.39 $0.08 
Diluted$0.51 $0.46 $0.37 $0.08 
ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
ITEM 9A.    CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) or 15d-15(e) under the Exchange Act) as of the end of the period covered by this annual report on Form 10-K. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.
52
Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2020 to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Our internal control system is designed to provide reasonable assurance regarding the preparation and fair presentation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles. All internal control systems, no matter how well designed, have inherent limitations and can provide only reasonable assurance that the objectives of the internal control system are met.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting as of December 31, 2020 using the criteria for effective internal control over financial reporting as described in “Internal Control—Integrated Framework,” issued by the Committee of Sponsoring Organization of the Treadway Commission (2013 framework) (the COSO Criteria). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2020.
Deloitte & Touche LLP, an independent registered public accounting firm, has issued its attestation report on our internal control over financial reporting as of December 31, 2020, which is included in Part IV, Item 15 of this annual report on Form 10-K.
Changes in Internal Control over Financial Reporting
There have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the year ended December 31, 2020.
ITEM 9B.    OTHER INFORMATION
None.
53
PART III
Certain information required by Part III is omitted from this annual report on Form 10-K because the registrant will file with the United States Securities and Exchange Commission a definitive proxy statement pursuant to Regulation 14A in connection with the solicitation of proxies for Omnicell’s Annual Meeting of Stockholders expected to be held in May 2021 (the “Proxy Statement”) not later than 120 days after the end of the fiscal year covered by this annual report on Form 10-K, and certain information included therein is incorporated herein by reference.
ITEM 10.    DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by this Item with respect to directors and executive officers may be found under the heading “Information About Our Executive Officers” in Part I, Item 1 of this annual report on Form 10-K, and in the sections entitled “Board and Corporate Governance Matters—Election of Directors” and “Board and Corporate Governance Matters—Information about our Directors and Nominees” appearing in the Proxy Statement. Such information is incorporated herein by reference.
The information required by this Item with respect to our audit committee and audit committee financial expert may be found in the section entitled “Board and Corporate Governance Matters—Information Regarding Committees of the Board of Directors—Audit Committee” appearing in the Proxy Statement. Such information is incorporated herein by reference.
The information required by this Item with respect to compliance with Section 16(a) of the Securities Exchange Act of 1934 may be found in the sections entitled “Delinquent Section 16(a) Reports” appearing in the Proxy Statement. Such information is incorporated herein by reference.
Our written Code of Conduct applies to all of our directors and employees, including executive officers, including without limitation our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The Code of Conduct is available on our website at www.omnicell.com under the hyperlink titled “Corporate Governance.” Changes to or waivers of the Code of Conduct will be disclosed on the same website. We intend to satisfy the disclosure requirement under Item 5.05 of Form 8-K regarding any amendment to, or waiver of, any provision of the Code of Conduct by disclosing such information on the same website.
ITEM 11.    EXECUTIVE COMPENSATION
The information required by this Item with respect to director and executive officer compensation is incorporated by reference to the sections of our Proxy Statement entitled “Executive Compensation” and “Board and Corporate Governance Matters—Director Compensation.”
The information required by this Item with respect to Compensation Committee interlocks and insider participation is incorporated herein by reference to the section of our Proxy Statement entitled “Board and Corporate Governance Matters—Information Regarding Committees of the Board of Directors—Compensation Committee—Compensation Committee Interlocks and Insider Participation.”
The information required by this Item with respect to our Compensation Committee’s review and discussion of the Compensation Discussion and Analysis included in the Proxy Statement is incorporated herein by reference to the section of our Proxy Statement entitled “Executive Compensation—Compensation Committee Report.”
ITEM 12.    SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
The information required by this Item with respect to security ownership of certain beneficial owners and management is incorporated herein by reference to the section of our Proxy Statement entitled “Stock Ownership—Security Ownership of Certain Beneficial Owners and Management.”
The information required by this Item with respect to securities authorized for issuance under our equity compensation plans is incorporated herein by reference to the section of our Proxy Statement entitled “Equity Plan Information—Equity Compensation Plan Information.”
ITEM 13.    CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
The information required by this Item with respect to related party transactions is incorporated herein by reference to the section of our Proxy Statement entitled “Board and Corporate Governance Matters—Certain Relationships and Related Transactions.”
54
The information required by this Item with respect to director independence is incorporated herein by reference to the section of our Proxy Statement entitled “Board and Corporate Governance Matters—Independence of the Board of Directors.”
ITEM 14.    PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is incorporated herein by reference to the section of our Proxy Statement entitled “Audit Matters—Ratification of Selection of Independent Registered Public Accounting Firm—Principal Accountant Fees and Services.”
55
PART IV
ITEM 15.    EXHIBITS AND FINANCIAL STATEMENT SCHEDULE
The following documents are included as part of this annual report on Form 10-K:
(1)    Consolidated Financial Statements:
(2)    Exhibits: The information required by this item is set forth on the exhibit index which precedes the signature page of this report.
ITEM 16.    FORM 10-K SUMMARY
None.
56
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Omnicell, Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Omnicell, Inc. and subsidiaries (the "Company") as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive income, stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2020, and the related notes and the schedule listed in the Index at Item 15 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 24, 2021, expressed an unqualified opinion on the Company's internal control over financial reporting.
Change in Accounting Principle
Effective January 1, 2019, the Company changed its method of accounting for leases due to the adoption of ASC Topic 842, Leases.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Inventory Valuation - Refer to Note 1 to the financial statements
Critical Audit Matter Description
The Company records write-downs for excess and slow-moving inventory based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These estimates require management judgment and are impacted by market and economic conditions, technology changes, and new product introductions. The Company's consolidated inventory balance is $96.3 million as of December 31, 2020.
We identified the inventory valuation as a critical audit matter because of the assumptions and judgments made by management to estimate the excess and slow-moving inventory, especially considering the presence of various inventory types and evolving product life cycles, which includes new product development. The analysis of inventory valuation required a high degree of auditor judgment when performing audit procedures to evaluate qualitative and quantitative factors considered and the reasonableness of the relevant management judgments.
F-1
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures over the inventory valuation included the following, among others:
•We tested the effectiveness of controls over inventory for valuation.
•We evaluated the appropriateness of management’s method, assumptions, and judgments used in developing their estimate of the excess and slow-moving inventory, which included consideration of demand for its products, potential obsolescence of technology, product life cycles, and pricing trends.
•We tested certain underlying data used and considered in the excess and obsolete inventory assessment, including the amount of inventory on hand, forecasted demand, and historical sales.
•We compared actual inventory usage and write-off activity in the current year to the excess and obsolete estimate by management in the prior year to evaluate management’s ability to make accurate estimates.
•We evaluated the valuation of excess and obsolete inventory for understatement by making selections of individual inventory items and evaluating the appropriateness of the inventory valuation and management judgments based on relevant product specific information. These procedures also included certain inquiries of production planning and supply chain employees.
•We evaluated whether the excess and obsolete inventory may be understated by evaluating write-off activity of inventory subsequent to December 31, 2020.
Capitalized Software - Software Development Costs for External Use — Refer to Notes 1 and 6 to the financial statements
Critical Audit Matter Description
The Company capitalizes certain costs for software that is to be sold, leased, or otherwise marketed once technological feasibility has been established and amortizes these costs over the estimated lives of the related products. The determination of whether a project’s software development costs are capitalized or expensed could have a significant impact on the financial statements. The Company capitalized $32.0 million of software development costs in the year ended December 31, 2020 and had total external capitalized software development costs, net of accumulated amortization, of $94.0 million as of December 31, 2020.
We identified management’s determination of capitalized software development costs to be a critical audit matter. Evaluating the Company’s determination of the project and related software development activities to be capitalized under relevant accounting guidance, including the extent to which software development costs incurred were capitalized, required subjective auditor judgment.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures to assess the appropriateness of capitalized software development costs included the following, among others:
•We tested the effectiveness of management’s capitalized software development cost controls.
•We obtained an understanding of management’s process for evaluating software development costs and the nature of software development costs capitalized.
•We tested management’s method of calculating capitalized software development costs. For a sample of projects, we performed audit procedures to agree capitalized labor costs to time records and made certain inquiries of project members to further assess the reasonableness of time allocated to the selected projects.
•For a sample of software development projects, we obtained an understanding of the new software enhancements and features planned for development by reviewing management’s project documentation and inquiring of project managers and engineers.
•For a sample of software development projects, we tested the timing of software development cost recognition as either a capitalized or an expensed development cost, depending on which stage of project development the cost was incurred. We also inquired of project managers and engineers regarding the date technological feasibility was reached and observed the new features developed in the working model.

F-2
/s/ DELOITTE & TOUCHE LLP
San Jose, California
February 24, 2021
We have served as the Company’s auditor since 2014.
F-3
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the stockholders and the Board of Directors of Omnicell, Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Omnicell, Inc. and subsidiaries (the “Company”) as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2020, of the Company and our report dated February 24, 2021, expressed an unqualified opinion on those financial statements and included an explanatory paragraph regarding the Company’s change in its method of accounting for leases in fiscal year 2019 due to the adoption of ASC Topic 842, Leases.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ DELOITTE & TOUCHE LLP

San Jose, California
February 24, 2021
F-4
OMNICELL, INC.
CONSOLIDATED BALANCE SHEETS
December 31,
20202019
(In thousands, except par value)
ASSETS
Current assets:
Cash and cash equivalents$485,928 $127,210 
Accounts receivable and unbilled receivables, net of allowances of $4,286 and $3,227, respectively
190,117 218,362 
Inventories96,298 108,011 
Prepaid expenses16,027 14,478 
Other current assets41,044 15,177 
Total current assets829,414 483,238 
Property and equipment, net59,073 54,246 
Long-term investment in sales-type leases, net22,156 19,750 
Operating lease right-of-use assets55,114 56,130 
Goodwill499,309 336,539 
Intangible assets, net168,211 124,867 
Long-term deferred tax assets15,019 14,142 
Prepaid commissions56,919 48,862 
Other long-term assets119,289 103,036 
Total assets$1,824,504 $1,240,810 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$40,309 $46,380 
Accrued compensation55,750 44,155 
Accrued liabilities80,311 55,567 
Deferred revenues, net100,053 90,894 
Total current liabilities276,423 236,996 
Long-term deferred revenues5,673 7,083 
Long-term deferred tax liabilities39,633 39,090 
Long-term operating lease liabilities48,897 50,669 
Other long-term liabilities19,174 11,718 
Revolving credit facility— 50,000 
Convertible senior notes, net467,201 — 
Total liabilities857,001 395,556 
Commitments and contingencies (Note 13)
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued
— — 
Common stock, $0.001 par value, 100,000 shares authorized; 52,677 and 51,277 shares issued; 42,783 and 42,132 shares outstanding, respectively
53 51 
Treasury stock at cost, 9,894 and 9,145 shares outstanding, respectively
(238,109)(185,074)
Additional paid-in capital920,359 780,931 
Retained earnings290,722 258,792 
Accumulated other comprehensive loss(5,522)(9,446)
Total stockholders’ equity967,503 845,254 
Total liabilities and stockholders’ equity$1,824,504 $1,240,810 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-5
OMNICELL, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Year Ended December 31,
202020192018
(In thousands, except per share data)
Revenues:
Product revenues$636,031 $659,602 $569,595 
Services and other revenues256,177 237,425 217,714 
Total revenues892,208 897,027 787,309 
Cost of revenues:
Cost of product revenues354,004 344,914 312,360 
Cost of services and other revenues124,912 115,201 102,619 
Total cost of revenues478,916 460,115 414,979 
Gross profit413,292 436,912 372,330 
Operating expenses:
Research and development70,161 68,644 64,843 
Selling, general, and administrative307,605 289,916 263,095 
Total operating expenses377,766 358,560 327,938 
Income from operations35,526 78,352 44,392 
Interest and other income (expense), net(6,177)(4,419)(8,776)
Income before provision for income taxes29,349 73,933 35,616 
Provision for (benefit from) income taxes(2,845)12,595 (2,113)
Net income$32,194 $61,338 $37,729 
Net income per share:
Basic$0.76 $1.48 $0.96 
Diluted$0.74 $1.43 $0.93 
Weighted-average shares outstanding:
Basic42,583 41,462 39,242 
Diluted43,743 42,943 40,559 
The accompanying notes are an integral part of these Consolidated Financial Statements.

F-6
OMNICELL, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Year Ended December 31,
202020192018
(In thousands)
Net income$32,194 $61,338 $37,729 
Other comprehensive income (loss), net of reclassification adjustments:
Unrealized loss on interest rate swap contracts, net of tax— (420)(421)
Foreign currency translation adjustments3,924 1,828 (4,320)
Other comprehensive income (loss)3,924 1,408 (4,741)
Comprehensive income$36,118 $62,746 $32,988 
The accompanying notes are an integral part of these Consolidated Financial Statements.

F-7
OMNICELL, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
Common StockTreasury Stock
Additional
Paid-In
Capital
Accumulated
Earnings
Accumulated Other
Comprehensive Income (Loss)
Stockholders’
Equity
SharesAmountSharesAmount
(In thousands)
Balances as of December 31, 201747,577 $48 (9,145)$(185,074)$585,755 $159,725 $(6,113)$554,341 
Net income— — — — — 37,729 — 37,729 
Other comprehensive loss— — — — — — (4,741)(4,741)
At the market equity offering, net of costs557 1 — — 39,566 — — 39,567 
Share-based compensation— — — — 28,885 — — 28,885 
Issuance of common stock under employee stock plans1,346 1 — — 30,610 — — 30,611 
Tax payments related to restricted stock units— — — — (6,775)— — (6,775)
Balances as of December 31, 201849,480 50 (9,145)(185,074)678,041 197,454 (10,854)679,617 
Net income— — — — — 61,338 — 61,338 
Other comprehensive income— — — — — — 1,408 1,408 
At the market equity offering, net of costs460 — — — 37,806 — — 37,806 
Share-based compensation— — — — 34,049 — — 34,049 
Issuance of common stock under employee stock plans1,337 1 — — 40,705 — — 40,706 
Tax payments related to restricted stock units— — — — (9,670)— — (9,670)
Balances as of December 31, 201951,277 51 (9,145)(185,074)780,931 258,792 (9,446)845,254 
Net income— — — — — 32,194 — 32,194 
Other comprehensive income— — — — — — 3,924 3,924 
Share-based compensation— — — — 44,697 — — 44,697 
Issuance of common stock under employee stock plans1,400 2 — — 54,268 — — 54,270 
Tax payments related to restricted stock units— — — — (8,738)— — (8,738)
Stock repurchases— — (749)(53,035)— — — (53,035)
Equity component of convertible senior note issuance, net of issuance costs— — — — 97,830 — — 97,830 
Purchase of convertible note hedge— — — — (100,625)— — (100,625)
Sale of warrants— — — — 51,290 — — 51,290 
Tax benefits related to convertible senior notes and convertible note hedge— — — — 706 — — 706 
Cumulative effect of a change in accounting principle related to credit losses— — — — — (264)— (264)
Balances as of December 31, 202052,677 $53 (9,894)$(238,109)$920,359 $290,722 $(5,522)$967,503 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-8
OMNICELL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended December 31,
202020192018
(In thousands)
Operating Activities
Net income$32,194 $61,338 $37,729 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization61,067 53,559 51,350 
Loss on disposal of property and equipment267 445 133 
Share-based compensation expense44,697 34,049 28,885 
Deferred income taxes(6,546)(1,339)(5,705)
Amortization of operating lease right-of-use assets10,528 10,562 — 
Amortization of debt issuance costs1,597 2,204 2,292 
Amortization of discount on convertible senior notes4,766 — — 
Changes in operating assets and liabilities:
Accounts receivable and unbilled receivables36,842 (21,540)(6,192)
Inventories12,359 (8,123)(6,763)
Prepaid expenses(2,081)2,909 (308)
Other current assets(6,408)(2,010)1,170 
Investment in sales-type leases(2,882)(3,699)(1,680)
Prepaid commissions(8,057)(2,719)(4,711)
Other long-term assets(7,675)4,528 (7,077)
Accounts payable(6,300)7,893 (9,154)
Accrued compensation11,595 2,495 14,419 
Accrued liabilities4,374 3,045 8,223 
Deferred revenues7,620 5,445 3,020 
Operating lease liabilities(9,543)(10,040)— 
Other long-term liabilities7,456 6,006 (1,665)
Net cash provided by operating activities185,870 145,008 103,966 
Investing Activities
Software development for external use(32,024)(45,770)(30,677)
Purchases of property and equipment(22,842)(15,894)(23,697)
Business acquisition(225,000)— — 
Net cash used in investing activities(279,866)(61,664)(54,374)
Financing Activities
Proceeds from revolving credit facility150,000 — — 
Repayment of debt and revolving credit facility(200,000)(90,000)(77,000)
Payments for debt issuance costs for revolving credit facility(550)(2,321)— 
Proceeds from issuance of convertible senior notes, net of issuance costs559,665 — — 
Purchase of convertible note hedge(100,625)— — 
Proceeds from sale of warrants51,290 — — 
At the market equity offering, net of offering costs— 37,806 39,567 
Proceeds from issuances under stock-based compensation plans54,270 40,706 30,611 
Employees’ taxes paid related to restricted stock units(8,738)(9,670)(6,775)
Stock repurchases(53,035)— — 
Change in customer funds, net3,992 — — 
Net cash provided by (used in) financing activities456,269 (23,479)(13,597)
Effect of exchange rate changes on cash and cash equivalents437 153 (1,227)
Net increase in cash, cash equivalents, and restricted cash362,710 60,018 34,768 
Cash, cash equivalents, and restricted cash at beginning of period127,210 67,192 32,424 
Cash, cash equivalents, and restricted cash at end of period$489,920 $127,210 $67,192 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-9
OMNICELL, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
Year Ended December 31,
202020192018
(In thousands)
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets:
Cash and cash equivalents$485,928 $127,210 $67,192 
Restricted cash included in Other current assets3,992 — — 
Cash, cash equivalents, and restricted cash at end of period$489,920 $127,210 $67,192 
Supplemental cash flow information
Cash paid for interest$522 $3,582 $7,487 
Cash paid for taxes, net of refunds$10,343 $7,761 $3,489 
Supplemental disclosure of non-cash activities
Unpaid purchases of property and equipment$405 $913 $1,123 
Transfers between inventory and property and equipment, net$— $1,552 $2,032 
Transfers from prepaid expenses to property and equipment$— $3,313 $— 
Balance transfer from term loan to revolving credit facility$— $80,000 $— 
The accompanying notes are an integral part of these Consolidated Financial Statements.
F-10
OMNICELL, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1.     Organization and Summary of Significant Accounting Policies
Business
Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company’s major products are medication management automation solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The Company’s market is primarily located in the United States and Europe. “Omnicell” or the “Company” collectively refer to Omnicell, Inc. and its subsidiaries.
Basis of Presentation
The accompanying Consolidated Financial Statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented.
Principles of Consolidation
The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
On October 1, 2020, the Company completed its acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The Consolidated Financial Statements include the results of operations of this recently acquired company, commencing as of the acquisition date. The significant accounting policies of the acquired business have been aligned to conform to the accounting policies of Omnicell.
Reclassifications and Adjustments
Certain prior-year amounts have been reclassified to conform with current-period presentation. These reclassifications include (i) a change in the presentation of certain items in the disaggregation of revenues for the years ended December 31, 2020, 2019, and 2018 in Note 3, Revenues, and (ii) a change in the presentation of certain items in the reconciliation of the provision for (benefit from) income taxes for the years ended December 31, 2019 and 2018 in Note 17, Income Taxes. These changes were not deemed material and were included to conform with current-period classification and presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts from the COVID-19 pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. Those policies are revenue recognition; accounts receivable, unbilled receivables, and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill; purchased intangibles and long-lived assets; fair value of assets acquired and liabilities assumed in business combinations; convertible senior notes; share-based compensation; and accounting for income taxes. As of December 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the ongoing uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.
Segment Reporting
The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.
F-11
Foreign Currency Translation and Remeasurement
Most of the Company’s foreign subsidiaries use the local currency of their respective countries as their functional currency. The Company translates the assets and liabilities of such non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recorded as foreign currency translation adjustments and included in accumulated other comprehensive income (loss) in stockholders’ equity.
Assets and liabilities denominated in a currency other than the functional currency are remeasured into the respective entity’s functional currency. Monetary assets and liabilities are remeasured at exchange rates in effect at the end of each period, and non-monetary assets and liabilities are remeasured at historical rates. Gains and losses from foreign currency remeasurement of monetary assets and liabilities are recorded in interest and other income (expense), net.
Revenue Recognition
The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories:
Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements with multi-year co-development plans. Solutions in this category include, but are not limited to, XT Series automated dispensing systems, the XR2 Automated Central Pharmacy system, and IV compounding automation solutions.
Technical services. Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements.
Consumables. Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.
Software-as-a-service (“SaaS”), subscription software, and technology-enabled services. Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth (formerly Population Health Solutions), 340B solutions, and services associated with Omnicell One (formerly Performance Center), Central Pharmacy Compounding Services, including the XR2 Automated Central Pharmacy system, and Central Pharmacy Compounding Services, including IV compounding automation solutions.
The following table summarizes revenue recognition for each revenue category which is further discussed below:
Revenue Category
Timing of Revenue Recognition
Income Statement Classification
Connected devices, software licenses, and other
Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer
Product
Technical services
Over time, as services are provided, typically ratably over the service term
Service
Consumables
Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer
Product
SaaS, subscription software, and technology-enabled services
Over time, as services are provided
Service
Prior to recognizing revenue, the Company identifies the contract, performance obligations, and transaction price, and allocates the transaction price to the performance obligations. All identified contracts meet the following required criteria:
Parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of the Company’s contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order.
Entity can identify each party’s rights regarding the goods or services to be transferred. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following the Company’s standard business process and terms.
F-12
The entity can identify the payment terms for the goods or services to be transferred. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, the Company’s standard payment terms are net 30 day terms.
The contract has commercial substance (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). The Company’s agreements are an exchange of cash for a combination of products and services which result in changes in the amount of the Company’s future cash flows.
It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. The Company performs a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected.
Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, the Company combines the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify its performance obligations, the Company considers all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, the Company considers an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of the Company’s sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services.
The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of the Company’s commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.
The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
The Company recognizes revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as the Company provides a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations recorded as deferred revenues, net of deferred cost of goods sold, at December 31, 2020 and 2019 were $105.7 million and $98.0 million, respectively, of which $100.1 million and $90.9 million, respectively, are expected to be completed within one year and are presented as current deferred revenues, net on the Consolidated Balance Sheets. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Revenues, contract assets, and contract liabilities are recorded net of associated taxes.
The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements are generally periodic and are billed on a monthly, quarterly, or annual basis. In certain circumstances, multiple years are billed at one time.
The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues, net. The Company typically recognizes product revenue, and correspondingly reduces deferred revenues, net, for equipment and software upon written customer acceptance of installation. Consumables are recorded as revenue upon shipment to or receipt by the customer, depending upon contract terms. The portion of deferred revenues, net, not expected to be recognized as revenue within twelve months of the balance sheet date are included in long-term deferred revenues on the Consolidated Balance Sheets.
F-13
The Company often enters into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. The Company’s change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.
In the normal course of business, the Company typically does not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. The Company establishes provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to the Consolidated Financial Statements for any periods presented.
The Company contracts with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. The Company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease the Company's products. Pursuant to the terms of GPO agreements and the GSA Contract, each member or agency contracts directly with Omnicell and can purchase the Company’s products at pre-negotiated contract terms and pricing. GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee ("IFF") to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $9.7 million, $11.1 million, and $8.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During the year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.
Contract Assets and Contract Liabilities
A contract asset is a right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration. A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from the customer. Contract liabilities include customer deposits under non-cancelable contracts, and current and non-current deferred revenue balances. The Company’s contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.
Significant changes in the contract assets and the contract liabilities balances during the period are the result of the issuance of invoices and recognition of deferred revenues in the normal course of business. As a result of the right to invoice for the transaction consideration becoming unconditional, unbilled contract assets as of December 31, 2019 which were invoiced during the year ended December 31, 2020 were not material. The contract modifications entered into during the year ended December 31, 2020 did not have a significant impact on the Company’s contract assets or deferred revenues.
Contract Costs
The Company has determined that certain incentive portions of its sales commission plans require capitalization since these payments are directly related to sales achieved during a time period. These commissions are earned on the basis of the total purchase order value of new product bookings. Since there are no commensurate commissions earned on renewal of the service bookings, the Company concluded that the capitalized asset is related to services provided under both the initial contract and renewal periods. The Company applies a practical expedient to account for the incremental costs of obtaining a contract as part of a portfolio of contracts with similar characteristics as the Company expects the effect on the financial statements of applying the practical expedient would not differ materially from applying the accounting guidance to the individual contracts within the portfolio. A pool of contracts is defined as all contracts booked in a particular quarter. The amortization for the capitalized asset is an estimate of the pool’s original contract term, generally one to five years, plus an estimate of future customer renewal periods resulting in a total amortization period of ten years. Costs to obtain a contract are allocated amongst performance obligations and recognized as sales and marketing expense consistent with the pattern of revenue recognition. Capitalized costs are periodically reviewed for impairment. In accordance with U.S. GAAP, while certain compensation elements are expensed as incurred, a portion of the pool’s capitalized asset is recorded as an expense over the first two quarters after booking, which represents the estimated period during which the product revenue associated with the contract is recorded. The remaining capitalized contract costs are recorded as expense ratably over the ten year estimated initial and renewal service periods. The Company recognized contract cost expense of $22.1 million, $24.4 million, and $21.1 million during the years
F-14
ended December 31, 2020, 2019, and 2018, respectively. The commission expenses paid or due to be paid as of the consolidated balance sheet date to be recognized in future periods are recorded in long-term prepaid commissions on the Consolidated Balance Sheets. There was no impairment loss recorded related to capitalized prepaid commissions as of and for the year ended December 31, 2020.
Lessor Leases
The Company determines if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
Sales-Type Leases
The Company enters into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. The Company’s sales-type lease agreements do not contain any material residual value guarantees.
For sales-type leases, the Company recognizes revenues for its hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. The Company recognizes service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. The Company recognizes interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.
The Company optimizes cash flows by selling a majority of its non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. The Company has no obligation to the leasing company once the lease has been sold. Some of the Company's sales-type leases, mostly those relating to U.S. government hospitals which comprise approximately 67% of the lease receivable balance, are retained in-house.
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of Accounting Standards Codification ("ASC") 842, Leases. Those agreements in place prior to January 1, 2019 continue to be treated as operating leases, however, any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements entered into prior to January 1, 2019 are non-cancelable, and most automatically renew for successive one year periods at the end of each lease term absent written notice from the customer. The Company’s operating lease agreements do not contain any material residual value guarantees.
For operating leases, rental income is generally recognized on a straight-line basis over the term of the associated lease, and recorded in services and other revenues in the Consolidated Statements of Operations. Leased assets under operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the Consolidated Balance Sheets. The depreciation expense of the leased assets is recognized on a straight-line basis over the contractual term of the associated lease, and recorded in cost of revenues in the Consolidated Statements of Operations.
Allowance for Credit Losses
The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.
The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective
F-15
(pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations.
The allowance for credit losses is presented in the Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:
December 31,
20202019
(In thousands)
Allowance for credit losses:
Accounts receivable and unbilled receivables$4,286 $3,227 
Long-term unbilled receivables (1)
30 — 
Net investment in sales-type leases (2)
265 225 
_________________________________________________
(1)    Included in other long-term assets in the Consolidated Balance Sheets.
(2)    Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively.
Funds Held for Customers and Customer Fund Liabilities
With the acquisition of the 340B Link Business, the Company now offers certain products and services in which it is customary for pharmacies to owe funds to the Company which are collected on behalf of, and, after a short holding period, disbursed to, the Company’s customers. The Company presents amounts due from pharmacies and amounts due to be disbursed to customers on a gross basis within other current assets and accrued liabilities, respectively, in the Consolidated Balance Sheets, as such amounts are expected to be settled within one year. Any funds received from the pharmacies that are held by the Company are segregated from its other corporate cash accounts. These funds are classified as restricted cash as the Company is contractually obligated to disburse these amounts to customers.
Sales of Accounts Receivable
The Company records the sale of its accounts receivables in accordance with accounting guidance for transfers and servicing of financial assets. The Company transferred non-recourse accounts receivable totaling $58.8 million, $48.3 million, and $46.6 million during the years ended December 31, 2020, 2019, and 2018, respectively, which approximated fair value, to leasing companies on a non-recourse basis. Accounts receivable balance included approximately $7.8 million and $4.6 million due from third-party leasing companies for transferred non-recourse accounts receivable as of December 31, 2020 and 2019, respectively.
Cash and Cash Equivalents
The Company classifies all highly-liquid investments with original maturities of three months or less as cash equivalents. The Company’s cash and cash equivalent balances include bank accounts and highly-liquid U.S. Government money market funds held in sweep accounts with financial institutions of high credit quality. The Company continuously monitors the credit worthiness of the financial institutions in which it invests. The Company has not experienced any credit losses from its cash equivalents. Cash and cash equivalents were $485.9 million and $127.2 million as of December 31, 2020 and 2019, respectively. As of December 31, 2020, cash equivalents were $447.2 million, which consisted of money market funds held in sweep accounts, and as of December 31, 2019, the Company had no cash equivalents.
Financial Instruments
For assets and liabilities measured at fair value, the amounts are based on an expected exit price representing the amount that would be received from the sale of an asset or paid to transfer a liability in a transaction between market participants. The fair value may be based on assumptions that market participants would use in pricing an asset or liability. ASC 820, Fair Value Measurement, establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs used in valuation techniques are assigned a hierarchical level, as follows:
Level 1 – Observable inputs, such as quoted prices in active markets for identical instruments;
Level 2 – Quoted prices for similar instruments in active markets, or quoted prices for identical instruments in inactive markets; and
F-16
Level 3 – Unobservable inputs for financial instruments reflecting Company’s assumptions.
Interest Rate Swap Agreements
The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.
The Company's interest rate swap agreements qualify as cash flow hedging instruments in accordance with ASC 815, Derivatives and Hedging. The Company records its interest rate swap agreements on its Consolidated Balance Sheets at fair value. The effective portion of changes in fair value are recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Any ineffective portion is recognized in earnings. On a quarterly basis, the Company performs a qualitative assessment to determine effectiveness. For further information, refer to Note 5, Fair Value of Financial Instruments. As of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.
Inventory
Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before the Company receives them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to the Company.
The Company has a supply agreement with one primary supplier for construction and supply of several sub-assemblies and inventory management of sub-assemblies used in its hardware products. There are no minimum purchase requirements. The contract with the Company’s supplier may be terminated by either the supplier or by the Company without cause and at any time upon delivery of six months’ notice. Purchases from this supplier were $76.3 million, $75.1 million, and $54.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Shipping Costs
Outbound freight billed to customers is recorded as product revenue. The related shipping and handling costs are expensed as part of selling, general, and administrative expense. Shipping and handling expenses were $15.6 million, $15.9 million, and $14.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Property and Equipment
Property and equipment less accumulated depreciation are stated at historical cost. The Company’s expenditures for property and equipment are primarily for computer equipment and software used in the administration of its business, and for leasehold improvements to its leased facilities. The Company also develops molds and dies used in long-term manufacturing arrangements with suppliers and for production automation equipment used in the manufacturing of consumable blister card components. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software
3 - 5 years
Leasehold and building improvementsShorter of the lease term or the estimated useful life
Furniture and fixtures
5 - 7 years
Equipment
2 - 12 years
The Company capitalizes costs related to computer software developed or obtained for internal use in accordance with ASC 350-40, Internal-Use Software. Software obtained for internal use includes enterprise-level business and finance software that the Company customizes to meet its specific operational needs, as well as certain costs for the development of its subscription and cloud-based offerings sold to its customers. Costs incurred in the application development phase are capitalized and amortized over their useful lives, which is generally five years. Costs recognized in the preliminary project phase and the post-implementation phase are expensed as incurred. The Company capitalized $6.8 million and $0.3 million of
F-17
costs related to the application development of enterprise-level software and its subscription and cloud-based offerings that were included in property and equipment during the years ended December 31, 2020 and 2019, respectively.
Software Development Costs
The Company capitalizes certain software development costs in accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. The Company establishes technological feasibility when it completes a detail program design or a working model. The Company amortizes development costs over the estimated lives of the related products, which is generally five years. The Company capitalized software development costs of $32.0 million and $45.8 million, which are included in other long-term assets as of December 31, 2020 and 2019, respectively. The Company recorded $23.1 million, $17.5 million, and $12.5 million to cost of revenues for amortization of capitalized software development costs for the years ended December 31, 2020, 2019, and 2018, respectively. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.
Lessee Leases
The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of its lease contracts do not provide an implicit rate, the Company uses its incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The Company does not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. The Company elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.
Many of the Company’s operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that the Company operates. The Company reviews each of its lease options at a time required by the terms of the lease contract, and notifies the lessor if it chooses to exercise the lease renewal option. Until the Company is reasonably certain that it will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.
Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When the Company has made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.
Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (i.e. Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. 
The Company’s operating lease agreements do not contain any material residual value guarantees, restrictions, or restriction covenants.
Business Combinations
The Company uses the acquisition method of accounting under ASC 805, Business Combinations. Each acquired company’s operating results are included in the Company's Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed.
Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements.
F-18
Goodwill and Acquired Intangible Assets
Goodwill
The Company reviews goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. The Company has one reporting unit, which is the same as its operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if the Company decides to bypass this option, it proceeds to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of the Company’s reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, the Company will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.
To determine the reporting unit’s fair value under the quantitative approach, the Company uses a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. The Company also considers its market capitalization on the date of the analysis to ensure the reasonableness of its reporting unit's fair value.
The Company performed a qualitative impairment assessment analysis as of October 1, 2020 for its reporting unit taking into consideration past, current, and projected future earnings, recent trends, and market conditions, and valuation metrics involving similar companies that are publicly-traded. Based on the result of this analysis, an impairment does not exist as of December 31, 2020, and there were no accumulated impairment losses.
Intangible Assets
In connection with its acquisitions, the Company generally recognizes assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from one to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.
The Company assesses the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. The Company’s cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of the Company’s intangible assets are subjective and are affected by changes to its business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of the Company’s assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on the Company’s operating results and financial condition. For the years ended December 31, 2020 and 2019, there were no events or changes in circumstances to indicate that intangible assets carrying amounts may not be recoverable.
Convertible Debt
The Company accounts for convertible debt and related transactions in accordance with ASC 470-20, Debt with Conversion and Other Options, ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. The Company evaluates convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.
F-19
Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance Sheets.
Valuation of Share-Based Compensation
The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. The Company recognizes compensation expense related to share-based compensation based on the grant date estimated fair value.
The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of its common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on the Company’s historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period.
The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period.
The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period.
Forfeiture rates are estimated based on the Company's historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.
Accounting for Income Taxes
The Company records an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740, Income Taxes, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, the Company will incur a benefit or detriment on its income tax expense in the period of change. If the Company were to determine that all or part of the net deferred tax assets are not realizable in the future, it will record a valuation allowance that would be charged to earnings in the period such determination is made.
In accordance with ASC 740, the Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.
Recently Adopted Authoritative Guidance
In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an
F-20
“expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.
Recently Issued Authoritative Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, as well as improves consistent application of and simplifies the guidance for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 will be effective for the Company beginning January 1, 2021. The Company does not expect ASU 2019-12 to have a material impact on its Consolidated Financial Statements.
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. This update permits the use of either the modified retrospective or fully retrospective method of transition. ASU 2020-06 will be effective for the Company beginning January 1, 2022. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its Consolidated Financial Statements.
There was no other recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Consolidated Financial Statements through the reporting date.
Note 2.    Business Combinations
340B Link Business Acquisition
On October 1, 2020, the Company completed the acquisition of all of the outstanding equity of the 340B Link Business pursuant to the terms and conditions of the Equity Purchase Agreement, dated August 11, 2020, as amended, by and among the Company, PSGH, LLC, BW Apothecary Holdings, LLC, the sellers identified therein and the sellers’ representative for total cash consideration of $225.0 million. The 340B Link Business acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner. The results of the 340B Link Business' operations have been included in the Company's consolidated results of operations, commencing as of the acquisition date.
F-21
The Company accounted for the acquisition of the 340B Link Business in accordance with ASC 805. The tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. The preliminary fair values assume management's best estimates based on information available at the acquisition date and may change over the measurement period, which will end no later than one year form the acquisition date, as additional information is received. The following table represents the preliminary allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of the acquisition reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheets:
340B Link Business
(Preliminary)
(In thousands)
Accounts receivable and unbilled receivables$8,197 
Prepaid expenses232 
Other current assets22,747 
Total current assets31,176 
Property and equipment531 
Operating lease right-of-use assets3,138 
Goodwill161,117 
Intangible assets62,800 
Total assets258,762 
Accounts payable568 
Accrued liabilities23,787 
Long-term deferred tax liabilities6,818 
Long-term operating lease liabilities2,589 
Total liabilities33,762 
Total purchase price$225,000 
The $161.1 million of goodwill arising from the 340B Link Business acquisition is primarily attributed to sales of future software-enabled services and solutions and the 340B Link Business’ assembled workforce. Goodwill that is expected to be deductible for tax purposes is approximately $93.9 million.
Intangible assets eligible for recognition separate from goodwill were those that satisfied either the contractual/legal criterion or the separability criterion in the accounting guidance. The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:
304B Link Business
Fair valueUseful life
(years)
(In thousands, except for years)
Customer relationships$53,000 21
Acquired technology9,000 5
Trade names200 1
Non-compete agreements600 3
Total purchased intangible assets$62,800 
The customer relationships intangible asset represents the fair value of the underlying relationships and agreements with the 340B Link Business’ customers. The acquired technology intangible asset represents the fair value of the 340B Link Business' portfolio of software and solutions that have reached technological feasibility and were part of the 340B Link Business’ offerings at the date of acquisition. The trade names intangible asset represents the fair value of brand and name recognition associated with the marketing of the 340B Link Business' software-enabled services and solutions. The non-compete agreements intangible asset represents the fair value of non-compete agreements with former key members of the 340B Link Business' management.
The fair value of the customer relationships intangible asset was determined based on the excess earnings method; the fair values of the acquired technology and trade names intangible assets were determined based on the relief-from-royalty
F-22
method; and the fair value of the non-compete agreements intangible asset was determined based on the lost profits method. The key assumptions used in estimating the fair values of intangible assets included forecasted financial information; customer attrition rates; royalty rates of 10.0% and 0.5% for the acquired technology and trade names intangible assets, respectively; discount rate of 14.0% for all intangible assets; and certain other assumptions.
The customer relationships and acquired technology intangible assets are being amortized using a double-declining method of amortization as such method better represents the economic benefits to be obtained. The trade names and non-compete agreements are being amortized over their estimated useful lives using the straight-line method of amortization.
The Company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that market participants would use. Actual results may differ from these estimates and assumptions.
The Company incurred approximately $6.5 million in acquisition-related costs related to the 340B Link Business acquisition during the year ended December 31, 2020. These costs were expensed as incurred, and are included in selling, general, and administrative expenses in the Company's Consolidated Statements of Operations.
Revenues and earnings from the 340B Link Business operations since the acquisition date through December 31, 2020 were $10.2 million and $1.3 million, respectively.
Pro Forma Financial Information
The following table presents certain unaudited pro forma information for illustrative purposes only, for the years ended December 31, 2020 and 2019 as if this acquisition had been completed on January 1, 2019. The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2019. The unaudited pro forma information combines the historical results of the acquisition with the Company’s consolidated historical results and includes certain adjustments including, but not limited to, amortization and depreciation of intangible assets and property and equipment acquired; imputed interest, interest expense, and amortization of debt issuance costs for the indebtedness incurred to complete the acquisition; and acquisition-related costs incurred.
Year Ended December 31,
20202019
(In thousands, except per share data)
Pro forma revenues$920,314 $929,106 
Pro forma net income$37,559 $56,897 

Note 3.    Revenues
Disaggregation of Revenues
The following table summarizes the Company’s revenues disaggregated by revenue type for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Connected devices, software licenses, and other$560,368 $573,844 $483,414 
Technical services202,383 194,183 183,202 
Consumables75,663 85,758 86,182 
SaaS, subscription software, and technology-enabled services53,794 43,242 34,511 
Total revenues$892,208 $897,027 $787,309 
F-23
The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
United States$797,602$806,900$685,881
Rest of world (1)
94,60690,127101,428
Total revenues$892,208$897,027$787,309
_________________________________________________
(1)    No individual country represented more than 10% of total revenues.
Contract Assets and Contract Liabilities
The following table reflects the Company’s contract assets and contract liabilities:
December 31,
20202019
(In thousands)
Short-term unbilled receivables, net (1)
$13,895 $11,707 
Long-term unbilled receivables, net (2)
17,205 12,260 
Total contract assets$31,100 $23,967 
Short-term deferred revenues, net
$100,053 $90,894 
Long-term deferred revenues
5,673 7,083 
Total contract liabilities$105,726 $97,977 
_________________________________________________
(1)     Included in accounts receivable and unbilled receivables in the Consolidated Balance Sheets.
(2)    Included in other long-term assets in the Consolidated Balance Sheets.
Short-term deferred revenues of $100.1 million and $90.9 million include deferred revenues from product sales and service contracts, net of deferred cost of sales of $21.0 million and $13.1 million, as of December 31, 2020 and 2019, respectively. The short-term deferred revenues from product sales relate to delivered and invoiced products, pending installation and acceptance, expected to occur within the next twelve months. During the year ended December 31, 2020, the Company recognized revenues of $84.0 million that were included in the corresponding gross short-term deferred revenue balance of $104.0 million as of December 31, 2019.
Long-term deferred revenues include deferred revenues from service contracts of $5.7 million and $7.1 million as of December 31, 2020 and 2019, respectively. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Significant Customers
There were no customers that accounted for more than 10% of the Company’s total revenues for the years ended December 31, 2020, 2019, and 2018. Also, there were no customers that accounted for more than 10% of the Company’s accounts receivable balance as of December 31, 2020 and 2019.
Note 4.    Net Income Per Share
Basic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period, using the treasury stock method. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units, as well as shares the Company could be obligated to issue from its convertible senior notes and warrants, as described in Note 10, Convertible Senior Notes. Any anti-dilutive weighted-average dilutive shares related to stock award plans, convertible senior notes, and warrants are excluded from the computation of the diluted net income per share.
F-24
The basic and diluted net income per share calculations for the years ended December 31, 2020, 2019, and 2018 were as follows:
Year Ended December 31,
202020192018
(In thousands, except per share data)
Net income$32,194 $61,338 $37,729 
Weighted-average shares outstanding - basic42,583 41,462 39,242 
Effect of dilutive securities from stock award plans1,160 1,481 1,317 
Effect of convertible senior notes and warrants— — — 
Weighted-average shares outstanding - diluted43,743 42,943 40,559 
Net income per share - basic$0.76 $1.48 $0.96 
Net income per share - diluted$0.74 $1.43 $0.93 
Anti-dilutive weighted-average shares related to stock award plans2,054 926 1,279 
Anti-dilutive weighted-average shares related to convertible senior notes and warrants11,816 — — 
Note 5.    Fair Value of Financial Instruments
Fair Value Hierarchy
The Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and credit facilities are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company's convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period. As of December 31, 2020, the fair value of the convertible senior notes was $782.3 million, compared to their carrying value of $467.2 million, which is net of unamortized discount and debt issuance costs and excludes amounts classified within additional paid-in capital. Refer to Note 9, Debt and Credit Agreements, for further information regarding the Company’s credit facilities and Note 10, Convertible Senior Notes, for further information regarding the Company’s convertible senior notes.
Interest Rate Swap Contracts
During 2016, the Company entered into an interest rate swap agreement with a combined notional amount of $100.0 million with one counterparty that became effective on June 30, 2016 and matured on April 30, 2019. The swap agreement required the Company to pay a fixed rate of 0.8% and provided that the Company receive a variable rate based on the one month LIBOR rate subject to a LIBOR floor of 0.0%. Amounts payable by or due to the Company were net settled with the respective counterparty on the last business day of each month, commencing July 31, 2016. The Company’s interest rate swap agreement matured during the second quarter of 2019, and, as of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.
F-25
Note 6.    Balance Sheet Components
Balance sheet details as of December 31, 2020 and 2019 are presented in the tables below:
December 31,
20202019
(In thousands)
Inventories:
Raw materials$28,205 $31,331 
Work in process7,973 7,620 
Finished goods60,120 69,060 
Total inventories$96,298 $108,011 
Other current assets:
Funds held for customers, including restricted cash (1)
$18,164 $— 
Net investment in sales-type leases, current portion10,246 9,770 
Prepaid income taxes10,095 4,347 
Other current assets2,539 1,060 
Total other current assets$41,044 $15,177 
Other long-term assets:
Capitalized software, net$94,027 $85,070 
Unbilled receivables, net17,205 12,260 
Deferred debt issuance costs4,253 4,700 
Other long-term assets3,804 1,006 
Total other long-term assets$119,289 $103,036 
Accrued liabilities:
Operating lease liabilities, current portion$12,197 $10,058 
Customer fund liabilities18,164 — 
Advance payments from customers6,981 4,006 
Rebates and lease buyouts21,815 14,911 
Group purchasing organization fees4,412 5,934 
Taxes payable3,520 3,744 
Other accrued liabilities13,222 16,914 
Total accrued liabilities$80,311 $55,567 
_________________________________________________
(1)    Includes $4.0 million of restricted cash.
F-26
The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the years ended December 31, 2020 and 2019:
Foreign currency translation adjustmentsUnrealized gain (loss) on interest rate swap hedgesTotal
(In thousands)
Balance as of December 31, 2018$(11,274)$420 $(10,854)
Other comprehensive income (loss) before reclassifications1,828 148 1,976 
Amounts reclassified from other comprehensive income (loss), net of tax— (568)(568)
Net current-period other comprehensive income (loss), net of tax1,828 (420)1,408 
Balance as of December 31, 2019(9,446)— (9,446)
Other comprehensive income (loss) before reclassifications3,924 — 3,924 
Amounts reclassified from other comprehensive income (loss), net of tax— — — 
Net current-period other comprehensive income (loss), net of tax3,924 — 3,924 
Balance as of December 31, 2020$(5,522)$— $(5,522)
Note 7.    Property and Equipment
The following table represents the property and equipment balances as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Equipment$81,034 $88,569 
Furniture and fixtures7,498 7,925 
Leasehold improvements19,517 18,979 
Software50,230 48,309 
Construction in progress7,095 6,179 
Property and equipment, gross (1)
165,374 169,961 
Accumulated depreciation and amortization (1)
(106,301)(115,715)
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)     The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.
Depreciation and amortization expense of property and equipment was $18.3 million, $17.2 million, and $15.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The geographic location of the Company's property and equipment, net, is based on the physical location in which it is located. The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
United States$53,203 $48,769 
Rest of world (1)
5,870 5,477 
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)    No individual country represented more than 10% of the total property and equipment, net.
F-27
Note 8.    Goodwill and Intangible Assets
Goodwill
The following table represents changes in the carrying amount of goodwill:
(In thousands)
Balance as of December 31, 2018$335,887 
Additions— 
Foreign currency exchange rate fluctuations652 
Balance as of December 31, 2019336,539 
Additions (1)
161,117 
Foreign currency exchange rate fluctuations1,653 
Balance as of December 31, 2020$499,309 
_________________________________________________
(1)     Additions represent the preliminary value assigned to goodwill in connection with the 340B Link Business acquisition in October 2020.
Intangible Assets, Net
The carrying amounts and useful lives of intangible assets as of December 31, 2020 and 2019 were as follows:
December 31, 2020
Gross carrying
amount (1)
Accumulated
amortization		Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$187,889 $(64,254)$(777)$122,858 
10 - 30
Acquired technology86,029 (44,851)6 41,184 
3 - 20
Backlog1,150 (1,078)— 72 4
Trade names7,850 (5,794)14 2,070 
1 - 12
Patents2,930 (1,455)2 1,477 
2 - 20
Non-compete agreements600 (50)— 550 3
Total intangibles assets, net$286,448 $(117,482)$(755)$168,211 
December 31, 2019
Gross carrying
amount (1)
Accumulated
amortization		 Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$135,234 $(54,860)$(1,058)$79,316 
10 - 30
Acquired technology77,142 (36,194)5 40,953 
3 - 20
Backlog1,150 (791)— 359 
4
Trade names7,650 (5,037)11 2,624 
6 - 12
Patents3,217 (1,603)1 1,615 
2 - 20
Total intangibles assets, net$224,393 $(98,485)$(1,041)$124,867 
_________________________________________________
(1)     The differences in gross carrying amounts between periods are primarily due to additions of intangible assets in connection with the 340B Link Business acquisition, partially offset by the write-off of certain fully amortized intangible assets.
Amortization expense of intangible assets was $19.7 million, $18.9 million, and $23.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.
F-28
The estimated future amortization expenses for amortizable intangible assets were as follows:
December 31,
2020
(In thousands)
2021$23,948 
202221,134 
202319,113 
202412,825 
202511,616 
Thereafter79,575 
Total$168,211 
Note 9.    Debt and Credit Agreements
2016 Senior Credit Facility
On January 5, 2016, the Company entered into a $400.0 million senior secured credit facility pursuant to a credit agreement with certain lenders, Wells Fargo Securities, LLC as sole lead arranger, and Wells Fargo Bank, National Association as administrative agent (as subsequently amended as discussed below, the “Prior Credit Agreement”). The Prior Credit Agreement provided for (a) a five-year revolving credit facility of $200.0 million, which was subsequently increased pursuant to the amendment discussed below (the “Prior Revolving Credit Facility”) and (b) a five-year $200.0 million term loan facility (the “Prior Term Loan Facility” and, together with the Prior Revolving Credit Facility, the “Prior Facilities”). In addition, the Prior Credit Agreement included a letter of credit sub-limit of up to $10.0 million and a swing line loan sub-limit of up to $10.0 million. The Prior Credit Agreement had an expiration date of January 5, 2021, upon which date all remaining outstanding borrowings were due and payable.
Loans under the Prior Facilities bore interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.50% to 2.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month, plus an applicable margin ranging from 0.50% to 1.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement). Undrawn commitments under the Prior Revolving Credit Facility were subject to a commitment fee ranging from 0.20% to 0.35% per annum based on the Company’s consolidated total net leverage ratio on the average daily unused portion of the Prior Revolving Credit Facility.
On each of April 11, 2017 and December 26, 2017, the parties entered into amendments to the Prior Credit Agreement. Under these amendments, the Prior Revolving Credit Facility was increased from $200.0 million to $315.0 million and certain other modifications were made. In connection with the December 2017 amendment, the Company incurred and capitalized an additional $2.1 million of debt issuance costs.
2019 Revolving Credit Facility
On November 15, 2019, the Company refinanced the Prior Credit Agreement and entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement replaced the Prior Credit Agreement and provides for (a) a five-year revolving credit facility of $500.0 million (the “Current Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable.
On November 15, 2019, the $80.0 million outstanding term loan balance under the Prior Facilities was transferred to the Current Revolving Credit Facility.
Loans under the Current Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the
F-29
prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Current Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Current Revolving Credit Facility. The applicable margin for and certain other terms of any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty.
On September 22, 2020, the parties entered into an amendment (the “Amendment”) to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions as described in Note 10, Convertible Senior Notes, expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter.
The A&R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum consolidated total net leverage ratio and maintain a minimum interest coverage ratio. In addition, the A&R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in full compliance with all covenants as of December 31, 2020.
The refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, Debt - Modifications and Extinguishments. In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&R Credit Agreement.
In connection with the A&R Credit Agreement, the Company incurred and capitalized an additional $2.3 million of debt issuance costs. In connection with the Amendment on September 22, 2020, the Company incurred and capitalized an additional $0.6 million of debt issuance costs. The debt issuance costs are being amortized to interest expense using the straight-line method through 2024. Amortization expense related to debt issuance costs was approximately $1.0 million, $2.2 million, and $2.3 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Interest expense (exclusive of fees and debt issuance cost amortization) was approximately $0.5 million, $3.6 million, and $7.5 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The following table represents changes in the carrying amount of the Company's debt obligations:
Current Revolving Credit Facility
(In thousands)
Balance as of December 31, 2019$50,000 
Proceeds150,000 
Repayments(200,000)
Balance as of December 31, 2020$— 
F-30
The following table represents changes in the balance of the Company's deferred debt issuance costs:
(In thousands)
Balance as of December 31, 2019$4,700 
Additions550 
Amortization(997)
Balance as of December 31, 2020$4,253 
Note 10. Convertible Senior Notes
0.25% Convertible Senior Notes due 2025
On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted.
The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions.
Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be.
If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of December 31, 2020, none of the criteria for a fundamental change or a conversion rate adjustment had been met.
The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least $150.0 million aggregate
F-31
principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes.
Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. Accordingly, at issuance, the Company allocated $461.8 million to the debt liability and $72.7 million to additional paid in capital, net of applicable issuance costs and deferred taxes. The difference between the principal amount of the Notes and the liability component, inclusive of issuance costs, represents the debt discount, which the Company will amortize to interest expense over the term of the Notes using an effective interest rate of 4.18%. The determination of the discount rate required certain estimates and assumptions. As of December 31, 2020, the remaining life of the Notes and the related debt discount and issuance cost accretion is approximately 4.7 years.
The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 8.1 million shares.
The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:
December 31,
2020
(In thousands)
Liability:
Principal amount$575,000 
Unamortized discount(95,744)
Unamortized debt issuance costs(12,055)
Convertible senior notes, liability component$467,201 
Equity:
Embedded conversion option$100,510 
Debt issuance costs(2,680)
Deferred tax impact(25,098)
Convertible senior notes, equity component (1)
$72,732 
_________________________________________________
(1)    Included in additional paid-in capital in the Consolidated Balance Sheets.
The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:
Year Ended
December 31,
2020
(In thousands)
Contractual coupon interest$379 
Amortization of discount$4,766 
Amortization of debt issuance costs$600 
Convertible Note Hedge and Warrant Transactions
In connection with the issuance of the Notes, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock.
The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The
F-32
convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes.
Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid in capital at issuance in the Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants.
Note 11.     Lessor Leases
Sales-Type Leases
On a recurring basis, the Company enters into multi-year, sales-type lease agreements with the majority varying in length from one to five years. The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Sales-type lease revenues$26,040 $37,175 $39,167 
Cost of sales-type lease revenues(10,624)(14,985)(16,185)
Selling profit on sales-type lease revenues$15,416 $22,190 $22,982 
Interest income on sales-type lease receivables$1,933 $1,756 $1,296 
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Net minimum lease payments to be received$35,331 $32,360 
Less: Unearned interest income portion(2,929)(2,840)
Net investment in sales-type leases32,402 29,520 
Less: Current portion (1)
(10,246)(9,770)
Long-term investment in sales-type leases, net$22,156 $19,750 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.
The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.
F-33
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:
December 31,
2020
(In thousands)
2021$11,312 
20229,499 
20237,334 
20244,535 
20252,616 
Thereafter35 
Total future minimum sales-type lease payments35,331 
Present value adjustment(2,929)
Total net investment in sales-type leases$32,402 
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of ASC 842, Leases. These agreements in place prior to January 1, 2019 continue to be treated as operating leases, however any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements generally have initial terms of one to seven years. The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Rental income$11,668 $12,660 $12,207 
The net carrying value of the leased equipment under operating leases was $1.4 million and $2.1 million, which includes accumulated depreciation of $2.5 million and $1.6 million, as of December 31, 2020 and 2019, respectively. Depreciation expense of the leased equipment for the years ended December 31, 2020, 2019, and 2018 was $0.6 million, $0.7 million, and $0.5 million, respectively.
The maturity schedule of future minimum lease payments under operating leases was as follows:
December 31, 2020
(In thousands)
2021$8,848 
20224,816 
20232,910 
2024852 
2025256 
Thereafter89 
Total future minimum operating lease payments$17,771 
Note 12. Lessee Leases
The Company has operating leases for office buildings, data centers, office equipment, and vehicles. The Company’s leases have initial terms of one to 12 years. As of December 31, 2020, the Company did not have any additional material operating leases that were entered into, but not yet commenced.
F-34
The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Consolidated Balance Sheets was as follows:
December 31, 2020
(In thousands)
2021$15,290 
202214,106 
202310,221 
20248,922 
20256,571 
Thereafter17,422 
Total operating lease payments72,532 
Present value adjustment(11,438)
Total operating lease liabilities (1)
$61,094 
_________________________________________________
(1)    Amount consists of a current and long-term portion of operating lease liabilities of $12.2 million and $48.9 million, respectively. The short-term portion of the operating lease liabilities is included in accrued liabilities in the Consolidated Balance Sheets.
Operating lease costs were $14.3 million and $14.6 million for the years ended December 31, 2020 and 2019, respectively. Short-term lease costs and variable lease costs were immaterial for the years ended December 31, 2020 and 2019, respectively.
The following table summarizes supplemental cash flow information related to the Company’s operating leases for the years ended December 31, 2020 and 2019:
Year Ended December 31,
20202019
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities$14,490 $14,636 
Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions$10,025 $1,204 
The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of December 31, 2020 and 2019:
December 31,
20202019
Weighted-average remaining lease term, years5.96.4
Weighted-average discount rate, %5.8 %6.4 %
Note 13.     Commitments and Contingencies
Purchase Obligations
In the ordinary course of business, the Company issues purchase orders based on its current manufacturing needs. As of December 31, 2020, the Company had non-cancelable purchase commitments of $72.8 million, of which $69.9 million are expected to be paid within the next twelve months. 
Legal Proceedings
The Company is currently involved in various legal proceedings.
A class action lawsuit was filed against the Company, on June 5, 2019, in the Circuit Court of Cook County, Illinois, Chancery Division, captioned Corey Heard, individually and on behalf of all others similarly situated, v. Omnicell, Inc., Case No. 2019-CH-06817. The complaint seeks class certification, monetary damages in the form of statutory damages for willful and/or reckless or, in the alternative, negligent violation of the Illinois Biometric Information Privacy Act (“BIPA”), and certain declaratory, injunctive, and other relief based on causes of action directed to allegations of violation of BIPA by the Company.
F-35
The complaint was served on the Company on June 13, 2019. On July 31, 2019, the Company filed a motion to stay or consolidate the case with the action Yana Mazya, et al. v. Northwestern Lake Forest Hospital, et al., Case No. 2018-CH-07161, pending in the Circuit Court of Cook County, Illinois, Chancery Division (the “Mazya Action”). The Court subsequently, on October 10, 2019, denied the motion, without prejudice, as being moot in view of the Company’s dismissal from the Mazya Action. The Company filed a motion to dismiss the complaint on October 31, 2019. The hearing on the Company’s motion to dismiss was held on September 2, 2020. The Court ruled from the bench and dismissed the complaint without prejudice giving plaintiff leave to file an amended complaint by September 30, 2020. Plaintiff filed an amended complaint on September 30, 2020 and the Company subsequently filed a motion to dismiss the complaint on October 28, 2020. The Company's motion to dismiss is now fully briefed and the Court has scheduled oral argument on the motion for June 4, 2021. The Company intends to defend the lawsuit vigorously.
On December 21, 2020, Becton, Dickinson and Company (“BD”) filed a complaint against the Company in the United States District Court for the Middle District of North Carolina, asserting claims of misappropriation under the Defend Trade Secrets Act, misappropriation under the North Carolina Trade Secrets Protection Act, unfair competition, and unfair/deceptive trade practices in violation of North Carolina law (the “Omnicell Complaint”). This action was commenced in relation to another action brought by BD, in the same Court, (the “Related Matter”) against a former BD employee who is also a former Company employee (the “Former Employee”) alleging that the Former Employee had violated the Former Employee’s legal obligations to BD regarding BD’s confidential and trade secret information when the Former Employee allegedly downloaded certain documents from BD’s information technology system following the end of the Former Employee’s employment with BD. In connection with the Related Matter, BD, the Former Employee, and the Company entered into a protocol to facilitate the return to BD of any BD documents that may have been resident, as a result of the Former Employee’s actions, on any devices belonging to the Former Employee or the Company. The Omnicell Complaint seeks injunctive relief and monetary damages in the form of compensatory, punitive, and exemplary damages, attorneys’ fees and costs, and pre-judgment and post-judgment interest. BD has not yet served the Omnicell Complaint on the Company, and, therefore, there are no response dates pending. The Company intends to defend the lawsuit vigorously.
As required under ASC 450, Contingencies, the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with the legal proceedings described above based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time or is not deemed material. The Company believes that it has valid defenses with respect to these legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of any of these legal proceedings or because of the diversion of management’s attention and the creation of significant expenses.
Guarantees
Under the Company’s certificate of incorporation and bylaws, the Company has agreed to indemnify its directors and executive officers to the fullest extent not prohibited by Delaware and other applicable law, subject to certain exceptions. The Company has entered into individual indemnification agreements with its directors and officers. The term of the indemnification period is for the entirety of the director’s or officer’s service to the Company and continues so long as the director or officer may be subject to any claim, action, or proceeding, and there is no limit on the potential amount of future payments that the Company could be required to make under these indemnification agreements. The Company has purchased a directors’ and officers’ liability insurance policy that may enable it to recover a portion of any future payments that it may be required to make under these indemnification agreements. Assuming the applicability of coverage and the willingness of the insurer to assume coverage and subject to certain retention, loss limits, and other policy provisions, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations. However, no assurances can be given that the insurers will not attempt to dispute the validity, applicability, or amount of coverage without expensive and time-consuming litigation against the insurers.
Additionally, the Company undertakes indemnification obligations in its ordinary course of business in connection with, among other things, the licensing of its products and the provision of its support services. In the ordinary course of the Company’s business, the Company has in the past and may in the future agree to indemnify another party, generally its business affiliates or customers, against certain losses suffered or incurred by the indemnified party in connection with various types of claims, which may include, without limitation, claims of intellectual property infringement, certain tax liabilities, its gross negligence or intentional acts in the performance of support services, and violations of laws. The term of these indemnification obligations is generally perpetual. In general, the Company attempts to limit the maximum potential amount of future payments that it may be required to make under these indemnification obligations to the amounts paid to it by a customer, but in some cases the obligation may not be so limited.
F-36
In addition, the Company has in the past and may in the future warrant to its customers that its products will conform to functional specifications for a limited period of time following the date of installation (generally not exceeding 30 days) or that its software media is free from material defects. Sales contracts for certain of the Company’s medication packaging systems often include limited warranties for up to six months, but the periodic activity and ending warranty balances the Company records have historically been immaterial.
From time to time, the Company may also warrant that its professional services will be performed in a good and workmanlike manner or in a professional manner consistent with industry standards. The Company generally seeks to disclaim most warranties, including any implied or statutory warranties such as warranties of merchantability, fitness for a particular purpose, title, quality, and non-infringement, as well as any liability with respect to incidental, consequential, special, exemplary, punitive, or similar damages. In some states, such disclaimers may not be enforceable. If necessary, the Company would provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. The Company has not been subject to any significant claims for such losses and has not incurred any material costs in defending or settling claims related to these indemnification obligations. Accordingly, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations or potential warranty claims and, therefore, no material liabilities have been recorded for such indemnification obligations as of December 31, 2020 and 2019.
Note 14.     Employee Benefits and Share-Based Compensation
Stock Purchase Plan
1997 Employee Stock Purchase Plan
The Company has an Employee Stock Purchase Plan (“ESPP”), under which employees can purchase shares of its common stock based on a percentage of their compensation, but not greater than 15% of their earnings; provided, however, an eligible employee’s right to purchase shares of the Company’s common stock may not accrue at a rate which exceeds $25,000 of the fair market value of such shares for each calendar year in which such rights are outstanding. The purchase price per share must be equal to the lower of 85% of the fair value of the common stock at the beginning of a 24-month offering period or the end of each six-month purchasing period.
There was a total of 1.2 million shares reserved for future issuance under the ESPP as of December 31, 2020.
Stock Award Plans
2009 Equity Incentive Plan
The 2009 Equity Incentive Plan (“2009 Plan”), as amended, provides for the issuance of incentive stock options, RSAs, RSUs, PSUs, and other stock awards to the Company’s employees, directors, and consultants. There were 5.9 million shares of common stock reserved for future issuance under the 2009 Plan as of December 31, 2020.
Options granted under the 2009 Plan generally become exercisable over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 36 equal monthly installments thereafter. The exercise prices of the options is the fair market value of common stock on the date of grant. RSUs generally vest over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 12 equal quarterly installments thereafter. Awards of restricted stock to non-employee directors are granted on the date of the annual meeting of stockholders and vest in full on the date of the next annual meeting of stockholders, provided such non-employee director remains a director on such date. The fair value of the awards on the date of issuance is amortized to expense from the date of grant to the date of vesting and are expensed ratably on a straight-line basis over the vesting period. PSUs granted to the Company’s executives might include performance and market conditions. PSUs become eligible for vesting when certain market or performance conditions are met.
F-37
Share-Based Compensation Expense
The following table sets forth the total share-based compensation expense recognized in the Company’s Consolidated Statements of Operations:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$7,469 $5,648 $4,634 
Research and development6,497 6,604 5,746 
Selling, general, and administrative30,731 21,797 18,505 
Total share-based compensation expense$44,697 $34,049 $28,885 
The Company did not capitalize any share-based compensation as inventory as such amounts were not material for the years ended December 31, 2020 and 2019. Income tax benefits realized from share-based compensation were $10.3 million, $11.0 million, and $6.5 million, for the years ended December 31, 2020, 2019, and 2018, respectively.
Stock Options and ESPP Shares
The following assumptions were used to value stock options and ESPP shares granted pursuant to the Company’s equity incentive plans for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
Stock options
Expected life, years4.74.44.8
Expected volatility, %39.4 %33.7 %31.1 %
Risk-free interest rate, %0.7 %2.0 %2.8 %
Estimated forfeiture rate, %5.7 %7.2 %6.9 %
Dividend yield, %— %— %— %
Year Ended December 31,
202020192018
Employee stock purchase plan shares
Expected life, years
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility, %
30.4% - 53.5%
28.2% - 39.9%
28.1% - 33.8%
Risk-free interest rate, %
0.1% - 2.7%
1.3% - 2.7%
0.8% - 2.7%
Dividend yield, %— %— %— %
F-38
Stock Options Activity
The following table summarizes the share option activity under the Company’s 2009 Plan during the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Outstanding at December 31, 20193,902 $52.75 7.7$113,198 
Granted1,351 78.83 
Exercised(891)42.67 
Expired(19)59.65 
Forfeited(411)66.65 
Outstanding at December 31, 20203,932 $62.50 7.8$226,160 
Exercisable at December 31, 20201,556 $45.49 6.2$115,949 
Vested and expected to vest at December 31, 2020 and thereafter3,755 $61.86 7.7$218,379 
The weighted-average fair value per share of options granted during the years ended December 31, 2020, 2019, and 2018 was $26.48, $23.54, and $17.22, respectively. The intrinsic value of options exercised during the years ended December 31, 2020, 2019, and 2018 was $39.8 million, $32.8 million, and $20.1 million, respectively. The tax benefit realized from stock options exercised was $7.1 million, $6.3 million, and $3.6 million, for the years ended December 31, 2020, 2019, and 2018, respectively.
As of December 31, 2020, total unrecognized compensation cost related to unvested stock options was $52.7 million, which is expected to be recognized over a weighted-average vesting period of 2.8 years.
Employee Stock Purchase Plan Activity
For the years ended December 31, 2020 and 2019, employees purchased approximately 333,000 and 374,000 shares of common stock, respectively, under the ESPP at a weighted-average price of $48.77 and $41.44, respectively. As of December 31, 2020, the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $4.1 million and is expected to be recognized over a weighted-average period of 1.3 years.
Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)
Summaries of the restricted stock activity under the 2009 Plan are presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Restricted stock units
Outstanding at December 31, 2019544 $66.65 1.6$44,492 
Granted (Awarded)343 74.52 
Vested (Released)(183)61.30 
Forfeited(124)67.16 
Outstanding and unvested at December 31, 2020580 $72.87 1.6$69,670 
The weighted-average grant date fair value per share of RSUs granted during the years ended December 31, 2020, 2019, and 2018 was $74.52, $78.49, and $59.52, respectively. The total fair value of RSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $11.2 million, $10.6 million, and $7.9 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to RSUs was $40.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 3.1 years.
F-39
Number of
Shares
Weighted-Average
Grant Date Fair Value
(In thousands, except per share data)
Restricted stock awards
Outstanding at December 31, 201917 $81.92 
Granted (Awarded)21 68.11 
Vested (Released)(17)81.92 
Outstanding and unvested at December 31, 202021 $68.11 
The weighted-average grant date fair value per share of RSAs granted during the years ended December 31, 2020, 2019, and 2018 was $68.11, $81.86, and $46.60, respectively. The total fair value of RSAs that vested in the years ended December 31, 2020, 2019, and 2018 was $1.4 million, $1.0 million, and $1.0 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to RSAs was $0.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 0.4 years.
Performance-Based Restricted Stock Units (PSUs)
In 2019, the Company granted 61,098 PSUs to its executive officers, all of which became eligible for vesting upon the achievement of a certain level of shareholder return. In 2020, the Company granted 62,759 PSUs to its executive officers, all, none, or a portion of which may become eligible for vesting depending on the level of shareholder return for the period from March 1, 2020 through March 1, 2021.
The fair value of PSU awards to executive officers is determined using a Monte Carlo simulation model. The number of shares that vest at the end of the performance period depends on the percentile ranking of the total shareholder return for Omnicell stock over the performance period relative to the total shareholder return of each of the other companies in the NASDAQ Healthcare Index (the “Index”).
For PSUs granted on February 13, 2020, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2020, compared to the trailing 20-day average stock price just prior to the first trading day of March 2021. For PSUs granted on February 13, 2019, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2019, compared to the trailing 20-day average stock price just prior to the first trading day of March 2020.
On March 5, 2019, the Compensation Committee confirmed the Company's total stockholder return at the 90th percentile rank of the Index. This resulted in 100% of the 2018 PSUs, or 110,432 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 5, 2019 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2019. Vesting is contingent upon continued service. Of the 110,432 shares eligible for time-based vesting under the 2018 PSUs, 67,066 shares, net of forfeitures, have vested as of December 31, 2020.
On March 3, 2020, the Compensation Committee confirmed the Company's total stockholder return at the 70th percentile rank of the Index. This resulted in 100% of the 2019 PSUs, or 61,098 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 3, 2020 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2020. Vesting is contingent upon continued service. Of the 61,098 shares eligible for time-based vesting under the 2019 PSUs, 30,548 shares, net of forfeitures, have vested as of December 31, 2020.
In addition to executive officers' PSU awards, from time to time, the Company may grant PSUs with specific performance and service conditions to certain employees on an ad hoc basis. Historically such grants have not been material.
F-40
A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value Per Unit
(In thousands, except per share data)
Outstanding at December 31, 2019134 $55.82 
Granted99 82.17 
Vested(73)50.54 
Forfeited(5)81.72 
Outstanding and unvested at December 31, 2020155 $74.26 
The weighted-average grant date fair value per share of PSUs granted during the years ended December 31, 2020, 2019, and 2018 was $82.17, $73.38, and $38.03, respectively. The total fair value of PSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $3.7 million, $3.5 million, and $3.2 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to PSUs was approximately $5.6 million, which is expected to be recognized over the remaining weighted-average period of 1.4 years.
Summary of Shares Reserved for Future Issuance under Equity Incentive Plans
The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of December 31, 2020:
Number of Shares
(In thousands)
Share options outstanding3,932 
Non-vested restricted stock awards756 
Shares authorized for future issuance1,250 
ESPP shares available for future issuance1,206 
Total shares reserved for future issuance7,144 
401(k) Plan
The Company has established a pre-tax savings plan under Section 401(k) of the Internal Revenue Code of 1986, as amended. The 401(k) Plan allows eligible employees in the United States to voluntarily contribute a portion of their pre-tax salary, subject to a maximum limit specified in the Internal Revenue Code. The Company matches 50% of employee contributions up to $3,000, annually. The Company’s contributions under this plan were $5.7 million, $5.1 million, and $4.6 million in the years ended December 31, 2020, 2019, and 2018, respectively.
Note 15. Stock Repurchase Program
On August 2, 2016, the Company’s Board of Directors (the “Board”) authorized a stock repurchase program providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2016 Repurchase Program”). The 2016 Repurchase Program is in addition to the stock repurchase program approved by the Board on November 4, 2014 providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2014 Repurchase Program”). As of December 31, 2020, the maximum dollar value of shares that may yet be purchased under the two repurchase programs was $54.9 million.
The timing, price, and volume of repurchases are to be based on market conditions, relevant securities laws, and other factors. The stock repurchases may be made from time to time on the open market, in privately negotiated transactions, or pursuant to a Rule 10b-18 plan, subject to the terms and conditions of that certain A&R Credit Agreement, as amended. The stock repurchase programs do not obligate the Company to repurchase any specific number of shares, and the Company may terminate or suspend the repurchase programs at any time.
On September 17, 2020, the Board authorized a one-time stock repurchase transaction providing for the repurchase of up to $75.0 million of the Company’s common stock in privately negotiated transactions concurrently with the issuance of the Notes, described in Note 10, Convertible Senior Notes. In September 2020, the Company repurchased 749,300 shares of its common stock from purchasers of the Notes in the offering in privately negotiated transactions effected through one of the
F-41
initial purchasers or its affiliate at an average price of $70.78 per share for an aggregate purchase price of approximately $53.0 million. There will be no further repurchases under this one-time authorization.
During the years ended December 31, 2020, 2019, and 2018, the Company did not repurchase any of its outstanding common stock, including under the 2014 Repurchase Program or the 2016 Repurchase Program, other than the separately-authorized one-time stock repurchase concurrent with the offering of the Notes in September 2020.
Note 16.    Equity Offerings
On November 3, 2017, the Company entered into a Distribution Agreement (the “Distribution Agreement”) with J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, and HSBC Securities (USA) Inc., as its sales agents, pursuant to which the Company was able to offer and sell from time to time through the sales agents up to $125.0 million maximum aggregate offering price of the Company’s common stock. Sales of the common stock pursuant to the Distribution Agreement may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the Nasdaq Stock Market, or sales made to or through a market maker other than on an exchange.
For the year ended December 31, 2018, the Company received gross proceeds of $40.3 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 557,000 shares of its common stock at an average price of approximately $72.40 per share.
For the year ended December 31, 2019, the Company received gross proceeds of $38.5 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 460,000 shares of its common stock at an average price of approximately $83.81 per share.
For the year ended December 31, 2020, the Company did not sell any of its common stock under the Distribution Agreement.
The registration statement under which the shares that could have been sold pursuant to the Distribution Agreement expired on November 3, 2020, and, accordingly, no additional sales will be made pursuant to the Distribution Agreement.
Note 17.     Income Taxes
The following is a geographical breakdown of income (loss) before the provision for income taxes:
Year Ended December 31,
202020192018
(In thousands)
Domestic$34,714 $81,641 $46,528 
Foreign(5,365)(7,708)(10,912)
Income (loss) before provision for income taxes$29,349 $73,933 $35,616 
The provision for (benefit from) income taxes consisted of the following:
Year Ended December 31,
202020192018
(In thousands)
Current:
Federal$1,874 $8,006 $1,404 
State1,733 4,549 1,832 
Foreign647 1,240 768 
Total current income taxes4,254 13,795 4,004 
Deferred:
Federal(3,868)(1,292)5,455 
State(2,494)(1,609)(909)
Foreign(737)1,701 (10,663)
Total deferred income taxes(7,099)(1,200)(6,117)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
F-42
The provision for (benefit from) income taxes differs from the amount computed by applying the statutory federal tax rate as follows:
Year Ended December 31,
202020192018
(In thousands)
U.S. federal tax provision at statutory rate$6,163 $15,525 $7,479 
State taxes(601)2,258 651 
Section 162(m) limitation2,550 2,279 738 
Non-deductible expenses325 619 686 
Uncertain tax positions(394)(2,472)(412)
Share-based compensation tax benefit(6,929)(7,892)(4,005)
Research tax credits(4,038)(3,805)(3,230)
Restructuring impact— 7,432 (4,205)
Foreign derived intangible income deduction(204)(449)(349)
Foreign rate differential(102)(1,424)561 
Other385 524 (27)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
As a result of global operational centralization activities during the year ended December 31, 2018, the Company recognized $4.2 million of tax benefit associated with making a check-the-box election to treat Aesynt Holding Coöperatief U.A. (Netherlands) as the U.S. disregarded entity beginning in the first quarter of 2018. Subsequently, during the year ended December 31, 2019, the Company recognized gain on the sale of certain intellectual property rights by Aesynt B.V. to Omnicell, Inc. and by Mach4 Automatisierungstechnik GmbH ("Mach4") to Omnicell, Inc., which resulted in a tax expense, net of tax benefit, of $7.4 million. As the Company continued with global operational centralization activities during the year ended December 31, 2020, Aesynt B.V. merged with and into Aesynt Holding B.V., with Aesynt Holding B.V. surviving and changing its name to Omnicell B.V., Aesynt Holding Coöperatief U.A. liquidated into Omnicell, Inc., and Omnicell GmbH merged with and into Mach4, with Mach4 surviving and changing its name to Omnicell GmbH. During the year ended December 31, 2020, the Company also recognized a gain on Omnicell Limited’s transferring shares of Omnicell GmbH to Omnicell International, LLC, which resulted in an immaterial tax expense.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was signed into law in response to the COVID-19 pandemic. The CARES Act, among other provisions, includes provisions related to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, net operating losses carryback periods, alternative minimum tax credit refunds, modification to the net interest expense deduction limitation, and technical amendments to tax depreciation methods for qualified improvement property placed in service after December 31, 2017. The provisions of the CARES Act did not have a material impact on the Company’s income taxes.
F-43
Significant components of the Company’s deferred tax assets (liabilities) were as follows:
December 31,
20202019
(In thousands)
Deferred tax assets (liabilities):
Deferred revenues$5,910 $4,129 
Share-based compensation8,094 6,483 
Inventory-related items4,953 3,507 
Tax credit carryforwards12,105 13,472 
Reserves and accruals8,160 5,712 
Loss carryforwards8,461 9,484 
Lease liability15,465 15,471 
Other, net1,578 543 
Gross deferred tax assets64,726 58,801 
Valuation allowance(1,199)(1,186)
Total net deferred tax assets63,527 57,615 
Intangibles(22,010)(18,941)
Depreciation and amortization(36,528)(35,941)
Prepaid expenses(15,654)(13,395)
Right-of-use assets(13,949)(14,286)
Total deferred tax liabilities(88,141)(82,563)
Net deferred tax liabilities$(24,614)$(24,948)
Deferred income tax assets (liabilities) are provided for temporary differences that will result in future tax deductions or future taxable income, as well as the future benefit of tax credit carryforwards. The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. On the basis of this evaluation, as of December 31, 2020, $1.2 million of valuation allowance was recorded on certain foreign net operating losses carried forward, as the Company believes that such deferred tax assets are not more likely than not to be realized.
As of December 31, 2020, the Company had $6.0 million of state net operating loss carryforwards expiring at various dates beginning in 2024, and $29.7 million of foreign net operating losses carried forward indefinitely. For income tax purposes, the Company has federal and California research tax credits carryforwards of $1.3 million and $17.0 million, respectively. Federal research tax credit carryforwards from prior years will begin to expire in 2035. California credits are available indefinitely to reduce cash taxes payable.
It is the Company's practice and intention to reinvest the earnings of its non-U.S. subsidiaries in those operations. As of December 31, 2020, the Company has not made a provision for U.S. federal income, withholding, and state income taxes on the outside basis difference related to certain foreign subsidiaries because earnings are intended to be indefinitely reinvested in operations outside the U.S.
The Company files income tax returns in the United States and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities, including major jurisdictions such as the United States, Germany, Italy, Netherlands, and the United Kingdom. With few exceptions, as of December 31, 2020, the Company was no longer subject to U.S., state, and foreign examination for years before 2017, 2016, and 2016, respectively.
F-44
The aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the three years ended December 31, 2020 was as follows:
(In thousands)
Balance as of December 31, 2017$10,741 
Increases related to tax positions taken during a prior period19 
Decreases related to tax positions taken during the prior period(1,257)
Increases related to tax positions taken during the current period870 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(412)
Balance as of December 31, 20189,961 
Increases related to tax positions taken during a prior period10 
Decreases related to tax positions taken during the prior period(6)
Increases related to tax positions taken during the current period9,282 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(2,472)
Balance as of December 31, 201916,775 
Increases related to tax positions taken during a prior period88 
Decreases related to tax positions taken during the prior period— 
Increases related to tax positions taken during the current period2,294 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(911)
Balance as of December 31, 2020$18,246 
The total amounts of gross unrecognized tax benefit that, if realized, would favorably affect the Company's effective income tax rate in future periods, was $18.2 million and $16.8 million as of December 31, 2020 and 2019, respectively. The Company recognizes interest and/or penalties related to uncertain tax positions in interest and other income (expense), net in the Consolidated Statements of Operations, accruing $0.4 million, $0.5 million, and $0.5 million for the years ended December 31, 2020, 2019, and 2018, respectively. Accrued interest and penalties are included within other long-term liabilities on the Consolidated Balance Sheets. The combined amount of cumulative accrued interest and penalties was approximately $1.4 million, $1.0 million, and $1.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The Company does not believe there will be any significant changes in its unrecognized tax positions over the next twelve months.
Note 18.    Restructuring Expenses
In the first quarter of 2020, the Company announced a company-wide organizational realignment initiative in order to more effectively align its organizational infrastructure and operations with the strategic vision of the autonomous pharmacy. In the second quarter of 2020, the Company continued its organizational realignment initiative, as well as initiated a restructuring plan to help mitigate the adverse impact of the COVID-19 pandemic on its business and financial results. During the year ended December 31, 2020, the Company incurred and accrued $10.0 million of employee severance costs and related expenses. As of December 31, 2020, the unpaid balance related to this restructuring plan was $0.6 million.
In the fourth quarter of 2018, the Company announced a company-wide organizational realignment initiative in order to align its organizational infrastructure for future expected growth. During the year ended December 31, 2018, the Company accrued and paid out $1.3 million of restructuring expenses, which includes severance and consulting-related expenses.
On March 2, 2018, the Company initiated the realignment of its Automation and Analytics commercial group in North America and France. During the year ended December 31, 2018, the Company accrued and paid out $3.0 million of employee severance costs and related expenses.
F-45
The following table summarizes the total restructuring expenses recognized in the Company’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$2,564 $— $186 
Research and development3,716 — — 
Selling, general, and administrative3,681 — 4,160 
Total restructuring expenses$9,961 $— $4,346 

F-46
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
Balance at
Beginning of Period (1)
Charged (Credited) to
Costs and Expenses (2)
Debited (Credited) to
Other Accounts (3)
Amounts
Written Off (4)
Other Adjustments (5)
Balance at
End of Period (1)
(In thousands)
Year ended December 31, 2018
Accounts receivable and unbilled receivables$5,738 $(127)$12 $(3,010)$(31)$2,582 
Long-term unbilled receivables— — — — — — 
Net investment in sales-type leases192 10 12 — — 214 
Total allowances deducted from assets$5,930 $(117)$24 $(3,010)$(31)$2,796 
Year ended December 31, 2019
Accounts receivable and unbilled receivables$2,582 $2,488 $— $(1,986)$143 $3,227 
Long-term unbilled receivables— — — — — — 
Net investment in sales-type leases214 11 — — — 225 
Total allowances deducted from assets$2,796 $2,499 $— $(1,986)$143 $3,452 
Year ended December 31, 2020
Accounts receivable and unbilled receivables$3,227 $1,095 $— $(535)$499 $4,286 
Long-term unbilled receivables— — — — 30 30 
Net investment in sales-type leases225 40 — — — 265 
Total allowances deducted from assets$3,452 $1,135 $— $(535)$529 $4,581 
__________________________________________________
(1)Allowance for credit losses.
(2)Represents amounts charged and credited for provisions for credit losses.
(3)Represents amounts debited to receivables as recoveries, increasing the allowance.
(4)Represents amounts written off from the allowance and receivable.
(5)Represents other adjustments, such as foreign currency translation, adoption of new accounting guidance, and purchase price accounting adjustments in connection with acquisitions.
F-47
INDEX TO EXHIBITS
Incorporated By Reference
Exhibit NumberExhibit DescriptionFormFile No.ExhibitFiling Date
2.18-K000-330432.110/29/2015
2.28-K000-330432.111/29/2016
2.38-K000-330432.18/12/2020
2.410-Q000-330432.210/30/2020
3.110-Q000-330433.19/20/2001
3.210-Q000-330433.28/9/2010
3.310-K000-330433.23/28/2003
3.48-K000-330433.18/12/2020
4.1Reference is made to Exhibits 3.1, 3.2, 3.3, and 3.4
4.2S-1/A333-570244.17/24/2001
4.310-K000-330434.72/26/2020
4.48-K000-330434.19/25/2020
4.58-K000-330434.29/25/2020
10.1*S-8333-20546599.27/2/2015
10.2*S-8333-23166999.15/22/2019
10.3*10-K000-3304310.173/11/2011
10.4*10-Q000-3304310.48/9/2012
10.5*10-Q000-3304310.58/9/2012
10.6*S-8333-22517999.45/24/2018
10.7*8-K000-3304310.13/8/2019
10.8*10-Q000-3304310.17/31/2020

Incorporated By Reference
Exhibit NumberExhibit DescriptionFormFile No.ExhibitFiling Date
10.9*+
10.10*+
10.11*8-K000-3304310.13/17/2010
10.12*10-Q000-3304310.15/5/2017
10.13*10-K000-3304310.342/26/2020
10.14*S-1333-5702410.123/14/2001
10.15*10-Q000-3304310.411/6/2015
10.16*10-K000-3304310.263/8/2004
10.17*10-K000-3304310.143/11/2011
10.18*10-K000-3304310.292/24/2009
10.19*10-Q000-3304310.311/6/2015
10.20*10-K000-3304310.412/27/2019
10.2110-K000-3304310.93/8/2012
10.22+
10.2310-Q000-3304310.35/6/2016
10.24+
10.25+
10.26+
10.27+
10.2810-Q000-3304310.35/5/2017
10.2910-K000-3304310.392/26/2020

Incorporated By Reference
Exhibit NumberExhibit DescriptionFormFile No.ExhibitFiling Date
10.308-K000-330431.111/3/2017
10.318-K000-3304310.111/18/2019
10.328-K000-3304310.19/22/2020
10.338-K000-3304310.19/25/2020
10.348-K000-3304310.29/25/2020
21.1+
23.1+
24.1+
31.1+
31.2+
32.1+
101.INS+
Inline XBRL Instance Document - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH+
Inline XBRL Taxonomy Extension Schema Document
101.CAL+
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF+
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB+
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE+
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104+
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101).
_________________________________________________
*    Indicates a management contract, compensation plan, or arrangement.
+    Filed herewith.

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
OMNICELL, INC.
Date:February 24, 2021By:/s/ PETER J. KUIPERS
Peter J. Kuipers,
Executive Vice President & Chief Financial Officer
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each of the persons whose signature appears below hereby constitutes and appoints Randall A. Lipps and Peter J. Kuipers, each of them acting individually, as his or her attorney-in-fact, each with the full power of substitution, for him or her in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming our signatures as they may be signed by our said attorney-in-fact and any and all amendments to this Annual Report on Form 10-K.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
SignatureTitleDate
/s/ RANDALL A. LIPPSChief Executive Officer, President and Chairman of the Board (Principal Executive Officer)February 24, 2021
Randall A. Lipps
/s/ PETER J. KUIPERSExecutive Vice President & Chief Financial Officer
(Principal Financial Officer)		February 24, 2021
Peter J. Kuipers
/s/ JOSEPH B. SPEARSSenior Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)February 24, 2021
Joseph B. Spears
/s/ JOANNE B. BAUERFebruary 24, 2021
Joanne B. BauerDirector
/s/ JAMES T. JUDSONFebruary 24, 2021
James T. JudsonDirector
/s/ VANCE B. MOOREFebruary 24, 2021
Vance B. Moore Director
/s/ MARK W. PARRISHFebruary 24, 2021
Mark W. ParrishDirector
/s/ ROBIN G. SEIMFebruary 24, 2021
Robin G. SeimDirector
/s/ BRUCE E. SCOTTFebruary 24, 2021
Bruce E. ScottDirector
/s/ BRUCE D. SMITHFebruary 24, 2021
Bruce D. SmithDirector
/s/ SARA J. WHITEFebruary 24, 2021
Sara J. WhiteDirector

S-1
 EX-10.9 2 exhibit109q4-20.htm EX-10.9 Document

Exhibit 10.9
Restricted Stock UnitOmnicell, Inc.
Grant Notice590 E. Middlefield,
Mountain View, CA 94043

Name:Employee ID:

You have been granted a Restricted Stock Unit Award in Omnicell, Inc. Common Stock as follows:

    Type of Award:     Restricted Stock Unit (RSU)
    Grant No.:    
    Equity Incentive Plan:    2009 Equity Incentive Plan
    Date of Grant:    
    Shares Subject to Award:     
    Fair Market Value per Unit:     
    Total Price of Stock Unit:     


Vesting Date
 
Number of Shares
Vesting on Vesting Date
   
   
   

Delivery Schedule: Pursuant to Section 6 of the 2009 Equity Incentive Plan Global Restricted Stock Unit Award Agreement (the “Restricted Stock Unit Award Agreement”), the Company shall deliver on each vesting date one share of Common Stock for each Stock Unit which vests on such date, less any shares to be withheld pursuant to Section 10 of such Global Restricted Stock Unit Award Agreement.
By your acceptance of this Restricted Stock Unit Grant, you agree that this award is granted under and governed by the terms and conditions of this Grant Notice, Omnicell, Inc.’s 2009 Equity Incentive Plan (as amended from time to time) (the “Plan”) and by the terms and conditions of the Global Restricted Stock Unit Award Agreement which is attached hereto.

You understand and agree that as of the Date of Grant, this Grant Notice, the Global Restricted Stock Unit Award Agreement and the Plan set forth the entire understanding between you and Omnicell, Inc. regarding the grant set forth herein, and the underlying Common Stock, and supersede all prior oral and written agreements on that subject.

Chief Financial Officer

Attachment: Global Restricted Stock Unit Award Agreement




Omnicell, Inc.
2009 Equity Incentive Plan
Global Restricted Stock Unit Award Agreement
Amended by the Compensation Committee
of the Board of Directors: July 22, 2020

Pursuant to the Restricted Stock Unit Grant Notice (“Grant Notice”) and this Global Restricted Stock Unit Award Agreement, including any country-specific appendix thereto (the “Appendix” and collectively, the “Agreement”) and in consideration of your services, Omnicell, Inc. (the “Company”) has awarded you a Restricted Stock Unit Award (the “Award”) under its 2009 Equity Incentive Plan (the “Plan”). Your Award is granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award. This Agreement shall be deemed to be agreed to by the Company and you upon the acceptance by you of the Grant Notice to which it is attached. Defined terms not explicitly defined in this Agreement shall have the same meanings given to them in the Plan. In the event of any conflict between the terms in this Agreement and the Plan, the terms of the Plan shall control. The details of your Award, in addition to those set forth in the Grant Notice and the Plan, are as follows.
1.Grant of the Award. This Award represents the right to be issued on a future date the number of shares of the Company’s Common Stock as indicated in the Grant Notice. As of the Date of Grant, the Company will credit to a bookkeeping account maintained by the Company for your benefit (the “Account”) the number of shares of Common Stock subject to the Award. This Award was granted in consideration of your future services to the Company or an Affiliate. Except as otherwise provided herein, you will not be required to make any payment to the Company (other than services to the Company or an Affiliate) with respect to your receipt of the Award, the vesting of the shares or the delivery of the underlying Common Stock.
2.Vesting. Subject to the limitations contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service. For purposes of your Award, a termination of your Continuous Service will be deemed to have occurred as of the date you are no longer actively providing services to the Company or an Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or otherwise rendering services, or the terms of your employment or other service agreement, if any). Your employment or service relationship will not be extended by any notice period (e.g., your period of service will not be extended by any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where you are employed or otherwise rendering services, or the terms of your employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when you are no longer providing Continuous Services for purposes of your Award (including whether you may still be considered to be providing services while on a leave of absence). Upon such termination of your Continuous Service, the shares
1


credited to the Account that were not vested on the date of such termination will be forfeited at no cost to the Company and you will have no further right, title or interest in or to such underlying shares of Common Stock. For the avoidance of doubt, service during any portion of the vesting period shall not entitle you to vest in a pro rata portion of the Award.
3.Number of Shares.
(a)The number of shares subject to your Award may be adjusted from time to time for Capitalization Adjustments, as provided in the Plan.
(b)Any shares, cash or other property that becomes subject to the Award pursuant to this Section 3, if any, shall be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable to the other shares covered by your Award.
(c)Notwithstanding the provisions of this Section 3, no fractional shares or rights for fractional shares of Common Stock shall be created pursuant to this Section 3. The Board shall, in its discretion, determine an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments referred to in this Section 3.
4.Compliance with Law. You may not be issued any shares under your Award unless either (i) the shares are registered under the Securities Act; or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Your Award also must comply with other applicable securities and exchange control laws and regulations relevant to the Company and the offer of the RSUs and the underlying shares of Common Stock, and you will not receive such shares if the Company determines that such receipt would not be in material compliance with such laws and regulations. You understand that the Company is under no obligation to register or qualify the shares of Common Stock with the SEC or any state or non-U.S. securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the shares of Common Stock. Further, you agree that the Company shall have unilateral authority to amend this Agreement without your consent, to the extent necessary to comply with securities or other laws applicable to the issuance of shares of Common Stock.
5.Limitations on Transfer. Your Award is not transferable, except by will or by applicable laws of descent and distribution. In addition to any other limitation on transfer created by applicable securities laws, you agree not to assign, hypothecate, donate, encumber or otherwise dispose of any interest in any of the shares of Common Stock subject to the Award until the shares are issued to you in accordance with Section 6 of this Agreement. After the shares have been issued to you, you are free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein and applicable securities laws. Notwithstanding the foregoing and to the extent permitted by applicable laws, (i) by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your death, shall thereafter be entitled to receive any distribution of Common Stock to which you
2


were entitled at the time of your death pursuant to this Agreement or (ii) upon receiving written permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your right to receive the distribution of Common Stock or other consideration hereunder, pursuant to a domestic relations order or marital settlement agreement that contains the information required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any division of this Award with the Company General Counsel prior to finalizing the domestic relations order or marital settlement agreement to verify that you may make such transfer, and if so, to help ensure the required information is contained within the domestic relations order or marital settlement agreement.
6.Date of Issuance. The Company will deliver to you a number of shares of the Company’s Common Stock equal to the number of vested shares subject to your Award, including any additional shares received pursuant to Section 3 above that relate to those vested shares on the applicable vesting date(s). However, if a scheduled delivery date falls on a date that is not a U.S. business day, such delivery date shall instead fall on the next following U.S. business day. The form of such delivery (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.
7.Dividends. You shall receive no benefit or adjustment to your Award with respect to any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment as provided in Section 9(a) of the Plan; provided, however, that this sentence shall not apply with respect to any shares of Common Stock that are delivered to you in connection with your Award after such shares have been delivered to you.
8.Restrictive Legends. The shares issued under your Award shall be endorsed with appropriate legends determined by the Company.
9.Award not a Service Contract.
(a)Your Continuous Service with the Company or an Affiliate is not for any specified term and may be terminated by you or by the Company or an Affiliate at any time, for any reason. Nothing in this Agreement (including, but not limited to, the vesting of your Award pursuant to the schedule set forth in Section 2 herein or the issuance of the shares subject to your Award), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan shall:  (i) confer upon you any right to continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Agreement or Plan; or (iv) deprive the Company or an Affiliate of the right to terminate you and without regard to any future vesting opportunity that you may have.
3


(b)By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to the schedule set forth in Section 2 is earned only by continuing to provide Continuous Service (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time to time, as it deems appropriate (a “reorganization”).  You further acknowledge and agree that such a reorganization could result in the termination of your Continuous Service, or the termination of Affiliate status of your employer and the loss of benefits available to you under this Agreement, including but not limited to, the termination of the right to continue vesting in the Award. You further acknowledge and agree that this Agreement, the Plan, the transactions contemplated hereunder and the vesting schedule set forth herein or any covenant of good faith and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement for the term of this Agreement, for any period, or at all, and shall not interfere in any way with your right or the Company’s right to terminate your Continuous Service at any time.
(c)No claim or entitlement to compensation or damages shall arise from forfeiture of the Awards resulting from the termination of your Continuous Service (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any).
10.Responsibility for Taxes.
(a)You acknowledge that, regardless of any action taken by the Company or, if different, the Affiliate employing or otherwise retaining your services (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”), is and remains your responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. You further acknowledge that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited to, the grant, vesting or settlement of the Award, the subsequent sale of shares of Common Stock acquired pursuant to such settlement and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, you acknowledge that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
4


    On or before the time you receive a distribution of the shares in respect of your Award, or at any time thereafter as requested by the Company and/or the Employer, you hereby authorize any required withholding from the Common Stock issuable to you and/or otherwise agree to make adequate provision in cash for any sums required to satisfy the Tax-Related Items. Except as provided below, the Company shall withhold from the shares of Common Stock issuable to you to satisfy the Tax-Related Items. By your acceptance of the Award, you agree that: (i) in the event that such withholding from the shares of Common Stock is problematic under applicable tax or securities law or has materially adverse accounting consequences, the Company shall instead withhold from any other compensation paid to you by the Company or the Employer in partial or full satisfaction of the Tax-Related Items, and (ii) the Company may determine in its sole discretion to instead withhold from any other compensation paid to you by the Company or the Employer in partial or full satisfaction of the Tax-Related Items, provided that if you are subject to reporting obligations under Section 16 of the Exchange Act, exercise of such discretion is subject to the prior approval and direction of the Committee. In no way limiting the foregoing, the Company is hereby authorized to withhold shares of Common Stock that are otherwise to be issued and delivered to you under this Award in partial or full satisfaction of the Tax-Related Items; provided, however, that no shares of Common Stock shall be withheld with a value exceeding the minimum amount of tax required to be withheld by law. If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common Stock subject to the vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.
(b)You agree to pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. Unless the obligation for Tax-Related Items is satisfied, the Company shall have no obligation to deliver to you any Common Stock.
(c)In the event the obligation of the Company and/or any Affiliate to withhold arises prior to the delivery to you of Common Stock or it is determined after the delivery of Common Stock to you that the amount of the withholding obligation was greater than the amount, if any, withheld by the Company and/or any Affiliate, you agree to indemnify and hold the Company and its Affiliates harmless from any failure by the Company and/or any Affiliate to withhold the proper amount.
11.Unsecured Obligation. Your Award is unfunded, and as a holder of a vested Award, you shall be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares pursuant to this Agreement. You shall not have
5


voting or any other rights as a stockholder of the Company with respect to the shares to be issued pursuant to this Agreement until such shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing contained in this Agreement, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.
12.Notices. Any notices provided for in your Award or the Plan shall be given in writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address provided to the Company. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and, if requested, to agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
13.Nature of Grant. In accepting the grant, you acknowledge, understand and agree that:
(a)the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(b)the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted in the past;
(c)all decisions with respect to future Awards or other grants, if any, will be at the sole discretion of the Company;
(d)you are voluntarily participating in the Plan;
(e)the Awards and the shares of Common Stock subject to the Awards, and the income from and value of same, are not intended to replace any pension rights or compensation;
(f)the Awards and the shares of Common Stock subject to the Awards, and the income from and value of same, are not part of normal or expected compensation for purposes of, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar mandatory payments;
(g)the future value of the underlying shares of Common Stock is unknown, indeterminable and cannot be predicted with certainty;
6


(h)unless otherwise agreed with the Company, the Awards and the shares of Common Stock acquired under the Plan, and the income from and value of same, are not granted as consideration for, or in connection with, any service you may provider as a director of any parent company or Affiliate;
(i)unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement, do not create any entitlement to have the Awards or any such benefits transferred to or assumed by another company, nor to be exchanged, cashed out or substituted for in connection with any corporate transaction affecting the Common Stock; and
(j)neither the Company, the Employer nor any Subsidiary or Affiliate of the Company shall be liable for any foreign exchange rate fluctuation between your local currency and the United States Dollar that may affect the value of the Awards or of any amounts due to you pursuant to the settlement of the Awards or the subsequent sale of any shares of Common Stock acquired upon settlement.
14.No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying shares of Common Stock. You should consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.
15.Data Privacy. If you would like to participate in the Plan, you will need to review the information provided in this Section 15 and, where applicable, declare consent to the processing and/or transfer of personal data as described below.
(a)Data Collection and Usage. The Company collects, processes and uses personal data about you, including but not limited to, your name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, which the Company receives from you or your Employer (“Personal Data”). In order you to participate in the Plan, the Company will collect Personal Data for purposes of allocating shares of Common Stock and implementing, administering and managing the Plan.
If you are based in the United Kingdom, the EU or EEA, the Company’s legal basis for the processing of Personal Data is the necessity of the processing for the Company's performance of its obligations under the Plan and, where applicable, the Company’s legitimate interest of complying with contractual or statutory obligations to which it is subject.
7


If you are based in any other jurisdiction, the Company's legal basis for the processing of Personal Data is your consent, as further described below.

(b)Stock Plan Administration and Service Providers. The Company may transfer Personal Data to Morgan Stanley/E*Trade (“Service Provider”), an independent service provider based in the U.S., which is assisting the Company with the implementation, administration and management of the Plan. Service Provider may open an account for you to receive and trade shares of Common Stock. You may be asked to acknowledge, or agree to, separate terms and data processing practices with Service Provider, with such agreement being a condition to the ability to participate in the Plan.
(c)International Data Transfers. Personal Data will be transferred from your country to the U.S., where the Company and its service providers are based. You understand and acknowledge that the U.S. might have enacted data privacy laws that are less protective or otherwise different from those applicable in your country of residence. For example, the EU Commission has issued only a limited adequacy finding with respect to the U.S. that applies solely if and to the extent companies self-certify and remain selfcertified under the EU/U.S. Privacy Shield program. In the absence of such certification, an appropriate level of protection can be achieved by implementing safeguards such as the Standard Contractual Clauses adopted by the EU Commission.
If you are based in the UK/EU/EEA, Personal Data will be transferred from the UK/EU/EEA to the Company based on the Company’s certification under the EU-U.S. Privacy Shield program. The onward transfer of Personal Data by the Company to Service Provider will be based on consent and/or applicable data protection laws. You may request a copy of such appropriate safeguards at GDPR@omnicell.com.
If you are based in any other jurisdiction, the Company’s legal basis for the transfer of the Personal Data to the U.S. is your consent, as further described below.
(d)Data Retention. The Company will use Personal Data only as long as necessary to implement, administer and manage your participation in the Plan or as required to comply with legal or regulatory obligations, including, without limitation, under tax and securities laws. When the Company no longer needs Personal Data for any of the above purposes, the Company will cease to use Personal Data for this purpose. If the Company keeps Personal Data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be relevant laws or regulations (if you are in the UK/EU/EEA) and/or your consent (if you are outside the UK/EU/EEA).
8


(e)Data Subject Rights. You understand that you may have a number of rights under data privacy laws in your jurisdiction. Subject to the conditions set out in the applicable law and depending on where you are based, such rights may include the right to (i) request access to, or copies of, Personal Data processed by the Company, (ii) rectification of incorrect Personal Data, (iii) deletion of Personal Data, (iv) restrictions on the processing of Personal Data, (v) object to the processing of Personal Data for legitimate interests, (vi) portability of Personal Data, (vii) lodge complaints with competent authorities in your jurisdiction, and/or to (viii) receive a list with the names and addresses of any potential recipients of Personal Data. To receive clarification regarding these rights or to exercise these rights, you can contact GDPR@omnicell.com or our EU Data Protection Officer as follows:
2B Advice GmbH
Joseph-Schumpeter-Allee 25, 53227 Bonn, Germany
Telephone: +49 228 926165 120
E-Mail: omnicell@2b-advice.com
(f)Necessary Disclosure of Personal Data. You understand that providing the Company with Personal Data is necessary for the performance of the Agreement and that your refusal to provide Personal Data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the Plan.
(g)Voluntariness and Consequences of Consent Denial or Withdrawal. If you are located in a jurisdiction outside the UK/EU/EEA, you hereby unambiguously consent to the collection, use and transfer, in electronic or other form, of your Personal Data, as described above and in any other grant materials, by and among, as applicable, your Employer, the Company and any Affiliate for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that you may, at any time, refuse or withdraw the consents herein, in any case without cost, by contacting in writing your human resources representative. If you do not consent or later seek to revoke your consent, your employment status or service with your Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant the Awards or other equity awards to you or administer or maintain such awards. Therefore, you understand that refusing or withdrawing consent may affect your ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, you should contact your local human resources representative.
9


Declaration of Consent. If you are based outside of the UK/EU/EEA, by accepting the Awards and indicating consent by signing the Grant Notice or through the Company’s online acceptance procedure, you explicitly declare your consent to the entirety of the Personal Data processing operations described above including, without limitation, the onward transfer of Personal Data by the Company to the Service Provider or, as the case may be, a different service provider of the Company in the U.S.

16.Miscellaneous.
(a)The rights and obligations of the Company under your Award shall be transferable to any one or more persons or entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. Your rights and obligations under your Award may only be assigned with the prior written consent of the Company.
(b)You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your Award.
(c)You acknowledge and agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award, and fully understand all provisions of your Award.
(d)This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
(e)All obligations of the Company under the Plan and this Agreement shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
17.Governing Plan Document. Your Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. Except as expressly provided herein, in the event of any conflict between the provisions of your Award and those of the Plan, the provisions of the Plan shall control.
18.Language. You acknowledge that you are sufficiently proficient in English or have consulted with an advisor who is sufficiently proficient in English, so as to allow you to understand the terms and conditions of this Agreement. If you have received this Agreement or any other document related to the Plan translated into a language other than English and if the
10


meaning of the translated version is different than the English version, the English version will control.
19.Severability. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.
20.Choice of Law; Venue. The interpretation, performance and enforcement of this Agreement will be governed by the law of the state of California without regard to such state’s conflicts of laws rules. For purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of Santa Clara County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.
21.Amendment. This Agreement may not be modified, amended or terminated except by an instrument in writing, signed or otherwise accepted by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which specifically states that it is amending this Agreement, so long as a copy of such amendment is delivered to you, and provided that no such amendment adversely affecting your rights hereunder may be made without your written consent. Without limiting the foregoing, the Board reserves the right, by written notice to you, to impose new provisions or to change the existing provisions of this Agreement in any way it may deem necessary or advisable for legal or administrative reasons to carry out the purpose of the grant.
22.Insider Trading Restrictions/Market Abuse Laws. You acknowledge that you may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including but not limited to the United States, your country, the broker’s country and the country or countries in which the Common Stock is listed, which may affect your ability, directly or indirectly, to purchase or sell, or attempt to sell or otherwise dispose of shares of Common Stock, rights to shares of Common Stock (e.g., Awards), or rights linked to the value of shares of Common Stock, during such times as you are considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdiction(s)). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before possessing the inside information. Furthermore, you understand that you may be prohibited from (i) disclosing the inside information to any third party, including fellow employees and (ii) “tipping” third parties by sharing with them Company insider information, or otherwise causing third parties to buy or sell Company securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may apply to you under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any applicable restrictions, and you should speak to your personal advisor on this matter.
11


23.Foreign Asset/Account Reporting Requirements. If you reside in a country outside the United States, there may be certain foreign asset and/or account reporting requirements which may affect your ability to acquire or hold shares of Common Stock or cash received from participating in the Plan (including from any dividends paid on shares of Common Stock) in a brokerage account or bank outside of your country. You may be required to report such accounts, assets or related transactions to the tax or other authorities in your country. You may also be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to your country within a certain time after receipt. It is your responsibility to comply with such regulations and you should speak to your personal legal advisor on this matter.
24.Appendix. Notwithstanding any provisions in this Agreement, the Award grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country. Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country, if any, will apply to you, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendix constitutes part of this Agreement.
25.Imposition of Other Requirements. The Company reserves the right to impose other requirements on your participation in the Plan, on the Awards and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
26.Waiver. You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other Participant.
27.Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

* * * * *









12


Appendix

Omnicell, Inc.
2009 Equity Incentive Plan

Global Restricted Stock Unit Award Agreement

Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Global Restricted Stock Unit Agreement (the “Agreement”) or the Plan.
Terms and Conditions
This Appendix includes additional terms and conditions that govern the Restricted Stock Unit Award (“RSUs”) granted to you under the Plan if you work and/or reside in one of the countries listed below. This Appendix forms part of the Agreement.
If you are a citizen or resident of a country other than the one in which you are currently residing and/or working, transfer employment and/or residency to another country after the Date of Grant, or are considered a resident of another country for local law purposes, the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall be applicable to you.
Notifications
This Appendix also includes information regarding exchange control and certain other issues of which you should be aware with respect to participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2020. Such laws are often complex and change frequently. As a result, the Company strongly recommends that you not rely on the information in this Appendix as the only source of information relating to the consequences of participation in the Plan because the information may be out of date at the time you vest in the RSUs and acquire shares of Common Stock or sell shares of Common Stock acquired under the Plan.
In addition, the information contained herein is general in nature and may not apply to your particular situation and the Company is not in a position to assure you of any particular result. Accordingly, you should seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.

Finally, if you are a citizen or resident of a country other than the one in which you are currently residing and/or working, transfer employment and/or residency to another country after the Date of Grant, or are considered a resident of another country for local law purposes, the information contained herein may not apply to you in the same manner.





13




Australia

Notifications
Offer Document. This Offer Document sets out information regarding the grant of RSUs over shares of the Company to Australian residents and is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000.
In addition to the information set out in this Offer Document, you also are being provided with copies of the following documents:
(a)the Agreement;
(b)the Grant Notice;
(c)the Plan;
(d)the U.S. prospectus for the Plan (the “Plan Prospectus”); and
(e)the Employee Information Supplement for Australia.
(collectively, the “Additional Documents”).
The Agreement sets out, among other details, the vesting conditions applicable to your RSUs, information on the settlement of your RSUs and the consequences of a change in the nature or status of your employment.
The other Additional Documents provide further information to assist you to make an informed investment decision in relation to your participation in the Plan. Neither the Plan nor the Plan Prospectus is a prospectus for the purposes of the Corporations Act.
You should not rely upon any oral statements made to you in relation to this offer. You should only rely upon the statements contained in this Offer Document and the Additional Documents when considering your participation in the Plan.
Securities Law Notification
Investment in shares involves a degree of risk. Eligible persons who elect to participate in the Plan should monitor their participation and consider all risk factors relevant to the acquisition of shares under the Plan as set out in this Offer Document and the Additional Documents.
The information contained in this Offer Document and the Additional Documents is general information only. Any information set out in this Offer Document or in the Additional Documents in relation to this offer of RSUs does not take into account your objectives, financial situation or needs.
14



Persons participating in the Plan should consider obtaining their own financial product advice from an independent person who is licensed by the Australian Securities and Investments Commission to give such advice.

Additional Risk Factors for Australian Residents

Australian residents should have regard to risk factors relevant to investment in securities generally and, in particular, to the holding of shares. For example, the price at which shares are quoted on the Nasdaq Global Select Market (“Nasdaq”) may increase or decrease due to a number of factors. There is no guarantee that the price of shares will increase. Factors which may affect the price of shares include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks.
More information about potential factors that could affect the Company’s business and financial results is included in the Company’s most recent Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q, available upon request. In addition, you should be aware that the Australian dollar value of shares you may acquire at vesting will be affected by the U.S. dollar/Australian dollar exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.
Shares of Common Stock
Shares represent common stock in a U.S. corporation, and are analogous to the common shares of an Australian corporation to the extent that your liability is limited as a shareholder. However, ownership of shares may not be taxed in the same manner as ownership of shares in an Australian corporation and a portion of the gain from a disposition of your shares of shares may be subject to U.S. federal income tax. You are urged to consult your own legal and tax advisors concerning the consequences to you of holding and disposing of shares.
Dividends may be paid on shares at the discretion of the board of directors of the Company
Shares are traded on the Nasdaq Stock Market in the United States of America and are traded under the symbol “OMCL”.
Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.
Ascertaining Market Price of Shares
15


You may ascertain the current or historical market price of shares as traded on the Nasdaq at http://www.nasdaq.com under the symbol “OMCL”. The Australian dollar equivalent of that price can be obtained at: http://www.rba.gov.au/statistics/frequency/exchange-rates.html.
This will not be a prediction of what the market price per share will be when the RSUs vest or when the shares are issued or of the applicable exchange rate on the actual vesting date or date the shares are issued.
Tax Information
The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to the conditions in the Act). For information related to the Australian tax consequences of the RSUs, please refer to the Employee Information Supplement for Australia.
Canada

Terms and Conditions

Settlement of RSUs.   Notwithstanding any discretion in the Plan or anything to the contrary in the Agreement, the RSUs do not provide any right for you, as a resident of Canada, to receive a cash payment and the RSUs shall be paid in shares of Common Stock only.

Nature of Grant. The following provision replaces Section 2 of the Agreement:
Subject to the limitations contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service.
For purposes of the Award, a termination of your Continuous Service will be deemed to occur as of the date that is the earlier of (i) the date of your termination, (ii) the date you receive notice of termination, or (iii) the date you are no longer actively providing services and will not be extended by any notice period (e.g., active service would not include any contractual notice period or any period of “garden leave” or similar period mandated under Canadian laws or the terms of your employment or service agreement, if any), regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or providing services or the terms of your employment or service agreement, if any; unless otherwise expressly provided in this Agreement or determined by the Company, your right to vest in the Awards under the Plan, if any, will terminate as of such date; in the event that the date you are no longer actively providing services cannot be reasonably determined under the terms of this Agreement and the Plan, the Committee shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of your Award (including whether you may still be considered to be providing services while on a leave of absence). Notwithstanding the foregoing, if applicable employment legislation explicitly requires continued vesting during a statutory notice period, your right to vest in the Awards, if any, will terminate effective as of the last date of the minimum statutory notice period but you will not earn or be entitled to pro-rated vesting if the vesting date falls after
16


the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.



The following provisions apply if you are a resident of Quebec:

Language Consent.  The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices, and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.

Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents, avis et procédures judiciaires, exécutés, donnés ou intentés en vertu de, ou liés directement ou indirectement à, la présente convention.

Data Privacy Notice and Consent.  This provision supplements Section 15 of the Agreement:

You hereby authorize the Company and the Company’s representative to discuss with and obtain all relevant information from all personnel (professional or not) involved in the administration and operation of the Plan. You further authorize the Company and your Employer to disclose and discuss your participation in the Plan with their advisors. You also authorize the Company and your Employer to record such information and keep it in your employee file.

Notifications
Securities Law Information. The sale of shares of Common Stock acquired under the Plan may not take place in Canada. This requirement will be satisfied where the shares of Common Stock are sold by the designated broker under the Plan through the facilities of the U.S. stock exchange on which the shares of Common Stock are currently listed (i.e., the Nasdaq stock market).

Foreign Asset/Account Reporting Information.  Canadian residents are required to report their foreign specified property (e.g., shares of Common Stock) on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds C$100,000 at any time in the year. The RSUs must be reported—generally at a nil cost—if the C$100,000 threshold is exceeded because of other foreign specific property held by you. The shares of Common Stock acquired under the Plan must be reported and their cost generally is the adjusted cost base (“ACB”) of the shares of Common Stock. The ACB ordinarily would equal the fair market value of the shares of Common Stock at the time of acquisition, but if such Canadian resident owns other shares of Common Stock, this ACB may have to be averaged with the ACB of the other shares. The form T1135 generally must be filed by April 30 of the following year. Canadian residents should consult with a personal advisor to ensure compliance with the applicable reporting requirements.

France

17


Terms and Conditions

RSUs Not Tax-Qualified. The RSUs granted under this Agreement are not intended to qualify for special tax and social security treatment pursuant to Sections L. 225-197-1 to L. 225-197-6 of the French Commercial Code, as amended.
Language Consent. By accepting the RSUs, you confirm having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language. You accept the terms of those documents accordingly.
En acceptant les droits sur des actions assujettis à restrictions (« restricted stock units » ou « RSUs »), vous confirmez avoir lu et compris le Plan et le Contrat, en ce compris tous les termes et conditions de ces documents, qui ont été fournis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.

Notifications

Foreign Asset/Account Reporting Information. French residents holding cash or securities (including shares of Common Stock) outside of France or maintaining a foreign bank or brokerage account (including accounts opened or closed during the tax year) must declare such assets and accounts to the French tax authorities when filing an annual tax return. Failure to comply could trigger significant penalties.

Germany

Notifications

Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank (Bundesbank). In the event you make or receive a payment in excess of this amount, you must report the payment to Bundesbank electronically using the “General Statistics Reporting Portal” (“Allgemeines Meldeportal Statistik”) available via Bundesbank’s website (www.bundesbank.de).

Foreign Asset/Account Reporting Information. If your acquisition of shares acquired under the Plan leads to a so-called qualified participation at any point during the calendar year, you may need to report the acquisition when you file your tax return for the relevant year. A qualified participation is attained if (i) you own at least 1% of the Company and the value of the shares of Common Stock acquired exceeds €150,000 or (ii) you hold shares of Common Stock exceeding 10% of the Company’s total Common Stock.

United Arab Emirates

Notifications

Securities Law Information. Participation in the Plan is being offered only to eligible
18


employees and is in the nature of providing equity incentives to employees in the United Arab
Emirates. The Plan and the Agreement are intended for distribution only to such employees and
must not be delivered to, or relied on by, any other person. Prospective purchasers of the
securities offered should conduct their own due diligence on the securities. The Emirates
Securities and Commodities Authority has no responsibility for reviewing or verifying any
documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai
Department of Economic Development has approved the Plan or the Agreement nor taken steps
to verify the information set out therein, and has no responsibility for such documents.



United Kingdom

Terms and Conditions

Settlement. The following provision supplements Section 3 of the Agreement:

Notwithstanding any discretion contained in the Plan or the Agreement, the RSUs will not be settled in cash or a combination of cash and shares of Common Stock. The RSUs will be settled only in shares of Common Stock.

Responsibility for Taxes. This provision supplements Section 10 of the Agreement:

Without limitation to Section 10 of the Agreement, you hereby agree that you are liable for any Tax-Related Items related to your participation in the Plan and hereby covenant to pay such Tax-Related Items, as and when requested by the Company or (if different) the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax or relevant authority).  You also hereby agree to indemnify and keep indemnified the Company and (if different) the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax or relevant authority) on your behalf.
Notwithstanding the foregoing, if you are an executive officer or director (as within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. Instead, any Tax-Related Items not collected or paid may constitute a benefit to you on which additional income tax and National Insurance Contributions (“NICs”) may be payable. You understand that you will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and/or the Employer (as appropriate) the amount of any employee NICs due on this additional benefit, which can be recovered by any means set out in the Agreement.

National Insurance Contributions Acknowledgment. As a condition of participation in the Plan and the vesting of the RSUs, you agree to accept any liability for secondary Class 1 NICs which may be payable by the Company and/or the Employer in connection with the RSUs and any event giving rise to Tax-Related Items (the “Employer NICs”). Without limitation to the foregoing, you agree to execute a joint election with the Company, the form of such joint
19


election being formally approved by HMRC (the “Joint Election”), and any other required consent or election. You further agree to execute such other joint elections as may be required between you and any successor to the Company and/or the Employer. You further agree that the Company and/or the Employer may collect the Employer NICs from you by any of the means set forth in Section 10 of the Agreement. You must enter into the Joint Election concurrent with the execution of the Agreement.

If you do not enter into a Joint Election prior to the vesting of the RSUs or if approval of the Joint Election has been withdrawn by HMRC, the RSUs shall become null and void without any liability to the Company and/or the Employer.
20
 EX-10.10 3 exhibit1010q4-20.htm EX-10.10 Document

Exhibit 10.10
Restricted Stock UnitOmnicell, Inc.
Grant Notice590 E. Middlefield,
Mountain View, CA 94043

Name:Employee ID:

You have been granted a Restricted Stock Unit Award in Omnicell, Inc. Common Stock as follows:

    Type of Award:     Restricted Stock Unit (RSU)
    Grant No.:    
    Equity Incentive Plan:    2009 Equity Incentive Plan
    Date of Grant:    
    Shares Subject to Award:     
    Fair Market Value per Unit:     
    Total Price of Stock Unit:     


Vesting Date
 
Number of Shares
Vesting on Vesting Date
   
   
   

Delivery Schedule: Pursuant to Section 6 of the 2009 Equity Incentive Plan Global Restricted Stock Unit Award Agreement (the “Restricted Stock Unit Award Agreement”), the Company shall deliver on each vesting date one share of Common Stock for each Stock Unit which vests on such date, less any shares to be withheld pursuant to Section 10 of such Global Restricted Stock Unit Award Agreement.
By your acceptance of this Restricted Stock Unit Grant, you agree that this award is granted under and governed by the terms and conditions of this Grant Notice, Omnicell, Inc.’s 2009 Equity Incentive Plan (as amended from time to time) (the “Plan”) and by the terms and conditions of the Global Restricted Stock Unit Award Agreement which is attached hereto.

You understand and agree that as of the Date of Grant, this Grant Notice, the Global Restricted Stock Unit Award Agreement and the Plan set forth the entire understanding between you and Omnicell, Inc. regarding the grant set forth herein, and the underlying Common Stock, and supersede all prior oral and written agreements on that subject.

Chief Financial Officer

Attachment: Global Restricted Stock Unit Award Agreement


1.


Omnicell, Inc.
2009 Equity Incentive Plan
Global Restricted Stock Unit Award Agreement
Amended by the Compensation Committee
of the Board of Directors: February 18, 2021

Pursuant to the Restricted Stock Unit Grant Notice (“Grant Notice”) and this Global Restricted Stock Unit Award Agreement, including any country-specific appendix thereto (the “Appendix” and collectively, the “Agreement”) and in consideration of your services, Omnicell, Inc. (the “Company”) has awarded you a Restricted Stock Unit Award (the “Award”) under its 2009 Equity Incentive Plan (the “Plan”). Your Award is granted to you effective as of the Date of Grant set forth in the Grant Notice for this Award. This Agreement shall be deemed to be agreed to by the Company and you upon the acceptance by you of the Grant Notice to which it is attached. Defined terms not explicitly defined in this Agreement shall have the same meanings given to them in the Plan. In the event of any conflict between the terms in this Agreement and the Plan, the terms of the Plan shall control. The details of your Award, in addition to those set forth in the Grant Notice and the Plan, are as follows.
1.Grant of the Award. This Award represents the right to be issued on a future date the number of shares of the Company’s Common Stock as indicated in the Grant Notice. As of the Date of Grant, the Company will credit to a bookkeeping account maintained by the Company for your benefit (the “Account”) the number of shares of Common Stock subject to the Award. This Award was granted in consideration of your future services to the Company or an Affiliate. Except as otherwise provided herein, you will not be required to make any payment to the Company (other than services to the Company or an Affiliate) with respect to your receipt of the Award, the vesting of the shares or the delivery of the underlying Common Stock.
2.Vesting. Subject to the limitations contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service. For purposes of your Award, a termination of your Continuous Service will be deemed to have occurred as of the date you are no longer actively providing services to the Company or an Affiliate (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or otherwise rendering services, or the terms of your employment or other service agreement, if any). Your employment or service relationship will not be extended by any notice period (e.g., your period of service will not be extended by any contractual notice period or any period of “garden leave” or similar period mandated under employment laws in the jurisdiction where you are employed or otherwise rendering services, or the terms of your employment or service agreement, if any). The Committee shall have the exclusive discretion to determine when you are no longer providing Continuous Services for purposes of your Award (including whether you may still be considered to be providing services while on a leave of absence). Upon such termination of your Continuous Service, the shares credited to the Account that were not vested on the date of such termination will be forfeited at no cost to the Company and you will have no further right, title or interest in or to such underlying shares of Common Stock.
2.


For the avoidance of doubt, service during any portion of the vesting period shall not entitle you to vest in a pro rata portion of the Award.
3.Number of Shares.
(a)The number of shares subject to your Award may be adjusted from time to time for Capitalization Adjustments, as provided in the Plan.
(b)Any shares, cash or other property that becomes subject to the Award pursuant to this Section 3, if any, shall be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of delivery as applicable to the other shares covered by your Award.
(c)Notwithstanding the provisions of this Section 3, no fractional shares or rights for fractional shares of Common Stock shall be created pursuant to this Section 3. The Board shall, in its discretion, determine an equivalent benefit for any fractional shares or fractional shares that might be created by the adjustments referred to in this Section 3.
4.Compliance with Law. You may not be issued any shares under your Award unless either (i) the shares are registered under the Securities Act; or (ii) the Company has determined that such issuance would be exempt from the registration requirements of the Securities Act. Your Award also must comply with other applicable securities and exchange control laws and regulations relevant to the Company and the offer of the RSUs and the underlying shares of Common Stock, and you will not receive such shares if the Company determines that such receipt would not be in material compliance with such laws and regulations. You understand that the Company is under no obligation to register or qualify the shares of Common Stock with the SEC or any state or non-U.S. securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the shares of Common Stock. Further, you agree that the Company shall have unilateral authority to amend this Agreement without your consent, to the extent necessary to comply with securities or other laws applicable to the issuance of shares of Common Stock.
5.Limitations on Transfer. Your Award is not transferable, except by will or by applicable laws of descent and distribution. In addition to any other limitation on transfer created by applicable securities laws, you agree not to assign, hypothecate, donate, encumber or otherwise dispose of any interest in any of the shares of Common Stock subject to the Award until the shares are issued to you in accordance with Section 6 of this Agreement. After the shares have been issued to you, you are free to assign, hypothecate, donate, encumber or otherwise dispose of any interest in such shares provided that any such actions are in compliance with the provisions herein and applicable securities laws. Notwithstanding the foregoing and to the extent permitted by applicable laws, (i) by delivering written notice to the Company, in a form satisfactory to the Company, you may designate a third party who, in the event of your death, shall thereafter be entitled to receive any distribution of Common Stock to which you were entitled at the time of your death pursuant to this Agreement or (ii) upon receiving written permission from the Board or its duly authorized designee, and provided that you and the designated transferee enter into transfer and other agreements required by the Company, you may transfer your right to receive the distribution of Common Stock or other consideration hereunder, pursuant to a domestic relations order or marital settlement agreement that contains the information
3.


required by the Company to effectuate the transfer. You are encouraged to discuss the proposed terms of any division of this Award with the Company General Counsel prior to finalizing the domestic relations order or marital settlement agreement to verify that you may make such transfer, and if so, to help ensure the required information is contained within the domestic relations order or marital settlement agreement.
6.Date of Issuance. The Company will deliver to you a number of shares of the Company’s Common Stock equal to the number of vested shares subject to your Award, including any additional shares received pursuant to Section 3 above that relate to those vested shares on the applicable vesting date(s). However, if a scheduled delivery date falls on a date that is not a U.S. business day, such delivery date shall instead fall on the next following U.S. business day. The form of such delivery (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.
7.Dividends. You shall receive no benefit or adjustment to your Award with respect to any cash dividend, stock dividend or other distribution that does not result from a Capitalization Adjustment as provided in Section 9(a) of the Plan; provided, however, that this sentence shall not apply with respect to any shares of Common Stock that are delivered to you in connection with your Award after such shares have been delivered to you.
8.Restrictive Legends. The shares issued under your Award shall be endorsed with appropriate legends determined by the Company.
9.Award not a Service Contract.
(a)Your Continuous Service with the Company or an Affiliate is not for any specified term and may be terminated by you or by the Company or an Affiliate at any time, for any reason. Nothing in this Agreement (including, but not limited to, the vesting of your Award pursuant to the schedule set forth in Section 2 herein or the issuance of the shares subject to your Award), the Plan or any covenant of good faith and fair dealing that may be found implicit in this Agreement or the Plan shall:  (i) confer upon you any right to continue in the employ of, or affiliation with, the Company or an Affiliate; (ii) constitute any promise or commitment by the Company or an Affiliate regarding the fact or nature of future positions, future work assignments, future compensation or any other term or condition of employment or affiliation; (iii) confer any right or benefit under this Agreement or the Plan unless such right or benefit has specifically accrued under the terms of this Agreement or Plan; or (iv) deprive the Company or an Affiliate of the right to terminate you and without regard to any future vesting opportunity that you may have.
(b)By accepting this Award, you acknowledge and agree that the right to continue vesting in the Award pursuant to the schedule set forth in Section 2 is earned only by continuing to provide Continuous Service (not through the act of being hired, being granted this Award or any other award or benefit) and that the Company has the right to reorganize, sell, spin-out or otherwise restructure one or more of its businesses or Affiliates at any time or from time to time, as it deems appropriate (a “reorganization”).  You further acknowledge and agree that such a reorganization could result in the
4.


termination of your Continuous Service, or the termination of Affiliate status of your employer and the loss of benefits available to you under this Agreement, including but not limited to, the termination of the right to continue vesting in the Award. You further acknowledge and agree that this Agreement, the Plan, the transactions contemplated hereunder and the vesting schedule set forth herein or any covenant of good faith and fair dealing that may be found implicit in any of them do not constitute an express or implied promise of continued engagement for the term of this Agreement, for any period, or at all, and shall not interfere in any way with your right or the Company’s right to terminate your Continuous Service at any time.
(c)No claim or entitlement to compensation or damages shall arise from forfeiture of the Awards resulting from the termination of your Continuous Service (for any reason whatsoever, whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or the terms of your employment agreement, if any).
10.Responsibility for Taxes.
(a)You acknowledge that, regardless of any action taken by the Company or, if different, the Affiliate employing or otherwise retaining your services (the “Employer”), the ultimate liability for all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to your participation in the Plan and legally applicable to you (“Tax-Related Items”), is and remains your responsibility and may exceed the amount, if any, actually withheld by the Company or the Employer. You further acknowledge that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Award, including, but not limited to, the grant, vesting or settlement of the Award, the subsequent sale of shares of Common Stock acquired pursuant to such settlement and the receipt of any dividends; and (ii) do not commit to and are under no obligation to structure the terms of the grant or any aspect of the Award to reduce or eliminate your liability for Tax-Related Items or achieve any particular tax result. Further, if you are subject to Tax-Related Items in more than one jurisdiction, you acknowledge that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.
    On or before the time you receive a distribution of the shares in respect of your Award, or at any time thereafter as requested by the Company and/or the Employer, you hereby authorize any required withholding from the Common Stock issuable to you and/or otherwise agree to make adequate provision in cash for any sums required to satisfy the Tax-Related Items. Except as provided below, the Company shall withhold from the shares of Common Stock issuable to you to satisfy the Tax-Related Items. By your acceptance of the Award, you agree that: (i) in the event that such withholding from the shares of Common Stock is problematic under applicable tax or securities law or has materially adverse accounting consequences, the Company shall instead withhold from
5.


any other compensation paid to you by the Company or the Employer in partial or full satisfaction of the Tax-Related Items, and (ii) the Company may determine in its sole discretion to instead withhold from any other compensation paid to you by the Company or the Employer in partial or full satisfaction of the Tax-Related Items, provided that if you are subject to reporting obligations under Section 16 of the Exchange Act, exercise of such discretion is subject to the prior approval and direction of the Committee. In no way limiting the foregoing, the Company is hereby authorized to withhold shares of Common Stock that are otherwise to be issued and delivered to you under this Award in partial or full satisfaction of the Tax-Related Items; provided, however, that no shares of Common Stock shall be withheld with a value exceeding the minimum amount of tax required to be withheld by law. If the obligation for Tax-Related Items is satisfied by withholding in shares of Common Stock, for tax purposes, you are deemed to have been issued the full number of shares of Common Stock subject to the vested Award, notwithstanding that a number of the shares of Common Stock are held back solely for the purpose of paying the Tax-Related Items.
(b)You agree to pay the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of your participation in the Plan that cannot be satisfied by the means previously described. Unless the obligation for Tax-Related Items is satisfied, the Company shall have no obligation to deliver to you any Common Stock.
(c)In the event the obligation of the Company and/or any Affiliate to withhold arises prior to the delivery to you of Common Stock or it is determined after the delivery of Common Stock to you that the amount of the withholding obligation was greater than the amount, if any, withheld by the Company and/or any Affiliate, you agree to indemnify and hold the Company and its Affiliates harmless from any failure by the Company and/or any Affiliate to withhold the proper amount.
11.Unsecured Obligation. Your Award is unfunded, and as a holder of a vested Award, you shall be considered an unsecured creditor of the Company with respect to the Company’s obligation, if any, to issue shares pursuant to this Agreement. You shall not have voting or any other rights as a stockholder of the Company with respect to the shares to be issued pursuant to this Agreement until such shares are issued to you pursuant to Section 6 of this Agreement. Upon such issuance, you will obtain full voting and other rights as a stockholder of the Company. Nothing contained in this Agreement, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind or a fiduciary relationship between you and the Company or any other person.
12.Notices. Any notices provided for in your Award or the Plan shall be given in writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address provided to the Company. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and, if requested, to agree to participate in the
6.


Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
13.Nature of Grant. In accepting the grant, you acknowledge, understand and agree that:
(a)the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, to the extent permitted by the Plan;
(b)the grant of the Award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of Awards, or benefits in lieu of Awards, even if Awards have been granted in the past;
(c)all decisions with respect to future Awards or other grants, if any, will be at the sole discretion of the Company;
(d)you are voluntarily participating in the Plan;
(e)the Awards and the shares of Common Stock subject to the Awards, and the income from and value of same, are not intended to replace any pension rights or compensation;
(f)the Awards and the shares of Common Stock subject to the Awards, and the income from and value of same, are not part of normal or expected compensation for purposes of, without limitation, calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, holiday pay, bonuses, long-service awards, pension or retirement or welfare benefits or similar mandatory payments;
(g)the future value of the underlying shares of Common Stock is unknown, indeterminable and cannot be predicted with certainty;
(h)unless otherwise agreed with the Company, the Awards and the shares of Common Stock acquired under the Plan, and the income from and value of same, are not granted as consideration for, or in connection with, any service you may provider as a director of any parent company or Affiliate;
(i)unless otherwise provided in the Plan or by the Company in its discretion, the Awards and the benefits evidenced by this Agreement, do not create any entitlement to have the Awards or any such benefits transferred to or assumed by another company, nor to be exchanged, cashed out or substituted for in connection with any corporate transaction affecting the Common Stock; and
(j)neither the Company, the Employer nor any Subsidiary or Affiliate of the Company shall be liable for any foreign exchange rate fluctuation between your local currency and the United States Dollar that may affect the value of the Awards or of any amounts due to you pursuant to the settlement of the Awards or the subsequent sale of any shares of Common Stock acquired upon settlement.
7.


14.No Advice Regarding Grant. The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding your participation in the Plan, or your acquisition or sale of the underlying shares of Common Stock. You should consult with your own personal tax, legal and financial advisors regarding your participation in the Plan before taking any action related to the Plan.
15.Data Privacy. If you would like to participate in the Plan, you will need to review the information provided in this Section 15 and, where applicable, declare consent to the processing and/or transfer of personal data as described below.
(a)Data Collection and Usage. The Company collects, processes and uses personal data about you, including but not limited to, your name, home address, email address and telephone number, date of birth, social insurance number, passport number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Awards or any other entitlement to shares awarded, canceled, exercised, vested, unvested or outstanding in your favor, which the Company receives from you or your Employer (“Personal Data”). In order you to participate in the Plan, the Company will collect Personal Data for purposes of allocating shares of Common Stock and implementing, administering and managing the Plan.
If you are based in the United Kingdom, the EU or EEA, the Company’s legal basis for the processing of Personal Data is the necessity of the processing for the Company's performance of its obligations under the Plan and, where applicable, the Company’s legitimate interest of complying with contractual or statutory obligations to which it is subject.
If you are based in any other jurisdiction, the Company's legal basis for the processing of Personal Data is your consent, as further described below.

(b)Stock Plan Administration and Service Providers. The Company may transfer Personal Data to Morgan Stanley/E*Trade (“Service Provider”), an independent service provider based in the U.S., which is assisting the Company with the implementation, administration and management of the Plan. Service Provider may open an account for you to receive and trade shares of Common Stock. You may be asked to acknowledge, or agree to, separate terms and data processing practices with Service Provider, with such agreement being a condition to the ability to participate in the Plan.
(c)International Data Transfers. Personal Data will be transferred from your country to the U.S., where the Company and its service providers are based. You understand and acknowledge that the U.S. might have enacted data privacy laws that are less protective or otherwise different from those applicable in your country of residence. For example, the EU Commission has issued only a limited adequacy finding with respect to the U.S. that applies solely if and to the extent companies self-
8.


certify and remain selfcertified under the EU/U.S. Privacy Shield program. In the absence of such certification, an appropriate level of protection can be achieved by implementing safeguards such as the Standard Contractual Clauses adopted by the EU Commission.
If you are based in the UK/EU/EEA, Personal Data will be transferred from the UK/EU/EEA to the Company based on the Company’s certification under the EU-U.S. Privacy Shield program. The onward transfer of Personal Data by the Company to Service Provider will be based on consent and/or applicable data protection laws. You may request a copy of such appropriate safeguards at GDPR@omnicell.com.
If you are based in any other jurisdiction, the Company’s legal basis for the transfer of the Personal Data to the U.S. is your consent, as further described below.
(d)Data Retention. The Company will use Personal Data only as long as necessary to implement, administer and manage your participation in the Plan or as required to comply with legal or regulatory obligations, including, without limitation, under tax and securities laws. When the Company no longer needs Personal Data for any of the above purposes, the Company will cease to use Personal Data for this purpose. If the Company keeps Personal Data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be relevant laws or regulations (if you are in the UK/EU/EEA) and/or your consent (if you are outside the UK/EU/EEA).
(e)Data Subject Rights. You understand that you may have a number of rights under data privacy laws in your jurisdiction. Subject to the conditions set out in the applicable law and depending on where you are based, such rights may include the right to (i) request access to, or copies of, Personal Data processed by the Company, (ii) rectification of incorrect Personal Data, (iii) deletion of Personal Data, (iv) restrictions on the processing of Personal Data, (v) object to the processing of Personal Data for legitimate interests, (vi) portability of Personal Data, (vii) lodge complaints with competent authorities in your jurisdiction, and/or to (viii) receive a list with the names and addresses of any potential recipients of Personal Data. To receive clarification regarding these rights or to exercise these rights, you can contact GDPR@omnicell.com or our EU Data Protection Officer as follows:
2B Advice GmbH
Joseph-Schumpeter-Allee 25, 53227 Bonn, Germany
Telephone: +49 228 926165 120
E-Mail: omnicell@2b-advice.com
(f)Necessary Disclosure of Personal Data. You understand that providing the Company with Personal Data is necessary for the performance of the Agreement and that your refusal to provide Personal Data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the Plan.
9.


(g)Voluntariness and Consequences of Consent Denial or Withdrawal. If you are located in a jurisdiction outside the UK/EU/EEA, you hereby unambiguously consent to the collection, use and transfer, in electronic or other form, of your Personal Data, as described above and in any other grant materials, by and among, as applicable, your Employer, the Company and any Affiliate for the exclusive purpose of implementing, administering and managing your participation in the Plan. You understand that you may, at any time, refuse or withdraw the consents herein, in any case without cost, by contacting in writing your human resources representative. If you do not consent or later seek to revoke your consent, your employment status or service with your Employer will not be affected; the only consequence of refusing or withdrawing consent is that the Company would not be able to grant the Awards or other equity awards to you or administer or maintain such awards. Therefore, you understand that refusing or withdrawing consent may affect your ability to participate in the Plan. For more information on the consequences of refusal to consent or withdrawal of consent, you should contact your local human resources representative.
Declaration of Consent. If you are based outside of the UK/EU/EEA, by accepting the Awards and indicating consent by signing the Grant Notice or through the Company’s online acceptance procedure, you explicitly declare your consent to the entirety of the Personal Data processing operations described above including, without limitation, the onward transfer of Personal Data by the Company to the Service Provider or, as the case may be, a different service provider of the Company in the U.S.

16.Miscellaneous.
(a)The rights and obligations of the Company under your Award shall be transferable to any one or more persons or entities, and all covenants and agreements hereunder shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. Your rights and obligations under your Award may only be assigned with the prior written consent of the Company.
(b)You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your Award.
(c)You acknowledge and agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award, and fully understand all provisions of your Award.
(d)This Agreement shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
10.


(e)All obligations of the Company under the Plan and this Agreement shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.
17.Governing Plan Document. Your Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. Except as expressly provided herein, in the event of any conflict between the provisions of your Award and those of the Plan, the provisions of the Plan shall control.
18.Language. You acknowledge that you are sufficiently proficient in English or have consulted with an advisor who is sufficiently proficient in English, so as to allow you to understand the terms and conditions of this Agreement. If you have received this Agreement or any other document related to the Plan translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control.
19.Severability. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity shall not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.
20.Choice of Law; Venue. The interpretation, performance and enforcement of this Agreement will be governed by the law of the state of California without regard to such state’s conflicts of laws rules. For purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the courts of Santa Clara County, California, or the federal courts for the United States for the Northern District of California, and no other courts, where this grant is made and/or to be performed.
21.Amendment. This Agreement may not be modified, amended or terminated except by an instrument in writing, signed or otherwise accepted by you and by a duly authorized representative of the Company. Notwithstanding the foregoing, this Agreement may be amended solely by the Board by a writing which specifically states that it is amending this Agreement, so long as a copy of such amendment is delivered to you, and provided that no such amendment adversely affecting your rights hereunder may be made without your written consent. Without limiting the foregoing, the Board reserves the right, by written notice to you, to impose new provisions or to change the existing provisions of this Agreement in any way it may deem necessary or advisable for legal or administrative reasons to carry out the purpose of the grant.
22.Insider Trading Restrictions/Market Abuse Laws. You acknowledge that you may be subject to insider trading restrictions and/or market abuse laws in applicable jurisdictions, including but not limited to the United States, your country, the broker’s country and the country or countries in which the Common Stock is listed, which may affect your ability, directly or indirectly, to purchase or sell, or
11.


attempt to sell or otherwise dispose of shares of Common Stock, rights to shares of Common Stock (e.g., Awards), or rights linked to the value of shares of Common Stock, during such times as you are considered to have “inside information” regarding the Company (as defined by the laws in the applicable jurisdiction(s)). Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before possessing the inside information. Furthermore, you understand that you may be prohibited from (i) disclosing the inside information to any third party, including fellow employees and (ii) “tipping” third parties by sharing with them Company insider information, or otherwise causing third parties to buy or sell Company securities. Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may apply to you under any applicable Company insider trading policy. You acknowledge that it is your responsibility to comply with any applicable restrictions, and you should speak to your personal advisor on this matter.
23.Foreign Asset/Account Reporting Requirements. If you reside in a country outside the United States, there may be certain foreign asset and/or account reporting requirements which may affect your ability to acquire or hold shares of Common Stock or cash received from participating in the Plan (including from any dividends paid on shares of Common Stock) in a brokerage account or bank outside of your country. You may be required to report such accounts, assets or related transactions to the tax or other authorities in your country. You may also be required to repatriate sale proceeds or other funds received as a result of participating in the Plan to your country within a certain time after receipt. It is your responsibility to comply with such regulations and you should speak to your personal legal advisor on this matter.
24.Appendix. Notwithstanding any provisions in this Agreement, the Award grant shall be subject to any special terms and conditions set forth in any Appendix to this Agreement for your country. Moreover, if you relocate to one of the countries included in the Appendix, the special terms and conditions for such country, if any, will apply to you, to the extent the Company determines that the application of such terms and conditions is necessary or advisable for legal or administrative reasons. The Appendix constitutes part of this Agreement.
25.Imposition of Other Requirements. The Company reserves the right to impose other requirements on your participation in the Plan, on the Awards and on any shares of Common Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require you to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.
26.Waiver. You acknowledge that a waiver by the Company of breach of any provision of this Agreement shall not operate or be construed as a waiver of any other provision of this Agreement, or of any subsequent breach by you or any other Participant.
27.Electronic Delivery and Acceptance. The Company may, in its sole discretion, decide to deliver any documents related to current or future participation in the Plan by electronic means. You hereby consent to receive such documents by electronic delivery and agree to participate in the Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.

12.


* * * * *
Appendix

Omnicell, Inc.
2009 Equity Incentive Plan

Global Restricted Stock Unit Award Agreement

Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Global Restricted Stock Unit Agreement (the “Agreement”) or the Plan.
Terms and Conditions
This Appendix includes additional terms and conditions that govern the Restricted Stock Unit Award (“RSUs”) granted to you under the Plan if you work and/or reside in one of the countries listed below. This Appendix forms part of the Agreement.
If you are a citizen or resident of a country other than the one in which you are currently residing and/or working, transfer employment and/or residency to another country after the Date of Grant, or are considered a resident of another country for local law purposes, the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall be applicable to you.
Notifications
This Appendix also includes information regarding exchange control and certain other issues of which you should be aware with respect to participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of May 2020. Such laws are often complex and change frequently. As a result, the Company strongly recommends that you not rely on the information in this Appendix as the only source of information relating to the consequences of participation in the Plan because the information may be out of date at the time you vest in the RSUs and acquire shares of Common Stock or sell shares of Common Stock acquired under the Plan.
In addition, the information contained herein is general in nature and may not apply to your particular situation and the Company is not in a position to assure you of any particular result. Accordingly, you should seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.

Finally, if you are a citizen or resident of a country other than the one in which you are currently residing and/or working, transfer employment and/or residency to another country after the Date of Grant, or are considered a resident of another country for local law purposes, the information contained herein may not apply to you in the same manner.






13.



Australia

Notifications
Offer Document. This Offer Document sets out information regarding the grant of RSUs over shares of the Company to Australian residents and is intended to comply with the provisions of the Corporations Act 2001, ASIC Regulatory Guide 49 and ASIC Class Order CO 14/1000.
In addition to the information set out in this Offer Document, you also are being provided with copies of the following documents:
(a)the Agreement;
(b)the Grant Notice;
(c)the Plan;
(d)the U.S. prospectus for the Plan (the “Plan Prospectus”); and
(e)the Employee Information Supplement for Australia.
(collectively, the “Additional Documents”).
The Agreement sets out, among other details, the vesting conditions applicable to your RSUs, information on the settlement of your RSUs and the consequences of a change in the nature or status of your employment.
The other Additional Documents provide further information to assist you to make an informed investment decision in relation to your participation in the Plan. Neither the Plan nor the Plan Prospectus is a prospectus for the purposes of the Corporations Act.
You should not rely upon any oral statements made to you in relation to this offer. You should only rely upon the statements contained in this Offer Document and the Additional Documents when considering your participation in the Plan.
Securities Law Notification
Investment in shares involves a degree of risk. Eligible persons who elect to participate in the Plan should monitor their participation and consider all risk factors relevant to the acquisition of shares under the Plan as set out in this Offer Document and the Additional Documents.
The information contained in this Offer Document and the Additional Documents is general information only. Any information set out in this Offer Document or in the Additional Documents in relation to this offer of RSUs does not take into account your objectives, financial situation or needs.

14.


Persons participating in the Plan should consider obtaining their own financial product advice from an independent person who is licensed by the Australian Securities and Investments Commission to give such advice.

Additional Risk Factors for Australian Residents

Australian residents should have regard to risk factors relevant to investment in securities generally and, in particular, to the holding of shares. For example, the price at which shares are quoted on the Nasdaq Global Select Market (“Nasdaq”) may increase or decrease due to a number of factors. There is no guarantee that the price of shares will increase. Factors which may affect the price of shares include fluctuations in the domestic and international market for listed stocks, general economic conditions, including interest rates, inflation rates, commodity and oil prices, changes to government fiscal, monetary or regulatory policies, legislation or regulation, the nature of the markets in which the Company operates and general operational and business risks.
More information about potential factors that could affect the Company’s business and financial results is included in the Company’s most recent Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q, available upon request. In addition, you should be aware that the Australian dollar value of shares you may acquire at vesting will be affected by the U.S. dollar/Australian dollar exchange rate. Participation in the Plan involves certain risks related to fluctuations in this rate of exchange.
Shares of Common Stock
Shares represent common stock in a U.S. corporation, and are analogous to the common shares of an Australian corporation to the extent that your liability is limited as a shareholder. However, ownership of shares may not be taxed in the same manner as ownership of shares in an Australian corporation and a portion of the gain from a disposition of your shares of shares may be subject to U.S. federal income tax. You are urged to consult your own legal and tax advisors concerning the consequences to you of holding and disposing of shares.
Dividends may be paid on shares at the discretion of the board of directors of the Company
Shares are traded on the Nasdaq Stock Market in the United States of America and are traded under the symbol “OMCL”.
Shares are not liable to any further calls for payment of capital or for other assessment by the Company and have no sinking fund provisions, pre-emptive rights, conversion rights or redemption provisions.
Ascertaining Market Price of Shares
You may ascertain the current or historical market price of shares as traded on the Nasdaq at http://www.nasdaq.com under the symbol “OMCL”. The Australian dollar equivalent of that price can be obtained at: http://www.rba.gov.au/statistics/frequency/exchange-rates.html.
15.


This will not be a prediction of what the market price per share will be when the RSUs vest or when the shares are issued or of the applicable exchange rate on the actual vesting date or date the shares are issued.
Tax Information
The Plan is a plan to which Subdivision 83A-C of the Income Tax Assessment Act 1997 (Cth) applies (subject to the conditions in the Act). For information related to the Australian tax consequences of the RSUs, please refer to the Employee Information Supplement for Australia.
Canada

Terms and Conditions

Settlement of RSUs.   Notwithstanding any discretion in the Plan or anything to the contrary in the Agreement, the RSUs do not provide any right for you, as a resident of Canada, to receive a cash payment and the RSUs shall be paid in shares of Common Stock only.

Nature of Grant. The following provision replaces Section 2 of the Agreement:
Subject to the limitations contained herein, your Award will vest, if at all, in accordance with the vesting schedule provided in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service.
For purposes of the Award, a termination of your Continuous Service will be deemed to occur as of the date that is the earlier of (i) the date of your termination, (ii) the date you receive notice of termination, or (iii) the date you are no longer actively providing services and will not be extended by any notice period (e.g., active service would not include any contractual notice period or any period of “garden leave” or similar period mandated under Canadian laws or the terms of your employment or service agreement, if any), regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where you are employed or providing services or the terms of your employment or service agreement, if any; unless otherwise expressly provided in this Agreement or determined by the Company, your right to vest in the Awards under the Plan, if any, will terminate as of such date; in the event that the date you are no longer actively providing services cannot be reasonably determined under the terms of this Agreement and the Plan, the Committee shall have the exclusive discretion to determine when you are no longer actively providing services for purposes of your Award (including whether you may still be considered to be providing services while on a leave of absence). Notwithstanding the foregoing, if applicable employment legislation explicitly requires continued vesting during a statutory notice period, your right to vest in the Awards, if any, will terminate effective as of the last date of the minimum statutory notice period but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.



The following provisions apply if you are a resident of Quebec:
16.



Language Consent.  The parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices, and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.

Les parties reconnaissent avoir exigé la rédaction en anglais de cette convention, ainsi que de tous documents, avis et procédures judiciaires, exécutés, donnés ou intentés en vertu de, ou liés directement ou indirectement à, la présente convention.

Data Privacy Notice and Consent.  This provision supplements Section 15 of the Agreement:

You hereby authorize the Company and the Company’s representative to discuss with and obtain all relevant information from all personnel (professional or not) involved in the administration and operation of the Plan. You further authorize the Company and your Employer to disclose and discuss your participation in the Plan with their advisors. You also authorize the Company and your Employer to record such information and keep it in your employee file.

Notifications
Securities Law Information. The sale of shares of Common Stock acquired under the Plan may not take place in Canada. This requirement will be satisfied where the shares of Common Stock are sold by the designated broker under the Plan through the facilities of the U.S. stock exchange on which the shares of Common Stock are currently listed (i.e., the Nasdaq stock market).

Foreign Asset/Account Reporting Information.  Canadian residents are required to report their foreign specified property (e.g., shares of Common Stock) on form T1135 (Foreign Income Verification Statement) if the total cost of the foreign specified property exceeds C$100,000 at any time in the year. The RSUs must be reported—generally at a nil cost—if the C$100,000 threshold is exceeded because of other foreign specific property held by you. The shares of Common Stock acquired under the Plan must be reported and their cost generally is the adjusted cost base (“ACB”) of the shares of Common Stock. The ACB ordinarily would equal the fair market value of the shares of Common Stock at the time of acquisition, but if such Canadian resident owns other shares of Common Stock, this ACB may have to be averaged with the ACB of the other shares. The form T1135 generally must be filed by April 30 of the following year. Canadian residents should consult with a personal advisor to ensure compliance with the applicable reporting requirements.

France

Terms and Conditions

RSUs Not Tax-Qualified. The RSUs granted under this Agreement are not intended to qualify for special tax and social security treatment pursuant to Sections L. 225-197-1 to L. 225-197-6 of the French Commercial Code, as amended.
17.


Language Consent. By accepting the RSUs, you confirm having read and understood the Plan and Agreement, including all terms and conditions included therein, which were provided in the English language. You accept the terms of those documents accordingly.
En acceptant les droits sur des actions assujettis à restrictions (« restricted stock units » ou « RSUs »), vous confirmez avoir lu et compris le Plan et le Contrat, en ce compris tous les termes et conditions de ces documents, qui ont été fournis en langue anglaise. Vous acceptez les dispositions de ces documents en connaissance de cause.

Notifications

Foreign Asset/Account Reporting Information. French residents holding cash or securities (including shares of Common Stock) outside of France or maintaining a foreign bank or brokerage account (including accounts opened or closed during the tax year) must declare such assets and accounts to the French tax authorities when filing an annual tax return. Failure to comply could trigger significant penalties.

Germany

Notifications

Exchange Control Information. Cross-border payments in excess of €12,500 must be reported monthly to the German Federal Bank (Bundesbank). In the event you make or receive a payment in excess of this amount, you must report the payment to Bundesbank electronically using the “General Statistics Reporting Portal” (“Allgemeines Meldeportal Statistik”) available via Bundesbank’s website (www.bundesbank.de).

Foreign Asset/Account Reporting Information. If your acquisition of shares acquired under the Plan leads to a so-called qualified participation at any point during the calendar year, you may need to report the acquisition when you file your tax return for the relevant year. A qualified participation is attained if (i) you own at least 1% of the Company and the value of the shares of Common Stock acquired exceeds €150,000 or (ii) you hold shares of Common Stock exceeding 10% of the Company’s total Common Stock.

India

Notifications

Exchange Control Information. You must repatriate all proceeds received from the sale of shares of Common Stock to India within 90 days of receipt and any cash dividends paid on shares of Common Stock acquired under the Plan within 180 days of receipt, or as prescribed under Indian exchange control laws as may be amended from time to time. You must maintain the foreign inward remittance certificate received from the bank where the foreign currency is deposited in the event that the Reserve Bank of India requests proof of repatriation. It is your responsibility to comply with applicable exchange control laws in India.
18.



Foreign Asset/Account Reporting Information. You are required to declare any foreign bank accounts and any foreign financial assets (including shares of Common Stock held outside India) in your annual tax return. You acknowledge that you are responsible for complying with this reporting obligation and you should confer with your personal tax advisor in this regard.

United Arab Emirates

Notifications

Securities Law Information. Participation in the Plan is being offered only to eligible
employees and is in the nature of providing equity incentives to employees in the United Arab
Emirates. The Plan and the Agreement are intended for distribution only to such employees and
must not be delivered to, or relied on by, any other person. Prospective purchasers of the
securities offered should conduct their own due diligence on the securities. The Emirates
Securities and Commodities Authority has no responsibility for reviewing or verifying any
documents in connection with the Plan. Neither the Ministry of Economy nor the Dubai
Department of Economic Development has approved the Plan or the Agreement nor taken steps
to verify the information set out therein, and has no responsibility for such documents.



United Kingdom

Terms and Conditions

Settlement. The following provision supplements Section 3 of the Agreement:

Notwithstanding any discretion contained in the Plan or the Agreement, the RSUs will not be settled in cash or a combination of cash and shares of Common Stock. The RSUs will be settled only in shares of Common Stock.

Responsibility for Taxes. This provision supplements Section 10 of the Agreement:

Without limitation to Section 10 of the Agreement, you hereby agree that you are liable for any Tax-Related Items related to your participation in the Plan and hereby covenant to pay such Tax-Related Items, as and when requested by the Company or (if different) the Employer or by Her Majesty’s Revenue & Customs (“HMRC”) (or any other tax or relevant authority).  You also hereby agree to indemnify and keep indemnified the Company and (if different) the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC (or any other tax or relevant authority) on your behalf.
Notwithstanding the foregoing, if you are an executive officer or director (as within the meaning of Section 13(k) of the Exchange Act), the terms of the immediately foregoing provision will not apply. Instead, any Tax-Related Items not collected or paid may constitute a benefit to you on which additional
19.


income tax and National Insurance Contributions (“NICs”) may be payable. You understand that you will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for paying to the Company and/or the Employer (as appropriate) the amount of any employee NICs due on this additional benefit, which can be recovered by any means set out in the Agreement.

National Insurance Contributions Acknowledgment. As a condition of participation in the Plan and the vesting of the RSUs, you agree to accept any liability for secondary Class 1 NICs which may be payable by the Company and/or the Employer in connection with the RSUs and any event giving rise to Tax-Related Items (the “Employer NICs”). Without limitation to the foregoing, you agree to execute a joint election with the Company, the form of such joint election being formally approved by HMRC (the “Joint Election”), and any other required consent or election. You further agree to execute such other joint elections as may be required between you and any successor to the Company and/or the Employer. You further agree that the Company and/or the Employer may collect the Employer NICs from you by any of the means set forth in Section 10 of the Agreement. You must enter into the Joint Election concurrent with the execution of the Agreement.

If you do not enter into a Joint Election prior to the vesting of the RSUs or if approval of the Joint Election has been withdrawn by HMRC, the RSUs shall become null and void without any liability to the Company and/or the Employer.
20.
 EX-10.22 4 exhibit1022q4-20.htm EX-10.22 Document

Exhibit 10.22

FIRST AMENDMENT TO LEASE

THIS FIRST AMENDMENT TO LEASE (this "First Amendment") is made and entered into as of this 28th day of September, 2012 (the "Effective Date"), by and between MIDDLEFIELD STATION ASSOCIATES, LLC, a Delaware limited liability company ("Landlord"), and OMNICELL, INC., a Delaware corporation ("Tenant").

RECITALS:

A.Landlord and Tenant entered into that certain Lease Agreement dated October 20, 2011 (the "Lease"), pursuant to which Landlord agreed to lease to Tenant certain premises (as more particularly described in the Lease) consisting of approximately ninety-nine thousand eight hundred eighty (99,880) rentable square feet and more commonly known as 590 Middlefield Road, Mountain View, California (the "Premises"). All capitalized terms used herein but not herein defined shall have the meaning ascribed to such terms in the Lease.

B.In lieu of executing the Commencement and Expiration Date Memorandum as required by Paragraph 3(c) of the Lease, Landlord and Tenant desire to enter into this First Amendment to specify the Commencement Date and the Expiration Date of the Lease, as well as to to otherwise amend the Lease on the terms and conditions set forth in this First Amendment.

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Landlord and Tenant hereby agree as follows:

I.    Incorporation of Recitals. The recitals expressed in A and B above are true and correct, incorporated herein and made a part of this First Amendment by this reference.

2.Term. Paragraph 3(a) of the Lease is hereby amended to provide that the Commencement Date is November 16, 2012, and the Expiration Date is October 15, 2022; provided that the Landlord Improvements are Substantially Complete (or would have been Substantially Complete but for any Tenant Delays) on or before November 16, 2012.
3.Rent.

(a)Paragraph 4(a) of the Lease is hereby amended such that the last two sentences of such paragraph are deleted.

(b)Beginning on the Commencement Date and continuing through the remainder of the Term, Tenant shall pay to Landlord all Rent, including Additional Rent and Base Rent, in accordance with Paragraph 4 of the Lease; provided, however, (A) the Base Rent payable by Tenant for the period from November 16, 2012 to November 30, 2012, shall be paid to Landlord on or before November 16, 2012, and (B) the Base Rent Schedule attached to the Lease as Exhibit B is deleted in its entirety and replaced with the following Base Rent Schedule:

Period
Monthly Rent*
Price/SF
Escalation (%)
11/16/12 – 11/30/12
$139,333
$2.79 NNN
Base
12/1/12 – 12/31/12
Abated
$2.79 NNN
Base
1/1/13 – 9/30/13
$278,665
$2.79 NNN
Base
10/1/13 – 9/30/14
$287,025
~$2.87 NNN
3%
10/1/14 – 9/30/15
$295,636
~$2.96 NNN
3%
10/1/15 – 9/30/16
$304,505
~$3.05 NNN
3%





10/1/16 – 9/30/17$313,640
~$3.14 NNN
3%
10/1/17 – 9/30/18$323,049
~$3.23 NNN
3%
10/1/18 – 9/30/19$332,741
~$3.33 NNN
3%
10/1/19 – 9/30/20$342,723
~$3.43 NNN
3%
10/1/20 – 9/30/21$353,005
~$3.53 NNN
3%
10/1/21 – 9/30/22$363,595
~$3.64 NNN
3%
10/1/22 – 10/15/22$187,251
~$3.75 NNN
3%

*Prorated for Partial Months

(iii) As of the Effective Date, Tenant has made an advance payment to Landlord on account of (A) Base Rent in the amount of Two Hundred Seventy-Eight Thousand Six Hundred Sixty-Five Dollars ($278,665) (the "Prepaid Base Rent"); and (B) Additional Rent in the amount of Forty-Two Thousand Seven Hundred Twenty-Five and 40/100 Dollars ($42,725.40) (the "Prepaid Additional Rent"). Landlord shall apply the Prepaid Base Rent to the first full month of Base Rent due under the Lease (January 2013), and shall apply the Prepaid Additional Rent to Additional Rent due under the Lease from the Commencement Date to December 31, 2012. Notwithstanding the foregoing, Tenant shall remain responsible for the payment of all Base Rent and Additional Rent due under the Lease and Landlord's receipt of the Prepaid Base Rent and Prepaid Additional Rent shall not excuse Tenant from payment of any additional amounts owed by Tenant under the Lease from and after the Commencement Date.

(iv) Paragraph 4(c)(1) of the Lease is hereby amended to provide that, with respect to Computation Year 2013 only, on or before December 15, 2012, Landlord shall give to Tenant notice of Landlord's estimate of the total amounts that will be payable by Tenant to Landlord (as opposed to direct payments by Tenant to the applicable vendor and service provider) under Paragraph 4(b) of the Lease for Computation Year 2013. All other provisions of Paragraph 4(c)(l) of the Lease shall remain as provided therein.

4.Brokers. Landlord and Tenant each warrant to the other that it has had no dealing with any real estate broker or agent in connection with this First Amendment, and that Landlord and Tenant know of no real estate broker who is entitled to or can claim a commission in connection with this First Amendment. Each party agrees to indemnify, defend and hold harmless the other party from and against any and all claims, demands, losses, liabilities, lawsuits, judgments, and costs and expenses (including, without limitation, reasonable attorneys' fees and expenses) with respect to any alleged leasing commission or equivalent compensation in connection with this Amendment as a result of the actions of the indemnifying party.

5.Miscellaneous.

(a)This First Amendment may be executed in one or more counterparts, each of which shall be an original, and all of which shall constitute one instrument. The parties contemplate that they may be executing counterparts of this First Amendment transmitted by facsimile or electronic mail in PDF format and agree and intend that a signature by facsimile machine or electronic mail in PDF format shall bind the party so signing with the same effect as though the signature were an original signature.

(b)Except as set forth in this First Amendment, the Lease shall remain unchanged, in full force and effect. If there is any inconsistency between the terms of this First Amendment and the terms of the Lease, the terms of this First Amendment shall control.





a.This First Amendment shall be governed by, construed, and enforced in accordance with the laws of the State of California.

b.Tenant hereby represents and warrants that each individual executing this First Amendment is duly authorized to execute and deliver the same in accordance with the provisions contained in Paragraph 44 of the Lease.

IN WITNESS WHEREOF, Landlord and Tenant have entered into this First Amendment as of the date first written above.


LANDLORD:

MIDDLEFIELD STATION ASSOCIATES, LLC,
a Delaware limited liability company



By: /s/ Bruce Burkard            
Name: Bruce Burkard
Its: Authorized Signatory


TENANT:

OMNICELL, INC.,
a Delaware corporation


By: /s/ Rob Seim            
Name: Rob Seim            
Its: Chief Financial Officer        


 EX-10.24 5 exhibit1024q4-20.htm EX-10.24 Document

Exhibit 10.24

Execution Copy

FIRST AMENDMENT TO LEASE

This FIRST AMENDMENT TO LEASE (this “First Amendment”) is entered into as of February April      8 , 2005, by and between the Multi-Employer Property Trust, a trust organized under 12 C.F.R. Section 9.18 (“Landlord”) and McKesson Automation Inc., a Pennsylvania corporation (“Tenant”), in consideration of the mutual covenants contained herein and the benefits to be derived herefrom.

WITNESSETH:

WHEREAS, TC Northeast Metro, Inc. ("TC"), a Delaware corporation, and Tenant entered into that Lease dated December 2l, 2001 (the "Lease"), pursuant to which Tenant leased from TC approximately sixty-one thousand eight hundred eighty-seven (61,887) rentable square feet consisting of the entire third (3rd) and fourth (4th) floors (the “Initial Premises”) of a certain building located at 500 Cranberry Woods Drive, Cranberry Township, Pennsylvania; and

WHEREAS, Tenant's obligations under the Lease have been guarantied by McKesson Corporation (the "Guarantor"), a Delaware corporation, pursuant to a certain Guaranty of Lease dated December 21, 2001 (the "Guaranty"); and

WHEREAS, TC subsequently assigned all of its right, title and interest under the Lease and Guaranty to the Landlord pursuant to a certain Assignment and Assumption Agreement dated December 28, 200 I between TC and the Landlord; and

WHEREAS, the Tenant desires to lease the entire second (2nd) floor of the Building, consisting of approximately twenty-nine thousand nine hundred forty-six (29,946) rentable square feet (the "Expansion Premises"); and

WHEREAS, Landlord and Tenant desire to amend the Lease as provided herein;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by both Landlord and Tenant, the parties hereto agree that the Lease shall be amended as follows:

1.    Recitals/Defined Terms. The foregoing recitals shall be considered an integral part of this First Amendment. Unless otherwise specifically stated in this First Amendment, all capitalized terms in this First Amendment shall have the meaning given to those terms in the Lease. In the event of any conflict between the Lease and this First Amendment, the terms of this First Amendment shall control.





BOJ 15687368.6/ 32203-000154



2.    Expansion Premises.

(a)    Landlord and Tenant hereby agree to add the Expansion Premises to the Premises in two (2) stages, with (i) the first stage consisting of the addition to the Premises, as of the First Expansion Commencement Date (as hereinafter defined), of that portion of the Expansion Premises consisting of approximately fourteen thousand nine hundred seventy-three (14,973) rentable square feet shown on First Amendment Exhibit A attached hereto ("Expansion Premises A"), and (ii) the second stage consisting of the addition to the Premises, as of the Second Expansion Commencement Date (as hereinafter defined), of that portion of the Expansion Premises consisting of approximately fourteen thousand nine hundred seventy-three (14,973) rentable square feet shown on First Amendment Exhibit B attached hereto ("Expansion Premises B''). Landlord hereby leases to Tenant, and Tenant hereby rents from Landlord, the Expansion Premises upon the terms and conditions of this First Amendment

(b)    As of the First Expansion Commencement Date, the entire Premises shall consist of approximately seventy-six thousand eight hundred sixty (76,860) rentable square feet comprising the entire (3rd) and fourth (4th) floors and a portion of the second (2nd) floor of the Building. On the First Expansion Commencement Date, Expansion Premises A shall become part of the Premises and, except as otherwise provided below, shall be subject to all of the terms and conditions of the Lease for the remainder of the Term.    

(c)    As of the Second Expansion Commencement Date, the entire Premises shall consist of approximately ninety-one thousand eight hundred thirty-three (91,833) rentable square feet consisting of the entire second (2nd), third (3rd) and fourth (4th) floors of the Building. On the Second Expansion Commencement Date, Expansion Premises B shall become part of the Premises and, except as otherwise provided below, shall be subject to all of the terms and conditions of the Lease for the remainder of the Term.

(d)    Notwithstanding anything to the contrary contained in the Lease, including but not limited to Section l, neither Expansion Premises A nor Expansion Premises B shall be subject to remeasurement and the rentable square footage thereof as recited in Section 2(a) hereof shall be shall be final, conclusive and controlling.

3.    Term.

(a)    The Term with respect to Expansion Premises A shall commence on the First Expansion Commencement Date (as hereinafter defined) and shall expire on the last day of that calendar month which is seventy-six (76) months after the First Expansion Commencement Date, provided that, if the First Expansion Commencement Date is the first day of a calendar month, the Term with respect to Expansion Premises A shall end on the last day of the seventy-sixth (76th) calendar month beginning on, and including, the First Expansion Commencement Date (the "Extended Lease Expiration Date”). Subject to subparagraphs 1.4(b), 1.4(c) and 1.4(d) of the Lease and subject to those provisions of Exhibit C relating to Tenant Delays, the "First Expansion Commencement Date" shall be the earlier to occur of: (i) the date of Substantial Completion of Expansion Premises A; or (ii) the date upon which Tenant commences the

BO l 15687368.6/32203-000154

-2-



beneficial use and occupancy of all or any material part of Expansion Premises A (other than for "Furniture Installation" and "Move-In"). The parties acknowledge the "Target Date" for Substantial Completion of Expansion Premises A is August 8, 2005, subject to Tenant's compliance with its responsibilities under the Approved Design Schedule, and Tenant's adherence to the other provisions of Exhibit C of the Lease as modified by Section 14 of this First Amendment (referred to herein as "Amended Exhibit C"), provided as more fully set forth in Amended Exhibit C, Landlord agrees to provide Tenant with access to Expansion Premises A for purposes of Furniture Installation and Move-In not less than thirty-one (31) days prior to the date Landlord then estimates that Substantial Completion of Expansion Premises A will occur. The parties acknowledge that Amended Exhibit C contains additional provisions concerning the rights and remedies of the parties (if any), and the effect on the First Expansion Commencement Date, in the event Substantial Completion of Expansion Premises A occurs past the dates set forth above, including if the same is due to any Tenant Delays or Force Majeure. Except as otherwise expressly provided in, or otherwise inconsistent with, this First Amendment, and except to the extent not applicable to Expansion Premises A, for purposes of this paragraph any references in subparagraphs l.4(b), 1.4(c) and 1.4(d) of the Lease to the "Premises",
"Commencement Date", and "Exhibit C" shall be deemed instead to refer to "Expansion Premises A", "First Expansion Premises", and Amended Exhibit C, respectively.

(b)    The Term with respect to Expansion Premises B shall commence on the Second Expansion Commencement Date (as hereinafter defined) and shall expire on the Extended Lease Expiration Date. Subject to subparagraphs l.4(b), l.4(c) and 1.4(d) of the Lease and subject to those provisions of Exhibit C relating to Tenant Delays, the "Second Expansion Commencement Date" shall be the earlier to occur of: (i) the later of (x) the date of Substantial Completion of Expansion Premises Band (y) May 15, 2006; or (ii) the date upon which Tenant commences the beneficial use and occupancy of all or any material part of Expansion Premises B (other than for "Furniture Installation" and "Move-In"). The parties acknowledge the "Target Date" for Substantial Completion of Expansion Premises B is May 15, 2006, subject to Tenant's compliance with its responsibilities under the Approved Design Schedule, and Tenant's adherence to the other provisions of Amended Exhibit C, provided as more fully set forth in Amended Exhibit C, Landlord agrees to provide Tenant with access to Expansion Premises B for purposes of Furniture Installation and Move-In not less than thirty-one (31) days prior to the later of (1) date Landlord then estimates that Substantial Completion of Expansion Premises B will occur and (2) May 15, 2006. The patties acknowledge that Amended Exhibit C contains additional provisions concerning the rights and remedies of the parties (if any), and the effect on the Second Expansion Commencement Date, in the event Substantial Completion of Expansion Premises B occurs past the dates set forth above, including if the same is due to any Tenant Delays or Force Majeure. Except as otherwise expressly provided in, or otherwise inconsistent with, this First Amendment, and except to the extent not applicable to Expansion Premises B, for purposes of this paragraph any references in subparagraphs 1.4(b), l.4(c) and 1.4(d) of the Lease to the "Premises", "Commencement Date", and "Exhibit C" shall be deemed instead to refer to "Expansion Premises B", "Second Expansion Premises", and Amended Exhibit C, respectively.

                                
BOl 15687368.6/ 32203 000154
-3-



(c)    The Term of the Lease as it relates to the Initial Premises is hereby extended to the Extended Lease Expiration Date, and all references in the Lease to the Lease Expiration Date shall hereafter mean and refer to the Extended Lease Expiration Date so that the Term of the Lease as it relates to the Initial Premises, Expansion Premises A, and Expansion Premises B shall all expire on the Extended Lease Expiration Date.

(d)    It is Landlord's intention to simultaneously pursue Substantial Completion of Landlord's Work for Expansion Premises A and Expansion Premises B, provided, however, nothing contained herein shall affect the Target Date for Substantial Completion of Expansion Premises B as set forth in Section 3(b) hereof Notwithstanding anything to the contrary contained herein, if Landlord achieves Substantial Completion of Expansion Premises B prior to the Target Date for same as set forth in Section 3(b) hereof, then at any time after such Substantial Completion Tenant may elect on one or more occasions to accelerate the Second Expansion Commencement Date with respect to all or any portion of Expansion Premises B consisting of not less than 5,000 rentable square feet (or the remaining balance of Expansion Premises B, if the same consists of less than 5,000 rentable square feet). Unless otherwise mutually agreed, Tenant shall provide Landlord with at least five (5) business days advance written notice of each such election. Further, in the event of any such election to accelerate the Second Expansion Commencement Date as to less than the entire Expansion Premises B, then all provisions of the Lease (as amended hereby) that are based upon the number of rentable square feet contained within the Premises and/or Expansion Premises B automatically shall be deemed amended accordingly. Such provisions include, without limitation, (i) Section 2(c) of this First Amendment with respect to the aggregate number of rentable square feet at any time contained within the Premises, (ii) Section 1.2 of the Lease, as amended by Section 4 of this First Amendment relating to the definition of "Tenant's Share" (which at any time shall he deemed to be a fraction equal to the then aggregate number of rentable square feet comprising the Premises divided by 119,444 (the aggregate number of rentable square feet in the Building)), and (iii) Subsection 1.5.1 of the Lease as amended by Section 5 of this First Amendment with respect to the acceleration of the Second Expansion Commencement Date and the amount of Base Rent payable for the applicable portion of Expansion Premises B.

(e)    Promptly after the First Expansion Commencement Date, Landlord and Tenant shall execute a memorandum confirming the First Expansion Commencement Date, the Rent Adjustment Date, and the Extended Lease Expiration Date. Such memorandum (the "First Expansion Date Memorandum") shall be in the form attached to this First Amendment as First Amendment Exhibit D. Promptly after the Second Expansion Commencement Date (or after each Second Expansion Commencement Date if the Tenant elects to have Landlord deliver less than the entire Expansion Premises B at one time as provided in Section 3(d) hereof), Landlord and Tenant shall execute a memorandum confirming the Second Expansion Commencement Date(s). Such memorandum (each a "Second Expansion Date Memorandum") shall be in the form attached to this First Amendment as First Amendment Exhibit E; (with Landlord and Tenant completing the applicable portions thereof). The failure of Tenant to execute the First Expansion Date Memorandum or any Second Expansion Date Memorandum shall not affect Tenant's obligations under the Lease as amended by this First Amendment. In no event shall



BOl 15687368.6 I 32203 000154
-4-



Tenant record this First Amendment, the First Expansion Date Memorandum, or any Second Expansion Date Memorandum.

4.    Tenant's Share,    Section l .2 of the Lease is hereby amended by deleting the second sentence thereof and substituting in its stead the following:

"Tenant's Share shall be (a) for the period beginning on the Commencement Date and ending on the date immediately preceding the First Expansion Commencement Date, Fifty-One and 81/100 Percent (51.81%) (i.e., 61,887/119,444) based upon the Premises containing 61,887 rentable square feet, and the Building containing l19,444 rentable square feet; (b) for the period beginning on the First Expansion Commencement Date and ending on the date immediately preceding the Second Expansion Commencement Date, Sixty-Four and 35/100 Percent (64.35%) (i.e., 76,860/119,444) based upon the Premises containing 76,849 rentable square feet, and the Building containing 119,444 rentable square feet; and (c) for the remaining period of the Term from and after the Second Expansion Commencement Date, Seventy-Six and 88/100 Percent (76.88%) (i.e., 91,833/119,444) based upon the Premises containing 91,822 rentable square feet, and the Building containing 119,444 rentable square feet."

5.    Base Rent. The Lease is hereby amended by deleting Subsection 1.5.1 thereof in its entirety and substituting in its stead the following:

"1.5.1 The rate per rentable square foot per annum, and the portion of the Lease term during which such monthly Base Rent is payable shall be determined from the following tables.

Initial Premises
Applicable Portion of Lease Term
Rate Per/Rentable Sq. Ft/ Annum
Annual Base Rent
Monthly Base
Rent    Installment
(Annual+ 12)
BeginningEnding
March 23, 2003
The date immediately preceding the Rent Adjustment Date
$21.50
$1,330,570.50
$110,880.88

Rent Adjustment Date

Extended Lease Expiration Date

$22.75

$1,407,929.25

$117,327.44


Expansion Premises A
Applicable Portion of lease Term
Rate Per/Rentable
Sq. Ft./ Annum
Annual Base Rent
Monthly Base
Rent    Installment
(Annual+ 12)
BeginningEnding
First Expansion Commencement Date
The date immediately preceding
the Rent Adjustment Date

$21.50

$321,919.50

$26,826.63

Rent Adjustment Date

Extended Lease Expiration Date

$22.75

$340,635.75

$28,386.31



BO1 15687368.6 / 32203-000154
-5-



Expansion Premises B
Applicable Portion of Lease Term
Rate Per/Rentable Sq. FU Annum
Annual Base Rent
Monthly Base
Rent    Installment (Annual+ 12)
BeginningEnding
Second Expansion Commencement Date
The date immediately preceding the Rent Adjustment Date

$21.50

$321,919.50

$26,826.63
Rent Adjustment Date
Extended Lease Expiration Date
$22.75
$340,635.75
$28,386.31

If the First Expansion Commencement Date or the Second Expansion Commencement Date is a date other than the first day of a calendar month, Base Rent for Expansion Premises A or Expansion Premises B (as applicable) for the partial month in which the First Expansion Commencement Date occurs shall be prorated. Notwithstanding the foregoing, provided that no Default exists under the Lease, Landlord shall abate all Base Rent applicable to Expansion Premises A for the first four (4) full calendar months of the Term beginning on or after the First Expansion Commencement Date (the "Expansion Premises A Abatement Period") (but not as to the partial month (if any) in which the First Expansion Commencement Date occurs).

As used herein, the "Rent Adjustment Date" shall mean and refer to the date which is forty (40) months after the First Expansion Commencement Date, provided that, if the First Expansion Commencement Date is a day other than the first day of a calendar month, the Rent Adjustment Date shall be the first day of the calendar month immediately following the date which is forty (40) months after the First Expansion Commencement Date.

Notwithstanding the foregoing rent schedules, if Tenant validly exercises any of its renewal options as set forth in this Lease, Base Rent for the renewal term(s) shall be as set forth in Section 50 hereof."

6.    Base Year.    Effective as of the First Expansion Premises Commencement Date:

(a)    Section 9.2 of the Lease shall be deemed amended such that the "Operating Costs Base Year" shall be calendar year 2005 for the entire Premises (i.e., the Initial Premises, the First Expansion Premises, and the Second Expansion Premises); and.

(b)    Section 10.2 of the Lease shall be deemed amended such that the "Real Estate Tax Base Year" shall be calendar year 2005 for the entire Premises (i.e., the Initial Premises, the First Expansion Premises, and the Second Expansion Premises), provided that if the Building has not been fully assessed as of the end of calendar year 2005, the Property Tax Base Year shall be the first tax year in which the Building is fully assessed.

7.    Notice Addresses. Section 1.8 of the Lease is hereby amended by substituting the following addresses for Landlord:

BO1 15687368.6 / 32203 000154

-6-



"If to Landlord:    Multi-Employer Property Trust
c/o Kennedy Associates Real Estate Counsel, Inc. Attention: Senior Vice President - Asset Management 1215 Fourth Ave., Suite 2400
Seattle, WA 98161
Facsimile: (206) 682-4769
with copies to:
Multi-Employer Property Trust
c/o Kennedy Associates Real Estate Counsel, Inc.
Attn: Vice President - Asset Management
7315 Wisconsin Avenue, Suite 350 West
Bethesda, MD 20814
Facsimile: (301) 656-9339
and
Multi-Employer Property Trust
c/o Riggs Bank N.A.
Attn: Senior Vice President/MEPT or Patrick O. Mayberry
808-17th SL N.W., 7th Floor
Washington, D.C., 20006-3944
Facsimile: (202) 835-6887
and with a copy to Manager at:
Trammell Crow Company
800 Cranberry Woods Drive, Suite 260
Cranberry Township, PA 16066."

8.    Payment Address.    Section 1.9 of the Lease is hereby amended by substituting the following address for payments to Landlord:

"Kennedy/MEPT - Cranberry Woods
500 Cranberry Woods Drive
File #30376
PO Box 60000
San Francisco, CA 94160."

9.    Tenant Improvements. Notwithstanding anything to the contrary contained in the Lease (including Section 17), (a) any improvements to be performed by Tenant to Expansion Premises A (or any portion thereof) prior to the First Expansion Commencement Date shall be governed by Amended Exhibit C, (b) any improvements to be performed by Tenant to Expansion Premises B (or any portion thereof) prior to the Second Expansion Commencement Date shall be




BOl 15687368,6/32203 000154

-7-



governed by Amended Exhibit C, and (c) all other improvements performed by Tenant to the Expansion Premises shall be treated as Alterations to the Premises and thus governed by Article 15 of the Lease.

10.     Parking.     Effective as of the First Expansion Premises Commencement Date, Tenant's parking allocation as set forth in Section 46 of the Lease shall be increased by an amount equal to five (5) parking spaces for each 1,000 square feet of rentable area of Expansion Premises A, and effective as of the Second Expansion Premises Commencement Date, Tenant's parking allocation as set forth in Section 46 of the Lease shall be further increased by an amount equal to five (5) parking spaces for each 1,000 square feet of rentable area of Expansion Premises B. Such parking allocation remains subject to adjustment in the event of any reduction or further expansion of the Premises as provided in Section 46 of the Lease.

11.    Renewal Option.     Without limiting any other term or condition hereof, Landlord and Tenant acknowledge and agree that the renewal options granted to Tenant under Section 50 of the Lease remain in full force and effect and hereafter apply to the entire Premises then leased to Tenant (i.e., the Initial Premises, Expansion Premises A, and Expansion Premises B) as of the end of the Initial Term and the First Renewal Term, as applicable. Tenant shall have no right to exercise any such option to renew for less then the entire Premises then leased by Tenant pursuant to the Lease. As used herein and in the Lease, "Initial Term" hereafter shall mean and refer to the period beginning on the First Expansion Commencement Date and ending on the Extended Lease Expiration Date as in effect immediately following the execution of this First Amendment.

12.    Expansion Options.

(a)    Section 52.1.1 of the Lease is hereby amended by deleting the last two (2) sentences thereof in their entirety and substituting the following in their stead:

"The second Expansion Option is a non-exclusive option to expand applicable to available space within the Building during the Initial Lease Term, all as more fully set forth in Section 52.3, below. The third Expansion Option is a right of first refusal applicable to vacant space within the Building during the ROFR Period (as hereinafter defined), all as more fully set forth in Section 52.4, below."

(b)    The Lease is hereby amended by deleting Section 52.3 thereof in its entirety and substituting in its stead the following:

"52.3 Additional Nonexclusive Expansion Option.

52.3.1    Subject to availability and any prior rights granted to other tenants of the Building and further subject to the terms and provisions of this Article 52, Tenant is hereby granted the non-exclusive option (the "Additional Expansion Option"), exercisable by Tenant at any time during the Initial Term, to lease any then available space (meaning space which is not leased to a third party and for




BOI 15687368.6 / 32203-000154

-8-



which Landlord has neither issued nor received a letter of intent or term sheet) in the Building (the "Available Space") for an initial term (the "Additional Expansion Term") coinciding with the balance of the Initial Term. Tenant shall exercise the Additional Expansion Option by delivering a written notice to Landlord (the "Additional Expansion Notice") at any time prior to the expiration of the Initial Term (i) stating Tenant's unqualified election to exercise the Additional Expansion Option, (ii) designating the portion (up to the whole) of the Available Space in the Building that Tenant is electing to lease (which designation shall be subject to Landlord's reasonable consent, and which shall be deemed to constitute the "Additional Expansion Space" once such designation is approved by Landlord), and (iii) shall attach a proposed space plan for the portion of the Additional Expansion Space so designated by Tenant. Landlord shall approve Tenant's designation of less than all of the Available Space so long as the balance remaining after such designation constitutes Independently Leasable Space (as defined in Section 1.1(d) of this Lease). The date upon which Landlord delivers possession of the Additional Expansion Space to Tenant in the condition contemplated under Section 52.3.2, below, is referred to herein as the "Additional Expansion Date".

52.3.2    Any leasehold created pursuant to Tenant's exercise of the Additional Expansion Option shall be upon substantially the same terms and conditions as this Lease, including the then current annual Base Rent per square foot of rentable area, the Operating Costs Base Year, the Real Estate Tax Base Year, and the Extended Lease Expiration Date; and the following additional provisions shall be applicable: (i) the Additional Expansion Term shall by its terms expire on the Extended Lease Expiration Date so that the Additional Expansion Term and the Initial Term of this Lease coincide, (ii) from and after the Additional Expansion Date, the Premises shall be deemed to include the Additional Expansion Space; (iii) Tenant's Share shall be modified to include the applicable percentage of the Building allocable to the Additional Expansion Space; (iv) Article 9 and 10 of this Lease shall be deemed amended mutatis mutandis to provide that Tenant will pay Expense Increases and Tax Increases with respect to the Additional Expansion Space on the same basis provided for herein; (v) Monthly Rent for the Additional Expansion Space shall commence on the earlier to occur of (A) the date Tenant commences actual occupancy of the Additional Expansion Space for purposes of conducting business operations therein, or (B) the Additional Expansion Date (such date, the "Additional Expansion Rent Commencement Date''); (vi) the Renewal Option described in Section 50 shall also apply with respect to the Additional Expansion Space; (viii) the allowance and construction provisions set forth in Section 52.2.3 below (and by application thereof, Exhibit C of this Lease), shall apply to the Additional Expansion Space; (ix) the number of parking spaces to be allocated to the Additional Expansion Space shall be as determined under Section 46 of this Lease based on the square footage of the Additional Expansion Space; (x) the Guaranty shall apply to Tenant's lease of the Additional Expansion Space; and (xi) all other provisions of the Lease shall be deemed amended mutatis mutandis to apply to the








BO1 15687368.6 / 32203-000154

-9-



Additional Expansion Space; provided, however, that Base Rent shall not be due or payable by Tenant on account of the Additional Expansion Space until the Additional Expansion Rent Commencement Date.

52.3.3    Tenant shall be granted an allowance for tenant improvements to be performed by Tenant with respect to the Additional Expansion Space, which if the Additional Expansion Rent Commencement Date occurs during the one-year period commencing on the First Expansion Commencement Date shall be Twenty-One and 00/100 Dollars ($21.00) per rentable square foot in the Additional Expansion Space leased by Tenant, and thereafter shall be in an amount equal to the product of (i) $21.00 per rentable square foot in the Additional Expansion Space leased by Tenant, and (ii) a fraction the numerator of which is the number of full calendar months remaining in the Initial Term as of the Additional Expansion Rent Commencement Date, and the denominator of which is sixty-four (64). Such allowance shall be funded to pay for (i) Tenant's share of applicable architectural fees for preparation of construction drawings for the Additional Expansion Space, (ii) permit fees associated with such work, and (iii) the cost of physical improvements to such Additional Expansion Space, with any unused amount to be credited against Rent becoming due for the Additional Expansion Space (but in no event shall more than 20% of such allowance be credited against Rent, and any amount in excess of 20% of the allowance which is not used for such items described in the preceding clauses (i), (ii), and (iii) shall be deemed forfeited by Tenant). Such allowance shall be funded substantially in accordance with the construction provisions of Exhibit C of this Lease as applied to such construction. The parties agree that the parties shall generally conform to the provisions of Exhibit C with respect to the design and construction of physical improvements to the Additional Expansion Space, as if fully restated in this Section 52.3 (and subject to any specific modifications as to timing or other points of detail expressly set forth in this Section 52.3).

52.3.4    Promptly after Tenant's exercise of the Additional Expansion Option, Landlord shall prepare and Landlord and Tenant shall execute an amendment to this Lease confirming such exercise and incorporating the applicable terms of this Section 52. These provisions shall be self-operative, and such amendment shall merely confirm in a separate written instrument the terms and provisions set forth herein.

52.3.5    Tenant acknowledges and agrees that the Additional Expansion Option is not exclusive to Tenant, and unless and until Tenant has exercised the Additional Expansion Option, Landlord shall have the right (subject only to Tenant's Right of First Refusal, as defined in Section 52.4 below, for the period that such Right of First Refusal is in effect) to lease the Additional Expansion Space to any person or entity, free from the effect of the Additional Expansion Option, on such terms as Landlord determines in its sole and absolute discretion."




B01 15687368.6 / 32203 00-0154
-10-



(c)    Section 52.4.l of the Lease is hereby amended by deleting the first sentence thereof in its entirety and substituting the following in its stead:

"Subject to the further terms of this Section 52.4, Tenant is hereby granted, solely during the twenty-four (24) month period (the "ROFR Period") beginning on the First Expansion Premises Commencement Date, a right of first refusal ("Right of First Refusal") to lease space which is vacant in the Project (any space subject to this Right of First Refusal being sometimes referred to herein as the "ROFR Space')."

(d)    Section 52.4.2 of the Lease is hereby amended by deleting the following text from the sixteenth (16th) line thereof:

"but in no event past the twenty-fourth (24th) month of the Initial Term” and substituting in its stead the following:
"but in no event past the end of the ROFR Period".

(e)    Section 52.4.2 of the Lease is hereby further amended by deleting the last
sentence thereof in its entirety and substituting the following in its stead:

"If Tenant delivers a ROFR Exercise Notice prior to the expiration of the applicable three (3) business day period described above in this Section 52.4.2, then the provisions of Section 52.4.3 (if such ROFR Notice is delivered prior to the end of the sixth full calendar month of the ROFR Period) or Section 52.4.4 (if such ROFR Notice is delivered after the end of the sixth full calendar month of the ROFR Period but prior to the end of the ROFR Period), below, shall be applicable."

(f)    Section 52.4.3.A of the Lease is hereby amended by deleting the first six (6) lines thereof which provide as follows:

"If the ROFR Exercise Notice is delivered prior to the end of the sixth (6th) full calendar month of the Initial Lease Term, then the ROFR Space will be leased to Tenant through an amendment to this Lease, upon substantially the same terms and conditions as this Lease, including the then current annual Base Rent per square foot of rentable area, the Operating Costs Base Year, the Real Estate Tax Base Year, and the Lease Expiration Date (which shall be coterminous with the Initial Term of this Lease), but subject to the following additional provisions:"

and substituting in its stead the following:

"If the ROFR Exercise Notice is delivered prior to the end of the sixth (6th) full calendar month of the ROFR Period, then the ROFR Space will be leased to




BOl 15687368.6 I 32203,000154

-11-



Tenant through an amendment to this Lease, upon substantially the same terms and conditions as the Expansion Premises A under this Lease, including the annual Base Rent per square foot of rentable area for the Expansion Premises A in effect from time to time (provided that if the ROFR Rent Commencement Date occurs during the Expansion Premises A Abatement Period, there shall be no corresponding abatement of any Rent with respect to the ROFR Space), the Operating Costs Base Year, the Real Estate Tax Base Year, and the Extended Lease Expiration Date (which shall be coterminous with the Initial Term of this Lease), but subject to the following additional provisions:".

(g)    Section 52.4.3.B of the Lease is hereby amended by deleting the first sentence thereof in its entirety and substituting the following in its stead:

"Tenant shall be granted an allowance for tenant improvements to be performed by Tenant with respect to a ROFR Space subject to this Section 52.4.3, which during the one-year period commencing on the First Expansion Commencement Date shall be Twenty-One and 00/100 Dollars ($21.00) per rentable square foot in the ROFR Space, and thereafter shall be in an amount equal to the product of (i) $21.00 per rentable square foot in the ROFR Space, and (ii) a fraction the numerator of which is the number of full calendar months remaining in the Initial Term as of the ROFR Rent Commencement Date, and the denominator of which is sixty-four (64),"

(h)    Section 52.4.4.A of the Lease is hereby deleted in its entirety and the following is substituted in its stead:

"If the ROFR Exercise Notice is delivered after the end of the sixth (6th) full calendar month of the ROFR Period but prior to the end of the ROFR Period, then the ROFR Space will be leased to Tenant under a lease instrument (a "ROFR Lease") on the business terms and conditions set forth in the LOI or, if applicable, Changed Terms Notice and otherwise having legal terms substantially consistent with the terms specified in this Lease."

13.    Construction of Expansion Premises. Except as otherwise provided for herein, construction of tenant improvements to the Expansion Premises and all matters related thereto shall be handled in substantially the same manner as provided for under Exhibit C of the Lease ("Exhibit C") as if fully restated herein, but subject to the following modifications as to timing and other
points of detail pertaining specifically to the Expansion Premises (or the applicable portion thereof), rather than the Initial Premises.






BO1 15687368.6 / 32203-000154
-12-



(a)    Except where the context requires otherwise, all references in Exhibit C to the "Premises" shall mean and refer to the Expansion Premises or the applicable portion thereof.
(b)    All references in Exhibit C to the "Approved Design Schedule" shall mean the approved schedule for the preparation, review and approval of the Construction Documents as set forth in First Amendment Schedule C-1 attached hereto.
(c)    All references in Exhibit C to the "Approved Schedule" shall mean the approved schedule for Completion of Landlord's Work as set forth in First Amendment Schedule C-1 attached hereto.

(d)    All references in Exhibit C to the "Approved Schematic Drawings" shall mean the as built plans attached hereto as First Amendment Schedule C-3.

(e)    There shall be no Base Building Construction Contract or Base Building GC for the remaining Base Building Improvements. The parties agree that any remaining Base Building Improvements that have not yet been completed for the Expansion Premises shall be completed by the TI GC pursuant to the TI Construction Contract, but pursuant to a separate scope of work which shall be bid separately from the Landlord's TI Work.

(f)    The last sentence of the definition of "Excess TI Costs" shall be deemed amended substituting "Part IV" in place of "Part VII".

(g)    All references in Exhibit C to the "Landlord's Architect" shall mean, initially, The Design Alliance, and any other architect selected by Landlord to replace or supplement such architect.

(h)    All references in Exhibit C to the "Tenant's Architect" shall mean, initially, The Design Alliance, and any other architect selected by Tenant to replace or supplement such architect, subject to Landlord's reasonable consent.

(i)    The "Steel Erection Completion Deadline" shall have no application to the Expansion Premises.

(j)    All references in Exhibit C to the "Test-Fit Allowance" shall mean an aggregate amount equal to Four Thousand Four Hundred Ninety-One and 90/100 Dollars ($4,491.90), calculated based upon fifteen cents ($0.15) per rentable square foot of the Expansion Premises. One-half of the Test-Fit Allowance is allocated to Expansion Premises A and one-half to Expansion Premises B.










B01 15687368.6 / 32203-000154
-13-



(k)    All references in Exhibit C to the "TI Allowance" shall mean an aggregate amount equal to Six Hundred Twenty-Eight Thousand Eight Hundred Sixty-Six and 00/100 Dollars ($628,866.00), calculated based upon Twenty-One and 00/100 Dollars ($21.00) per rentable square foot of the Expansion Premises. One-half of the TI Allowance is allocated to Expansion Premises A and one-half to Expansion Premises B.

(l)    All references in Exhibit C to the "TI Construction Contract" shall mean the construction contract entered into with the TI GC for the construction of the Landlord's TI Work and the remaining Landlord's Base Building Work, provided that such TI Construction Contract shall contain a separate scope of work for Landlord's Base Building Work which shall be priced separately from the Landlord's TI Work.

(m)    The definition of "TI GC" shall be deemed amended by deleting the word "by" from the first line thereof.

(n)    Section I.F. entitled "Timing" shall be replaced with the following:

"Landlord and Tenant acknowledge that all specific dates set forth in this Exhibit C as they relate to the Expansion Premises, including the dates set forth in the Approved Schedule, the dates set forth for initial submission of the Space Plan and the TI Plans and the dates set forth in Section III.C.(i) and (ii) (as dates upon which Tenant may have the right to terminate this First Amendment in its entirety or solely as to Expansion Premises B if certain events have not occurred by such dates), and all other dates derived therefrom in this Exhibit C, are predicated on the assumption that this First Amendment will be executed and delivered on or before March 1, 2005. Accordingly, and notwithstanding any provision of this Exhibit C to the contrary, in the event this First Amendment was not executed and delivered by Tenant on or before March 1, 2005, then (in addition to all other extensions which may be contemplated herein due to Landlord Delays, Tenant Delays and/or Force Majeure, if any) each such date referenced herein shall be deemed to have been extended one (1) day for each day elapsing between March 1, 2005 and the date upon which this First Amendment is executed and delivered by Tenant, provided, however, that the Expansion. Premises A Rent Abatement Period shall be reduced one day for each day elapsing between March 1, 2005 and the date upon which this First Amendment is executed and delivered by Tenant to Landlord."

(o)    Section III.B.(ii)(B) shall be amended to delete all of the text of clause (b) which begins "an amount equal to the differential" and ends with "is achieved by Landlord" and substitute in its stead ''zero”.

(p)    Section III.C.(ii) shall be replaced with the following:

"(ii)    If Landlord fails to achieve Substantial Completion of Landlord's Work on or before January 1, 2006 with respect to Expansion Premises A (or to




B01 15687368.6 / 32203-000154

-14-



tender possession of Expansion Premises A to Tenant with substantial completion achieved to the extent necessary for Tenant to lawfully commence Furniture Installation in Expansion Premises A by January 1, 2006, which dates shall be extended one (1) day for each day of delay in actually achieving Substantial Completion of Expansion Premises A (or such lesser standard of substantial completion, as applicable) caused by Tenant Delays and Force Majeure (as so extended, a "Completion Deadline"), then Tenant shall have the right to terminate this First Amendment pursuant to this Section III.C.(ii) by written notice of termination to Landlord delivered no later than ten (10) business days after the Completion Deadline, in which event this First Amendment shall be deemed void, ab initio, and of no further force or effect, and the parties shall be released from all liabilities and obligations arising under this First Amendment with respect to the Expansion Premises. If Tenant fails or declines to deliver such termination notice within ten (10) business days after the applicable Completion Deadline, then Tenant will be deemed to have waived its termination right under this Section III.C.(ii), and this First Amendment shall continue in full force and effect at any time thereafter until the date Landlord achieves Substantial Completion (or such lesser standard of substantial completion necessary for Tenant to lawfully commence Furniture Installation, as applicable).

(iii) If Landlord fails to achieve Substantial Completion of Landlord's Work on or before October 15, 2006 with respect to Expansion Premises B (or to tender possession of Expansion Premises B to Tenant with substantial completion achieved to the extent necessary for Tenant to lawfully commence Furniture Installation in Expansion Premises B by October 15, 2006, which dates shall be extended one (1) day for each day of delay in actually achieving Substantial Completion of Expansion Premises B (or such lesser standard of substantial completion, as applicable) caused by Tenant Delays and Force Majeure (as so extended, a "Completion Deadline'''), then Tenant shall have the right to partially terminate this First Amendment as to Expansion Premises B (but not as to Expansion Premises A) pursuant to this Section III.C.(ii) by written notice of partial termination to Landlord delivered no later than ten (10) business days after the applicable Completion Deadline, in which event this First Amendment shall be deemed void, ab initio as to Expansion Premises B (but not as to Expansion Premises A), and of no further force or effect with respect to Expansion Premises B, and the parties shall be released from all liabilities and obligations arising hereunder with respect to Expansion Premises B (but not as to Expansion Premises A). If Tenant fails or declines to deliver such partial termination notice within ten (10) business days after the applicable Completion Deadline, then Tenant will be deemed to have waived its partial termination right under this Section III.C.(ii), and this First Amendment shall continue in full force and effect as to Expansion Premises B (as well as Expansion Premises A) at any time thereafter until the date Landlord achieves Substantial Completion (or such lesser standard of substantial completion necessary for Tenant to lawfully commence Furniture Installation, as applicable)."





BO1 15687368.6/32203-000154
-15-



(q)    Notwithstanding anything to the contrary contained in Exhibit C or elsewhere in the Lease, lo the extent Exhibit C permits any portion of the TI Allowance to be applied against Rent, the same may only be applied against Rent applicable to the Expansion Premises. Further, no portion of the TI Allowance may be used for, or applied to, Leasing Expenses or Rent until all TI Costs have been paid for both Expansion Premises A and Expansion Premises B.

(r)    No fees or reimbursements shall be charged by Landlord for review, approvals or participation in the design or construction process for any initial improvements made to the Expansion Premises pursuant to Exhibit C.

(s)    Notwithstanding anything to the contrary set forth in the Lease, as amended by the First Amendment, Base Building Improvements shall include all of the improvements set forth in First Amendment Schedule D attached hereto.

14.    Consent of Guarantor. Contemporaneously with the execution of this First Amendment, Tenant shall deliver to Landlord a consent in the form of Exhibit C attached hereto, duly executed by the Guarantor.

15.    Landlord's Authorized Agents. Notwithstanding anything contained in the Lease or this First Amendment to the contrary, including without limitation, the definition of Landlord's Agents, only Kennedy Associates Real Estate Counsel, Inc., the authorized signatory of this First Amendment, and officers of Riggs Bank N.A., the trustee of Landlord, are authorized to amend, renew or terminate the Lease, or to compromise any of Landlord's claims under the Lease or to bind Landlord in any manner. Without limiting the effect of the previous sentence, no property manager or broker shall be considered an authorized agent of Landlord to amend, renew or terminate the Lease, to compromise any of Landlord's claims under the Lease or to bind Landlord in any manner.

16.    Limitation on Recourse. Landlord has executed this First Amendment by its authorized representative signing solely in a representative capacity. Notwithstanding anything contained in this First Amendment or the Lease to the contrary, Tenant confirms that the covenants of Landlord under the Lease as amended hereby are made and intended, not as personal covenants of the Landlord's authorized representative or trustee, or for the purpose of binding such authorized representative or trustee personally, but solely in the exercise of the representative powers conferred upon such authorized representative and trustee by their principal. Notwithstanding anything contained in this First Amendment or the Lease to the contrary, liability with respect to the entry and performance of the Lease (as amended hereby) by or on behalf of Landlord, however it may arise, shall be asserted and enforced only against Landlord's estate and equity interest in the Building. Neither Landlord nor any of Landlord's Agents shall have any personal liability in the event of any claim against Landlord arising out of or in connection with the Lease as amended, the relationship of Landlord and Tenant or Tenant's use of the Premises. Further, in no event whatsoever shall any Landlord's Agent have any liability or responsibility whatsoever arising out of or in connection with the Lease as amended, the relationship of Landlord and Tenant or Tenant's use of the Premises. Any and all personal liability, if any, beyond that




BOl 15687368.6 / 32203-000154

-16-



which may be asserted under this paragraph, is expressly waived and released by Tenant and by all persons claiming by, through or under Tenant.

17.    Brokers. Tenant was represented in the transaction evidenced by this First Amendment by Grubb & Ellis Company, a licensed real estate broker. Landlord was represented in the transaction evidenced by this First Amendment by Trammell Crow Company, a licensed real estate broker. Except as provided in the next sentence, each party to this First Amendment shall indemnify, defend and hold harmless the other party from and against any and all claims asserted against such other party by any real estate broker, finder or intermediary relating to any act of the indemnifying party in connection with this First Amendment. Landlord shall be solely responsible for paying any commission or fee owed to Landlord's broker, Trammell Crow Company, in connection with this First Amendment. Landlord also shall be responsible for the payment of any commission or fee owed to Grubb & Ellis Company in connection with this First Amendment pursuant to a written agreement between Landlord and Grubb & Ellis Company.

18.    Offer to Lease. The submission of this First Amendment to Tenant or its broker or other agent does not constitute an offer to Tenant to lease the Expansion Premises or any portion thereof. This First Amendment shall have no force or effect until: (a) is executed and delivered by Tenant to Landlord; and (b) itis executed and delivered by Landlord to Tenant.

19.    Severability; Captions. If any clause or provision of this First Amendment is determined to be illegal, invalid, or unenforceable under present or future laws, the remainder of this First Amendment shall not be affected by such determination, and in lieu of each clause or provision that is determined to be illegal, invalid or unenforceable, there be added as a part of this First Amendment a clause or provision as similar in terms to such illegal, invalid or unenforceable clause or provision as may be possible and be legal, valid and enforceable. Headings or captions in this First Amendment are added as a matter of convenience only and in no way define, limit or otherwise affect the construction or interpretation of this Lease.

20.    Incorporation of Prior Agreement; Amendments. The Lease, together with this First Amendment contains all of the agreements of the parties hereto with respect to any matter covered or mentioned therein or herein, and no prior agreement or understanding pertaining to any such matter shall be effective for any purpose. No provision of the Lease as amended by this First Amendment may be amended or added to except by an agreement in writing signed by the parties to the Lease or their respective successors in interest.

21.    Authority. Each individual executing this First Amendment on behalf of Tenant represents and warrants to Landlord that he or she is duly authorized to so execute and deliver this First Amendment and that all corporate actions and consents required for execution of this First Amendment have been given, granted or obtained. If requested by Landlord, Tenant shall, within ten (10) days after demand by Landlord, deliver to Landlord satisfactory evidence of the due authorization of this First Amendment and the authority of the person executing this First Amendment on its behalf.

22.    Ratification of Lease. The Lease, as herein amended, remains in full force and



BO1 15687368,6 / 32203-000154

-17-



effect and is hereby ratified and reaffirmed in all respects.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK.]
[SIGNATURES COMMENCE ON FOLLOWING PAGE]












































BO1 15687368.6/ 32203-00-0154
-18-




WHEREFORE, the parties set their hands and seals as of the date first written above.

LANDLORD

MULTI-EMPLOYER PROPERTY
    TRUST, a trust organized under 12 C.F.R. Section 9.18

By: Kennedy Associates Real Estate Counsel, Inc., Authorized Signatory

By: /s/ Jeanette R. Flory        
Name: Jeanette R. Flory        
Its: Vice President        


TENANT

McKesson Automation Inc., a
Pennsylvania corporation

By: /s/ Kristina Veaco                            
Name: Kristina Veaco                            
Its: V.P. & Secretary                            

List of Exhibits to First Amendment

♦    First Amendment Exhibit A- Drawing Showing Location of Expansion Premises A
♦    First Amendment Exhibit B - Drawing Showing Location of Expansion Premises B
♦    First Amendment Exhibit C - Form of Guarantor's Consent
♦    First Amendment Exhibit D - Form of Lease Memorandum (First Expansion
Commencement Date)
♦    First Amendment Exhibit E - Form of Lease Memorandum (Second Expansion
Commencement Date)


List of Schedules to First Amendment

♦    First Amendment Schedule C-1 -Approved Schedule
♦    First Amendment Schedule C-3 - Approved Schematic Drawings
♦    First Amendment Schedule D - Base Building Improvements





BO1 15687368.6 / 32203-000154
-19-


 EX-10.25 6 exhibit1025q4-20.htm EX-10.25 Document

Exhibit 10.25

SECOND AMENDMENT TO LEASE


This SECOND AMENDMENT TO LEASE (this "Second Amendment") is entered into as of April 21, 2008, by and between NewTower Trust Company Multi-Employer Property Trust, a trust organized under 12 C.F.R. Section 9.18 and formerly known as the Multi Employer Property Trust ("Landlord") and McKesson Automation Inc., a Pennsylvania corporation ("Tenant"), in consideration of the mutual covenants contained herein and the benefits to be derived here from.

WITNESSETH:

WHEREAS, TC Northeast Metro, Inc. ("TC"), a Delaware corporation, and Tenant entered into that certain Lease dated December 21, 2001 (the "Original Lease"), pursuant to which Tenant leased from TC approximately sixty-one thousand eight hundred eighty-seven (61,887) rentable square feet consisting of the entire third (3rd) and fourth (4th) floors (the "Initial Premises") of a certain building located at 500 Cranberry Woods Drive, Cranberry Township, Pennsylvania (referred to herein and in the Original Lease as the "Building"); and

WHEREAS, Tenant's obligations under the Lease have been guarantied by McKesson Corporation (the "Guarantor"), a Delaware corporation, pursuant to a certain Guaranty of Lease dated December 21, 2001 (the '"Guaranty"); and

WHEREAS, TC subsequently assigned all of its right, title and interest under the Lease and Guaranty to the Landlord pursuant to a certain Assignment and Assumption Agreement dated December 28, 2001 between TC and the Landlord; and

WHEREAS, Landlord and Tenant entered into a certain First Amendment to Lease dated February 8, 2005 (the "First Amendment") pursuant to which the Original Lease was amended to include the entire second (2nd) floor of the Building, consisting of approximately twenty-nine thousand nine hundred forty-six (29,946) rentable square feet (the "Expansion Premises") (the Original Lease as amended by the First Amendment is hereinafter referred to as the "Lease"); and

WHEREAS, as of the date hereof: the Tenant currently leases an aggregate of approximately ninety-one thousand eight hundred thirty-three (91,833) rentable square feet of the Building; and

WHEREAS, the Tenant desires to lease an additional ten thousand nine hundred eight (1 0,908) rentable square feet located on the first (1st) floor of the Building (the "Second Amendment Premises"); and

WHERE AS, Landlord and Tenant desire to amend the Lease as provided herein;




-1-
BOl 15908418.8 /32203~000154



NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by both Landlord and Tenant, the parties hereto agree that the Lease shall be further amended as follows:

1.    Recitals/Defined Terms. The foregoing recitals shall be considered an integral part of this Second Amendment. Unless otherwise specifically stated in this Second Amendment, all capitalized terms in this Second Amendment shall have the meaning given to those terms in the Lease. In the event of any conflict between the Lease and this Second Amendment, the terms of this Second Amendment shall control.

2.    Second Amendment Premises.

(a)    Landlord and Tenant hereby agree to add the Second Amendment Premises to the Premises in two (2) stages, with (i) the first stage consisting of the addition to the Premises, as of the Second Amendment Expansion Commencement Date A (as hereinafter defined), of that portion of the Second Amendment Premises consisting of approximately six thousand one hundred twenty-one (6,121) rentable square feet shown on Second Amendment Exhibit A attached hereto ("Second Amendment Premises A"), and (ii) the second stage consisting of the addition to the Premises, as of the Second Amendment Expansion Commencement Date B (as hereinafter defined), of that portion of the Second Amendment Premises consisting of approximately four thousand seven hundred eighty-seven (4,787) rentable square feet shown on Second Amendment Exhibit A attached hereto ("Second Amendment Premises B"). Landlord hereby leases to Tenant, and Tenant hereby rents from Landlord, the Second Amendment Premises upon the terms and conditions of this Second Amendment.

(b)    As of the Second Amendment Expansion Commencement Date A, the entire Premises shall consist of approximately ninety-seven thousand nine hundred fifty-four (97,954) rentable square feet consisting of (i) the entire second (2nd), third (3rd) and fourth (4th) floors of the Building, and, (ii) a portion of the first (1st) floor of the Building containing approximately six thousand one hundred twenty-one (6,121) rentable square feet. On the Second Amendment Expansion Commencement Date A, Second Amendment Premises A shall become part of the Premises and, except as otherwise provided below, shall be subject to all of the terms and conditions of the Lease for the remainder of the Term.

(c)    As of the Second Amendment Expansion Commencement Date B, the entire Premises shall consist of approximately one hundred two thousand seven hundred forty-one (102,741) rentable square feet consisting of (i) the entire second (2nd), third (3rd) and fourth (4th) floors of the Building, and (ii) a portion of the first (1st) floor of the Building containing an aggregate of ten thousand nine hundred eight (10,908) rentable square feet. On the Second Amendment Expansion Commencement Date B, Expansion Premises B shall become part of the Premises and, except as otherwise provided below, shall be subject to all of the terms and conditions of the Lease for the remainder of the Term.

(d)    Notwithstanding anything to the contrary contained in the Lease, including but not limited to Section 1, neither Second Amendment Premises A nor Second Amendment


BOl 15908418.8/32203-000154
-2-


Premises B shall be subject to remeasurement and the rentable square footage thereof as recited in Section 2(a) hereof shall be shall be final, conclusive and controlling.

(e)    Tenant acknowledges and agrees that this Second Amendment satisfies all of Landlord's obligations under Section 52 of the Lease as it relates to any right of Tenant thereunder to expand into all or any portion of the Second Amendment Premises.

3.     Term

(a)    Landlord and Tenant acknowledge, confirm and agree that the Term of the Lease, as previously extended to the Extended Lease Expiration Date (as defined in the First Amendment) expires on December 31, 2011.

(b)    The Term with respect to Second Amendment Premises A shall commence on the Second Amendment Expansion Commencement Date A (as hereinafter defined) and shall expire on December 31, 2011. Subject to subparagraphs l.4(b), l.4(c) and 1.4(d) of the Lease and subject to those provisions of Exhibit C relating to Tenant Delays, (i) if Tenant executes and delivers this Second Amendment to Landlord on or before April 21, 2008, the "Second Amendment Expansion Commencement Date A" shall be the earlier to occur of: (x) the date of Substantial Completion of Second Amendment Premises A; or (y) the date upon which Tenant commences the beneficial use and occupancy of all or any material part of Second Amendment Premises A (other than for Furniture Installation and Move-In). and (ii) if Tenant executes and delivers this Second Amendment to Landlord after April 21, 2008, the "Second Amendment Expansion Commencement Date A" shall be the earlier to occur of: (x) April 1, 2008, whether or not Landlord has achieved Substantial Completion of Second Amendment Premises A; or (y) the date upon which Tenant commences the beneficial use and occupancy of all or any material part of Second Amendment Premises A (other than for Furniture Installation and Move-In). Tenant acknowledges and agrees that the fixed commencement date as of April 1, 2008 for Second Amendment Premises A as aforesaid in the event that Tenant does not execute and deliver this Second Amendment to Landlord on or before April 21, 2008 was a material inducement for Landlord to enter into this Second Amendment and that Landlord would not have entered into this Second Amendment without such provision. Landlord shall deliver Second Amendment Premises A to Tenant upon the later of the Second Amendment Expansion Commencement Date A or the Substantial Completion of Second Amendment Premises A, provided, however, Landlord agrees to provide Tenant with access to Second Amendment Premises A for purposes of Furniture Installation and Move-In not less than fifteen (15) days prior to the date Landlord then estimates that Substantial Completion of Second Amendment Premises A will occur. Except as otherwise expressly provided in, or otherwise inconsistent with, this Second Amendment, and except to the extent not applicable to Second Amendment Premises A. for purposes of this paragraph any references in subparagraphs l.4(b), l.4(c) and l.4(d) of the Lease to the "Premises", "Commencement Date'', and "Exhibit C" shall be deemed instead to refer to "Second Amendment Premises A", "Second Amendment Expansion Commencement Date A", and Second Amended Exhibit C (as defined in Section 8 hereof), respectively.





801 1590&418.8 / 32203-000154
-3-


(c)        Promptly after the Second Amendment Expansion Commencement Date A, Landlord and Tenant shall execute a memorandum confirming the Second Amendment Expansion Commencement Date A. Such memorandum (the "Second Amendment Expansion Date Memorandum A") shall be in the form attached to this Second Amendment as Second Amendment Exhibit D. The failure of Tenant to execute the Second Amendment Expansion Date Memorandum A shall not affect Tenant's obligations under the Lease as amended by this Second Amendment. In no event shall Tenant record this Second Amendment or the Second Amendment Expansion Date Memorandum A.

(d)    The Term with respect to Second Amendment Premises B shall commence on the Second Amendment Expansion Commencement Date B (as hereinafter defined) and shall expire on December 31, 2011. Subject to subparagraphs l.4(b), l .4(c) and 1.4(d) of the Lease and subject to those provisions of Exhibit C relating to Tenant Delays, (i) if Tenant executes and delivers this Second Amendment to Landlord on or before April 21, 2008, the "Second Amendment Expansion Commencement Date B" shall be the earlier to occur of: (x) the later of (1) the date of Substantial Completion of Second Amendment Premises B or (2) October 1, 2008; or (y) the date upon which Tenant commences the beneficial use and occupancy of all or any material part of Second Amendment Premises B (other than for Furniture Installation and Move-In), and (ii) if Tenant executes and delivers this Second Amendment to Landlord after April 21, 2008, the "Second Amendment Expansion Commencement Date B" shall be the earlier to occur of: (x) October 1, 2008, whether or not Landlord has achieved Substantial Completion of Second Amendment Premises B; or (y) the date upon which Tenant commences the beneficial use and occupancy of all or any material part of Second Amendment Premises B (other than for Furniture Installation and Move-In). Tenant acknowledges and agrees that the outside fixed commencement date for Second Amendment Premises B as aforesaid in the event that Tenant does not execute and deliver this Second Amendment to Landlord on or before April 21, 2008 was a material inducement for Landlord to enter into this Second Amendment and that Landlord would not have entered into this Second Amendment without such provision. Landlord shall deliver Second Amendment Premises B to Tenant upon the later of the Second Amendment Expansion Commencement Date B or the Substantial Completion of Second Amendment Premises B, provided, however, Landlord agrees to provide Tenant with access to Second Amendment Premises B for purposes of Furniture Installation and Move-In not less than fifteen (15) days prior to the later of (1) the date Landlord then estimates that Substantial Completion of Second Amendment Premises B will occur or (2) October 1, 2008. Except as otherwise expressly provided in, or otherwise inconsistent with, this Second Amendment, and except to the extent not applicable to Second Amendment Premises B, for purposes of this paragraph any references in subparagraphs l .4(b), 1.4(c) and 1.4(d) of the Lease to the "Premises", "Commencement Date", and "Exhibit C" shall be deemed instead to refer to "Second Amendment Premises B", "Second Amendment Expansion Commencement Date B", and Second Amended Exhibit C, respectively.

(e)    Notwithstanding anything to the contrary contained herein, if Landlord achieves Substantial Completion of Second Amendment Premises B prior to October 1, 2008, then at any time after such Substantial Completion Tenant may elect to accelerate the Second Amendment Expansion Commencement Date B with respect to all (but not less than all) of Second

BO1159084I8.8 /J220J-000154
-4-


Amendment Premises B. Unless otherwise mutually agreed, Tenant shall provide Landlord with at least five (5) business days advance written notice of such election.

(f)    Promptly after the Second Amendment Expansion Commencement Date B, Landlord and Tenant shall execute a memorandum confirming the Second Amendment Expansion Commencement Date B. Such memorandum (the "Second Amendment Expansion Date Memorandum B") shall be in the form attached to this Second Amendment as Second Amendment Exhibit E. The failure of Tenant to execute the Second Amendment Expansion Date Memorandum B shall not affect Tenant's obligations under the Lease as amended by this Second Amendment. In no event shall Tenant record this Second Amendment or Second Amendment Expansion Date Memorandum B.

4.    Tenant's Share.    Section 1.2 of the Lease is hereby amended by deleting the second sentence thereof and substituting in its stead the following:

"Tenant's Share shall be (a) for the period beginning on the Commencement Date and ending on the date immediately preceding the First Expansion Commencement Date, Fifty-One and 81/100 Percent (51.81%) (i.e., 61,887/119,444) based upon the Premises containing 61,887 rentable square feet, and the Building containing 119,444 rentable square feet; (b) for the period beginning on the First Expansion Commencement Date (i.e. August 8, 2005) and ending on the date immediately preceding the Second Expansion Commencement Date (i.e. May 14, 2006), Sixty-Four and 35/100 Percent (64.35%) (i.e., 76,860/119,444) based upon the Premises containing 76,860 rentable square feet, and the Building containing 119,444 rentable square feet; (c) for the period beginning on Second Expansion Commencement Date (i.e. May 15, 2006) and ending on the date immediately preceding the Second Amendment Expansion Commencement Date A, Seventy-Six and 88/100 Percent (76.88%) (i.e., 91,833/119,444) based upon the Premises containing 91,833 rentable square feet, and the Building containing 119,444 rentable square feet; (d) for the period beginning on the Second Amendment Expansion Commencement Date A and ending on the date immediately preceding the Second Amendment Expansion Commencement Date B, Eighty-Two and 01/100 Percent (82.01%) (i.e., 97,954/119,444) based upon the Premises containing 97,954 rentable square feet, and the Building containing 119,444 rentable square feet; and (e) for the period beginning on the Second Amendment Expansion Commencement Date B and continuing for the remainder of the Term, Eighty-Six and 02/100 Percent (86.02%) (i.e., 102,741/119,444) based upon the Premises containing 102,741 rentable square feet, and the Building containing 119.444 rentable square feet."

5.    Base Rent. The Lease is hereby amended by deleting Subsection 1.5.1 thereof in its entirety and substituting in its stead the following:






IlOl 15908418.8/32203-000154

-5-


"1.5.1 The rate per rentable square foot per annum, and the portion of the Lease Term during which such monthly Base Rent is payable shall be determined from the following tables.

Initial Premises
Applicable Portion of Lease Term
Annual Base Rent
Monthly Base
Rent    Installment (Annual - 12)
BeginningEndingRate Per/Rentable Sq. Ft./Annum

March 23, 2003

December 31, 2008

$21.50

$1,330,570.50

$110,880.88
January 1, 2009
December 31, 2011
$22.75
$1,407,929.25
$117,327.44

    Expansion Premises A
Applicable Portion of Lease Term     Rate Per/Rentable
Annual Base Rent
Monthly Base
Rent    Installment (Annual - 12)
BeginningEnding
Sq. Ft./ Annum

August 8, 2005

December 31, 2008

$21.50

$321,919.50

$26.826.63
January 1, 2009
December 31, 2011
$22.75
$340 635.75
$28.386.31

Expansion Premises B
Applicable Portion of Lease Term     Rate Per/Rentable
Annual Base Rent
Monthly Base
Rent    Installment (Annual - 12)
BeginningEnding
Sq. Ft./ Annum

March 15, 2006

December 31, 2008

$21.50

$321,919.50

$26.826.63
January 1, 2009
December 31, 2011
$22.75
$340 635.75
$28.386.31

Second Amendment Premises A
Applicable Portion of Lease Term     Rate Per/Rentable
Annual Base Rent
Monthly Base
Rent    Installment (Annual – 12)
BeginningEnding
Sq. Ft./ Annum
Second Amendment Expansion Commencement Date A
December 31, 2008
$21.50
$131,601.50
$10,966.79
January 1, 2009
December 31, 2011
$22.75
$139,252.75
$11,604.40


Second Amendment Premises B
Applicable Portion of Lease Term     Rate Per/Rentable
Annual Base Rent
Monthly Base
Rent    Installment (Annual – 12)
BeginningEnding
Sq. Ft./ Annum
Second Amendment Expansion Commencement Date B
December 31, 2008
$21.50
$102,920.50
$8,576.71
January 1, 2009
December 31, 2011
$22.75
$108,904.25
$9,075.35




BO! 15908418 8 / 32203-000154
-6-


If the First Expansion Commencement Date, the Second Expansion Commencement Date, the Second Amendment Expansion Commencement Date A, or the Second Amendment Expansion Commencement Date B is a date other than the first day of a calendar month, Base Rent for Expansion Premises A, Expansion Premises B, Second Amendment Premises A, or Second Amendment Premises B (as applicable) for the partial month in which the applicable expansion commencement date occurs shall be prorated. Notwithstanding the foregoing, Landlord abated all Base Rent applicable to Expansion Premises A for the period from August 8, 2005 through October 3l, 2005 (the "Expansion Premises A Abatement Period").

Landlord and Tenant acknowledge, confirm and agree that the (a) the "First Expansion Commencement Date" as defined in the First Amendment was August 8, 2005, (b) the "Second Expansion Commencement Date" as defined in the First Amendment was May 15, 2006, and (c) the "Rent Adjustment Date" as defined in the First Amendment is January 1, 2009.

Notwithstanding the foregoing rent schedules, if Tenant validly exercises any of its renewal options as set forth in this Lease, Base Rent for the renewal term(s) shall be as set forth in Section 50 hereof"

6.    Base Year.

Without limiting the generality of the last sentences of each of subsections 2(b) and 2(c) hereof:

(a)    the Operating Costs Base Year applicable to Second Amendment Premises A and Second Amendment Premises B shall be the same Operating Costs Base Year applicable lo the entire Premises as in effect immediately prior to this Second Amendment (i.e. calendar year 2005); and.

(b)    the Real Estate Tax Base Year applicable to Second Amendment Premises A and Second Amendment Premises B shall be the same Real Estate Tax Base Year applicable to the entire Premises as in effect immediately prior to this Second Amendment (i.e. calendar year 2005), provided that if the Building has not been fully assessed as of the end of calendar year 2005, the Property Tax Base Year shall be the first tax year in which the Building is fully assessed.

7.    Notice Addresses. Section 1.8 of the Lease is hereby amended by substituting the following addresses for Landlord and Tenant:









BOI 15908418 8/ 32203-000154

-7-



"If to Landlord:    NewTower Trust Company Multi-Employer Property Trust
c/o Kennedy Associates Real Estate Counsel, LP
Attention: Executive Vice President - Asset Management
1215 Fourth Ave., Suite 2400
Seattle, WA 98161
Facsimile: (206) 682-4769
with copies to:
NewTower Trust Company Multi-Employer Property Trust
c/o Kennedy Associates Real Estate Counsel, LP
Attn: Senior Vice President - Asset Management 7315 Wisconsin Avenue, Suite 350 West
Bethesda, MD 20814
Facsimile: (301) 656-9339
and
NewTower Trust Company Multi-Employer Property Trust
c/o NewTower Trust Company
Attn: President/MEPT or Patrick O. Mayberry
Three Bethesda Metro Center, Suite 1600
Bethesda, MD 2081 4
Facsimile: (240) 235-9961
and with a copy to Manager at:
CB Richard Ellis, Inc.
800 Cranberry Woods Drive, Suite 260
Cranberry Township, Pennsylvania 16066
Facsimile: (724) 778-4119

"If to Tenant    McKesson Automation, Inc.
c/o McKesson Corporation
One Post Street, 34th Floor
San Francisco, CA 94104
Attention: McKesson Real Estate
with copies to:








BOI 15908418.8 / 32203-000154
-8-


CB Richard Ellis, Inc.
Attention: McKesson Lease Administration
5100 Poplar Avenue, Suite 1000
Memphis, TN 38137."

8.    Tenant Improvements.    Notwithstanding anything to the contrary contained in the Lease (including Section 17), (a) any improvements to be performed by Tenant to Second Amendment Premises A (or any portion thereof) prior to the Second Amendment Expansion Commencement Date A shall be governed by Exhibit C of the Lease as modified by Section 11 of this Second Amendment (referred to herein as "Second Amended Exhibit C"), (b) any improvements to be performed by Tenant to Second Amendment Premises B (or any portion thereof) prior to the Second Amendment Expansion Commencement Date B shall be governed by Second Amended Exhibit C, and (c) all other improvements performed by Tenant to the Second Amendment Premises shall be treated as Alterations to the Premises and thus governed by Article 15 of the Lease.

9.    Parking. Effective as of the Second Amendment Expansion Premises Commencement Date A, Tenant's parking allocation as set forth in Section 46 of the Lease shall be increased by an amount equal to five (5) parking spaces for each 1,000 square feet of rentable area of Second Amendment Premises A, and effective as of the Second Amendment Expansion Premises Commencement Date B, Tenant's parking allocation as set forth in Section 46 of the Lease shall be further increased by an amount equal to five (5) parking spaces for each 1,000 square feet of rentable area of Second Amendment Premises B. Such parking allocation remains subject to adjustment in the event of any reduction or further expansion of the Premises as provided in Section 46 of the Lease.

10. Renewal Option. Without limiting any other term or condition hereof, Landlord and Tenant acknowledge and agree that the renewal options granted to Tenant under Section 50 of the Lease remain in full force and effect and hereafter apply to the entire Premises then leased to Tenant (i.e., the Initial Premises, Expansion Premises A, Expansion Premises B, Second Amendment Premises A, and Second Amendment Premises B) as of the end of the Initial Term and the First Renewal Term, as applicable. Tenant shall have no right to exercise any such option to renew for less then the entire Premises then leased by Tenant pursuant to the Lease. As used herein and in the Lease, "Initial Term" hereafter shall mean and refer to the period beginning on the First Expansion Commencement Date and ending on the Extended Lease Expiration Date (i.e., December 31, 2011).

11.    Construction of Expansion Premises. Except as otherwise provided for herein, construction of tenant improvements to the Second Amendment Premises and all matters related thereto shall be handled in substantially the same manner as provided for under Exhibit C of the Lease ("Exhibit C") as if fully restated herein, but subject to the following modifications as to timing and other points of detail pertaining specifically to the Second Amendment Premises (or the applicable portion thereof), rather than the Initial Premises and/or the Expansion Premises.







B01 l590841U/3120J-0CYJl54
-9-



(a)    Except where the context requires otherwise, all references in Exhibit C to the "Premises" shall mean and refer to the Second Amendment Premises or the applicable portion thereof.

(b)    All references in Exhibit C to the "Approved Design Schedule'' shall mean the approved schedule for the preparation, review and approval of the Construction Documents as set forth in Second Amendment Schedule C-1 attached hereto.

(c)    All references in Exhibit C to the "Approved Schedule" shall mean the approved schedule for Completion of Landlord's Work as set forth in Second Amendment Schedule C-1 attached hereto.

(d)    All references in Exhibit C to the "Approved Schematic Drawings" shall mean the as built plans attached hereto as Second Amendment Schedule C-3.

(e)    There shall be no Base Building Construction Contract or Base Building GC for the remaining Base Building Improvements. The parties agree that any remaining Base Building Improvements that have not yet been completed for the Second Amendment Premises shall be completed by the TI GC pursuant to the TI Construction Contract, but pursuant to a separate scope of work which shall be bid separately from the Landlord's TI Work.

(f)    The last sentence of the definition of "Excess TI Costs" shall be deemed amended substituting "Part IV" in place of "Part VII".

(g)    All references in Exhibit C to the "Landlord's Architect" shall mean, initially, The Design Alliance, and any other architect selected by Landlord to replace or supplement such architect.

(h)    All references in Exhibit C to the "Tenant's Architect" shall mean, initially, The Design Alliance, and any other architect selected by Tenant to replace or supplement such architect, subject to Landlord's reasonable consent.

(i)    The "Steel Erection Completion Deadline" shall have no application to the Second Amendment Premises.

(j)    All references in Exhibit C to the 'Test-Fit Allowance" shall have no applicability to the Second Amendment Premises, and Landlord shall have no obligation to provide any Test Fit Allowance with respect to the Second Amendment Premises.

(k)    All references in Exhibit C to the "TI Allowance" shall mean (i) with respect to Second Amendment Premises A, an amount equal to the product of (1) One Hundred Twenty Eight Thousand Five Hundred forty-One and 00/100 Dollars ($128,541.00) (calculated based upon Twenty-One and 00/100 Dollars ($21.00) per rentable square foot of the Second Amendment Premises A), times (2) a fraction, the numerator of which is the number of full months remaining in the Term (exclusive of any Renewal Terms) as of Second Amendment





BO! 15908418 8; 32203-000154
-10-




Expansion Commencement Date A and the denominator of which is sixty-four (64), and (ii) with respect to Second Amendment Premises B, an amount equal to the product of (1) One Hundred Thousand Five Hundred Twenty-Seven and 00/100 Dollars ($100,527.00) (calculated based upon Twenty-One and 00/100 Dollars ($21.00) per rentable square foot of the Second Amendment Premises B), times (2) a fraction, the numerator of which is the number of full months remaining in the Term (exclusive of any Renewal Terms) as of Second Amendment Expansion Commencement Date B and the denominator of which is sixty-four (64). By way of examples only, (A) if the Second Amendment Expansion Commencement Date A is April 1, 2008, the TI Allowance with respect to Second Amendment Premises B shall be Ninety Thousand Three Hundred Eighty and 80/100 Dollars ($90,380.39) calculated as follows: $128,541.00 x (45/64) = $90,380.39, and (B) if the Second Amendment Expansion Commencement Date B is October 1, 2008, the TI Allowance with respect to Second Amendment Premises B shall be Sixty-One Thousand Two Hundred Fifty-Eight and 64/100 Dollars ($61,258.64) calculated as follows: $100,527.00 x (39/64) = $61,258.64.

(l)    All references in Exhibit C to the "TI Construction Contract" shall mean the construction contract entered into with the TI GC for the construction of the Landlord's TI Work and the remaining Landlord's Base Building Work, provided that such TI Construction Contract shall contain a separate scope of work for Landlord's Base Building Work which shall be priced separately from the Landlord's TI Work.

(m)    The definition of "TI GC" shall be deemed amended by deleting the word "by" from the first line thereof.

(n)    Section 1.F. entitled "Timing" shall have no application to the Second Amendment Premises.

(o)    Section 111.B shall be replaced with the following:

"B.    Effect of Delay. To the extent any phase of Landlord's Work is not Substantially Completed as of the date indicated within the Approved Schedule, the following provisions shall apply:

(i)    Provided that Tenant has executed and delivered this Second Amendment to Landlord on or before April 21, 2008, if and to the extent Substantial Completion of Second Amendment Premises A is delayed beyond the date set forth in the Approved Schedule, then the Second Amendment Expansion Commencement Date A shall be the date upon which Substantial Completion of the Landlord's Work occurs with respect to Second Amendment Premises A, and notwithstanding anything herein to the contrary. such delay (whether or not constituting Landlord Delay) shall not (X) otherwise result in or give rise to any rent abatement or any damages or penalties payable by Landlord to Tenant, nor (Y) constitute a default by Landlord under this Lease; provided that to the extent such delay is caused by Tenant Delay(s), the Second Amendment Expansion


BOI 15908418.8 I 32203-000154
-11-


Commencement Date A shall be deemed to be the date upon which Landlord's Work with respect to Second Amendment Premises A would have been Substantially Completed (and Tenant permitted to lawfully occupy Second Amendment Premises A) but for such Tenant Delay(s). However, if Tenant executes and delivers this Second Amendment to Landlord after April 21, 2008 and Substantial Completion of Second Amendment Premises A is delayed beyond the date (if any) set forth in the Approved Schedule, then notwithstanding anything herein to the contrary, such delay (whether or not constituting Landlord Delay) shall not (X) delay the occurrence of Second Amendment Expansion Commencement Date A or otherwise result in or give rise to any rent abatement or any damages or penalties payable by Landlord to Tenant, nor (Y) constitute a default by Landlord under this Lease.

(ii)    Provided that Tenant has executed and delivered this Second Amendment to Landlord on or before April 21, 2008, if and to the extent Substantial Completion of Second Amendment Premises B is delayed beyond the date set forth in the Approved Schedule, then the Second Amendment Expansion Commencement Date B shall be the date upon which Substantial Completion of the Landlord's Work occurs with respect to Second Amendment Premises B, and notwithstanding anything herein to the contrary, such delay (whether or not constituting Landlord Delay) shall not (X) otherwise result in or give rise to any rent abatement or any damages or penalties payable by Landlord to Tenant, nor (Y) constitute a default by Landlord under this Lease; provided that to the extent such delay is caused by Tenant Delay(s), the Second Amendment Expansion Commencement Date B shall be deemed to be the date upon which Landlord's Work with respect to Second Amendment Premises B would have been Substantially Completed (and Tenant permitted to lawfully occupy Second Amendment Premises B) but for such Tenant Delay(s). However, if Tenant executes and delivers this Second Amendment to Landlord after April 21, 2008 and Substantial Completion of Second Amendment Premises B is delayed beyond the date (if any) set forth in the Approved Schedule, then notwithstanding anything herein to the contrary, such delay (whether or not constituting Landlord Delay) shall not (X) delay the occurrence of Second Amendment Expansion Commencement Date B or otherwise result in or give rise to any rent abatement or any damages or penalties payable by Landlord to Tenant, nor (Y) constitute a default by Landlord under this Lease.

(p)    Section III.C shall have no application to the Second Amendment Premises

(q)    Notwithstanding anything to the contrary contained in Exhibit C or elsewhere in the Lease, except as expressly set forth in this Section l 1 (q), the TI Allowance shall be used solely to pay TI Costs associated with the performance of Landlord's TI Work for the Second




BOl 15908418.8 / 32203---000154
-12-




Amendment Premises and the Construction Management Fee (as defined Section 11(r) hereof). To the extent costs expended by Landlord to construct Second Amendment Expansion Premises A are less than the TI Allowance allocated to Second Amendment Expansion Premises A pursuant to Section 11(k) of this Second Amendment, the unexpended amount shall be added to the TI Allowance allocated to Second Amendment Expansion Premises B pursuant to Section 11(k) of this Second Amendment. To the extent costs expended by Landlord to construct Second Amendment Expansion Premises B are less than the TI Allowance allocated to Second Amendment Premises B plus the unexpended portion of the TI Allowance allocated to Second Amendment Premises A, such excess amount may be expended on costs associated with the installation of data/voice cabling, security systems and other equipment integrated within Second Amendment Expansion Premises B (the "Miscellaneous TI Related Costs") provided that Tenant has requested funding of such Miscellaneous TI Related Costs and satisfied all Miscellaneous TI Related Costs Funding Requirements (as defined below) prior to the date which is six (6) months after the Second Amendment Expansion Commencement Date B; and, if after such further application, the full amount of the TI Allowance allocated to Second Amendment Expansion Premises A and Second Amendment Expansion Premises B still has not been utilized, Tenant be entitled to credit the unused amount against payments of Rent due under the Lease solely with respect to the Second Amendment Premises if, but only if, Tenant so directs Landlord in writing prior to the date which is six (6) months after the Second Amendment Expansion Commencement Date B. As used herein, "Miscellaneous TI Related Costs Funding Requirements" include the submission of invoices for the applicable work, including a letter from Tenant specifically approving such invoices and directing Landlord to pay a specified amount to a specified party, or requesting reimbursement for such expenses to the extent already paid by Tenant, together with certifications regarding completion (or partial completion) of such work by appropriate design professions, lien waivers (to the extent reasonably applicable to the type of expense being funded) which may be partial or final lien waivers depending upon the status of completion, and satisfaction or other reasonable and customary funding requirements invoked by Landlord's lender(s) and (if applicable) equity funding sources. In the event that Tenant fails to satisfy all Miscellaneous TI Related Costs Funding Requirements prior to the date which is six (6) months after the Second Amendment Expansion Commencement Date B, then Tenant shall have no further right to use any unexpended balance of the TI Allowance allocated to Second Amendment Premises A and/or Second Amendment Premises B for any Miscellaneous TI Related Costs. Further, if Tenant fails to direct Landlord in writing to apply any unexpended balance of the TI Allowance allocated to Second Amendment Premises A and/or Second Amendment Premises B against the Rent payable on account of the Second Amendment Premises prior to the date which is six (6) months after the Second Amendment Expansion Commencement Date B, then any remaining unexpended balance of the TI Allowance allocated to Second Amendment Premises A and/or Second Amendment Premises B shall be deemed forfeited by Tenant and Landlord shall have no further obligation on account thereof.

(r)    Tenant shall promptly reimburse Landlord for all reasonable costs, including architects, engineers', and consultants fees incurred by Landlord in connection with Landlord's review of the Tenant's TI Plans and/or any request from Tenant for a TI Change Order and all such costs shall constitute TI Costs. Tenant also agrees to pay the Landlord a construction






BOL 15908418.8 / 32203-000154
-13-



management fee (the "Construction Management Fee") equal to four percent (4%) of the aggregate TI Costs for the Second Amendment Premises.

(s)    Notwithstanding anything to the contrary set forth in the Lease, as amended by the Second Amendment, Base Building Improvements shall include all of the improvements set forth in Second Amendment Schedule D attached hereto.

(t)    In the event of any inconsistency between Exhibit C and the Lease, the terms of Exhibit C as amended by this Second Amendment shall control.

12.    Surrender Obligations Relating to Landlord's Work. Without in any way limiting Tenant's obligations with respect to any portion of the Premises as in effect prior to this Second Amendment, Tenant acknowledges, confirms and agrees that, pursuant to Section 26.2 of the Lease, upon the expiration or earlier termination of the Lease, Tenant shall be obligated to remove any leasehold improvements that were constructed as part of Landlord's Work with respect to the Second Amendment Premises, or otherwise pursuant to Second Amended Exhibit C, and restore the Second Amendment Premises to its pre-existing condition if (a) such leasehold improvements are not standard Class A office improvements, and (b) Landlord notifies Tenant, at the time of its approval of the Construction Drawings pursuant to Second Amended Exhibit C, or any applicable change order, that Tenant would be required to remove such improvements upon surrender of the Second Amendment Premises.

13.    Consent of Guarantor. Contemporaneously with the execution of this Second Amendment, Tenant shall deliver to Landlord a consent in the form of Second Amendment Exhibit C attached hereto, duly executed by the Guarantor.

14.    Landlord's Authorized Agents. Notwithstanding anything contained in the Lease or this Second Amendment to the contrary, including without limitation, the definition of Landlord's Agents. only Kennedy Associates Real Estate Counsel, LP, the authorized signatory of this Second Amendment, and officers of NewTower Trust Company, the trustee of Landlord, are authorized to amend, renew or terminate the Lease, or to compromise any of Landlord's claims under the Lease or to bind Landlord in any manner. Without limiting the effect of the previous sentence, no property manager or broker shall be considered an authorized agent of Landlord to amend, renew or terminate the Lease, to compromise any of Landlord's claims under the Lease or to bind Landlord in any manner.

15.    Limitation on Recourse. Landlord has executed this Second Amendment by its authorized representative signing solely in a representative capacity. Notwithstanding anything contained in this Second Amendment or the Lease to the contrary, Tenant confirms that the covenants of Landlord under the Lease as amended hereby are made and intended, not as personal covenants of the Landlord's authorized representative or trustee, or for the purpose of binding such authorized representative or trustee personally, but solely in the exercise of the representative powers conferred upon such authorized representative and trustee by their principal. Notwithstanding anything contained in this Second Amendment or the Lease to the contrary, liability with respect to the entry and performance of the Lease (as amended hereby) by or on




BOJ 1590841!!.8 / 32203-000154
-14-


behalf of Landlord, however it may arise, shall be asserted and enforced only against Landlord's estate and equity interest in the Building. Neither Landlord nor any of Landlord's Agents shall have any personal liability in the event of any claim against Landlord arising out of or in connection with the Lease as amended, the relationship of Landlord and Tenant or Tenant's use of the Premises. Further, in no event whatsoever shall any Landlord's Agent have any liability or responsibility whatsoever arising out of or in connection with the Lease as amended, the relationship of Landlord and Tenant or Tenant's use of the Premises. Any and all personal liability, if any, beyond that which may be asserted under this paragraph, is expressly waived and released by Tenant and by all persons claiming by, through or under Tenant.

16.    Brokers. Tenant was represented in the transaction evidenced by this Second Amendment by CB Richard Ellis, Inc. ("CB Richard Ellis"), a licensed real estate broker. Landlord also was represented in the transaction evidenced by this Second Amendment by CB Richard Ellis. Each party to this Second Amendment shall indemnify, defend and hold harmless the other party from and against any and all claims asserted against such other party by any real estate broker, finder or intermediary relating to any act of the indemnifying party in connection with this Second Amendment. Landlord shall be solely responsible for paying any commission or fee owed to CB Richard Ellis as Landlord's broker in connection with this Second Amendment, and CB Richard Ellis as Landlord's broker shall be responsible for any commission or fee payable to CB Richard Ellis in its capacity as Tenant's broker.

17.    Offer to Lease. The submission of this Second Amendment to Tenant or its broker or other agent does not constitute an offer to Tenant to lease the Second Amendment Premises or any portion thereof. This Second Amendment shall have no force or effect until: (a) is executed and delivered by Tenant to Landlord; and (b) it is executed and delivered by Landlord to Tenant.

18.    Severability; Captions. If any clause or provision of this Second Amendment is detem1ined to be illegal, invalid, or unenforceable under present or future laws, the remainder of this Second Amendment shall not be affected by such determination, and in lieu of each clause or provision that is determined to be illegal, invalid or unenforceable, there be added as a part of this Second Amendment a clause or provision as similar in terms to such illegal, invalid or unenforceable clause or provision as may be possible and be legal, valid and enforceable. Headings or captions in this Second Amendment are added as a matter of convenience only and in no way define, limit or otherwise affect the construction or interpretation of this Lease.

19.    Incorporation of Prior Agreement; Amendments. The Lease, together with this Second Amendment contains all of the agreements of the parties hereto with respect to any matter covered or mentioned therein or herein, and no prior agreement or understanding pertaining to any such matter shall be effective for any purpose. No provision of the Lease as amended by this Second Amendment may be amended or added to except by an agreement in writing signed by the parties to the Lease or their respective successors in interest.

20.    Authority. Each individual executing this Second Amendment on behalf of Tenant represents and warrants to Landlord that he or she is duly authorized to so execute and deliver this Second Amendment and that all corporate actions and consents required for execution of this


HO! 15908418.8 I 32203-000154
-15-


Second Amendment have been given, granted or obtained. If requested by Landlord, Tenant shall, within ten (10) days after demand by Landlord, deliver to Landlord satisfactory evidence of the due authorization of this Second Amendment and the authority of the person executing this Second Amendment on its behalf.

21.    Ratification of Lease. The Lease, as herein amended, remains in full force and effect and is hereby ratified and reaffirmed in all respects.

[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK.]
[SIGNATURES COMMENCE ON FOLLOWING PAGE]






































BOl l5908418.8/J2203-000154
-16-




WHEREFORE, the parties set their hands and seals as of the date first written above.

LANDLORD

NEW TOWER TRUST COMPANY MULTI EMPLOYER PROPERTY TRUST, a trust
organized under 12 C.F.R. Section 9.18

By:        Kennedy Associates Real Estate Counsel, LP, Authorized Signatory

By: Kennedy Associates Real Estate Counsel GP, LLC, its general partner

By: /s/ Jeanette R. Flory            
Name: Jeanette R. Flory            
Its: Senior Vice President                


TENANT

MCKESSON AUTOMATION INC., a
Pennsylvania corporation

By: /s/ Nicholas A. Loiacono            
Name: Nicholas A. Loiacono            
Its: VP & Treasurer            



List of Exhibits to Second Amendment

♦    Second Amendment Exhibit A - Drawing Showing Location of Second Amendment Premises A and Second Amendment Premises B
♦    Second Amendment Exhibit B - Intentionally Omitted
♦    Second Amendment Exhibit C - Form of Guarantor's Consent
♦    Second Amendment Exhibit D - Form of Lease Memorandum (Second Amendment Expansion Commencement Date A)
♦    Second Amendment Exhibit E -Form of Lease Memorandum (Second Amendment Expansion Commencement Date B)







BO! 15908418 8 / 32203-000154
-17-


List of Schedules to Second Amendment

♦    Second Amendment Schedule C-1 - Approved Schedule
♦    Second Amendment Schedule C-3 - Approved Schematic Drawings
♦    Second Amendment Schedule D - Base Building Improvements













































801159084!88/32203-000154
-18-

 EX-10.26 7 exhibit1026q4-20.htm EX-10.26 Document

THIRD AMENDMENT TO LEASE

THIS THIRD AMENDMENT TO LEASE (this "Third Amendment") is made as of the 11th day of January, 2011, between Cranberry Cochran Road, L.P., a Delaware limited partnership, Cranberry Noble Land, L.P., a Delaware limited partnership, Cranberry Harmar Land, L.P., a Delaware limited partnership, Cranberry Hempfield, L.P., a Delaware limited partnership, Cranberry Kennedy Land, L.P., a Delaware limited partnership, Cranberry McKnight Land, L.P., a Delaware limited partnership, Cranberry Perrysville, L.P., a Delaware limited partnership, McKnight Cranberry, L.P., a Delaware limited partnership, Cranberry South East, L.P., a Delaware limited partnership, Cranberry West Liberty, L.P., a Delaware limited partnership, Cranberry Westmore Land, L.P., a Delaware limited partnership, Cranberry Kittanning Land, L.P., a Delaware limited partnership, Cranberry Rich Land, L.P., a Delaware limited partnership, Cranberry Murrysville Land, L.P., a Delaware limited partnership, Cranberry Castle Shannon, L.P., a Delaware limited partnership, Cranberry Beers School, L.P., a Delaware limited partnership, together as tenants in common (collectively, "Landlord"), successor in interest to NewTower Trust Company Multi-Employer Property Trust, a trust organized under 12 C.F.R. Section 9.18, and McKesson Automation Inc., a Pennsylvania corporation ("Tenant").

WHEREAS, Landlord and Tenant are parties to that certain Lease dated December 21, 2001 (the "Original Lease"), pursuant to which Tenant leased approximately sixty-one thousand eight hundred eight-seven (61,887) rentable square feet consisting of the entire third (3rd) and fourth (4th) floors (the "Initial Premises") of a certain building ("Building") located at 500 Cranberry Woods Drive, Cranberry Township, Pennsylvania;

WHEREAS, Landlord and Tenant are parties to a certain First Amendment to Lease dated February 8, 2005 (the "First Amendment") pursuant to which Tenant leased the entire second (2nd) floor of the Building, consisting of approximately twenty-nine thousand nine hundred forty-six (29,946) rentable square feet (the "Expansion Premises") resulting in an aggregate of approximately ninety-one thousand eight hundred thirty-three (91,833) rentable square feet of the Building under lease to Tenant;

WHEREAS, Landlord and Tenant are parties to a certain Second Amendment to Lease dated April 21, 2008 (the "Second Amendment") pursuant to which Tenant leased an additional ten thousand nine hundred eight (10,908) rentable square feet located on the first (1st) floor of the Building ("Second Amendment Premises") resulting in an aggregate
of approximately one hundred two thousand seven hundred forty-one (102,741) rentable square feet of the Building under lease to Tenant;

WHEREAS, the Initial Premises, the Expansion Premises and the Second Amendment Premises are collectively referred to herein as the "Premises";

WHEREAS, the Original Lease, the First Amendment and the Second Amendment are collectively referred to herein as the "Lease";

WHEREAS, the Term of the Lease is scheduled to expire on December 31, 2011;

WHEREAS, Tenant's obligations under the Lease have been guaranteed by McKesson Corporation, a Delaware corporation ("Guarantor"), pursuant to a certain


Guaranty of Lease dated December 21, 2001, subsequently ratified and confirmed (the "Guaranty"); and

WHEREAS, Landlord and Tenant desire to amend the Lease to extend the Lease Term and to revise certain other provisions in accordance with the terms and conditions of this Third Amendment.

NOW THEREFORE, in consideration for the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, Landlord and Tenant, intending to be legally bound hereby, agree as follows:

1.    The foregoing recitals are incorporated herein by reference and made a part of this Third Amendment as though fully set forth herein. All capitalized terms used but not otherwise defined in this Third Amendment shall have the meaning ascribed to them in the Lease.

2.    The Lease (Section 1.3 of the Original Lease, as amended by Paragraph 3 of the Second Amendment) is hereby amended by inserting the following in addition to all other provisions:

"Notwithstanding anything to the contrary contained in this Lease, the Lease Term shall be extended for a period of 5 years beginning on January 1, 2012 and ending on December 31, 2016 ("Extended Term") so that the Lease Term shall expire on December 31, 2016 ("Expiration Date")."

3.    The Lease (including Exhibit C to the Original Lease, as amended, and all provisions of the Lease relating to the improvement of the Premises, the construction or installation at the Premises of any Improvements by Landlord or Tenant, or the payment by Landlord to Tenant of any allowance or sum of money for or relating to the improvement of the Premises) is hereby amended by inserting the following in addition to all other provisions:

"Tenant is currently in possession of the Premises, is familiar with the condition of the Premises and accepts the Premises in "as-is" condition except that, prior to January 1, 2012, and, subject to Tenant's timely approval of plans and specifications, Landlord, at Tenant's sole cost and expense over and above Tenant's Improvement Allowance set forth hereinafter, shall perform all necessary work to reconfigure, paint, carpet and install typical office suite improvements at the Premises as reasonably directed by Tenant for the conduct of Tenant's business ("Tenant's Work").

Tenant's Work shall be performed in accordance with plans and specifications to be prepared and approved by Landlord and Tenant prior to Landlord commencing Tenant's Work. Landlord's approval of the plans and specifications shall not be unreasonably withheld or delayed and shall not be deemed to be a representation or warranty with regard to the sufficiency or compliance of the plans and specifications or the Tenant's Work.
2


Landlord shall have the right to select its space planner, architect and contractor for the planning and construction of Tenant's Work.
As a contribution to the performance of Tenant's Work, Landlord shall contribute, as "Tenant's Improvement Allowance", the amount of $513,705.00 ($5.00 per square foot of rentable area of the Premises). Tenant's Improvement Allowance shall be used, to the extent sufficient, to pay the costs associated with Tenant's Work at the Premises, which shall include, but not be limited to, (i) all hard costs to complete Tenant's Work (such as labor and materials, general conditions, rubbish removal, utilities, building permits, inspections fees, insurance and the like), (ii) all soft costs to complete Tenant's Work (such as architectural and engineering fees, and the cost of plans and specifications), (iii) any sales tax levied on the Tenant's Work, and (iv) Landlord's fee for supervision of Tenant's Work in the amount of four percent (4%) of the cost of Tenant's Work (items (i) - (iv) above are collectively referred to as the "Cost of Tenant's Work"). In the event the final actual Cost of Tenant's Work exceeds the Tenant's Improvement Allowance, Tenant shall pay reimburse such excess to Landlord in one lump sum within thirty (30) days after receipt of a reasonably detailed invoice from Landlord following completion of Tenant's Work. In the event that the actual cost of Tenant's Work is less than Tenant's Improvement Allowance, Landlord shall, upon written request from Tenant received by Landlord after January 1, 2012, but no later than June 30, 2012, apply an amount equal to the difference between the Tenant's Improvement Allowance and the actual Cost of Tenant's Work to the next ensuing installments of Base Rent owing under this Lease."

4.    The Lease (Section 1.5.1 of the Original Lease as amended by Paragraph 5 of the Second Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, during the Extended Term, Tenant shall pay to Landlord Base Rent for the Premises in monthly installments on the first day of each calendar month, in advance, without offset or deduction of any kind, as follows:
i.) $207,622.44 per month ($24.25 per square foot of rentable area per year contained in the Existing Premises) during the period of the Extended Term beginning on January 1, 2012 and ending on December 31, 2013; and

ii.) $211,903.31 per month ($24.75 per square foot of rentable area per year contained in the Premises) during the period of the Extended Term beginning on January 1, 2014 and ending on December 31, 2014; and

iii.) $216,184.19 per month ($25.25 per square foot of rentable area per year contained in the Premises) during the period of the Extended Term beginning on January 1, 2015 and ending on December 31, 2016."

3


5.    The Lease (Section 1.2 of the Original Lease as amended by Paragraph 4 of the Second Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, Landlord and Tenant acknowledge and agree that Tenant's Share during the Extended Term shall be 86.02% (102,741 / 119,444), as may be adjusted from time to time in accordance with Section 1.2 of the Original Lease."

6.    The Lease (Section 9.2 of the Original Lease as amended by Paragraph 6 of the Second Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, commencing on January l, 2012, the Operating Costs Base Year shall be Calendar Year 2012."

7.    Section 9.5 (1) of the Original Lease is hereby deleted in its entirety, and in lieu thereof is inserted the following:

"(1) any capital expenditures incurred with the intent of bringing about a reduction in Costs of Electricity or Operating Costs, or increasing the efficiency of any Building System, provided, however, that the annual amount of such capital expenditure includable in Operating Costs shall not exceed the lesser of (i) the annual amount of the decrease in Operating Costs attributable to such capital expenditure or (ii) the annual amount resulting from the amortization of such capital expenditure over its useful life in equal installments, provided that any unamortized amount of such capital expenditure may be carried forward to subsequent Calendar Years.”

8.    The Lease (Section 10.2 of the Original Lease as amended by Paragraph 6 of the Second Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, commencing on January 1, 2012, the Real Estate Tax Base Year shall be Calendar Year 2012."

9.    Section 21.4.1 of the Original Lease shall be amended by deleting the language "and to Section 21.3.5, above," from the second line of the first sentence of Section 21.4.1 and inserting in lieu thereof the language “, and without Landlord's prior written consent," reflecting the intent of Landlord and Tenant that Tenant may assign the Lease or sublet the Premises in accordance with Section 21.4.1 without obtaining Landlord's prior written consent.

10.    The Lease (Section 26.2 of the Original Lease as amended by Paragraph 12 of the Second Amendment) shall be amended by inserting in addition thereto the following:
4



"Without in any way limiting Tenant's obligations with respect to any portion of the Premises as in effect prior to this Third Amendment, Tenant acknowledges, confirms and agrees that, pursuant to Section 26.2 of the Original Lease (as amended by Paragraph 12 of the Second Amendment), upon the expiration or earlier termination of the Lease, Tenant shall be obligated to remove any leasehold improvements that were constructed as part of Tenant's Work (as defined in Paragraph 3 of the Third Amendment) and restore the Premises to its pre-existing condition if (a) such leasehold improvements (or a portion thereof) constituting Tenant's Work are not standard Class A office improvements, and (b) Landlord notifies Tenant, at the time of its approval of the construction drawings pursuant to Exhibit C, or any applicable change order, that Tenant would be required to remove such improvements constituting Tenant's Work (or a portion thereof) upon surrender of the Premises."

11.    Section 34.5 of the Original Lease is hereby deleted in its entirety, and in lieu thereof is inserted the following:

"34.5 Judgment and/or Offset of Rent for Amounts Due and Owing. If Landlord, within thirty (30) days after the receipt from Tenant of its written demand therefor, fails to reimburse Tenant for the reasonable costs and expenses of Tenant's exercise of its self help rights hereunder, Tenant may (a) seek the entry of a judgment against Landlord for the amount thereof, plus interest at the Default Rate and Tenant's reasonable costs of collection (including reasonable attorney's fees) and/or (b) offset against the next payments of Base Rent and additional rent payable by Tenant hereunder the amounts reasonably expended by Tenant in curing Landlord's default, including, without limitation, all costs and reasonable attorneys' fees, together with interest thereon at the lesser of six and one- half percent (6.5%) per annum or the maximum rate permitted by applicable laws from the date of each expenditure until paid. Notwithstanding the foregoing Tenant's right to offset against payments of Base Rent and additional rent payable by Tenant hereunder shall be limited to amounts reasonably expended by Tenant in performing maintenance and repairs which were not caused by the negligence of the willfully malicious act of Tenant or Tenant's Agents."

12.    Article 50 of the Lease, as amended by Paragraph 11 of the First Amendment and Paragraph 10 of the Second Amendment, shall be deleted in its entirety and in lieu thereof shall be inserted the following:

"50.    RENEWAL OPTION

A.) Renewal Option. Tenant is hereby granted one (1) option ("Renewal Option") to renew this Lease for a period of five (5) years ("Renewal Term"). Tenant may exercise the Renewal Option upon written notice ("Renewal Notice") given to Landlord no earlier than 365 days and no later than 270 days before the expiration of the Extended Term (“Notice Period”).
5


If Tenant fails to give Landlord the Renewal Notice within the Notice Period, then Tenant shall be deemed to have elected not to exercise the Renewal Option and this Renewal Option shall be deemed to null and void; time being of the essence in with regard to delivery of the Renewal Notice.

B.) Renewal Term. If the Renewal Notice is timely given, the Renewal Term will be on the same terms and conditions as those contained in the Lease except as follows:

i.    There shall be no further rights to renew after the exercise of the Renewal Option granted herein;

ii.    Any Tenant Improvement Allowances, TI Allowance, rental concessions, Landlord's Work or other such allowance improvements provided by Landlord to Tenant in the Lease shall not be applicable in the Renewal Term;

iii.    The Base Rent for the Renewal Term shall be 100% of the Fair Market Rental Value as determined by agreement between Landlord and Tenant or, if Landlord and Tenant are unable to agree, as set forth in sub paragraph C immediately below. For purposes of this Article 50 the Fair Market Rental Value of the Premises shall be the amount that a willing, comparable, new (i.e., non-renewal), non-equity tenant would pay, and that a willing landlord of a comparable space, both in terms of size and age of the Premises and within a five (5) mile radius of Cranberry Woods Office Park, would accept at arms' length. The Fair Market Rental Value for the Renewal Term may be less than the Base Rent paid by Tenant for the last year of the Extended Term. Appropriate consideration shall be given to (a) the annual rental rate per rentable square foot; (b) the definition of rentable square feet for purposes of comparing the rate; (c) location, quality and age of the Building; (d) the financial condition (e.g., creditworthiness) of Tenant; (e) escalation (including type, base year and stop) and abatement provisions reflecting free rent and /or no rent during the period of construction; (f) brokerage commissions, if any, (g) length of the lease term; (h) size and location (including floor level) of the Premises; (i) building standard work letter and/or tenant improvement allowance, if any; provided, however, the Fair Market Rental Value shall not include any tenant improvements or any alterations made by Tenant; (j) condition of space; (k) lease takeover/assumptions; (l) moving expenses and other concessions; (m) extent of services to be provided; (n) distinctions between "gross" and "net" leases; (o) base year figures or expense stops for escalation purposes for both operating costs and ad valorem/real estate taxes; (p) the time the particular rental rate under consideration becomes or is to become effective; (q) applicable caps, if any, on the amount of real estate taxes and assessments passed through to tenants; and (r) other generally applicable conditions of tenancy for the space in question. Tenant shall obtain the same rent and other benefits that Landlord would otherwise give to any comparable prospective tenant.
6



iv.    Base Year. Notwithstanding anything to the contrary contained in the Lease, commencing on January l, 2017, the Operating Costs Base Year and Real Estate Tax Base Year for the Renewal Term shall be Calendar Year 2017.

C.) Acceptance/Rejection. If Landlord and Tenant are not able to agree on the Base Rent for the Renewal Term by a date which is two-hundred forty (240) days prior to the commencement date of the Renewal Term, then within thirty (30) days thereafter ("Appointment Period") each party shall appoint a real estate appraiser with at least ten (10) years full time commercial appraisal experience in valuing leasehold commercial office space in the vicinity of the Premises to determine the Base Rent based on the then Fair Market Rental Value for the Renewal Term. If either party fails to appoint a real estate appraiser within the Appointment Period the Base Rent of the duly appointed appraiser shall control. The two (2) appraisers appointed by the parties shall meet to set the then Base Rent for the Renewal Term. If they are unable to agree within twenty (20) days after expiration of the Appointment Period, they shall select a third appraiser, who shall be a person who meets the qualifications set forth in this paragraph and who has not previously acted in any capacity for either party. If the two appraisers are unable to agree upon a third appraiser, either of the parties may apply to the then presiding judge of the Common Pleas Court of Butler County, Pennsylvania for the selection of the third (3rd) appraiser, who shall be a person who meets the qualifications set forth above. Landlord and Tenant shall each bear one-half (1/2) of the cost of appointing the third appraiser and of paying the third appraiser's fee. As soon as possible following selection or appointment of the third appraiser, the appraisers shall set the Base Rent for the Premises for the Renewal Term. If a majority of the appraisers is unable to set the Base Rent within twenty (20) days after appointment of the third appraiser, the three (3) appraisals shall be added together and their total divided by three (3); the resulting quotient shall be the Base Rent rate for the Premises for the Renewal Term. If the low appraisal is more than ten percent (10%) lower than the middle appraisal, the low appraisal shall be disregarded; if the high appraisal is more than ten percent (10%) higher than the middle appraisal, the high appraisal shall be disregarded. If only one appraisal is disregarded, the remaining two (2) appraisals shall be added together and their total divided by two (2), and the resulting quotient shall be the Base Rent rate for the Premises for the Renewal Term. If two of the appraisals shall be disregarded, the middle appraisal shall determine the Base Rent rate in the Renewal Term. Base Rent for the Renewal Term as so determined shall be effective as of the commencement date of the Renewal Term and shall be adjusted retroactively if determined after the commencement date of the Renewal Term.

7


D.) Restrictions/Conditions. Tenant's Renewal Option shall be personal to McKesson Automation Inc., and shall terminate if (i) a Default shall exist at the time of exercise of the Renewal Option or the commencement date of the Renewal Term, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of exercise of the Renewal Option or the commencement date of the Renewal Term, (ii) the Lease or Tenant's right to possession of the Premises has been terminated, (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises to any person or entity except a person or entity not requiring Landlord's consent as provided in Paragraph 9 of this Third Amendment

13.    Article 52 of the Lease, as amended by Paragraph 12 of the First, shall be deleted in its entirety and in lieu thereof shall be inserted the following:

"52.    EXPANSION

52.1 Non-Exclusive Expansion Option

(a)    During the Extended Term and the Renewal Term Tenant shall have the non-exclusive right ("Expansion Option"), but not the obligation, to add to the Premises any available office space in the Building that is then vacant and is not subject to a lease, letter of intent, term sheet or other such agreement for use or occupancy by a third party ("Available Expansion Space"). Tenant acknowledges and agrees that this Expansion Option is not exclusive to Tenant and, unless and until Tenant exercise this Expansion Option, Landlord shall have the unencumbered right (subject only to Tenant's Right of First Refusal set forth in Section 52.2 below) to lease the Available Expansion Space to any person or entity on such terms as Landlord determines in its sole discretion.

(b)    Tenant may exercise the Expansion Option at any time during the Extended Term by written notice identifying the portion of the Available Expansion Space that Tenant desires to add to the Premises ("Office Expansion Space"). The configuration of the Office Expansion Space shall be subject to Landlord's reasonable approval based on the proportion of windows to rentable area, ingress, egress, access to common and core areas of the Building and the like with regard to both the Office Expansion Space and the remaining Available Expansion Space. Any Office Expansion Space with respect to which Tenant exercises its rights will be delivered by Landlord to Tenant in its "as-is" condition along with payment by Landlord to Tenant of an Office Expansion Allowance equal to the amount of $5.00 per square foot of rentable area of the Office Expansion Space desired by Tenant times a fraction, the numerator of which is the number of days remaining in the five (5) year Extended Term or the Renewal Term (if the Renewal Option has been duly exercised) after the applicable Office Expansion Space is added to the Premises and the denominator of which is the 1,825. Any Office Expansion Space will become part of the Premises on the date on which Landlord delivers such Office Expansion Space to Tenant
8


in the condition required herein and the Premises will then be deemed to include any such Office Expansion Space. All of the provisions of this Lease will apply to any Office Expansion Space added to the Premises, provided, however, Landlord will not be obligated to grant any concessions or allowances with respect to any Office Expansion Space except as set forth in this Section 52.1.

(c)    The Base Rent rate for any Office Expansion Space will be the Base Rent rate in effect on the date on which the applicable Office Expansion Space becomes part of the Premises, subject to subsequent increases, if any, as provided in this Third Amendment. The Base Rent will be increased as of the day on which the Office Expansion Space becomes part of the Premises by an amount equal to the product of (i) the number of rentable square feet of the applicable Office Expansion Space multiplied by (ii) the Base Rent per rentable square foot of the Premises in effect on the day on which the Office Expansion Space becomes part of the Premises. Tenant's Share will be increased as of the day on which any Office Expansion Space becomes part of the Premises to a fraction whose numerator is the sum of the rentable square feet of the Premises and the new Office Expansion Space, and whose denominator is the rentable square feet of the Building. The Base Rent and Tenant's Share will be increased in a similar manner whenever Office Expansion Space is added to the Premises.

(d)    Tenant's rights granted in this Paragraph are personal to McKesson Automation, Inc. and shall terminate if (i) a Default shall exist at the time of exercise of the Expansion Option, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of exercise of the Expansion Option, (ii) the Lease or Tenant's right to possession of the Premises has been terminated, (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises to any person or entity except a person or entity not requiring Landlord's consent as provided in Paragraph 9 of this Third Amendment, or (iv) less than two full years remain in the Lease Term (unless during the Extended Term Tenant exercises the Renewal Option.

52.2    Right of First Refusal

(a)    Refusal Space/Offer. Reference is made to any available office space in the Building that is then vacant and is not subject to a lease, letter of intent, term sheet or other such agreement for use or occupancy by a third party ("Available Refusal Space"). If during the Extended Term or the Renewal Term, Landlord receives a bona fide offer from a third party ("Third Party Offer'') to lease all or any portion of the Available Refusal Space ("Refusal Space'') and Landlord is willing to accept the terms of such Third Party Offer, Landlord shall first offer ("Offer Notice") to lease to Tenant the Refusal Space on the same terms and conditions as the Third Party Offer; such Offer Notice shall be in writing, specify the rent to be paid for the Refusal Space, contain the other basic terms and conditions of the Third
9


Party Offer and the date on which the Refusal Space shall be included in the Premises. Tenant shall notify Landlord in writing whether Tenant elects to lease all of the Refusal Space on the same terms and conditions as the Third Party Offer set forth in the Offer Notice within fifteen (15) business days after Landlord delivers to Tenant the Offer Notice, time being of the essence.

(b)    Acceptance. If Tenant timely elects to lease the Refusal Space within such fifteen ( 15) business day period, then Landlord and Tenant shall execute an amendment to the Lease, effective as of the date the Refusal Space is to be included in the Premises, on the same terms as the Lease except (i) the Base Rent rate for the Refusal Space shall be the amount specified in the Offer Notice, (ii) the lease term for the Refusal Space shall be that specified in the Offer Notice and, if the lease term in the Offer Notice extends beyond the expiration of the Term of this Lease, Tenant shall be permitted to extend the Term of this Lease to be coterminous with the lease term for the Refusal Space, (iii) the Refusal Space shall be delivered to Tenant and Tenant shall take same in "as-is" condition, and Landlord shall not be required to construct any tenant improvements in the Refusal Space or provide to Tenant any allowances other than those contained in the Offer Notice, if any, and (iv) any other terms set forth in the Lease which are inconsistent with the terms of the Offer Notice shall be modified accordingly with respect to the Refusal Space. Notwithstanding the foregoing, if the Offer Notice includes space in excess of that desired by Tenant, Tenant must exercise its right hereunder, if at all, as to all of the space contained in the Offer Notice. If the Offer Notice is for less than all the Available Refusal Space, then the Right of First Refusal shall continue for the remainder of any Available Refusal Space.

(c)    Rejection. If Tenant fails or is unable to timely exercise its right hereunder, then such right shall lapse, time being of the essence with respect to the exercise thereof, and Landlord may lease the portion of the Refusal Space described in the Offer Notice to the third party on the terms contained in the Offer Notice or such terms as Landlord may elect.

(d)    On-Going Right. If an Offer Notice that was rejected is for less than all of the Refusal Space, then Landlord shall only be obligated to offer such remaining portion of the Refusal Space to Tenant if a Third Party Offer is subsequently received for such remaining portion.

(e)    Exclusion. For purposes hereof, if an Offer Notice is delivered for less than all of the Available Refusal Space, but such notice provides for an expansion, right of first refusal, or other preferential right to lease some of the remaining portion of the Available Refusal Space, then such remaining portion of the Available Refusal Space shall thereafter be excluded from the grant of the Right of First Refusal contained herein.

10


(f)    Restrictions. This Right of First Refusal is personal to McKesson Automation Inc. and shall terminate if (i) a Default shall exist at the time of Tenants' election to lease the Refusal Space, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of Tenant's election to lease the Refusal Space, (ii) the Lease or Tenant's right to possession of the Premises has been terminated, (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises to any person or entity except a person or entity not requiring Landlord's consent as provided in Paragraph 9 of this Third Amendment, or (iv) less than two full years remain in the Lease Term (unless during the Extended Term Tenant exercises the Renewal Option."

14.    The second sentence of Article 28 of the Original Lease is hereby deleted in its entirety, and in lieu thereof is inserted the following:
"During any such holdover tenancy, unless Landlord has otherwise agreed in writing, Tenant agrees to pay to Landlord an occupancy charge equal to
(A)    125% of the stated monthly Base Rent for the last full month of the Extended Term or Renewal Term (as applicable) then ending, calculated on a per diem basis, for each day of the first (1st) month of such holdover, (B)    150% of the stated monthly Base Rent for the last full month of the Extended Term or Renewal Term (as applicable) then ending, calculated on a per diem basis, for each day after the first month of such holdover, and (C) one hundred percent (100%) of the additional rent which would have been payable by Tenant for the period of such holdover, calculated on a per diem basis using the additional rent which had otherwise been payable by Tenant for the last full month of the Extended Term or the Renewal Term (as applicable) then ending."

15.    As a condition precedent to execution of this Third Amendment by Tenant Landlord, at its sole cost and expense, shall cause any existing mortgagee or trust deed beneficiary holding a lien encumbering the Building to enter into the subordination, non-disturbance and attornment agreement in the form attached hereto as Exhibit B.

l6.    The Lease (Paragraph 7 of the Second Amendment and the provisions of the Lease amended thereby relating to Landlord's address) is hereby amended by inserting the following in addition to all other provisions:

"Notwithstanding anything to the contrary contained in this Lease, the Notice address for Landlord and the address for payment of Rent shall be as follows, until written notice of a change in address is issued to Tenant:

Notices:    McKnight Cranberry, LP
310-330 Grant Street, Suite 2400
Pittsburgh, PA 15219
Attn: McKnight Property Management

With a copy to:
11


McKnight Cranberry, LP
310-330 Grant Street, Suite 2500
Pittsburgh, PA 15219
Attn: McKnight Realty Partners, Legal Counsel Payment of Rent:
Payable to:
McKnight Cranberry, LP

Mailed to:
First Commonwealth Bank
Attn: Lockbox Department
Lockbox Account Number 7110282131 Philadelphia and Sixth Streets
P.O. Box 374 Indiana, PA 15701"

17.    The Lease shall be amended by inserting the following in addition to all other provisions:

"ANTI TERRORISM PROVISION:

(a)    Landlord and Tenant certify, each to the other, that to their knowledge:
(i)    It is not in violation of any Anti-Terrorism Law;

(ii)    It is not, as of the date hereof:

(1) conducting any business or engaging in any transaction or dealing with any Prohibited Person, including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Prohibited Person;

(2) dealing in, or otherwise engaging in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224; or

(iii)    engaging in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate any of the prohibitions set forth in, any Anti-Terrorism Law; and

(iv)    It, nor any of its officers, directors, shareholders or members, as applicable, is a Prohibited Person; provided, however this paragraph shall not apply to any person to the extent that such person's interest in the Tenant is through a U.S. Publicly-Traded Entity. As used in this Third Amendment, U.S. Publicly-Traded Entity means a person, other than an individual,
12


whose securities are listed on a national securities exchange, or quoted on an automated quotation system, in the United States, or a wholly-owned subsidiary of such a person ("U.S. Publicly-Traded Entity'').

(b)    Tenant hereby agrees to defend, indemnify, and hold harmless Landlord from and against any and all claims, damages, losses, liabilities and expenses (including reasonable attorneys' fees and costs) arising from or related to any breach of the foregoing certification; and Landlord hereby agrees to defend, indemnify, and hold harmless Tenant from and against any and all claims, damages, losses, liabilities and expenses (including attorneys' fees and costs) arising from or related to any breach of the foregoing certification.

(c)    If at any time any of these representations becomes false, then it shall be considered a material default under this Lease.

As used herein, "Anti-Terrorism Law" is defined as any law relating to terrorism, anti-terrorism, money-laundering or anti-money laundering activities, including without limitation the United States Bank Secrecy Act, the United States Money Laundering Control Act of 1986, Executive Order No. 13224, and Title 3 of the USA Patriot Act, and any regulations promulgated under any of them. As used herein "Executive Order No. 13224" is defined as Executive Order No. 13224 on Terrorist Financing effective September 24, 2001, and relating to "Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism", as may be amended from time to time. "Prohibited Person" is defined as (i) a person or entity that is listed in the Annex to Executive Order No. 13224, or a person or entity owned or controlled by an entity that is listed in the Annex to Executive Order No. 13224; (ii) a person or entity with whom Landlord is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law; or (iii) a person or entity that is named as a "specially designated national and blocked person" on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control at its official website, http://www.treas.gov/ofac/tl lsdn.pdf or at any replacement website or other official publication of such list. "USA Patriot Act" is defined as the "Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001" (Public Law 107-56), as may be amended from time to time."

18.    Tenant was represented in the transaction evidenced by this Third Amendment by CB Richard Ellis, Inc. ("CB Richard Ellis"), a licensed real estate broker. Landlord also was represented in the transaction evidenced by this Third Amendment by CB Richard Ellis. Landlord shall be solely responsible for paying any commission or fee owed to CB Richard Ellis as Landlord's broker in connection with this Third Amendment, and CB Richard Ellis as Landlord's broker shall be responsible for any commission or fee payable to CB Richard Ellis in its capacity as Tenant's broker. Each party to this Third Amendment shall indemnify, defend and hold harmless the other party from and against any and all claims asserted against such other party by
13


any other real estate broker (excluding CB Richard Ellis), finder or intermediary relating to any act of the indemnifying party in connection with this Third Amendment.

19.    Subject to the limitation on personal liability set forth in Section 34.1 of the Original Lease, Paragraph 16 of the First Amendment and Paragraph 15 of theSecond Amendment, the liability of the entities constituting Landlord hereunder shall be joint and several.
20.    All other terms, conditions, covenants, agreements and provisions contained in the Lease that are not revised by or in conflict with the terms of this Third Amendment shall remain in full force and effect and are hereby ratified and confirmed by Landlord and Tenant to the extent consistent with this Third Amendment.

21.    The submission of this Third Amendment to Tenant or its broker or other agent does not constitute an offer. This Third Amendment shall have no force or effect until: (a) it is executed and delivered by Tenant to Landlord; and (b) it is executed and delivered by Landlord to Tenant.

22.    Contemporaneously with the execution of this Third Amendment, Tenant shall deliver to Landlord a CONSENT OF GUARANTOR executed by McKesson Corporation the form set forth on Exhibit A attached hereto and made a part hereof.

IN WITNESS WHEREOF, Landlord and Tenant have caused this Third Amendment to be executed as of the date first written above.

LANDLORD:

Cranberry Cochran Road, L.P., a
Delaware limited partnership

By: Cranberry Cochran Road GP, LLC, its General Partner, a Delaware limited liability company


By: /s/ William C. Rudolph    
Name: William C. Rudolph, member
Cranberry Noble Land, L.P., a Delaware limited partnership

By: Cranberry Noble Land GP, LLC, its General Partner, a Delaware limited liability company

By: Noble Land Associates, its sole member

14


By: /s/ William C. Rudolph        
Name: William C. Rudolph
Title: General Partner

Cranberry Harmar Land, L.P., a
Delaware limited partnership

By: Cranberry Harmar Land GP, LLC, its General Partner, a Delaware limited liability company

By: Harmar Land Co., its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Hempfield, L.P., a Delaware limited partnership

By: Cranberry Hempfield GP, LLC, its General Partner, a Delaware limited liability company

By: Hempfield Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Kennedy Land, L.P., a
Delaware limited partnership

By: Cranberry Kennedy Land GP, LLC, its General Partner, a Delaware limited liability company

By: Kennedy Land Associates, its sole member


By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry McKnight Land, L.P., a
Delaware limited partnership

15


By: Cranberry McKnight Land GP, LLC, its General Partner, a Delaware limited liability company

By: McKnight Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Perrysville, L.P., a Delaware limited partnership

By: Cranberry Perrysville GP, LLC, its General Partner, a Delaware limited liability company

By: Perrysville Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner
McKnight Cranberry, L.P., a Delaware limited partnership

By: McKnight Cranberry GP, LLC, its General Partner, a Delaware limited liability company
                         By: /s/ William C. Rudolph        
Name: William C. Rudolph, member

Cranberry South East, L.P., a Delaware limited partnership

By: Cranberry South East GP, LLC, its General Partner, a Delaware limited liability company

By: Wendy's South East Co., its sole member

By: /s/ William C. Rudolph        
Name: William C. Rudolph Title: General Partner
16



Cranberry West Liberty, L.P., a Delaware limited partnership

By: Cranberry West Liberty GP, LLC, its General Partner, a Delaware limited liability company

By: Wendy's West Liberty Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner
Cranberry Westmore Land, L.P., a
Delaware limited partnership

By: Cranberry Westmore Land GP, LLC, its General Partner, a Delaware limited liability company

By: Westmore Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Kittanning Land, L.P., a
Delaware limited partnership

By: Cranberry Kittanning Land GP, LLC, its General Partner, a Delaware limited liability company

By: Kittanning Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Rich Land, L.P., a Delaware limited partnership

17


By: Cranberry Rich Land GP, LLC, its General Partner, a Delaware limited liability company

By: Rich Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner
Cranberry Murrysville Land, L.P., a
Delaware limited partnership

By: Cranberry Murrysville Land GP, LLC, its General Partner, a Delaware limited liability company

By: Murrysville Land Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph Title: General Partner

Cranberry Castle Shannon, L.P., a
Delaware limited partnership

By: Cranberry Castle Shannon GP, LLC, its General Partner, a Delaware limited liability company

By: Castle Shannon Associates, its sole member

By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner

Cranberry Beers School, L.P., a Delaware limited partnership

By: Cranberry Beers School GP, LLC, its General Partner, a Delaware limited liability company

By: Beers School Land Associates, its sole member
18




By: /s/ William C. Rudolph    
Name: William C. Rudolph
Title: General Partner
TENANT:


McKesson Automation Inc.,
a Pennsylvania corporation
By: /s/ Nicholas A. Loiacono
Nicholas A. Loiacono
Vice President and Treasurer


19


List of Exhibits to Third Amendment

♦    Third Amendment Exhibit A- Consent of Guarantor
♦    Third Amendment Exhibit B - Form of Subordination, Non-Disturbance and Attornment Agreement
20

 EX-10.27 8 exhibit1027q4-20.htm EX-10.27 Document

FOURTH AMENDMENT TO LEASE

THIS FOURTH. AMENDMENT TO LEASE (this "Fourth Amendment") is made as of the 29th day of October, 2013, between McKnight Cranberry III, L.P., a Delaware limited Partnership ("Landlord"), successor by assignment to Cranberry Cochran Road, L.P., a Delaware limited partnership, Cranberry Noble Land, L.P., a Delaware limited partnership, Cranberry Harmar Land, L.P., a Delaware limited partnership, Cranberry Hempfield, L.P., a Delaware limited partnership, Cranberry Kennedy Land, L.P., a Delaware limited partnership, Cranberry McKnight Land, L.P., a Delaware limited partnership, Cranberry Perrysville, L.P., a Delaware limited partnership, McKnight Cranberry, L.P., a Delaware limited partnership, Cranberry South East, L.P., a Delaware limited partnership, Cranberry West Liberty, L.P., a Delaware limited partnership, Cranberry Westmore Land, L.P., a Delaware limited partnership, Cranberry Kittanning Land, L.P., a Delaware limited partnership, Cranberry Rich Land, L.P., a Delaware limited partnership, Cranberry Murrysville Land, L.P., a Delaware limited partnership, Cranberry Castle Shannon, L.P., a Delaware limited partnership, Cranberry Beers School, L.P., a Delaware limited partnership, together as tenants in common, and McKesson Automation Inc., a Pennsylvania corporation ("Tenant").

WHEREAS, Landlord and Tenant are parties to that certain Lease dated December 21, 2001 (the "Original Lease"), a certain First Amendment to Lease dated February 8, 2005 (the "First Amendment"), a certain Second Amendment to Lease dated April 21, 2008 (the "Second Amendment") and a certain Third Amendment to Lease dated January 11, 2011 (the "Third Amendment") pursuant to which Tenant leases approximately one hundred two thousand seven hundred forty-one (102,741) rentable square feet ("Premises") of a certain building located at 500 Cranberry Woods Drive, Cranberry Township, Pennsylvania ("Building");

WHEREAS, the Original Lease, the First Amendment, the Second Amendment and the Third Amendment are collectively referred to herein as the "Lease”;
WHEREAS, the Term of the Lease is scheduled to expire on December 31, 2016; WHEREAS, Tenant's obligations under the Lease, prior to this Fourth
Amendment, have been guaranteed by McKesson Corporation, a Delaware corporation ("Guarantor"), pursuant to a certain Guaranty of Lease dated December 21, 2001, subsequently ratified and confirmed (the "Guaranty");

WHEREAS, Guarantor is selling its equity interest in Tenant to a third party buyer (the "Transaction") and in connection with such sale desires to be released from the Guaranty;

WHEREAS, Landlord recognizes that Tenant provided ten business days' prior notice for the Transaction; and
WHEREAS, Landlord and Tenant desire to amend the Lease to (i) terminate the Guaranty, (ii) extend the Lease Term, and (iii) revise certain other provisions in accordance with the terms and conditions of this Fourth Amendment.

NOW THEREFORE, in consideration for the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, Landlord and Tenant, intending to be legally bound hereby, agree that as of the Change of Control Effective Date (as defined below) the following modifications shall be made to the Lease:



1.    Recitals. The foregoing recitals are incorporated herein by reference and made a part of this Fourth Amendment as though fully set forth herein. All capitalized terms used but not otherwise defined or re-defined in this Fourth Amendment shall have the meaning ascribed to them in the Lease. For purposes of this Fourth Amendment, the phrase "Change of Control Effective Date" shall mean the date on which McKesson Corporation completes the Transaction as evidenced by written notice to be delivered by McKesson Corporation to Landlord.

2.    Lease Term. The Lease (Section 1.3 of the Original Lease, as amended by Paragraph 3 of the Second Amendment and Paragraph 2 of the Third Amendment) is hereby amended by inserting the following in addition to all other provisions:

"Notwithstanding anything to the contrary contained in this Lease, the Lease Term shall be extended for a period of 3 years beginning on January 1, 2017 and ending on December 31, 2019 ("Second Extended Term") so that the Lease Term shall expire on December 31, 2019 ("Expiration Date"), subject to Tenant's Early Termination Right as set forth in Paragraph 13 of this Fourth Amendment and Tenant's Renewal Option as set forth in Paragraph 10 of this Fourth Amendment."

3.    Condition of Premises. The Lease (including Exhibit C to the Original Lease, as amended by Paragraph 3 of the Third Amendment, and all provisions of the Lease relating to the improvement of the Premises by Landlord, the construction or installation at the Premises of any Improvements by Landlord, or the payment by Landlord to Tenant of any allowance or sum of money for or relating to the
Improvement of the Premises) is hereby amended by inserting the following in addition to all other provisions:

"Tenant is currently in possession of the Premises, is familiar with the condition of the Premises and accepts the Premises during the Second Extended Term in its then "as-is" condition, with all faults and without any improvement or allowance required of Landlord."

4.    Base Rent. The Lease (Section 1.5.1 of the Original Lease as amended by Paragraph 5 of the Second Amendment and Paragraph 4 of the Third Amendment) shall be amended by inserting in addition thereto the following:
"Notwithstanding anything to the contrary contained in this Lease, during the Second Extended Term, Tenant shall pay to Landlord Base Rent for the Premises in monthly installments on the first day of each calendar month, in advance, without offset or deduction of any kind, as follows:

i.)        $216,184.19 per month (based on a rate of $25.25 per square foot of rentable area per year contained in the Premises) during the period of the Second Extended Term beginning on January 1, 2017 and ending on December 31, 2017; and

ii.)        $220,465.06 per month (based on a rate of $25.75 per square foot of rentable area per year contained in the Premises) during the period of the Second
2


Extended Term beginning on January 1, 2018 and ending on December 31, 2019."

5.    Tenant's Share. The Lease (Section 1.2 of the Original Lease as amended by Paragraph 4 of the Second Amendment and Paragraph 5 of the Third Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, Landlord and Tenant acknowledge and agree that beginning on January 1, 2017 and ending on the Expiration Date Tenant' s Share shall be 86.02% (102,741 / 119,444), as may be adjusted from time to time in accordance with Section 1.2 of the Original Lease."

6.    Operating Cost Base Year. The Lease (Section 9.2 of the Original Lease as amended by Paragraph 6 of the Second Amendment and Paragraph 6 of the Third Amendment) shall be amended by inserting in addition thereto the following:

"Notwithstanding anything to the contrary contained in this Lease, Landlord and Tenant acknowledge and agree that beginning on January 1, 2017 and ending on the Expiration Date, the Operating Costs Base Year shall be Calendar Year 2017."

7.    Real Estate Tax Base Year. The Lease (Section 10.2 of the Original Lease as amended by Paragraph 6 of the Second Amendment and Paragraph 8 of the Third Amendment) shall be amended by inserting in addition thereto the following:

''Notwithstanding anything to the contrary contained in this Lease, Landlord and Tenant acknowledge and agree that beginning on January 1, 2017 and ending on the Expiration Date, the Real Estate Tax Base Year shall be Calendar Year 2017."

8.    Enforcement of Final Judgment for Amounts Due and Owing. Paragraph 11 of the Third Amendment, which amended Section 34.5 of the Original Lease, shall be deleted in its entirety, reflecting the intent of Landlord and Tenant that Section 34.5 as set forth in the Original Lease prior to the Third Amendment shall be inserted and reinstated in the Lease.

9.    Renewal Option. Article 50 of the Lease, as amended by Paragraph 11 of the First Amendment, Paragraph 10 of the Second Amendment and Paragraph 12 of the Third Amendment, shall be deleted in its entirety and in lieu thereof shall be inserted the following:

"50.    RENEWAL OPTION

A.) Renewal Option. Tenant is hereby granted one (1) option ("Renewal Option") to extend the Lease Term for a period of five (5) years ("Renewal Term"). Tenant may exercise the Renewal Option upon written notice ("Renewal Notice") given to Landlord no earlier than 365 days and no later than 270 days before the Expiration Date of the Lease Term ("Notice Period"). If Tenant fails to give Landlord the Renewal Notice within the Notice Period, then Tenant shall be deemed to have elected not to exercise the Renewal Option and this Renewal Option shall be deemed to null and void; time being of the essence in with regard to delivery of the Renewal Notice.
3



B.) Renewal Term. If the Renewal Notice is timely given, the Renewal Term will be on the same terms and conditions as those contained in the Lease except as follows:

i.    There shall be no further rights to renew after the exercise of the Renewal Option granted herein;

ii.    Any Tenant Improvement Allowances, TI Allowance, rental concessions, Landlord's Work or other such allowance or improvements provided by Landlord to Tenant in the Lease shall not be applicable in the Renewal Term;

iii.    The Base Rent for the Renewal Term shall be 100% of the Fair Market Rental Value as determined by agreement between Landlord and Tenant or, if Landlord and Tenant are unable to agree, as set forth in sub paragraph C immediately below. For purposes of this Article 50 the Fair Market Rental Value of the Premises shall be the amount that a willing, comparable, new (i.e., non-renewal), non-equity tenant would pay, and that a willing landlord of a comparable space, both in terms of size and age of the Premises and within a five (5) mile radius of Cranberry Woods Office Park, would accept at arms' length. The Fair Market Rental Value for the Renewal Term may be less than or greater than the Base Rent paid by Tenant during the Lease Term. Appropriate consideration shall be given to (a) the annual rental rate per rentable square foot; (b) the definition of rentable square feet for purposes of comparing the rate; (c) location, quality and age of the Building; (d) the financial condition (e.g., creditworthiness) of Tenant; (e) escalation (including type, base year and stop) and abatement provisions reflecting free rent and /or no rent during the period of construction; (f) brokerage commissions, if any, (g) length of the lease term; (h) size and location (including floor level) of the Premises; (i) building standard work letter and/or tenant improvement allowance, if any; provided, however, the Fair Market Rental Value shall not include any tenant improvements or any alterations made by Tenant; (j) condition of space; (k) lease takeover/assumptions; (1) moving expenses and other concessions; (m) extent of services to be provided; (n) distinctions between "gross" and "net" leases; (o) base year figures or expense stops for escalation purposes for both operating costs and ad valorem/real estate taxes; (p) the time the particular rental rate under consideration becomes or is to become effective; (q) applicable caps, if any, on the amount of real estate taxes and assessments passed through to tenants; and (r) other generally applicable conditions of tenancy for the space in question. Tenant shall obtain the same rent and other benefits that Landlord would otherwise give to any comparable prospective tenant.

iv.    Base Year. Notwithstanding anything to the contrary contained in the Lease, commencing on January 1, 2020, the Operating Costs Base Year and Real Estate Tax Base Year during the entire Renewal Term shall be Calendar Year 2020.

C.) Acceptance/Rejection. If Landlord and Tenant are not able to agree on the Base Rent for the Renewal Term by a date which is two-hundred forty (240) days prior to the commencement date of the Renewal Term, then within thirty (30) days thereafter ("Appointment Period") each party shall appoint a real estate appraiser with at least ten (10) years full time commercial appraisal experience in valuing leasehold
4


commercial office space in the vicinity of the Premises to determine the Base Rent based on the then Fair Market Rental Value for the Renewal Term. If either party fails to appoint a real estate appraiser within the Appointment Period the Base Rent of the duly appointed appraiser shall control. The two (2) appraisers appointed by the parties shall meet to set the then Base Rent for the Renewal Term. If they are unable to agree within twenty (20) days after expiration of the Appointment Period, they shall select a third appraiser, who shall be a person who meets the qualifications set forth in this paragraph and who has not previously acted in any capacity for either party. If the two appraisers are unable to agree upon a third appraiser, either of the parties may apply to the then presiding judge of the Common Pleas Court of Butler County, Pennsylvania for the selection of the third (3rd) appraiser, who shall be a person who meets the qualifications set forth above. Landlord and Tenant shall each bear one-half (1/2) of the cost of appointing the third appraiser and of paying the third appraiser's fee. As soon as possible following selection or appointment of the third appraiser, the appraisers shall set the Base Rent for the Premises for the Renewal Term. If a majority of the appraisers is unable to set the Base Rent within twenty (20) days after appointment of the third appraiser, the three (3) appraisals shall be added together and their total divided by three (3); the resulting quotient shall be the Base Rent rate for the Premises for the Renewal Term. If the low appraisal is more than ten percent (10%) lower than the middle appraisal, the low appraisal shall be disregarded; if the high appraisal is more than ten percent (10%) higher than the middle appraisal, the high appraisal shall be disregarded. If only one appraisal is disregarded, the remaining two (2) appraisals shall be added together and their total divided by two (2), and the resulting quotient shall be the Base Rent rate for the Premises for the Renewal Term. If two of the appraisals shall be disregarded, the middle appraisal shall determine the Base Rent rate in the Renewal Term. Base Rent for the Renewal Term as so determined shall be effective as of the commencement date of the Renewal Term and shall be adjusted retroactively if determined after the commencement date of the Renewal Term.

D.) Restrictions/Conditions. Tenant's Renewal Option shall be personal to McKesson Automation Inc. and shall terminate if (i) a Default shall exist at the time of exercise of the Renewal Option or the commencement date of the Renewal Term, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of exercise of the Renewal Option or the commencement date of the Renewal Term, (ii) the Lease or Tenant' s right to possession of the Premises has been terminated, (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises except to an entity not requiring Landlord's consent as provided in the Lease."

10.    Expansion. Article 52 of the Lease, as amended by Paragraph 12 of the First Amendment and Paragraph 13 of the Third Amendment, shall be deleted in its entirety and in lieu thereof shall be inserted the following:

"52.    EXPANSION

52.1    Non-Exclusive Expansion Option

5


(a)    During the Lease Term Tenant shall have the non-exclusive right ("Expansion Option"), but not the obligation, to add to the Premises any available office space in the Building that is then vacant and is not subject to a lease, letter of intent, term sheet or other such agreement for use or occupancy by a third party ("Available Expansion Space"). Tenant acknowledges and agrees that this Expansion Option is not exclusive to Tenant and, unless and until Tenant exercise this Expansion Option, Landlord shall have the unencumbered right (subject only to Tenant's Right of First Refusal set forth in Section 52.2 below) to lease the Available Expansion Space to any person or entity on such terms as Landlord determines in its sole discretion.

(b)    Tenant may exercise the Expansion Option at any time during the Lease Term by written notice identifying the portion of the Available Expansion Space that Tenant desires to add to the Premises ("Office Expansion Space"). The configuration of the Office Expansion Space shall be subject to Landlord's reasonable approval based on the proportion of windows to rentable area, ingress, egress, access to common and core areas of the Building and the like with regard to both the Office Expansion Space and the remaining Available Expansion Space. Any Office Expansion Space with respect to which Tenant exercises its rights will be delivered by Landlord to Tenant in its "as-is" condition along with payment by Landlord to Tenant of an Office Expansion Allowance equal to the amount of $5.00 per square foot of rentable area of the Office Expansion Space desired by Tenant times a fraction, the numerator of which is the number of days remaining in the Lease Term after the applicable Office Expansion Space is added to the Premises and the denominator of which is the 2,920. Any Office Expansion Space will become part of the Premises on the date on which Landlord delivers such Office Expansion Space to Tenant in the condition required herein and the Premises will then be deemed to include any such Office Expansion Space. All of the provisions of this Lease will apply to any Office Expansion Space added to the Premises, provided, however, Landlord will not be obligated to grant any concessions or allowances with respect to any Office Expansion Space except as set forth in this Section 52.1.

(c)    The Base Rent rate for any Office Expansion Space will be the Base Rent rate in effect on the date on which the applicable Office Expansion Space becomes part of the Premises, subject to subsequent increases in Base Rent during the Lease Term. The Base Rent will be increased as of the day on which the Office Expansion Space becomes part of the Premises by an amount equal to the product of (i) the number of rentable square feet of the applicable Office Expansion Space multiplied by (ii) the Base Rent per rentable square foot of the Premises in effect on the day on which the Office Expansion Space becomes part of the Premises. Tenant's Share will be increased as of the day on which any Office Expansion Space becomes part of the Premises to a fraction whose numerator is the sum of the rentable square feet of the Premises and the new Office Expansion Space, and whose denominator is the rentable square feet of the Building. The Base Rent and Tenant's Share will be increased in a similar manner whenever Office Expansion Space is added to the Premises.

(d)    Tenant’s rights granted in this Paragraph are personal to McKesson Automation, Inc. and shall terminate if (i) a Default shall exist at the time
6


of exercise of the Expansion Option, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of exercise of the Expansion Option, (ii) the Lease or Tenant's right to possession of the Premises has been terminated, (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises except to an entity not requiring Landlord's consent as provided in the Lease or (iv) less than two full years remain in the Lease Term.

52.2    Right of First Refusal

(a)    Refusal Space/Offer. Reference is made to any available office space in the Building that is then vacant and is not subject to a lease, letter of intent, term sheet or other such agreement for use or occupancy by a third party ("Available Refusal Space"). If during the Lease Term, Landlord receives a bona fide offer from a third party ("Third Party Offer") to lease all or any portion of the Available Refusal Space ("Refusal Space") and Landlord is willing to accept the terms of such Third Party Offer, Landlord shall first offer ("Offer Notice") to lease to Tenant the Refusal Space on the same terms and conditions as the Third Party Offer; such Offer Notice shall be in writing, specify the rent to be paid for the Refusal Space, contain the other basic terms and conditions of the Third Party Offer and the date on which the Refusal Space shall be included in the Premises. Tenant shall notify Landlord in writing whether Tenant elects to lease all of the Refusal Space on the same terms and conditions as the Third Party Offer set forth in the Offer Notice within fifteen (15) business days after Landlord delivers to Tenant the Offer Notice, time being of the essence.

(b)    Acceptance. If Tenant timely elects to lease the Refusal Space within such fifteen (15) business day period, then Landlord and Tenant shall execute an amendment to the Lease, effective as of the date the Refusal Space is to be included in the Premises, on the same terms as the Lease except (i) the Base Rent rate for the Refusal Space shall be the amount specified in the Offer Notice, (ii) the lease term for the Refusal Space shall be that specified in the Offer Notice and, if the lease term in the Offer Notice extends beyond the expiration of the Lease Term of this Lease, Tenant shall be permitted to extend the Lease Term of this Lease to be coterminous with the lease term for the Refusal Space, (iii) the Refusal Space shall be delivered to Tenant and Tenant shall take same in "as-is" condition, and Landlord shall not be required to construct any tenant improvements in the Refusal Space or provide to Tenant any allowances other than those contained in the Offer Notice, if any, and (iv) any other terms set forth in the Lease which are inconsistent with the terms of the Offer Notice shall be modified accordingly with respect to the Refusal Space. Notwithstanding the foregoing, if the Offer Notice includes space in excess of that desired by Tenant, Tenant must exercise its right hereunder, if at all, as to all of the space contained in the Offer Notice. If the Offer Notice is for less than all the Available Refusal Space, then the Right of First Refusal shall continue for the remainder of any Available Refusal Space.

(c)    Rejection. If Tenant fails or is unable to timely exercise its right hereunder, then such right shall lapse, time being of the essence with respect to the exercise thereof,
7


and Landlord may lease the portion of the Refusal Space described in the Offer Notice to the third party on the terms contained in the Offer Notice or such terms as Landlord may elect.

(d)    On-Going Right. If an Offer Notice that was rejected is for less than all of the Refusal Space, then Landlord shall only be obligated to offer such remaining portion of the Refusal Space to Tenant if a Third Party Offer is subsequently received for such remaining portion.

(e)    Exclusion. For purposes hereof, if an Offer Notice is delivered for less than all of the Available Refusal Space, but such notice provides for an expansion, right of first refusal, or other preferential right to lease some of the remaining portion of the Available Refusal Space, then such remaining portion of the Available Refusal Space shall thereafter be excluded from the grant of the Right of First Refusal contained herein.

(f)    Restrictions. This Right of First Refusal is personal to McKesson Automation Inc. and shall terminate if (i) a Default shall exist at the time of Tenants' election to lease the Refusal Space, or an event has occurred which with notice and the lapse of time shall be a Default if not cured at the time of Tenant's election to lease the Refusal Space, (ii) the Lease or Tenant's right to possession of the Premises has been terminated , (iii) Tenant transfers any of its interest in this Lease or any portion of the Premises except to an entity not requiring Landlord' s consent as provided in the Lease, or (iv) less than two full years remain in the Lease Term."

11.    Hold Over. The second sentence of Article 28 of the Original Lease as amended by Paragraph 14 of the Third Amendment is hereby deleted in its entirety, and in lieu thereof is inserted the following:

“During any such holdover tenancy, unless Landlord has otherwise agreed in writing, Tenant agrees to pay to Landlord an occupancy charge equal to
(A) 125% of the stated monthly Base Rent for the last full month of the Lease Term then ending, calculated on a per diem basis, for each day of the first (1st) month of such holdover, (B) 150% of the stated monthly Base Rent for the last full month of the Lease Term then ending, calculated on a per diem basis, for each day after the first month of such holdover, and (C) one hundred percent (100%) of the additional rent which would have been payable by Tenant for the period of such holdover, calculated on a per diem basis using the additional rent which had otherwise been payable by Tenant for the last full month of the Lease Term then ending."

12.    Tenant's Early Termination Right. The Lease shall be amended by inserting the following in addition to all other provisions:

"TENANT'S EARLY TERMINATION RIGHT:

a.) Termination Option. Subject to and contingent upon (i) the satisfaction of all conditions precedent contained herein, and (ii) the payment of the Termination Fee
8


(as defined hereinafter in subparagraph b.), Tenant shall have one (1) option to terminate this Lease ("Termination Option") effective on December 31, 2018 ("Effective Date of Termination") on the terms and conditions set forth herein.

b.) Definitions. The term "Termination Fee" shall mean an amount equal to eight thousand five hundred and sixty one dollars and seventy five cents ($8,561.75) per month, as prorated for less than a full calendar month, payable by Tenant to Landlord in accordance with the terms and conditions of this Lease applicable to the payment of Base Rent, beginning on the date on which Landlord receives the Tenant's Termination Notice (as defined hereinafter in subparagraph d.) and ending on the Effective Date of Termination.

c.) Conditions Precedent. Tenant's Termination Option shall be conditioned on and subject to the satisfaction of the following conditions precedent on or prior to the Effective Date of Termination: (i) Tenant shall not be in default of its obligations under this Lease, and no event shall have occurred which with the lapse of time shall be a default if not cured, (ii) the Lease or Tenant' s right to possession of the Premises has not been terminated, (iii) Tenant has not transferred any of its interest in this Lease or any portion of the Premises to any person or entity, wherein, for the avoidance of doubt, a sublease of the Premises shall not constitute a transfer provided that Tenant does not transfer its Termination Option to any sub-lessee, (iv) Tenant has provided the Landlord with the "Termination Notice" (as defined hereinafter in subparagraph d.) in a timely fashion, time being of the essence (v) Tenant shall have paid all Base Rent and all other amounts owing under this Lease through the Effective Date of Termination, (vi) Tenant shall have paid to Landlord the Termination Fee, and (vii) Tenant shall have vacated and returned the Premises to Landlord in the condition required under this Lease as of the Effective Date of Termination. In the event that any of these conditions precedent shall not be satisfied when required, time being of the essence, Tenant shall not have the right to terminate this Lease and any Termination Notice issued by Tenant prior thereto shall be without force or effect.

d.) Exercise of Termination Option. Tenant may exercise its Termination Option upon written notice ("Termination Notice") delivered to Landlord no later than March 31, 2018, time being of the essence with regard to the delivery of such Termination Notice. If Tenant fails or refuses to (i) pay to Landlord the Termination Fee as and when required, or (ii) satisfy all conditions precedent, Tenant shall not have the right to terminate this Lease as of the applicable Effective Date of Termination, and any Termination Notice issued by Tenant prior thereto shall be without force or effect.

Subject to the foregoing, on the Effective Date of Termination of this Lease, Landlord and Tenant agree that this Lease shall be terminated and rendered null and void and Tenant shall return the Premises to Landlord in accordance with the terms and conditions specified in this Lease. Neither Landlord nor Tenant shall be responsible for their respective duties and obligations under the Lease occurring after termination, except for those duties and obligations specifically identified as surviving termination.
9



13.    Landlord's Address. The Lease (Paragraph 7 of the Second Amendment, Paragraph 16 of the Third Amendment and the provisions of the Lease amended thereby relating to Landlord ' s address) is hereby amended by inserting the following in addition to all other provisions:

"Notwithstanding anything to the contrary contained in this Lease, the Notice address for Landlord and the address for payment of Rent shall be as follows, until written notice of a change in address is issued to Tenant:

Notices and Rent Payment:
McKnight Cranberry III, LP 310 Grant Street, Suite 2400
Pittsburgh, PA 15219
Attn: McKnight Property Management

With a copy of Notices to:
McKnight Cranberry III, LP 310 Grant Street, Suite 2500
Pittsburgh, PA 15219
Attn: McKnight Realty Partners, Legal Counsel

14.    Anti-Terrorism Provision. Landlord and Tenant agree as follows with regard to this Fourth Amendment and the Lease:

"ANTI TERRORISM PROVISION:
(a)    Landlord and Tenant certify, each to the other, that to their knowledge:

(i)    It is not in violation of any Anti-Terrorism Law;

(ii)    It is not, as of the date hereof:

(1)    conducting any business or engaging in any transaction or dealing with any Prohibited Person, including the making or receiving of any contribution of funds, goods or services to or for the benefit of any Prohibited Person;

(2)    dealing in, or otherwise engaging in any transaction relating to, any property or interests in property blocked pursuant to Executive Order No. 13224; or

(iii)    engaging in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding, or attempts to violate any of the prohibitions set forth in, any Anti-Terrorism Law; and

(iv)    It, nor any of its officers, directors, shareholders or members, as applicable, is a Prohibited Person; provided, however this paragraph shall not apply to any person to the extent that such person’s interest in the Tenant is through a U.S. Publicly-Traded Entity. As used in this Fourth Amendment, U.S. Publicly-Traded Entity
10


means a person, other than an individual, whose securities are listed on a national securities exchange, or quoted on an automated quotation system, in the United States, or a wholly-owned subsidiary of such a person ("U.S. Publicly-Traded Entity").

(b)    Tenant hereby agrees to defend, indemnify, and hold harmless Landlord from and against any and all claims, damages, losses, liabilities and expenses (including reasonable attorneys' fees and costs) arising from or related to any breach of the foregoing certification; and Landlord hereby agrees to defend, indemnify, and hold harmless Tenant from and against any and all claims, damages, losses, liabilities and expenses (including attorneys' fees and costs) arising from or related to any breach of the foregoing certification.

(c)    If at any time any of these representations becomes false, then it shall be considered a material default under this Lease.

As used herein, "Anti-Terrorism Law" is defined as any law relating to terrorism, anti-terrorism, money-laundering or anti-money laundering activities, including without limitation the United States Bank Secrecy
Act, the United States Money Laundering Control Act of 1986, Executive Order No. 13224, and Title 3 of the USA Patriot Act, and any regulations promulgated under any of them. As used herein "Executive Order No.
13224" is defined as Executive Order No. 13224 on Terrorist Financing effective September 24, 2001, and relating to "Blocking Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism", as may be amended from time to time. "Prohibited Person" is defined as (i) a person or entity that is listed in the Annex to Executive Order No. 13224, or a person or entity owned or controlled by an entity that is listed in the Annex to Executive Order No. 13224; (ii) a person or entity with whom Landlord is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law; or (iii) a person or entity that is named as a "specially designated national and blocked person" on the most current list published by the U.S. Treasury Department Office of Foreign Assets Control at its official website, http://www.treas.gov/ofac/tl 1sdn.pdf or at any replacement website or other official publication of such list. "USA Patriot Act" is defined as the " Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001" (Public Law 107-56), as may be amended from time to time."

15.    Brokers. Tenant was represented in the transaction evidenced by this Fourth Amendment by Newmark Grubb Knight Frank, a licensed real estate broker. Landlord also was represented in the transaction evidenced by this Fourth Amendment by CBRE. Landlord shall be solely responsible for paying the commission or fee owed to Newmark Grubb Knight Frank in accordance with a mutually acceptable separate commission agreement between Landlord and Newmark Grubb Knight Frank. Each party to this Fourth Amendment shall indemnify, defend and hold harmless the other party from and against any and all claims asserted against such other indemnified party by any other real estate broker, finder or intermediary claiming representation of the indemnifying party (excluding, with regard to Tenant, Newmark Grubb Knight Frank and CBRE) in connection with this Fourth Amendment.
11


16.    Termination of Guaranty and Release of Guarantor. In consideration of this Fourth Amendment and upon the Change of Control Effective Date Landlord agrees that the Guaranty shall be rendered null and void and of no further force or effect, and that Guarantor shall be released of all obligations and duties owing to Landlord, or to be performed by Guarantor, pursuant to the Guaranty.

17.    Effect. All other terms, conditions, covenants, agreements and provisions contained in the Lease that are not revised by or in conflict with the terms of this Fourth Amendment shall remain in full force and effect and are hereby ratified and confirmed by Landlord and Tenant to the extent consistent with this Fourth Amendment.
18.    No Offer. The submission of this Fourth Amendment to Tenant or its broker or other agent does not constitute an offer. This Fourth Amendment shall have no force or effect until: (a) it is executed and delivered by Tenant to Landlord; and
(b) it is executed and delivered by Landlord to Tenant.

IN WITNESS WHEREOF, Landlord and Tenant have caused this Fourth Amendment to be executed as of the date first written above.

LANDLORD:

MCKNIGHT CRANBERRY III, L.P.

By:        McKnight Cranberry III GP, LLC, General Partner


By: /s/ William C. Rudolph
William C. Rudolph, Managing Member

TENANT:
MCKESSON AUTOMATION INC.,
a Pennsylvania corporation

By: /s/ Neil M. Ebner            
Neil M. Ebner VP of Finance and IT        
(Please print name and title)
ATTEST

By:                
(Please print name and title)

12

 EX-21.1 9 exhibit211q4-20.htm EX-21.1 Document

Exhibit 21.1
List of Subsidiaries
Entity's name for conducting businessJurisdiction of incorporation
Aesynt Pty LtdAustralia
Omnicell Pty LtdAustralia
Omnicell (Beijing) Technology Co. LtdChina
Omnicell GmbHFederal Republic of Germany
Omnicell SASFrance
Omnicell S.r.l.Italy
Omnicell B.V.Netherlands
Omnicell LimitedUnited Kingdom
ateb, Inc. United States
MedPak Holdings, Inc.United States
MTS Medication Technologies, Inc.United States
MTS Packaging Systems, Inc.United States
Omnicell International, LLCUnited States
340B Investment, LLCUnited States
340B Solutions, LLCUnited States
340B Link, LLCUnited States







 EX-23.1 10 exhibit231q4-20.htm EX-23.1 Document

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-3 Nos. 333-117592 and 333-221332, and Form S-8 Nos. 333-67828, 333-82818, 333-104427, 333-107356, 333-116103, 333-125080, 333-132556, 333-142857, 333-149758, 333-159562, 333-176146, 333-190930, 333-205465, 333-225179, and 333-231669 of our reports dated February 24, 2021, relating to the financial statements and financial statement schedule of Omnicell, Inc. and subsidiaries (the “Company”) and the effectiveness of the Company's internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.

/s/ Deloitte & Touche LLP

San Jose, California
February 24, 2021





EX-31.1 11 exhibit311q4-20.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION
 
I, Randall A. Lipps, certify that:
 
1.I have reviewed this annual report on Form 10-K of Omnicell, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
February 24, 2021 
 /s/ Randall A. Lipps
 Randall A. Lipps
 President and Chief Executive Officer
(Principal Executive Officer)


 EX-31.2 12 exhibit312q4-20.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION
 
I, Peter J. Kuipers, certify that:
 
1.I have reviewed this annual report on Form 10-K of Omnicell, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
February 24, 2021 
 /s/ Peter J. Kuipers
 Peter J. Kuipers
 Executive Vice President & Chief Financial Officer
(Principal Financial Officer)


 EX-32.1 13 exhibit321q4-20.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION
 
Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Randall A. Lipps, the President and Chief Executive Officer of Omnicell, Inc. (the “Company”) and Peter J. Kuipers, the Executive Vice President & Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
1.The Company’s Annual Report on Form 10-K for the period ended December 31, 2020, to which this Certification is attached as Exhibit 32.1 (the "Annual Report") fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act; and
2.The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations the Company.
In Witness Whereof, the undersigned have set their hands hereto as of the 24th day of February 2021.
/s/ Randall A. Lipps /s/ Peter J. Kuipers
Randall A. Lipps Peter J. Kuipers
President and Chief Executive Officer Executive Vice President & Chief Financial Officer
(Principal Executive Officer)(Principal Financial Officer)
 
"This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Omnicell, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing."

 EX-101.SCH 14 omcl-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - Consolidated Statements of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2404401 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2107102 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 2308302 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - Business Combinations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details) link:presentationLink link:calculationLink link:definitionLink 2411406 - Disclosure - Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details) link:presentationLink link:calculationLink link:definitionLink 2412407 - Disclosure - Business Combinations - Pro Forma Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 2113103 - Disclosure - Revenues link:presentationLink link:calculationLink link:definitionLink 2314303 - Disclosure - Revenues (Tables) link:presentationLink link:calculationLink link:definitionLink 2415408 - Disclosure - Revenues - Disaggregation of Revenues by Revenue Type (Details) link:presentationLink link:calculationLink link:definitionLink 2416409 - Disclosure - Revenues - Dissagregation of Revenues by Geographic Region (Details) link:presentationLink link:calculationLink link:definitionLink 2417410 - Disclosure - Revenues - Contract Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2418411 - Disclosure - Revenues - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2119104 - Disclosure - Net Income Per Share link:presentationLink link:calculationLink link:definitionLink 2320304 - Disclosure - Net Income Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2421412 - Disclosure - Net Income Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2122105 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2423413 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2124106 - Disclosure - Balance Sheet Components link:presentationLink link:calculationLink link:definitionLink 2325305 - Disclosure - Balance Sheet Components (Tables) link:presentationLink link:calculationLink link:definitionLink 2426414 - Disclosure - Balance Sheet Components - Balance Sheet Components (Details) link:presentationLink link:calculationLink link:definitionLink 2427415 - Disclosure - Balance Sheet Components - Accumulated Other Comprehensive Income (Details) link:presentationLink link:calculationLink link:definitionLink 2128107 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 2329306 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2430416 - Disclosure - Property and Equipment - Property and Equipment Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2431417 - Disclosure - Property and Equipment - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2432418 - Disclosure - Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2133108 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2334307 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2435419 - Disclosure - Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 2436420 - Disclosure - Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2437421 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2438422 - Disclosure - Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2139109 - Disclosure - Debt and Credit Agreements link:presentationLink link:calculationLink link:definitionLink 2340308 - Disclosure - Debt and Credit Agreement (Tables) link:presentationLink link:calculationLink link:definitionLink 2441423 - Disclosure - Debt and Credit Agreements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2442424 - Disclosure - Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 2443425 - Disclosure - Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2144110 - Disclosure - Convertible Senior Notes link:presentationLink link:calculationLink link:definitionLink 2345309 - Disclosure - Convertible Senior Notes (Tables) link:presentationLink link:calculationLink link:definitionLink 2446426 - Disclosure - Convertible Senior Notes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2447427 - Disclosure - Convertible Senior Notes - Convertible Debt Balances (Details) link:presentationLink link:calculationLink link:definitionLink 2448428 - Disclosure - Convertible Senior Notes - Summary of the Components of Interest Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2149111 - Disclosure - Lessor Leases link:presentationLink link:calculationLink link:definitionLink 2350310 - Disclosure - Lessor Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2451429 - Disclosure - Lessor Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2452430 - Disclosure - Lessor Leases - Income Recognized from Sales-Type Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2453431 - Disclosure - Lessor Leases - Components of Sales-Type Lease Receivables (Details) link:presentationLink link:calculationLink link:definitionLink 2454432 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2454432 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2455433 - Disclosure - Lessor Leases - Income Recognized from Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2456434 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2157112 - Disclosure - Lessee Leases link:presentationLink link:calculationLink link:definitionLink 2358311 - Disclosure - Lessee Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2459435 - Disclosure - Lessee Leases - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2460436 - Disclosure - Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2460436 - Disclosure - Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2461437 - Disclosure - Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2462438 - Disclosure - Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2163113 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2464439 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2165114 - Disclosure - Employee Benefits and Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2366312 - Disclosure - Employee Benefits and Share-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2467440 - Disclosure - Employee Benefits and Share-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2468441 - Disclosure - Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 2469442 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 2470443 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details) link:presentationLink link:calculationLink link:definitionLink 2471444 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2472445 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2473446 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2474447 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2475448 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details) link:presentationLink link:calculationLink link:definitionLink 2176115 - Disclosure - Stock Repurchase Program link:presentationLink link:calculationLink link:definitionLink 2477449 - Disclosure - Stock Repurchase Program (Details) link:presentationLink link:calculationLink link:definitionLink 2178116 - Disclosure - Equity Offerings link:presentationLink link:calculationLink link:definitionLink 2479450 - Disclosure - Equity Offerings (Details) link:presentationLink link:calculationLink link:definitionLink 2180117 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2381313 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2482451 - Disclosure - Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2483452 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2484453 - Disclosure - Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 2485454 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2486455 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2487456 - Disclosure - Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details) link:presentationLink link:calculationLink link:definitionLink 2188118 - Disclosure - Restructuring Expenses link:presentationLink link:calculationLink link:definitionLink 2389314 - Disclosure - Restructuring Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2490457 - Disclosure - Restructuring Expenses - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2491458 - Disclosure - Restructuring Expenses - Summary of Restructuring Expenses (Details) link:presentationLink link:calculationLink link:definitionLink 2192119 - Disclosure - Schedule II Valuation and Qualifying Accounts link:presentationLink link:calculationLink link:definitionLink 2493459 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 15 omcl-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 16 omcl-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 17 omcl-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Awards granted (in shares) Granted (Awarded) (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Intangibles Deferred Tax Liabilities, Intangible Assets Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amortization of discount on convertible senior notes Amortization of Debt Discount (Premium) Swing Line Loan Bridge Loan [Member] Long-term deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Liability: Debt Instrument, Convertible, Liability Component [Abstract] Debt Instrument, Convertible, Liability Component Software Development Costs Research, Development, and Computer Software, Policy [Policy Text Block] Purchase of convertible note hedge Purchase of convertible note hedge Adjustments To Additional Paid In Capital, Convertible Note Hedge Adjustments To Additional Paid In Capital, Convertible Note Hedge Statistical Measurement [Domain] Statistical Measurement [Domain] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] 2025 Lessor, Operating Lease, Payment to be Received, Year Five Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Interest Rate Option Two Credit Agreement, Interest Rate Option Two [Member] Credit Agreement, Interest Rate Option Two [Member] Percentile rank of stockholder return Share Based Compensation Arrangement by Share-based Payment, Determination of Performance Based Award Share Based Compensation Arrangement by Share-based Payment, Determination of Performance Based Award Security Exchange Name Security Exchange Name Employee Benefits and Share-Based Compensation Compensation and Employee Benefit Plans [Text Block] SaaS, subscription software, and technology-enabled services Hardware And Software [Member] Hardware And Software Accrued liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities Total current liabilities Liabilities, Current PSUs Performance-Based Restricted Stock Performance Shares [Member] Outstanding (in dollars per share) Outstanding (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Variable Rate [Domain] Variable Rate [Domain] Foreign derived intangible income deduction Effective Income Tax Rate Reconciliation, Deduction, Extraterritorial Income Exclusion, Amount ASSETS Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Convertible senior notes, net Convertible Notes Payable, Noncurrent Section 162(m) limitation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Excess Compensation Under Section 162(m), Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, Excess Compensation Under Section 162(m), Amount Issuance of common stock under employee stock plans Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Measurement input used in estimating the fair values of intangible assets Business Combination, Acquired Intangible Assets, Measurement Input Business Combination, Acquired Intangible Assets, Measurement Input Income Recognized from Sales-Type Leases Sales-type Lease, Lease Income [Table Text Block] Useful life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Fees to GPOs Group Purchasing Organization Fees Group Purchasing Organization Fees Number of shares repurchased (in shares) Treasury Stock, Shares, Acquired 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Outstanding at beginning of year (in shares) Outstanding at end of year (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Debt Instrument, Covenant Terms [Axis] Debt Instrument, Covenant Terms [Axis] Debt Instrument, Covenant Terms AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] State Current State and Local Tax Expense (Benefit) Tax credit carryforward amount Tax Credit Carryforward, Amount Changes in the Balance of Deferred Debt Issuance Costs Schedule Of Debt Issuance Costs, Net [Table Text Block] Schedule Of Debt Issuance Costs, Net Total operating expenses Operating Expenses Other comprehensive income (loss), net of reclassification adjustments: Other Comprehensive Income (Loss), Net of Tax [Abstract] Amortization of operating lease right-of-use assets Amortization Of Operating Lease ROU Asset Amortization Of Operating Lease ROU Asset Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Standard warranty period (up to) Standard Product Warrant Description, Duration Following Installation Standard Product Warrant Description, Duration Following Installation Other long-term liabilities Other Liabilities, Noncurrent Long-term deferred tax assets Deferred Income Tax Assets, Net Fair value of awards vested Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Limited warranty period (up to) Standard Product Warrant, Duration of Limited Warranty Standard Product Warrant, Duration of Limited Warranty Work in process Inventory, Work in Process, Net of Reserves Inventories Total inventories Inventory, Net Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Other current assets Other Assets, Miscellaneous, Current Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract] Concentration risk percentage Concentration Risk, Percentage Embedded conversion option Debt Instrument, Convertible, Embedded Conversion Option Debt Instrument, Convertible, Embedded Conversion Option SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Long-term operating lease liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Liabilities Statement [Line Items] Statement [Line Items] Computer equipment and related software Computer Equipment [Member] Term of debt instrument Debt Instrument, Term Less: Unearned interest income portion Present value adjustment Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Statement [Table] Statement [Table] Type of Restructuring [Domain] Type of Restructuring [Domain] Statistical Measurement [Axis] Statistical Measurement [Axis] Deferred income taxes Deferred Income Taxes and Tax Credits Other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other Strike price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Entity Small Business Entity Small Business Principles of Consolidation Consolidation, Policy [Policy Text Block] Original terms of contracts Capitalized Contract Cost, Original Term Of Contract Capitalized Contract Cost, Original Term Of Contract Number of shares sold (in shares) Sale of Stock, Number of Shares Issued in Transaction Debt and Credit Agreement Convertible Senior Notes Debt Disclosure [Text Block] Prepaid expenses Prepaid Expense, Current Share Repurchase Program [Domain] Share Repurchase Program [Domain] Deferred tax impact Debt Instrument, Convertible, Tax Effect Of Equity Component Of Convertible Debt Debt Instrument, Convertible, Tax Effect Of Equity Component Of Convertible Debt Amendment Flag Amendment Flag Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Uncertain tax positions, interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Change in customer funds, net Proceeds From (Payments For) Customer Funds, Net Proceeds From (Payments For) Customer Funds, Net Prepaid expenses Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Prepaid Expense Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Prepaid Expense Non-deductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, less Share-Based Compensation and Acquisition Cost, Amount Effective Income Tax Rate Reconciliation, Nondeductible Expense, less Share-Based Compensation and Acquisition Cost, Amount Other accrued liabilities Other Accrued Liabilities, Current Wells Fargo Bank Wells Fargo Bank, National Association [Member] Wells Fargo Bank, National Association [Member] Amounts reclassified from other comprehensive income (loss), net of tax Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block] Restructuring Expenses Restructuring and Related Activities Disclosure [Text Block] Accrued liabilities: Accrued Liabilities, Current [Abstract] Allowance for Credit Losses Credit Loss, Financial Instrument [Policy Text Block] Cash equivalents Cash Equivalents, at Carrying Value Interest Rate Swap Agreements Derivatives, Policy [Policy Text Block] Unpaid purchases of property and equipment Capital Expenditures Incurred but Not yet Paid Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Unrecognized compensation cost of unvested stock options Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Lessor Leases Lessor, Leases [Policy Text Block] Commitments and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] ESPP ESPP shares available for future issuance Employee Stock [Member] Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Accounts receivable and unbilled receivables, net of allowance Accounts receivable and unbilled receivables Accounts Receivable, Allowance for Credit Loss, Current Income Statement Location [Domain] Income Statement Location [Domain] Research tax credits Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two State and Local Jurisdiction State and Local Jurisdiction [Member] Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Selling, general, and administrative Selling, General and Administrative Expense Deferred revenues Deferred Tax Assets, Deferred Income 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three Other long-term assets Total other long-term assets Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] 2024 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four Estimated forfeiture rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Estimated Forfeiture Rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Estimated Forfeiture Rate Total assets Assets Interest expense Interest Expense, Debt Organization and Summary of Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Outstanding (in shares) Outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Backlog Order or Production Backlog [Member] Period for notice of termination Contract Termination Requirement, Period of Notification Contract Termination Requirement, Period of Notification Antidilutive Securities [Axis] Antidilutive Securities [Axis] Lessor, Lease, Description [Table] Lessor, Lease, Description [Table] Lessor Leases Lessor, Operating Leases [Text Block] Cost of product and service revenues Cost of Sales [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Share-based compensation tax benefit Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount Weighted-Average Remaining Years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Term Lessor Leases Lessor, Sales-type Leases [Text Block] Summary of Performance-Based Restricted Stock Activity Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block] Total liabilities Liabilities Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Retirement Plan Type [Axis] Retirement Plan Type [Axis] Present value adjustment Lessee, Operating Lease, Liability, Undiscounted Excess Amount Remaining weighted-average vesting period Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 2018 Performance Based Restricted Stock Units 2018 Performance Based Restricted Stock Units [Member] 2018 Performance Based Restricted Stock Units Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Inventories Increase (Decrease) in Inventories Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Additional Paid-In Capital Additional Paid-in Capital [Member] Other long-term assets Other Assets, Miscellaneous, Noncurrent Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Common stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Revolving Credit Facility Current Revolving Credit Facility Revolving Credit Facility [Member] Income before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Exercisable (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Property and Equipment Property, Plant and Equipment [Member] Outstanding at beginning of year (in dollars per share) Outstanding at end of year (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Business acquisition Payments to Acquire Businesses, Net of Cash Acquired Common stock, shares authorized (in shares) Common Stock, Shares Authorized Property and equipment, gross Property, Plant and Equipment, Gross Effect of dilutive securities from stock award plans (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Federal Deferred Federal Income Tax Expense (Benefit) Accounts receivable due from third-party leasing companies for transferred non-recourse accounts receivable Transfer of Financial Assets Accounted for as Sales, Receivable from Third-Party Leasing Company, Amount Transfer of Financial Assets Accounted for as Sales, Receivable from Third-Party Leasing Company, Amount Omnicell Plan Omnicell Plan [Member] Omnicell Plan [Member] Advance payments from customers Contract with Customer, Liability, Customer Advances and Deposits, Current Contract with Customer, Liability, Customer Advances and Deposits, Current SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Accrued compensation Increase (Decrease) in Employee Related Liabilities Income Statement [Abstract] Income Statement [Abstract] Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Summary of Restricted Stock Awards Activity Nonvested Restricted Stock Shares Activity [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Income Tax Authority [Domain] Income Tax Authority [Domain] Officer Officer [Member] Shares purchased under ESPP (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Purchased Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Purchased Software Software and Software Development Costs [Member] Revolving credit facility Long-term Line of Credit, Noncurrent Weighted-average price (in dollars per share) Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Purchased In Period, Weighted Average Price Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Purchased In Period, Weighted Average Price Net investment in sales-type leases Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Shares reserved for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Prepaid expenses Increase (Decrease) in Prepaid Expense Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Accumulated impairment loss on goodwill Goodwill, Impaired, Accumulated Impairment Loss Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank Wells Fargo Securities, LLC, Citizens Bank, N.A. And JPMorgan Chase Bank, N.A [Member] Wells Fargo Securities, LLC, Citizens Bank, N.A. And JPMorgan Chase Bank, N.A Employees’ taxes paid related to restricted stock units Payment, Tax Withholding, Share-based Payment Arrangement Inventories: Inventory, Net, Items Net of Reserve Alternative [Abstract] Summary of Restructuring Expenses Restructuring and Related Costs [Table Text Block] Additions Goodwill, Acquired During Period Deferred tax asset related to the convertible note hedge transaction Deferred Tax Asset, Convertible Debt Hedge Deferred Tax Asset, Convertible Debt Hedge Useful life of property and equipment Property, Plant and Equipment, Useful Life Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Purchases from suppliers Payments to Suppliers Maximum secured net leverage ratio Debt Instrument, Covenant, Maximum Secured Net Leverage Ratio Debt Instrument, Covenant, Maximum Secured Net Leverage Ratio Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Software development costs capitalized Capitalized Computer Software, Period Increase (Decrease) Other current assets Increase (Decrease) in Other Current Assets Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Royalty Rate Measurement Input, Royalty Rate [Member] Measurement Input, Royalty Rate Restricted Stock Awards RSAs Restricted Stock [Member] Finished goods Inventory, Finished Goods, Net of Reserves Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Share-based Payment Arrangement [Abstract] Operating lease liabilities, current portion Current portion of operating lease liabilities Operating Lease, Liability, Current Connected devices, software licenses, and other Connected Devices, Software Licenses, And Other [Member] Connected Devices, Software Licenses, And Other Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Assumptions Used to Value Stock Options Granted Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Total current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Employer matching contribution, percent of employee contribution Defined Contribution Plan, Employer Matching Contribution, Percent of Match Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Accounts receivable and unbilled receivables Accounts Receivable [Member] Interest Rate Swap Interest Rate Swap [Member] Customer [Domain] Customer [Domain] Cumulative Effect of a Change in Accounting Principle Cumulative Effect, Period of Adoption, Adjustment [Member] Entity Registrant Name Entity Registrant Name Business Acquisition [Line Items] Business Acquisition [Line Items] Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Proceeds from sale of warrants Proceeds from Issuance of Warrants Deferred debt issuance costs Balance Balance Debt Issuance Costs, Net Shipping Costs Shipping and Handling [Member] Weighted-Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Convertible Senior Notes Convertible Senior Notes [Member] Convertible Senior Notes Lease Receivable Lease Receivable [Member] Lease Receivable [Member] 2019 Performance Based Restricted Stock Units 2019 Performance Based Restricted Stock Units [Member] 2019 Performance Based Restricted Stock Units Cost of sales-type lease revenues Capital Leases, Income Statement, Cost Of Goods Sold, Sales Type Lease Capital Leases, Income Statement, Cost Of Goods Sold, Sales Type Lease Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Stock Repurchase Program Treasury Stock [Text Block] Unpaid balance related to restructuring plan Restructuring Reserve Thereafter Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, after Year Five Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Sale of Stock [Axis] Sale of Stock [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Total net deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Period 2 Debt Instrument, Redemption, Period Two [Member] Purchase price of common stock, percent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent Restructuring Type [Axis] Restructuring Type [Axis] Goodwill Balance Balance Goodwill Technical services Technical Services [Member] Technical Services Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 2021 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Options and warrants to purchase shares (in shares) Class of Warrant or Right, Outstanding Warrant Warrant [Member] Loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards Purchase of convertible note hedge Payments for Hedge, Financing Activities Aggregate principal amount Debt Instrument, Face Amount Other current assets Total other current assets Other Assets, Current Term of sales-type leases Lessor, Sales-type Lease, Term of Contract Changes in the Carrying Amount of Goodwill Schedule of Goodwill [Table Text Block] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Tax benefits related to convertible senior notes and convertible note hedge Adjustments To Additional Paid In Capital, Tax Benefits Related To Convertible Debt And Hedge Adjustments To Additional Paid In Capital, Tax Benefits Related To Convertible Debt And Hedge Equity [Abstract] Equity [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Net investment in sales-type leases, current portion Less: current portion Net Investment in Lease, Current Fair value of purchased intangible assets Indefinite-lived Intangible Assets Acquired Deferred revenues, net Deferred revenues, net of cost of goods sold, expected to be completed within one year Short-term deferred revenues, net Contract with Customer, Liability, Current Reserves and accruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Interest income on sales-type lease receivables Capital Leases, Income Statement, Interest Income, Sales Type Lease Capital Leases, Income Statement, Interest Income, Sales Type Lease Customer Concentration Risk Customer Concentration Risk [Member] Estimated Future Amortization Expense for Intangible Assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Diluted (in shares) Weighted-average shares outstanding — diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Number of operating segments Number of Operating Segments Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Restructuring Plan [Axis] Restructuring Plan [Axis] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Repayment of debt and revolving credit facility Repayments Repayments of Long-term Debt Sale of warrants Adjustments to Additional Paid in Capital, Warrant Issued Beginning of the period balance End of the period balance Unrecognized Tax Benefits Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Common stock, $0.001 par value, 100,000 shares authorized; 52,677 and 51,277 shares issued; 42,783 and 42,132 shares outstanding, respectively Common Stock, Value, Issued Document Fiscal Year Focus Document Fiscal Year Focus 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Gross short-term deferred revenue Contract with Customer, Liability, Current, Gross Contract with Customer, Liability, Current, Gross SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Decreases related to settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Entity Current Reporting Status Entity Current Reporting Status Price per share sold (in dollars per share) Sale of Stock, Price Per Share 2023 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three Balance transfer from term loan to revolving credit facility Other Noncash Investing And Financing Items, Loan Amount Transferred Other Noncash Investing And Financing Items, Loan Amount Transferred Amortization of capitalized software development costs Capitalized Computer Software, Amortization Net Income Per Share Earnings Per Share, Policy [Policy Text Block] Percentage of award vesting Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Q1-Q2 2020 Restructuring Plan Q1-Q2 2020 Restructuring Plan [Member] Q1-Q2 2020 Restructuring Plan Accounts receivable and unbilled receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivable And Unbilled Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivable And Unbilled Receivables Total operating lease liabilities Operating Lease, Liability Net deferred tax liabilities Deferred Tax Liabilities, Net Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Accounting Policies [Line Items] Accounting Policies [Line Items] [Line Items] for Accounting Policies [Table] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Total stockholders’ equity Balance Balance Stockholders' Equity Attributable to Parent Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Purchase price Business Combination, Consideration Transferred Entity Address, City or Town Entity Address, City or Town Accrued compensation Employee-related Liabilities, Current RSUs Restricted Stock Units (RSUs) [Member] Other long-term assets: Other Assets, Noncurrent [Abstract] Maximum percentage of earnings allowed for purchase of shares Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Other Assets Other Assets [Member] Purchasing period Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Purchasing Period Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Purchasing Period Product revenues Product [Member] Maximum fair market value of shares Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount Primary Supplier Primary Supplier [Member] Primary Supplier [Member] Right-of-use assets Deferred Tax Liabilities, Leasing Arrangements Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Other long-term assets Increase (Decrease) in Other Noncurrent Assets 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three Construction in progress Construction in Progress [Member] Revenue Recognition and Shipping Costs Revenue from Contract with Customer [Policy Text Block] 2014 Share Repurchase Program 2014 Share Repurchase Program [Member] 2014 Share Repurchase Program Leases [Abstract] Leases [Abstract] One-Time Stock Repurchase Transaction One-Time Stock Repurchase - September 2020 [Member] One-Time Stock Repurchase - September 2020 Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Net operating loss Operating Loss Carryforwards Earnings Per Share [Abstract] Earnings Per Share [Abstract] Significant Components of Deferred Tax Assets (Liabilities) Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Q4 2018 Restructuring Plan Q4 2018 Restructuring Plan [Member] Q4 2018 Restructuring Plan [Member] Net investment in sales-type leases Net Investment in Lease 340B Link Business 340B Link Business [Member] 340B Link Business 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Unrecognized compensation cost Share-Based Payment Arrangement, Award, Excluding Option, Cost Not Yet Recognized, Amount Share-Based Payment Arrangement, Award, Excluding Option, Cost Not Yet Recognized, Amount Contract cost expense Capitalized Contract Costs Recognized Capitalized Contract Costs Recognized Sales-type lease revenues Sales-type Lease, Revenue Term Loan Facility Prior Term Loan Facility Term Loan Facility [Member] Term Loan Facility [Member] Term of operating leases Lessor, Operating Lease, Term of Contract Repurchase price as a percent of principal amount Debt Instrument, Redemption Price, Percentage Entity Filer Category Entity Filer Category Share-Based Compensation Expense Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Common Stock Common Stock [Member] Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Product and Service [Domain] Product and Service [Domain] LIBOR Plus 1.00% London Interbank Offering Rate (LIBOR) Plus 1.00% [Member] London Interbank Offering Rate (LIBOR) Plus 1.00% Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] 401(k) contributions Defined Contribution Plan, Cost Acquired Technology Acquired technology Technology-Based Intangible Assets [Member] Supplier [Axis] Supplier [Axis] Transfers between inventory and property and equipment, net Inventory Transferred to Property and Equipment Inventory Transferred to Property and Equipment 2021 Lessor, Operating Lease, Payment to be Received, Year One Secured Credit Facility Secured Debt [Member] Class of Treasury Stock [Table] Class of Treasury Stock [Table] Leasehold improvements Leasehold Improvements [Member] Revenues Revenue Benchmark [Member] Interest rate Debt Instrument, Interest Rate, Stated Percentage Acquired Indefinite-lived Intangible Assets [Line Items] Acquired Indefinite-lived Intangible Assets [Line Items] Investment in sales-type leases Increase (Decrease) in Leasing Receivables Supplemental disclosure of non-cash activities Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract] Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Net increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Business Combinations Business Combination Disclosure [Text Block] Interest and other income (expense), net Nonoperating Income (Expense) Stock Options Share options outstanding Share-based Payment Arrangement, Option [Member] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Treasury stock, shares outstanding (in shares) Balance (in shares) Balance (in shares) Treasury Stock, Shares Sale of Stock [Domain] Sale of Stock [Domain] Employee Severance Costs and Related Expenses Employee Severance [Member] State Deferred State and Local Income Tax Expense (Benefit) Domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Maximum amount of employer contribution Defined Contribution Plan, Employer Matching Contribution, Maximum Contribution Defined Contribution Plan, Employer Matching Contribution, Maximum Contribution Convertible Note Hedge Equity Option [Member] Expected volatility (maximum) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Additional paid-in capital Additional Paid in Capital Selling profit on sales-type lease revenues Sales-type Lease, Selling Profit (Loss) 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Non-recourse accounts receivable transferred Transfer of Financial Assets Accounted for as Sales, Fair Value of Derecognized Assets Cash paid for taxes, net of refunds Income Taxes Paid, Net Summary of Restricted Stock Unit Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Diluted (in dollars per share) Net income per share - diluted (in dollars per share) Earnings Per Share, Diluted Change in the Balance of Gross Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Goodwill and Acquired Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Changes in the Carrying Amount of Debt Obligations Schedule of Long-term Debt Instruments [Table Text Block] Depreciation and amortization expense of property and equipment Depreciation expense Depreciation Entity Address, Address Line One Entity Address, Address Line One Non-compete agreements Noncompete Agreements [Member] Entity Emerging Growth Company Entity Emerging Growth Company Threshold consecutive trading days Debt Instrument, Convertible, Threshold Consecutive Trading Days Total deferred income taxes Deferred Income Tax Expense (Benefit) Pro forma revenues Business Acquisition, Pro Forma Revenue Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table] Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Offering period Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Offering Period Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Offering Period Maximum Maximum [Member] Federal Funds Fed Funds Effective Rate Overnight Index Swap Rate [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Share-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Equity: Debt Instrument, Convertible, Equity Component [Abstract] Debt Instrument, Convertible, Equity Component Non-vested restricted stock awards Restricted Stock Awards (RSAs) And Restricted Stock Units (RSUs) [Member] Restricted Stock Awards (RSAs) And Restricted Stock Units (RSUs) Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] 2023 Lessor, Operating Lease, Payment to be Received, Year Three Cost of sales-type lease revenues Cost of Goods Sold, Sales-type Lease Ten Largest GPOs Ten Largest Group Purchasing Organizations (GPOs) [Member] Ten Largest Group Purchasing Organizations (GPOs) [Member] Variable rate floor Derivative, Basis Spread on Variable Rate Other Postretirement Benefit Plan Other Postretirement Benefits Plan [Member] Trading Symbol Trading Symbol Balance Sheet Components Condensed Balance Sheet [Table Text Block] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] 2016 and 2014 Share Repurchase Programs 2016 and 2014 Share Repurchase Programs [Member] 2016 and 2014 Share Repurchase Programs [Member] Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Proceeds from issuances under stock-based compensation plans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised Total contract assets Contract with Customer, Asset, after Allowance for Credit Loss Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Equipment Equipment [Member] Foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Entity Shell Company Entity Shell Company Segment Reporting Segment Reporting, Policy [Policy Text Block] Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Entity Public Float Entity Public Float Business Combinations Business Combinations Policy [Policy Text Block] Document Type Document Type ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Treasury Stock Treasury Stock [Member] Services and other revenues Service [Member] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] Vested (Released) (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Summary of changes in accumulated balances of other comprehensive income (loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] 2022 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Lessee Leases Lessee, Leases [Policy Text Block] Stock repurchases (in shares) Stock Repurchased During Period, Shares Other Current Assets Other Current Assets [Member] Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Line of Credit Line of Credit [Member] Convertible Debt Securities and Warrants Convertible Debt Securities And Warrants [Member] Convertible Debt Securities And Warrants Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Thereafter Lessor, Operating Lease, Payment to be Received, after Year Five Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Long-term deferred tax liabilities Deferred Income Tax Liabilities, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Proceeds from issuance of convertible senior notes, net of issuance costs Proceeds from Convertible Debt Income from operations Operating Income (Loss) Payments for debt issuance costs for revolving credit facility Debt issuance costs incurred and capitalized Additions Payments of Debt Issuance Costs Ordinary Shares Reserved for Future Issuance Under Equity Incentive Plans Schedule of Share-based Compensation, Future Issuance of Shares [Table Text Block] Schedule of Share-based Compensation, Future Issuance of Shares Long-term Debt [Roll Forward] Long-term Debt [Roll Forward] Long-term Debt [Roll Forward] Contract Assets and Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Funds held for customers, including restricted cash Funds Held for Clients Variable Rate [Axis] Variable Rate [Axis] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Commitments and contingencies (Note 13) Commitments and Contingencies Guarantees Guarantees, Indemnifications and Warranties Policies [Policy Text Block] Tax payments related to restricted stock units Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Vesting in Equal Monthly Installments Share-based Payment Arrangement, Tranche Two [Member] Stock repurchases Aggregate purchase price for repurchased shares Payments for Repurchase of Common Stock Vesting period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Furniture and fixtures Furniture and Fixtures [Member] Taxes payable Taxes Payable, Current Trading days used for stock price appreciation calculation Share-based Compensation Arrangement by Share-based Payment Award, Trading Days Share-based Compensation Arrangement by Share-based Payment Award, Trading Days Entity Address, State or Province Entity Address, State or Province Vested (Released) (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period U.S. federal tax provision at statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Accounts payable Accounts Payable, Current Foreign currency exchange rate fluctuations Goodwill, Foreign Currency Translation Gain (Loss) Schedule of Cash and Cash Equivalents [Table] Schedule of Cash and Cash Equivalents [Table] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value Retained earnings Retained Earnings (Accumulated Deficit) Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] Unamortized discount Debt Instrument, Unamortized Discount Depreciation and amortization Deferred Tax Liabilities, Property, Plant and Equipment Restructuring impact Effective Income Tax Rate Reconciliation, Gain On Investment Effective Income Tax Rate Reconciliation, Gain On Investment Group purchasing organization fees Accrued Group Purchasing Organization Fees Accrued Group Purchasing Organization Fees Convertible Debt Balances Convertible Debt [Table Text Block] Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Stockholders’ equity: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Customer [Axis] Customer [Axis] Selling profit on sales-type lease revenues Capital Leases, Income Statement, Selling Profit (Loss), Sales Type Lease Capital Leases, Income Statement, Selling Profit (Loss), Sales Type Lease Foreign currency exchange rate fluctuations Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Accounting for Income Taxes Income Tax, Policy [Policy Text Block] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Share-based compensation APIC, Share-based Payment Arrangement, Increase for Cost Recognition Accounting Policies [Table] Accounting Policies [Table] Accounting Policies [Table] Long-term unbilled receivables Contract with Customer, Asset, Unbilled Receivables, Noncurrent [Member] Contract with Customer, Asset, Unbilled Receivables, Noncurrent Supplemental Cash Flow Information Related to Operating Leases Lessee, Operating Lease, Supplemental Cash Flow Information [Table Text Block] Lessee, Operating Lease, Supplemental Cash Flow Information Revenues Revenues Revenue from Contract with Customer, Excluding Assessed Tax Lender Name [Axis] Lender Name [Axis] Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] Conversion ratio Debt Instrument, Convertible, Conversion Ratio Net tax expense on sale of intellectual property rights Income Tax Expense (Benefit), Sale Of Intellectual Property Rights Income Tax Expense (Benefit), Sale Of Intellectual Property Rights Foreign Deferred Foreign Income Tax Expense (Benefit) Net income per share: Earnings Per Share, Basic and Diluted [Abstract] Entity Voluntary Filers Entity Voluntary Filers Acquisition related costs Business Combination, Acquisition Related Costs Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Thereafter Finite-Lived Intangible Asset, Expected Amortization, after Year Five Credit Facility [Axis] Credit Facility [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total future minimum operating lease payments Lessor, Operating Lease, Payments to be Received Equity component of convertible senior note issuance, net of issuance costs Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature Expected volatility (minimum) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Foreign Tax Authority Foreign Tax Authority [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Business Combinations [Abstract] Business Combinations [Abstract] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Earnings from operations since the acquisition date Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Unamortized debt issuance costs Unamortized Debt Issuance Expense Amortization period for capitalized contract costs Capitalized Contract Cost, Amortization Period At the market equity offering, net of offering costs Proceeds from Issuance of Common Stock Income Recognized from Operating Leases Operating Lease, Lease Income [Table Text Block] Period 1 Debt Instrument, Redemption, Period One [Member] Selling, general, and administrative Selling, general, and administrative Selling, General and Administrative Expenses [Member] Goodwill [Roll Forward] Goodwill [Roll Forward] Calculation of Basic and Diluted Net Income Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Incremental Loan Facility Incremental Loan Facility [Member] Incremental Loan Facility Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Fair Value Hierarchy Fair Value Measurement, Policy [Policy Text Block] Rebates and lease buyouts Accrued Liabilities, Rebates and Lease Buyouts, Current Accrued Liabilities, Rebates and Lease Buyouts, Current Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Number of reporting units Number of Reporting Units Derivative Instrument [Axis] Derivative Instrument [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Debt Instrument, Covenant Terms [Domain] Debt Instrument, Covenant Terms [Domain] Debt Instrument, Covenant Terms Geographical [Axis] Geographical [Axis] Debited (Credited) to Other Accounts SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account Other current assets: Other Assets, Current [Abstract] Other Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Pro forma net income Business Acquisition, Pro Forma Net Income (Loss) Proceeds Proceeds from Debt, Net of Issuance Costs Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Income Statement Location [Axis] Income Statement Location [Axis] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Funds Held for Customers and Customer Fund Liabilities Funds Held For Customers And Customer Fund Liabilities [Policy Text Block] Funds Held For Customers And Customer Fund Liabilities Average price of repurchased shares (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Federal Current Federal Tax Expense (Benefit) Notional amount Derivative, Notional Amount Maximum number of shares issuable upon conversion (in shares) Debt Instrument, Convertible, Number Of Shares Issuable Debt Instrument, Convertible, Number Of Shares Issuable Amortization expense of intangible assets Amortization of Intangible Assets Prepaid income taxes Prepaid Taxes Share-based Goods and Nonemployee Services Transaction, Supplier [Domain] Supplier [Domain] Threshold percentage of stock price trigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger 1997 Plan 1997 Employee Stock Purchase Plan [Member] 1997 Employee Stock Purchase Plan [Member] At the market equity offering, net of costs Stock Issued During Period, Value, New Issues Accounts receivable and unbilled receivables, net of allowances of $4,286 and $3,227, respectively Receivables, Net, Current Title of 12(b) Security Title of 12(b) Security Estimated useful life of software-related products Capitalized Computer Software, Estimated Useful Life Capitalized Computer Software, Estimated Useful Life Awards vested by period end (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Net carrying amount Total Finite-Lived Intangible Assets, Net Weighted-average fair value per share (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 2022 Lessor, Operating Lease, Payment to be Received, Year Two Vesting [Domain] Vesting [Domain] Balance transfer Balance transfer Long-Term Debt, Transfer Long-Term Debt, Transfer Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Research Tax Credit Carryforward Research Tax Credit Carryforward [Member] Gross proceeds from sales of common stock Sale of Stock, Consideration Received on Transaction Depreciation and amortization Depreciation, Depletion and Amortization Provision For (Benefit From) Income Taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Product and Service [Axis] Product and Service [Axis] Weighted average period of compensation cost recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Rest of world Non-US [Member] Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate Lessee, Operating Lease, Lease Assumptions [Table Text Block] Lessee, Operating Lease, Lease Assumptions Deferred revenues recognized Contract with Customer, Liability, Revenue Recognized Accounts payable Increase (Decrease) in Accounts Payable Raw materials Inventory, Raw Materials, Net of Reserves Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Debt Instrument [Axis] Debt Instrument [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Maximum aggregate offering price Sale of Stock, Authorized Amount Sale of Stock, Authorized Amount Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accrued liabilities Increase (Decrease) in Accrued Liabilities Awards eligible for vesting (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Eligible for Vesting Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Eligible for Vesting Summary of Identifiable Intangible Assets Acquired Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Unbilled receivables, net Unbilled Contracts Receivable Adjustments to reconcile net income to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Inventory-related items Deferred Tax Assets, Inventory State taxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Total net investment in sales-type leases Sales-type and Direct Financing Leases, Lease Receivable Research and development Research and Development Expense Internal Revenue Service (IRS) Domestic Tax Authority [Member] Reclassifications and Adjustments Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] Contractual coupon interest Interest Expense, Debt, Excluding Amortization Loss on disposal of property and equipment Gain (Loss) on Disposition of Assets Long-term operating lease liabilities Long-term portion of operating lease liabilities Operating Lease, Liability, Noncurrent 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Convertible Note Hedge Rights Convertible Note Hedge Rights [Member] Convertible Note Hedge Rights Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Current assets: Assets, Current [Abstract] Goodwill expected to be deductible for tax purposes Business Acquisition, Goodwill, Expected Tax Deductible Amount Rental income Operating Leases, Income Statement, Lease Revenue Remaining value of shares authorized for repurchase under stock repurchase programs Stock Repurchase Program, Remaining Authorized Repurchase Amount Long-term unbilled receivables Contract with Customer, Asset, Allowance for Credit Loss, Noncurrent Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Patents Patents [Member] Additional principal amount subject to purchasers' option Debt Instrument, Accordion Feature, Increase Limit Debt Instrument, Accordion Feature, Increase Limit Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Interest Rate Option One Credit Agreement, Interest Rate Option One [Member] Credit Agreement, Interest Rate Option One [Member] Amount Written Off SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Operating lease liabilities Increase (Decrease) In Operating Lease Liabilities Increase (Decrease) In Operating Lease Liabilities Other comprehensive income (loss) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent City Area Code City Area Code Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Value of shares authorized for repurchase under stock repurchase programs Stock Repurchase Program, Authorized Amount Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Disaggregation of Revenues by Revenue Type and Geographic Region Disaggregation of Revenue [Table Text Block] Term of operating leases Lessee, Operating Lease, Term of Contract Distribution Agreement Distribution Agreement [Member] Distribution Agreement [Member] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Share-based compensation expense Share-based Payment Arrangement, Noncash Expense Stock repurchases Stock Repurchased During Period, Value Sales-type lease revenues Capital Leases, Income Statement, Sales Type Lease Revenue Leased Equipment under Operating Leases Assets Leased to Others [Member] Consumables Consumables [Member] Consumables Cover page. Cover [Abstract] Measurement Input Type [Axis] Measurement Input Type [Axis] Shares authorized for future issuance future grants and awards [Member] future grants and awards [Member] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Net investment in sales-type leases Net Investment in Sales-Type Leases [Member] Net Investment in Sales-Type Leases [Member] Geographical Breakdown of Income (Loss) before the Provision for Income Taxes Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Remaining life of debt discount and issuance cost accretion Debt Instrument, Convertible, Remaining Discount Amortization Period Carrying value of debt Outstanding balance Balance Balance Convertible senior notes, liability component Long-term Debt Deferred revenues Increase (Decrease) in Contract with Customer, Liability Lessee Leases Lessee, Operating Leases [Text Block] Retirement Plan Name [Axis] Retirement Plan Name [Axis] Customer relationships Customer Relationships [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Cost of revenues Cost of Goods and Services Sold Equity Components [Axis] Equity Components [Axis] Unrealized loss on interest rate swap contracts, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Gross deferred tax assets Deferred Tax Assets, Gross Minimum Minimum [Member] Total assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Balance Sheet Location [Domain] Balance Sheet Location [Domain] Total unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Debt issuance costs Debt Issuance Costs, Net, Equity Component Debt Issuance Costs, Net, Equity Component Long-term unbilled receivables Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent Entity Interactive Data Current Entity Interactive Data Current Lease liability Deferred Tax Assets, Leasing Arrangements Deferred Tax Assets, Leasing Arrangements United States UNITED STATES Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Equity Offerings Stockholders' Equity Note Disclosure [Text Block] Deferred tax assets (liabilities): Components of Deferred Tax Assets and Liabilities [Abstract] Summary of Share Option Activity Share-based Payment Arrangement, Option, Activity [Table Text Block] Minimum required purchase obligation Non-cancelable purchase commitments Purchase Obligation Share-Based Awards Share-based Payment Arrangement [Policy Text Block] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Foreign Current Foreign Tax Expense (Benefit) Impairment loss related to capitalized prepaid commissions Capitalized Contract Cost, Impairment Loss Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Carrying Amounts and Useful Lives of Intangible Assets Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Total deferred tax liabilities Deferred Tax Liabilities, Gross U.S. Government Hospitals U.S. Government Hospitals [Member] U.S. Government Hospitals [Member] Number of reporting segments Number of Reportable Segments Retirement Plan Type [Domain] Retirement Plan Type [Domain] Charged (Credited) to Cost and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Research and development Research and Development Expense [Member] Total operating lease payments Lessee, Operating Lease, Liability, to be Paid Q1 2018 Restructuring Plan Q1 2018 Restructuring Plan [Member] [Member] Q1 2018 Restructuring Plan [Member] [Member] Other, net Deferred Tax Assets, Other Threshold trading days Debt Instrument, Convertible, Threshold Trading Days Risk-free interest rate (minimum) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Rental income Operating Lease, Lease Income Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Foreign Currency Translation and Remeasurement Foreign Currency Transactions and Translations Policy [Policy Text Block] Restructuring expenses Restructuring Costs Restructuring payments Payments for Restructuring Summary of the Components of Interest Expense Schedule Of Interest Expense, Debt [Table Text Block] Schedule Of Interest Expense, Debt Document Transition Report Document Transition Report Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Title of Individual [Axis] Title of Individual [Axis] Assumptions Used to Value ESPP Shares Granted Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Deferred: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Deferred cost of sales Contract With Customer, Asset, Current, Deferred Cost Of Goods And Services Sold Contract With Customer, Asset, Current, Deferred Cost Of Goods And Services Sold Vesting [Axis] Vesting [Axis] Current: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] 2025 Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Five Operating lease right-of-use assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets Recognition period Revenue, Performance Obligation, Description of Timing Fixed interest rate Derivative, Fixed Interest Rate Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Vested and expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Credit Facility [Domain] Credit Facility [Domain] Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Basic (in dollars per share) Net income per share - basic (in dollars per share) Earnings Per Share, Basic Unrecognized tax benefits that would impact tax expense Unrecognized Tax Benefits that Would Impact Effective Tax Rate Expected life Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Entity File Number Entity File Number Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term 2024 Lessor, Operating Lease, Payment to be Received, Year Four Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Share-based compensation expense Share-based Payment Arrangement, Expense Unrealized gain (loss) on interest rate swap hedges AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Initial term and renewal service periods Capitalized Contract Cost, Initial Term And Renewal Service Periods Capitalized Contract Cost, Initial Term And Renewal Service Periods Balance Sheet Location [Axis] Balance Sheet Location [Axis] Weighted-average shares outstanding: Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract] Prepaid commissions Capitalized Contract Cost, Net, Noncurrent Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Document Annual Report Document Annual Report Income tax benefit from share-based compensation Share-based Payment Arrangement, Expense, Tax Benefit Issuance of common stock under employee stock plans (in shares) Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Total purchase price Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Weighted-average grant date fair value per award granted (in dollars per share) Granted (Awarded) (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Debt Debt, Policy [Policy Text Block] Prepaid expenses Deferred Tax Liabilities, Other Tax benefit associated with making a check-the-box election to treat Aesynt as a U.S. disregarded entity Income Tax Expense (Benefit), Election Of U.S. Disregarded Entity Treatment Income Tax Expense (Benefit), Election Of U.S. Disregarded Entity Treatment Capitalized software, net Capitalized Computer Software, Net Accounts receivable and unbilled receivables Increase (Decrease) in Accounts Receivable Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Issuance costs on sales of common stock Payments of Stock Issuance Costs Concentration Risk Type [Domain] Concentration Risk Type [Domain] Total liabilities and stockholders’ equity Liabilities and Equity Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Income Taxes Income Tax Disclosure [Text Block] Decreases related to expiration of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Operating lease cost Operating Lease, Cost Total liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Interest and penalties accrued Income Tax Examination, Penalties and Interest Accrued Anti-dilutive weighted-average shares related to stock award plans (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Summary of Revenue Recognition for Revenue Category Summary Of Revenue Categories [Table Text Block] Summary Of Revenue Categories Total current income taxes Current Income Tax Expense (Benefit) Long-term investment in sales-type leases, net Long-term investment in sales-type leases, net Net Investment in Lease, Noncurrent Increases related to tax positions taken during the current period Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Increases related to tax positions taken during a prior period Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Prepaid commissions Increase (Decrease) in Prepaid Commissions Increase (Decrease) in Prepaid Commissions Estimated useful lives of intangible assets Useful life Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Gross profit Gross Profit Property and equipment, net Total property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Net income Net income Net income Net Income (Loss) Attributable to Parent Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Equity component of convertible senior notes Convertible senior notes, equity component Debt Instrument, Convertible, Carrying Amount of Equity Component LIBOR London Interbank Offered Rate (LIBOR) [Member] Trade Names Trade names Trade Names [Member] Internal Use Software and Software Development Costs Internal Use Software and Software Development Costs [Member] Internal Use Software and Software Development Costs [Member] Current Fiscal Year End Date Current Fiscal Year End Date Operating expenses: Operating Expenses [Abstract] Percentage of shares eligible for time-based vesting Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Percent Eligible for Time-based Vesting Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Percent Eligible for Time-based Vesting Other Adjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment Transfers from prepaid expenses to property and equipment Transfers Between Prepaid Expenses to PP&E Transfers Between Prepaid Expenses to PP&E Customer fund liabilities Customer Fund Liability, Current Customer Fund Liability, Current Intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Long-term deferred revenues Long-term deferred revenues Contract with Customer, Liability, Noncurrent Tax benefit realized from stock options exercised Income Tax Expense (Benefit), Awards Exercised Income Tax Expense (Benefit), Awards Exercised Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Software development for external use Payments for Software, For External Use Payments for Software, For External Use Risk-free interest rate (maximum) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Convertible Debt Convertible Debt [Member] Estimated Useful Lives of Assets Property and Equipment Property, Plant and Equipment [Table Text Block] 2016 Repurchase Program 2016 Repurchase Program [Member] The 2016 Repurchase Program [Member] At the market offering, net of offering costs (in shares) Stock Issued During Period, Shares, New Issues Gross carrying amount Finite-Lived Intangible Assets, Gross Lessor, Lease, Description [Line Items] Lessor, Lease, Description [Line Items] Aggregate principal amount of Notes that must be outstanding and not subject to redemption if the Company redeems less than all of the Notes Debt Instrument, Redemption, Face Amount Of Notes That Must Be Outstanding Debt Instrument, Redemption, Face Amount Of Notes That Must Be Outstanding Sales of Accounts Receivable Transfers and Servicing of Financial Assets, Transfers of Financial Assets, Sales, Policy [Policy Text Block] Components of Sales-Type Lease Receivables Schedule of Receivables with Imputed Interest [Table Text Block] Accumulated depreciation and amortization Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Short-term unbilled receivables Contract with Customer, Asset, after Allowance for Credit Loss, Current Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued Preferred Stock, Value, Outstanding Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Basic (in shares) Weighted-average shares outstanding — basic (in shares) Weighted Average Number of Shares Outstanding, Basic Spread on variable interest rate Debt Instrument, Basis Spread on Variable Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Plan Name [Domain] Plan Name [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Revenues Revenue from Contract with Customer [Text Block] Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Fair value of long-term debt Long-term Debt, Fair Value Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Inventory Inventory, Policy [Policy Text Block] Provision for (benefit from) income taxes Total provision for (benefit from) income taxes Income Tax Expense (Benefit) Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Cash, cash equivalents, and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Operating lease renewal terms Lessor, Operating Lease, Renewal Term Relationship to Entity [Domain] Title of Individual [Domain] Local Phone Number Local Phone Number Pro Forma Financial Information Business Acquisition, Pro Forma Information [Table Text Block] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Vesting One Year from Commencement Date Share-based Payment Arrangement, Tranche One [Member] Intrinsic value of options exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Change In Debt Issuance Costs, Net [Roll Forward] Change In Debt Issuance Costs, Net [Roll Forward] Change In Debt Issuance Costs, Net Revenue from operations since the acquisition date Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Principal amount Long-term Debt, Gross Decreases related to tax positions taken during the prior period Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Deferred revenues, net of cost of goods sold Total contract liabilities Contract with Customer, Liability Schedule II Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Weighted-Average Grant Date Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Fair value of awards vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Amortization of debt issuance costs Amortization Amortization of Debt Issuance Costs Non-cancelable purchase commitments expected to be paid within the next twelve months Purchase Obligation, to be Paid, Year One For Calendar Quarters Ending September 30, 2020, December 31, 2020 and March 31, 2021 Debt Instrument, Covenant Period 1 [Member] Debt Instrument, Covenant Period 1 Restricted cash Restricted Cash Accumulated Earnings Retained Earnings [Member] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Net minimum lease payments to be received Total future minimum sales-type lease payments Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received Award Type [Domain] Award Type [Domain] Maturity Schedule of Future Minimum Lease Payments under Operating Leases Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block] Calendar Quarters Ending Thereafter Debt Instrument, Covenant Period 2 [Member] Debt Instrument, Covenant Period 2 Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Commitment fee rate on undrawn commitments Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Commitments and Contingencies Commitments Contingencies and Guarantees [Text Block] 2009 Plan 2009 Plan [Member] 2009 Plan [Member] Treasury stock at cost, 9,894 and 9,145 shares outstanding, respectively Treasury Stock, Value Weighted-Average Remaining Years Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Remaining Term [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Remaining Term Net Income Per Share Earnings Per Share [Text Block] Summary of Allowance for Credit Losses by Asset Type Credit Loss, Financial Instrument [Table Text Block] Credit Loss, Financial Instrument Current liabilities: Liabilities, Current [Abstract] Vested and expected to vest (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Interest income on sales-type lease receivables Sales-type Lease, Interest Income, Lease Receivable Recently Adopted Authoritative and Recently Issued Authoritative Guidance New Accounting Pronouncements, Policy [Policy Text Block] Proceeds from revolving credit facility Proceeds from Lines of Credit Discount Rate Measurement Input, Discount Rate [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] EX-101.PRE 18 omcl-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 19 omcl-20201231_g1.jpg begin 644 omcl-20201231_g1.jpg M_]C_X 02D9)1@ ! 0$ > !X #_X1$017AI9@ 34T *@ @ ! $[ ( M 7 (2H=I 0 ! (8IR= $ N 0VNH< < @, /@ M &UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E M;&5M96YT&UP M;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG M=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL> M)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@("@D*% L+%"H< M&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*O_ !$( I8$?P,!(@ "$0$#$0'_Q ? !!0$! 0$! 0 M 0(#! 4&!P@)"@O_Q "U$ " 0,# @0#!04$! 7T! @, !!$%$B$Q M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4 ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C MY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! 0$! 0$! 0(#! 4& M!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< 0(#$00%(3$&$D%1!V%Q$R(R M@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JB MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR M\_3U]O?X^?K_V@ , P$ A$#$0 _ /I&BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH SO$&KQZ#X>OM4F&Y;6%I G=VQ\JCW)P/QKG/ ,VJV$M[X?\27DMYJ$ M*17J33,2SQRK\RC/995D4>@VU+XL;^V/%&@>&U^:-I3J5ZO_ $RA(**?]Z4I M_P!\&E\7-_8OB+0?$H^6*.?^SKULX_M^QUU%62';"1*=J2*O1&#E0< 9#'/08?-I M0<#$WBO2K M+PUI::[X?MHM-NK.YA+K:H(DN(VD5'CD5,K;P_YTD-C!:?;KU8G*-.&[LT$3*XZ;]N-ZYZJV0031=]!W?0Z*BO/=^QO4 M5PG@K1XM?T(:AXHD;6[I9YK9?MJAHT$,K1 JF-NX[-Q;&23Z8%78($\.?$*R MT[3/1MF X/HYNXK6:TOI)8[>ZDA#LI@VD[&!.-S8^IKK*X[Q)>Q6 M'Q)\,33K.R_8M0&(('F;K;_PH"?QQ1+84]ON_,V)/"]FR$1WFK1/_"ZZK<$J M?7#.0?H017*ZOK>JP?#WQC97=Y)_:NB0NBWT/[IY4:,/'+\N-K8;!Q@94D8S MBNJD\3VRQDV]AJUQ)_#$NF3H6/IN=54?B0*Y'Q'I=[:_#/QIJFKJL=_JL$DS MPHP80(L02./(X)"KDD<9)J96MH1.UO=/18CF%">3M%.K M_!^C/:*=3LXM4N M74&2ZOD$LC'U!(^4>@7 '& ,54\)M,DWB#0)+F:2+2[P0VTK/ND2*2%)%7<> M25+D G/ 'I57?4TN^IU5%<[/X;\*Z=:&75K2QD'\=UJ965V/J9),G/XUD>#- M06[T3Q/;VTDSV-E?S0V?G[MRQ&%' &[G;EVV_P"SCMBB^MF+FL[,[FBN#^'_ M (4TJX^'NA7&K6D.IW$VGP-YEY&)-B[!M10>% &!QC.,GDDTZ71+:_\ BO<6 MLS2+90:#:@VT;E5EQ/.%#$YWGD>V, =L4[N]A\SO:QO45ROA)IY[+7M%N+RYD73K^2SAN&DS*(FC1U M^<\EE$F 3D_*,YJ:Z\.^$=,L]VJV>GA3UN+_ &O(Y]3(^6)_'-%]+CYFU:K.=T-M TN%YWX' 'J2< ? M6G?N/FWN7ZYOXA7,]G\/]7GLYY;>9(04EA-_>GD)=_P!3CZ 52^)AQ\-=:XS^X' _WA2?PBDWR-FE_P (S8_\]]4_ M\&UU_P#'*LV.D6VGS-)!)>.S+M(N+Z:88^CN0#[]:K?VS??]"UJG_?RU_P#C MU)J-S+=>%=4>>QN+)A:RCRYVC+'Y#S\C,/UHT#3L;%%<5X-\):3/X)TB;5K. M'4[F:P@9IKN,2$#8,*N?N@# &.F>3S6_<^&M+O+GSM0A-VB(J1V]PY>&, = MHS\N?<@GWH3;5QIMJ]C6HKS^XNM&TOXA>';7PL8(3>3307T5B,0,HA=U#A?E M$@9 1_%C=V-3+I$.K_%C7$O7D:UCTVR+VRMM28EI\;\"M!6V MV76GQ7LQ'SW=T/,G<_WO,/S _0C';%.[O8?,[VL;U%<%:^([GP_X!\133SM= MRZ%=SVEM+=/EG VF+>W?'F*I8\G&3S4MC%X(6P0:SJVC:M?,H-Q=WMS%*\C] MR"3\HST"X &,=*7,+G.XHKS1537=,\4>&M(U!-173U@O=)G$_G&)SEXX]^23 MMDB.,G.U@*[*#Q-:2>"5\2O\MK]B^UN.A ";BOU'(^M-2N-33-FBO/\ X>P7 MN@ZM=Z3JTK//JMLFM?,<[9G.VX0=\!O+/_ ZT[^9+_XA(9N;/P[9-=RMC@3R M@JOXK&KG_MH*2EI<%.ZN=;17(>&=&M_$.B6^N^)K:/4+O4HQ<+#=+YD=M&_* M1HC9 PI ) R3DFGK$/"_C+3K.R=ETO6%EB%H6)2WG1=X,>?NJR*X*C R 1WR M^;J',[7.LKG/%]U<6TOA\6T\D(FUF&.3RW*[T*OE3CJ.!Q[5B>'- L]5\6>+ M9]407D$>K!8K68;HE;[/#ERO1B1@@;RX M4"*#L?H!P.E)MM$N3<;G8T5R-S?R^-+VXTO1;DQ:/;2&'4;^%\-,XZP1$=.O MS/VS@PLXK6RA2"WA0)'%&N%11T %4G10!PGAS3[CQ%KFL>*8]3N[)+J8V=GY"1$- M;0DJ&_>(W#/YC<8X(K5USPA/KNA7FF7GB'4I(;F(H5>.VQGL?EB!X.#P0>*Z M&UM;>RM8[:R@CM[>)0L<42!%0>@ X J6I45:S(4%:S/-YM9EU#P;X7UO5,I) MHVK(-7)!_RG-=[=ZK8V.GF^N[N*.UP")2W#9Z >I/8#D]J MEAL[:W\[[/;Q1>>YDFV(%\QR "S8ZD@#D^E5+;P]HME<'(EBM45 MA^(&:$F@46CSR)_-^ 4=RJ/LBO5N7!4AEC34/,RJ2?I7J$=S!-%%+%-&\ M0,TDF@C%HP_!E"\\,7;+%>65U/) C'!GMY)&D21 M?[P ?:<="ISVH\531ZSK&D^'[,B:=+Z&]N]AS]GAA;>"WH6<( #UR3T!KH[[ M3;'4XA%J5E;WD:G(2XB60 _0BEL]/L].A\G3[2"UBSG9!$$7/T I\KM8.5VY M3G=+_P"2K>(O^P;8?^A7%.^(_P#R(5]_UTM__1\==&EK;QW]PQPL4J2%XPQZ*&#N ?4 =Q6QKVNVN@Z3)=W#!W M(Q;P*?GN)/X40=R3CI]:T9(TFC:.5%=&&&5AD$>A%4K+0=(TV;SM.TJQM)<8 MWP6R(WY@46:V'9K8XR;2IM#\)^!].NR#<0:I;";;TWE)"V/Q)KT*HI[6WN3$ M;F".8PR"2/S$#;''1AGH>3S[U+0E8(QY3E?AQ_R*+?\ 82O_ /TKEI=7_P"2 MH^&/^O'4/YV]=);6MO9P^59P101[F?9$@4;F)9C@=R223W)H>UMY+J*YD@C: MXA5ECE9 60-C< >H!VC/K@>E'+HD+E]U(YCPA+'H]]J7AJ[80W,=[/=VBNHH\8S)J]SI_AFT82W,]Y!<72H<^1!%(LI9O3)15'J3 MQT-='>Z=9:G"(=2L[>[B!R$GB61<_0BBRTZRTV(Q:=9V]I&3DI!$J GUP!1R MNU@Y7;EZ'-QRIIGQ7O/MKB)=7TZW6T=S@220O+OC![MB13CJ1GT-0?$_5;.V M\(RV,LR_:[F6#RX5^9B!,A+$#HH]3QR!U(KK;RRM=0MC;W]M#=0MR8IHPZG\ M#Q5:+0-'@MI+>#2;&."4@R1);(%<@@C(Q@X(!_"DT[-"<79I$D]]ISWW]E75 MQ;FYEB\P6LK#=(A)&0IZC(Q_^NN4UO3[#PWJ^DR>&$CL+^ZOXHY+&U;9')77\B*98Z/IFF,S:;IUI M9EQAC;P+'N^N!3:N-ILN5RVK_P#)4?#'_7CJ'\[>NIJ)[6WDNHKF2"-KB%66 M.5D!9 V-P!Z@':,^N!Z4VKE25T2UR_Q+_P"28>(O^P?+_P"@UU%17-K!>VLE MM>01W$$JE9(I4#*X/4$'@BAJZL$E=-#H?]2G^Z/Y5PHO+[3[SXCW>DP>??02 M1R6\>,[G%C$1QWY[=^E=Z!@8' J**UMX)YIH8(XY;A@TSH@#2$ *"Q[D <] M@!2:N*4;V,'1+30(M'@UL3P7>Z(2MJMTX=VSR27/W1D]!@#I@8K(\)7D-\OC M>>W+;)-2=EWH4)4VL.&P><'&0>XY%=1_PCFB?;#=?V/I_P!I+;C-]E3?GUW8 MSFKBV=JDT\J6T*R7.//<1@&7 P-Q[X''/:ERLGE>AA_#[_DFOAO_ +!=O_Z+ M6H+?_DK^H?\ 8"M?_1]Q72V]O#:6T=O:0QP01($CBB4*J*!@ < =J06MN+ MQKL01BY:,1-,$&\H"2%+=< L3CW/K3MHA\NB78YOXE_\DWUG_K@/_0A74U%< MVMO>VSV]Y!'<02##Q2H&5A[@\&I:=M;E6UN>="_O=+TKX@WNEJQN8=4W*43> M4'V>WW.%[E5RV/:NHLK7P[I6G+JR26K1F,.=3N)1(T@Q]XRMR?SQZ5L0VMO; M23/;P11/._F2LB!3(V -S8ZG R>P%4HO#FB077VF#1]/CN-V[S4M4#Y]<@9 MS4J+1"BT<7I-B?%7@#Q=9V):.2]U&\\CS4*%6)#(64\C/RGGL:[+P]KL&OZ6 MEQ'^ZN4 2[M7XDMIP%5;W0='U*<3:CI5C=RJ,"2>V1V'XD4*+0U%HD$ECK%E<0I)#=V[[H M)@C!E/&&4D?7!K@=-EFU;^R/!EVYEETBZ;^TBPSOAMBI@)_ZZ;H7Y_NM7>7% MS::)8QXMI5@4[$BL[1Y=O!/W(U.!P><8_.LKPUITO]I:KK]]:?9;K5)$"1,H M#I!&NV,-C^(_,Q';V MSV]Y!'<02##Q2H&5A[@\&J:NK%R5TT2UGZ__ ,BWJ7_7I+_Z :T*;)&DL;1R MHKHX*LK#(8'J"*8V9'@[_D1=!_[!MO\ ^BEK)M%@U[QEK=EKX$GV&2,6>GRG M,;0F-6\[9TR]3@G%7]+_ .2K>(O^P;8?^A7%;Z:3IT<$$,=A:I%;R"6&-85" MQ..C*,<'D\CUJ9+6WCNY+I((EN)55))@@#NJYV@GJ0-QP.V3ZTN5WN+E=[_U ML\MV@O((YX6(+1RH&4X.1P>." ?PJ6J MMK.;&SQ]IDU>9H QX,BI$R ^VY178Z%KEIK^FK=6C;7'R MSV[\26\G>-UZJP.1S]>E78+6WMC*;:".$S2&64QH%WN0 6..IX')]*JWN@Z/ MJ5P)]1TJQNY@,"2>V1V ],D4DFB5%K8FM-1L[]YTLKF*X-N_ER^6P;8V,X)' M?VKSV1=NLR^ <$QS:HM\%)_Y<6)G8?3SE:/'HPKT>"WAM85AMH8X8E&%2-0J MCZ 4TV=L;X7AMXC=+&8A/L&\)G.W=UQGG%#5PE%LY[QD1ITFD>(;]W(3[*2CG_&K[4;G<'\02R7+$]5B<;(A^$2I^.:Z:YMH+R MUDMKN&.>"52DD4J!E=3U!!X(]JHKH+[1],U0H=3TZTO"GW3<0+)M^F0<5/;6MO96ZP6 M<$5O"OW8XD"J/H!Q19VL'*[6.:\&_P#(<\8?]AK_ -MH*@^(UC'J5IH-E-)+ M''/K4".T+E&P5DR PY&>G%=9#:V]M),]O!%$\[^9*R(%,C8 W-CJ< #)[ 43 MVMO!QU.::5AI6>A-1113*"BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BJ]^\R:;]45X+_;WQ:_YXZK_P""U?\ XBC^WOBU_P \=5_\%J__ !%'UJ/\K^X/ MK\?Y)?<>]45X+_;WQ:_YXZK_ ."U?_B*/[>^+7_/'5?_ 6K_P#$4?6H_P K M^X/K\?Y)?<>]45X+_;WQ:_YXZK_X+5_^(H_M[XM?\\=5_P#!:O\ \11]:C_* M_N#Z_'^27W'O5%>"_P!O?%K_ )XZK_X+5_\ B*/[>^+7_/'5?_!:O_Q%'UJ/ M\K^X/K\?Y)?<>]45X+_;WQ:_YXZK_P""U?\ XBC^WOBU_P \=5_\%J__ !%' MUJ/\K^X/K\?Y)?<>]45X+_;WQ:_YXZK_ ."U?_B*/[>^+7_/'5?_ 6K_P#$ M4?6H_P K^X/K\?Y)?<>]45X+_;WQ:_YXZK_X+5_^(H_MCXM2<^5JHQ_TXJO_ M +)1]:7\K^X/K\?Y)?<>]45X+_:GQ:_YYZK_ . :_P#Q-']J?%K_ )YZK_X! MK_\ $T?6E_*_N#Z]'^27W'O5%>"_VI\6O^>>J_\ @&O_ ,31_:GQ:_YYZK_X M!K_\31]:7\K^X/KT?Y)?<>]45X+_ &I\6O\ GGJO_@&O_P 31_:GQ:_YYZK_ M . :_P#Q-'UI?RO[@^O1_DE]Q[U17@O]J?%K_GGJO_@&O_Q-']J?%K_GGJO_ M (!K_P#$T?6E_*_N#Z]'^27W'O5%>"_VI\6O^>>J_P#@&O\ \31_:GQ:_P"> M>J_^ :__ !-'UI?RO[@^O1_DE]Q[U17@O]J?%K_GGJO_ (!K_P#$T?VI\6O^ M>>J_^ :__$T?6E_*_N#Z]'^27W'O5%>"_P!J?%K_ )YZK_X!K_\ $T?:_BT> M=NJ_]^5_PH^M+^5A]>7\DON/>J*\%^U?%K^[JO\ WY7_ H^U?%K^[JO_?E? M\*/K2_E8?7E_)+[CWJBL'P0^K/X.L6\1^:-2/F>=YRX;_6-MR/\ =Q6]75%\ MR3.Z,N:*EW.>\>W,]GX#U:XM)I()HX,I+$Y5E.1R".13CXKTG3(K6TU.^*7C MVD<_E^6[O(IR,@ '<!D\9J#XC?\DZUG_KA_[,*S=,16^*5JS*"5\,Q%21 MT_?&L)2:J:>7ZG-.--!L[Z>SFO6-S;OLEABMY9'4X!Z*I.,$<]*FOO%.CZY%8OA%%_X37Q@^T;_M<0W8YQY?2L[25UQO'GB@:??$ M2+VW>1S%L&PJ5=?EZ_C2]I*R\W_747M:ED^[:^Z_GY'80^(M(N-%?5HK^$V* M9WS$X"'.,$'D')'!YYJM9^,-$OM0BLH;MUN)L^4D]O+%YF/[I=0&_"L%5E\& MPZSJFKR6M_+J-U 4M+2,QH)C\O\ $6QDX8D^A]JK^+%U?^T?"\NKW5FF[6X MEI;(>.&RQ=CEL=.% YH=220.M-*_7K]_K_F=/?>+]$T^]EM+B[=IX?\ 6K#; MR3>7QGYBBD+QZTR34=+O=:T.:+5K@/<).UI! Y\F[ 4;BX P=HY&2,$GK5#^ MQ]8T34-2O_#,]E>6U[.US-9W6582XPP25>!G'1A@'\:S%UB#7_%?@35+6)H8 M[J*_?RVZJ=B@CWY!Y[]:'.6S_K4)5)+27=?FEOE;M<=XQQ_P ) MAX/SC=]NDQZX\O\ _578UK"3;:?0Z*MTOT7ZGI.E^)=)UFYDMK"Y+7$:[WAEA M>)PO3=M< X]^E5)_'/AZW9Q)?L4C8J\R6\KQ*0<',BJ5Z^]4FT767\4:9K.L MZAI@%@LR[;6V>-I49.02SMG&-P'L:HWNJ:EX@\!W^H6)L]+TB2TF,8=#)-(@ M5AZA4S_P+%:..8=9TVV74S(NH332)B*SF\KB1@OS[2O0#^*L;0CG7_ .? M^@&__HM*W/A?_P B!:#N)K@$>G[YZB$I.>G];$4YRE4T>]_RB9G@SQOI]KX0 MM_[6Z62;S9&CEG*#S6V[V .WC'4CCVKL[K6M-LM)74[F\B2R9599MV5< M-TQCKGMBN<^&$4;?#VW5HU*R37&\$?>_>N.?7CBN5\.,&T?X=&^/^A>==!B_ MW?.^80Y]\Y HC.481\U_E_F*%6<*<4^J7Z+7[ST2P\4Z/J+3+;W3J88C-)Y\ M$D.$'5OG49 ]15>/QQX>EN(HA?,OG.$CDDMI4C_2N$\>RZS>_#Z:\OI;*RM7:!X[.$%Y'S(F 9"0.!SA5 M[=<57A6[B"EH$@DD\U2ST^XM(+N;9 M+>2^5 @1F+MC.. <# ZGBLF7QWXOO65INI6 MWB7Q8VNJQ.FZ/8+Y1Z_O95#N?J$VC\:JZOJ.IZ]\.=1U&W-GI>DR6$KQ1%?, MED3:<*3D*F[I@!CSZU#J.S<3.5:5FX^=OE\^YJW=].?BEI5M#=2?9)=-ED,2 MR'RW.X8;'0G'>M[3]8L=5T=-4L)_-LY%9EEV,N0"0>" >H/:N(T;GQEX1_[% MW^BU=^'[JOPAMMS*/*@G$F3]PAWSGTHA-\S^?Z"I5&Y-=[O_ -)_S.B_X2;1 MQH,6LF]5;";'E2LK N2< !2-Q.1TQFC2_$NDZS_2O-=)%\;'X?"UEM8@8;GRGNXV>,3=L@,O.,[>>N:[-="UN?Q9I6K:M? MZ9FR$J!+6W>-IE=<%26=LX(##Z&B-22 M>-[#XAS>,;Z3PX^H#33Y?DB&Y"+_ *M=V!N'\6:P/[+^+7_/35?_ ,7_P"* MKEEB&FUR,X98MQDX^S;MY'O5%>"_V7\6O^>FJ_\ @8O_ ,51_9?Q:_YZ:K_X M&+_\52^LO^1D_79?\^Y?<>]45X+_ &7\6O\ GIJO_@8O_P 51_9?Q:_YZ:K_ M .!B_P#Q5'UE_P C#Z[+_GW+[CWJBO!?[+^+7_/35?\ P,7_ .*H_LOXM?\ M/35?_ Q?_BJ/K+_D8?79?\^Y?<>]45X+_9?Q:_YZ:K_X&+_\51_9?Q:_YZ:K M_P"!B_\ Q5'UE_R,/KLO^?J*\%_LOXM?\]-5_\ Q?_ (JC^R_BU_ST MU7_P,7_XJCZR_P"1A]=E_P ^Y?<>]45X+_9?Q:_YZ:K_ .!B_P#Q5']D?%J3 MY?,U4?\ ;\H_]GH^LO\ D8?79?\ /N7W'O5%>"_V#\6O^>VJ_P#@R7_XNC^P M?BU_SVU7_P &2_\ Q='UF7\C#ZY+_GW+[CWJBO!?[!^+7_/;5?\ P9+_ /%T M?V#\6O\ GMJO_@R7_P"+H^LR_D8?7)?\^Y?<>]45X+_8/Q:_Y[:K_P"#)?\ MXNC^P?BU_P ]M5_\&2__ !='UF7\C#ZY+_GW+[CWJBO!?[!^+7_/;5?_ 9+ M_P#%T?V#\6O^>VJ_^#)?_BZ/K,OY&'UR7_/N7W'O5%>"_P!@_%K_ )[:K_X, ME_\ BZ/[!^+7_/;5?_!DO_Q='UF7\C#ZY+_GW+[CWJBO!?[!^+7_ #VU7_P9 M+_\ %T?V#\6O^>VJ_P#@R7_XNCZS+^1A]&_B=X?\0R"W:?[ M!>9V^1;?V#\6O^>VJ_^#)?_BZ\Y6*66X$2(TDK-M"J,ECZ M>]8U,7.+5HV]3GK8^I%JT&O7J?8%%>8?#/1_'5@L1U:Z%OI6.+2\!DEQ_LC. M4_$_\!KT^NVG-SC=JQZ=&HZD.9JWJ%%%%:&H4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %; M4M.M=7TZ:PU"+SK:==LB;BNX?4$&HHM&L(-4748H-MVMJ+02;V.(@VX+C..O M?K[U>HI65[D\J;NT4TTJRCUB754AQ>RQ"%Y=[T<<\B1%NN3&&"_I6]12<8O="=.#W13L]*LK"\O+NTA\N>^<27#;V.]@ M, X)P./3%5M4\-:3K-S'V:U:*.5-6L-PBU9K0 MR$\+:+'I-QIHT^-K2Y.Z9)"7,AXY+$DD\#G.>*KQ>"/#\4L,HLG:6"598I9+ MF5W1E.1AF8G&>W0^E;]%')'L3[.'9&%<^"]!N[F:>6R=7G8O,(KF6-9&/4LJ ML%.>^1S5T:#IBW.GSI:*DFFHZ6FPE1$K@!@ #@Y '7-:%%')'L/V<%LD4],T MFRT:T-KIL/DPF1I"N]F^9CDG))/6LG4=!LK+PPNE:?H"ZE9^:2;,SA2,DL65 MG/7M=%10XIJP.$6K6//].\(RW'BG3-0&BR:1;Z>6D9KJ]^TS3,1A5!W MMM49)Z_A7H%%%*$%#85.G&FG;J4M/T>QTK1TTNP@\JSC5E6+>S8!))Y))ZD] MZKGPSH[:!%HKV*/I\./+A=F;9@Y!#$Y!YZYS6K13Y8[6*Y(VM8R-.\+:1I5V M+JSMG^T*I599IY)F4'J 78X_"JW_ @OAS>Y_LT;'8N8?.D\H,>XCW;0?<"N M@HIQ/LX6MRHS+;PYI5I/836]L5DTZ$P6K&5SY<9&"O)YZ=\U#!X2T2VU0 MZA;V9BG,IF(2:01ES_%Y>[;GWQ6S13Y8]A^SAV*FEZ59Z+IZ6.F0^3;HS,J; MBV"Q+'DDGJ355/#&C)X?30_L$;:;']V!R6V\DY!))SDDYSFM6BCE6UA\D;6L M8]GX4T:Q\[R;1G\^(PR?:)Y)MR'JOSL< X'%5#\/_#1MC ^G,\1&U5>YE;RQ M_L9;Y/\ @.*Z.BER0[$^RIO3E7W%.'2;*WU:?4XH=MY<1K'++O8[E7H,$X_2 MH=6\/Z7K9A;4K42R0$F*57:-TSUPZD$?G6E15G:#8M9Z3:K;V[.TA0,6 MRQZGDFLT> _#8#J--'EOD^3Y\GEJ3U*INVJ>>H Q70T4N2+5K$NG!I)I:&;; M^'],M;NSN8+8K-96WV6W]DN3IX#RR>9(BRN(W M;KDQAMA/U%;M%')'L'LX/HC*/AG1VT"+17L4?3X<>7"[,VS!R"&)R#SUSFFZ M=X6TC2KL75G;/]H52JRS3R3,H/4 NQQ^%:]%'+'L'LX7O8****HL**** "BB MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M "L/P_X-T/PRI.EV2K.WWKB3YI&_X$>GT&!6Y12<4W=DN,6TVM@HHHIE!116 M%KOB_3/#]PD%YYTDSKN\N% 2H]3D@=OK4RDHJ[(G4C37-)V1NT5C>'_%%EXD M^T?88IX_L^W?YRJ,[LXQ@G^Z:J>)-5O;#Q/X3M+2;RX-0U"6&Y38I\Q%M9I M,D9'S(IXQT]*(R4E=!"<9QYHNZ.DHKB4^)]B^F-JO]AZTND13-%/J+0Q"* J MY0LP\S>5!&2RJP Z]#CLKA97MI5MI%BF9"(Y&3<$;'!*Y&<'MD519)17$:D^ MM^%]5T.1_$MSJRZCJ"6F@H%,T\ZW$D2R(=P"Q@;V7C<3C(*U;M;GQ1XETK5==TC7 MFL6M[NZ@L-.^RQ/!(()&CQ,2ID)=D)^1UP".N.0#T"BLWP[K,7B+PSINLVZ[ M(]0M8[A4)R4WJ&VGW& M8_0CKST% '245R=E\0]/O);&3^SM2@TW4IA!9:K-'&+>X=ON 8FV\WE3:D8HA"GS;=^TR"4IG^((1CGIS0!U%%^ M,8H-:N=+TS2-3UFXLPIO#8K%MMBPW!6:21,L5P=J[C@CCD5SGACQO<7>F:%= MZO=WC2W=KJER\*VL:K(D$ZJ-_1D95( X.6W<@4 >C45R%A\1;2]CTNYDT36 M+/3]5>..UO[J&-8B\@^1642%UR3@$J%)Q@\BG7WQ"M;2/4KBUT75]1L-+:1+ MN^M(HS$CQ@[U :170AECN(EE0..0& (S M[\UP/A3XC3/X1TJ^\0:=JDD5Q(()]7\B)8%D:4HN5#!]N[:NX)MY'/>@#T6B MN;U3QI!I^I7=E9Z3J>K2:>BR7S6$<96V##< V]U+-M^;:@9L$<6ZW,-7U/4_#L^BRR1 M65_!J!G@FB4.)( !M;.2"KA@<'!]QBL>3X@Z[)\(++Q!-I=]IUTT>FR/>&." M2.Y$L\*R>5&CN_S*[8#*#SQ@T >HT5@:9XMCO]>_L>\TK4=)O7MVN8$OECQ< M1*RJS*8W<9!9E7.H/+'"+Q8MN]$#[=R2,"2NXC:3]QLX[ MQ:EX\T[3M4N].6SOKNZMYH;98[9$/GSRHT@B0LX&X(A8[L CF@#IZ*XG7_& M>J65GIDUMX?U*VN)M6AM);*X6#S)HV5S\C"4QY^4<[QCO6E=>,?LOV*V?0=5 M?5;Q'D32H_(:=(T8*7=O-\I5Y7^/G('7( !TE%*QU*>:^O9+ M!;.* &>&XC1V:-UW<'Y",@D<@YV_-21_$$2ZC-I:>&-=.KP*)9-.\N#>L1Z2 M>9YOE%200/GR2",<&@#KZ*Y5?'^GW&F:;*@<$=\HS*1SU5B* +M%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>:^.OC M)IOA>ZDT[2H1J6HQG$@W8BA/HQ[GV'YUL?%/Q3+X4\#7%S:/LO+EA;V[#JK- MG+?@ 3]<5\JLQ9BS$LQ.22?5H:!;Q7?B73+:Y020S7<4&H15^1'DK$5Y.W,SL?^%W^-?^?NU_\!5H_P"%W^-?^?NU_P# 5:X[ MQ!;16?B;4[:V01PPWOS3.Z_X7?XU_Y^[7_P%6C_ (7?XU_Y^[7_ ,!5KCU\/:N^KII::?.U M](BNMN%RVTKN!/H,'/-2ZKX7UC1+=+C4;,I [;!-'(LB;O[I920#[&CV&&O; ME0_;8FU[LZO_ (7?XU_Y^[7_ ,!5H_X7?XU_Y^[7_P !5KG/$FGVMEIWAZ2U MA$;W>F+-.03\[^8XS^0'Y4>#]/LK_6)WU:$S65G93WR^"_'VD>-[)I-.=H;J( S6DI&^/W]Q[C]*^2 MZT_#FOW?ACQ!:ZM8,1);N"R@\2)_$I]B*PQ& I3C[BLS:ACJD)>^[H^R:*@L M;R+4-/M[RW.8KB)94/J&&1_.IZ^:V/HMPHHHH *\P\>>&]3E\127]G:374-R MJ_ZF,L4(4+@@<_PYSTYKT^BLJM-58\K.?$8>.(AR2.$^&FGWMA_:?VZSGMM_ ME;/.B9-V-^<9'/45H^*K.YN/%O@R:WMY98K;4YGG=$++$IM)U!8CH-S 9/<@ M=ZZJH9KRVMYH(;BXBBEN7*0([A6E8*6(4'J=JDX'8$]J=."IQ4450I*C35-= M#S:32=1/[.NLZ:-/NOM\EKJ"I:^2WFL6FE*@)C)R""..IJ[4,5W;37$UO#<1236Y431HX+1Y&1N'4 M9'(S6AL>?^%+ZP;5(-6U^/7;WQ%=@1>;-H%\D%D'(S%%NA"QH#P7)R<98U)H M^I7O@W0K_0)-'U.[O[>YNGTTVUE))%=))(\D1,J@QQXW[6WLN"I/(()]!9E1 M2SD*JC)). !4,M]:010RSW4,<<[K'$[R "1F^ZJD]2>P'6@#@]1\,WFD?"WP MMH4$,EW/IU[I*S>0A?B.XB,C\?PC#$GL!5?7[.U@N-7M-&'BQ9KZ1WETNSLW M6TNI6&"WVAHL1JQY8I*O4G&37I=% '+>$3:^&[32/ [M*]_8:/%,TGEGRW52 M(V(;IG=V]"*H^,='O=6\9:2EG'*L;Z-JMLUT$)2%Y!;A-S#@$X)'KM/I78"R MMAJ+7XA7[4T0A,O?8"2%^F6)J>@#R72-+EU#1]'T+7=0\9QSVSVOF:<=*@6W MB>%T88N4M0AC5D!RLF2H]3BJ/BT:IKG@_7+76-/\2WVN":7R;&VM)EM(HUE_ M=LC(!',-@#8+.Y).%R ![12,RHI9R%51DDG H X?3KV7PCXC\10:EIFI7$. MI7XO[.ZLK*2Y64-%&AC8QJ=C*T9^_@;2O/6N5T;2-6.G>'6FTB^@=-*UY98Y M+=@T3RSQM&C>C, <#O@XS7L2.LD:O&P=& *LIR"/44M 'GFH:9?O\*?"-HEE M<-@ MZFL2^\#:%J5Q-+?Q7MPD[EY;:34KDV[DG)S!YGED9[;<4 7_ V"/"ND@C!% ME#D'_<%<$NDZC_PS_;:=]@NOMR^3FU\EO-&+I6/R8STY^G->G@!5 48 X ': MJNHZG8:19->:M>VUC:H0&GN95C1<],LQ H \Y>SU'0?%?B'[7JGB?3[?4+X7 MEM)HVEQ7D4P,2*0Q^S2NCJ4Q\Q"X"D=Z+>WFT*33]#G'B:+PW#I<8LQ96LC3 M33%WWI.\";HBJ[-N-B\MD\<>E6EW;7]G%=V-Q%5[:#3]02694)2-F:VVAFZ G:V >N#Z5-XSATRXT^V36=/U.YB2?S([G3(Y7 MFM) IQ(/*_> X)&5!ZD'@UT=% 'E5\NLR^!];U*:6^N(= O(]4T6YU6W\BYD M2% \B.I53@CS8PS*&(8YSP3>LM*M?^$ M[KQ3I>I7%QJUZ=4N'T^.1I[*9\M M&P\H^8"B[8\H">.1@FNVUC0-/U^&.'5HY9X8VW>2+B1(Y/9T5@)!QT8$>U:( M&!@<"@#R:8ZZ\$5T\6M:IHNEZY:75J]W8LMZ8=C++^ZVK(ZJS#&5WD;NN 3= MUO[9-XUM_$UK<^)-.TJ[TP6ADT[2A)/%)',[?O()8))0K!^"J#[OS=17IE0V MEW;7]G%=V-Q%'+^P_MR^2X\07%[=W M.IV@A=6A(0?,JDL?<5TUM:7*_%[4KQK>46KZ%:1+.4.QG6>X)4 M-T) 921UP1ZUU-% 'EUIIUI#I$Z^(])UR-AX@U2ZM;W3K::R[MBA2Q('<\8&?6J=^7T MR-7O?$%U&')"_N(V)P,G@)Z FK.I?\AO1_\ KK+_ .BFK UX_9?$DCS3;3(L M;1,9?*;9RKQQL3@'@$G@X.,\BNNE%.R\O+NR\1RW"*VU MFB6%@#Z<+4_]FWW_ $&[K_OU%_\ $5B^%9F?7+R/(=HX$2X8@<.K-M (^]P2 M"'6M+5?$T&FW'D1P274BG]X(NB<9QGUQSCL.N*)QFI\D5?Y((RBXF"#ZUH6M[!> M6,5W$^(I%W MQCV/O5+6:65((-\F"#_LO62;;Y6OP1HTDKK\S5HHHK$U" MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH ***Y;XA>()] \+L=/S_:%[(MK:XZAV[_@,_CBKIP=2:@NI M$YJ$7)]"#Q%\1+/2=1.E:3:3:SJO0VUKR(S_ +36E?OSZ5NUV.5*G[L(W\V#\Q[ UY/7UAXQ\.1^*_"MW MI3L$DD >&0_P2+RI^G8^Q-?+&HZ==Z3J,UCJ,#07,#;9(V'0_P!1[U[&!K1G M#E2LUT/)QM*4)\S=[E:M3PO_ ,CAHW_7_!_Z,6LNIK*[EL+^WO+? EMY5EC+ M#(W*'AIT7POU>6]EO(1-J4, M-P]DBL_E[&95;<1A2V?J0*H3>/+RXN))Y]%T"261B[NVFH2Q)R2:I6GBN^LM M2N[JW@LEBO5"7%E]G'V:11T!CZ>^1R#7/*-24%&UK6Z]C=2A&;E?>YK1W.CQ M>"M;LM*76+N*3R7+7$,:Q6\@?Y7)5C@D;E]\UI+ID?BV_P##FNW?_'L\+1ZM M)_=-JN68^[1A?QKEM4\3W6I:FZ#J&C6DRK9ZAM\]2N3QZ'MGH?45/LIVNM[_ / _X(_:PO9['6Z5JEOJ MVC>,];U.6[AENIH%D>S16DCA=VRHW$87(13ST %4=-N=$MO#^OVVE)K5ZEQ9 M?O$E@C$4+!U*2L0QQ@\9_P!JN;T;7+W0;QY[!HSYL9BFBE0/',AZJRG@BKFH M^*[J]TQ].M;.QTRSE8/-%8P[/.(Z;B220.PSBAT6I-+;3\+ JR<;O?4M^+_^ M03X5_P"P.O\ Z.DJMX:U#6-'M]5U'18(W1+80W,SQA_)1W&& /?*@9P:S;_5 M+G48+**Y*E+&W%O#M7&$#%N?4Y8U+HNNWV@7CW&GNG[V,Q312H'CF0]593P1 M6O(_9\MK_P##F?.O:< @5@TZ47%M MVM?H*I)225[A24M=1X!\&W/C'Q#% $86$+![N;'"K_=SZGH!^-7.:A%REL1" M+G)11ZIX;U7XG6?A?3+?3]"TJ2UCM8Q"\TV'9-HVDC>.<5I_V]\6/^A>T7_O M]_\ 9UWB(L<:I&H5% 55'0 =!2U\S*K%N_(OZ^9]&J4DK<[."_M[XL?]"]HO M_?[_ .SH_M[XL?\ 0O:+_P!_O_LZ[VBE[2/\B_'_ #*]G+^=FA1117$=85S' MB>_N+3Q5X0MX&017FHRQ3!HU8E1:3.,$@E?F4N1\2QS7OC[PC!: MVMU)]ANI;RXF%N_DQQFVFB&9<;-Q9A\N=V.<8H PX-4\4:CX!E\:)=QVLBW6CK9R/;( MWEK<-"&W# +Y$AZG(SP1Q6V_@#4AHMQX!SUK'ATVZL_A[X'F MN-:OK])KW1RD%RD 2 94X0QQJQ'./F+=![FN_P!:\,QZWK6G7TUP4CLX;F%X M0F3()D"GYL_+C'H!@AQ@G%=AKFCVOB#0;S2;_?\ 9[R)HG,;;67/ M\2GL0>0?44 ,*@. 1]UR M^>/QS=9UK5O"N@Z5+JOB]1O(. MY=>&/$&J^'-4T76O$EM)&&V2*A0Y4_>5E9E*Y'!X(.#0!RFB^+UGUO5M%MO' M-AJ]K'IJWT.L%[:1K3#[95D\H+'C!0J2!C)SG%5'\1W:ZW-I$.O:AKFG7^BW MLS37UC'"J21"/'DND48=2)3G[V/E^;J*ZG4O"^LZ_H%[IOB#7;60S^6T+6.G M&%8GCD616*O+(7^91D;@",C'-1?\(;JFH>(;75O$6NPWA@LKFR^S6EA]GCV3 M;-S#,CL&^09R2/0#N ,88-&DU&VE66!I(YD=4,4A@"KM8R(0= MH(PW)[=#;^!=4_X1VRTJ^\0QR?V0T+Z5=6]AY4L#1 JIDS(RR90E6 " @GIG MC4;P]J>KZ5?Z;XNU.TU"SO;9[9X;*Q:U&UA@L2TLAW>F" /2@#E/$^CZ]9P^ M&KC6/$T^H.VNV/VBV:UA2%6,@_U95 X /]YGR/SKT'5Y##I%S(-0BTW9&6-Y M,JE80.K'<0.!GKQ7+3^#?$.H#28=7\50W-MI=[!=+LTW9+<>4V0)7\P@D^JJ MO/.#TK?\4:"OB;PYSV+/J\K">W6-G0K9SD$"167/;E3UXP>:OVOA;6'\7:?K^N:[!>2V-M/;+;V MUAY$6)2A+#,CL&_=C.20>P'?2UC0?[6UK0K_ .T^5_9%V]SY?E[O-W021;9-2@M[BRAT^)K)$>=(G1I%CW1L-_&92=P P> M:[G3="_L_P 1:UJOVCS/[4>%O*V8\KRXPG7/.<9Z#%23R" -MG\3ZY+XIG@\4SZ>FF: MC-;V4,-G RX6-& D+H2RY;L5/7GIBK:Z[XCC\+>&/%]UKC3)J]Q8K;_ &M>RW>?+V^5O14V]?FQ MLSGCKTK/_P"$(_XH30?#?]H?\@=[!OM'D?Z[[,Z-]W=\N[R\=3C/>@#C=0^( M/VJ#7M1@\>Z5H]UI]S<0V&BS2VH$_D,5_?!_WN9&5L;2F%*]>]\^/=331/$L M@FW74MM:7FA*Z*"%O$$<*8P-^V<,,D$X(S71P>%]:TBXNX_#>O6UII]W'R@5O!PT> M[GY=CC<, ]2* ,"U\9ZM+H7AF":YQJ?VBX369$B7)2S#K<$*1@;G$8X P)., M<4V35?%-E\/HO'=UKI!K M?3O'&L^(6NFG34T"I9M'\MN6"B4@YYWF-"1@8(/K5!/ &I#0X/#&X" MJ+;?8L7+0*P*P-/OP4 7B,,5'7J: #0I=>U[Q=XA>3Q%<6^G:5JJ06]G!;0 M8D3R(9&5W9"Q4[S]TJPR>>@',_"?Q++K_AWPUX?T&^2VATG3+>?4IMJEYL@J M(8PP(*AE.]QT("CG./1M#T#^Q=0UNY%QYPU6_P#MFSR]OE?N8XMO4Y_U><\= M<8XS6%IOP[32-#\,V^GZ@(=1\/HL27RV^!<1' EC=-WW7 S][A@KC_]=9?_ $4U1WNMV2_:HI[.YGB@RDSK M;[T'R@L,^F#S6/XBUBX&N6$-K$81'>BV%R2&(9T&?EQ_=?@GN.E9=KJ>I7,5 MW;O+']EO9Y89)5M7DD\P( V%4], <^IZ8KOA0;BI/M^K..59*3BOZT-;Q1*F MGBR@T>/[+=X9HY84P(XL@,,!2#G(P",9&>U4_#=QJDL$^D66-JDL;^0$M 6Y M8$$#GSVIM.-@VF6.DVSF,D:CO_=+M4;O,; 'H,XJY-XBM8;>23R+X[%+8^QRC.!Z M[:R7UN2\N;"&]AV2I=PR;HE9HPKH=N6Q@'+ >]9Q]M+=:%OV<=CK****XSJ" MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH *X'XA_-XI\&1MRAU$DCU("XKOJX'XA?\C=X+_["#?R6NK" M_P 5>C_)G/B?X?W?FCKJ***@H*P?$W@K0_%L(&L6@:91A+B,[9$'^]W'LPT5T_7*_\QS?5*'\IX]_PS_;_P#0PR_^ H_^*H_X9_M_^AAE_P# M4?\ Q5>PT4?7:_\ -^0?4Z'\IX]_PS_;_P#0PR_^ H_^*H_X9_M_^AAE_P# M4?\ Q5>PT4?7:_\ -^0?4Z'\IX]_PS_;_P#0PR_^ H_^*H_X9_M_^AAE_P# M4?\ Q5>PT4?7:_\ -^0?4Z'\IX]_PS_;_P#0PR_^ H_^*H_X9_M_^AAE_P# M4?\ Q5>PT4?7:_\ -^0?4Z'\IX]_PS_;_P#0PR_^ H_^*H_X9_M_^AAE_P# M4?\ Q5>PT4?7:_\ -^0?4Z'\IY7IWP&T:"=7U+5+N\0'_5HJQ _4\G\J](TO M2;#1+!++2;6.UMTZ)&,9/J?4^YJY16-2M4J?&[FM.C3I_ K!11161J%%%% & MA1116!L%%%(M"M=6 MLDEC@N5+(LP 88)'(!([>M><)IB:5X_\&WFE^%[+PW#?74\,OE.HN;E3:ROM MF5!M(!0'EW.<=,$]3!;:!YCF2W+.0.!DDG H ]9HKR"/P[I.A_#[P5KVEV,5OJQN=)5[Y1^^D M69XDD1G^\RE7(VDX'&.@I\?A_2/$/PT\3>(=:LX;W6W.I[[F49FM#&\J+$C= M8PJJHPN,]3G/(!ZY6!+XRTQ/!J^)D$\M@^S:$0!SND$8X)'<^O2KGAK_ )%/ M2?\ KRA_] %>2Q>&]%B_9]&HV^E6=OJ%VD4<][! L<\BF\3(,B@-V'?L/2@# MVVBO-=>TZQ\$^+M.O/"VG0V4MQIFHFXBMDVBZ:*-)(RX'WV#9PQR?F//-8>C MZ/=RZ'X=U3P_X/U--<\VTNI]>EGLLWL;,IG,CK<%V1XV]\-Z)H_AA&T[4[F6:]T_28K>W^VF*$E4?&%D5EA +'>ZH,9('5AWKRR_M-3T>/4;:ST2]\+>&=5O M-,MS"TT">0TEQY=QY8@E<1JZ&($Y7DDC!YK?\?>$]!T7X<:LNBZ5;::+@VT< MOV)/)WC[1'R=N,MR?FZ^] 'HM%>=:IH>F>&?'>D?V!8PZ<-0L+^.\6W78+G8 MB,K.!]Y@2<,SBO6<@;"DCR( #G.*](US5_%%M'-J1U*^A:\E/[W3TBF=(Q$_6+:B*V5QDG/>N5&O:M+H MM[K-Q/)!J,_@?3'GN5.UX]\\XDESV(4LWM0![I17GFK^&M&\'ZCX:O?"]C#I M]Y+JD-G(;?Y6O875MXE/_+4@ OELD%S07;37MU;FUN(A;E0)I% 2;<,_(0NSRQZOXI@2>2V@OM5T:SNIXW*,D,JQH_S#E<@[<]MV:ZK6="\( M^%- G\KP_%'%?20VIL].C$37DAD'EH0"H)+=2QP1G<<9H Z36]5@T'0-0U>\ M21[?3[62ZE6( NRHI8A02!G XR15JWF6YMHIT!"R(' /7!&:\4U[36T2?Q?: MVNB:=H%G=>"[Z4V6G/E79/E$CJJJH?#$<9XZD]![+I7_ "![/_K@G_H(H M4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M !1110 4444 %%%% !574TN9-+N%L6*7!C/ED'!SZ9[9Z9JU133L[B:NK'%V M>E7.JW#R,[/;?:+6]MIY?O?(Q#HW^T -OY>]21*OA[4K2U:-KF98KFXV0]S) M*#DDX 7/)-6=!UVWM[*9=1#6>^ZF>(NI*NAD8@@CC/4$=13]0O9-7FCBL+& M>[L!S<2QA4\W'2,%R,KGDD?3N:[W*?.XR7N_\"QQI1Y5);EFRUV[U2V%UINF M&6U0#P:26W:Q99K M3P_=1P$,EY&SHXEB;ELC>22.H_$=ZV(]?TB*)4CG*HH 4"%^ /PJG[FM-7_K MR$O>^-_U\R[87T>H6HFC5D()5XW7#(PZJ15FL/PG=&]TNXG:-HV>\F)##D@N M2#^6/RK$>HF)_]EKH#U-9V@$_\([8?]<%K12?*VR''6R*/VC3/ M^@W>_P#?UO\ XFC[1IG_ $&[W_OZW_Q-:%U>7?V];.P2$R"+S7:2'SD,9/(! ((/ M0\@]3U]JTR3@U,IE?\@:R_Z]X__014 MSV?DRH]/-%JBBBL30**** "BBB@ HHHH **** -"BBBL#8*S-:\/:;X@2W&I MPR,]M)YD$T%Q)!+$Q!!*R1LK+D$@X/(K3K$\1^*;;PU)IT=Q9WMY-J5PUM;Q M6<0=BXC9\$$C PA&>@[X&2 ""W\!>&[5)EATXCS[F"ZE)N)6:2:%@TKW4=QJ=FES)%;S6J[R=OE3;?,4KG!#;%ZCMQU-84?Q! M$NHS:6GAC73J\"B633O+@WK$>DGF>;Y14D$#Y\D@C'!J[;^,H+_0;74])TG5 M-0-Q(\7V6&%%EA=&*NLF]U1"K CENW&: $L_ /AVQO[&]BM+B2ZT]RUI-85.T'?Y>61U*M MOQSUZUT.G^)EO-:ATFZTN^TZ^EM'O/*NC"VU%D")>6T+00S6FHW%J4C8@E?W3KU(&?H/04Z#PAH\$B2&*ZGE2VF MM1+=7T\[^5*5+KND8W[LPLK1)K%VH?7N MD4L$!SG<%P3QT9?6@"W8VB6&GV]G$24MXEB4GJ0H '\JPD\ >'(XKJ%+.<6] MTQ>2V^W3^2"9!(2D>_8F74$[0,U+JOBR/3]8.DV.E:AK-^D N)H+!8_W,9)" MEVE=%!)5L+G)P>*YOQ#XUN]2M_#R^$_[0QJEW/#<+:10+>1&%'+QA;DB-6#+ MAMV> <9R* .WN-*LKO4[34+B'?=62R+ ^XC8' #\9P<@#J#659^!= L+J.:R MMKF%(I/-CM4OYQ;(V<@K!O\ *&#SPO!K2CN6T_PZMS?&YD:WM?,F\\1^G%<]:?$>SN+73KZYT76+#2]1,2P:C=11"'=)@(&"R%TR6 W M,H7)ZT =5>6=OJ-C/97T*3VUQ&T4T4@RKHPP5(]"#6(O@3P^ND_V:]M,@<#81BL"R\>WEG<>)O[0TO5=4MM+U.5#/9P1;+6W M6-&P=S*TF,L<*';]!71WOB=H?(.E:'JFM)/ MPLMBL2H$;.WYI9$!/&=H)(R M,CD4 /@\(Z+#IMY8R6TMY;WR".Y%_=2W;2J,X4M*S-@9.!GC-0IX(T-;&XM) M(;RYAN-@=;K4;BEZ7JNI3ZM;2W%O!; MPHK*(G5)%GV7AG7;R]LHX9+F"&. >5YD>\*6 M:4(6'0@,3D<9�!OWFCV-_?6UY=P>9<6J2)"^]AM60 ., X.0!UZ=JKGPQI M#>&[70#:?\2RT$"PP>:_R"%E:/YL[C@HIY/..<\U@Q?$W39["#5(=*U=M&D= M(WU1K=$AA9F"X=6<2X5CM+!" <\X!-7]:\8-HINY'\.ZU=65DI>YO8(XA&B@ M99@'D5W ')V*W0XR: 'ZCX#\.ZK>W-S>64A:\(-U'%=S1171 P/-B1PDG ^ M8'BM!O#^E/?7%V]E&TMS9K8S!LE'@4N1&4^[C,C]N6MK8:7:WTUO MUGU".SU32]2T62>"2XMCJ"1A9XTP7*E';! ()5MK8YQP<2:) MXN;7&M)(O#^L6UC>IYEO?3I#Y4BE=P)"R,Z CIN5>H]: +LOAG1YUU-;FQCG M7551+U92768*NQM4O^$$T!K">SG@N[F&?9N^U:C<3LFQMR['>0 MM'A@"-Iᯨ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y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omcl-20201231_g2.jpg begin 644 omcl-20201231_g2.jpg M_]C_X 02D9)1@ ! 0$ > !X #_X1$017AI9@ 34T *@ @ ! $[ ( M 7 (2H=I 0 ! (8IR= $ N 0VNH< < @, /@ M &UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E M;&5M96YT&UP M;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG M=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL> M)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@("@D*% L+%"H< M&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*O_ !$( I<$8@,!(@ "$0$#$0'_Q ? !!0$! 0$! 0 M 0(#! 4&!P@)"@O_Q "U$ " 0,# @0#!04$! 7T! @, !!$%$B$Q M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4 ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C MY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! 0$! 0$! 0(#! 4& M!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< 0(#$00%(3$&$D%1!V%Q$R(R M@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JB MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR M\_3U]O?X^?K_V@ , P$ A$#$0 _ /I&BBB@ HKE-/N+WQC)->1WLUCH2R-% M;+;'9+>!25:0OU5,YVA<$XR3SBK]QX;9(]^CZMJ-E=+RKRWJ-RBL;PWKE)NPF[6.EH MKF_ %U<7G@NUGO)Y+B9IK@&25RS$">0#D^@ 'X5TE"=U<$[JX45S?P[NKB]^ M'&A7-[/)<7$ME&TDLKEV#=%GN)'EEDL('>1V+,[&-222>I)[UK4UJ@3NKA1110,***S M=?UJ+0=(>\DB:>0LL4$"'#32N=J(/J2.>PR>U&PF[*YI45SUIH-_>1"?Q)JM MU)%I$^SS-M+(0<94'&>PK0 MD\,6C(1%>ZM"_P##(NJ7#%3ZX9RI_$$47=Q7=]#9HK \)ZI>7UOJ-EJ ME7SVGLU)NRN)NRN:]%%!ZT7U"^MCI****8PHHHH **Y_QC MJ%Y9Z;96VFS?9[C4KZ&S6? )B5B2S 'C.U6QGN15VQT&VT^Z6XBN=0DD5"A% MQJ$TJ-G')1F*YXZ@"E?6Q-];&G117*6<]_XON[B>"\FL-"@E:"(VQVRWK(2K M/OZJFX$#;@G;G.#BANPV['5T5B2^%X@A-CJFK6ST01(8;BPGNFD MYW!DDB4#TQB0_D*5[";L;-%%%,84444 %%%% !1110 4444 %%%. M/$L5[=Z@8K5[988X;^:)(PT()PJ.!R>:3=A-V.PHKDO$EG<>&M!N]'2HV^) M5[IK7NJFSCTBWN%B_M6YP)&FF4MGS,\A5'X5+;1+;1V]%H17*6$A25]0GD9"!D%=SG:?<8-==$MAU%%%,H**I:U?/I MF@:A?Q*KO:VTDRJW0E5) /Y4_2[IK[2+.[D4*]Q DK*O0%E!Q^M*^MA7UL6J M**Y7Q(KW/C3PW8M#=%GN)'EEDL('>1V+,[&-222>I) M[UK4+5"3NKA17-> ;JXO/"S2WD\L\GV^]3?*Y8[5N9%49/8 =@*Z6DG=7" M+NKA1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9W MB*:6W\+ZK-;Y\Z.SF>/']X(2/UK1ILD:31/'*H9'4JRGN#U% GL97A."*V\& M:-#; ")+&$)CTV"M>N1\*WH\/0Q>%-;E\F>S_TG@NJX5EZ_ M+GH:Z+5-7L-&M# M,?\ *I2U5_,A*[5_,RO[!CB^(']@07=S#H<]C]O;3HI"L?F*X0J".5C(924! MVDK[D&QXRT;3_#OA6\UWP_:0Z9?:7']I22S01>:%.6C<*,.K#(P<]@_[ 4O_ */CI?B7_P DP\1?]@^7_P!!HLK,&ERR*?BRR&J^-_"D!N9[ M>-TO"Y@?8S+L3*[AR,^H(/O5[5_!^CC1KAM,LXM-O8HF>"]M$$#PMH=I=0W%CIEO9S0G*O:+Y)/LVS&X M>QR*Y>/5]$UOQ1JY\2ZK9)::=<_8[73KFZ14+* 7E="?F)8E1G( 7CJ:[BXO M+:U>%+FXCB:=Q'$KN 9&] .Y^EBD M]75PV5ZX8'&*IER2NDC*U#4_#NA:OI-YX5U'3H_M%]%9W=C97">7/'*VP-Y: MG&Y6*G#6OI?_)5O$7_ &#;#_T*XKH;C4;.UNH+:XN8HY[EML,3,-TA MQG@=3TKGM+_Y*MXB_P"P;8?^A7%*UF*UFO7]!?AO_P B'9_]=[G_ -*)*ZFN M6^&__(AV?_7>Y_\ 2B2NIJH_"BX?"C@OAS/KJ_#701;:;ITD0LH]CR:@Z,1C MJ0(3@^V36QKEQXA/A_41)I>F*OV67<5U*0D#8>WD#-1_#+_DEWAW_KQC_E6S MK_\ R+>I?]>DO_H!J8KW2(I\BUZ&7H&FQ:K\.] M[B6=(OL%LSK!,T9D'E#Y M25P=I[@$9^E9OBS3?">D:#>%;6TLM02W=K5K) EWY@4E2A7YRGKQFJPO MI+?P=X(M)IWM--OH8(;RZCI75U\/O#M_>22K:736LFKRP9!6! MH\L?EY"[]F['12>V:VH/#/A6_L5ETVPL!&ZCR[K3\1OCU66/#?B#4?AC5=/L M? _AH7EY!!]IL+=(3)(%$C>4IV@G@GVJCXRT?1M(T.]UFR2/2=5CB9K6YL_W M4DLP!*(57_6[FXV,#G-'2X=+[G8J-J@9)P,9/4UR_B?]]XN\(6TG^I-]-*1V M+I;2%?YD_A[5T=F\TEC ]U&(YVC4R(.BL1R/SK(\6Z3=:EIMO<:4$.IZ; M6BR-M61U!#1D]@R,RY[9SVJI;&DM4;YB%Y>62*%UO#+Y3%6D38AV9'(!XSCG&1WK8N=.T/PKIMYK-II5K; M&QM9)7:WB6-F15+$$@<].^:HZN,>/_"0/!\F\_\ 1:5NZWIPUCP_J&F.=JWM MK);D^@="O]:5M6Q):M]?^ <;H4OA2\TB"]\4ZMHNJ:I=1B6X:[N(I%B+<^6B ML2$5>@ ],G))JYX8U.RM_&=[H>C:E%?:9)9K>VZ1W F%JP?9)&#DX4Y1@O;+ M8XZ:OA#64U+0X+:?$.IV42PWUHQP\,B@ \?W3U!Z$$$5=N]6C-KJ4>DR17FH M64#/]F1@2'VDHIQT)(Z4DM$Q):)E!_#/AJPM6GU>WM;K_GI=ZJ5F9OJ\G3Z# M ]JS? E_!-J_B.QTR25]+M+F(V:R9VH'B!81YY\O<"1VY.."*L^%K?1[SPY9 MZ[=20W]U+ LD]]=D,R/C+KS_ *L Y&T8QC&.*K^#]1MM3\9^++FRJD@X;H<<4=4'56*WP^\-Z'>> M,GN]&T^>:1&+R2VJ,S'>W4D9 M-=TB+'&J1J%11A548 'I7*?#>XB7P);6SR*LU@\MO=1L<-#(LC95AV]>>Q!K MK 0R@J<@\@CO50MRHJFERHY'QXTZW?A0V<<,_\ D*>$?^PZO_I-<5T\DB11 ML\K*B*,LS' ^M+JQ)7;.&M#:CX:^)5CFEDOS#=R:DLZ".1+AHR2&0$A1C;M MP2-H&">M7O#7A'2)?"^G2:K90:G=RVD327-W&)&)V#A<_= Z #&,5D23+JD/ MCS6K$[M-GTT6T,H'RW#Q12[Y%/=?G5<]]I]*[/P[_P BOI?_ %YP_P#H I1L MV3%)LY.?5=&U7QEJ5CK^J6D&FZ/Y=O%87%RL:SRL@=G<$C> &50#QD,>M0:Y MJ7AK01:ZOX5U'3(+B&ZB2XL[&YC"W<+R!'!C4X+ -N#8R"O7!(.O83Q>'O'6 MKVE^PMX-:ECO+.5SA))1&LX_Q?NU8#N&..AKI+K4;.RE@CN[F*&2XD$<* M.P#2,>RCJ:+70)73*VH:!8:K>I<:DCW21H%6VEDF& 7!R%QT^:J?BZ^TRWU3PWI-D8EECUF!WA@3 MY85PZC=CA62/3-.MH[B\2)RAN))&8)& MQ'.P!"Q'?*H^.O">BV_P]UZ73K"'3IH=-N'$MD@A9L1L2K;<;E/((.>I[ M\U:EN(_#OQ(GN;]UAL= MNI=SK')<:=<10Q]6D9HF Y/J3V )/ H=K.X.W*[F?K%G;7^M^!;>^MX;F! MO.W13('4XMB1D'BNC?1=*TRPO)--TRSLY&MW5GM[=8R1CH2!TKG]7E2SU7P- M>W3"*U25X7F8X5'DMF5 3VRW ]R!WKK-1=/[/NH]R[_(=MN><8ZXIQMJ.-M? MZZ''^ ?"VEW7P^T&XU:V35)9=.@(-Z@E6-3&N$12-J@# X&3U.22:OZ IT?Q MMJOA^W=SIXLX+^VB9BPMR[R(Z+GD*3&"!T&3BK/P^_Y)KX;_ .P7;_\ HM:@ MM_\ DK^H?]@*U_\ 1]Q22LD)))1L=361<^&M)NKR:]U6$7Q;Y@MZWF10@#^% M&^51[XSZFM>N/T**V\1:KK#:^BW-Y9:A)#'97!W);Q*?W3B,\?.N&WX)YQGC M I]C25MBE87NE6?Q0L;#PNT:V=W87!NXK7_CV,B-'L*[?E$@W,&QSAAGM3M) MT.UU7X@^,)-2+W%O'>6P6S=OW);[)#\S+_&>@PV0.PYJ2YU*PN_BOH%MI\BR M"TLKY)&B'[M6)@(0,.-P"DE1R!C/6KWAG_D=?&?_ %_6W_I'#4+?Y_H9*S=O M/]"MKFGVOAC4]%U'0H4L!/J,5E.7*Y9!QN5MI#=>".AJ>\1_$OC* MYTF>21=*TN"-[B&.0K]IFDR55R.2BJN=O0EQG.!3O'?_ ![:%_V';+_T94:W M$?A_XC7IU!EAM-=AA-M.YPGGQ JT1/8E2A4=\-WIO>Q3T=NAF?$;PKHUK\-] M-X8I_ &O MQW./+.G3EB3C&(R<_AC-8.MZ\'7PSH^HZHFF)J5L;F_G:80L8T1,QJY(VEG< M<@YP&JUXAOD\71MX;T)UNH9W5-3NXSNB@@SETW#@NP&W:,X!)..,R^)-FB>) M-%\0NA6QMHIK&\D49$$3RR6TM[JD1F>U?:P;[- M.'VL.@)!&1S@\'/->A2ZA9P6!O9KN&.T5=YG:0! OKNZ8KD_'6IV=M_PB.HS MW"QV?]M1R&9N%"FVGPQ/8_)/OFN4UF_N=2^$NJ6VKNMQ>6%ZMAZM8:;IK7]]>0PVBC/G,XVGTQZD]@.3VK@-0LKM/A/KFHW-K)%-J%X=4>WV MDO%%YJ, 1ZB) 2/7-$K= FDMNS.WM_#>AVEPD]KHNGP31G*21VJ*RGU! R*Y M;PQH%GJFL>)I]4#7<*ZU*L=I+S"IV1DL4Z,QXY;.,<8R<]M#>6UQ;0W$%Q%) M#. 8I$<%9 1D8/?(KG/!/_'SXG_[#LW_ *+BIM*Z*:5T5[JSM_#/C70?[&C6 MSM=6DFM;JTA 6)BL32I($'"L"A!(QD-SG KL:Y7Q5_R-W@S_ +"4W_I)-754 MX[L<=VCE]8:36O&5MX?\Z2&Q@M/MUZL3E&G#.4CC)'(7*N3Z[0.FA?$*VU>^(BL=1L1I[W#' M"Q2I(7C#'HH8.X!]0!W%;&O:[:Z#I,EW<,'XD_A1!W)..GUI::W% MIK%?!E]>6L92^U.V::W=0RABC[E(/4 Y'X5VECH^F:6SMIFG6E MFSC#FW@6,L/? &:XF;2IM#\)^!].NR#<0:I;";;TWE)"V/Q)KT*B/F$-[O"DC]:R_ L44/P]T!+?!3^SH&!!SDF,$G\R:WB RD, M,@\$'O7'^'+N/PF4\+ZRZV\<3LNE74K8CN8225CW=!(@.W;U( (SSAO1W&]) M)G85R^N?\E%\*_\ 7.]_] 2N@OM0L],M6N=1NH;6!1EI)G"J/Q-X=2JQ^=&/++9^Z"5"Y/=A1+8)O3[OS.FU'_ )!=U_UQ?_T$ MUY\DTL'P=\',[S1Z:8K(:G)"2&2V\KDDKR%W;-Q'\.[MFNU\0ZM9:7H5Q/>S MJBO$RQJ.6E8KPJ*.6)]!61X*U.QT_P"'/A1+^[AMFN-.MTA\UPH=O*4[03W] MJ4M78F5G*WD7(/#/A6_L5ETVPL!&ZCR[K3\1OCU66/#?B#67J^G6>H?%31[? M4;6&\B71KI@EQ&L@R)8!G!&,\G\Z=XRT?1M(T.]UFR2/2=5CB9K6YL_W4DLP M!*(57_6[FXV,#G-)3A?M!:%_+!]<*V/7!I/L) MVVMV-+6C8>#?"^I:EHVF6=O,D7R)#"L8DDSM0-M'(W,/SHL/!NF+8I_;5M%J M]^R@SWE[&)7=^Y&[.T9Z*N .,5)XQTZ76_"6IZ=8%&O#"'A0MC+J=Z ^@++B MKFBZY9:[I27UG( I'[V)SAX'_B1Q_"P/!!IV5RK+FLS(T1Y='\77OAUIY)[- MK9;ZQ\Z0N\*[BDD6X\E0=I&3QOQT K(^'WAO3[_PE!=:M$-1+7%QY<5T \<* MB>085#\H/4EL9.>N -31Y4USQ]?:S9D26%G9KI\-PIRL\A??(5/0JN$7/KN M':G?#?\ Y$.S_P"N]S_Z424E9O[R4DVOF95]H4=EX\TW1]/NKBQT;5+:>>XL M+5]B%X2@PN.8U82_,$QG8/?-_P 3^&=-T[PO?ZAH-K#I.HV-L]Q;W5G&(V#( MI8!L??4XP5;(()J;5_\ DJ/AC_KQU#^=O6EXM_Y$O6_^P?/_ .BVHLM1\JM( MP/$GB))H/#EC/J*:1%K2F>YN#.(BL*(&9%,H)\F&:) M/WA [!XTR>P)/0&NR-_9K8?;C=0"TV[_ +09!Y>WUW=,>]"UW!*[=SSO4=0N M?%?@7P==2W/D7-UJT$V2IP1TR*[>T\+Z'8S136FE6L4\1RD MXB'FY[DO]XY[Y/-8_BVXBNX_"US;2"2&;6K=T=>C*4<@UUM.*UU'%*^H5Q6F MRZI'\0?%8TVSM+A2]IN-Q=M$0?('0"-L_I7:UR_A_P#Y'WQ;_P!=+3_T0*[L(_"'A?Q#.\%J=*Q(%C)=D^XGCP^'?#>A3W6B16ECK=JR26XT^,)*,.,[PG_ "SQD-NXP?7%:WC6 M:*/5]#36I#%X?D>87KLQ6+S=J^2)3V0_/UXSMSVJE\1Y='T3X>ZGIUK';VTL MT'[NVMHP&*A@2Q51PH&26/ ]:["?4=/2\BT^ZNH%N+E"8X)& ,R]#M!^][@> MM%M6A6U:]"C%X8\/MY-SIUA;6K*PDCGL (2<'(^9,;AQT.0>A%8.K:MINH^. MKG2==U2WM-,TVWC9[6:Y6(74TF3\X)&Y54#CH2V3T%+XGTW3O#@MK[PW%'IV ML37D*0V]J?+6]!D4.CQ#AQL+$MC*XSD8JW]HC\._$&]EU!A!9:Y#"8;ESA!< M1AE,9/0%EVE@7 '& ,56^)?_ "3# MQ%_V#Y?_ $&NEA_U*?[H_E2LG(5DYZG,>%3,LGB'P_)=3O%IEX(;:8R;I(XI M(4D5=QR25+D G/ 'I4]SX=\)Z;9E]6M+!E_BN=2*R2.?4R298G\:P9KZ^TV? MXCWND1&6]@FA>%0FXY%G#SM[XZX[XQ71:9:>';+2X]9CFM[B-HA(=5N9 [2+ MUW&1N@]A@#L!2782L]#F=(O_ +;\-O&$<\,:"?#^ES'1--\W[+$_F?9(]V[8#G..N>]86A/_;/A3QT-/221 MKJ^NQ"C(59MUNFWY3R,Y!&>H(KJ/">HVEYX+TF[M[B-X3:1*7W#Y6"@%3Z$' M@CL>*4;/<4;-JYM5R'BA[M/'OA8Z?!#/-LO<)/,8EQL3^(*Q_2NOKE]<_P"2 MB^%?^N=[_P"@)5RV+GM]WYFC]I\1_P#0*TO_ ,& .N*ZJO/IKZ^TV?XCWND1&6]@FA>%0FXY%G#SM[XZX[XQ2=E9BE:-F;U MSX=\)Z;9E]6M+!E_BN=2*R2.?4R298G\:Q?#5_\ ;? _B>..2XDM+.YN[>T^ MT;MZPB,,H^;YL#<<9YVXK>TRT\.V6EQZS'-;W$;1"0ZK#_ GH\_@K M1Y=3LX]3FEL(6,E\HF*@Q@A5W<*!T %6-,\SP]XV.A+/+)IM_:/=V45D+JI_BVK&H)Z98CJ*-+*PU:RL8VDZV_A MWX0ZEJ<)C6:*_O4B:4X19'O9$0M[!F!/M6A:0^!$LU34]5T;5+ME'G7E[=12 M2R-W;<3\O/0# ';&*SM,TRXU?X0ZA;6*"2Z74;R>!"<;Y(KYY%7/NR ?C7;Z M-K=EKVGK=Z?+N'22-N'A?NCKU5@>"#2CK;T)BKV]#CM/U>];0O%VE>&+\:I/ MID6_2YUF$S8DB+)'NR=S*X8#)SC;FM/P[I'@[6-&AEL;2RU!P@\V6=!)+]&$;H/[PF4AE^H-.Q7+\S3L;*+3[-+:W:4Q)G;YLK2$ G.-S$G M SQSP.*L5SW@>\O+[PM%+?3/<;9YH[>YD'S7$"R,L4C>[(%.>_7O70U:U1I% MW5T%%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %%%07MW%I^GW%Y M<$B&WB:60@<[5&3^@H =V[07D$5Q"WWHY4#*?J#Q52ST#1].F$NGZ38 MVL@& \%LB,/Q K*TB+7-;TR'4K_5I=-^UQK+%:6,41$*,,@,TB,6;!&2,#/: MM*PM=7M+YUN]1CO[)D.PR0A)T;(QDKA6&,_PJ1[YXG?6Q-[ZV-.HK6UM[*UC MMK*".WMXE"QQ1($5!Z #@"H-.@O8!<_VA=K=%[AWA(C"^7$3\J<=<>O>KE4, MB^RVYO!=F"/[2(S$)M@WA"UMY+B&>2")IH PBD9 6C!X.T]1G SBI&574JX#*PP01D$4M9T)NM M.M]1N=5O!O:'9ZO=ZU<6#WL:7*6 MEK#"8XD;#*A+HS,=I&3D=\8K=TZ"]@%S_:%VMT7N'>$B,+Y<1/RIQUQZ]Z2= MQ)WZ$=CH&CZ9-YNFZ38VDF"-]O;)&?S JU=V5KJ%NUO?VT-S"W6.:,.I_ \5 M-156'9%*QT;2],8G3=-M+,L,$V\"QY_(582UMX[N2Z2");B55228( [JN=H) MZD#<<#MD^M2T4!9$5M:V]G;B"S@CMX5)(CB0*H).3P/4DG\:EHK-\1ZROA[P MUJ&KO"9ULH&F,0;:7VC.,]J6R#1(NVMK;V5K';64$=O;Q*%CBB0(J#T ' %/ MDC26-HY45T<%65AD,#U!%*K;E##H1FEIC(#96IL19&VA-H$$8@\L>6$ P%V] M,8[5!9:'I.FN7T[2[*T9AM+06Z(2/3@5>)P,G@5PW@[Q5J6J^([A=2D4Z=JL M4EWHOR!<11R&-ER!\Q*F.3J3ASV%2VDT2VDTF=@NFV*:;/N_:(%DV_3(- M)9:-I>FL6T[3;2T8]3! J$_D*4P7W]MK.+M18"W*-:^6,F7<"'W=?NY&/>H- M"UI=W%F06SN,4A0M^.W.*-+BTN7GM;>6XBN)8(WFA#"*5D!:/ M=UVGJ,X&<=:EHHIE%*^T72]4D1]3TVSO'C&$:X@60K],@XJ>UL[:QMQ!8V\5 MM"O2.% BC\!4U9EWK2VOB73=',+,U_!/,)0W">5Y>1COGS/TI:+46BU'2^'= M$GO&NYM'L)+EFW-,]JAI R<# MMDU-119!9&?=Z!H]_=?:;[2;&YN, >;-;([X],D9[5?50JA5 P !TI:*86 M15O]+L-5A2'5+&VO8HW$B)QTKV\,MLUO+%&\#(4:) ME!4J1@J1TQCC%.CC2&)(XD6.-%"JBC 4#H .PHCD6:))(SN1U#*?4&G59H17 M-K!>6[07D$<\+C#1RH&5OJ#Q5:QT/2=,DWZ;I=E9N1C=;VZ1G'ID"G:1!?6V MD6T.K7:WM['&%FN5C""5N[;1P,^E7*7F+1ZE6_TO3]41$U.QMKQ$.56XA60* M?49!Q3$T;2XK5+:/3;1+=)%E2)8%"JZG*L!C ((!!Z@U=HHL@LADT$5S"\-Q M$DL3C#)(H96'H0>M4(?#FB6\>U-M-!%);LNTQ.@*$>F.F*K66B:5IH<:?IEG:"1=CB"W1-R^AP.17 M(Z3XNU&+Q_J^G:RZMI4FH?8K"8(%\B80QR>6Q Y#ASM)YRI'<5WE2FF*+4M2 M.WMX;2VCM[2&."") D<42A510, #@ #M2"UMQ>-=B",7+1B)I@@WE 20I;K M@%B<>Y]:QO"^I7>HSZZMY+Y@M-6EMX?E V1A$(7@<\L>3SS6]36J&K-!5&^T M32M3E674M,L[R11A7N+=)"!Z D5>HICW*R:=8QFV*6=NIM<_9R(E'DY&#MX^ M7(XXJ2*UMX)YIH8(XY;A@TSH@#2$ *"Q[D <]@!4M% $4]K;W0C%U!',(Y% ME02(&V.IR&&>A'8TMQ;PW=N\%U#'-"XP\X/6I*P-"U.[O/%'B:TN9= M\%C=PQVZ;0-BM;1N1D#)^9B><]:0FTB[%X;T."":"'1M/CBG3RY8TM4"R+_= M88Y'L:T@,# X%%%,+)$%[8VFI6;VNHVL-W;28WPSQAT;!!&5/!P0#]16?_PB M7AS(/_"/Z7D=/]"C_P *UZ*5D%DQL44<$2QPQK'&HPJ(N /H*<1D8/(HHIC, MR/PUH4-S]HBT73DFW;O-6T0-GUSC.:S?%UI/=ZAX8,%O),D.LK),40L$3[/. M-S8Z#+ 9/'(]:Z6BE96)<5:QFV_AS1+2Z%S:Z-I\-P#D2QVJ*P/KD#-:5%%, M=DC.M_#VBVEU]JM=(L(;C<6\Z.V17R>IR!G-7(+6WMC*;:".$S2&64QH%WN0 M 6..IX')]*HZ;K2ZCK&L:>L+(VESQPLY;(DWQ))D#M]_'X5/J$%[,;3^S[M; M81W"O.#&&\V( [DYZ9R.1Z4M.@E:VA/+:V\\T,L\$4DENQ>%W0$QL05)4GH< M$C([$U+113*&R1I-&T3S[U+110,*CN+>&[A:&ZACFB;[ MR2*&4_4&I*S=9UE=';3E>$R_;KU+08;&PL&.[W^[TI,3M;4+;PWH=E*LMGHV MGV\B_=>*U12/H0*T)(TFB:.9%DC<89&&0P]"*=13L%DC/M/#^C6$ADL=(L;9 MV!4M#;(A(/49 JP-.LAIZ6 L[?[&B"-;?RE\M5' 4+C ]*L44K(+(SK3P]H MMA.)['2+"VF'22&V1&'X@5:N[*UU"V:WO[:&Z@;[T4T8=3]0>*Y;XDZ[K&AZ M+8OX<(-_/>A1$5#>;&DPDU=Q&6.EV&F*ZZ;8VUFKD%Q;PK&&QTS@:!H^H7'VB_TFQN MIL8\V:V1VQ]2,U2\9:K=:5X:F;2R!J=TZ6ECD _OI#M4X/!VY+'/933_ =J MDVM>"M'U&[;=I)/XU+15%$3VMO)=17,D$;7$*LLI[4A-I&]'&D,21Q(L<:*%5%& H'0 =A63S[U+1699ZRMYXAU/2A"RMIZ0NTA;(?S QZ=L;?UH#1&G6;=>'-$OKM[J]T M;3[BXD #S36J.[8&!EB,G K2HIA9/

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�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end GRAPHIC 21 omcl-20201231_g3.jpg begin 644 omcl-20201231_g3.jpg M_]C_X 02D9)1@ ! 0$ > !X #_X1$017AI9@ 34T *@ @ ! $[ ( M 7 (2H=I 0 ! (8IR= $ N 0VNH< < @, /@ M &UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E M;&5M96YT&UP M;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG M=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL> M)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@("@D*% L+%"H< M&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*O_ !$( I\$=P,!(@ "$0$#$0'_Q ? !!0$! 0$! 0 M 0(#! 4&!P@)"@O_Q "U$ " 0,# @0#!04$! 7T! @, !!$%$B$Q M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4 ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C MY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! 0$! 0$! 0(#! 4& M!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< 0(#$00%(3$&$D%1!V%Q$R(R M@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JB MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR M\_3U]O?X^?K_V@ , P$ A$#$0 _ /I&BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M#E]<_P"2B^%?^N=[_P"@)745R^N?\E%\*_\ 7.]_] 2NHJ5NR([O^N@$X&3P M*SH/$.BW5TMM;:O837#'"Q1W*,Y/T!S7/>.+R*76=!T.]%PUC?/-<7<=O!)* MTT<*KB,J@)VEI%)XY"X/!J[J-[H.JZ3)IM[IVH/:NNWRQH]T-GH5_=_*1U!' M(-'-J'-JT=*2%4EC@#DD]JRT\3Z#).L":WIS2LVT1B[C+$^F,]:SO#=O+KW@ M/3X?%5K)--L"SQW<3(TIC8@,Z'!^;:&P1WZ5)J6KZ'/IMQID$":P&C,1L+./ MS0W^PQ'RI]6( HOI<.;2YT-9UWXAT:PNOLU]J]A;3_\ /*:Y1&_(G-<;I^MW M\'P-T6XAN6&HWEM:6<,[O)%-6L[=8;:%H)S%&,*/W&YL#MDY.!ZU'X(U2Q M@\/P:G>V^HRZKJ<8NKRX&E7+[F<;@H81XV*"%4#C %2G;3U)C*VGK^9VUM=0 M7ENL]G/'/"XRLD3AE;Z$<56GUS2;5'>YU2RA6.4PNTEPBA9 2AR>&P0<=>: MYO3)$A^(F_1K&]AT_4;.1[W?8S01K<1LFQ_G0#E-\$Z9;?\)!X MIU)XP]S_ &Q+$CMSY:B.,D+Z9SSCK@9Z"GS,?,WHCK;.^M-1MA<:?=0W4#$@ M2P2!U/XCBJVOVNG7OA^^MM27RU5".26XQ]:OJBIG8H7<(O^P?+_Z#5/8J6D6="US;6S6\,MQ%&\YV0*[@&4A2<*.YP">. MP)JK%XBT2>\6TAUBPDN6;:L*72%R?3;G.:YKQK86^J:UX-L[U"\$FH2;T#$; MP+64X..H.,$=",@\&NIOM'T_4=(DTN[M(GLI$*&'8 H'L.Q'8CH:5VQ7;;L7 M:*Y[P%>W&H> M(N+V5IIS;A'E;[SE25W'W.,FNAIIW5RD[JYRWPR_P"27>'? M^O&/^5=37+?#+_DEWAW_ *\8_P"5=32C\*)A\**%[KND:;+Y6HZI96DF,[)[ MA$./7!-6K6[M[VW6XLYXKB%_NR1.&5OH1Q66)?#_ (8!B5K6RDF)D,:\RS$G M).!EG/OS6#X3NA-\1O%"6UG-96KP65)"*.0"=H)%%];! MS6:1T\VOZ/;1[[C5K&)/,:+<]RBC>IPRY)Z@C!'45:MKRVO;5+FSN(KBW<96 M6)PR,/8C@UR/P\TRUB&O:AY8:ZFUR_4RMR547#@*OH.IP.Y)JSXJ1=0UO1/# M9S'::@\]S>*GR^=%$%)C)'9GD3/J 1W-+F=KB4GRW-F#Q'HEU>"TMM9T^:Y) M*B&.Z1G)'4;0FG3[BSA>S*[ M?(*#:![#M[$=*\]L=3GT;X#Z>UE++'<3^79Q2QJ7=#+/Y>X 9)8!B1P22!0Y M-;CZ#IFE MKIUGIVH);*NTH='NCO\ 4MF/YB>Y/6H?! DMIM9T^"WNH=*M[L/IWVFVDAVQ MN@9HU#@':K[P.P! [4^;4%+6QU=4KW6M+TR14U+4K.T=AE5GG6,D?0FKM9#M MH/AV:69VM+*>\D:1R2/-G8GG_:;Z#.*;*9H6=]::C;BXT^ZANH2<"2"0.I_$ M<5#-K.EV\,LL^I6D4<,ODR.\Z@(_!V$D\-R..O-9L.".#MR0"<>@!I_@O2;)O$'B?4Y(1)=C6)8DD?YO+79&<* M#]W)ZXZX&>@J>9LA2;V.KL=3L-4C:33;VWO$4[6:WE60 ^A(-3S3Q6T+S7$J M11(,L\C!54>I)Z5RWB:)-/\ %_AG5;51'="T,C[6]<-&I&>G/ MJ:#!'XB^(%Y#J"K-8Z'%#Y5NXRC7$@+&0CH2JA0N>FYJ?-T'S/8J^/-=TC5/ MAIXCCTS5+*\==/E)6WN$D(&WT!-=G#_J4_W1_*N1^*FG6E[\,]:>YMXY'MK. M22!R/FC8+U4]1Z'U''2NNA_U*?[H_E0K\P*_,[E36M5M]#T2[U.\W&&UB:1@ MHR6QT4>Y. /K6-IWAJ34X5OO&)^VW@XIOQ$ MS_PBT6[_ %']IV/VC_KG]JCS^'2NIHW8;RLS$E\': Z_Z/ID-C)VFL!]FD4^ MNZ/!K2:6#3-/1KV["Q0JJ-<7,@7)X4%FX&2(0[;-+TPKGY2=2D!( M^GD5RWBG5E\4?!5M4CC>U74(K:0*'RT>Z9.C>H]:3:6PFU%.QUS^(-&BOOL< MFKV*76_9Y#7*!]WIMSG/M5B\O[/3H/.U"[@M8LX\R>0(N?3)IMGIMG86"65I M;1QV\8 $848^I]3[USOAF&/6=T58KVQN84F=1@SV\DBQR1MZC#;AGHR@BGJI MTCXG/@8M]>LP<]OM$''YM&P_[]T7UL+F:=F='<7EM:&(7=Q% 9Y!%%YCA?,< M]%7/4G!X'/%35Y]XWTVX\5:W-8Z>S"70;'[? 5S_ ,?K-F ?4")OPDK>O_%* M#X=MXCT]=S3V:RVL?4F60 1H??>RK1S:L.?5W+E[_8NK/IL]Q>6\GV>_+6C) M<##7"K(A08/S, 9 5Z\'TJ]+J-E;RRQ3WEO%)#$)I$>5040D@.03PI((STX- M<9J.DKH6G^ M,!W&VU>-7?\ OO\ 9K@LWXL2?QJ>72K/4?C-<2WT G^S:);/ M$DG*!C//\VWH2.Q/3)Q2NQ2*,LEO<)(0/4@&KQ(5 M26. .23VKD_B/#'%X1FU>- M]I3IP^9K0V;;Q%HEY>"TM-8T^>Y)($ M,5TC.<=?E!S5VUNK>]M8[FRGCN+>50TH(X(J"\TFPO]--A=6L;VV M!'MP$QT*X^Z1V(Y%87PR_P"27>'?^O&/^5%W>P[N]F;/B"_ETKPSJFH6T?F3 M6EG+/&F,[F5"P'YBLC1/"VCW.BVMSJ=M#K%U7J+,TC,,DC<"%7GA5P M *Z9E5U*N RL,$$9!%2#G[RQGA3V^7&>^>*M7NHV6G1"3 M4+RWM(V. T\JH"?3)-96C>(Y;O5)='UFQ_LW5HHO.$0D\V*>/.#)&^!D D @ M@$9''(-<]X:UBQO-4U77-1@O[B[:]FM;9TTZ>98((G,85&5"HR5+'!ZG!Z4K MI;"YDM$=K9:C9:G"9M-O+>[B!P7@E61<_4&GW5W;6-NT][<16\*_>DE<(H^I M/%_>*H)Z ''4TB7,#S6VL:?- M%&RJ\D=TC*I8@*"0>"20!ZDBKDMW;03QP37$4X.>G3.#U I?%FG6VJ>._"MM?)YL!6 M\9XR?E?")PP[CU!X-#DT#DUIZ'00>(M$NKI;6UUC3YKAB0L,=TC.?H IV=F[#*K<7"1DCU )%5_$6D66I^&;NQN8%,(A8Q[1@Q, 2K*1]U M@>01TK.^'MI O@G2]1"%KW4K2*ZN[B0[I)I'0,2S'D\G@= , 4[N]AW=['1P M3PW4"36TJ31.,I)&P96'J".M17NI6.FQJ^HWMO:(QPK3RJ@/XDUSFC1)I?Q* MUK3;)1%:7-C;Z@85X5)F>6-V Z#<(U)]2,^M9OA/6+&ZFOM?U&WOYKZZNYHX MI$TVXE6&"-RB(C*A&,+N..K,YD>UU(G3 MIX5>$QLR.Y9 N5=5 )YPY'>ET?2K*[^)WB>^NH1--;M:B'S#N6/, RP4\!NV M>N.*.9AS/9'46.KZ;JA<:9J%K>>7C?\ 9YUDV_7!.*Q=0\31Z7X]@T[4;^VL M["33'G'VAU3=*)5488_[)/%0>.8X[1]%UF! E];ZI:P+,O#-%+*(WC)[J0V< M'C(![5))_P E>@_[ 4O_ */CH;>P-O8WK'5=/U17.F7]M>",@.;>99-N>F<$ MXJL_B?0(YS#)K>FK*&VF-KN,-GTQGK4?BZSO]0\'ZK::.Q6]FMG2'#["3CH& M[$],]LU2T3Q!X;ELK?28C#ILHC$0TN\002+QC:(VQNQC&5R#V)IWUL-R:=CI M%8,H92"",@@]:6H;2TM[&U2VLH(X($SLCC4*JY.> .G)J:J+"BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M.0\47UIIWCWPM/J%U#:PA+T&2>0(N2B<9/%;'_"6^'/^@_I?_@;'_C6O14V= MR;--G+:^3/<:+XGT11J<6GR2K*MH1(TMO(-KE,'YBK*C;1UVD=<5>'C+PZT/ MF+K%JS?\\5?,V?3ROOY]L9]JVZ*+,+.^ARGC&:6YT#3+@07']FO>0OJ[8 [FM^BB MSN%G>YYUH>D7&L_ O2;.QV"_MK>&2 .< 7$$@8*3V^9-I/;FNFL_&NB36B/? M7D>F76W][97K"*:-NZ[&P6YXR,@]B1C.T\@$=,X..PJ7PUK,'AO1;?0?$]PFGW.FH+:.>Z8)%=1+\L M)?^1H\$_]A"7_ -))JZVBBA*P)6NBG.*TJ*232L**:21P_@[6M&TKP_$FMWEO9:[M_XF:WCA)Y M)Q]\\\L"?NXR,;0*?X=OQ>_$_7IOL\]ND^FV;6_GIL:9%><%PIY R<88 ]\< MBNUHI:<;9HYO,0$CIRH!/N:Z2\U/7KJT>'2M!GM+J0%4GOYH?+A)_B M(C=RV.NW'/3(ZU>T#2(] \/6.E0.9$M(5CWMU<@I1M/& MFBRVZG4;R+2;O;F6SU!Q#+&>XPV-PS_$N0>QK4TW4H-5MFN+02^4'**TD3)O MQW4, 2OOT..*MT56I:OU"N'\)ZOI>E6=POB2ZMK#7S/+]N-Y($DE.\[2I;[T M>W;MVY &!UR*[BBAK6XFKNYQ.F:HFI?%B26.">*"31MMO).FS[0$G^9E4\[1 MO49(&>HXYJ[X)_X^?$__ &'9O_1<5=31241*-F3SVR>*[R'_ %*?[H_E3Z*:3O<: M3O=E'6M*M]=T2[TR\W"&ZB,;,IPRYZ,#Z@X(]Q6/IOB.73($L/&/^AWD(V?; MBI%M= <"02?=0G@E&((.<9'-=-11;6X-:W1AS^,M CC!M]1BOY#]V'3\W,C' MT"QY/Y\5R5U876E? &RL=0A:"YM[>T26)NJ,)H\CBO2:*3C<3BWN%'UU:VC,ESHTZW M\849+*F1(H^L9D'XBNDHI]SF_!*FZTFXUN0$2:U#<.1%PL(_[]JG MXDUS=C;2'QA'X/>-OLFFZA)K"G;\OD-\\29]II'P/2$5Z111R[!R:(Y;QG_R M%/"/_8=7_P!)KBBW_P"2OZA_V K7_P!'W%=311RZW#EUNWN+'6]*\26EO+;JMO:2=X;UOL\J^Q23##\ MJVJ*K4O7H65Z_$&V5M[QLW1&5RW!P"",9P<=A12Y>I/+UZF7: M^)-*O[^.TTVZ6^=P27M1YL<8 S\SKE5[8!.3FL43#PGXPU.XOU9-)UEHYUN@ MI,=O.J!&63^Z&5$(8\9!!.<9ZZLV^O\ 4;2["P:-+?6Q4?O+:>,.&YR"LA48 MZT(E2-1=1'+NO"YX YR21QU(UM< M_P"2B^%?^N=[_P"@)2:G9ZIXHN+*UN=/;3=+@NH[FY^TRH\EP8V#I&%C9@%W MA226_AQCG-=32LVQ6;;?H5M1_P"07=?]<7_]!-8WP^_Y)KX;_P"P7;_^BUKH MJ*JVMR[:W.6M_P#DK^H?]@*U_P#1]Q4&BWL/@Z2\T;7&%E9BZEN+"]EX@>*1 MS(4+]%969AM;&0 1GG'844N4GE,RT\1:7J%^MIIMR+UBI9I+8&2) /[T@^4' MGIG-97A__D??%O\ UTM/_1 KJ**=AV;M,C'<5UU%)QUN)QN[F6?$>EM8 M7%Y:7(OH;;;YIL5-P5!/HF2<#D@9.!5#4/$/A#4].D@U'4--O8&!#VKLLKMV MQY7+$^V,UT=%/4=F8/@F&^M_"%G%J@F693)L6X),B1>8WEJ^>=P3:#GTK>HH MH2LK#2LK!1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 44V21(HR\KJB*,EF. /QJ&&_L[B3RX+N"5\9VI( M"8@5P=RY-%Q76X^BBB@84444 %%%% !1110 44R6:.")I)Y%CC7J[L !^)I] !11 M10 444Q9HWD>-)%9X\;U# EGT %%,BFCGC$D$BR(>C(P M(/;J*?0 4444 %%%% !1110 4444 %%%% !1110 445'-<0VT>^XECB3.-TC M!1G\: V)**HV&KVE_81W,<\2[HEE=/,!,8(S\WIBI/[4T_\ Y_K;_O\ +_C2 MYE:Y*G%J]RU14/VVU^RK<_:8?(;[LOF#:?H>E+!"#@@\]-E=&&593D$?6BZ8*2>PZB MBBF,**** "BBB@ HHID4T<\>^"19$R1N1@1D'!Y'N,4 /HHHH **;)(D,322 MNJ1HI9G8X"@=23V%*"&4%2"",@CO0 M%,\Z/S_)\Q?-V[]FX;MN<9QZ4^@ H MHHH **** "BBF--&DJ1/(JR29V(6 +8ZX'?% #Z**9%-'/'O@D61,D;D8$9! MP>1[C% #Z*** "BBB@ HHHH **1W6-&=V"JHR6)P /6A'62-7C8.C %64Y!' MJ#0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11 M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M &/,@U'Q-]GE^>VLH%E:,_=:1RP4D=\!21]:O:C8IJ%FT3?)(!F*4?>B?LP/ M8BJ5WNT[71J#*?LD\(AG91GRV4DJQ [?,1GMQVJ6[UB 6[+ITL=W=R B&*)@ MV6[$XZ =R:RTL^8YTXI24_Z[%2WU^:6UT@1VOGSW\3%CO"!&4#<3QTR3_A5B M75;J"_ALI; &>X!,)CFRA ^]N) (P"#P#G-4X[+^SM3\/6F=QA@F4MZG:N3^ M=6M0_P"1HT?_ '+C_P!!6I3E;5]OT(4I\NKUNE^7^99AU"3^TA8WD"PRO&98 MF23>K@$!AD@^U*P-U;Z=&JY8*LES@O@D<84^G?']:=>_\C9I M7_7O<_SCI/"W_(MVW^])_P"C&JDVY6O_ %H4I2=3EOW_ $_S%35[>ZDTF2.W M#B\9]CO@-"0C$]NO!4X-31:C/>23?V?;QR11.8_-EF*!V'#8PIX!XS6#I7^J M\-_]?%S_ .@R5IZ-E5+GR/[?BO[B21+.ZM%C299&C56#%AN((QD-QG MTJ?9ILGVJ6SE,]Q';,AD\YY JGG&22.H!QUIW;ZEAX/\JQM#_P"0AHO_ &!!_.*M#Q7_ ,BG MJ/\ UP-*+M3;_K8B#:HR:_K0L'4)I=1N+2SMTD-L%\QY92@RPR ,*<\5:MWF M>/-Q"(G!(VJ^X'W!P/Y"LZ\&EO?.TEX+.\0!6D6;RF(QD9SPPY[@BI-#NI[N MQ=[E_-"S.D<#D#IR:AAU*X.MC3KFT6(F!IUE2;>" RC'0'^+_]=0W;"P\217UR=MM+ M;& RG[L;!MPW'L"">?45%'=V]UXUB^S3)*$T^0,4.0#YB=^E)R=]^I+F[[]= MBSI.J7>JV<5VMC'##(?XYR6P#@D +_44Z#4KF]MFN;"S22WR?+,DVQI0.X&T MC![9(_"J_AJ/S?"-K'DKOB99[KR+%MK<5U=6:1QL(KR%WCD8X(=" R$=B,GOV-+_ M &U'_P )&=)\LY\K?YN>-_79CUV\UE-;36OAQ-1DB:.>WNWO_*(PR(SL63V^ M1CQZTAB=?#XUK8WV@7/]H$8^;R^A7U_U7%+GE^OR(]I.VOK\B_JNL1P+?1M9 MK=16L4;RAVX+,W"X(/;G/TJ8ZI.A.>/Y]*Q[M M2_@F_OI 1)?/YYSU"E@$'X*%K4L?^1LU;_KA;?\ M2A2DY+^NXU.;FE??_[; M_)$T.KH/MJWR"V>Q >7#[EV$$A@<#/0]NHJ&ZU>]MM(EU$Z:IBCB:7RS<8DV M@9Y&W XZ\G'OTK/U"TEOK[Q%;6XS*]I;[ 3C<1YAQ^.,58UK6;&?PK?D7"K) M):2+Y+']XK%"-I7J#1S.SNP=25G=VM?\V;D,GFPI)C&]0V/3(KG]9OLPZE'; M0B&:WN;0&56P9-SH>2!GH<=ZW;3_ (\H/^N:_P JYC4U9I-?*J6V7%F[8&<* MI1B?P )JJC?+_79E5V^33S_)F]=:A-8VIEN;>,NTB11)%*6WNS;0"2HQR1S4 MTA4?2H+F]TJZLI$N+BWGMVPKX8,HST)(Z=.O'2J< M=R+?5+2#3;YKZ*9F$T+2"7REVD[]_4<@#!)SGCFFY6>Y3E9[Z?(OZU_R -0_ MZ]9/_035:UOV2"QLK6'SKAK5)6W/L6-,8!)P>IX /0U9UK_ ) &H?\ 7K)_ MZ":Q;:&*VOX+B]>2*WNK&%%F$S1JKH#E201C(;(SZ&E)M2T)J2:J:&S!J+O= M3VD]N4N84$@1'#"13D J3CN".<5#=:I=V%G]KO+*-(5(\P)<;G0$@9QMP>OK M4$DEI##>WFCAKV^@MR%_>O+[AN(HKQ(WAEAQ[U0D1=:O/$<%C(',MI#&C _*S8D[]QGC-#D[KO=_DPE)W3ZW>GR9J- MJUTFG?V@^GXM@OF,OF_O0G7.W&,XYQN_6G3:M)_:T-C9VRS^;;^>)6EVJ%SC MG@U52?2); &ZN98BR;9;>2[DWJ>A4INS[8QS3H8HX?%L,4*[8TTS:B\\ 2# MYIW?()[E=.MWG MM<21W]N52*3?YGS@\$@<]N15W4!IDEV!=W M;J-/EE$IB;:?0\;AD=.16/<7 M4UQ B23&Y@AU6V6&Y*@>8-ZD].#@Y&1P:4V[-7%4D[.+9M/J-Q;7%LM_:I%' M<.(U>.;?M?SJK+K26EGJ-S%8@M;WJP,B, 96;RQNSCK\XZ^G M6I/$/W=-_P"PA#_,UCWKB/1]<=LX75XB<#/\4%$I-7_KH%2VVI:0]AI\R7,]YB-%B8-M!( MRQQT '.36]6D7=M&T)7DU>Z,JUU2\OGNA;6,>VWG>'=)<;=Y4XR,*?UIQUR$ M::]R8I/-CE\AK<8+^;G&P=CU'/HM5 M7AFEMY=66&7R3J4=VL04[C$J!-VWKD@;L=<"L^=VNF8>TERIIW9LS:E<6?DO M?VB1P2.J-)'-O\LL<#<"HXR<9&:5-0GN;JYBLK>-TMI!$[RRE,OM#$ !3T## MFJ6MWEOJ6E_8;"9+B>Z9%41-NVC<"6..@ '>IKDZ4]Y+)]O^PW:D+(R3>6QQ MTRK<-[$@U7,[Z,MS=[)Z?+S)9+TKJ&G175F@GG,H#;PWE;5SD''.1]*K>&)K MR70;,R)&Z%3F1IB7/)[;?ZU4M[F>[U#0I;H?/YERJOMV^8H4A7V]L@ X]ZM> M&;F"'1;6SEFC2ZCW1M"S@.&#'C;UJ8RO+^O(F$^:I>_]6B.M=9C_ +)M)+:R M"R74C1PVT9 &0S9.<# X))Q5LZC+!>P6]];K$MP2LN* MP--S;Z=HE^X8P027"2L!G8'9@&/MD8)[9K3U&XBU*\T^VL9%G9+E;B1XSN6- M%SU(]3@ 41D[?<*%23C=O73]":TU2\OI+L6UC&$MYWAWRW&T.5/484_K^M6] M.OEU"U\U4:-U=HY(VZHZG!'Y]_2J7A[_ %>H_P#80G_]"H\/?ZO4?^PA/_Z% M51;TN:0E+W;O>Y?N);E)$2VM1*&!+.\H15_0DG\*KPZI_IES;7L:6\EO$LQ* MR;U,9SSG QC:<@BH-1NG&KQ6L]U]BM&@+^:"%,C[L; QZ<<\<\^U92P6][K& ML6VFLQ^T:8(Q*S,V]B7&0QSD#(&?:E*;3T%.HU*T?ZT-N#4+VZM5N;>P7R7^ M9!)/M=E['&W R.<$TU=4N9]6N[*VLT86NS=+)-M!W*" %)S26.L62Z;")YD M@E1%22!SAT8<%=O7K^=,TS_D8]:_WX?_ $6*=WI9CYF^6TM_3LRQ_:$TMY): MVMNDDL"*9V:4JB,1D*#M))QST'&/7%0R:XEO:7CW,#)/9E1)"K [MWW"K>A] M3C'.14=I-'I>K:C%>NL*W,PN(99#A7!15*@],@KTZX(J)6MKO4-1O[H*=.:& M.UW,N4EPS$M[@%P,].#SQ2YGW%SRMH]=?EN::37_ )B>;:0A&.&,=P6*^^"H MS^=06NI75_;FXL[2)H2[*ADG*LP4D9P%..1ZU1-PEI?64>D7[722S!)+8R>< M%3'+!N67'N<=J2ZETV&WGNM-U+['/AG,:/D,_O$WZO!JU\;989F2.V$GE$I@8;CYFSGL<=JN4M$:RE9+S- M/3;]=1L_."&-E=HY$)SM=6*D9[C(ZU2U$-;:[;7\\3RVD<#QDHA?R7)!WE1S M@@$9'2H_"?E_V5.(4:-!>3[48$%1O) (/3@BM.XU"UM)ECNIEA+@E6DRJG_@ M1XS[9S27O039*?/33D^Q1\._9+G0=,FC\F66&UCCWKAF0[!E<]O<4NK.][>0 MZ1"Q43*9;EE."L0.,?5CQ] :R=$\J6;0I-. +I9*MZ\?W=OE#:K'H6W8P.HP M:U=)'GZQJ]V?^>RVZ^P1 3_X\QJ(N\4C.$N:"C_6U_\ @#?+23Q5%;E5\FRL MQ)%'CA69BN<>P3 ],TZ\ MO$VFRQ?*;I9())([V<[+ M>XMO(:0]$=6++N/8$,W/J*:\L>I^(;(VC"6*R5Y))5.5W,NU5![G!8T_+K?^ MOP'IMUNOS_R(M#O[.VM[U;BZ@B87]R2)) I \UO6GZ))###?7098+":Z+V^_ MY1@JH+#/8L"13-"OK2""]2>ZAC?[?<_*\@!_UK=C4VC8?4]2EM!BQD=/**C" M,^#O9?8_+R.I!I1^R*#^#7^K#[/7;:XU"^@>YME2"5$B82#YP45CWYY)'%:M M4[2Q:VU"_N"X87\>8V%JDD,3F/S)9M@=@<-M 4\ \9XYJIX>N8+;3 M_L5Q/'%=1W$RM"[@-DRL1@=\@@CZT:-=6^F6+6%_,EO-;229\T[=ZERP9<]0 M0?SR*SB]$KF$)6C%7Z?TB*_U)[NVTV6U5HI1J*Q21.VW:P# J2,\?GVK7>:] M2($6D;R,X4*D_P H']XDJ/T!-@. >?6M M34M54M:K:7D:6\DI2>Z1E81#:2!GD DX&32C+=L49[N3[%E=1ECU.&RO+=(V MN$9HGCE+@E<9!RHQUJOX7_Y $?\ UWG_ /1SU0S9?\);I?V29[AQ',KS-(T@ M/R@@;B<9ZG J_P"%_P#D 1_]=Y__ $<].+;G]_Z#IR]5H]757ODOD6W:Q19)2K[UV,"00< _P )XQ4-_=,- M92TN+HV5H8-XD#!#*^[!7<>F!@\8/-8K6T=]-XAM],)ZNB([>>P2$2MPJNK%L$]LAN_7%*_O:/L+FM/27;]18))W\ M:D7,*Q,M@=NR3>&'F#G. ?TJSI&J7>K6%O>"RC@AF ;#SDL!ZX"X^G(_"JT% MW!=^-2;:5952P(+)RN?,'&>AJ3PTGF^#;",DC=:A8VP M(@P#G@\Y8#&/6J&D_8;32(;;4;E[6YM4$4L;W;IRHQD#<.#U&..:M-%HL=K: MP,_V954R6[EVB9=W7#G!YSR,_A0I2:W'&4VD[K^OD6;K49["RGN+VU4",H$$ M4NX.S-M R0,-WYF4JG-UTT[=T;\>H2+J*65[ L,DJ%X623>K MXZC. 01G/3I67H]^++P_:HD33SW%U.D42G&X^:Y))[ 9)JQ+*FI>(; V3B6 M.S\R2:5#E1N3:%SW)SG'M639P@:=I=[+YGV>"YNDF,;,I0/(X#?+S@$#/UH< MG?\ KR*E.7-=/O\ ^V_D="-0EBU"&TO;=8C.3>K,!DJ<@$''/X&K5U/ M]FLYI]N[RHV?;G&<#.*SXUTFXO(%CN#JIUAHTU)9[<+/ M81"5D23;XE^R%FC:P0J[,6\S"R@L&/+#/&:3F^G]:"E5>EG_5C6EN[N]T":>2TC@BE MM7< S%G *$CC;C]:2SU#[-HVF6\$?GW4MM'LB#8P-HRS'LH]?P%2M_R*)_Z\ M?_:=9.F6TFAZ=9ZH)9+B&:",7N_DHN/E9?0+G!'ISU%#;37H#E)23\M6;;:A M(^H/9VENLLD2!IF>3:B9Z+G!)/?ITK-UG4Y)=#OX]K6]W:RQ*ZJ^1RZD$,.H M(]L]>*55MH->OI+V9XHKP1RP3+.T:/A I&00,\ _0U'JL-E+H>HS:9OGD)B\ MZ0.\FX(X;@DG. 3THDY-/YBG*3C+7O\ J;T+7+$_:(HHQV\N4OG\U%35#!>V MMT2+6YAF(&3Y<@; _"IJV1UK;<****8PHHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (9TN69#;31 MQXSN$D1?/Y,,57M]/=-2>^NIQ-,8_*0(FQ47.3@9)R2!SGM5ZBE9-W)<4W=A M1113*"BBB@ HHHH :X9HV"-M8@@-C.#ZXK/N]/O+^U:UNKR,0R?+*(8"K.O= M?[N-NXYQ_]>K=%%)*RLA)**L@HHHIC"BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** (;2V2RLH+6(L8X(UC4L>< 8&?RJ: MBBC825E9!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILDB11 MM)*ZHB LS,N"5)P:NTQ[A114#WUI%?16I SSB@">BBB@ HHHH **** "BBB@ HJ*YNH+*UDN;R>.W@B4M)+*X54 ZDD M\ 4^.1)HDDB=9(W4,KJA![B@!U%96H>*?#^DW9M=5UW3+*X #&&YO(XW M /0X8@U5_P"$\\(?]#5HG_@QA_\ BJ7,B>:/8_-%KYJ^;LZ;MFVL=S93QW%O*H:.6)PZN/4$<$4V\O;73K.2[U"YAM;:(9>:>0 M(B#..6/ Y- $]% .1D2QNH;E$D:-V MAD#A74X*DCH0>H[5+)(D4;22NJ(@+,S' 4#J2: '45%:W5O>VL=S93QW%O*H M:.6)PZN/4$<$5+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!GZ__ ,BWJ7_7 MI+_Z :Y+X=6F@/\ #?06N[?36F-E'O,B1EB<=\\UUNO_ /(MZE_UZ2_^@&N, M^'?@WPQ>_#C0KF]\.:1<7$ME&TDLMC$[.<=22N2:S?Q&4K\ZMV.GU?5](\(> M%;S6%@C6S@ >#<6\C+N^SZDDDT8)ZLA5 M1QZ!C6CJ7AS0KGPO+X?N;2VM=+N!Y0MX0L*@ELC:!@ [N1CO7):Q+XE^'&FP MZB=>_M_2(IHH)+2_A4705V"#9*F-[ D'#+T!YHDVO0)-K7H,M=0UZ#XN^+DT M73H-2406.]+F_-N(OW;XV_NWSG)ST_'-;DVK(/'7AZRU31($U2ZL[B07*S[S M:[=NY%.T;@V>O'3I5/PX0OQF\:*Q 9K:P90>I 1P2/;-&N?\EK\+?]@^]_\ M9*2O;Y_J2KI7\_U)+/QWJ>KZGJVGZ'X9>ZFTN]DM9)9KP10G;C!W[2=QR?E" MG&.3R*98_$*\U+4+G1K/PQ>?V[9/MN[6694A@4@%7,W((8'Y<*2<'@#DI\-O M^/[QI_V,EQ_Z!'1X;_Y+'XV_Z]]/_P#1;T)RTU!.32UW-/0_%T]]XBG\/Z[I M+:3JL<'VF-!.)XKB+=M+(X S@]00#S3&\0^*)]\NF^#R;=6(3[;J*02R 'J$ M"MC/8,1^%9NJN(OCAH\C9VKHERQP,\"1:;H5UK/CKP['KUSKK:-I-UO>*UT] M$$BQ*Q'[R=LX;CG:%QZT7>P^9[7,WQOXG3Q%\(8]8TE)8'DO[>,PRML9)%N MK(Q&>X(SSQ796.K:T@N)_$NDV6EV4$+2M<1:B9\;>3D&)<#&3G/:O)(/)B_9 M[+0R VT>N B0OD;!>##%O3&.:]3^(MG\E^I0M_&NN:CI?]L:1X1FN-+93)$\EZL=Q-'U#)%M/4<@%@35^X M\>Z+#X+MO$T;RSVEYM2VAB3,LTK':(@O]_<",9XP?2L?POI>IZMX5TV]TKQW MJ'V26V0QJEI9D(-H&S_5=5Z'/.16'K.B6?@RP\'.M\UYI%EKS27%S*5VQM+O M 9MH"@*Y// &:?-)*X^:25_\BYX^U[Q&_P .=:_M/PFUM:SV3IYD-^DTD.X8 MS(F!@ ]2K-CK7>>'?^17TO\ Z\X?_0!6+\3IHHOA=X@:21$5K&15+, "2, # MW)K:\._\BOI?_7G#_P"@"FOB*2M/?H37&DZ==S&6ZL+6>0C!>2%6)_$BN%^% MVD:;<:!JK7&GVLK+K5XH+P*Q $G Y'2O1:X;X4?\B]JW_8AP:F.KZQXD M\7:QHNC:A%I%KH_E1W$X@$MQ+)(FX;0WRHH''?%,FL: MIJ&D:GIS:9JNGB-YH/.$J,C@E71P!D<'J 16/\'/^286'_7Q=?\ I1)6;X*L MX;'XP>*;>'4)]1=+*U\Z>XF$DAD^;(., 8X^4 >E:7P<_Y)A8?]?%U_Z424 M1;;5_,(MN2OY_FCN&944LY"JHR23@ 5X2SW#.WQ>'F;5UD*%Y_Y!H_<'CU_B M_7WKT7XI:I<67@N33],.=2UJ5--M%S@[I#AC[ +N.>W%4!IOB8>"?^$8_P"$ M2TO[%]B^Q_\ (:.=NW;N_P"/?KW^M$]78*GO.W;\SL-:U[3] T&XUC49@MG M@T^+5E8S^%M;M[;5XQECY4,@&['4C:4.>^":]9UZ[M_P#A$-1N MO/B^SM92.)MXV%2AP<],'UHYN8?,Y[.VAR/ACQ-:^&/@_P"&)[B*:YN+FVAM M[2TMP#)<2L.%7/'N2> *ROBGK?B%_ACJ\6K^%S:6\\:*)[>^2X\H^8I_>+M7 M XQE=W452TJ5+'3OA+J5\0FG112P22,<*DLL($1)[NR_0MZWXUFT7Q-IOA^ST6;4KJ_M&FA, M4P0!E8##9&%7&26SVQ@YJ:]\776A:']K\1Z1]GO);E;:TLK.Y%PUT[#Y0K%4 MQWSD# !-9=Y_R6[0?^P)"N,@C)'?M5-NS9;E))NYJ7/C34]$EM9/%7A[^SM/N9E@^V07JW @9CA?-& MU=H)XR-P%6M4\67 M!K[6=#N+#7O&^HR6$P7S5>VM(QPP(^81 CD#O5W6?"":GKO]KZ)KESI&M0PK M;2S6^R19$^\JRQ-D'KD=#S3]X?O_ -6+,/B:\M-)U.^\3Z++I$>G0>>[K.DZ M2J 2=A7!)&WH0.H]:H6WBKQ1AJUAXA^&_AN;4= M&\0?VEI&FQ[CINK1@L(A@;$G7# XX 8$=*5W:XN9VOT^1UFJZUJUO=PVNC^' MIK^22$2O+-<+!#%DX"E_F);CD*IP*K:+XKN;SQ)-X?US2?[+U-+87<:I<">* M:+=M+*^%.0>""!6?+XCU3Q!XJ&@Z#/%I21Z?%?7-S/#YLW[S[J1H3M&.['/7 M&*Q=(T^/3OCX(CJUSJEV?#SFXEN959E;STP-J@*@QR% '7/>CF=]!N3OIW(? MAYJ^M0Z9K-MHOAYK[R]9O&:>XNUMXB3(?E4X9F/K\N.1SZ=-!XJC\0:!K]G< M64VF:II]O(EW8SD%DW(2K*PX92.C"J?PFEC?0M91'5GCUR\#J#DKF3(SZ<5G MW,B:A\3?%MU8?-;V7AX65TZ\J;@EW SZA>#Z4E=11,6U%:EKPOXDM?#'P;\- M7-S%+<33VT-O;6L !DGE8?*BY('J2>P!K0N?&FIZ)+:R>*O#W]G:?978U5L-4T_5$E?3+ZVO%AD,4 MC6\RR!''53@G!]J32>Y+C%[HR+7P)XSO"IFAN[B2X#%>A_>,V M,>V*;:^ /#5I>0W*:>TLENP>'[3 M221@JHH&223P !WIEI>6U_:1W5C<17-O*-TH(X-+ECV#ECV,K5_!^ MAZ[J$=]J5D6NXD\M9XII(7*9SM+(P)7V.14T'AC1[:]T^[@LPDVFPO!:,)&_ M=HV-PQG!S@Q1TW1K#2)+U].@\EKZY:ZN#O9M\K MR3CH.! M@46VC6%GK-]JMO!LO;]8UN9=['S!&"$X)P, GH![U/K'!X'/%3T60[(HR:+83:[!K,D&;^"%H(YM[?*C$$C;G!Y YQF ML=OAWX5:YEF.DKB9S)) )I! [$YR8=WED_\ :Z:BCE3$XQ>Z,BV\*Z)::+= M:1#I\?\ 9]Y)))/;NS.KLYRWWB<<\X' [8INB^$M%\/3F;2K62*0Q^4&DN)) M=J9!VC>QVC@<#'05LT460I9$8* MQ^HK630M*CT/^QDT^W&F>68_LGECR]IYQM^O/UJU3QP0H,M)*X5 M5^I/%4M/\1Z)J\S1:5K&GWTB]4MKI)&'X*32M%!:*9D#X:>$OLS6[Z0)8&C: M-8I;B618U92IV!F(3@GE<$=JZ6WMXK2UBM[==D4*"-%R3A0, 9/M4E%-)+8: MBEL@JCI.BV&AV\T&EP>1'-.]Q(N]FW2.L^&](\0B'^U[ M)+A[=MT,H9DDB/\ LNI##\#3-&\+:-H$LTVE6*Q3S@"6=W:65\=,NY+'\ZUZ M*5E>XN57O8Y_4? OAW5=4EU&\T_-U.H69XIY(O. & '", __ (&G:CX(\/Z MK?)>7=@5N4C$7G6\\D#,@Z*QC9=P]CFMZBCE787+'L8^E>$]#T._>\TC3H[. M=X! QB9@I0,6 VYQG))SC//6K6C:-8>']+CT[2(/L]K&S,L>]FP68LW+$GDD MFKU%%DAI);&?>Z'IVHZI8:C>V_FW6G,[6KEV C+#!.T'!..Y!QVQ6A113'8R M[?PWI-KJ&IWD-FHFU;;]M#,S)-M7:,H25''!P!GOFLN'X;^$X,*FD(8@=RV[ MS2-"ASG*QEBBG// KH;2^M+^-Y+&ZAN421HW:&0.%=3@J2.A!ZCM4]3RID\L M7T,M?#6CCPW'H#:?%)I<<0B6VES(H4=!ELG\$9;5[:?2//B9#&%G MN99/+7T0LQ*?\!Q75USVI>-M'TW6+?2R\US=S7,=JZVT>];=W("^8W1>HXSG M'0&AJ/44E#J:3Z)I\FN0:N]OF_MX&MXIM[?+&Q!(QG!Y Y(S5B^L;74K&6SU M"WCN;:9=LD,JAE<>X-3T4[(JR.9@^'7A:"2%ETPR+ RM%%/#-!UG4#?WMAB]*A&N;>:2"5E'0%XV4G\36Y11RKL+ECM8Q[+PEH.GZ M7=:=:Z7;BTO"3BCE78.6/8QM8\):)KUU#=:E9;KF!=D=Q#,\,BKUV[XV5L>V<4S3O!G MA_2-2BU#3=-CMKJ*)XEE1VR58@MNYPQ) Y.3QUKX']6TTW;-]E\86DMRFX_= MNHI7)'XQL#GO@5Z]XHN?L7A#6+HG'D6,\FJ6R?/,WY #_@55/AKJ4^F?!JQ:*QN=2N;*26U%M;X\QV%PR#J0 ""23@ M &E\&WT7C?QUJ'BZ#(?&LVB^++'P_9Z+-J5U?VSS0F*8( RL!AL MC"KC)+9[8P\M_A]7/G6XM[2-4MX"_G)NP@^9\+N.&8X MQGM71ZC_ ,EUT7_L#7/_ *,6GS2O;T*YI7MZ%#QG=:I=1^$6UK38M.G7Q7:J ML<-UYZNNR3Y@VU?<8([5T^J^*OL_B2UT#1K,:GJ!O&5UX?\02"Z?6 MY#=6>L.H5KJ3 WPR'^\.JCI@X]!1=J5A7:DU^)T>I>+9T\12:#X>TIM6U"WB M66ZW7 AAM@WW0[D$[CUP%/'-2:#XK;4M:N]#U;3GTK5[6)9S;M*)4EB)QYD; MC&X9X.0"#7':)INH2?$WQC8P^([O1[N2XBNUBB@@?[1"T8"N/,1B0I!4X.!Q M73Z=X2:T\90ZUJ7B.ZU/4(K1X$CGB@C_ '18$G$:*3AL;* MZ]&.3@9Z"M_7O &@ZW8>6EA!87D0S:WUI&(IK9QRK*RX/!QQTK&\)7@ I12:U)BHN+YOF<3IOQ(N;+X>:3J>K6$E]J#:BNDW<5NP#F4.R%U M&,$G:#MXY;J*U-1\:ZSH=H-2UWPI+;Z2I!FG@O%GEMU)^\\04<#OM9L5Q-S8 M7&C_ U\+W&L*+6XO/%-OJ%PLAP(?,E9\'/3"XS^->F>-M0L],\#:Q<:DZK; M_8Y4(;^,LI4*/4DD#\:E-VW)BY-:O9%+Q#XW_L;5M"L=/TN;5VUN.9[>-I#Y+9& .]12^--0TC4;.'Q7H!TRTO9E@AOH+L7$22-]U9/E4ID\9 MP1[URMA!-I6O?"6UU-A%/'IUW$PD."&^SQ )SWZ#%;_Q@DCD^'L^F*0U]J5Q M!;V48^\TOFJ@ )-,TWQ;.WB"+0O$6E-I&H7,;26FV<3PW(7[X1P =PZD%0< M'V^Q_&3Q7;WQVW%]:V5Q:YX\R)$*/CUP_P#.E\;,+KQ]X*L+4[KR.]DN MW"\E(%C(8GT!) ]S3N[7'S.U_/\ 4D@\=ZIJ>O:QI&A^&S=3Z5./^PS_P"TDI+$A?CSJJL0&?0H&4'JP$K D>V:G5I._4G5I-OJ M:K^*;RT\0>'=&U/2XX;K64NFD\JZ\Q;?R5# [!OW!A_=Q[U9\4^)/\ A&H- M,D^R_:?M^I06&/,V;/-.-_0YQZ<9]16%XL=8?BSX#EE(2,_VA$';@;VB3:N? M4X./6H_BI<0I#X7@>5%FD\1V12,L-S . M,M3\-Z5X?EOKJQ2&3SOM CBVNI;+L1\N#@ ,3R>,&K>@>+)M1UZZT'6M+;2 M=6MX%N1#YPFCFA)V[T< 9 ;@Y P:R_#?_)8_&W_7OI__ *+>B;_DOUK_ -BW M)_Z4+1=[^8*4M[]3G/$^L07OP5\27.CZPU M^0D^@%[&2:]HOK.VU;2[BRNE$MM=PM%( >&1A@_H:F-WMV_S)C=[/HOU(-4U MJTTKPY=:U*X>UM[9KG.7O+?4WLM2R>MI:D.#CT93$ >_->OWNEV M>HQVZ7D/F+;3I<1 ,5VR(".A[=*I-S*3<]BW1116AL%%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 <;\3;Z[L/#NGR6-U-;2/JUI&SPR M%"RM( 5)'8CJ*M^,?%_3Z8_P 9))HO M!=I):PB>=-5M&CB+;=["3A<]LGC-87V+7?AWKT7C/Q'?[/R MWR-%W\M+/$WA2^T2?PKI,4=S"8X MW_M@MY+8^5@OD#[IP<9'3M5.36B*(VN82C* M4#C*D$C# @=03CO1=ZWI]EK%CI=S<;;W4 YMH0C,7"#+$D A0 >IQ7#ZC#=^ M%_&7A'7[]E+WUJNB:K(&RID8!HWSW_>!AD]B*N^&Q_PD7Q,U[Q WS6NF :19 M'MN7YIF'_ B%S[48?%"_U[4]9MO#OA"_GL[RTLYM6NI+>0JQ M5 5CC)'7#QTXKTYF5%+.0JJ,DDX %>2^!O%^DMK'B#Q-JGV\3ZM=;;;R] M,N956UC&V/#)&5YY)P:)]@J-:1O:YZ-X8UR+Q+X7T[6+? 6\@60J/X&Q\R_@ MV1^%5-0\=>'-,U"6QN=1WW4./.BMH))S#G^_Y:MM_'%<5\.]34M+2>W>%FAD!)4(ZJV%?CI_%71?"6UMX?AGI5Q!AYKU#YSQ^%$9-VL*,W))(R?#'CG3EUSQ5?W^M-/I+:G;6]E+O>6)"\0PHQD("V< MG@ ]>:]%N+B*TM9;BX<1PPH7D<]%4#)/Y5YA8>'+?Q%>_$W1-B1K=W480A/?#45C973:EE+^+SK6-8)&EE3^\(@N_'OCFK>B^*=&\0R3Q M:3>>;-;X\Z"2)XI8\]"4T9M1U2.S7]W$4C6" $A/ M,E;H,YP ">IQ7.Z6=9;X\1RZZEG!+-X=AYKD?A?!$K>+IUB032>)KY7D"_,P#C )]LG\ZYW M4[F?2+CXN-I686BBMI4$?&QY+;+N/?DG/K2YFE=BYY))L[BX^(GA:VN)8GU3 MS/(ZEJ$,$%P0(6)R92>0% R6/T! MJ/PG86>F>$=+M=,1$MDM8RFP8#94'=[D]<^]<5K$NJ-\<(DT[2[74&T_1!): MP7%V;=8]\I5Y%^1\GA5Z#BFY-(;E)*[.ST?Q;HFO74EKIM[NNHUWO;30O#*% MSC=LD56Q[XQ2:QXOT/0KQ+34KX+=NN];:&)YI2O][9&&;'OBN:OM*\5:UXP\ M/:MP*C>*8-?^,DL>D:H]UIJ: K- LC!(YA<$$M&?NO MM(Z@'&*] KA8HHX_V@[AD15:3PRC.0,%C]I(R?4X 'T KNJ<;ZW'"]G?N><^ M#;2X\>^'AX@UG7-5BGN9I0+.PO7MH[,*Y41[4()8 9);.:E S!H?MI5GA&.1O !8?7D>M8NH?#NR?4I]3\/:C?^'M0G;?+)82_NIG_O M21-E6_(5R7B#Q1XBMO!/C30=9EAEU;2K.-H[ZU0QBX@E.-^W^%@,YQQZ=*GX M5J1?D7O([67XC^$XI'#:NIC1]CW"0R- K9Q@S!=@Y_VJU-6\1Z1H5G;7>K7\ M5M;74HBAF;)1F*EA\PX VJ3DX''6N8TW_A(X?#%OI5MX/T>33OLHA6/^VFVO M&5QT^S]Q_.N9U/P_>:3X#\ :%XC6*:6#Q);Q.JN9%,?[XHN2!G"E1T'2CFE8 M.>21W,?Q&\+R75M -0E1[J988&ELIT21V^Z [(%(/KG%;^H7]MI>FW%_?RB& MUMHFEFD()VJHR3@= M%;023F'/]_RU;;^.*YP,]G\7]?>S0;X?#D1B0#C(=\#]*T/A-;6\7PSTJXAP M\U[&;FYFZM+*S$LS'N<\?A0F[V%&3;LO,WY?$NC0Z NMS:E;QZ:ZAEN7;"L# MTQ[^W6JNF^-O#^K:BEA9WY%W("8X;B"2!I0.24$BKN&.XS7+>/VO7^(O@ZRL M[&WO4!NKJ.UGN#!'+,BK@EMKW@DGD"_WBL:L M0/QW2POLE4 JT;=<,I (/U%Z1XC\/^-]4\1>';&U MUFVU:.$7-G+<>1-$T2[08W(*D$134G>S*4GS69O44459H%%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !17+>.;_QE865JW@/2;/4[AI"+A+MPH1,<$9D3O[FN+_X2+XY?]";HG_? MY?\ Y(J'.SM9F4?\)%\ M?V\#6\4QD;Y8V()&,X/( M')&:\Q_X2+XY?]";HG_?Y?\ Y(H_X2+XY?\ 0FZ)_P!_E_\ DBES1[?@'/%; M1?W'I^IZ-8:PUF=1@\XV-TEW;_.R[)5!"MP1G&X\'(]J9K>@:;XBLDM-8MOM M$4CZSX6T;Q \$FK6*3S6^?)G#,DL>>NV12&'X&FZ/X M4T70;F6YTNR$=S*NR2XDE>65EZX+N2V,]LUYU_PD7QR_Z$W1/^_R_P#R11_P MD7QR_P"A-T3_ +_+_P#)%'/&][/[@]I&]^5_<=VG@+PU'J;7\6F^7,TXN&6. M>18S*#D/Y8;9NR,YQFNBKR+_ (2+XY?]";HG_?Y?_DBC_A(OCE_T)NB?]_E_ M^2*%-+9/[@52*VB_N/3-;\/:3XCLA::YI\%["#N595R4/JIZ@^XK*T_X<^%- M,OHKVVTA'N(3F*2YFDG,9_V?,9MOX5Q'_"1?'+_H3=$_[_+_ /)%'_"1?'+_ M *$W1/\ O\O_ ,D4N:+=[?@)SBW=Q?W'4?$_2IM8TO0[:*QDOHQKMH]Q$L1D M B#'>6 !^7!Y)XK0MOA[X7M;J&>/2@[6[!H$FGDECA(Z%$=BJX]@*X?_ (2+ MXY?]";HG_?Y?_DBC_A(OCE_T)NB?]_E_^2*.:-[M/[A$$OM,:^TV.._%TQB+1QDQQ[-S#[I)'!R#D<=*WM-\$^'])U%;^ST_-V@( M2>XFDG>,'LID9BH^F*X#_A(OCE_T)NB?]_E_^2*/^$B^.7_0FZ)_W^7_ .2* M.:-[V?W!S1NWRO[CTG6?#>D>(1#_ &O9)%M& MT"6:;2K%8IYP!+.[M+*^.F7<_\)%\]G]Q7M(WORO[CT_3]%L-*NKZXL(/*EU";S[EM[-YCX M S@DXX X&!576O"FB^(+FWN-5L_,N+8$13Q3/#(@/4;T(./;.*\Z_P"$B^.7 M_0FZ)_W^7_Y(H_X2+XY?]";HG_?Y?_DBCG5K6?W![2-KW$18,5VYQU&-]>\9WFFRZ>^H".VM8;A-LOE(J@NR_PEBHX/( %=U7D7_"1?'+_H3=$_[_ M "__ "11_P )%\1?\ "1?'+_H3 M=$_[_+_\D4?\)%\U79_<>NT5Y%_PD7QR_P"A M-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G]P>U79_<>NT5Y%_PD7QR M_P"A-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G]P>U79_<>NT5Y%_P MD7QR_P"A-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G]P>U79_<>NT5 MY%_PD7QR_P"A-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G]P>U79_< M>NT5Y%_PD7QR_P"A-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G]P>U M79_<>NT5Y%_PD7QR_P"A-T3_ +_+_P#)%'_"1?'+_H3=$_[_ "__ "11[1=G M]P>U79_<>NT5Y%_PD7QR_P"A-T3_ +_+_P#)%7-(U[XR3:U8Q:QX3T>#3WN( MUNI8Y5+1Q%AO8?OSR%R>A^AH]HNS^X?M5V?W'J-%%%:&H4444 8?BSPW_P ) M1IEM:?:_LOD7L-UO\O?N\MMVW&1U]>U;%Q;PW=K+;W4:RPRH4DC<9#*1@@BN M:\DV>IW#2$7"7;A0B8X(S(G?W-<7_P )%\S_$SYH_RO\3I?BG-8)\.=0LKBY#7C)&+ M)-P,SW 8&+:.I8L!T]ZV_!>@GPWX/T_396WW"1[[ER_10JW;"(RJ!T ?[1G'XU=_X2+XY?]";HG_?Y?_DBES+FO9_< M"FN;F:?W'I7B32[C6_#5_I=G>_8);R%H1<^7O,8;@D#(YQD=1CK4^CZ7;Z+H MMGIEF,06D*PIQU"C&?J>M>7?\)%\5N^U1/T4G M(V[6RPZ\]JSK+P1J.@RW$7A7Q$VG:9/*THL9[-;A;=F.6\H[E*@GG!W <\5R MG_"1?'+_ *$W1/\ O\O_ ,D4?\)%\%/"#>&;_6+J35)]1?5)HYG>X0!U94"G)'!R3.UU3PE=R>*6\0>']8_LR]FMUM[E);87$4 MZJ25)7SR_-(.SJ(O$FI7, MRW4.OB%9+5HL"-8XO+()R=VX<]!CIS7!?\)%\$/[5N-/U"UU.XL-9T^,QQ:A$JL9%(^99$/RNI/.. M,'IBN&_X2+XY?]";HG_?Y?\ Y(H_X2+XY?\ 0FZ)_P!_E_\ DBCFC:UG^(#;NU\0 MWFK^%];;29+\AKRVDMA<03.!C?MRI5L=2#SQFN._X2+XY?\ 0FZ)_P!_E_\ MDBC_ (2+XY?]";HG_?Y?_DBCFCV?XASQ[/\ $[+1O!ESIWC.7Q'?ZY/J5S-8 M_8W66%4"CS-X*;3A5']W!Y).:ZIUWHRDD;AC(KR/_A(OCE_T)NB?]_E_^2*/ M^$B^.7_0FZ)_W^7_ .2*:FELF-5(K9/[F=E!X:\3:?&+?3O&+O;+P@U&P6XE M5?3S R;C[L"?7-3Z1X*L[*#53JL\NL7>LJ%U"XNE4>:@4J$"J %4 D "N&_X M2+XY?]";HG_?Y?\ Y(H_X2+XY?\ 0FZ)_P!_E_\ DBES1[/\1<\>S^YG6V7A M+Q#H]DNG:/XO=-/B&R!;NP2>:%.RK)N (';,.]R4# J<;0N=_4#C'2N(_P"$B^.7_0FZ)_W^7_Y(H_X2+XY?]";H MG_?Y?_DBCFCV?XAS1M:S_$]=KCO#?P\MO#OC'5-=CO'G6[+?9K4QX6T#MOD" MG)SN;GH,8QS7)_\ "1?'+_H3=$_[_+_\D4?\)%\NT#;@C@KC!%-AT'Q*]S;G4O%IDMX9%D:.TT](&FVD':[%FX M..0H7(XKB/\ A(OCE_T)NB?]_E_^2*/^$B^.7_0FZ)_W^7_Y(HYH]G^(<\>S M_$[N]T3Q!_:4]SH_BAK>&=@WV6\LEN$B. #L(9& XS@DC-2>&O# T";4+RYO MI=1U'4Y5EN[J1 F_:NU5"C@*!P!7 ?\ "1?'+_H3=$_[_+_\D4?\)%\S#GC>]G]S/7:*\B_X2+XY?]";HG_?Y?\ Y(H_X2+XY?\ M0FZ)_P!_E_\ DBJ]HNS^XKVJ[/[CUVBO(O\ A(OCE_T)NB?]_E_^2*/^$B^. M7_0FZ)_W^7_Y(H]HNS^X/:KL_N/7:*\B_P"$B^.7_0FZ)_W^7_Y(H_X2+XY? M]";HG_?Y?_DBCVB[/[@]JNS^X]=HKR+_ (2+XY?]";HG_?Y?_DBC_A(OCE_T M)NB?]_E_^2*/:+L_N#VJ[/[CUVBO(O\ A(OCE_T)NB?]_E_^2*/^$B^.7_0F MZ)_W^7_Y(H]HNS^X/:KL_N/7:*\B_P"$B^.7_0FZ)_W^7_Y(H_X2+XY?]";H MG_?Y?_DBCVB[/[@]JNS^X]=HKR+_ (2+XY?]";HG_?Y?_DBM+P_KGQ=N/$%G M#XB\+:3::8\F+F>&52Z)Z@>>W\C1[1=G]PU53>S^X]+HHHK0U"BBB@ HHHH M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHI RL6"L"5.& /0XS_(B@!:*** " MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ** M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH MH ***"<#)Z4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4 M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6#XO\ &>D>"-&.HZW, M5#';##&,R3-Z*/ZG@5O5\B_&?Q%/K_Q-U&-W)M].>%V<,?J6W'\O2LJ ML^2-S"O4]G&Z.MU/]I76Y+AO['T2P@AS\HNF>5B/?:5%4/\ AI'Q?_T#M%_[ M\2__ !VO(Z*XO:S[GF^WJ=SUS_AI#Q?_ - [1?\ OQ+_ /':/^&D/%__ $#M M%_[\2_\ QVO(Z*7M9]P]O4[GKG_#2'B__H':+_WXE_\ CM'_ TAXO\ ^@=H MO_?B7_X[7D=%'M9]P]O4[GKG_#2'B_\ Z!VB_P#?B7_X[1_PTAXO_P"@=HO_ M 'XE_P#CM>1T4>UGW#V]3N>N?\-(>+_^@=HO_?B7_P".T?\ #2'B_P#Z!VB_ M]^)?_CM>1T4>UGW#V]3N>N?\-(>+_P#H':+_ -^)?_CM'_#2'B__ *!VB_\ M?B7_ ..UY'11[6?+_ /H':+_W MXE_^.UY'11[6?+_\ H':+_P!^ M)?\ X[7D=%'M9]P]O4[GKG_#2'B__H':+_WXE_\ CM'_ TAXO\ ^@=HO_?B M7_X[7D=%'M9]P]O4[GKG_#2'B_\ Z!VB_P#?B7_X[1_PTAXO_P"@=HO_ 'XE M_P#CM>1T4>UGW#V]3N>N?\-(>+_^@=HO_?B7_P".T?\ #2'B_P#Z!VB_]^)? M_CM>1T4>UGW#V]3N>N?\-(>+_P#H':+_ -^)?_CM'_#2'B__ *!VB_\ ?B7_ M ..UY'11[6?+_ /H':+_WXE_^ M.UY'11[6?+_\ H':+_P!^)?\ MX[7D=%'M9]P]O4[GKG_#2'B__H':+_WXE_\ CM'_ TAXO\ ^@=HO_?B7_X[ M7D=%'M9]P]O4[GKG_#2'B_\ Z!VB_P#?B7_X[5BS_:4\1I,#?Z/I<\6>5@$D M3'\2S?RKQNBG[6?\+:Y<>'/$]CJ=LY0PRC> ?O(>&'XC-?9>AZC]MM5).3BNRC4YUJ>CA MZKJ1UW1K5Y%9^._[!_:&UWP[J,NVPU1[?R2QXBG^SQ ?]]<+]0OO7KM?(WQM M9D^,^MLA*LIMR"#@@_9XZ*TG%)KN+$3<(J2[GUS17"_"7QROC?P;')"=)/^P3=?^B6I2V)E\+-R"9+FWCGB.8Y$#J?4$9%/KF/ MAMJ/]J_#/0+HG._P#DHWB3_L*W7_HYJ^V:^)O'?_)1O$G_ &%;K_T:UA@_M?( M[.OD7XW_ /)9-<_[=_\ TGCKZZKY%^-__)9-<_[=_P#TGCJL1\!>+_AKU,_X M:^-9? WC*WU EC92_N;R,?Q1D]<>JGD?3'>OL>">*YMXY[>19894#QNIR&4C M((/IBO@JOHW]GWQY_:&EOX3U*7-S9J9+)F/+Q=T^JD\>Q_V:SP]2SY6986K9 M\C/:Z***[3T0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO+/ MB%\3K7_A']2L_"QU*YNK6>&.6_L(3Y,#>5(&1T-1ZO\0=,TS5YM*M M+'5-8OX,>=;Z7:&8Q9&1N8X4'';-',K7#GC:]SJJ*Y+1OB-I.JZVFCW=IJ6B MZE*"T-KJMMY+3 ==A!*GZ9S6OXC\3:5X5TT7NM7'DQLXCB15+/*YZ*BCDFCF M5KCYHM7N:U%<0/BII=O+%_;FC:]H5M,P1+W4K'RX[622WLX6G<0@%F4#/&2 3^-"DF"E%[%^BN%M_B@+NUBN;;P7XME@F0 M21R)81E74C(((DY!%;OAGQCI'BR.?^RY9%N+5MES:7,1BF@;T9#TZ=1D4*28 ME.+=DS=HHHJBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L#QY M_P DX\2?]@FZ_P#1+5OU@>//^2<>)/\ L$W7_HEJ4MF3+X6<7^SUJ/VSX8_9 M2W-C>RQ >@;#_P W->IUX#^S-J.)=?TQCU6&X0?3F@H MHHK4V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **** "BBB@ HHHH *^)O'?\ R4;Q)_V%;K_T:U?;-?$WCO\ Y*-X MD_["MU_Z-:N7$[(X<9\*,"BBBN(\X**** "BBB@ KU_X9W]UI?P;\:WNG3O; MW,+1M'+&<,IQU%>05Z_\,[QM/^#?C6[2&"=HFC81W$2RQMQT96X(^M:4_B-J M/Q?)_D3?#77M4\>C7=$\9W#:GI0TYYS/Z?I.EB3RDNM1F:-9G[A JL6Q@]NQ]#2W_Q#UZ\T:;28&L]-L+C_ M %]OIMG';+-_O; "?3W[UU_BJVN/$/P0\'W'A^*2XM]-,L%]! IQRM[X'USPUJVB3PW%G<1ZA/']@U*TD\VW:3>,QP M<$>O7!K+_%WQ&UVRU/4M.N=9L88IKJ=F,<N MA@A?1/A/X-TO6HFAU"Z\0QW%M;R_+)%&'.6V]<<_^/BNHB_Y+%\2/^P/'_Z3 MI5J"_KT+5..WI^3/';KX;:A'H-]JVF:MH^LV^G\W:Z=ZEA66.<1N4$L1)1\'&Y<@'!ZC(%=%H7@/4M;T*;6Y;NQTK2XI/* M%YJ,QC21_P"ZF%8L?H/Y&N;EBD@F>&>-HY8V*NCJ0RD<$$'H:]5UBVFU_P#9 M[\-_V# ]P-,NY4OH( 7:-R7(=@.>IRK'#?Z?+YD3'=@KD@$,.>".Q]#7H_QDO-1T>XNM,TCQ%I]AI,5E% - M"B++(ZM@'"[-O?.=W051M8)="^!^E6&O(T5YJ&O1SV-O,NV2.,%^K:U9:="P62\N(X%8C M."[!0?UKTWQYXMG\!ZPWA'P)MTJVT]$6YNHXU\ZZE*@EFGW[6L]ZKM%%)I6L[2[9I& Z[24"GL.&[ MU6\,_#S4]5\4:+I^MP7&DVNJRR+'-/'L9Q&NYMJMSZ '&,L.M>L?"ZP@TOXD MW^GZ3X1GT^TLXI89=4O&DDEE*L O)PB[N3A1SQS@548\S]XNG!S?OGDOASX= M:CXD\+W/B&+4M+L-/M;@V\TE].T>PA5;/"D8^=0.^>U)8?#S4-5U2ZMM,U/2 M;JUL[<7%UJ27#"U@4YQN8J"#P>,5TFD?\FPZ[_V'%_\ 08*O?#.6"]^$/BK2 M8=-35[Y)X[IM.,CHUQ$-G0H0QP48X!ZX'<9%&-TO(%"+:7EHKEJ]+GUW4K;X=ZWI^G>!%TK1[EH M_M=P\D[!'W#:1YK'G('3VS7FE1));&4TDU8****@S"BBB@ HHHH *^Q?!G^K MKXZK[%\&?ZNNS#=3T,']KY'9U\B_&_\ Y+)KG_;O_P"D\=?75?(OQO\ ^2R: MY_V[_P#I/'58CX"\7_#7J<#5_1-8O/#^N6FJZ;)Y=U:2B2,]CCJ#Z@C((]#5 M"K%C97&I:A!96,337-Q(L44:]68G %<2WT/-5[Z'VSX5\1V?BSPS9ZSIY_=7 M*99,Y,;CAD/N#D?K6O7.^!/"5OX*\'VFCP$/(@\RXE'_ "TE;[S?3L/8"NBK MU8WMJ>Y&_*N;<****904444 %%%% !1110 4444 %%%% !1110 4444 07L, MEQI]Q#!)Y4LD3(C_ -UB, _A7@L&N:;9_ RZ\(W933]?T^[ACN+&;Y9)6^V( MV]<_?!'/&<8],&OH&O/?C/HNFWWP]N[R[L;>6ZAEMEBN&C'F(&N(U8!NH!#$ M?C651.UT8U8NSDNS/0&C1G5V12R9VL1RN?2A(HXBYCC5"[;FVKC9 M6]O=?#?X@:%HUCJ-U>>'M<\V".RNY/,:SD0!@8V/.TYQCW)]*Z'QCXQN-(NH M-#\-V@U+Q'?+N@MR<)"G0RRGLH_6JYE;4KG5FWT,3XN-%([E=LMXX^6%?[D2_P *_P _;I67;?Z%^T5>+-P-0T%'A8_Q M%)0"H]\ G\*AI[OJS-IWN^K1VVMZ3;Z[H5[I=X@:&[A:)@1G&1P?J#S^%>7: M3J4^I?LO7INV+7%KI]Q:N2<_ZLLJC/\ NA:];GGCMK:2>9ML<2%W8]@!DFO& M_#L$D?[+^K3RJ4^UVUY<*I[!F;'\J<]_DQU/B^3/2_ YQ\//#I/ _LJV_P#1 M2UR>C/#JWQ]U74]$=9+*UTA+2^GB.Y)+@R;@N>A8* ..F,54\*_!WP)J7@W1 M;Z]T+S;FZL()IG^V3C<[1J6. ^!R3TJQIMNWPV^(.C>&M-GEF\/Z\D_DVTYW MM:31J&)5NI4@@8.>:6ME?87O6CS+0],HHHK8Z HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "L#QY_R3CQ)_V";K_P!$M6_6!X\_Y)QXD_[!-U_Z M):E+9DR^%GSK^S]J/V+XIQ6Y; OK26#'J0!)_P"TZ^J:^*OA[J/]D_$;0;PG M:JWT:N?16;:WZ,:^U:Y\._=LRM;^ZAM+G'GV\ZOJ6I7BW>HZA=7=RF-LT\[.ZX.1ABLZIJ%Y'=W^I7=S:=G="#D88G(YYJ\WC7Q2SH[>)=8+1_<8W\ MN5XQQ\W'%8E%%V',RY_:^I?V?-8?VA=?8YY?.EM_.;RY)./G9IP M->]?L]> ]S2>,-2BX7=#IZL.IZ/)_-1_P+VKR7P1X3NO&GBVTT>URJR-OGE M_P!5$/O-_0>Y K[/T[3[;2M-M["PB$-M;1K%%&O\*@8%94(7?,S#"TN9\[Z% MFBBBNX],**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*[M_M=G-; MF22+SHV3S(FVNF1C*GL1VKQ[XAZ3X[TCP%>6]UKNG:SI*RVX,MW;M'=#]_'L MY7Y6^;;DGDC/>O9JAO+*UU"U:VO[:&Z@8@M%-&'4D$$9!XX(!^HJ)1YD1.', MK'%:)X)UFX\70>)_'.J6]]?6:,EE:6496WMMPPS#=R21W/\ 08I?\(SXYTSQ MYKVOZ-_PCURNIM&L9OY9Q)%$BX" *F!GJ>3R*](HHY$+V:.*5_BCN&Z#PB%S MSB:ZSC_OFKGC'P?)XAFT_4])O_[,UO2W9[.[V;U(88:-U[J1^7XD'J:*?*K6 M8^16LSS[4M ^(/BBP?2=>U+0]-TZ<;+J32EF>:5.ZCS,!0>AZ]?SW]=\,+<_ M#J\\,Z(L5NKV)M+82$A$^7 R0"?J<$UT5%'*@Y$>>Z18_$[1]$L=,@C\)21V M5O';H[SW.Y@BA03A.O%7=#\':M)XN3Q1XRU*WO-0MXFAL[:RC*P6JM]X@M\S M,1D9/_ZNUHI)/^P3=?^B6I2V9,OA9\41R M-%*LD9VNC!E([$5]V:7>KJ>CV=_']RZ@29<>C*#_ %KX1K[%^$6H_P!I_"?0 MI2>*/^@4?^_\?_Q5SGV#V53^5G-45TO_ KWQ1_T"S_W_C_^*H_X5[XH_P"@ M6?\ O_'_ /%4>SGV#V53^5G-45TO_"O?%'_0+/\ W_C_ /BJ/^%>^*/^@6?^ M_P#'_P#%4>SGV#V53^5G-45TO_"O?%'_ $"S_P!_X_\ XJC_ (5[XH_Z!9_[ M_P ?_P 51[.?8/95/Y6^*/^@6?^_\ M?_Q5'LY]@]E4_E9S5%=+_P *]\4?] L_]_X__BJ/^%>^*/\ H%G_ +_Q_P#Q M5'LY]@]E4_E9S5%=+_PKWQ1_T"S_ -_X_P#XJC_A7OBC_H%G_O\ Q_\ Q5'L MY]@]E4_E9S5%=+_PKWQ1_P! L_\ ?^/_ .*H_P"%>^*/^@6?^_\ '_\ %4>S MGV#V53^5G-45TO\ PKWQ1_T"S_W_ (__ (JC_A7OBC_H%G_O_'_\51[.?8/9 M5/Y6)I9 KV*P@_Q/,A _(DT>SGV#V53^5F M#I=C)J6JVUG$"6FD"\=AGD_@,FOKSP:A$.:\J\#?#D:/*)Y?](O'&#)MPJ#T M7_'^5>WZ'IWV*U4$DZ<==V:]?(OQO\ ^2R:Y_V[_P#I/'7U MU7A\G@3_ (2W]I+6[Z_BW:7I9MI90PXED^SQ[$]^F3[#'>BM%R22[AB8N<5% M=SI?@EX$_P"$3\)#4+^+;JFJ*LL@8?\DX\2?\ 8)NO_1+4I;,F7PL^)J^F M?V<-1^T^ [ZQ8Y:TOF('HKJI'ZAJ^9J]N_9HU'R_$&MZ:6_X^+5)P/\ KFVW M_P!J5Y]%VFCRL,[54?15%%%>B>N%%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4$9n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end GRAPHIC 22 omcl-20201231_g4.jpg begin 644 omcl-20201231_g4.jpg M_]C_X 02D9)1@ ! 0$ > !X #_X1$017AI9@ 34T *@ @ ! $[ ( M 7 (2H=I 0 ! (8IR= $ N 0VNH< < @, /@ M &UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D8R]E M;&5M96YT&UP M;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @/#]X<&%C:V5T(&5N9#TG M=R<_/O_; $, !P4%!@4$!P8%!@@'!P@*$0L*"0D*%0\0#!$8%1H9&!48%QL> M)R$;'24=%Q@B+B(E*"DK+"L:("\S+RHR)RHK*O_; $,!!P@("@D*% L+%"H< M&!PJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*O_ !$( HH$@0,!(@ "$0$#$0'_Q ? !!0$! 0$! 0 M 0(#! 4&!P@)"@O_Q "U$ " 0,# @0#!04$! 7T! @, !!$%$B$Q M008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4 ME9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+C MY.7FY^CIZO'R\_3U]O?X^?K_Q ? 0 # 0$! 0$! 0$! 0(#! 4& M!P@)"@O_Q "U$0 " 0($! ,$!P4$! ! G< 0(#$00%(3$&$D%1!V%Q$R(R M@0@40I&AL<$)(S-2\!5B7J"@X2%AH>(B8J2DY25EI>8F9JB MHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(RKR M\_3U]O?X^?K_V@ , P$ A$#$0 _ /I&BBB@ IKND4;22,J(H+,S' '4DTZ MN6\?3O+HL&AVS%;G7;A;%2IY6,Y:9N/2-7Y]2*3=E<4G97.DMKJ"]M8[FSGC MN()5#1RQ.&5P>A!'!%2UR?@O;I-]K/A< (FFW'GV:^EM/EU ]E?S$^BBNLH3 MNA1=T5[V_L]-MC<:C=P6D 8*99Y B@DX R>,D\51'BSPZS!1K^EDL< "\CY/ MYUE_$+_D!Z=_V&M/_P#2F.NI=5D1D=0RL,%2,@CTI7=[!=WL"LKJ&0AE89!! MR"*6N4\)QK8>)?$NE6/RZ;:SPO!$OW8))(]TD:C^$?=;;T&\XK7N?$>F6UY) M:^;+//#_ *V.TMI+AH_9A&K;3R.#SS33TU!25KLU**J:;JMCJ]NT^G7"3HKE M'QD,C#JK*>5/L0#7+>#?%2R^%H&U(ZE>*O_VK8_V.VJI=1R6"PFM9O<--=* 7@M87GD3/(W+&K%?QQ3[#7=.U.XFM[69A<0J&DMYH M7BE53T;8X#8/KC%.Z*NC0HJKIFI6FL:;#?Z=+YUM.NZ-]I7/..00"#D$8(R* M2[U2SL;JSMKJ79-?2&*W0(S%V"ECT!P >3@?G3N%U:Y;HHJIJNHP:1H]YJ5 MV<06D#SR8_NJI)_E0,DO+ZTT^#SK^ZAM8LX\R>0(N?J:@L=;TK4Y&CTW4[.\ M=1EEM[A9"/J :R/#&BO+#%KNOQK/K-VOFDO\PM%;D11Y^Z , DS+.[CJ@0#<6'=<9'I3[3Q'I MEY?)9)-+#=2*6CANK:2W>0#J5$BJ6QWQG%%T/F7 M%<$97<$X.,$EB %ZG/ J*+Q3I,MU!;O-/;27#!8?M=I+;K*QZ*K2*H8^ MP.:+H.9&E)=6\-Q#!-/''-.2(HV*EK.OIM+36=+CO@AOI'D% MB60DA@A+X(&!\N>N*DU+6+#2(XWU"X$1E;9$@4L\C8SA54%F..< &BX7+M%9 MEIXBTV\O4M$DFAN) 3'%=6LMNT@ R=HD5=V!SQFGWVNZ?I]TEK<3LURZ[Q;P M1/-)M_O;$!;'OC%%T%T:%0I>6TDEQ&EQ"SVQ G4."8B5# ,/X?E(//8@U6T[ M7-/U626*RG)FAP98)8VBEC!Z%D_\ 7Q#_ .D45*XG M+:QTSZQID=K:W,FHVB07KHEK*TZA9V<954.<,2.@'6KET4:Y\+_!T+^6 M$MXK"[8NN6'E*KC:>Q) &?0L.]=1?Z[I^FW4=K?9(9I([K:6$%S!)!(RCJ0LB@D:A9Z=#YVH7<%K%G&^>4(N?J34-EKFDZE,8M.U2RNY%&2D%PCD?@#7/Z%' M%?>/O$<^I*LE]8S0PVBOSY-NT*L&0=MS^9DCJ5QVKHM0TC3]55!J-G#<&-@\ M;.OS1L.05;JI]Q4W;$FWJBY17*:CKCZ=\2+>VG>[:S?29)/)M[>28>8)D 8J MBDCC(S[UK2>)-.@TF\U*Y:ZMK2R0R3R7%E-%M4#)(#("W3L#3YD',C5HK'/B MO2?,=8Y;B<1N4>2WLYI8U8=075"HQWYX[U+>>(=,L;W['+<-)=@!FM[:%YY% M!Z$I&"0/>%X90O3=L^,5@: M;XC^S^,?%-I?M?S1V]W +=(;.:=8U-M$Q **0,L2<>]',A.21V%%58M1MI=/ M:]9G@MT!9WNHF@V =20X! ]S62W!YNH[.9X/KYH39CWSBBZ0- MI;FQ<7$-K;2W%U*D,$*%Y)9&"JB@9+$G@ #G-/1UD171@RL,A@<@CUK'EUS0 M=3\-ZG>2W$5UI-O'-'>OL9D**I\P8Q\PVYZ9SVS6BMQ:V^FK<>9'#:1Q!_,< M[51 ,Y)/08]:+AQG6''KYI39CWSBMM65U#(0R ML,@@Y!%%TP33V%J![VUBO8K.2YA2YF5FB@:0!Y OWB%ZD#(SCIFIZ\MUAI+[ M4M6\1PV@7^.WAW"[QC^]YDH[_P"K6E*5B92Y3U*BFQ2I/"DL+!XY M%#*PZ,#R#6)!XTT*\A66QNI;P,N[;:6DTSJ/]I44E?Q S3NBKI;F[15/3=7L M-7BD?3KE9O*;9*N"KQ-C.UE."IP0<$ \U2?Q;HB7=Q:?;#)=6TWDR6\4,DD@ M?:K<(JDL,.O(!'/6BZ#F1LT5G6&OZ=J5T]K;3LMU&NYK>>)X90O][8X#8]\8 MIFH>)-)TN]-I?W@BN!$)A%L8LREBHVX!W$D'Y1D\=*+H+JUS4HJC8:O:ZC+) M';K._/%% MT',C:HJ"TO;6_LX[NQN(KBVD&Y)8G#*P]B*S1XLTB0M]EEN+Q5.#)96K68NM.N$N(2Q4LA^ZPX*D=01W!Y%5;KQ)IEI?/9 MM-+/K66K?#/Q0]A.)/*TRZ21"I1XV\ECAE8 M J<'."!5JR\3Z7!I\$(DN+AX(467[):37 C;:.&,:L ?8]*7,KBYE:=<1W-O)G;)&V0<'!'U!!!':K%44%%<9X6\3C[/JD>I'4;B6'6+V M)&2PGF546=PJAD0C QGBNGGU:RM-,&H7DXM;; .^X4Q$9Z JP!!/3&,YI* M2:N2I)JY10I)[#.36Q1=,::>P57O M=1LM-A\[4;RWM(LXWSRJBY^I-0ZUJL.AZ%>ZI<@M%9P/,RKU;:,[1[GI^-97 MAKP^888]7UP+=:Y[G/VB5=R6\,;2RLO\ >"("V/?&*+H=U:YH45GZ?KNG:G:)X954]&,;@-CWQBHK_Q-I&F:@UC>W?EW2Q)+Y(C=F979E7: #N)* M/P,GC.*+H+K62UCME#RO>V\EL%4YYS(J\<'FJI\7Z0(// MWWAM\9^T#3[@Q8_O;]FW'OG%%T',NYMT5S/C?5FM_ -SJ6E79Y\AXKBV;=N5 MI4&5*]003TZYK3M]?L[FX2&.'4%9S@&33;B-1]69 !^)HNKV%S*]C3HJA?ZY MI^FW$=O=3G[1*NY((8FED9^,4FG:[IVJ3RP6"=2GU+P3I]WJ$WFS"-HY9V 'F&-F M3>>W.W=^-%];,+N]F;]%8A\8:*(6G6XFDMEZW45I,\ 'KYJH4Q[YQ6H;ZT&G M_;OM,/V3R_-^T>8/+V8SNW=,8YS1=#NF3T5BKXNTEH1,&O/((SY_]GW'E8]= M^S;CWSBK%YXBTBPL[*\N]0ACM;YPEO<;LQN2C.#N' &U&.20..M%T',NYI45 MB-XPT5%62:XG@@8X%S-9S1P?7S60(![YK;!#*"IR#R".]%TP33V"BL7_ (2W M1SO,,\]S'&2'FM;2::)2.N9$4KQWYXK4L[RVU"SCNK&XCN;>4926)PRL/8BB MZ8)I[$U%85MXTT*]MX9K"ZEO%FB695M;2:9E1AD%E12RY']X"M'3=7L=7BDD MTZX6;RG\N5<%7B;KM93@J<$'! /-%TP4D]F7*;)(D4;22NJ(@+,S' 4#J2:R MYO$VEPWDUJLD]Q-;G;,MI:2W'EMC.UC&K '!'!YYI\>LZ3J6G7CK.LL$",+J M-T8-&N"2'0C<.,\$470OFE-@'OG%+F74GF5]36N;JWLK9[B\GCMX(QEY97"JH]R>!1)=6\-Q# M!-/''-.2(HV*I:[<:3'X>N9]<,;Z9Y8:8LAD4KD8X )/;I61 MXB_Y'SPA_P!=[K_TG:ANPV['21W5O-<3013QO- 0)8U<%H\C(W#J,CGFI:SK M*72WUK4X[((+^-HA>D(022F4R<8/R^F:YKP-XL2X\!Z--J7]J7-V]HAFF_LZ MYDWMCD[E0@_4&CF5PYDG9G;454T_5+/5!8,C(4D !*D, >A!] MP11J6J6>D6?VK49O*A\Q(@0I8EG8*H ))+,!P*JX[JURW1110,**** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N0LF_MWXHWMV/FM M/#]L+.(YR#<2X>4_4((U_$UT^H71L=-N;M8);@P1-((84+/(0,[5 Y)/0"N8 M\*^"]/A\.V\GB#2K*[U:Z+75[+/;J[>=(2[#+#. 3@?2I=VTB)7;20GBA_[# M\9:!X@!VP3N=)O#VV2G=$Q^DB@9_VS785S.N^ M!U70;VQMM*L+.>:%EAN(; M9$>)\?*P8#(P<'BM+PU?7FI>&;"ZU2UEM+YX0+F&5"A60<-P>V02/4$&A73" M-U)W,;XD(TGAVQ1)&B9M8L )$ W(?M*2%9YIQ):YGE<;GD.9LDDDGFK&G:==ZUX MDO=:U6R>SM7LO[/M;:4CS&C+%I'< D+DA0!U '.,XI-!O;OPUI<.BZY9WLHL MD$%M?6ML]PEQ$O"$B,%D<+@$,,9&03FDMR5OY"Z?!J+_ !"DU)='N;"QNM/\ MNZ:>2']Y,CCRSA)&).UG&?0 >E+\-_\ D0[/_KO<_P#I1)6SI^J/J-Q*$T^[ M@MT V3W,?E>8>X"-\XQZD"N=\+74GAG29-%U:POQ+:W,YBFM[.2>.XC>5G5@ MT:L%.' *M@Y![-[77VL;J?3[G33:3&"%I)+=P^]2T M:Y8@@L/E!P0,]W3Q?X;OK"U^TVCDJ89KFU>+;*C!T8*X!(#*O;M2Z-! MT:'VVH7%G:Q6UKX5U*&&)0D<:/:@*HZ #SJYX65]9>&?''GZ?+I]A<1S7-G# M*\9*EX/WN C, #(&;KU8UO6GB:1+=4UO2=1L[Y5_>QP6@Z^W:GHP=FMRQX4M8;+ MP?I%O:QK'$EG%A5'J@)_4YK7JAH4;P^'=-CE1HY$M(E9&&"I"#(([&K]4MC2 M.QR_CS-II%GK:&0>JLI!_0UR/PYL]5>&\U/Q%;36] M_LAT]1,I4M' F"X![-(TC#U!%2][$2^*WGQ^TCXEE_0PC\*L^-+&XOO"ET=/0R7UH4O+ M15'+2Q,)%4?[VW;_ ,"IO@FUN(?#:W5_#)!>:E/)?3Q2KM>,R,6",.Q5=JX_ MV:/M6"WO6^9=NM6TS2[IH/O7UA:25O]IE0$C./O' XZUS,EY>77Q8T M*6;3WL(&TV]1#*Z^;+AH"=P4D!1\I )SG.0*M:+/)X=U#6(-8LKUY+K4);J* M\MK.2=9XG.44F-6*E%PF&QPHQUJ*274M2^(^A:@VDW-OIL-M=P)-*IWEG$;9 M=1_JU/EX&X@D]AQE-W0F[HM^&A_8_B;6] /RPF0:E9KC \N8GS%'TE#'_@8H MT_\ XG7Q"O\ 4#\UKHT7V"W)Z&9]KS,/H/+7ZAJB\>3R:$MCXJM86FDTUFAF MB0?--#-A=OO^\$1_ UK^%=)DT;PW:VURV^[8&:[D_OSR$O(W_?3&A;V!;\O; M^OZ]"SHVBZ?X?TJ+3='MEM;.$L8XE8D+DECU)/4DUC_$>-Y/AOKHB!8K9N[ M=2J_,P_(&MC1M4&LZ3#?+9WED)=W[B^@,,J88CYE/3.,CV(JW+%'/"\,R!XY M%*NK#(8$8(JK)JR+LG&R"&2.:".2%@T;J&0CH01Q3ZY72#?^$;<:3?6MU?:7 M;_+97MLAF>.+^&*6,?.2HX#*&! &<'KN")5^),T9S%Y7E9[%ULQN_F!^%=3X5MH+/PCI4- MK$L48M(B%08&2H)/XDYK,E\/MI'PYU73H6DO;R>TN9)I0I+W,\BL6; ]2< = MA@5M:%&\/AW38Y4:.1+2)61A@J0@R".QI16I,4T]3F]'L+2/XN^(YTMHQ-]A MLY!)MY5G,JN1Z;A$F?7:*L_$50GAFWO5 %Q9ZG92P/CE&-S&A_-78?0FI=-M M;B/XEZ]=/!*MO+8621S%"$=E:?< >A(W#([9'K2^/K6XO/"+PV<$D\IO;)MD M2%FPMU$S' [ D^@!-+[+^8K>X_F5;FU@N/C%8RSPI(\&BRO$S+DHWG(,CT. M"1^-6_B% D_PX\0>8,F+3YIXSW5XT+HP]"&4'\*1[6X/Q2ANQ!)]F&C21&;8 M=@ ?$%O:Q/-/-IERD<4:EF=C$P"@#DDGC%/HQVTD9 M6IRM/XK\#S2'+R&X9CCN;9C4WA_&I>-_$FHS_,]C/'IUL&_Y9H(DD?'IN:3G M_=7TIEY9W3>(/!:9J MHC:Y%NN^2VF1=@?8.65E"@XR05'!!.%UO_6PNM_/]#J*X/P3J5T]A?:L=!O[ MNXU*^GD>YC>WPR+(T<:#=*&PJH!@CU]:ZBTUV._O(H;2QU$HX)>:>SDMTC&, MC/F!22>F #[XK(T[[3X1N[VSN+*YN=(GN9+NTN+2%IC"9&+O$\:@O]\L00", M-@X(Y;U:8WJTQE]'JE_XMT'4K30KRT:VEDBNYIY+< VSQMD'9*Q.)!&0,=JC MTK_D8?'O_7Q#_P"D45;]IK7V^_6&UTZ^$&TE[FX@:!5/8;7PQ)]ACWK&TRSN M8]=\;2/;3*ES/$8&,9 E LXE)4_Q?,"..X(I6_KY":[?UH6OA]_R37PW_P!@ MNW_]%K565+WP_P",M2U5M.GU"PU.*%3+:*'EM6C!&TIG+(^QWTMO>Z9J*1J1Y=Q#;-< M)*#_ -<]S*?9@*?V4-?"KDNEZ]I>N,XT^Y62: @R0R(TA:-P&7//4#O6 ME7*E)=;\;Z7J=E97-M;:?#,LUU<0F%IQ( !$%8!R 1N)( RHQG)QU54GPJ5BO+64Q3(I.=NX=5S_"V1[5BWU]KO@VW^W:G>+KFB MQ8^TRO"(KJV3./,.S"2*.X"J0,GGI6O-KLUE?S0ZAI%\D"G]U=6L9N4D'NJ MNI]BN/0GME^)+NY\2Z)=:%HMC> ZC$UO/=W5L\$=O$XVNW[P LVTG 4'G&2* MEVZ;DRMNMQ[$-\7+SDC>5BIX564,3]!2Z-">TD=-I]K#9:;;6MK&L4,,2I&BC 50, 55N]5TS2[ MMHG.;R8!S!;PF2:3C 8J@)QQC)XXZUH1#$* \':*Y/2II?#VLZVFKV5Y(;V] M:Y@O;:TDN%EB*J%1O+4E2F"N" ,8()R:IZ%MVL5+N\O+SXG^&I9=.>QM_L]X MB-.R^;+\J$_*I.%X!Y.2>PQSH>&?^1U\9_\ 7];?^D<-5+FXU'4_'_AZ]72+ MJ#3815"'+/&"&9 /W:?)@%L$DXP.,SVSS>'O&FNSWME=R6>K/#<07-K; MO.%98EB9&5 64_(""1@YZ\5*WOY_H9K>_G^@SQW-)-J'AW2A:2WEO>7YDN+> M(H#,L4;2!3O95QN"D@GG;6N^JW%]2:-EVLC/:D$>F/.Z55URTN-*(3%^]TS5XKC'-N=.E8 M@^F]08S]0V/>GU*ZO4Y%[/4+7P3HOAO58)+:*^UHV'EO(K-]C#2RHA*EAS'& MJ$ G@XKT=$2*-8XU5$4!551@ #H *P-=TZ]\0>';6>WA^PZG:SQWMM#<,"%D M0YV.5R,,I*G&<;N^*D@\4*]M_I.D:M!=JOSVOV&1\-Z"108S]=V/I0K((VBS MDDABM_A;\08H(UCC6;50J(, ?(W05KZL/M]WX/T:8_Z+<$W,Z=I1#$&53[;V M5O\ @-9-@EYJ'PP\B M:AI<8;4M(99D@D;8)E,922(D_=)5C@GHP&:A;$+5?UW.GHK#_P"$JA-N2FE: MP;G'_'J=.E#;O[N\CR_QWX]ZVU)9 67:2.5)Z5K=,V33V,;Q?K;>'O"=_J,2 M[[B./9;1_P!^9CMC7\6(I?#N@1:-X0L]%F F6.W\N+0KC0;IR]UH%R]@Q8\M$.86_&,I^(-+\,8(H/AUIG MDQ)'Y@=WVJ!N8NV2?4^]1Q:,/#GQ$MKG1M.$6F:M:M;7:6L.(XIHR7CD8*, M%2ZYXYVUG_#OQ!]C\#:?;ZAIVH1A%?RIH+22XCE7>V"#&K%3V(8#GIDJJ%& #@GN/2F-:P MR_&47$D:M+!H0\MB/N[IV!Q^'%.U/[3XNNK.QM[.ZMM)AN([F[N;J%H3-Y;; MTB1&PWWU4DD 8&!G/%E;6X_X6A)=^1)]F.C+&)MAV;_.8[=W3..<4;NXWJ[C M?']Q)%X2>W@D>)]0NK>Q,B'!59IDC8@]CM9N:Z"VMH;.UBMK2)88(4"1QH,! M5' K/\ $^C-KWAVYL(I1#.VV2"5AD)*C!T8CT#*,^U5K;Q,RVBC5M)U*UOE M7$D$5G).A8?W9$!0@GH20?4"JV>I6TKLI:.B:?\ $+7M)B4"UNK6#4A%_"LC MM)')Q_M>6I^N3WK3_P"$@T^(FUTN":_>'Y/*L(=R(1_#OXC4CI@L*R+?1-6U M&T\2:E-_Q+M3UBV-M9HS M:1JC"/<5R-VYV8X)QG':I]%UN+3] M+*31=3M; MFVA6)K.*PD90P&"%D \LC/0[A[XJ4[$IV,C0-2O+"?Q_?7=JEO+;W(N1;(^Y M5Q9QL,XXW$!=V.^>3UKH_!E@NG^#].7<9)IH%N+B9OO2RN-SN?T749X9%0DLC1FW6/&_&"PV'#4N@WMUX9TN'1-U;VFJT>E6B.I5EA0%2,$':.*K[1:UE6"1(9Y+4Q2,A"R8A .T] M#@\<5T=$=AQV.6\ ?\@O5_\ L.ZC_P"E+T7RC4OB=I]I3PU<:MI^J6-]MEU*XO+:XM[22>.6.9S)UC#;6!8J0V.@( MSFK6JP7B:QIGB?2K.:X*6[6]W9$!)6@?#94,1\Z,H^4GD%AUQ4_9(7PI&[J& MGVVJZ;<6%_$LUM2M-.B-!)*_60QNT>X^YV MY_&B^\1SS6+QZ!IE_<:A(I6(7%G);QQL>C.\BJ-HZG&2>P-7_#VD+H'AVQTM M)#-]EB"-*PYD;JS?B23^-5N]"MY71E?$<'_A7FJN 2L4:2R #/R(ZL__ (Z# M73*RNH9"&5AD$'((IEQ!%=6TMO<1K)#*A21&'#*1@@_A7,Z7-J/A2!-*U*TN M]0TZW79::A;1F9Q$/NI+&N7+ <;E!# 9.#U-G<-I7.JKE;51J?Q0U![CYET> MQ@CMD/1'F+L[CW(1!^!]:OR>(VE98]*TG4;N9O\ GK;/;1K[LTH7CZ GVJKJ M-K>:1XM_MZRM9;RUN[9;6_@@ ,B;&9HY54GYL;W4@A9HW!PT;J,HZGL58 @^U7*^)8OAK>ZA&LAN[A;IU8#&_P"Q MR.#CV8 UN:WJMWK.ES:9X=LKT7-XAA-U";;3[>62UTZZ='=4)$:"TE0%B.G) R>YJ9:O0B6KT\OS.MKDOA9! M%!\+= $$21A[-'8(H&YCR2?X8 @YZC!+=E)%MI25_/]#6U&---^)FC75L/+;5X)[2["CB7RU\R M-C[KAQGT;%+X%"WL.JZW*-US?ZE<(7;DK%#*T4:>P 3./5B>]26-O>ZWXKBU MN]M);&RL8'AL8)P!)(\A&^5E'W1A0J@\\DD#.*CT\7/A34]1MY[.XN-)O+E[ MRWN+6%IC"\AW21NB9;[^6! (PV#C'*ZW)6]^@>.P+*STW7(AMN=.U&V"NO!: M.65(9$^A5^GJ >U1Q6T,GQIN[EXU::'0+=8W(Y4-<3YQ]<"GZDMSXLU'3[2" MSN8-*M;J.[NKBZA:$S-&=R1HCX;[X4EB ,+@9SQ/!:W ^*=]=F"06S:-;1+, M4.PN)YR5#=,@,#CW'K1N[@]97-^Y6!K=_M8C,*C>_F@;1CG)SQQC.?:LH^)$ MN4_XDEC=:F2/EDC3RX3[^8^ 1[KN^AJ'QK87FH>'U6PA^U&"Z@N);0$ W422 M!FC!/&2!T/!Q@\&I&\2K)"%TW2M3N+EAA89+*2W4'_:>10H ]B?8&J;U*;UL M=V.A:M>?!JXTPE01'&3NF:F M.GW(F&EK]D3WNI7"_:(I(,>7%(8D0;Y5( "=,#DD]ZN MZI'J>H^(M!O[/0;VUEL[HK//-+;X^S.C!U.V4D_-L;&.JBI+,77A/5-1BFLK MBZTB]N7O(9[2(RO!)(!P,2 ,Q)] 1UYH2TLP2TLV:E<9K+WL?Q6TDZ=;P3R_V/=Y6>Z MIKVH:XWANX%IH;7-L98KR&5KAIDSAUBRJ!77(Z@\," <'$/C.SBTCP9I7A_3 M+:1K.YO+;3V@A90[PYRR98@?,J$')&=QK?\ $VA?V[I82WE^S7]M(+BQNL9, M$R]#[@\J1W4D5FW,-_XO\%Q.UJ^E:S;S),D5PC!8[F%P>N/FC8KC<,Y5OPJ6 MGJB6GJC135KR*-8X_"^IHB@*JK):@ #H /.KF8O#6KWG@G7M(2R_L]7U$W&F MV]S(A4Q;XYO+/ELP52XD7'8'I716_BA?) U'2M4L[L#YX%L99U!]I(U*,/0Y M'N!5AM6O%TC[=_8EX7\S!M T?G;,XW8W8Z<[,K&W5$UVV MN]#E)VD7L)$(/3 F7,>/3YAGTJGXWMX)[SPC%+%')$=>1MC*"I(MYR#CZ\UH M7/B.UFLY(X]*U2\D="OV5M-E029'*EI%"8[$DXKD]5L]0\.>%? 5I+ U]>V6 MJ1*T$<@RV+:?**S8!P.!D@' Y%)O0F3T[GI$L49M:1$AUM=$@D#8:."6>,!0>ORQR[0>V!78S>*5-N?L&D:M=7 M9X2W:QDA&[WD=0@'JMJNIZ]JT!MKG4#''#;$@M!!&#L#$$C<2SL<$@9 [9I[M6*T;5BE M\*K:"U^%N@BVA2(26BR/L7&YFY+'U)]:D51!\76$0"?:M%WS8XWM', A/J0' M89]*F^'=K<67PXT*VO8)+>XBLHUDBE0HR''0@\@T/:W!^*4-V()/LPT:2(S; M#L#F9"%W=,X!.*2^%$I>Y'Y&?H5S/X-M+C3-9TZ\>W6ZGGCU*T@:=)EDD9\N MJ9=7&[!RN.,Y]-J]U&QU;PCJ5YIES#=0M:3+YL3 \A6RI]"#G@]*2'Q.@7;J M&E:K93C[T?V&2VT^[GD\5ZJEC-:0:E:K'!;.@$DKI&X,A0 M<@MN5<'DA!GTHVT0;*R,V\@BN? OP^BN(DEC:[T_*.H(.(2>AKT1U61&1U#* MPP5(R"/2N U&UU.#P+X*^RZ7NR)O+E5![+YFT>@ %=5XB_Y'SPA_UWNO\ TG:LK5_#VHVWPJUN":,W M>K:B[W<\=LA?,CN#L4 9(50%!QR%S6UKUK<3>-/"T\,$DD,$UR99%0E8P8& MW'MD\,?\ *IM# MM;B'QMXHGE@D2&>2U,4C(0LF(0#M/0X/'%9WA"]D\->%+30M6T[45N]-C-OF M&RDFCG53A71T!7YA@X)!!SG&*:T?WE+1W?G^9;4?V+\2V ^6V\06V?;[3 .? MQ:(C_OU1JO\ Q.O'VF:8.;;28SJ5SZ&0Y2!?_1C?\!6K'C:VEE\-M?V:EKO2 MI%U&W7IN:/ED_P"!)O3_ (%4?@F)[G3;G7KA&6?6YS=@.#E(B[-F_\ 9S0K<\;#.I9.HR#@@\C(SVZX M/2LN27Q3)"4CL](MY","8WDLH7W\ORES]-P^M;=%*PFKF9X?T6/0-'2QCF>X M?>\LUQ(!NFE=B[N<=RS&M.BBGL"5E9!1110,**** "L;PCH]QH'A2QTR\>-Y MK=&5VB)*G+$\9 /?TK9HI6UN*VMPK%T#1KC2M1UZXN'B9-2U#[5$$))5?)C3 M#9 PF>,5M446"UPHHHIC"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ M HHHH **** "BBB@ K%\'Z/<>'_!NE:3>O&]Q9VR12-$25) [$@''X5M44K: MW%;6X4444QA1110 4444 %%%% !1110 4444 %%%% !1110 5B^(-'N-5O-" MEMWC5=.U);N42$@L@AE3"X!YS(.N.,\UM44FKB:N%%%%,84444 %%%% !111 M0 4444 %%%% !1110!A:[I^K:U'-I:_9;73)\)-<+.[3O&0-Z!-@"D\KG<>. M<9/&W'&L4:QQJ%1 %50. !VIU%*PK:W"BBBF,**** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,CQ)XJ MT;PAIL=_XBO/L=M)*(4?RGDRY!(&$!/13^5_]#!_Y)7'_P ;K _: M1_Y)S8?]A6/_ -%2U\R5RU:TH2LCBK8B5.?*CZY_X7A\/?\ H/\ _DE'P]_Z#_\ Y)7'_P ;KY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A M>'P]_P"@_P#^25Q_\;KY&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE' MP]_Z#_\ Y)7'_P ;KY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P] M_P"@_P#^25Q_\;KY&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z M#_\ Y)7'_P ;KY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@ M_P#^25Q_\;KY&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ MY)7'_P ;KY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^ M25Q_\;KY&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7' M_P ;KY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_ M\;KY&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ; MKY&HH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_\;KY M&HH^L3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ;KY&H MH^L3#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_\;KY&HH^ ML3#ZW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ;KY&HH^L3 M#ZW4[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_\;KY&HH^L3#Z MW4[(^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ;KY&HH^L3#ZW4 M[(^N?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_\;KY&HH^L3#ZW4[( M^N?^%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ;KY&HH^L3#ZW4[(^N M?^%X?#W_ *#_ /Y)7'_QNC_A>'P]_P"@_P#^25Q_\;KY&HH^L3#ZW4[(^N?^ M%X?#W_H/_P#DE'P]_Z#_\ Y)7'_P ;KY&HH^L3#ZW4[(^R-%^* MW@SQ%K$&EZ/K'VB\GW>7%]EF3=M4L>60 < GDUUX8-TKXS^&=PUK\1M+F0X9 M3+C\8G%?7&B71FM$,C#+<#)ZG&?Z5TTIN<;L[*%1U(W9#XC\8Z%X3^S?\)!? M?9/M6[R?W+ONVXW?=4X^\.OK6'_PN+P+_P!!S_R4G_\ B*XG]HGKX=_[>?\ MVE7B=<5?%SIU'%)'G8G'5*55PBE9?Y>I]1?\+B\"_P#0;_\ )2?_ .(H_P"% MQ>!?^@W_ .2D_P#\17R[16/UZKV7]?,Y_P"TZW9?C_F?47_"XO O_0;_ /)2 M?_XBC_A<7@7_ *#?_DI/_P#$5\NT4?7JO9?U\P_M.MV7X_YGU%_PN+P+_P!! MO_R4G_\ B*/^%Q>!?^@W_P"2D_\ \17R[11]>J]E_7S#^TZW9?C_ )GU%_PN M+P+_ -!O_P E)_\ XBC_ (7%X%_Z#?\ Y*3_ /Q%?+M%'UZKV7]?,/[3K=E^ M/^9]1?\ "XO O_0;_P#)2?\ ^(H_X7%X%_Z#?_DI/_\ $5\NT4?7JO9?U\P_ MM.MV7X_YGU%_PN+P+_T&_P#R4G_^(H_X7%X%_P"@W_Y*3_\ Q%?+M%'UZKV7 M]?,/[3K=E^/^9]1?\+B\"_\ 0;_\E)__ (BC_A<7@7_H-_\ DI/_ /$5\NT4 M?7JO9?U\P_M.MV7X_P"9]1?\+B\"_P#0;_\ )2?_ .(H_P"%Q>!?^@W_ .2D M_P#\17R[11]>J]E_7S#^TZW9?C_F?47_ N+P+_T&_\ R4G_ /B*/^%Q>!?^ M@W_Y*3__ !%?+M%'UZKV7]?,/[3K=E^/^9]1?\+B\"_]!O\ \E)__B*/^%Q> M!?\ H-_^2D__ ,17R[11]>J]E_7S#^TZW9?C_F?47_"XO O_ $&__)2?_P"( MH_X7%X%_Z#?_ )*3_P#Q%?+M%'UZKV7]?,/[3K=E^/\ F?47_"XO O\ T&__ M "4G_P#B*/\ A<7@7_H-_P#DI/\ _$5\NT4?7JO9?U\P_M.MV7X_YGU%_P + MB\"_]!O_ ,E)_P#XBC_A<7@7_H-_^2D__P 17R[11]>J]E_7S#^TZW9?C_F? M47_"XO O_0;_ /)2?_XBC_A<7@7_ *#?_DI/_P#$5\NT4?7JO9?U\P_M.MV7 MX_YGU%_PN+P+_P!!O_R4G_\ B*/^%Q>!?^@W_P"2D_\ \17R[11]>J]E_7S# M^TZW9?C_ )GU%_PN+P+_ -!O_P E)_\ XBC_ (7%X%_Z#?\ Y*3_ /Q%?+M% M'UZKV7]?,/[3K=E^/^9]1?\ "XO O_0;_P#)2?\ ^(H_X7%X%_Z#?_DI/_\ M$5\NT4?7JO9?U\P_M.MV7X_YGU%_PN+P+_T&_P#R4G_^(H_X7%X%_P"@W_Y* M3_\ Q%?+M%'UZKV7]?,/[3K=E^/^9]1?\+B\"_\ 0;_\E)__ (BC_A<7@7_H M-_\ DI/_ /$5\NT4?7JO9?U\P_M.MV7X_P"9]1?\+B\"_P#0;_\ )2?_ .(H M_P"%Q>!?^@W_ .2D_P#\17R[11]>J]E_7S#^TZW9?C_F?47_ N+P+_T&_\ MR4G_ /B*/^%Q>!?^@W_Y*3__ !%?+M%'UZKV7]?,/[3K=E^/^9]1?\+B\"_] M!O\ \E)__B*/^%Q>!?\ H-_^2D__ ,17R[11]>J]E_7S#^TZW9?C_F?6N@_$ M#PUXGOWLM$U+[3<)&963R)$PH(!.64#JPKI 0>E?+GPINWL_%TKQG!:T93_W MVG^%?2NFS[[-'D8#.!DGN>!7H8>HZL.:1ZV%K2K4N>1:N+B.TM9;BX;9%"A= MVP3A0,D\>U8/_">^&_\ H(_^0)/_ (FM'Q%_R+&J?]>DO_H!KPFL\17E2:43 MFQN+J8>244M3V7_A/?#?_01_\@2?_$T?\)[X;_Z"/_D"3_XFO&J*YOKE3LC@ M_M2MV7X_YGLO_">^&_\ H(_^0)/_ (FC_A/?#?\ T$?_ "!)_P#$UXU11]^&_^@C_Y D_^)H_X3WPW_P!!'_R!)_\ $UXU11]< MJ=D']J5NR_'_ #/9?^$]\-_]!'_R!)_\31_PGOAO_H(_^0)/_B:\:HH^N5.R M#^U*W9?C_F>R_P#">^&_^@C_ .0)/_B:/^$]\-_]!'_R!)_\37C5%'URIV0? MVI6[+\?\SV7_ (3WPW_T$?\ R!)_\31_PGOAO_H(_P#D"3_XFO&J*/KE3L@_ MM2MV7X_YGLO_ GOAO\ Z"/_ ) D_P#B:/\ A/?#?_01_P#($G_Q->-44?7* MG9!_:E;LOQ_S/9?^$]\-_P#01_\ ($G_ ,31_P )[X;_ .@C_P"0)/\ XFO& MJ*/KE3L@_M2MV7X_YGLO_">^&_\ H(_^0)/_ (FC_A/?#?\ T$?_ "!)_P#$ MUXU11]^&_^@C_Y D_^)H_X3WPW_P!!'_R!)_\ M$UXU11]R_P#">^&_^@C_ .0)/_B:/^$]\-_]!'_R!)_\37C5 M%'URIV0?VI6[+\?\SV7_ (3WPW_T$?\ R!)_\31_PGOAO_H(_P#D"3_XFO&J M*/KE3L@_M2MV7X_YGLO_ GOAO\ Z"/_ ) D_P#B:/\ A/?#?_01_P#($G_Q M->-44?7*G9!_:E;LOQ_S/9?^$]\-_P#01_\ ($G_ ,31_P )[X;_ .@C_P"0 M)/\ XFO&J*/KE3L@_M2MV7X_YGLO_">^&_\ H(_^0)/_ (FC_A/?#?\ T$?_ M "!)_P#$UXU11]^&_^@C_Y D_^)H_X3WPW_P!! M'_R!)_\ $UXU11]R_P#">^&_^@C_ .0)/_B:/^$]\-_]!'_R M!)_\37C5%'URIV0?VI6[+\?\SVF#QMX?N;F.""_W22N$1?)D&23@#)6MU7#= M#FO +*0PW]O(O5)58?@:]C\.7CW5J&>G& M:C%R=D7&#F[(\PHKZ3T/0]'\'IX0\)^(/#.D7FH:M]J6YNI41V0I\RG)4EMP M8 Y([YZ^P)K1TI=#5X>5M# MQ>BG21O#*T?]M_L.7[/]GSY MGF8.W9CG=G&, M@._@_0UZQ\5]"L_%>DI;V*_\5!HNF17J1@?-:*^A_#VKQ6.C_#?3KX@V.M:??:?.K-A3O,>WCH26 7_@1KB_AKX?\ M^$<^(&O:EK"EH?"4$\DA(QOD&Y4P/73;Y[@:E+(WJS*"3^9K$\$ZMKFO?$[7=)URXGU/PT'NA?)?N9(;>- M2VT@MPAR .,<9].'[/S'[%72OO\ Y7/$J*]4OIQ\./AMHUQX> CUCQ"TLS:D M4!DBMU(VHA/W20RDX[Y]L+X.U"Y^)6B:SX;\3,=0O;6P>\TR_FYFA=, H9.I M5LCKGH?;$\FMNI/L]>6^IY517T%XGT&T\7_#+PWH\"XUZS\/V]_8 =9T$:K) M$/?A2!ZX[ UAZ=%Y_P +?AM%_P ]/$87\YW%/V>HW1:=KGC-%>S?'O3(=1OK M#Q'I8\P/-+I=R$Y(FB=@!CU.&'_ 170^*=%M-*^$VDZ' RFXT'4K)KO:W2>3 ME\_]_L_B/2CV;NUV'[%W:OL?/%%>U?%'_A8O_"R=4_X1S_A*/[-_<^3]@^T> M3_J4W;=GR_>SG'?-7OAQ<6=Y\*=?A\;R32PW^LBUNYKEBTD;ND:J[%NU'L_>L+V/O.-SP>BO8_!VA7WA*R^)>E7A9+FSTLA9%XW#:Y5U^HP:;\- MO%&OWWA+QS-?:YJ5S+:Z49('FNY':%MK_,I)^4\#D>E"AM<2I;)O^D>/45T4 MMOXI\6:1=:S>75UJ=II8Q+-=WH_\ (^:=]9/_ $6U?5&F_P#,&_Z^V_\ 1$M=E'X/G_D>AA_X7S7Z M'GO[1/WO#O\ V\_^TJ\3KVS]HG[WAW_MY_\ :5>)UYN+_C2_KH>/CO\ >)?+ M\D%%%%N^$?^/(5Y%!_P ?$?\ OC^=>N^$?^/(5Z>"^%GO MY5\$O4Z:BBBNX]@\A_:1_P"2=6'_ &%8_P#T5+7S+7TU^TC_ ,DZL/\ L*Q_ M^BI:^9:\^O\ &>5BOX@4445@V^(_#FI>'?@5+9>.5MC MPKQ6VD$-W#*V=J.K''H#7L'Q-TC0?%^DZMX MV\)ZY<:@]O-#]LMF1ECB4J$!4,H.> >_>M8;,WI_#)]2*T^&NG7D&G/XW\9R MV?B75XUEM()29&4-]S>S,/%=I>,MWXRTZU\K3Y+V5 MG11RI8$Y.,&/'L<<9-6]8\#O\3-:T?QEHNJVD6EO;PB]\R3:]HT?WU '' ]Q MSSTYK(FTS2/B-\3/%GB.ZU.;3M TY$+WML/F8A1&I'!R#L8],]/6M;6::1OR M\K32_P"#IN><>+=!U7PYXENK#7RK7V1+(Z/N#[QNW9]\UBUV?Q5US3/$'CR> M]T.Y-U9B"&))BA7<50 \$ _I7&5SRLI.QR324FD%>B?"N\M(--\86MU?6EI+ M?:++;VPNKE(1+(P("AG(&SB9F!9%!) M"X!R>.^![T1;3T"#:E=#;CPKJ%K;23R7&D,D:EF$6LVDC$#T5926/L 37?\ MQ \:II/Q1T+7O#E];WGV338$D^SSJZ/\S[XF(R!D'![C(-<;KO@#6?#_ (5T MKQ#=_9Y=/U-%>-H'8F+^)GBW0;GP"T^@W-LVI^*9+>?4H8I0[PK%&OR, ?E.X M#@]?F]Z\O\6^$]2\&:^^D:P(S,J+(LD+$I(IZ,I(!QD$=!R#6I?_ R\0V?C M&#PS$D%[?S0+< VSGRTC.?F9F P!CG\.I--RDV]"W.;&?X5&;5 MK&,6$5\+LMZU"\FL=&U_0M3U"($_8[:Z??)@9(0NBHYP M.S&LV\\&ZE8^#8?$DS0_99+QK*2 %A-!*N[(D4J OW?7N*?-+L'/-+;^K6.K MDGT_QE\/]/T"\U:RL-?\.R2Q0-=W"K!=PL>BR_=R,*!S@@<=<@\.S:?\./#V MKZEYQR&G>$[_4?">J>(UEM MX+#372.0RLVZ5V. J Y/(SG Y'OB]!\/-;N/A[-XQC\@Z=$Y4Q[F,K ,$+! M0N-H).>>QJ;O>Q**DTYOA_J7A_4+>:\TO1[<2"&4/Y;A0&C< \ M<9!![$UW]SXG\(ZE_P (583UX.1CJ M*\-T3PY!KDEM FOZ9:7=U*(8[6X2YWEBVU>4B9>21_%]<5J7OP\DL?$J^'YO M$6CG5FN8[86RBYSO=E ^;R=N/F!//3WXJE*6Y<:D]7;<[_P-XI\/WGB#Q3IO MBB]MH[#^UVUFQEEF55:1)B3M8G!+#9@#J-U96B^,(->\->,WU6]M[:YN]4L[ MZ".XN%0NOGCSN#H4S0W$43N7D*J&)C&WD8 M.><'CI6'X>\*7WB6TU>XL9;>--)LWO9Q,S LB@DA< Y/'? ]Z.:6BL+GFK)K MO_7R.P^*.D/XC^).J:KHVI:+&E!'((Z4VVGM=,^! M7B#1;N_L?[1.K1.MO%>12LZ[8CN78Q##KR,@8/H:YG1_!&HZKH:A*8TE?NJ LQ^@['T-,U'PA)9:"VKV>LZ1JEJCJD@L[AO,CW="TV\'B+#=/*%>]B"L8L9^ M^PR1@9.3D]17(_#;4[&Q\)>.8;Z]M[:6ZTHQP)-*J-,VU_E4$_,>1P/6N3\+ M>'+OQ;XDM=$TV2"*YNM^Q[AB$&U&/]&N+D)/-G_GFG\59==/9 M^!;^7P]'KFIWUAHVGS$BWDU"1PUQCJ41%9F'OBFZOX%U32$T^X\ZSOM/U&01 M6^H64ID@9\XVDX!4CT('0^AJ.5VV,G%VV.:HKN;CX775MXH?PY+XCT)=84J/ MLK23KN9E#*H=H0A)## W=ZX_4=.N])U*XL-2@:WNK=S'+$_56'\_J.#0XM;B M<7'(;? M1]!UW2KVXFC>0NHN$2,* ?F+Q*><\8!Z&+A4@U M!KQ;/]X2$#LP4'.,[>0>E;(^%][+K]SH5GKVBW.L6VX&Q669'=E&2JL\2HQ^C4_ M\CYIWUD_]%M7U1IO_,&_Z^V_]$2UV4?@^?\ D>AA_P"%\U^AY[^T3][P[_V\ M_P#M*O$Z]L_:)^]X=_[>?_:5>)UYN+_C2_KH>/CO]XE\OR0H!8@ 9)X %>M3 M_!*%K&SMK7Q!!%KTELLTMA=$#.?[N.0 01G!Z=JY;X5>'O\ A(?']DDR[K:S M/VJ?/3"= ?JVT?3-4O'OB-_$?CJ_U.&1O*67R[9E.,1IPI'UQG\:F"A&'--7 MN334(4N>:O=V7ZD&N^"/$7AR?R]4TJ=%)PLL:[XV^C#(_K60EE=22B*.VF:0 M]$6,DG\*]HT#QEKF@? Z;7;J]>\O)+P0V1N_GVKD CU/W7[UKR?$;5M)^%*> M(M;^R-J>HL4T^*&(@*.S-DG.,%OR'>M?84WK=K2YM]6I/7F:TOMT/$8?"7B. MX4F'0=2< 9R+1_\ "LN>WFM9FBN89(9%^\DBE2/P->A6?Q(^)>N.QTF6XN1% MRPM;!' ^N%-7!\8)[C-CXY\,6.IA#M??%Y)Y97.%2-2S,?0 =:ZG4OAIXFT?PNVNZE9+;VR, \3/\ MO4!. Q4=!G ZYYZ5Z7K.O:5X'\%:?XA\ ^'[2-=7)!NI>(O$U]H?B^]DO+;78&A'F'Y4?!P%'1<@D<=\5HJ--2Y)/5_=Y&J MP]*,E3G+5_=Y'D]=-X(\+V_B6_OCJ%Q);V6G6;W=P85#2.J_PJ#W]\'I[UE: M_HUQX?\ $%[I5V/WMK*4)Q]X=F^A&#^-2>']8U;0-1.J:&\D&-%\*Z39-XHDOKC5;Z(7"V-E(D0@C/3>[*WS'G@#L1[UHP6N MC^.?".N:D-)@T?5M(A6X:6R)6"=>?E,9.%)"GIWQ]*;\8T:Z\46>LP?/8:C8 MQ26TH^Z0!RH]QD''O6SC:#GN=+@E!U-'M;\>GX&9JOA"TN/#MMK_ (1FN;NR MEN!:S6UPH,]O*?N@E>&!R,'CJ/7B;7/#_AKPC<1:9K4NHZCJJJK72V,T<44& MX9V@LC%B ?8=.E=!X)N(_#WPQEU#5SY5O>:W9FW#C[XBE1W8#TPC#\*YKXJ6 M%Q9?$74I)P3'=.)X).TB,!@@^W(_"G*,8PYTM=/U'.$8T_:):NWRW_.Q/I?A M?P]KFD^)M1TR;4UATJS2:W6X,:L7(;<&P""/E&,8-6_AU\.;7QAI&H7FHW4U MMM?[/9&-E >786(;(.0!MZ$=Z7X>?\B)X[_Z\$_]J5T>JV][X3T7P9I=A-91 MS:?(-1OHY]0@@]V6C1Z9\9M6O+3:;/5-& MEO(73E26*;L$<'+9;C^\*\*L[G['?07/DQ3^3(LGE3INC?!SM9>X.,$>E95: M:@DO-F%:DJ<4O-_H0UVDWA[0=,^'NB:_?PZC=W&I23(\<%Y'"B;'901F)CT MKE=3OO[3U*:\-M;6OFG/DVL7EQIQC"KVKT+4[V"R^"?A)KG3+74 T]T MRTH M"?O7Y'ENI_/-332][T_5$T8Q?/Y+]49/A3P]X>\8:A>:=9PZE8W:V4DMKYM[ M'*LDJ]%.(E..<\>AK/\ ?A>#Q3XE-IJ$LEO8V\$EQ=2QD!D11V)! Y(ZCIF MH=$\21Z3XST[6;6Q@L([:5?,AMC(RE.0_P#K'8Y*DCKBO1_%FG1^!O#WBR]M M\;O$5XD%H<@CR67S'(]OF=?P%:0C&2YGTW_0UIPC./._L[_I_D&/# M^@Z%J+6VK7?]KP-,%%]%%Y0&W _U+9^]^E0>$/#V@>*];OXO(U*TM+/3)+O9 M]LC>1W1E&-WE $-TVDY[]JW/&=_;V7@/P1]ITFSU#?8/@W+S+LX3IYFGY%\L?;*. MEM-/D9>E>'/#_B/0=4O=*&I6EWI,7VJ>VN+A)5F@&2VUUC7:V >JD=.O9OB+ MP)Y.J:/_ ,(J\U_INN(ILI),%@_1D<@ CJ>!@9]#6TKV>F_"2\U'P5:RXOG M^R:N]W,)9K9>RKA54JV[&[&?F'?[MGX9:_>VO@'Q.J%'.DP_:K)G7<8)'5U) M7/3I^I]:%"#:B^JO=?UV!4Z5E*M-_$% P!TY).)=-EN'F:Z>UOXG8,L3\E2, %00 > M<_>'X\N[M([/(Q9F.69CDD^M>@?#@_VYH?B+PA)\S7]K]ILU)P!/'R!Z\_+^ M"FL86G-JV^QST^6I-JV^WZ?Y%'3?!$=]X$MM4)N#JFIZBMEIT*,/+8?Q.PP3 M@889!&,4:OI/@WP[JW]DWT^K:E;^--/N=,\;:O;WL;))]KDD&[^ M)68LK#V((-:3C&$=%JM#:K&-.'NK5.S^[_/\CKM+^&%G<^-]/L)KZ:XT75+1 M[JSN[?".R@9VD$$ C(SQW'3H,+2/"VGQ>$SXF\4W%S%8R2F"TMK0+YURXZG+ M9"J,'L>A]L^J>#T.EW'@;1;T ZA%8W=S(K??A20Y52.H]/\ @%9+75V_\!_*[ M,:PLO"NLZGI5A8IK%M<7=_#!*LTL4B"-W"DJX52&YXRI%2>(['POX?\ $E]I M7]G:O22Y#L?4A9@N?H *Q5G3YM-SF5G2YM$[]O(X>4QF9S"K)&6.Q7;< M0.P)P,GWP*;117.DO_H!KPFO=O$7_ "+&I_\ 7I+_ .@&O":R MQOQ(Y,U^./H:.EZ%J.LN!86LDB;PK2 ?*OU-;?B+P+>:7,C:7'->VWEY=PH) M5AUX':I?AYJWV/4KBVNKR."R>)I&65@H+# R#V./Y5KWVJ6&F>"KQ/#^M&>5 MIN6EDS)\QPVT'GU.?K40ITW3NS*E1HRHO;LO,YGP=!HEWJC6VNHS&7 M@)';?1T%F%-N;42C][OQALXXZ]_4UP6DW$-IK% MG<709H8ID=PHR< YKM+CX@Z8VJ[TT99+9P!*6'1A],>OY44II0M>S##5 M8QI6/PKJ/#.J6ESX*N[+7=4^ MSPHXCCVOB14P#@=R.HZ'O22A.J[[$Q5*KB)7M;I;1:?YG-Z]X7U#1+FF?0_UK$KNO'.K1G1]-L=+U%;FT:/\ >8?M<+656 M,8SM$Y\3"$*CC#8EMX'NKJ*WA&9)7"*#ZDX%;VK1Z1H5U_9T=BNH7$('GSS2 MNJEL9(55(Q]365HMW'8ZY97,P!CBF5FR.@SR?PZUJ>(;*6P\17-W)9I>VETY MEAD;?Y;ASD8*,.1G'7^E$5[C:"FDJ3DM[^MD,LM/L?$>M6MMIMM)8*5+7.9/ M,50.ZD\_GW-->_T!+_RH]'\RR4[?.,\@E89^_P!=OOC%=/I\.GZ-J&C2_9EL M6U.TDCF^9L*QVD?>)QSQ^-<7+H6I1:J=.-I(USNP%53AAG&X'T]ZTE%Q6BU- MJD)4XJR3=]=/)6Z'1R>%K**/5;.,>?<+;+>V,VX[FC[@J.#TQT[UE>']-M)M M-U34M2B\V"TAQ&I8J&E;[O((_P FMRZUB+2_&6D6L4JR0V-NEG.P/!SPV?IP M?J#4'BNW3P]H46C0$ W-S)<2;3_ #A ?PQ^(JY1BKR73^E_7D:SA35YI?#?[ M^GXO\"KXF@T[1-0@M[72;:17MDE9I9)BUCB2V8&SC.9;6.0]3W92?PJ'PW<9\.^) M9YH8IO3R$U#ZPX^O1=F0P:=IVJ^'7U"&T%G- M:W,<GZCSI]^L M<4P)X0^6NU_;!_SQ3<8\MGY:_>5*%/V=FEK;7[W?TV3,/7M)@MX=$73X-LMY M:1NX#$[W;'J>.36EXJ\-6&G:+'/I@S-:2+#>'<3EBH.[D\=1T_O>U;\VD)#X M@T?[6ZFWTG3]\LA&%RG /MSS^%9>C/!J]QK5A+J5M<'5 TD:*LF4<9(^\@'' M'?\ A%4Z:NTUO_E_F6Z$4Y1:5Y:+RLOU>A5E\+V=UX*M+NQ3;J1B:=EW,3,B MG#8&>V1T_K6;9:/!=^"WNHX=U\VH+;QON(X(7C&<=3UK4U*_N=$TGPM&8]1L#FSFU.*\1%'W!\N5_ J?Y4N2+?HOTW)]E M3DWI:T=?N6IS>KQ:3H-V-.2P74+B$+Y\\TKJ"Q&2%52,?4YJ;2;72=0L]:OA MI85;2!'BA>=V ;YL\@@D' XJ#QAITR:[+?0HTMI>$20S(,JV1TSZY[5>\,17 M.GZ)XA\^!HI!:HZI/%U'SX.UA@BH2_>--::]/(RBOW[@XJROT79V.:GO8)H6 M2/3+6!CTDC:4L/\ OIR/TJG5_P#M.\GF@\I(%E257B\BTC1MP/'W5!//:HM2 MFO+C499=3W_:F(\SS$VMT&,C QQBN=V>IQ2LU=?E8U_"&DV>HWMS/JR@V-I" M7ERY49/3D<^I_"H]1\/21>,6T>V&T2S#RB>@1N0?? _E6JMO%IWP^CMYKN&T MGU63S29@YS&N, ;%)[ \^IK2N+F!9/#WB(SQSK"?LEU-&& S@C=R <#YCR.] M=*IQY4GOHSO5&#IJ+W5F^]GO]RLSG-2ET32]0:QMM,%Z+=BDL\\SJTC#@X"D M <^QJ+3Y].O-;M;5=&MU@N+A(_GFE9U#, >0P'?CC\Z;XCTB[L]>N 87=+B5 MG@=%)$@8Y&#W/-0Z-!+;>*M.BN(GBD6[AW)(I4CYAV-9._/9KKV.=N2J\KBD MK]D:=U!IZ^,%TB/2[=(/ML<)<22[]I<9ZOCD<=*V;;PII-VNM0F,02177D6T MAD;$9(&T=>>3CGUK&N_^2H+_ -A*/_T,5M:N[1Z%XF>-BK+J*%64X(.4YK>* MC[S:VN==-0]]RBG9OIY,P-$T:&1-'=4UE-JW;:=)!=H!U=5.'_ M !'^>*Q/$\;ZG#INMV4(N;46R1RHH)$;*22K8Y YQV_E4N"C"ZU_X![K5#IL=I M<).J1M&TF"IV\X9CGJ:YBN>::M_E7P2]3IJ M***[CV#R']I'_DG5A_V%8_\ T5+7S+7TU^TC_P DZL/^PK'_ .BI:^9:\^O\ M9Y6*_B!1116!RA7N/A+28/'/PAL?#_A_4(=*2VO-_B!'X>5,EA)N[C@8!X^7 MK\O/B,<,LV?*C=]O)VJ3BI+>]N[)9EM+F:W$\9BF$4A7S$/56QU'L:N,N5ZF ME.2B]4>LWWPJT2[\2>&HO"FK7TVA^(#/OE9<^6(1D\X'4Y R.W>NK\,>&=#\ M'S7WB31=>6X\&264D&IV]V-[R2H=NW&!R23CC/)&,,*\P\/?&+Q5X9T"#1]- MDM#:VX81>;!N9023USSR34?@7POJ'C7^T1>ZW_9N@VLBW6I2R2X3<,X77(M?Z_ XV[>&2]G>TC,4#2,8HV.2BYX&>^!4->DZM MX!MO$<][J?@&S>S\-Z99DR7^HRLJW4B!BS)D9YX'0 $<[47%Z MA7I/PG_Y /CS_L7I_P#T%J\VKI?"?B[_ (1>PUZV^P_:O[8TZ2QW>;L\G<"- M^-IW8STX^M.#2E=CIM*5V>P7&M6$?ACP5X8\08&C^(-#2WDD(_U$P">5(/3# M']03TJLNAWGAOPCX'TC4EVW%IXRB1L=&'F,0P]B""/8UY3XJ\8?\)-HOA[3_ M +#]F_L6S%KYGG;_ #N%&[&T;?N].>M=%>?&&\U+1_#-IJ6FB>YT+4(+QKG[ M1@W0BSA2-IVDC&6R>1G'.*U]I&^IT>UBV[_UL=;XW5?B%-XCT$+NU_P[=2W& MG\0/]T>M='XM+0R^.KJUXO(_#EHB.OWEC8S>9@]N /RKPZX\< M7G_"R)/%^FQ?9+AKK[0L)?> #P4)P,@C(/ ZUNZK\7KZ\\?_ /"2V&G16R26 M8LKFQFD\Z.XBR+M(ELBPN%O8?+ MVGDMO&!7MNKQP:YXK^(_@F$#==11ZC9(HQFX2*-G'U9MOY&O--.\:^'M"U9M M6T+P@8=07YK8W6HM/#;-C[RIL4G_ ($QQ63H'C&_T7QW!XIF)O+M;AIIP[;? M.WY#C('&0Q[<>E1&2BK&<)1@K7.M\40R:/\ #'PEX.L4+:AJSC4[F-?E9FD. MV)2._!QSW0?AZ#%J5GIOCS3?A@\BOI?]AM87 4##7$B[RQ]"57\WKRFZ^) O M_BK!XQOM)\Z*V*F#3_M&!&%3"@/L[-\WW>M4KGXF^+9M>DU./7M1B#7!G6U% MW)Y*C=D)LSC;VQCI34XIZ?TBE4C%W7])?YD&AZ;-H_Q3TW3;H8FM-9BA?CJ5 MF S^E=9XB_Y.>A_[#EG_ .A1US>O>-H=9^)$'BR'2?LC)/!/+:_:-XD>,CHV MT8R%'8^O-1ZCXS^W_$]/%_V#R]M]#=_9/.SGRRIV[]O?;UQWZ5-TE;S(YHI6 M3ZGLESX@N?"NE>/=9L@&EM?$43%"E1>%OB9>>'/!.M>&9;3[;::E!+'"QF*&V:1"K$#!R.0=O'(/ M/-:>TC"-)AE5-+3189(YR#L+N<.YP#V"DX!/-.(;CPS;Z#XKT==:M+(G M[#*MP8)[4'JH)M*FD6:1A; MI%=!V.X_*"80N?JV/>H/!/B;_A#O&-CKOV3[9]D\S]QYOE[]T;)][!QC=GIV MK(O;C[7?W%SMV>=*TFW.<9.<9J;KEL1S+DMY_P"1Z+\Z^SSPI_<)V,K#@8RO&*-2\>^;IMAH^AZ4FDZ+ M9W*W3VJ3F22YE!SNDD(&?88P/P&+YES.1ISQYW.YZ5XB\(0:S\=M6U=]9M@F MDFVOKFQACE>ZV1Q1G 78%;..JLV,CC/%>1>-O$*>*_&FI:U#"T$5W*#'&Q&X M*%"C..^ ":U[_P")%[-\5'\:Z=;?8I6>,FU,N\,BQK&R%L#(8*>W&?;-<]XB MU&QU?7[J_P!+TW^S+>X?S!:B;S!&3UP=HXSSC''2E.2=[=Q5)QDG;N>C7T6F M2_L\^%QK%W=VL8U"?8UK:K.Q.Z3@AI$P/?)^E1?!:/3HOB]:+I%U=74'V.4E M[JV6!@V#QM61QC&.<_A7/+XUTRY^'^F>%M8T6[GCT^>2=+BUU!869/T*4H\T7 MVMW.UTD#XAS>%?%=N-^N:+J5G:ZP@&6FB\U=D^!^.3CU[+6MXI2RD\$>/EU. MXN+>W_X20;I+>!9G!VQ8^4N@/_?5>1^!/&EYX%\2IJMI']HC*&.>V+[1,A[9 MP<$'!!QVKH;WXGV6JZ3KVFZGH-PUOK.H_;V-OJ"QO$0$ 7)B8'[G7 ZU2G'E MUW*C4BXZ[_\ ,?PO#I,7Q&\+_V->WMWG5;;S/M=FD&W]ZF,;97SW],>_;TE MO#UI9_%GQ#XUN=6AN+30KIKFXLK..1[E20=H(95 'AK1M/B1=6/Q*O?%=M9*(KYW M%S8/)N66)NL9;;[ YQU'3M4QE%;D0E&*U[G2^+-2-W\#H=2LT^SC7?$-Q=7B M(<_,6D*H3WP%4_\ 17(:%X#D\213_V/KVDS7%M9M>36Q%PKHBXW#)A"D@L! MPQ^N.:GTSQY!IL.J:4=$CN_#>H3&;^RKBX):!NQ24 $$8 SCH!]:FT7QUH_A M>/4G\.>&YHKN_MI+4S7NI><(XWQE0JQIW ZDGWH;BW=@W"33;.R^&.M6&L>" MYSXELVOG\%YU&R?()*;6/E'/8,H(^B]A7DFMZQ=^(-'? M^WG_ -I5XG7MG[1/WO#O_;S_ .TJ\3KS<7_&E_70\?'?[Q+Y?DCUCPQ&_@_X M*ZMKP1A?ZTWV6V('*IRN?;^,_@*\GQCK7>:'\8?$^@Z5;:=;_8YK:V01QK-! MDA1T&016J/C=<7'_ "%/"^D7?K\A&?SW42]E.*7-:WD.3HU(Q7-:R[?>.^)? M_$E^'/@_PZ/E?R#=3+Z,0/ZN_P"5+H>M^$?$_P /-/\ #WC#4IM,FTF8O'(B M$^:G/ .#V;&/85JZK;Z3\:=-CO='G^P>([*#8;"9_ED0$G"GTR3\P]<$=#7C M^H:?=Z5?RV6HV\EM.08*FKJ2<)^*YTR. M#2/AS&NEZ5:])3$"\Y[DA@<#Z\GOZ5IH^F?&;0VCD6"P\86<>58#:MVH_I^J M_2O/?"_@_5_%$=Y<:-;Q7/\ 9ZK)) [X:0'/RJ._0UZ'<:%8^,=/3Q+\/(QH M_B+3"/M6EQ (0R_W1Z\'V;H>:<)5)ZRU3Z?Y>A5.56HFY:I]/+R\T0>![2?6 M_!OB3X?:M$T.H6N;FTCE&&1P>1]-V/PGZJ>.>*Y;4_$_P )UU:ZNU\/ M7NHSS3-([Y*QLQ.20"XP#]*=2FG"+YE_P/\ @#JT8RA%\R5MF^J_X&Q7^*-M M%XG\+Z-X[T] /M$8MKY5_@D&<9^A#+G_ ':\\T;7]4\/W+SZ/=O;/(NR0 !E M=?0J00?Q%=[K/Q3T>?PA>^'=!\*QV-K=J02THPK5D*]%([CJ<>V#UQ652TZJY'JS&K:I63IRU>[\^ID7W MC#6]1TQ].GNXX[.1]\D%M;10*[9SEA&JYYYYING^+=:TS3#IUM=J]D6W?9KB M".>,'KD+(K <\\5HR_$KQ5)?O\W)3>BW_IG%:S MXAU7Q!/'+K%X]R8EVQJ0%2,>BJH 'X"KEMXUU^VTV'3Q>)/:0$&&*[MHK@1X MZ;?,5L8[8Z5UGA2^N/B!I&K:!XA;[=>6UD]WI][-S+$Z8!0OU*G(Z^_MB#XD M_P#(I>!O^P4/_04I\LN5U%(?)+E=52?].QSR^//$JW%Y-_:19[U$CGWPQL&1 M,[5 *X &3P,=:RM8UB_U[5)=1U:X-Q=S8WR%0N< < #@=A7K?@_P#Y$7P/ M_P!C W\I:Q?BOI%KJ4]QXHT5,+%>R6&I1#K'-&Q57P.@8 ?FO/_$MBEFMMJ0465NUM!NMXFV1-MRO*G(^1>N>E01^ M+]4AFCEACTN*6-PZ/'I%HK*P.001'D !^%4_B/XAOK7XLWMA=ZG?#1A+;BXLTN'$;1&.,NNP''()X[Y MHE%QO[ST=OZU\@G&4;WF]';^M?(\[U/4KO6-2FO]1E$MS.=TCA%7)QCHH '3 ML*TH/&&LV^CVVE"6UFL;4L8(;FP@G$98EB070GDDUZ'XQO?&5GK3ZQX2N7N? M#>Q?LJV 66W1-HRKQ@$#D'DC\>U>2W,[75W-<2*BO*[.P10J@DYX Z#VK*:= M.6C=S&HI4I.S=_NO^.I8U'5KC5/+^TQV:>7G;]FLH;?.<=?+5=W3OG'..IJQ MJOB75];L;&SU2]:XM]/C\NV0HHV+@#J ">%')R:RJ*SYGW,>:6NNYO?\)IK; M:?:64\EGH[&L.BGSR[C]I/NS2TGQ!J>AQW<>F7/E1WL7DW$;1K(LJ>A M5@1W//7DTFG:]J6DV%_9:?<^5;ZA&([I/+5O,49P,D$CJ>F*SJ*7,UU$IR6S M"KFDZM>Z'JD.HZ7/]GNX"3'(%#;<@@\$$'@FJ=%)-IW1*;3NBSJ&H76JZC/? MZA,9[FXYO2>-M>=+:-;N.".UN%N8H MK>UBA02J36!13YY]Q M^TG_ #,?-*T]Q),X0-(Q9A&@102<\*H ]@ !3***@@**** "BBB@ HHHH * M*** .N^&O_(TO_U[G_T-:^BG_P"0#;_]?=K_ .CXZ^=?AK_R-+_]>Y_]#6OH MI_\ D V__7W:_P#H^.O9PO\ ^\]_!_[J_F:'B+_ )%C4_\ KTE_] ->$U[M MXB_Y%C4_^O27_P! ->$UEC?B1R9K\*;DE?1> M9R&EZ9&K>7['=>(\7@.UBL?[M6]">GZU8\ M)6?]F^)=:TM)!]K%O)%;R'C)!_\ U'\*XJ6":&Y:":-UF5MK(P^8'TQ564(I MM79IRQHTU*4;MM_*WH7M=T*YT"_^SW)5U8;HI4^[(OJ*S*[3Q1#+'X9\.Z?= M_P#'_M/RMU53@ ']!^%6-2N-"\(W$>E?V-%J,JHIN)YB,DGTR#_2G*DN9ZV7 M^83P\5-ZV2MOY]#@Z*Z+Q?I%II]S:7>F!EL[^$31QMU3ID?3D5SM8RBXNS.: MI!TY.+"K=OJFH6^*U=+\,)>>,;G2;AY$@MS(7<$!M@X4YQCG*]JJ,9.SCZ%TZ=25G#J[&!<75 MQ=R>9=3R3/C&Z1RQ_,U876=36$1+J-V(P,!!.VW'IC-:UEX96?QI-I%PTBV\ M+.7=2-P0#*GICG*]N]+K&E:1I5MI]P([VX2]@\T#[0B%>G^P?6GR32;M^U(NS M@<9\LYZ^U5==T>VTW3]*N+9I2;VW\UQ(P.TX' P!ZTG"23(E1G%/7:U_T*@U M[5U4!=5O@!P +E^/UJ*35-0F\SSKZYD\U0LFZ9CO Z \\@9/YU?N-'MX?!UI MJRO(9YK@Q,I(V@#=T&,YX]:/#&CV^M:C-;W3R(D=NTH,9 .01Z@\GM4$ M,\MM,LMO*\4B_==&*L/H1702:;HZ>%XM8\B^/F7/D>3]J3C@G.?+]NF*:VF: M3'X836&AO6$EUY"PBY0;1M)SN\OGIZ#K1R2[^8.E.]W+I?KL8EQ>W5VJBZN9 MIPA)422%MN>3C/3-)]KN?LGV7[1+]GW;O)WG9GUQTS5N*U@U2\M[/2;6>.>5 M]O[ZX5Q^B+C'7O5V^M= TV\-G(U]>21-LFEB=(U##KM!4D\^XIMR%"33E M?3:YF6VJ:A9Q^7:7US G7;%,RC\@:(]5U&&:26*_NDDDQO=9F!?'3)SS6UIV MC:/?RZE+#-=RVUI9FX5?EC?>/2GRSZ,T5.I96?>VO8SVUS5G7:^J7K#(.#<.>G/K52>>:YF::YE> M:5OO/(Q9C]2:W]>TK2M"OXK=XKRX$ENDH(N$3!.GJ*'"6MWL$J4]>:6V^YSTUU<7*QBXGDE$:[$#N6V+Z M#/04JW5PMJULL\H@=MS1!SM8^I'3/ K.]5Z*+L.9] MR:&[N+=)$MYY8EE7;(J.5#CT..HYI;:^N[)B;.ZFMRW4Q2%<_E4%%%V',ULR MSWJ@7EY/< '($LK-C\S5:BBDVWN)MMW84444""BBB@ HHHH **** )(/ M^/B/_?'\Z]=\(_\ 'D*\B@_X^(_]\?SKUWPC_P >0KT\%\+/?RKX)>ITU%%% M=Q[!Y#^TC_R3JP_["L?_ **EKYEKZ:_:1_Y)U8?]A6/_ -%2U\RUY]?XSRL5 M_$"N\^&_AOP_J5CKFO>+CB>!O^22 M_$3_ *Y6/_HQZSA\1C3MS:^?Y&K/\=[S3"+3P7H&F:3ID?"1/$6=O=MI S^9 M]S3A\9-)\1@0?$+P?8W\;<&YLP4E0>VXY_)Q7DE%/VDBO;3[GK?D_!!_F^TZ MU'NYV8;Y?;[IJ+4O#G@W11HGBO06OM:\.7-Z;:ZTZ7(D:4*64#AGR;_P!P@;S MKMQE455RQSZ\UI>'6WW&UZ;W:^29KZC8:QXLLEU7XB3KX1\&6F#!I,9V22@? M=4J!G/'IG^ZHZUS?Q4\/:#'X)T7Q#HFB/H#37#6RVDPVR3PX)64KDG/'4\_. M,YXK:NBWAJ*'Q?\ %R[;5=>==VEZ&6&V+T9E'RKS[8'NW \F\5>+-6\8ZT^I M:U<&1SQ'$O"0K_=4=A^I[T3:2UW"I**BT]W]_P#P/0Q:[OX;:%I.K6/BF[UC M3TOCI>DR7EO')+(B^8H)&=C*2..F:X2O3?A!,UMI7CB>,(7CT"9U$D:NI(4G ME6!##V((/>LH?$<]))S5SB[K6["XM9(H?"^E6KN,+-#+=ET]QOG9?S!KM/B/ M9>'O!FO6.GZ;X6TZ>.;3XKEWN;B[+;V+ _=F48^4=JX>_P#$=[J5H;>X@TU$ M)!S;:7;0/Q_MQQJWZUZ7\9=5L[+Q5IL5SH&G:BYTF!O.N9+A6 R_'[N5!C\, M\]:I6Y6RXV<6_3H9.EZ?H$_PHUKQ7-X;L7O+?4H[>& SW0A1"L8(P)MQY)/+ M'D^F!57P!!H?C'XA:1HU_P"&M/MK29I6E^RSW0:0+#(P!+3-@;@#Q@\=<9%; M6@7UO%\ /$=U)I5I/"VM(19R/,(ER(L %9 ^!VRQ]\U0^$VH6U_\8O#_ -ET M>RTS9]IW"T>9O,S;R=?-D?ICMCKWJM+Q+27-';I^9%;^%M"T#PK>^*O$=I)? M137\EGI>FI,T:OM8@N[CYL#:1@8Z>_&5I=[X;UW5=*TP^%(;*>XU&"-Y[:^G M*-$T@#(4=F.2#C(85UFL6DOB_P"$BVFB(UU?^'=6N3X\EO+5O-48+8P#GC%)Z-)$R5FDEH> M@:UX0\,Z'IWCR_BT."Y.BWEM%90W%Q/L19-@8';(I/WB>37!:3=Z7KGB+2=- M?PUIMI'9@,@]<9]"*]<\3WDNGZ+\4KF!8'DCU"RP+B M!)D.3$.4<%3U[CCKUKR;0-'H[J*PC5-3MV!M=.@MR?WB]3&BDCV-. M=DTOZW*J**DDOR\V=#\8/A]9>%-1CU'PW&1H\[F!X_,+_9IU'*DMDX8?,,D] M^V*VM9^&&@_\)P$1)--T#3]#34]1:)VD=CE\A=Q)!;;]/E/&:M:EK%I/\7/% M7@W7WQI&O3)&KG_EVN?+3RY!Z<@ ^ORYX!KJ?$+1R^-=7\(2S1PWFL^&(H+5 MW;"M,C2X7/ON)_ U?+%MLTY(-MI=3Q.3Q'X2:ZF5? T(M"I$174[A9E//S%B MQ4]N-M:^J^#K'Q'X+TCQ#X&T]HYFE6PU*P25G\NX) 5P7)(5B1WP,K[UQ[>& MM<75)=-_L>^:]AYDMTMW9U'K@#I[]*]"^ .HW5KXJU:W@F987TN29DZ@NC+M M;ZC>_M$_>\._]O/_ +2KQ.O;/VB?O>'?^WG_ -I5XG7F MXO\ C2_KH>/CO]XE\OR04445RG&3V5[Q7=C/);W$+;HY8VPRGZUZQ8:] MH/Q7T^/2/%GEZ;XBC7;:ZBB@+,?[I^O]T_ACI7D% ..E:TZCAINNQM2K.GIN MGNCW_3/#$EI';:?I\$?A_P 7:3%B"XC4_9]4C'4L?X@>X/S*>>E66T&]\1S+ MXHT2%O#'BFRE\B]CN%(@N2,9!(^\IR,,,Y_(UYGI/QD\6Z3IJ62W$%TD8VI) M=1%W4>F[(S^.:RO$OQ$\1^++*.SU>]5K=&W>7%&$#MV+8ZXKK]O24=+G>\50 M4=$_3_@]_-'J/Q%\XSCL37@]%% M\03#6%9M,U"V>SN]HSM1\?-M[XQ^1/TKE M:*SC)Q=T90FX24D=5<>" NH/';>(]!DLL%DNWU!%R,\ QY+AO8*?K6J;G3_& M'@/3](GU2UL]8T-G2W>[D\J*ZA8] [8 (PN <=/RT>Y MZ#H,MCX!T+5-0GU*SNM;O[5K2TMK&X6?R V-SNZ$J",# !/3WX=K$EGXS\#^ M'A8ZE8VVH:1 ;2>TO+E("X^4!U9R >%R>>_M7GE%/VNG+;0KVWN\EM/Z9Z[I MVLZ3H4?@WPX=5L[F2SU WE[=Q3 P0YW87?T/WN3[>]8FG>)[&R^)7B&UU&1+ MCP_K=Y/#=%7!0HTC;)0P],YR.Q)]*\]HINL]+=/^&&\3+2RV_P K'H7Q*U*Q MO_BQ%=V-[;W-L/L^9X95=.,9^8''%4/B1<6.K_%:_EM[^!K*>2!?M<3>;&J^ M5&&;Y/*D3*I>/(EIN%%%%9F04444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% '7?#7_D:7_Z]S_Z&M?13_P#(!M_^ONU_ M]'QU\Z_#7_D:7_Z]S_Z&M?13_P#(!M_^ONU_]'QU[.%_@?>>_@_]U?S-#Q%_ MR+&I_P#7I+_Z :\)KW;Q%_R+&I_]>DO_ * :\)K+&_$CDS7XX^AI^'M2NM)U MN"YL8C-(#M,0!/F ]1Q7<^19:9(VLV7A741>X++&X^2-CWP"2/R_*LJPD'A3 MP=#J5M")-3U(D1R,N?*0>GZ?G[5B1>*?$4-T)Q?W3-G)5R64_P# >E1&2II* M7KZ&-.4:$5&>^^RT^_J1Z?%K.L^(6N-.60WQD,K2+\NPD]2>PKT19=60*MU> M^'SJ*C 9P=X/Y]?PK)\5ZU<66AVBV-NMI>:I&)[IX%P?NCC/OG]*\\,4I.2C MD_0TE=7"MO MXEM8+[6_#E_)=1H 98!M68#ZD?Y[U5\!ZG+>NVC:I%]JA5?.MQ,N=C*>G/;O M[8K"U#Q7XANKYY#=7%N QQ%"2JK[<=?QIIQBN;=/H-2ITX^T;;4NF^J[W(_% MFJ7.I:LJW%F]C';H(X;=UP46L*N[M+F3QEX=O+358\ZC8Q&:WN-F"P'4'^7X MCTKA*PJK7FO>YR8B+YO:7NI#XY'AE22-MKHP92.Q'2O1=<:.ST?4=>MV"MJU MO!'%V()'S?\ CH_2O-ZNSZO?76FP6$\Y>UMSF.,J/E_'&3U[T4ZBBF@HUE3C M)/KMZ[?J=WJ+I'H]]XE0*KW^G10KM/(=OE;\AM_*L#Q9_P @/PY_UY#^2UA/ MJM[)I,>FO.39Q/O2+:.#SWQGN:2[U*[OH+:&ZE\R.U3RX1M VKZ<#GIWJYU5 M)-?U?J;5<3&<6DMU^-[LWO%G_(#\.?\ 7D/Y+5GQ''A+8V]UFR&#,T M@V\+TVL/UKF+O4KN^@MH;J7S([5/+A&T#:OIP.>G>B[U*[OH+:&ZE\R.U3RX M1M VKZ<#GIWI.HM;=;$2KQ;FUU2_"QT>JRI-\-]/>.".W4WK?NXRQ4)/ MZU%X _Y#EU_UY2?S6L%]2NY-+CTYY%KM!O3RIDE3^^A*9'^>X MJ77--ATWP+="S.#X:6S2VL5R#J!&R4N /E;GY6!_6N<;4;IM+73FES:) M)YJQ[1PV",YQGN:F@UN^MK 62/$ULK^8(I;>.0!O7YE-2JBO\K$*O&__ &[8 MU_"-]:GQA9.UI!:##HOEL^-Q4@9WL?I^-9$L,=AJ5S;ZQ;W$LR.0?+F$9SGD M\HV<]:AN=0FNXPLJ6ZA3D&&VCC.?JJ@U;_X27566,2W"3&(81IH(Y&7_ ($R MDU/-%JS(]I!QY7T=]EU\OD==:Z19Z)<:Q!!Y\D#Z.97#N-W.[(!"X' ]#67* MT-GX&>X\/Q,([MO)OGF??)%Z+P ,'/7'<>O&&WB'59);B22\9GN8?(E+*IRG M]T<<=3TQ5>SU2\L(;B&UFV1W*[)4*!@X^A!]:T=6.R7T59:_*_]:F] MX_\ ^0Y:_P#7E'_-J/'_ /R'+7_KRC_FU8.H:E=ZI.DU_+YLB((U.T+A1T' M'K1J&I7>J3I-?R^;(B"-3M"X4=!P!ZU$JB?-YF=2M&7/;JT=5H6K75M\/]4> M-AOM&"0.1S&)" V#^)-<55J+4;J#3I[&*7;;7!4RIM!W$'(YQD=.U5:F<^9) M=C.K5YXQ79?U^@4445F8!1110 4444 %%%% !1110 4444 %%%% !1110!)! M_P ?$?\ OC^=>N^$?^/(5Y%!_P ?$?\ OC^=>N^$?^/(5Z>"^%GOY5\$O4Z: MBBBNX]@\A_:1_P"2=6'_ &%8_P#T5+7S+7TU^TC_ ,DZL/\ L*Q_^BI:^9:\ M^O\ &>5BOX@5V_P[\9:-X;M=9TWQ/IDVHZ7JT<0EC@;#;HV)4=1Q\Q[]A7$4 M5BFT[HYXR<7='K#?$7X&27X=^ M#S:ZC(I47FH/YAASW7+,?PR!ZYKR6BCVCZ![:71+[BYJNK7^MZE+J&K74EW= M3'+RR')/M[#V' JG1169EN%7=-UG5-&E>31]2N["21=KO:SM$6'H2I&15*B@ M-C:N/&7B>[MI+>[\1ZO/!*I22*6^E974\$$%L$>U9]_J=_JDRS:G>W%Y*B"- M7N)6D95'1023P,GBJM%.[8-M[EI-3OX]-DTZ.]N$L97$DEJLK")V&,,4S@G@ M<^U-L;^[TR\2[TVZGM+F/.R:WD,;KD8.&'(R"1^-5Z* NRU:ZG?V%Z;RQO;F MVNB23/#*R.<]?F!S5N[\4>(-0:)K_7-2N6@<21&:[DHK*HHNPN MS7@\6^([6>>>V\0:I#+3CCFG7'C'Q-=QB.Z\1ZM.@=7 M"R7TK ,I#*<%NH(!![$5C4478^9]R>\O+K4+N2ZO[F:ZN)#EYII"[N>G+'DU M)?ZMJ.J727.IW]U>7"*%66XF:1U .0 220!DU4HH%=FS+XP\33VIMIO$6K20 M,NTQ/?2%2/3!;&*H6&IW^ES--IE[<6WE:-F4]5)!'!P.*JT4787844 M44A!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!TOP M]_Y'S3OK)_Z+:OJC3?\ F#?]?;?^B):^8OAE9/<^,HIU'R6T;.Q]R-H'ZG\J M^G]/4K_8V?\ G[;_ -$2UVT?X?S_ ,CT:"_=?-?FCSO]HG[WAW_MY_\ :5>) MU[9^T3][P[_V\_\ M*O$Z\S%_P :7]=#QL=_O$OE^2"BBBN4XPHHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH * M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#KOAK_R-+_]>Y_]#6OH MI_\ D V__7W:_P#H^.OGWX96COK4]R!\JH(\^I)!_P#9:^@Y5VZ#;Y_Y^[7_ M -'QU[6%5J'WGT$%?S+_B+_D6-3_Z])?_ $ UX37NWB+_ )%C4_\ KTE_ M] ->$UCC?B1QYK\];;_OU_\ 7H_X6/KOK;?]^O\ Z]26JE[J,#US7KOA-"MD, M^E>G@U[K9]!E2?LY/S.DHHHKN/7/(?VD?^2=6'_85C_]%2U\RU]T:SHVGZW9 M"VU6QMKZ)6WK'2!\J^Y/05]-#X6:2IR-)L0?46R?X5JV/@>*W"HD:QHO144 #\*:PVNK''!Z MZLX?X>>"AH]LL0_>32$--*!]X^@]A7K4EO\ 9Y]&3_I[;_T1+5C3M(ALD&U1 MFEU+C4-'_P"OQO\ T1+72TE&R\CKE%1BDO+\SR/]HG[WAW_MY_\ :5>)U]B: MYH.G:W"@U+3[6\:('RS<0K)LSC.,@XS@?D*XJ?X::8TA*:79J,]!;I_A7%6P MDJE1R3/.Q& E6JN:>Y\X45]%_P#"LM._Z!MI_P!^%_PH_P"%9:=_T#;3_OPO M^%8_4)=S#^RY_P R/G2BOHO_ (5EIW_0-M/^_"_X4?\ "LM._P"@;:?]^%_P MH^H2[A_9<_YD?.E%?1?_ K+3O\ H&VG_?A?\*/^%9:=_P! VT_[\+_A1]0E MW#^RY_S(^=**^B_^%9:=_P! VT_[\+_A1_PK+3O^@;:?]^%_PH^H2[A_9<_Y MD?.E%?1?_"LM._Z!MI_WX7_"C_A66G?] VT_[\+_ (4?4)=P_LN?\R/G2BOH MO_A66G?] VT_[\+_ (4?\*RT[_H&VG_?A?\ "CZA+N']ES_F1\Z45]%_\*RT M[_H&VG_?A?\ "C_A66G?] VT_P"_"_X4?4)=P_LN?\R/G2BOHO\ X5EIW_0- MM/\ OPO^%'_"LM._Z!MI_P!^%_PH^H2[A_9<_P"9'SI17T7_ ,*RT[_H&VG_ M 'X7_"C_ (5EIW_0-M/^_"_X4?4)=P_LN?\ ,CYTHKZ+_P"%9:=_T#;3_OPO M^%'_ K+3O\ H&VG_?A?\*/J$NX?V7/^9'SI17T7_P *RT[_ *!MI_WX7_"C M_A66G?\ 0-M/^_"_X4?4)=P_LN?\R/G2BOHO_A66G?\ 0-M/^_"_X4?\*RT[ M_H&VG_?A?\*/J$NX?V7/^9'SI17T7_PK+3O^@;:?]^%_PH_X5EIW_0-M/^_" M_P"%'U"7I**C3<5M8/$7_(L:G_ ->DO_H!KPFOH2:))H7BE171U*LK M#(8'J"*X_5/!UM/,3;VL,0]$C _E6%>@ZK33./&8.6(DFG:QY717H?\ P@P_ MYYK_ -\BC_A!A_SS7_OD5S?4I=SA_LJ?\R//**]#_P"$&'_/-?\ OD4?\(,/ M^>:_]\BCZE+N']E3_F1YY17H?_"##_GFO_?(H_X08?\ /-?^^11]2EW#^RI_ MS(\\HKT/_A!A_P \U_[Y%'_"##_GFO\ WR*/J4NX?V5/^9'GE%>A_P#"##_G MFO\ WR*/^$&'_/-?^^11]2EW#^RI_P R//**]#_X08?\\U_[Y%'_ @P_P"> M:_\ ?(H^I2[A_94_YD>>45Z'_P (,/\ GFO_ 'R*/^$&'_/-?^^11]2EW#^R MI_S(\\HKT/\ X08?\\U_[Y%'_"##_GFO_?(H^I2[A_94_P"9'GE%>A_\(,/^ M>:_]\BC_ (08?\\U_P"^11]2EW#^RI_S(\\HKT/_ (08?\\U_P"^11_P@P_Y MYK_WR*/J4NX?V5/^9'GE%>A_\(,/^>:_]\BC_A!A_P \U_[Y%'U*7:_P#?(H^I2[A_94_YD>>45Z'_ ,(,/^>: M_P#?(H_X08?\\U_[Y%'U*7:_\ ?(H_X08?\\U_[Y%'U*7:_]\BCZE+N']E3_ )D>>45Z'_P@P_YY MK_WR*/\ A!A_SS7_ +Y%'U*7>45Z'_P@P_YYK_WR*/^$&'_ #S7_OD4?4I=P_LJ?\R/ M/**]#_X08?\ /-?^^11_P@P_YYK_ -\BCZE+N']E3_F1YY17H?\ P@P_YYK_ M -\BC_A!A_SS7_OD4?4I=P_LJ?\ ,CSRG*K.V%!)]J]!_P"$&'_/-?\ OD58 MM_!6UAD #V%4L$[ZLJ.5._O2.3T/29)KA?ER2>?:O6-)M/LMHJXYQ4&FZ'#9 M*,*,UK@8&!7?"*A'E1[-.G&E!0CL%%%%4:!1@>E%% "8'I1@>E+10 F!Z48' MI2T4 )@>E&!Z5EZ%XBL]?T'^UK=9;>$-*DB7 "O$T;%6# $C@J>_2H_"WBG3 M_%_AV+6M+\U+:1G7;.H5T*L0=P!('3/7H12NAE9_A_6[?Q'H5M MJUE'-';W(+1"90&*@D X!/!QD>Q%:-/<$[JZ$P/2C ]*6LVPURVU'6M5TR!) M5FTJ2..=G "L9(Q(-N#D\,,Y YH"YHX'I1@>E+10,3 ]*,#TJKIE^=2L1E+10 F!Z48'I5:PU.SU1)VL)Q,MO.]M*0"-LB'#+SZ&K5 "8'I1@ M>E+6;X?UVV\1Z.NHV*2QPM++$%F #9CD9#T)&,J<<]*!7UL:.!Z48'I2T4#$ MP/2C ]*6B@!,#THP/2EHH 3 ]*,#TI:* $P/2EQ110 5G:G_ ,A#2/\ K\;_ M -$2UHUG:G_R$-(_Z_&_]$2U,MB*FWS7YFC1@>E%%46)@>E&!Z4M% "8'I1@ M>E+10 F!Z48'I7.7_BVZTVTN+N\\*ZQ%;6Z,\DS3V055');FXZ8IMEXNOM0L M8;NU\':\89T$D9=[-"5(R#M:X!'XBIYD3S+8Z7 ]*,#TKD-.^(UIJJJMCHNK M2W#M,([=5@+.L1 =PPEV%0Q"@[N3TS6JGBO3IK;2)K43W']L2;+:-$PXPI9F M8$C:%"G/H<#J:.9,%.+-K ]*,#TI:*HH3 ]*,#TI:* $P/2C ]*6LWQ!KEMX ME+ M10 F!Z48'I2T4 )@>E&!Z4M% "8'I1@>E5K;4[.[O[RRMIQ)<6+(EQ& U MRT\.Z6;Z^$C)YB1)'"NYY9'8*J*.Y)(J73+Z;4+4S7&FW>G.&V^3=F,N1@'/ M[MV&.?7/!I7UL%U>Q;P/2C ]*6JNI:G9Z/8->ZE.(+=&1&D8$@%F"J./5F _ M&F,LX'I1@>E5;Z^-D]JHM+FY^TW A)MT#"'()WOR,(,8)YY(XJW0 F!Z48'I M2T4 )@>E&!Z4M% "8'I1@>E+10 F!Z48'I2T4 )@>E&!Z4M% "8'I1@>E+10 M F!Z4N*** "L[7/^0?%_U^6O_H^.M&L[7/\ D'Q?]?EK_P"CXZF7PLBI\#]# M1HQ115%B8'I1@>E+10 F!Z48'I575]2AT;1;[5+I7>"RMY+B18P"Q5%+$ $@ M9P/45@-X\BMK*"_U;0M6TW39PA%].('B0/C:7\N5V4'(Y(P.^*3:6Y+DEN=3 M@>E&!Z4M9NKZY;:++IL=TDKG4KU;*'RP#M=E9@6R1@80],GIQ3V&W8T<#THP M/2EHH&)@>E&!Z4M58=3L[C5+K3H9U:[M$1YXL'**^=I].=IZ>E %G ]*,#TJ M*[N4LK&>ZE#%((VD8*.2 ,G'Y5!H^J0ZWH=EJEHLB07L"3QK* &"LH8 @$C. M#ZF@5];%S ]*,#TI:*!B8'I1@>E5K^^-C]FQ:7-UY\Z0_P"CH&\K=_&W(P@[ MG]*M4 )@>E&!Z4M% "8'I1@>E+10 F!Z48'I2U!>WEOIVGW%[>R"*VMHFFED M()"(HR3QZ &@"; ]*,#TK*UGQ'9:+X=_MJ<2SVA,(7R%!9A*ZHI )'&7!^E: MU%Q70F!Z48'I5;3+XZEIT=V;2YLS)N_<7:!)%PQ'(!/7&1ST(JU0,3 ]*,#T MI:* $P/2C ]*6B@!,#THP/2EHH 3 ]*,#TI:JV-\;[[3FTN;;[/.T(^T(%\W M&/G3DY0YX/'0\4 6<#THP/2FS2K!;R2N"5C4L0.N ,U3T+6+?Q!H-EJUDDB6 M]Y$LL:R@!@#Z@$C/XT"OK8O8'I1@>E5K;4[.[O[RRMIQ)<6+(EQ& E+10 F!Z48'I2UFV&N6VHZUJNF0)*LVE21QSLX 5C)&)! MMPE+BBB@84444 %%%% !1110 5Y_\ $'Q+J.GZE#I^G3M; M)Y(DD=.&8DD 9[8QV]:] KF_%7@Z'Q(\4ZSFVNHALW[=P9.3@C(Z$]?<]>,8 MUXSE"T-SEQ<*DZ35+

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�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end GRAPHIC 23 omcl-20201231_g5.jpg begin 644 omcl-20201231_g5.jpg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Ȕ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
XML 28 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 485,928 $ 127,210
Accounts receivable and unbilled receivables, net of allowances of $4,286 and $3,227, respectively 190,117 218,362
Inventories 96,298 108,011
Prepaid expenses 16,027 14,478
Other current assets 41,044 15,177
Total current assets 829,414 483,238
Property and equipment, net 59,073 54,246
Long-term investment in sales-type leases, net 22,156 19,750
Operating lease right-of-use assets 55,114 56,130
Goodwill 499,309 336,539
Intangible assets, net 168,211 124,867
Long-term deferred tax assets 15,019 14,142
Prepaid commissions 56,919 48,862
Other long-term assets 119,289 103,036
Total assets 1,824,504 1,240,810
Current liabilities:    
Accounts payable 40,309 46,380
Accrued compensation 55,750 44,155
Accrued liabilities 80,311 55,567
Deferred revenues, net 100,053 90,894
Total current liabilities 276,423 236,996
Long-term deferred revenues 5,673 7,083
Long-term deferred tax liabilities 39,633 39,090
Long-term operating lease liabilities 48,897 50,669
Other long-term liabilities 19,174 11,718
Revolving credit facility 0 50,000
Convertible senior notes, net 467,201 0
Total liabilities 857,001 395,556
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued 0 0
Common stock, $0.001 par value, 100,000 shares authorized; 52,677 and 51,277 shares issued; 42,783 and 42,132 shares outstanding, respectively 53 51
Treasury stock at cost, 9,894 and 9,145 shares outstanding, respectively (238,109) (185,074)
Additional paid-in capital 920,359 780,931
Retained earnings 290,722 258,792
Accumulated other comprehensive loss (5,522) (9,446)
Total stockholders’ equity 967,503 845,254
Total liabilities and stockholders’ equity $ 1,824,504 $ 1,240,810
XML 29 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
Accounts receivable and unbilled receivables, net of allowance $ 4,286 $ 3,227
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 52,677,000 51,277,000
Common stock, shares outstanding (in shares) 42,783,000 42,132,000
Treasury stock, shares outstanding (in shares) 9,894,000 9,145,000
XML 30 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues $ 892,208 $ 897,027 $ 787,309
Cost of revenues 478,916 460,115 414,979
Gross profit 413,292 436,912 372,330
Operating expenses:      
Research and development 70,161 68,644 64,843
Selling, general, and administrative 307,605 289,916 263,095
Total operating expenses 377,766 358,560 327,938
Income from operations 35,526 78,352 44,392
Interest and other income (expense), net (6,177) (4,419) (8,776)
Income before provision for income taxes 29,349 73,933 35,616
Provision for (benefit from) income taxes (2,845) 12,595 (2,113)
Net income $ 32,194 $ 61,338 $ 37,729
Net income per share:      
Basic (in dollars per share) $ 0.76 $ 1.48 $ 0.96
Diluted (in dollars per share) $ 0.74 $ 1.43 $ 0.93
Weighted-average shares outstanding:      
Basic (in shares) 42,583 41,462 39,242
Diluted (in shares) 43,743 42,943 40,559
Product revenues      
Revenues $ 636,031 $ 659,602 $ 569,595
Cost of revenues 354,004 344,914 312,360
Services and other revenues      
Revenues 256,177 237,425 217,714
Cost of revenues $ 124,912 $ 115,201 $ 102,619
XML 31 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]      
Net income $ 32,194 $ 61,338 $ 37,729
Other comprehensive income (loss), net of reclassification adjustments:      
Unrealized loss on interest rate swap contracts, net of tax 0 (420) (421)
Foreign currency translation adjustments 3,924 1,828 (4,320)
Other comprehensive income (loss) 3,924 1,408 (4,741)
Comprehensive income $ 36,118 $ 62,746 $ 32,988
XML 32 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect of a Change in Accounting Principle
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Earnings
Accumulated Earnings
Cumulative Effect of a Change in Accounting Principle
Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Dec. 31, 2017     47,577          
Balance (in shares) at Dec. 31, 2017       (9,145)        
Balance at Dec. 31, 2017 $ 554,341   $ 48 $ (185,074) $ 585,755 $ 159,725   $ (6,113)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 37,729         37,729    
Other comprehensive income (loss) (4,741)             (4,741)
At the market offering, net of offering costs (in shares)     557          
At the market equity offering, net of costs 39,567   $ 1   39,566      
Share-based compensation 28,885       28,885      
Issuance of common stock under employee stock plans (in shares)     1,346          
Issuance of common stock under employee stock plans 30,611   $ 1   30,610      
Tax payments related to restricted stock units (6,775)       (6,775)      
Balance (in shares) at Dec. 31, 2018     49,480          
Balance (in shares) at Dec. 31, 2018       (9,145)        
Balance at Dec. 31, 2018 679,617   $ 50 $ (185,074) 678,041 197,454   (10,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 61,338         61,338    
Other comprehensive income (loss) 1,408             1,408
At the market offering, net of offering costs (in shares)     460          
At the market equity offering, net of costs 37,806   $ 0   37,806      
Share-based compensation 34,049       34,049      
Issuance of common stock under employee stock plans (in shares)     1,337          
Issuance of common stock under employee stock plans 40,706   $ 1   40,705      
Tax payments related to restricted stock units $ (9,670)       (9,670)      
Balance (in shares) at Dec. 31, 2019 42,132   51,277          
Balance (in shares) at Dec. 31, 2019 (9,145)     (9,145)        
Balance at Dec. 31, 2019 $ 845,254 $ (264) $ 51 $ (185,074) 780,931 258,792 $ (264) (9,446)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member              
Net income $ 32,194         32,194    
Other comprehensive income (loss) 3,924             3,924
Share-based compensation 44,697       44,697      
Issuance of common stock under employee stock plans (in shares)     1,400          
Issuance of common stock under employee stock plans 54,270   $ 2   54,268      
Tax payments related to restricted stock units (8,738)       (8,738)      
Stock repurchases (in shares)       (749)        
Stock repurchases (53,035)     $ (53,035)        
Equity component of convertible senior note issuance, net of issuance costs 97,830       97,830      
Purchase of convertible note hedge (100,625)       (100,625)      
Sale of warrants 51,290       51,290      
Tax benefits related to convertible senior notes and convertible note hedge $ 706       706      
Balance (in shares) at Dec. 31, 2020 42,783   52,677          
Balance (in shares) at Dec. 31, 2020 (9,894)     (9,894)        
Balance at Dec. 31, 2020 $ 967,503   $ 53 $ (238,109) $ 920,359 $ 290,722   $ (5,522)
XML 33 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Activities      
Net income $ 32,194 $ 61,338 $ 37,729
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 61,067 53,559 51,350
Loss on disposal of property and equipment 267 445 133
Share-based compensation expense 44,697 34,049 28,885
Deferred income taxes (6,546) (1,339) (5,705)
Amortization of operating lease right-of-use assets 10,528 10,562 0
Amortization of debt issuance costs 1,597 2,204 2,292
Amortization of discount on convertible senior notes 4,766 0 0
Changes in operating assets and liabilities:      
Accounts receivable and unbilled receivables 36,842 (21,540) (6,192)
Inventories 12,359 (8,123) (6,763)
Prepaid expenses (2,081) 2,909 (308)
Other current assets (6,408) (2,010) 1,170
Investment in sales-type leases (2,882) (3,699) (1,680)
Prepaid commissions (8,057) (2,719) (4,711)
Other long-term assets (7,675) 4,528 (7,077)
Accounts payable (6,300) 7,893 (9,154)
Accrued compensation 11,595 2,495 14,419
Accrued liabilities 4,374 3,045 8,223
Deferred revenues 7,620 5,445 3,020
Operating lease liabilities (9,543) (10,040) 0
Other long-term liabilities 7,456 6,006 (1,665)
Net cash provided by operating activities 185,870 145,008 103,966
Investing Activities      
Software development for external use (32,024) (45,770) (30,677)
Purchases of property and equipment (22,842) (15,894) (23,697)
Business acquisition (225,000) 0 0
Net cash used in investing activities (279,866) (61,664) (54,374)
Financing Activities      
Proceeds from revolving credit facility 150,000 0 0
Repayment of debt and revolving credit facility (200,000) (90,000) (77,000)
Payments for debt issuance costs for revolving credit facility (550) (2,321) 0
Proceeds from issuance of convertible senior notes, net of issuance costs 559,665 0 0
Purchase of convertible note hedge (100,625) 0 0
Proceeds from sale of warrants 51,290 0 0
At the market equity offering, net of offering costs 0 37,806 39,567
Proceeds from issuances under stock-based compensation plans 54,270 40,706 30,611
Employees’ taxes paid related to restricted stock units (8,738) (9,670) (6,775)
Stock repurchases (53,035) 0 0
Change in customer funds, net 3,992 0 0
Net cash provided by (used in) financing activities 456,269 (23,479) (13,597)
Effect of exchange rate changes on cash and cash equivalents 437 153 (1,227)
Net increase in cash, cash equivalents, and restricted cash 362,710 60,018 34,768
Cash, cash equivalents, and restricted cash at beginning of period 127,210 67,192 32,424
Cash, cash equivalents, and restricted cash at end of period 489,920 127,210 67,192
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets:      
Cash, cash equivalents, and restricted cash at end of period 127,210 127,210 67,192
Supplemental cash flow information      
Cash paid for interest 522 3,582 7,487
Cash paid for taxes, net of refunds 10,343 7,761 3,489
Supplemental disclosure of non-cash activities      
Unpaid purchases of property and equipment 405 913 1,123
Transfers between inventory and property and equipment, net 0 1,552 2,032
Transfers from prepaid expenses to property and equipment 0 3,313 0
Balance transfer from term loan to revolving credit facility $ 0 $ 80,000 $ 0
XML 34 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Business
Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company’s major products are medication management automation solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The Company’s market is primarily located in the United States and Europe. “Omnicell” or the “Company” collectively refer to Omnicell, Inc. and its subsidiaries.
Basis of Presentation
The accompanying Consolidated Financial Statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented.
Principles of Consolidation
The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
On October 1, 2020, the Company completed its acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The Consolidated Financial Statements include the results of operations of this recently acquired company, commencing as of the acquisition date. The significant accounting policies of the acquired business have been aligned to conform to the accounting policies of Omnicell.
Reclassifications and Adjustments
Certain prior-year amounts have been reclassified to conform with current-period presentation. These reclassifications include (i) a change in the presentation of certain items in the disaggregation of revenues for the years ended December 31, 2020, 2019, and 2018 in Note 3, Revenues, and (ii) a change in the presentation of certain items in the reconciliation of the provision for (benefit from) income taxes for the years ended December 31, 2019 and 2018 in Note 17, Income Taxes. These changes were not deemed material and were included to conform with current-period classification and presentation.
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts from the COVID-19 pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. Those policies are revenue recognition; accounts receivable, unbilled receivables, and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill; purchased intangibles and long-lived assets; fair value of assets acquired and liabilities assumed in business combinations; convertible senior notes; share-based compensation; and accounting for income taxes. As of December 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the ongoing uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.
Segment Reporting
The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.
Foreign Currency Translation and Remeasurement
Most of the Company’s foreign subsidiaries use the local currency of their respective countries as their functional currency. The Company translates the assets and liabilities of such non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recorded as foreign currency translation adjustments and included in accumulated other comprehensive income (loss) in stockholders’ equity.
Assets and liabilities denominated in a currency other than the functional currency are remeasured into the respective entity’s functional currency. Monetary assets and liabilities are remeasured at exchange rates in effect at the end of each period, and non-monetary assets and liabilities are remeasured at historical rates. Gains and losses from foreign currency remeasurement of monetary assets and liabilities are recorded in interest and other income (expense), net.
Revenue Recognition
The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories:
Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements with multi-year co-development plans. Solutions in this category include, but are not limited to, XT Series automated dispensing systems, the XR2 Automated Central Pharmacy system, and IV compounding automation solutions.
Technical services. Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements.
Consumables. Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.
Software-as-a-service (“SaaS”), subscription software, and technology-enabled services. Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth (formerly Population Health Solutions), 340B solutions, and services associated with Omnicell One (formerly Performance Center), Central Pharmacy Compounding Services, including the XR2 Automated Central Pharmacy system, and Central Pharmacy Compounding Services, including IV compounding automation solutions.
The following table summarizes revenue recognition for each revenue category which is further discussed below:
Revenue Category
Timing of Revenue Recognition
Income Statement Classification
Connected devices, software licenses, and other
Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer
Product
Technical services
Over time, as services are provided, typically ratably over the service term
Service
Consumables
Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer
Product
SaaS, subscription software, and technology-enabled services
Over time, as services are provided
Service
Prior to recognizing revenue, the Company identifies the contract, performance obligations, and transaction price, and allocates the transaction price to the performance obligations. All identified contracts meet the following required criteria:
Parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of the Company’s contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order.
Entity can identify each party’s rights regarding the goods or services to be transferred. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following the Company’s standard business process and terms.
The entity can identify the payment terms for the goods or services to be transferred. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, the Company’s standard payment terms are net 30 day terms.
The contract has commercial substance (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). The Company’s agreements are an exchange of cash for a combination of products and services which result in changes in the amount of the Company’s future cash flows.
It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. The Company performs a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected.
Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, the Company combines the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify its performance obligations, the Company considers all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, the Company considers an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of the Company’s sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services.
The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of the Company’s commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.
The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
The Company recognizes revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as the Company provides a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations recorded as deferred revenues, net of deferred cost of goods sold, at December 31, 2020 and 2019 were $105.7 million and $98.0 million, respectively, of which $100.1 million and $90.9 million, respectively, are expected to be completed within one year and are presented as current deferred revenues, net on the Consolidated Balance Sheets. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Revenues, contract assets, and contract liabilities are recorded net of associated taxes.
The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements are generally periodic and are billed on a monthly, quarterly, or annual basis. In certain circumstances, multiple years are billed at one time.
The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues, net. The Company typically recognizes product revenue, and correspondingly reduces deferred revenues, net, for equipment and software upon written customer acceptance of installation. Consumables are recorded as revenue upon shipment to or receipt by the customer, depending upon contract terms. The portion of deferred revenues, net, not expected to be recognized as revenue within twelve months of the balance sheet date are included in long-term deferred revenues on the Consolidated Balance Sheets.
The Company often enters into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. The Company’s change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.
In the normal course of business, the Company typically does not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. The Company establishes provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to the Consolidated Financial Statements for any periods presented.
The Company contracts with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. The Company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease the Company's products. Pursuant to the terms of GPO agreements and the GSA Contract, each member or agency contracts directly with Omnicell and can purchase the Company’s products at pre-negotiated contract terms and pricing. GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee ("IFF") to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $9.7 million, $11.1 million, and $8.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During the year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.
Contract Assets and Contract Liabilities
A contract asset is a right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration. A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from the customer. Contract liabilities include customer deposits under non-cancelable contracts, and current and non-current deferred revenue balances. The Company’s contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.
Significant changes in the contract assets and the contract liabilities balances during the period are the result of the issuance of invoices and recognition of deferred revenues in the normal course of business. As a result of the right to invoice for the transaction consideration becoming unconditional, unbilled contract assets as of December 31, 2019 which were invoiced during the year ended December 31, 2020 were not material. The contract modifications entered into during the year ended December 31, 2020 did not have a significant impact on the Company’s contract assets or deferred revenues.
Contract Costs
The Company has determined that certain incentive portions of its sales commission plans require capitalization since these payments are directly related to sales achieved during a time period. These commissions are earned on the basis of the total purchase order value of new product bookings. Since there are no commensurate commissions earned on renewal of the service bookings, the Company concluded that the capitalized asset is related to services provided under both the initial contract and renewal periods. The Company applies a practical expedient to account for the incremental costs of obtaining a contract as part of a portfolio of contracts with similar characteristics as the Company expects the effect on the financial statements of applying the practical expedient would not differ materially from applying the accounting guidance to the individual contracts within the portfolio. A pool of contracts is defined as all contracts booked in a particular quarter. The amortization for the capitalized asset is an estimate of the pool’s original contract term, generally one to five years, plus an estimate of future customer renewal periods resulting in a total amortization period of ten years. Costs to obtain a contract are allocated amongst performance obligations and recognized as sales and marketing expense consistent with the pattern of revenue recognition. Capitalized costs are periodically reviewed for impairment. In accordance with U.S. GAAP, while certain compensation elements are expensed as incurred, a portion of the pool’s capitalized asset is recorded as an expense over the first two quarters after booking, which represents the estimated period during which the product revenue associated with the contract is recorded. The remaining capitalized contract costs are recorded as expense ratably over the ten year estimated initial and renewal service periods. The Company recognized contract cost expense of $22.1 million, $24.4 million, and $21.1 million during the years
ended December 31, 2020, 2019, and 2018, respectively. The commission expenses paid or due to be paid as of the consolidated balance sheet date to be recognized in future periods are recorded in long-term prepaid commissions on the Consolidated Balance Sheets. There was no impairment loss recorded related to capitalized prepaid commissions as of and for the year ended December 31, 2020.
Lessor Leases
The Company determines if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
Sales-Type Leases
The Company enters into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. The Company’s sales-type lease agreements do not contain any material residual value guarantees.
For sales-type leases, the Company recognizes revenues for its hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. The Company recognizes service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. The Company recognizes interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.
The Company optimizes cash flows by selling a majority of its non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. The Company has no obligation to the leasing company once the lease has been sold. Some of the Company's sales-type leases, mostly those relating to U.S. government hospitals which comprise approximately 67% of the lease receivable balance, are retained in-house.
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of Accounting Standards Codification ("ASC") 842, Leases. Those agreements in place prior to January 1, 2019 continue to be treated as operating leases, however, any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements entered into prior to January 1, 2019 are non-cancelable, and most automatically renew for successive one year periods at the end of each lease term absent written notice from the customer. The Company’s operating lease agreements do not contain any material residual value guarantees.
For operating leases, rental income is generally recognized on a straight-line basis over the term of the associated lease, and recorded in services and other revenues in the Consolidated Statements of Operations. Leased assets under operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the Consolidated Balance Sheets. The depreciation expense of the leased assets is recognized on a straight-line basis over the contractual term of the associated lease, and recorded in cost of revenues in the Consolidated Statements of Operations.
Allowance for Credit Losses
The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.
The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective
(pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations.
The allowance for credit losses is presented in the Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:
December 31,
20202019
(In thousands)
Allowance for credit losses:
Accounts receivable and unbilled receivables$4,286 $3,227 
Long-term unbilled receivables (1)
30 — 
Net investment in sales-type leases (2)
265 225 
_________________________________________________
(1)    Included in other long-term assets in the Consolidated Balance Sheets.
(2)    Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively.
Funds Held for Customers and Customer Fund Liabilities
With the acquisition of the 340B Link Business, the Company now offers certain products and services in which it is customary for pharmacies to owe funds to the Company which are collected on behalf of, and, after a short holding period, disbursed to, the Company’s customers. The Company presents amounts due from pharmacies and amounts due to be disbursed to customers on a gross basis within other current assets and accrued liabilities, respectively, in the Consolidated Balance Sheets, as such amounts are expected to be settled within one year. Any funds received from the pharmacies that are held by the Company are segregated from its other corporate cash accounts. These funds are classified as restricted cash as the Company is contractually obligated to disburse these amounts to customers.
Sales of Accounts Receivable
The Company records the sale of its accounts receivables in accordance with accounting guidance for transfers and servicing of financial assets. The Company transferred non-recourse accounts receivable totaling $58.8 million, $48.3 million, and $46.6 million during the years ended December 31, 2020, 2019, and 2018, respectively, which approximated fair value, to leasing companies on a non-recourse basis. Accounts receivable balance included approximately $7.8 million and $4.6 million due from third-party leasing companies for transferred non-recourse accounts receivable as of December 31, 2020 and 2019, respectively.
Cash and Cash Equivalents
The Company classifies all highly-liquid investments with original maturities of three months or less as cash equivalents. The Company’s cash and cash equivalent balances include bank accounts and highly-liquid U.S. Government money market funds held in sweep accounts with financial institutions of high credit quality. The Company continuously monitors the credit worthiness of the financial institutions in which it invests. The Company has not experienced any credit losses from its cash equivalents. Cash and cash equivalents were $485.9 million and $127.2 million as of December 31, 2020 and 2019, respectively. As of December 31, 2020, cash equivalents were $447.2 million, which consisted of money market funds held in sweep accounts, and as of December 31, 2019, the Company had no cash equivalents.
Financial Instruments
For assets and liabilities measured at fair value, the amounts are based on an expected exit price representing the amount that would be received from the sale of an asset or paid to transfer a liability in a transaction between market participants. The fair value may be based on assumptions that market participants would use in pricing an asset or liability. ASC 820, Fair Value Measurement, establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs used in valuation techniques are assigned a hierarchical level, as follows:
Level 1 – Observable inputs, such as quoted prices in active markets for identical instruments;
Level 2 – Quoted prices for similar instruments in active markets, or quoted prices for identical instruments in inactive markets; and
Level 3 – Unobservable inputs for financial instruments reflecting Company’s assumptions.
Interest Rate Swap Agreements
The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.
The Company's interest rate swap agreements qualify as cash flow hedging instruments in accordance with ASC 815, Derivatives and Hedging. The Company records its interest rate swap agreements on its Consolidated Balance Sheets at fair value. The effective portion of changes in fair value are recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Any ineffective portion is recognized in earnings. On a quarterly basis, the Company performs a qualitative assessment to determine effectiveness. For further information, refer to Note 5, Fair Value of Financial Instruments. As of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.
Inventory
Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before the Company receives them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to the Company.
The Company has a supply agreement with one primary supplier for construction and supply of several sub-assemblies and inventory management of sub-assemblies used in its hardware products. There are no minimum purchase requirements. The contract with the Company’s supplier may be terminated by either the supplier or by the Company without cause and at any time upon delivery of six months’ notice. Purchases from this supplier were $76.3 million, $75.1 million, and $54.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Shipping Costs
Outbound freight billed to customers is recorded as product revenue. The related shipping and handling costs are expensed as part of selling, general, and administrative expense. Shipping and handling expenses were $15.6 million, $15.9 million, and $14.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Property and Equipment
Property and equipment less accumulated depreciation are stated at historical cost. The Company’s expenditures for property and equipment are primarily for computer equipment and software used in the administration of its business, and for leasehold improvements to its leased facilities. The Company also develops molds and dies used in long-term manufacturing arrangements with suppliers and for production automation equipment used in the manufacturing of consumable blister card components. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software
3 - 5 years
Leasehold and building improvementsShorter of the lease term or the estimated useful life
Furniture and fixtures
5 - 7 years
Equipment
2 - 12 years
The Company capitalizes costs related to computer software developed or obtained for internal use in accordance with ASC 350-40, Internal-Use Software. Software obtained for internal use includes enterprise-level business and finance software that the Company customizes to meet its specific operational needs, as well as certain costs for the development of its subscription and cloud-based offerings sold to its customers. Costs incurred in the application development phase are capitalized and amortized over their useful lives, which is generally five years. Costs recognized in the preliminary project phase and the post-implementation phase are expensed as incurred. The Company capitalized $6.8 million and $0.3 million of
costs related to the application development of enterprise-level software and its subscription and cloud-based offerings that were included in property and equipment during the years ended December 31, 2020 and 2019, respectively.
Software Development Costs
The Company capitalizes certain software development costs in accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. The Company establishes technological feasibility when it completes a detail program design or a working model. The Company amortizes development costs over the estimated lives of the related products, which is generally five years. The Company capitalized software development costs of $32.0 million and $45.8 million, which are included in other long-term assets as of December 31, 2020 and 2019, respectively. The Company recorded $23.1 million, $17.5 million, and $12.5 million to cost of revenues for amortization of capitalized software development costs for the years ended December 31, 2020, 2019, and 2018, respectively. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.
Lessee Leases
The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of its lease contracts do not provide an implicit rate, the Company uses its incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The Company does not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. The Company elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.
Many of the Company’s operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that the Company operates. The Company reviews each of its lease options at a time required by the terms of the lease contract, and notifies the lessor if it chooses to exercise the lease renewal option. Until the Company is reasonably certain that it will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.
Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When the Company has made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.
Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (i.e. Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. 
The Company’s operating lease agreements do not contain any material residual value guarantees, restrictions, or restriction covenants.
Business Combinations
The Company uses the acquisition method of accounting under ASC 805, Business Combinations. Each acquired company’s operating results are included in the Company's Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed.
Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements.
Goodwill and Acquired Intangible Assets
Goodwill
The Company reviews goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. The Company has one reporting unit, which is the same as its operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if the Company decides to bypass this option, it proceeds to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of the Company’s reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, the Company will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.
To determine the reporting unit’s fair value under the quantitative approach, the Company uses a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. The Company also considers its market capitalization on the date of the analysis to ensure the reasonableness of its reporting unit's fair value.
The Company performed a qualitative impairment assessment analysis as of October 1, 2020 for its reporting unit taking into consideration past, current, and projected future earnings, recent trends, and market conditions, and valuation metrics involving similar companies that are publicly-traded. Based on the result of this analysis, an impairment does not exist as of December 31, 2020, and there were no accumulated impairment losses.
Intangible Assets
In connection with its acquisitions, the Company generally recognizes assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from one to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.
The Company assesses the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. The Company’s cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of the Company’s intangible assets are subjective and are affected by changes to its business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of the Company’s assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on the Company’s operating results and financial condition. For the years ended December 31, 2020 and 2019, there were no events or changes in circumstances to indicate that intangible assets carrying amounts may not be recoverable.
Convertible Debt
The Company accounts for convertible debt and related transactions in accordance with ASC 470-20, Debt with Conversion and Other Options, ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. The Company evaluates convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.
Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance Sheets.
Valuation of Share-Based Compensation
The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. The Company recognizes compensation expense related to share-based compensation based on the grant date estimated fair value.
The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of its common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on the Company’s historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period.
The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period.
The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period.
Forfeiture rates are estimated based on the Company's historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.
Accounting for Income Taxes
The Company records an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740, Income Taxes, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, the Company will incur a benefit or detriment on its income tax expense in the period of change. If the Company were to determine that all or part of the net deferred tax assets are not realizable in the future, it will record a valuation allowance that would be charged to earnings in the period such determination is made.
In accordance with ASC 740, the Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.
Recently Adopted Authoritative Guidance
In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an
“expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.
Recently Issued Authoritative Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, as well as improves consistent application of and simplifies the guidance for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 will be effective for the Company beginning January 1, 2021. The Company does not expect ASU 2019-12 to have a material impact on its Consolidated Financial Statements.
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. This update permits the use of either the modified retrospective or fully retrospective method of transition. ASU 2020-06 will be effective for the Company beginning January 1, 2022. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its Consolidated Financial Statements.
There was no other recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Consolidated Financial Statements through the reporting date.
XML 35 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations
 12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Business Combinations Business Combinations
340B Link Business Acquisition
On October 1, 2020, the Company completed the acquisition of all of the outstanding equity of the 340B Link Business pursuant to the terms and conditions of the Equity Purchase Agreement, dated August 11, 2020, as amended, by and among the Company, PSGH, LLC, BW Apothecary Holdings, LLC, the sellers identified therein and the sellers’ representative for total cash consideration of $225.0 million. The 340B Link Business acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner. The results of the 340B Link Business' operations have been included in the Company's consolidated results of operations, commencing as of the acquisition date.
The Company accounted for the acquisition of the 340B Link Business in accordance with ASC 805. The tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. The preliminary fair values assume management's best estimates based on information available at the acquisition date and may change over the measurement period, which will end no later than one year form the acquisition date, as additional information is received. The following table represents the preliminary allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of the acquisition reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheets:
340B Link Business
(Preliminary)
(In thousands)
Accounts receivable and unbilled receivables$8,197 
Prepaid expenses232 
Other current assets22,747 
Total current assets31,176 
Property and equipment531 
Operating lease right-of-use assets3,138 
Goodwill161,117 
Intangible assets62,800 
Total assets258,762 
Accounts payable568 
Accrued liabilities23,787 
Long-term deferred tax liabilities6,818 
Long-term operating lease liabilities2,589 
Total liabilities33,762 
Total purchase price$225,000 
The $161.1 million of goodwill arising from the 340B Link Business acquisition is primarily attributed to sales of future software-enabled services and solutions and the 340B Link Business’ assembled workforce. Goodwill that is expected to be deductible for tax purposes is approximately $93.9 million.
Intangible assets eligible for recognition separate from goodwill were those that satisfied either the contractual/legal criterion or the separability criterion in the accounting guidance. The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:
304B Link Business
Fair valueUseful life
(years)
(In thousands, except for years)
Customer relationships$53,000 21
Acquired technology9,000 5
Trade names200 1
Non-compete agreements600 3
Total purchased intangible assets$62,800 
The customer relationships intangible asset represents the fair value of the underlying relationships and agreements with the 340B Link Business’ customers. The acquired technology intangible asset represents the fair value of the 340B Link Business' portfolio of software and solutions that have reached technological feasibility and were part of the 340B Link Business’ offerings at the date of acquisition. The trade names intangible asset represents the fair value of brand and name recognition associated with the marketing of the 340B Link Business' software-enabled services and solutions. The non-compete agreements intangible asset represents the fair value of non-compete agreements with former key members of the 340B Link Business' management.
The fair value of the customer relationships intangible asset was determined based on the excess earnings method; the fair values of the acquired technology and trade names intangible assets were determined based on the relief-from-royalty
method; and the fair value of the non-compete agreements intangible asset was determined based on the lost profits method. The key assumptions used in estimating the fair values of intangible assets included forecasted financial information; customer attrition rates; royalty rates of 10.0% and 0.5% for the acquired technology and trade names intangible assets, respectively; discount rate of 14.0% for all intangible assets; and certain other assumptions.
The customer relationships and acquired technology intangible assets are being amortized using a double-declining method of amortization as such method better represents the economic benefits to be obtained. The trade names and non-compete agreements are being amortized over their estimated useful lives using the straight-line method of amortization.
The Company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that market participants would use. Actual results may differ from these estimates and assumptions.
The Company incurred approximately $6.5 million in acquisition-related costs related to the 340B Link Business acquisition during the year ended December 31, 2020. These costs were expensed as incurred, and are included in selling, general, and administrative expenses in the Company's Consolidated Statements of Operations.
Revenues and earnings from the 340B Link Business operations since the acquisition date through December 31, 2020 were $10.2 million and $1.3 million, respectively.
Pro Forma Financial Information
The following table presents certain unaudited pro forma information for illustrative purposes only, for the years ended December 31, 2020 and 2019 as if this acquisition had been completed on January 1, 2019. The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2019. The unaudited pro forma information combines the historical results of the acquisition with the Company’s consolidated historical results and includes certain adjustments including, but not limited to, amortization and depreciation of intangible assets and property and equipment acquired; imputed interest, interest expense, and amortization of debt issuance costs for the indebtedness incurred to complete the acquisition; and acquisition-related costs incurred.
Year Ended December 31,
20202019
(In thousands, except per share data)
Pro forma revenues$920,314 $929,106 
Pro forma net income$37,559 $56,897 
XML 36 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues
 12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
Disaggregation of Revenues
The following table summarizes the Company’s revenues disaggregated by revenue type for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Connected devices, software licenses, and other$560,368 $573,844 $483,414 
Technical services202,383 194,183 183,202 
Consumables75,663 85,758 86,182 
SaaS, subscription software, and technology-enabled services53,794 43,242 34,511 
Total revenues$892,208 $897,027 $787,309 
The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
United States$797,602$806,900$685,881
Rest of world (1)
94,60690,127101,428
Total revenues$892,208$897,027$787,309
_________________________________________________
(1)    No individual country represented more than 10% of total revenues.
Contract Assets and Contract Liabilities
The following table reflects the Company’s contract assets and contract liabilities:
December 31,
20202019
(In thousands)
Short-term unbilled receivables, net (1)
$13,895 $11,707 
Long-term unbilled receivables, net (2)
17,205 12,260 
Total contract assets$31,100 $23,967 
Short-term deferred revenues, net
$100,053 $90,894 
Long-term deferred revenues
5,673 7,083 
Total contract liabilities$105,726 $97,977 
_________________________________________________
(1)     Included in accounts receivable and unbilled receivables in the Consolidated Balance Sheets.
(2)    Included in other long-term assets in the Consolidated Balance Sheets.
Short-term deferred revenues of $100.1 million and $90.9 million include deferred revenues from product sales and service contracts, net of deferred cost of sales of $21.0 million and $13.1 million, as of December 31, 2020 and 2019, respectively. The short-term deferred revenues from product sales relate to delivered and invoiced products, pending installation and acceptance, expected to occur within the next twelve months. During the year ended December 31, 2020, the Company recognized revenues of $84.0 million that were included in the corresponding gross short-term deferred revenue balance of $104.0 million as of December 31, 2019.
Long-term deferred revenues include deferred revenues from service contracts of $5.7 million and $7.1 million as of December 31, 2020 and 2019, respectively. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Significant Customers
There were no customers that accounted for more than 10% of the Company’s total revenues for the years ended December 31, 2020, 2019, and 2018. Also, there were no customers that accounted for more than 10% of the Company’s accounts receivable balance as of December 31, 2020 and 2019.
XML 37 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Net Income Per Share
 12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per ShareBasic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period, using the treasury stock method. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units, as well as shares the Company could be obligated to issue from its convertible senior notes and warrants, as described in Note 10, Convertible Senior Notes. Any anti-dilutive weighted-average dilutive shares related to stock award plans, convertible senior notes, and warrants are excluded from the computation of the diluted net income per share.
The basic and diluted net income per share calculations for the years ended December 31, 2020, 2019, and 2018 were as follows:
Year Ended December 31,
202020192018
(In thousands, except per share data)
Net income$32,194 $61,338 $37,729 
Weighted-average shares outstanding - basic42,583 41,462 39,242 
Effect of dilutive securities from stock award plans1,160 1,481 1,317 
Effect of convertible senior notes and warrants— — — 
Weighted-average shares outstanding - diluted43,743 42,943 40,559 
Net income per share - basic$0.76 $1.48 $0.96 
Net income per share - diluted$0.74 $1.43 $0.93 
Anti-dilutive weighted-average shares related to stock award plans2,054 926 1,279 
Anti-dilutive weighted-average shares related to convertible senior notes and warrants11,816 — — 
XML 38 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments
 12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
Fair Value Hierarchy
The Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and credit facilities are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company's convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period. As of December 31, 2020, the fair value of the convertible senior notes was $782.3 million, compared to their carrying value of $467.2 million, which is net of unamortized discount and debt issuance costs and excludes amounts classified within additional paid-in capital. Refer to Note 9, Debt and Credit Agreements, for further information regarding the Company’s credit facilities and Note 10, Convertible Senior Notes, for further information regarding the Company’s convertible senior notes.
Interest Rate Swap Contracts
During 2016, the Company entered into an interest rate swap agreement with a combined notional amount of $100.0 million with one counterparty that became effective on June 30, 2016 and matured on April 30, 2019. The swap agreement required the Company to pay a fixed rate of 0.8% and provided that the Company receive a variable rate based on the one month LIBOR rate subject to a LIBOR floor of 0.0%. Amounts payable by or due to the Company were net settled with the respective counterparty on the last business day of each month, commencing July 31, 2016. The Company’s interest rate swap agreement matured during the second quarter of 2019, and, as of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.
XML 39 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Components
 12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Balance sheet details as of December 31, 2020 and 2019 are presented in the tables below:
December 31,
20202019
(In thousands)
Inventories:
Raw materials$28,205 $31,331 
Work in process7,973 7,620 
Finished goods60,120 69,060 
Total inventories$96,298 $108,011 
Other current assets:
Funds held for customers, including restricted cash (1)
$18,164 $— 
Net investment in sales-type leases, current portion10,246 9,770 
Prepaid income taxes10,095 4,347 
Other current assets2,539 1,060 
Total other current assets$41,044 $15,177 
Other long-term assets:
Capitalized software, net$94,027 $85,070 
Unbilled receivables, net17,205 12,260 
Deferred debt issuance costs4,253 4,700 
Other long-term assets3,804 1,006 
Total other long-term assets$119,289 $103,036 
Accrued liabilities:
Operating lease liabilities, current portion$12,197 $10,058 
Customer fund liabilities18,164 — 
Advance payments from customers6,981 4,006 
Rebates and lease buyouts21,815 14,911 
Group purchasing organization fees4,412 5,934 
Taxes payable3,520 3,744 
Other accrued liabilities13,222 16,914 
Total accrued liabilities$80,311 $55,567 
_________________________________________________
(1)    Includes $4.0 million of restricted cash.
The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the years ended December 31, 2020 and 2019:
Foreign currency translation adjustmentsUnrealized gain (loss) on interest rate swap hedgesTotal
(In thousands)
Balance as of December 31, 2018$(11,274)$420 $(10,854)
Other comprehensive income (loss) before reclassifications1,828 148 1,976 
Amounts reclassified from other comprehensive income (loss), net of tax— (568)(568)
Net current-period other comprehensive income (loss), net of tax1,828 (420)1,408 
Balance as of December 31, 2019(9,446)— (9,446)
Other comprehensive income (loss) before reclassifications3,924 — 3,924 
Amounts reclassified from other comprehensive income (loss), net of tax— — — 
Net current-period other comprehensive income (loss), net of tax3,924 — 3,924 
Balance as of December 31, 2020$(5,522)$— $(5,522)
XML 40 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment
 12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
Property and Equipment Property and Equipment
The following table represents the property and equipment balances as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Equipment$81,034 $88,569 
Furniture and fixtures7,498 7,925 
Leasehold improvements19,517 18,979 
Software50,230 48,309 
Construction in progress7,095 6,179 
Property and equipment, gross (1)
165,374 169,961 
Accumulated depreciation and amortization (1)
(106,301)(115,715)
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)     The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.
Depreciation and amortization expense of property and equipment was $18.3 million, $17.2 million, and $15.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The geographic location of the Company's property and equipment, net, is based on the physical location in which it is located. The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
United States$53,203 $48,769 
Rest of world (1)
5,870 5,477 
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)    No individual country represented more than 10% of the total property and equipment, net.
XML 41 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets
 12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
The following table represents changes in the carrying amount of goodwill:
(In thousands)
Balance as of December 31, 2018$335,887 
Additions— 
Foreign currency exchange rate fluctuations652 
Balance as of December 31, 2019336,539 
Additions (1)
161,117 
Foreign currency exchange rate fluctuations1,653 
Balance as of December 31, 2020$499,309 
_________________________________________________
(1)     Additions represent the preliminary value assigned to goodwill in connection with the 340B Link Business acquisition in October 2020.
Intangible Assets, Net
The carrying amounts and useful lives of intangible assets as of December 31, 2020 and 2019 were as follows:
December 31, 2020
Gross carrying
amount (1)
Accumulated
amortization		Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$187,889 $(64,254)$(777)$122,858 
10 - 30
Acquired technology86,029 (44,851)6 41,184 
3 - 20
Backlog1,150 (1,078)— 72 4
Trade names7,850 (5,794)14 2,070 
1 - 12
Patents2,930 (1,455)2 1,477 
2 - 20
Non-compete agreements600 (50)— 550 3
Total intangibles assets, net$286,448 $(117,482)$(755)$168,211 
December 31, 2019
Gross carrying
amount (1)
Accumulated
amortization		 Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$135,234 $(54,860)$(1,058)$79,316 
10 - 30
Acquired technology77,142 (36,194)5 40,953 
3 - 20
Backlog1,150 (791)— 359 
4
Trade names7,650 (5,037)11 2,624 
6 - 12
Patents3,217 (1,603)1 1,615 
2 - 20
Total intangibles assets, net$224,393 $(98,485)$(1,041)$124,867 
_________________________________________________
(1)     The differences in gross carrying amounts between periods are primarily due to additions of intangible assets in connection with the 340B Link Business acquisition, partially offset by the write-off of certain fully amortized intangible assets.
Amortization expense of intangible assets was $19.7 million, $18.9 million, and $23.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The estimated future amortization expenses for amortizable intangible assets were as follows:
December 31,
2020
(In thousands)
2021$23,948 
202221,134 
202319,113 
202412,825 
202511,616 
Thereafter79,575 
Total$168,211 
XML 42 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Debt and Credit Agreements
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Debt and Credit Agreement Debt and Credit Agreements
2016 Senior Credit Facility
On January 5, 2016, the Company entered into a $400.0 million senior secured credit facility pursuant to a credit agreement with certain lenders, Wells Fargo Securities, LLC as sole lead arranger, and Wells Fargo Bank, National Association as administrative agent (as subsequently amended as discussed below, the “Prior Credit Agreement”). The Prior Credit Agreement provided for (a) a five-year revolving credit facility of $200.0 million, which was subsequently increased pursuant to the amendment discussed below (the “Prior Revolving Credit Facility”) and (b) a five-year $200.0 million term loan facility (the “Prior Term Loan Facility” and, together with the Prior Revolving Credit Facility, the “Prior Facilities”). In addition, the Prior Credit Agreement included a letter of credit sub-limit of up to $10.0 million and a swing line loan sub-limit of up to $10.0 million. The Prior Credit Agreement had an expiration date of January 5, 2021, upon which date all remaining outstanding borrowings were due and payable.
Loans under the Prior Facilities bore interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.50% to 2.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month, plus an applicable margin ranging from 0.50% to 1.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement). Undrawn commitments under the Prior Revolving Credit Facility were subject to a commitment fee ranging from 0.20% to 0.35% per annum based on the Company’s consolidated total net leverage ratio on the average daily unused portion of the Prior Revolving Credit Facility.
On each of April 11, 2017 and December 26, 2017, the parties entered into amendments to the Prior Credit Agreement. Under these amendments, the Prior Revolving Credit Facility was increased from $200.0 million to $315.0 million and certain other modifications were made. In connection with the December 2017 amendment, the Company incurred and capitalized an additional $2.1 million of debt issuance costs.
2019 Revolving Credit Facility
On November 15, 2019, the Company refinanced the Prior Credit Agreement and entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement replaced the Prior Credit Agreement and provides for (a) a five-year revolving credit facility of $500.0 million (the “Current Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable.
On November 15, 2019, the $80.0 million outstanding term loan balance under the Prior Facilities was transferred to the Current Revolving Credit Facility.
Loans under the Current Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the
prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Current Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Current Revolving Credit Facility. The applicable margin for and certain other terms of any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty.
On September 22, 2020, the parties entered into an amendment (the “Amendment”) to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions as described in Note 10, Convertible Senior Notes, expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter.
The A&R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum consolidated total net leverage ratio and maintain a minimum interest coverage ratio. In addition, the A&R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in full compliance with all covenants as of December 31, 2020.
The refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, Debt - Modifications and Extinguishments. In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&R Credit Agreement.
In connection with the A&R Credit Agreement, the Company incurred and capitalized an additional $2.3 million of debt issuance costs. In connection with the Amendment on September 22, 2020, the Company incurred and capitalized an additional $0.6 million of debt issuance costs. The debt issuance costs are being amortized to interest expense using the straight-line method through 2024. Amortization expense related to debt issuance costs was approximately $1.0 million, $2.2 million, and $2.3 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Interest expense (exclusive of fees and debt issuance cost amortization) was approximately $0.5 million, $3.6 million, and $7.5 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The following table represents changes in the carrying amount of the Company's debt obligations:
Current Revolving Credit Facility
(In thousands)
Balance as of December 31, 2019$50,000 
Proceeds150,000 
Repayments(200,000)
Balance as of December 31, 2020$— 
The following table represents changes in the balance of the Company's deferred debt issuance costs:
(In thousands)
Balance as of December 31, 2019$4,700 
Additions550 
Amortization(997)
Balance as of December 31, 2020$4,253 
Convertible Senior Notes
0.25% Convertible Senior Notes due 2025
On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted.
The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions.
Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be.
If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of December 31, 2020, none of the criteria for a fundamental change or a conversion rate adjustment had been met.
The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least $150.0 million aggregate
principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes.
Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. Accordingly, at issuance, the Company allocated $461.8 million to the debt liability and $72.7 million to additional paid in capital, net of applicable issuance costs and deferred taxes. The difference between the principal amount of the Notes and the liability component, inclusive of issuance costs, represents the debt discount, which the Company will amortize to interest expense over the term of the Notes using an effective interest rate of 4.18%. The determination of the discount rate required certain estimates and assumptions. As of December 31, 2020, the remaining life of the Notes and the related debt discount and issuance cost accretion is approximately 4.7 years.
The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 8.1 million shares.
The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:
December 31,
2020
(In thousands)
Liability:
Principal amount$575,000 
Unamortized discount(95,744)
Unamortized debt issuance costs(12,055)
Convertible senior notes, liability component$467,201 
Equity:
Embedded conversion option$100,510 
Debt issuance costs(2,680)
Deferred tax impact(25,098)
Convertible senior notes, equity component (1)
$72,732 
_________________________________________________
(1)    Included in additional paid-in capital in the Consolidated Balance Sheets.
The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:
Year Ended
December 31,
2020
(In thousands)
Contractual coupon interest$379 
Amortization of discount$4,766 
Amortization of debt issuance costs$600 
Convertible Note Hedge and Warrant Transactions
In connection with the issuance of the Notes, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock.
The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The
convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes.Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid in capital at issuance in the Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants.
XML 43 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Convertible Senior Notes
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Convertible Senior Notes Debt and Credit Agreements
2016 Senior Credit Facility
On January 5, 2016, the Company entered into a $400.0 million senior secured credit facility pursuant to a credit agreement with certain lenders, Wells Fargo Securities, LLC as sole lead arranger, and Wells Fargo Bank, National Association as administrative agent (as subsequently amended as discussed below, the “Prior Credit Agreement”). The Prior Credit Agreement provided for (a) a five-year revolving credit facility of $200.0 million, which was subsequently increased pursuant to the amendment discussed below (the “Prior Revolving Credit Facility”) and (b) a five-year $200.0 million term loan facility (the “Prior Term Loan Facility” and, together with the Prior Revolving Credit Facility, the “Prior Facilities”). In addition, the Prior Credit Agreement included a letter of credit sub-limit of up to $10.0 million and a swing line loan sub-limit of up to $10.0 million. The Prior Credit Agreement had an expiration date of January 5, 2021, upon which date all remaining outstanding borrowings were due and payable.
Loans under the Prior Facilities bore interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.50% to 2.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month, plus an applicable margin ranging from 0.50% to 1.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement). Undrawn commitments under the Prior Revolving Credit Facility were subject to a commitment fee ranging from 0.20% to 0.35% per annum based on the Company’s consolidated total net leverage ratio on the average daily unused portion of the Prior Revolving Credit Facility.
On each of April 11, 2017 and December 26, 2017, the parties entered into amendments to the Prior Credit Agreement. Under these amendments, the Prior Revolving Credit Facility was increased from $200.0 million to $315.0 million and certain other modifications were made. In connection with the December 2017 amendment, the Company incurred and capitalized an additional $2.1 million of debt issuance costs.
2019 Revolving Credit Facility
On November 15, 2019, the Company refinanced the Prior Credit Agreement and entered into an Amended and Restated Credit Agreement (the “A&R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers and Wells Fargo Bank, National Association, as administrative agent. The A&R Credit Agreement replaced the Prior Credit Agreement and provides for (a) a five-year revolving credit facility of $500.0 million (the “Current Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable.
On November 15, 2019, the $80.0 million outstanding term loan balance under the Prior Facilities was transferred to the Current Revolving Credit Facility.
Loans under the Current Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the
prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Current Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Current Revolving Credit Facility. The applicable margin for and certain other terms of any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty.
On September 22, 2020, the parties entered into an amendment (the “Amendment”) to the A&R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions as described in Note 10, Convertible Senior Notes, expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter.
The A&R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum consolidated total net leverage ratio and maintain a minimum interest coverage ratio. In addition, the A&R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in full compliance with all covenants as of December 31, 2020.
The refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, Debt - Modifications and Extinguishments. In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&R Credit Agreement.
In connection with the A&R Credit Agreement, the Company incurred and capitalized an additional $2.3 million of debt issuance costs. In connection with the Amendment on September 22, 2020, the Company incurred and capitalized an additional $0.6 million of debt issuance costs. The debt issuance costs are being amortized to interest expense using the straight-line method through 2024. Amortization expense related to debt issuance costs was approximately $1.0 million, $2.2 million, and $2.3 million for the years ended December 31, 2020, 2019, and 2018, respectively.
Interest expense (exclusive of fees and debt issuance cost amortization) was approximately $0.5 million, $3.6 million, and $7.5 million for the years ended December 31, 2020, 2019, and 2018, respectively.
The following table represents changes in the carrying amount of the Company's debt obligations:
Current Revolving Credit Facility
(In thousands)
Balance as of December 31, 2019$50,000 
Proceeds150,000 
Repayments(200,000)
Balance as of December 31, 2020$— 
The following table represents changes in the balance of the Company's deferred debt issuance costs:
(In thousands)
Balance as of December 31, 2019$4,700 
Additions550 
Amortization(997)
Balance as of December 31, 2020$4,253 
Convertible Senior Notes
0.25% Convertible Senior Notes due 2025
On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted.
The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions.
Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be.
If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of December 31, 2020, none of the criteria for a fundamental change or a conversion rate adjustment had been met.
The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least $150.0 million aggregate
principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes.
Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. Accordingly, at issuance, the Company allocated $461.8 million to the debt liability and $72.7 million to additional paid in capital, net of applicable issuance costs and deferred taxes. The difference between the principal amount of the Notes and the liability component, inclusive of issuance costs, represents the debt discount, which the Company will amortize to interest expense over the term of the Notes using an effective interest rate of 4.18%. The determination of the discount rate required certain estimates and assumptions. As of December 31, 2020, the remaining life of the Notes and the related debt discount and issuance cost accretion is approximately 4.7 years.
The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 8.1 million shares.
The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:
December 31,
2020
(In thousands)
Liability:
Principal amount$575,000 
Unamortized discount(95,744)
Unamortized debt issuance costs(12,055)
Convertible senior notes, liability component$467,201 
Equity:
Embedded conversion option$100,510 
Debt issuance costs(2,680)
Deferred tax impact(25,098)
Convertible senior notes, equity component (1)
$72,732 
_________________________________________________
(1)    Included in additional paid-in capital in the Consolidated Balance Sheets.
The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:
Year Ended
December 31,
2020
(In thousands)
Contractual coupon interest$379 
Amortization of discount$4,766 
Amortization of debt issuance costs$600 
Convertible Note Hedge and Warrant Transactions
In connection with the issuance of the Notes, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock.
The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The
convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes.Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid in capital at issuance in the Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants.
XML 44 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Lessor Leases Lessor Leases
Sales-Type Leases
On a recurring basis, the Company enters into multi-year, sales-type lease agreements with the majority varying in length from one to five years. The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Sales-type lease revenues$26,040 $37,175 $39,167 
Cost of sales-type lease revenues(10,624)(14,985)(16,185)
Selling profit on sales-type lease revenues$15,416 $22,190 $22,982 
Interest income on sales-type lease receivables$1,933 $1,756 $1,296 
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Net minimum lease payments to be received$35,331 $32,360 
Less: Unearned interest income portion(2,929)(2,840)
Net investment in sales-type leases32,402 29,520 
Less: Current portion (1)
(10,246)(9,770)
Long-term investment in sales-type leases, net$22,156 $19,750 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.
The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:
December 31,
2020
(In thousands)
2021$11,312 
20229,499 
20237,334 
20244,535 
20252,616 
Thereafter35 
Total future minimum sales-type lease payments35,331 
Present value adjustment(2,929)
Total net investment in sales-type leases$32,402 
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of ASC 842, Leases. These agreements in place prior to January 1, 2019 continue to be treated as operating leases, however any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements generally have initial terms of one to seven years. The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Rental income$11,668 $12,660 $12,207 
The net carrying value of the leased equipment under operating leases was $1.4 million and $2.1 million, which includes accumulated depreciation of $2.5 million and $1.6 million, as of December 31, 2020 and 2019, respectively. Depreciation expense of the leased equipment for the years ended December 31, 2020, 2019, and 2018 was $0.6 million, $0.7 million, and $0.5 million, respectively.
The maturity schedule of future minimum lease payments under operating leases was as follows:
December 31, 2020
(In thousands)
2021$8,848 
20224,816 
20232,910 
2024852 
2025256 
Thereafter89 
Total future minimum operating lease payments$17,771 
Lessor Leases Lessor Leases
Sales-Type Leases
On a recurring basis, the Company enters into multi-year, sales-type lease agreements with the majority varying in length from one to five years. The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Sales-type lease revenues$26,040 $37,175 $39,167 
Cost of sales-type lease revenues(10,624)(14,985)(16,185)
Selling profit on sales-type lease revenues$15,416 $22,190 $22,982 
Interest income on sales-type lease receivables$1,933 $1,756 $1,296 
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Net minimum lease payments to be received$35,331 $32,360 
Less: Unearned interest income portion(2,929)(2,840)
Net investment in sales-type leases32,402 29,520 
Less: Current portion (1)
(10,246)(9,770)
Long-term investment in sales-type leases, net$22,156 $19,750 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.
The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:
December 31,
2020
(In thousands)
2021$11,312 
20229,499 
20237,334 
20244,535 
20252,616 
Thereafter35 
Total future minimum sales-type lease payments35,331 
Present value adjustment(2,929)
Total net investment in sales-type leases$32,402 
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of ASC 842, Leases. These agreements in place prior to January 1, 2019 continue to be treated as operating leases, however any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements generally have initial terms of one to seven years. The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Rental income$11,668 $12,660 $12,207 
The net carrying value of the leased equipment under operating leases was $1.4 million and $2.1 million, which includes accumulated depreciation of $2.5 million and $1.6 million, as of December 31, 2020 and 2019, respectively. Depreciation expense of the leased equipment for the years ended December 31, 2020, 2019, and 2018 was $0.6 million, $0.7 million, and $0.5 million, respectively.
The maturity schedule of future minimum lease payments under operating leases was as follows:
December 31, 2020
(In thousands)
2021$8,848 
20224,816 
20232,910 
2024852 
2025256 
Thereafter89 
Total future minimum operating lease payments$17,771 
XML 45 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Lessee Leases Lessee LeasesThe Company has operating leases for office buildings, data centers, office equipment, and vehicles. The Company’s leases have initial terms of one to 12 years. As of December 31, 2020, the Company did not have any additional material operating leases that were entered into, but not yet commenced.
The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Consolidated Balance Sheets was as follows:
December 31, 2020
(In thousands)
2021$15,290 
202214,106 
202310,221 
20248,922 
20256,571 
Thereafter17,422 
Total operating lease payments72,532 
Present value adjustment(11,438)
Total operating lease liabilities (1)
$61,094 
_________________________________________________
(1)    Amount consists of a current and long-term portion of operating lease liabilities of $12.2 million and $48.9 million, respectively. The short-term portion of the operating lease liabilities is included in accrued liabilities in the Consolidated Balance Sheets.
Operating lease costs were $14.3 million and $14.6 million for the years ended December 31, 2020 and 2019, respectively. Short-term lease costs and variable lease costs were immaterial for the years ended December 31, 2020 and 2019, respectively.
The following table summarizes supplemental cash flow information related to the Company’s operating leases for the years ended December 31, 2020 and 2019:
Year Ended December 31,
20202019
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities$14,490 $14,636 
Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions$10,025 $1,204 
The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of December 31, 2020 and 2019:
December 31,
20202019
Weighted-average remaining lease term, years5.96.4
Weighted-average discount rate, %5.8 %6.4 %
XML 46 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
In the ordinary course of business, the Company issues purchase orders based on its current manufacturing needs. As of December 31, 2020, the Company had non-cancelable purchase commitments of $72.8 million, of which $69.9 million are expected to be paid within the next twelve months. 
Legal Proceedings
The Company is currently involved in various legal proceedings.
A class action lawsuit was filed against the Company, on June 5, 2019, in the Circuit Court of Cook County, Illinois, Chancery Division, captioned Corey Heard, individually and on behalf of all others similarly situated, v. Omnicell, Inc., Case No. 2019-CH-06817. The complaint seeks class certification, monetary damages in the form of statutory damages for willful and/or reckless or, in the alternative, negligent violation of the Illinois Biometric Information Privacy Act (“BIPA”), and certain declaratory, injunctive, and other relief based on causes of action directed to allegations of violation of BIPA by the Company.
The complaint was served on the Company on June 13, 2019. On July 31, 2019, the Company filed a motion to stay or consolidate the case with the action Yana Mazya, et al. v. Northwestern Lake Forest Hospital, et al., Case No. 2018-CH-07161, pending in the Circuit Court of Cook County, Illinois, Chancery Division (the “Mazya Action”). The Court subsequently, on October 10, 2019, denied the motion, without prejudice, as being moot in view of the Company’s dismissal from the Mazya Action. The Company filed a motion to dismiss the complaint on October 31, 2019. The hearing on the Company’s motion to dismiss was held on September 2, 2020. The Court ruled from the bench and dismissed the complaint without prejudice giving plaintiff leave to file an amended complaint by September 30, 2020. Plaintiff filed an amended complaint on September 30, 2020 and the Company subsequently filed a motion to dismiss the complaint on October 28, 2020. The Company's motion to dismiss is now fully briefed and the Court has scheduled oral argument on the motion for June 4, 2021. The Company intends to defend the lawsuit vigorously.
On December 21, 2020, Becton, Dickinson and Company (“BD”) filed a complaint against the Company in the United States District Court for the Middle District of North Carolina, asserting claims of misappropriation under the Defend Trade Secrets Act, misappropriation under the North Carolina Trade Secrets Protection Act, unfair competition, and unfair/deceptive trade practices in violation of North Carolina law (the “Omnicell Complaint”). This action was commenced in relation to another action brought by BD, in the same Court, (the “Related Matter”) against a former BD employee who is also a former Company employee (the “Former Employee”) alleging that the Former Employee had violated the Former Employee’s legal obligations to BD regarding BD’s confidential and trade secret information when the Former Employee allegedly downloaded certain documents from BD’s information technology system following the end of the Former Employee’s employment with BD. In connection with the Related Matter, BD, the Former Employee, and the Company entered into a protocol to facilitate the return to BD of any BD documents that may have been resident, as a result of the Former Employee’s actions, on any devices belonging to the Former Employee or the Company. The Omnicell Complaint seeks injunctive relief and monetary damages in the form of compensatory, punitive, and exemplary damages, attorneys’ fees and costs, and pre-judgment and post-judgment interest. BD has not yet served the Omnicell Complaint on the Company, and, therefore, there are no response dates pending. The Company intends to defend the lawsuit vigorously.
As required under ASC 450, Contingencies, the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with the legal proceedings described above based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time or is not deemed material. The Company believes that it has valid defenses with respect to these legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of any of these legal proceedings or because of the diversion of management’s attention and the creation of significant expenses.
Guarantees
Under the Company’s certificate of incorporation and bylaws, the Company has agreed to indemnify its directors and executive officers to the fullest extent not prohibited by Delaware and other applicable law, subject to certain exceptions. The Company has entered into individual indemnification agreements with its directors and officers. The term of the indemnification period is for the entirety of the director’s or officer’s service to the Company and continues so long as the director or officer may be subject to any claim, action, or proceeding, and there is no limit on the potential amount of future payments that the Company could be required to make under these indemnification agreements. The Company has purchased a directors’ and officers’ liability insurance policy that may enable it to recover a portion of any future payments that it may be required to make under these indemnification agreements. Assuming the applicability of coverage and the willingness of the insurer to assume coverage and subject to certain retention, loss limits, and other policy provisions, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations. However, no assurances can be given that the insurers will not attempt to dispute the validity, applicability, or amount of coverage without expensive and time-consuming litigation against the insurers.
Additionally, the Company undertakes indemnification obligations in its ordinary course of business in connection with, among other things, the licensing of its products and the provision of its support services. In the ordinary course of the Company’s business, the Company has in the past and may in the future agree to indemnify another party, generally its business affiliates or customers, against certain losses suffered or incurred by the indemnified party in connection with various types of claims, which may include, without limitation, claims of intellectual property infringement, certain tax liabilities, its gross negligence or intentional acts in the performance of support services, and violations of laws. The term of these indemnification obligations is generally perpetual. In general, the Company attempts to limit the maximum potential amount of future payments that it may be required to make under these indemnification obligations to the amounts paid to it by a customer, but in some cases the obligation may not be so limited.
In addition, the Company has in the past and may in the future warrant to its customers that its products will conform to functional specifications for a limited period of time following the date of installation (generally not exceeding 30 days) or that its software media is free from material defects. Sales contracts for certain of the Company’s medication packaging systems often include limited warranties for up to six months, but the periodic activity and ending warranty balances the Company records have historically been immaterial.
From time to time, the Company may also warrant that its professional services will be performed in a good and workmanlike manner or in a professional manner consistent with industry standards. The Company generally seeks to disclaim most warranties, including any implied or statutory warranties such as warranties of merchantability, fitness for a particular purpose, title, quality, and non-infringement, as well as any liability with respect to incidental, consequential, special, exemplary, punitive, or similar damages. In some states, such disclaimers may not be enforceable. If necessary, the Company would provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. The Company has not been subject to any significant claims for such losses and has not incurred any material costs in defending or settling claims related to these indemnification obligations. Accordingly, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations or potential warranty claims and, therefore, no material liabilities have been recorded for such indemnification obligations as of December 31, 2020 and 2019.
XML 47 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation
 12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Employee Benefits and Share-Based Compensation Employee Benefits and Share-Based Compensation
Stock Purchase Plan
1997 Employee Stock Purchase Plan
The Company has an Employee Stock Purchase Plan (“ESPP”), under which employees can purchase shares of its common stock based on a percentage of their compensation, but not greater than 15% of their earnings; provided, however, an eligible employee’s right to purchase shares of the Company’s common stock may not accrue at a rate which exceeds $25,000 of the fair market value of such shares for each calendar year in which such rights are outstanding. The purchase price per share must be equal to the lower of 85% of the fair value of the common stock at the beginning of a 24-month offering period or the end of each six-month purchasing period.
There was a total of 1.2 million shares reserved for future issuance under the ESPP as of December 31, 2020.
Stock Award Plans
2009 Equity Incentive Plan
The 2009 Equity Incentive Plan (“2009 Plan”), as amended, provides for the issuance of incentive stock options, RSAs, RSUs, PSUs, and other stock awards to the Company’s employees, directors, and consultants. There were 5.9 million shares of common stock reserved for future issuance under the 2009 Plan as of December 31, 2020.
Options granted under the 2009 Plan generally become exercisable over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 36 equal monthly installments thereafter. The exercise prices of the options is the fair market value of common stock on the date of grant. RSUs generally vest over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 12 equal quarterly installments thereafter. Awards of restricted stock to non-employee directors are granted on the date of the annual meeting of stockholders and vest in full on the date of the next annual meeting of stockholders, provided such non-employee director remains a director on such date. The fair value of the awards on the date of issuance is amortized to expense from the date of grant to the date of vesting and are expensed ratably on a straight-line basis over the vesting period. PSUs granted to the Company’s executives might include performance and market conditions. PSUs become eligible for vesting when certain market or performance conditions are met.
Share-Based Compensation Expense
The following table sets forth the total share-based compensation expense recognized in the Company’s Consolidated Statements of Operations:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$7,469 $5,648 $4,634 
Research and development6,497 6,604 5,746 
Selling, general, and administrative30,731 21,797 18,505 
Total share-based compensation expense$44,697 $34,049 $28,885 
The Company did not capitalize any share-based compensation as inventory as such amounts were not material for the years ended December 31, 2020 and 2019. Income tax benefits realized from share-based compensation were $10.3 million, $11.0 million, and $6.5 million, for the years ended December 31, 2020, 2019, and 2018, respectively.
Stock Options and ESPP Shares
The following assumptions were used to value stock options and ESPP shares granted pursuant to the Company’s equity incentive plans for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
Stock options
Expected life, years4.74.44.8
Expected volatility, %39.4 %33.7 %31.1 %
Risk-free interest rate, %0.7 %2.0 %2.8 %
Estimated forfeiture rate, %5.7 %7.2 %6.9 %
Dividend yield, %— %— %— %
Year Ended December 31,
202020192018
Employee stock purchase plan shares
Expected life, years
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility, %
30.4% - 53.5%
28.2% - 39.9%
28.1% - 33.8%
Risk-free interest rate, %
0.1% - 2.7%
1.3% - 2.7%
0.8% - 2.7%
Dividend yield, %— %— %— %
Stock Options Activity
The following table summarizes the share option activity under the Company’s 2009 Plan during the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Outstanding at December 31, 20193,902 $52.75 7.7$113,198 
Granted1,351 78.83 
Exercised(891)42.67 
Expired(19)59.65 
Forfeited(411)66.65 
Outstanding at December 31, 20203,932 $62.50 7.8$226,160 
Exercisable at December 31, 20201,556 $45.49 6.2$115,949 
Vested and expected to vest at December 31, 2020 and thereafter3,755 $61.86 7.7$218,379 
The weighted-average fair value per share of options granted during the years ended December 31, 2020, 2019, and 2018 was $26.48, $23.54, and $17.22, respectively. The intrinsic value of options exercised during the years ended December 31, 2020, 2019, and 2018 was $39.8 million, $32.8 million, and $20.1 million, respectively. The tax benefit realized from stock options exercised was $7.1 million, $6.3 million, and $3.6 million, for the years ended December 31, 2020, 2019, and 2018, respectively.
As of December 31, 2020, total unrecognized compensation cost related to unvested stock options was $52.7 million, which is expected to be recognized over a weighted-average vesting period of 2.8 years.
Employee Stock Purchase Plan Activity
For the years ended December 31, 2020 and 2019, employees purchased approximately 333,000 and 374,000 shares of common stock, respectively, under the ESPP at a weighted-average price of $48.77 and $41.44, respectively. As of December 31, 2020, the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $4.1 million and is expected to be recognized over a weighted-average period of 1.3 years.
Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)
Summaries of the restricted stock activity under the 2009 Plan are presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Restricted stock units
Outstanding at December 31, 2019544 $66.65 1.6$44,492 
Granted (Awarded)343 74.52 
Vested (Released)(183)61.30 
Forfeited(124)67.16 
Outstanding and unvested at December 31, 2020580 $72.87 1.6$69,670 
The weighted-average grant date fair value per share of RSUs granted during the years ended December 31, 2020, 2019, and 2018 was $74.52, $78.49, and $59.52, respectively. The total fair value of RSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $11.2 million, $10.6 million, and $7.9 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to RSUs was $40.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 3.1 years.
Number of
Shares
Weighted-Average
Grant Date Fair Value
(In thousands, except per share data)
Restricted stock awards
Outstanding at December 31, 201917 $81.92 
Granted (Awarded)21 68.11 
Vested (Released)(17)81.92 
Outstanding and unvested at December 31, 202021 $68.11 
The weighted-average grant date fair value per share of RSAs granted during the years ended December 31, 2020, 2019, and 2018 was $68.11, $81.86, and $46.60, respectively. The total fair value of RSAs that vested in the years ended December 31, 2020, 2019, and 2018 was $1.4 million, $1.0 million, and $1.0 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to RSAs was $0.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 0.4 years.
Performance-Based Restricted Stock Units (PSUs)
In 2019, the Company granted 61,098 PSUs to its executive officers, all of which became eligible for vesting upon the achievement of a certain level of shareholder return. In 2020, the Company granted 62,759 PSUs to its executive officers, all, none, or a portion of which may become eligible for vesting depending on the level of shareholder return for the period from March 1, 2020 through March 1, 2021.
The fair value of PSU awards to executive officers is determined using a Monte Carlo simulation model. The number of shares that vest at the end of the performance period depends on the percentile ranking of the total shareholder return for Omnicell stock over the performance period relative to the total shareholder return of each of the other companies in the NASDAQ Healthcare Index (the “Index”).
For PSUs granted on February 13, 2020, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2020, compared to the trailing 20-day average stock price just prior to the first trading day of March 2021. For PSUs granted on February 13, 2019, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2019, compared to the trailing 20-day average stock price just prior to the first trading day of March 2020.
On March 5, 2019, the Compensation Committee confirmed the Company's total stockholder return at the 90th percentile rank of the Index. This resulted in 100% of the 2018 PSUs, or 110,432 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 5, 2019 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2019. Vesting is contingent upon continued service. Of the 110,432 shares eligible for time-based vesting under the 2018 PSUs, 67,066 shares, net of forfeitures, have vested as of December 31, 2020.
On March 3, 2020, the Compensation Committee confirmed the Company's total stockholder return at the 70th percentile rank of the Index. This resulted in 100% of the 2019 PSUs, or 61,098 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 3, 2020 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2020. Vesting is contingent upon continued service. Of the 61,098 shares eligible for time-based vesting under the 2019 PSUs, 30,548 shares, net of forfeitures, have vested as of December 31, 2020.
In addition to executive officers' PSU awards, from time to time, the Company may grant PSUs with specific performance and service conditions to certain employees on an ad hoc basis. Historically such grants have not been material.
A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value Per Unit
(In thousands, except per share data)
Outstanding at December 31, 2019134 $55.82 
Granted99 82.17 
Vested(73)50.54 
Forfeited(5)81.72 
Outstanding and unvested at December 31, 2020155 $74.26 
The weighted-average grant date fair value per share of PSUs granted during the years ended December 31, 2020, 2019, and 2018 was $82.17, $73.38, and $38.03, respectively. The total fair value of PSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $3.7 million, $3.5 million, and $3.2 million, respectively.
As of December 31, 2020, total unrecognized compensation cost related to PSUs was approximately $5.6 million, which is expected to be recognized over the remaining weighted-average period of 1.4 years.
Summary of Shares Reserved for Future Issuance under Equity Incentive Plans
The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of December 31, 2020:
Number of Shares
(In thousands)
Share options outstanding3,932 
Non-vested restricted stock awards756 
Shares authorized for future issuance1,250 
ESPP shares available for future issuance1,206 
Total shares reserved for future issuance7,144 
401(k) Plan
The Company has established a pre-tax savings plan under Section 401(k) of the Internal Revenue Code of 1986, as amended. The 401(k) Plan allows eligible employees in the United States to voluntarily contribute a portion of their pre-tax salary, subject to a maximum limit specified in the Internal Revenue Code. The Company matches 50% of employee contributions up to $3,000, annually. The Company’s contributions under this plan were $5.7 million, $5.1 million, and $4.6 million in the years ended December 31, 2020, 2019, and 2018, respectively.
XML 48 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Repurchase Program
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Stock Repurchase Program Stock Repurchase Program
On August 2, 2016, the Company’s Board of Directors (the “Board”) authorized a stock repurchase program providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2016 Repurchase Program”). The 2016 Repurchase Program is in addition to the stock repurchase program approved by the Board on November 4, 2014 providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2014 Repurchase Program”). As of December 31, 2020, the maximum dollar value of shares that may yet be purchased under the two repurchase programs was $54.9 million.
The timing, price, and volume of repurchases are to be based on market conditions, relevant securities laws, and other factors. The stock repurchases may be made from time to time on the open market, in privately negotiated transactions, or pursuant to a Rule 10b-18 plan, subject to the terms and conditions of that certain A&R Credit Agreement, as amended. The stock repurchase programs do not obligate the Company to repurchase any specific number of shares, and the Company may terminate or suspend the repurchase programs at any time.
On September 17, 2020, the Board authorized a one-time stock repurchase transaction providing for the repurchase of up to $75.0 million of the Company’s common stock in privately negotiated transactions concurrently with the issuance of the Notes, described in Note 10, Convertible Senior Notes. In September 2020, the Company repurchased 749,300 shares of its common stock from purchasers of the Notes in the offering in privately negotiated transactions effected through one of the
initial purchasers or its affiliate at an average price of $70.78 per share for an aggregate purchase price of approximately $53.0 million. There will be no further repurchases under this one-time authorization.
During the years ended December 31, 2020, 2019, and 2018, the Company did not repurchase any of its outstanding common stock, including under the 2014 Repurchase Program or the 2016 Repurchase Program, other than the separately-authorized one-time stock repurchase concurrent with the offering of the Notes in September 2020.
XML 49 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Offerings
 12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Equity Offerings Equity Offerings
On November 3, 2017, the Company entered into a Distribution Agreement (the “Distribution Agreement”) with J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, and HSBC Securities (USA) Inc., as its sales agents, pursuant to which the Company was able to offer and sell from time to time through the sales agents up to $125.0 million maximum aggregate offering price of the Company’s common stock. Sales of the common stock pursuant to the Distribution Agreement may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the Nasdaq Stock Market, or sales made to or through a market maker other than on an exchange.
For the year ended December 31, 2018, the Company received gross proceeds of $40.3 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 557,000 shares of its common stock at an average price of approximately $72.40 per share.
For the year ended December 31, 2019, the Company received gross proceeds of $38.5 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 460,000 shares of its common stock at an average price of approximately $83.81 per share.
For the year ended December 31, 2020, the Company did not sell any of its common stock under the Distribution Agreement.
The registration statement under which the shares that could have been sold pursuant to the Distribution Agreement expired on November 3, 2020, and, accordingly, no additional sales will be made pursuant to the Distribution Agreement.
XML 50 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The following is a geographical breakdown of income (loss) before the provision for income taxes:
Year Ended December 31,
202020192018
(In thousands)
Domestic$34,714 $81,641 $46,528 
Foreign(5,365)(7,708)(10,912)
Income (loss) before provision for income taxes$29,349 $73,933 $35,616 
The provision for (benefit from) income taxes consisted of the following:
Year Ended December 31,
202020192018
(In thousands)
Current:
Federal$1,874 $8,006 $1,404 
State1,733 4,549 1,832 
Foreign647 1,240 768 
Total current income taxes4,254 13,795 4,004 
Deferred:
Federal(3,868)(1,292)5,455 
State(2,494)(1,609)(909)
Foreign(737)1,701 (10,663)
Total deferred income taxes(7,099)(1,200)(6,117)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
The provision for (benefit from) income taxes differs from the amount computed by applying the statutory federal tax rate as follows:
Year Ended December 31,
202020192018
(In thousands)
U.S. federal tax provision at statutory rate$6,163 $15,525 $7,479 
State taxes(601)2,258 651 
Section 162(m) limitation2,550 2,279 738 
Non-deductible expenses325 619 686 
Uncertain tax positions(394)(2,472)(412)
Share-based compensation tax benefit(6,929)(7,892)(4,005)
Research tax credits(4,038)(3,805)(3,230)
Restructuring impact— 7,432 (4,205)
Foreign derived intangible income deduction(204)(449)(349)
Foreign rate differential(102)(1,424)561 
Other385 524 (27)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
As a result of global operational centralization activities during the year ended December 31, 2018, the Company recognized $4.2 million of tax benefit associated with making a check-the-box election to treat Aesynt Holding Coöperatief U.A. (Netherlands) as the U.S. disregarded entity beginning in the first quarter of 2018. Subsequently, during the year ended December 31, 2019, the Company recognized gain on the sale of certain intellectual property rights by Aesynt B.V. to Omnicell, Inc. and by Mach4 Automatisierungstechnik GmbH ("Mach4") to Omnicell, Inc., which resulted in a tax expense, net of tax benefit, of $7.4 million. As the Company continued with global operational centralization activities during the year ended December 31, 2020, Aesynt B.V. merged with and into Aesynt Holding B.V., with Aesynt Holding B.V. surviving and changing its name to Omnicell B.V., Aesynt Holding Coöperatief U.A. liquidated into Omnicell, Inc., and Omnicell GmbH merged with and into Mach4, with Mach4 surviving and changing its name to Omnicell GmbH. During the year ended December 31, 2020, the Company also recognized a gain on Omnicell Limited’s transferring shares of Omnicell GmbH to Omnicell International, LLC, which resulted in an immaterial tax expense.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was signed into law in response to the COVID-19 pandemic. The CARES Act, among other provisions, includes provisions related to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, net operating losses carryback periods, alternative minimum tax credit refunds, modification to the net interest expense deduction limitation, and technical amendments to tax depreciation methods for qualified improvement property placed in service after December 31, 2017. The provisions of the CARES Act did not have a material impact on the Company’s income taxes.
Significant components of the Company’s deferred tax assets (liabilities) were as follows:
December 31,
20202019
(In thousands)
Deferred tax assets (liabilities):
Deferred revenues$5,910 $4,129 
Share-based compensation8,094 6,483 
Inventory-related items4,953 3,507 
Tax credit carryforwards12,105 13,472 
Reserves and accruals8,160 5,712 
Loss carryforwards8,461 9,484 
Lease liability15,465 15,471 
Other, net1,578 543 
Gross deferred tax assets64,726 58,801 
Valuation allowance(1,199)(1,186)
Total net deferred tax assets63,527 57,615 
Intangibles(22,010)(18,941)
Depreciation and amortization(36,528)(35,941)
Prepaid expenses(15,654)(13,395)
Right-of-use assets(13,949)(14,286)
Total deferred tax liabilities(88,141)(82,563)
Net deferred tax liabilities$(24,614)$(24,948)
Deferred income tax assets (liabilities) are provided for temporary differences that will result in future tax deductions or future taxable income, as well as the future benefit of tax credit carryforwards. The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. On the basis of this evaluation, as of December 31, 2020, $1.2 million of valuation allowance was recorded on certain foreign net operating losses carried forward, as the Company believes that such deferred tax assets are not more likely than not to be realized.
As of December 31, 2020, the Company had $6.0 million of state net operating loss carryforwards expiring at various dates beginning in 2024, and $29.7 million of foreign net operating losses carried forward indefinitely. For income tax purposes, the Company has federal and California research tax credits carryforwards of $1.3 million and $17.0 million, respectively. Federal research tax credit carryforwards from prior years will begin to expire in 2035. California credits are available indefinitely to reduce cash taxes payable.
It is the Company's practice and intention to reinvest the earnings of its non-U.S. subsidiaries in those operations. As of December 31, 2020, the Company has not made a provision for U.S. federal income, withholding, and state income taxes on the outside basis difference related to certain foreign subsidiaries because earnings are intended to be indefinitely reinvested in operations outside the U.S.
The Company files income tax returns in the United States and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities, including major jurisdictions such as the United States, Germany, Italy, Netherlands, and the United Kingdom. With few exceptions, as of December 31, 2020, the Company was no longer subject to U.S., state, and foreign examination for years before 2017, 2016, and 2016, respectively.
The aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the three years ended December 31, 2020 was as follows:
(In thousands)
Balance as of December 31, 2017$10,741 
Increases related to tax positions taken during a prior period19 
Decreases related to tax positions taken during the prior period(1,257)
Increases related to tax positions taken during the current period870 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(412)
Balance as of December 31, 20189,961 
Increases related to tax positions taken during a prior period10 
Decreases related to tax positions taken during the prior period(6)
Increases related to tax positions taken during the current period9,282 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(2,472)
Balance as of December 31, 201916,775 
Increases related to tax positions taken during a prior period88 
Decreases related to tax positions taken during the prior period— 
Increases related to tax positions taken during the current period2,294 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(911)
Balance as of December 31, 2020$18,246 
The total amounts of gross unrecognized tax benefit that, if realized, would favorably affect the Company's effective income tax rate in future periods, was $18.2 million and $16.8 million as of December 31, 2020 and 2019, respectively. The Company recognizes interest and/or penalties related to uncertain tax positions in interest and other income (expense), net in the Consolidated Statements of Operations, accruing $0.4 million, $0.5 million, and $0.5 million for the years ended December 31, 2020, 2019, and 2018, respectively. Accrued interest and penalties are included within other long-term liabilities on the Consolidated Balance Sheets. The combined amount of cumulative accrued interest and penalties was approximately $1.4 million, $1.0 million, and $1.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The Company does not believe there will be any significant changes in its unrecognized tax positions over the next twelve months.
XML 51 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring Expenses
 12 Months Ended
Dec. 31, 2020
Restructuring and Related Activities [Abstract]  
Restructuring Expenses Restructuring Expenses
In the first quarter of 2020, the Company announced a company-wide organizational realignment initiative in order to more effectively align its organizational infrastructure and operations with the strategic vision of the autonomous pharmacy. In the second quarter of 2020, the Company continued its organizational realignment initiative, as well as initiated a restructuring plan to help mitigate the adverse impact of the COVID-19 pandemic on its business and financial results. During the year ended December 31, 2020, the Company incurred and accrued $10.0 million of employee severance costs and related expenses. As of December 31, 2020, the unpaid balance related to this restructuring plan was $0.6 million.
In the fourth quarter of 2018, the Company announced a company-wide organizational realignment initiative in order to align its organizational infrastructure for future expected growth. During the year ended December 31, 2018, the Company accrued and paid out $1.3 million of restructuring expenses, which includes severance and consulting-related expenses.
On March 2, 2018, the Company initiated the realignment of its Automation and Analytics commercial group in North America and France. During the year ended December 31, 2018, the Company accrued and paid out $3.0 million of employee severance costs and related expenses.
The following table summarizes the total restructuring expenses recognized in the Company’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$2,564 $— $186 
Research and development3,716 — — 
Selling, general, and administrative3,681 — 4,160 
Total restructuring expenses$9,961 $— $4,346 
XML 52 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2020
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II Valuation and Qualifying Accounts
SCHEDULE II
VALUATION AND QUALIFYING ACCOUNTS
Balance at
Beginning of Period (1)
Charged (Credited) to
Costs and Expenses (2)
Debited (Credited) to
Other Accounts (3)
Amounts
Written Off (4)
Other Adjustments (5)
Balance at
End of Period (1)
(In thousands)
Year ended December 31, 2018
Accounts receivable and unbilled receivables$5,738 $(127)$12 $(3,010)$(31)$2,582 
Long-term unbilled receivables— — — — — — 
Net investment in sales-type leases192 10 12 — — 214 
Total allowances deducted from assets$5,930 $(117)$24 $(3,010)$(31)$2,796 
Year ended December 31, 2019
Accounts receivable and unbilled receivables$2,582 $2,488 $— $(1,986)$143 $3,227 
Long-term unbilled receivables— — — — — — 
Net investment in sales-type leases214 11 — — — 225 
Total allowances deducted from assets$2,796 $2,499 $— $(1,986)$143 $3,452 
Year ended December 31, 2020
Accounts receivable and unbilled receivables$3,227 $1,095 $— $(535)$499 $4,286 
Long-term unbilled receivables— — — — 30 30 
Net investment in sales-type leases225 40 — — — 265 
Total allowances deducted from assets$3,452 $1,135 $— $(535)$529 $4,581 
__________________________________________________
(1)Allowance for credit losses.
(2)Represents amounts charged and credited for provisions for credit losses.
(3)Represents amounts debited to receivables as recoveries, increasing the allowance.
(4)Represents amounts written off from the allowance and receivable.
(5)Represents other adjustments, such as foreign currency translation, adoption of new accounting guidance, and purchase price accounting adjustments in connection with acquisitions.
XML 53 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying Consolidated Financial Statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented.
Principles of Consolidation
Principles of Consolidation
The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
On October 1, 2020, the Company completed its acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The Consolidated Financial Statements include the results of operations of this recently acquired company, commencing as of the acquisition date. The significant accounting policies of the acquired business have been aligned to conform to the accounting policies of Omnicell.
Reclassifications and Adjustments Reclassifications and AdjustmentsCertain prior-year amounts have been reclassified to conform with current-period presentation. These reclassifications include (i) a change in the presentation of certain items in the disaggregation of revenues for the years ended December 31, 2020, 2019, and 2018 in Note 3, Revenues, and (ii) a change in the presentation of certain items in the reconciliation of the provision for (benefit from) income taxes for the years ended December 31, 2019 and 2018 in Note 17, Income Taxes. These changes were not deemed material and were included to conform with current-period classification and presentation.
Use of Estimates
Use of Estimates
The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts from the COVID-19 pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. Those policies are revenue recognition; accounts receivable, unbilled receivables, and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill; purchased intangibles and long-lived assets; fair value of assets acquired and liabilities assumed in business combinations; convertible senior notes; share-based compensation; and accounting for income taxes. As of December 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the ongoing uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.
Segment Reporting
Segment Reporting
The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.
Foreign Currency Translation and Remeasurement
Foreign Currency Translation and Remeasurement
Most of the Company’s foreign subsidiaries use the local currency of their respective countries as their functional currency. The Company translates the assets and liabilities of such non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recorded as foreign currency translation adjustments and included in accumulated other comprehensive income (loss) in stockholders’ equity.
Assets and liabilities denominated in a currency other than the functional currency are remeasured into the respective entity’s functional currency. Monetary assets and liabilities are remeasured at exchange rates in effect at the end of each period, and non-monetary assets and liabilities are remeasured at historical rates. Gains and losses from foreign currency remeasurement of monetary assets and liabilities are recorded in interest and other income (expense), net.
Revenue Recognition and Shipping Costs
Revenue Recognition
The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories:
Connected devices, software licenses, and other. Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements with multi-year co-development plans. Solutions in this category include, but are not limited to, XT Series automated dispensing systems, the XR2 Automated Central Pharmacy system, and IV compounding automation solutions.
Technical services. Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements.
Consumables. Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.
Software-as-a-service (“SaaS”), subscription software, and technology-enabled services. Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth (formerly Population Health Solutions), 340B solutions, and services associated with Omnicell One (formerly Performance Center), Central Pharmacy Compounding Services, including the XR2 Automated Central Pharmacy system, and Central Pharmacy Compounding Services, including IV compounding automation solutions.
The following table summarizes revenue recognition for each revenue category which is further discussed below:
Revenue Category
Timing of Revenue Recognition
Income Statement Classification
Connected devices, software licenses, and other
Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer
Product
Technical services
Over time, as services are provided, typically ratably over the service term
Service
Consumables
Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer
Product
SaaS, subscription software, and technology-enabled services
Over time, as services are provided
Service
Prior to recognizing revenue, the Company identifies the contract, performance obligations, and transaction price, and allocates the transaction price to the performance obligations. All identified contracts meet the following required criteria:
Parties to the contract have approved the contract (in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of the Company’s contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order.
Entity can identify each party’s rights regarding the goods or services to be transferred. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following the Company’s standard business process and terms.
The entity can identify the payment terms for the goods or services to be transferred. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, the Company’s standard payment terms are net 30 day terms.
The contract has commercial substance (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). The Company’s agreements are an exchange of cash for a combination of products and services which result in changes in the amount of the Company’s future cash flows.
It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer. The Company performs a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected.
Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, the Company combines the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify its performance obligations, the Company considers all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, the Company considers an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of the Company’s sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services.
The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of the Company’s commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.
The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
The Company recognizes revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as the Company provides a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations recorded as deferred revenues, net of deferred cost of goods sold, at December 31, 2020 and 2019 were $105.7 million and $98.0 million, respectively, of which $100.1 million and $90.9 million, respectively, are expected to be completed within one year and are presented as current deferred revenues, net on the Consolidated Balance Sheets. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.
Revenues, contract assets, and contract liabilities are recorded net of associated taxes.
The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements are generally periodic and are billed on a monthly, quarterly, or annual basis. In certain circumstances, multiple years are billed at one time.
The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues, net. The Company typically recognizes product revenue, and correspondingly reduces deferred revenues, net, for equipment and software upon written customer acceptance of installation. Consumables are recorded as revenue upon shipment to or receipt by the customer, depending upon contract terms. The portion of deferred revenues, net, not expected to be recognized as revenue within twelve months of the balance sheet date are included in long-term deferred revenues on the Consolidated Balance Sheets.
The Company often enters into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. The Company’s change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.
In the normal course of business, the Company typically does not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. The Company establishes provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to the Consolidated Financial Statements for any periods presented.
The Company contracts with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. The Company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease the Company's products. Pursuant to the terms of GPO agreements and the GSA Contract, each member or agency contracts directly with Omnicell and can purchase the Company’s products at pre-negotiated contract terms and pricing. GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee ("IFF") to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $9.7 million, $11.1 million, and $8.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During the year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.
Contract Assets and Contract Liabilities
A contract asset is a right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration. A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from the customer. Contract liabilities include customer deposits under non-cancelable contracts, and current and non-current deferred revenue balances. The Company’s contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.
Significant changes in the contract assets and the contract liabilities balances during the period are the result of the issuance of invoices and recognition of deferred revenues in the normal course of business. As a result of the right to invoice for the transaction consideration becoming unconditional, unbilled contract assets as of December 31, 2019 which were invoiced during the year ended December 31, 2020 were not material. The contract modifications entered into during the year ended December 31, 2020 did not have a significant impact on the Company’s contract assets or deferred revenues.
Contract Costs
The Company has determined that certain incentive portions of its sales commission plans require capitalization since these payments are directly related to sales achieved during a time period. These commissions are earned on the basis of the total purchase order value of new product bookings. Since there are no commensurate commissions earned on renewal of the service bookings, the Company concluded that the capitalized asset is related to services provided under both the initial contract and renewal periods. The Company applies a practical expedient to account for the incremental costs of obtaining a contract as part of a portfolio of contracts with similar characteristics as the Company expects the effect on the financial statements of applying the practical expedient would not differ materially from applying the accounting guidance to the individual contracts within the portfolio. A pool of contracts is defined as all contracts booked in a particular quarter. The amortization for the capitalized asset is an estimate of the pool’s original contract term, generally one to five years, plus an estimate of future customer renewal periods resulting in a total amortization period of ten years. Costs to obtain a contract are allocated amongst performance obligations and recognized as sales and marketing expense consistent with the pattern of revenue recognition. Capitalized costs are periodically reviewed for impairment. In accordance with U.S. GAAP, while certain compensation elements are expensed as incurred, a portion of the pool’s capitalized asset is recorded as an expense over the first two quarters after booking, which represents the estimated period during which the product revenue associated with the contract is recorded. The remaining capitalized contract costs are recorded as expense ratably over the ten year estimated initial and renewal service periodsShipping CostsOutbound freight billed to customers is recorded as product revenue. The related shipping and handling costs are expensed as part of selling, general, and administrative expense.
Lessor Leases
Lessor Leases
The Company determines if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.
Sales-Type Leases
The Company enters into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. The Company’s sales-type lease agreements do not contain any material residual value guarantees.
For sales-type leases, the Company recognizes revenues for its hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. The Company recognizes service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. The Company recognizes interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.
The Company optimizes cash flows by selling a majority of its non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. The Company has no obligation to the leasing company once the lease has been sold. Some of the Company's sales-type leases, mostly those relating to U.S. government hospitals which comprise approximately 67% of the lease receivable balance, are retained in-house.
Operating Leases
The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of Accounting Standards Codification ("ASC") 842, Leases. Those agreements in place prior to January 1, 2019 continue to be treated as operating leases, however, any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements entered into prior to January 1, 2019 are non-cancelable, and most automatically renew for successive one year periods at the end of each lease term absent written notice from the customer. The Company’s operating lease agreements do not contain any material residual value guarantees.
For operating leases, rental income is generally recognized on a straight-line basis over the term of the associated lease, and recorded in services and other revenues in the Consolidated Statements of Operations. Leased assets under operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the Consolidated Balance Sheets. The depreciation expense of the leased assets is recognized on a straight-line basis over the contractual term of the associated lease, and recorded in cost of revenues in the Consolidated Statements of Operations.
Allowance for Credit Losses
Allowance for Credit Losses
The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.
The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective
(pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations.
Funds Held for Customers and Customer Fund Liabilities
Funds Held for Customers and Customer Fund Liabilities
With the acquisition of the 340B Link Business, the Company now offers certain products and services in which it is customary for pharmacies to owe funds to the Company which are collected on behalf of, and, after a short holding period, disbursed to, the Company’s customers. The Company presents amounts due from pharmacies and amounts due to be disbursed to customers on a gross basis within other current assets and accrued liabilities, respectively, in the Consolidated Balance Sheets, as such amounts are expected to be settled within one year. Any funds received from the pharmacies that are held by the Company are segregated from its other corporate cash accounts. These funds are classified as restricted cash as the Company is contractually obligated to disburse these amounts to customers.
Sales of Accounts Receivable Sales of Accounts ReceivableThe Company records the sale of its accounts receivables in accordance with accounting guidance for transfers and servicing of financial assets.
Cash Equivalents Cash and Cash EquivalentsThe Company classifies all highly-liquid investments with original maturities of three months or less as cash equivalents. The Company’s cash and cash equivalent balances include bank accounts and highly-liquid U.S. Government money market funds held in sweep accounts with financial institutions of high credit quality. The Company continuously monitors the credit worthiness of the financial institutions in which it invests. The Company has not experienced any credit losses from its cash equivalents.
Financial Instruments
Financial Instruments
For assets and liabilities measured at fair value, the amounts are based on an expected exit price representing the amount that would be received from the sale of an asset or paid to transfer a liability in a transaction between market participants. The fair value may be based on assumptions that market participants would use in pricing an asset or liability. ASC 820, Fair Value Measurement, establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs used in valuation techniques are assigned a hierarchical level, as follows:
Level 1 – Observable inputs, such as quoted prices in active markets for identical instruments;
Level 2 – Quoted prices for similar instruments in active markets, or quoted prices for identical instruments in inactive markets; and
Level 3 – Unobservable inputs for financial instruments reflecting Company’s assumptions.
Interest Rate Swap Agreements
Interest Rate Swap Agreements
The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.
The Company's interest rate swap agreements qualify as cash flow hedging instruments in accordance with ASC 815, Derivatives and Hedging. The Company records its interest rate swap agreements on its Consolidated Balance Sheets at fair value. The effective portion of changes in fair value are recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Any ineffective portion is recognized in earnings. On a quarterly basis, the Company performs a qualitative assessment to determine effectiveness. For further information, refer to Note 5, Fair Value of Financial Instruments.
Inventory
Inventory
Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before the Company receives them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to the Company.
The Company has a supply agreement with one primary supplier for construction and supply of several sub-assemblies and inventory management of sub-assemblies used in its hardware products. There are no minimum purchase requirements. The contract with the Company’s supplier may be terminated by either the supplier or by the Company without cause and at any time upon delivery of six months’ notice.
Property and Equipment
Property and Equipment
Property and equipment less accumulated depreciation are stated at historical cost. The Company’s expenditures for property and equipment are primarily for computer equipment and software used in the administration of its business, and for leasehold improvements to its leased facilities. The Company also develops molds and dies used in long-term manufacturing arrangements with suppliers and for production automation equipment used in the manufacturing of consumable blister card components. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software
3 - 5 years
Leasehold and building improvementsShorter of the lease term or the estimated useful life
Furniture and fixtures
5 - 7 years
Equipment
2 - 12 years
The Company capitalizes costs related to computer software developed or obtained for internal use in accordance with ASC 350-40, Internal-Use Software. Software obtained for internal use includes enterprise-level business and finance software that the Company customizes to meet its specific operational needs, as well as certain costs for the development of its subscription and cloud-based offerings sold to its customers. Costs incurred in the application development phase are capitalized and amortized over their useful lives, which is generally five years. Costs recognized in the preliminary project phase and the post-implementation phase are expensed as incurred.
Software Development Costs
Software Development Costs
The Company capitalizes certain software development costs in accordance with ASC 985-20, Costs of Software to Be Sold, Leased, or Marketed, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. The Company establishes technological feasibility when it completes a detail program design or a working model. The Company amortizes development costs over the estimated lives of the related products, which is generally five years. The Company capitalized software development costs of $32.0 million and $45.8 million, which are included in other long-term assets as of December 31, 2020 and 2019, respectively. The Company recorded $23.1 million, $17.5 million, and $12.5 million to cost of revenues for amortization of capitalized software development costs for the years ended December 31, 2020, 2019, and 2018, respectively. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.
Lessee Leases
Lessee Leases
The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of its lease contracts do not provide an implicit rate, the Company uses its incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The Company does not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. The Company elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.
Many of the Company’s operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that the Company operates. The Company reviews each of its lease options at a time required by the terms of the lease contract, and notifies the lessor if it chooses to exercise the lease renewal option. Until the Company is reasonably certain that it will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.
Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When the Company has made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.
Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (i.e. Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. 
The Company’s operating lease agreements do not contain any material residual value guarantees, restrictions, or restriction covenants.
Business Combinations
Business Combinations
The Company uses the acquisition method of accounting under ASC 805, Business Combinations. Each acquired company’s operating results are included in the Company's Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed.
Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements.
Goodwill and Acquired Intangible Assets
Goodwill and Acquired Intangible Assets
Goodwill
The Company reviews goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. The Company has one reporting unit, which is the same as its operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if the Company decides to bypass this option, it proceeds to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of the Company’s reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, the Company will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.
To determine the reporting unit’s fair value under the quantitative approach, the Company uses a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. The Company also considers its market capitalization on the date of the analysis to ensure the reasonableness of its reporting unit's fair value.
The Company performed a qualitative impairment assessment analysis as of October 1, 2020 for its reporting unit taking into consideration past, current, and projected future earnings, recent trends, and market conditions, and valuation metrics involving similar companies that are publicly-traded. Based on the result of this analysis, an impairment does not exist as of December 31, 2020, and there were no accumulated impairment losses.
Intangible Assets
In connection with its acquisitions, the Company generally recognizes assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from one to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.
The Company assesses the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. The Company’s cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of the Company’s intangible assets are subjective and are affected by changes to its business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of the Company’s assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on the Company’s operating results and financial condition. For the years ended December 31, 2020 and 2019, there were no events or changes in circumstances to indicate that intangible assets carrying amounts may not be recoverable.
Debt
Convertible Debt
The Company accounts for convertible debt and related transactions in accordance with ASC 470-20, Debt with Conversion and Other Options, ASC 815, Derivatives and Hedging, and ASC 480, Distinguishing Liabilities from Equity. The Company evaluates convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.
Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance SheetThe refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, Debt - Modifications and Extinguishments. In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&R Credit Agreement.Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner.
Share-Based Awards
Valuation of Share-Based Compensation
The Company accounts for share-based compensation in accordance with ASC 718, Stock Compensation. The Company recognizes compensation expense related to share-based compensation based on the grant date estimated fair value.
The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of its common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on the Company’s historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period.
The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period.
The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period.
Forfeiture rates are estimated based on the Company's historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.
Awards of restricted stock to non-employee directors are granted on the date of the annual meeting of stockholders and vest in full on the date of the next annual meeting of stockholders, provided such non-employee director remains a director on such date. The fair value of the awards on the date of issuance is amortized to expense from the date of grant to the date of vesting and are expensed ratably on a straight-line basis over the vesting period. PSUs granted to the Company’s executives might include performance and market conditions. PSUs become eligible for vesting when certain market or performance conditions are met.
Accounting for Income Taxes
Accounting for Income Taxes
The Company records an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740, Income Taxes, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, the Company will incur a benefit or detriment on its income tax expense in the period of change. If the Company were to determine that all or part of the net deferred tax assets are not realizable in the future, it will record a valuation allowance that would be charged to earnings in the period such determination is made.
In accordance with ASC 740, the Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.
Recently Adopted Authoritative and Recently Issued Authoritative Guidance
Recently Adopted Authoritative Guidance
In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an
“expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.
Recently Issued Authoritative Guidance
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes. The update simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, as well as improves consistent application of and simplifies the guidance for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 will be effective for the Company beginning January 1, 2021. The Company does not expect ASU 2019-12 to have a material impact on its Consolidated Financial Statements.
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40). The update simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. This update permits the use of either the modified retrospective or fully retrospective method of transition. ASU 2020-06 will be effective for the Company beginning January 1, 2022. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its Consolidated Financial Statements.
There was no other recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Consolidated Financial Statements through the reporting date.
Net Income Per Share Basic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period, using the treasury stock method. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units, as well as shares the Company could be obligated to issue from its convertible senior notes and warrants, as described in Note 10, Convertible Senior Notes. Any anti-dilutive weighted-average dilutive shares related to stock award plans, convertible senior notes, and warrants are excluded from the computation of the diluted net income per share.
Fair Value Hierarchy Fair Value HierarchyThe Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and credit facilities are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company's convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period.
Commitments and Contingencies As required under ASC 450, Contingencies, the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with the legal proceedings described above based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time or is not deemed material. The Company believes that it has valid defenses with respect to these legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of any of these legal proceedings or because of the diversion of management’s attention and the creation of significant expenses.
Guarantees
Guarantees
Under the Company’s certificate of incorporation and bylaws, the Company has agreed to indemnify its directors and executive officers to the fullest extent not prohibited by Delaware and other applicable law, subject to certain exceptions. The Company has entered into individual indemnification agreements with its directors and officers. The term of the indemnification period is for the entirety of the director’s or officer’s service to the Company and continues so long as the director or officer may be subject to any claim, action, or proceeding, and there is no limit on the potential amount of future payments that the Company could be required to make under these indemnification agreements. The Company has purchased a directors’ and officers’ liability insurance policy that may enable it to recover a portion of any future payments that it may be required to make under these indemnification agreements. Assuming the applicability of coverage and the willingness of the insurer to assume coverage and subject to certain retention, loss limits, and other policy provisions, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations. However, no assurances can be given that the insurers will not attempt to dispute the validity, applicability, or amount of coverage without expensive and time-consuming litigation against the insurers.
Additionally, the Company undertakes indemnification obligations in its ordinary course of business in connection with, among other things, the licensing of its products and the provision of its support services. In the ordinary course of the Company’s business, the Company has in the past and may in the future agree to indemnify another party, generally its business affiliates or customers, against certain losses suffered or incurred by the indemnified party in connection with various types of claims, which may include, without limitation, claims of intellectual property infringement, certain tax liabilities, its gross negligence or intentional acts in the performance of support services, and violations of laws. The term of these indemnification obligations is generally perpetual. In general, the Company attempts to limit the maximum potential amount of future payments that it may be required to make under these indemnification obligations to the amounts paid to it by a customer, but in some cases the obligation may not be so limited.
In addition, the Company has in the past and may in the future warrant to its customers that its products will conform to functional specifications for a limited period of time following the date of installation (generally not exceeding 30 days) or that its software media is free from material defects. Sales contracts for certain of the Company’s medication packaging systems often include limited warranties for up to six months, but the periodic activity and ending warranty balances the Company records have historically been immaterial.From time to time, the Company may also warrant that its professional services will be performed in a good and workmanlike manner or in a professional manner consistent with industry standards. The Company generally seeks to disclaim most warranties, including any implied or statutory warranties such as warranties of merchantability, fitness for a particular purpose, title, quality, and non-infringement, as well as any liability with respect to incidental, consequential, special, exemplary, punitive, or similar damages. In some states, such disclaimers may not be enforceable. If necessary, the Company would provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. The Company has not been subject to any significant claims for such losses and has not incurred any material costs in defending or settling claims related to these indemnification obligations.
XML 54 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Summary of Allowance for Credit Losses by Asset Type
The allowance for credit losses is presented in the Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:
December 31,
20202019
(In thousands)
Allowance for credit losses:
Accounts receivable and unbilled receivables$4,286 $3,227 
Long-term unbilled receivables (1)
30 — 
Net investment in sales-type leases (2)
265 225 
_________________________________________________
(1)    Included in other long-term assets in the Consolidated Balance Sheets.
(2)    Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively.
Estimated Useful Lives of Assets Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software
3 - 5 years
Leasehold and building improvementsShorter of the lease term or the estimated useful life
Furniture and fixtures
5 - 7 years
Equipment
2 - 12 years
The following table represents the property and equipment balances as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Equipment$81,034 $88,569 
Furniture and fixtures7,498 7,925 
Leasehold improvements19,517 18,979 
Software50,230 48,309 
Construction in progress7,095 6,179 
Property and equipment, gross (1)
165,374 169,961 
Accumulated depreciation and amortization (1)
(106,301)(115,715)
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)     The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.
The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
United States$53,203 $48,769 
Rest of world (1)
5,870 5,477 
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)    No individual country represented more than 10% of the total property and equipment, net.
Summary of Revenue Recognition for Revenue Category
The following table summarizes revenue recognition for each revenue category which is further discussed below:
Revenue Category
Timing of Revenue Recognition
Income Statement Classification
Connected devices, software licenses, and other
Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer
Product
Technical services
Over time, as services are provided, typically ratably over the service term
Service
Consumables
Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer
Product
SaaS, subscription software, and technology-enabled services
Over time, as services are provided
Service
XML 55 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations (Tables)
 12 Months Ended
Dec. 31, 2020
Business Combinations [Abstract]  
Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company The following table represents the preliminary allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of the acquisition reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheets:
340B Link Business
(Preliminary)
(In thousands)
Accounts receivable and unbilled receivables$8,197 
Prepaid expenses232 
Other current assets22,747 
Total current assets31,176 
Property and equipment531 
Operating lease right-of-use assets3,138 
Goodwill161,117 
Intangible assets62,800 
Total assets258,762 
Accounts payable568 
Accrued liabilities23,787 
Long-term deferred tax liabilities6,818 
Long-term operating lease liabilities2,589 
Total liabilities33,762 
Total purchase price$225,000 
Summary of Identifiable Intangible Assets Acquired The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:
304B Link Business
Fair valueUseful life
(years)
(In thousands, except for years)
Customer relationships$53,000 21
Acquired technology9,000 5
Trade names200 1
Non-compete agreements600 3
Total purchased intangible assets$62,800 
Pro Forma Financial Information
The following table presents certain unaudited pro forma information for illustrative purposes only, for the years ended December 31, 2020 and 2019 as if this acquisition had been completed on January 1, 2019. The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2019. The unaudited pro forma information combines the historical results of the acquisition with the Company’s consolidated historical results and includes certain adjustments including, but not limited to, amortization and depreciation of intangible assets and property and equipment acquired; imputed interest, interest expense, and amortization of debt issuance costs for the indebtedness incurred to complete the acquisition; and acquisition-related costs incurred.
Year Ended December 31,
20202019
(In thousands, except per share data)
Pro forma revenues$920,314 $929,106 
Pro forma net income$37,559 $56,897 
XML 56 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues (Tables)
 12 Months Ended
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenues by Revenue Type and Geographic Region
The following table summarizes the Company’s revenues disaggregated by revenue type for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Connected devices, software licenses, and other$560,368 $573,844 $483,414 
Technical services202,383 194,183 183,202 
Consumables75,663 85,758 86,182 
SaaS, subscription software, and technology-enabled services53,794 43,242 34,511 
Total revenues$892,208 $897,027 $787,309 
The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
United States$797,602$806,900$685,881
Rest of world (1)
94,60690,127101,428
Total revenues$892,208$897,027$787,309
_________________________________________________
(1)    No individual country represented more than 10% of total revenues.
Contract Assets and Liabilities
The following table reflects the Company’s contract assets and contract liabilities:
December 31,
20202019
(In thousands)
Short-term unbilled receivables, net (1)
$13,895 $11,707 
Long-term unbilled receivables, net (2)
17,205 12,260 
Total contract assets$31,100 $23,967 
Short-term deferred revenues, net
$100,053 $90,894 
Long-term deferred revenues
5,673 7,083 
Total contract liabilities$105,726 $97,977 
_________________________________________________
(1)     Included in accounts receivable and unbilled receivables in the Consolidated Balance Sheets.
(2)    Included in other long-term assets in the Consolidated Balance Sheets.
XML 57 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Net Income Per Share (Tables)
 12 Months Ended
Dec. 31, 2020
Earnings Per Share [Abstract]  
Calculation of Basic and Diluted Net Income Per Share
The basic and diluted net income per share calculations for the years ended December 31, 2020, 2019, and 2018 were as follows:
Year Ended December 31,
202020192018
(In thousands, except per share data)
Net income$32,194 $61,338 $37,729 
Weighted-average shares outstanding - basic42,583 41,462 39,242 
Effect of dilutive securities from stock award plans1,160 1,481 1,317 
Effect of convertible senior notes and warrants— — — 
Weighted-average shares outstanding - diluted43,743 42,943 40,559 
Net income per share - basic$0.76 $1.48 $0.96 
Net income per share - diluted$0.74 $1.43 $0.93 
Anti-dilutive weighted-average shares related to stock award plans2,054 926 1,279 
Anti-dilutive weighted-average shares related to convertible senior notes and warrants11,816 — — 
XML 58 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components
Balance sheet details as of December 31, 2020 and 2019 are presented in the tables below:
December 31,
20202019
(In thousands)
Inventories:
Raw materials$28,205 $31,331 
Work in process7,973 7,620 
Finished goods60,120 69,060 
Total inventories$96,298 $108,011 
Other current assets:
Funds held for customers, including restricted cash (1)
$18,164 $— 
Net investment in sales-type leases, current portion10,246 9,770 
Prepaid income taxes10,095 4,347 
Other current assets2,539 1,060 
Total other current assets$41,044 $15,177 
Other long-term assets:
Capitalized software, net$94,027 $85,070 
Unbilled receivables, net17,205 12,260 
Deferred debt issuance costs4,253 4,700 
Other long-term assets3,804 1,006 
Total other long-term assets$119,289 $103,036 
Accrued liabilities:
Operating lease liabilities, current portion$12,197 $10,058 
Customer fund liabilities18,164 — 
Advance payments from customers6,981 4,006 
Rebates and lease buyouts21,815 14,911 
Group purchasing organization fees4,412 5,934 
Taxes payable3,520 3,744 
Other accrued liabilities13,222 16,914 
Total accrued liabilities$80,311 $55,567 
_________________________________________________
(1)    Includes $4.0 million of restricted cash.
Summary of changes in accumulated balances of other comprehensive income (loss)
The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the years ended December 31, 2020 and 2019:
Foreign currency translation adjustmentsUnrealized gain (loss) on interest rate swap hedgesTotal
(In thousands)
Balance as of December 31, 2018$(11,274)$420 $(10,854)
Other comprehensive income (loss) before reclassifications1,828 148 1,976 
Amounts reclassified from other comprehensive income (loss), net of tax— (568)(568)
Net current-period other comprehensive income (loss), net of tax1,828 (420)1,408 
Balance as of December 31, 2019(9,446)— (9,446)
Other comprehensive income (loss) before reclassifications3,924 — 3,924 
Amounts reclassified from other comprehensive income (loss), net of tax— — — 
Net current-period other comprehensive income (loss), net of tax3,924 — 3,924 
Balance as of December 31, 2020$(5,522)$— $(5,522)
XML 59 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment (Tables)
 12 Months Ended
Dec. 31, 2020
Property, Plant and Equipment [Abstract]  
Property and Equipment Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:
Computer equipment and related software
3 - 5 years
Leasehold and building improvementsShorter of the lease term or the estimated useful life
Furniture and fixtures
5 - 7 years
Equipment
2 - 12 years
The following table represents the property and equipment balances as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Equipment$81,034 $88,569 
Furniture and fixtures7,498 7,925 
Leasehold improvements19,517 18,979 
Software50,230 48,309 
Construction in progress7,095 6,179 
Property and equipment, gross (1)
165,374 169,961 
Accumulated depreciation and amortization (1)
(106,301)(115,715)
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)     The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.
The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
United States$53,203 $48,769 
Rest of world (1)
5,870 5,477 
Total property and equipment, net$59,073 $54,246 
_________________________________________________
(1)    No individual country represented more than 10% of the total property and equipment, net.
XML 60 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Changes in the Carrying Amount of Goodwill
The following table represents changes in the carrying amount of goodwill:
(In thousands)
Balance as of December 31, 2018$335,887 
Additions— 
Foreign currency exchange rate fluctuations652 
Balance as of December 31, 2019336,539 
Additions (1)
161,117 
Foreign currency exchange rate fluctuations1,653 
Balance as of December 31, 2020$499,309 
_________________________________________________
(1)     Additions represent the preliminary value assigned to goodwill in connection with the 340B Link Business acquisition in October 2020.
Carrying Amounts and Useful Lives of Intangible Assets
The carrying amounts and useful lives of intangible assets as of December 31, 2020 and 2019 were as follows:
December 31, 2020
Gross carrying
amount (1)
Accumulated
amortization		Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$187,889 $(64,254)$(777)$122,858 
10 - 30
Acquired technology86,029 (44,851)6 41,184 
3 - 20
Backlog1,150 (1,078)— 72 4
Trade names7,850 (5,794)14 2,070 
1 - 12
Patents2,930 (1,455)2 1,477 
2 - 20
Non-compete agreements600 (50)— 550 3
Total intangibles assets, net$286,448 $(117,482)$(755)$168,211 
December 31, 2019
Gross carrying
amount (1)
Accumulated
amortization		 Foreign currency exchange
rate fluctuations		Net carrying
amount		Useful life
(years)
(In thousands, except for years)
Customer relationships$135,234 $(54,860)$(1,058)$79,316 
10 - 30
Acquired technology77,142 (36,194)5 40,953 
3 - 20
Backlog1,150 (791)— 359 
4
Trade names7,650 (5,037)11 2,624 
6 - 12
Patents3,217 (1,603)1 1,615 
2 - 20
Total intangibles assets, net$224,393 $(98,485)$(1,041)$124,867 
_________________________________________________
(1)     The differences in gross carrying amounts between periods are primarily due to additions of intangible assets in connection with the 340B Link Business acquisition, partially offset by the write-off of certain fully amortized intangible assets.
Estimated Future Amortization Expense for Intangible Assets
The estimated future amortization expenses for amortizable intangible assets were as follows:
December 31,
2020
(In thousands)
2021$23,948 
202221,134 
202319,113 
202412,825 
202511,616 
Thereafter79,575 
Total$168,211 
XML 61 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Debt and Credit Agreement (Tables)
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Changes in the Carrying Amount of Debt Obligations
The following table represents changes in the carrying amount of the Company's debt obligations:
Current Revolving Credit Facility
(In thousands)
Balance as of December 31, 2019$50,000 
Proceeds150,000 
Repayments(200,000)
Balance as of December 31, 2020$— 
Changes in the Balance of Deferred Debt Issuance Costs
The following table represents changes in the balance of the Company's deferred debt issuance costs:
(In thousands)
Balance as of December 31, 2019$4,700 
Additions550 
Amortization(997)
Balance as of December 31, 2020$4,253 
XML 62 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Convertible Senior Notes (Tables)
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Convertible Debt Balances
The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:
December 31,
2020
(In thousands)
Liability:
Principal amount$575,000 
Unamortized discount(95,744)
Unamortized debt issuance costs(12,055)
Convertible senior notes, liability component$467,201 
Equity:
Embedded conversion option$100,510 
Debt issuance costs(2,680)
Deferred tax impact(25,098)
Convertible senior notes, equity component (1)
$72,732 
_________________________________________________
(1)    Included in additional paid-in capital in the Consolidated Balance Sheets.
Summary of the Components of Interest Expense
The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:
Year Ended
December 31,
2020
(In thousands)
Contractual coupon interest$379 
Amortization of discount$4,766 
Amortization of debt issuance costs$600 
XML 63 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases (Tables)
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Income Recognized from Sales-Type Leases The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Sales-type lease revenues$26,040 $37,175 $39,167 
Cost of sales-type lease revenues(10,624)(14,985)(16,185)
Selling profit on sales-type lease revenues$15,416 $22,190 $22,982 
Interest income on sales-type lease receivables$1,933 $1,756 $1,296 
Components of Sales-Type Lease Receivables
The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:
December 31,
20202019
(In thousands)
Net minimum lease payments to be received$35,331 $32,360 
Less: Unearned interest income portion(2,929)(2,840)
Net investment in sales-type leases32,402 29,520 
Less: Current portion (1)
(10,246)(9,770)
Long-term investment in sales-type leases, net$22,156 $19,750 
_________________________________________________
(1)    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.
Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases
The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:
December 31,
2020
(In thousands)
2021$11,312 
20229,499 
20237,334 
20244,535 
20252,616 
Thereafter35 
Total future minimum sales-type lease payments35,331 
Present value adjustment(2,929)
Total net investment in sales-type leases$32,402 
Income Recognized from Operating Leases The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Rental income$11,668 $12,660 $12,207 
Maturity Schedule of Future Minimum Lease Payments under Operating Leases
The maturity schedule of future minimum lease payments under operating leases was as follows:
December 31, 2020
(In thousands)
2021$8,848 
20224,816 
20232,910 
2024852 
2025256 
Thereafter89 
Total future minimum operating lease payments$17,771 
XML 64 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases (Tables)
 12 Months Ended
Dec. 31, 2020
Leases [Abstract]  
Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities
The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Consolidated Balance Sheets was as follows:
December 31, 2020
(In thousands)
2021$15,290 
202214,106 
202310,221 
20248,922 
20256,571 
Thereafter17,422 
Total operating lease payments72,532 
Present value adjustment(11,438)
Total operating lease liabilities (1)
$61,094 
_________________________________________________
(1)    Amount consists of a current and long-term portion of operating lease liabilities of $12.2 million and $48.9 million, respectively. The short-term portion of the operating lease liabilities is included in accrued liabilities in the Consolidated Balance Sheets.
Supplemental Cash Flow Information Related to Operating Leases
The following table summarizes supplemental cash flow information related to the Company’s operating leases for the years ended December 31, 2020 and 2019:
Year Ended December 31,
20202019
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities$14,490 $14,636 
Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions$10,025 $1,204 
Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate
The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of December 31, 2020 and 2019:
December 31,
20202019
Weighted-average remaining lease term, years5.96.4
Weighted-average discount rate, %5.8 %6.4 %
XML 65 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Share-Based Compensation Expense
The following table sets forth the total share-based compensation expense recognized in the Company’s Consolidated Statements of Operations:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$7,469 $5,648 $4,634 
Research and development6,497 6,604 5,746 
Selling, general, and administrative30,731 21,797 18,505 
Total share-based compensation expense$44,697 $34,049 $28,885 
Assumptions Used to Value Stock Options Granted
The following assumptions were used to value stock options and ESPP shares granted pursuant to the Company’s equity incentive plans for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
Stock options
Expected life, years4.74.44.8
Expected volatility, %39.4 %33.7 %31.1 %
Risk-free interest rate, %0.7 %2.0 %2.8 %
Estimated forfeiture rate, %5.7 %7.2 %6.9 %
Dividend yield, %— %— %— %
Assumptions Used to Value ESPP Shares Granted
Year Ended December 31,
202020192018
Employee stock purchase plan shares
Expected life, years
0.5 - 2.0
0.5 - 2.0
0.5 - 2.0
Expected volatility, %
30.4% - 53.5%
28.2% - 39.9%
28.1% - 33.8%
Risk-free interest rate, %
0.1% - 2.7%
1.3% - 2.7%
0.8% - 2.7%
Dividend yield, %— %— %— %
Summary of Share Option Activity
The following table summarizes the share option activity under the Company’s 2009 Plan during the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Outstanding at December 31, 20193,902 $52.75 7.7$113,198 
Granted1,351 78.83 
Exercised(891)42.67 
Expired(19)59.65 
Forfeited(411)66.65 
Outstanding at December 31, 20203,932 $62.50 7.8$226,160 
Exercisable at December 31, 20201,556 $45.49 6.2$115,949 
Vested and expected to vest at December 31, 2020 and thereafter3,755 $61.86 7.7$218,379 
Summary of Restricted Stock Unit Activity
Summaries of the restricted stock activity under the 2009 Plan are presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value
Weighted-Average
Remaining Years
Aggregate
Intrinsic Value
(In thousands, except per share data)
Restricted stock units
Outstanding at December 31, 2019544 $66.65 1.6$44,492 
Granted (Awarded)343 74.52 
Vested (Released)(183)61.30 
Forfeited(124)67.16 
Outstanding and unvested at December 31, 2020580 $72.87 1.6$69,670 
Summary of Restricted Stock Awards Activity
Number of
Shares
Weighted-Average
Grant Date Fair Value
(In thousands, except per share data)
Restricted stock awards
Outstanding at December 31, 201917 $81.92 
Granted (Awarded)21 68.11 
Vested (Released)(17)81.92 
Outstanding and unvested at December 31, 202021 $68.11 
Summary of Performance-Based Restricted Stock Activity
A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the year ended December 31, 2020:
Number of
Shares
Weighted-Average
Grant Date Fair Value Per Unit
(In thousands, except per share data)
Outstanding at December 31, 2019134 $55.82 
Granted99 82.17 
Vested(73)50.54 
Forfeited(5)81.72 
Outstanding and unvested at December 31, 2020155 $74.26 
Ordinary Shares Reserved for Future Issuance Under Equity Incentive Plans
The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of December 31, 2020:
Number of Shares
(In thousands)
Share options outstanding3,932 
Non-vested restricted stock awards756 
Shares authorized for future issuance1,250 
ESPP shares available for future issuance1,206 
Total shares reserved for future issuance7,144 
XML 66 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Geographical Breakdown of Income (Loss) before the Provision for Income Taxes
The following is a geographical breakdown of income (loss) before the provision for income taxes:
Year Ended December 31,
202020192018
(In thousands)
Domestic$34,714 $81,641 $46,528 
Foreign(5,365)(7,708)(10,912)
Income (loss) before provision for income taxes$29,349 $73,933 $35,616 
Provision For (Benefit From) Income Taxes
The provision for (benefit from) income taxes consisted of the following:
Year Ended December 31,
202020192018
(In thousands)
Current:
Federal$1,874 $8,006 $1,404 
State1,733 4,549 1,832 
Foreign647 1,240 768 
Total current income taxes4,254 13,795 4,004 
Deferred:
Federal(3,868)(1,292)5,455 
State(2,494)(1,609)(909)
Foreign(737)1,701 (10,663)
Total deferred income taxes(7,099)(1,200)(6,117)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate
The provision for (benefit from) income taxes differs from the amount computed by applying the statutory federal tax rate as follows:
Year Ended December 31,
202020192018
(In thousands)
U.S. federal tax provision at statutory rate$6,163 $15,525 $7,479 
State taxes(601)2,258 651 
Section 162(m) limitation2,550 2,279 738 
Non-deductible expenses325 619 686 
Uncertain tax positions(394)(2,472)(412)
Share-based compensation tax benefit(6,929)(7,892)(4,005)
Research tax credits(4,038)(3,805)(3,230)
Restructuring impact— 7,432 (4,205)
Foreign derived intangible income deduction(204)(449)(349)
Foreign rate differential(102)(1,424)561 
Other385 524 (27)
Total provision for (benefit from) income taxes$(2,845)$12,595 $(2,113)
Significant Components of Deferred Tax Assets (Liabilities)
Significant components of the Company’s deferred tax assets (liabilities) were as follows:
December 31,
20202019
(In thousands)
Deferred tax assets (liabilities):
Deferred revenues$5,910 $4,129 
Share-based compensation8,094 6,483 
Inventory-related items4,953 3,507 
Tax credit carryforwards12,105 13,472 
Reserves and accruals8,160 5,712 
Loss carryforwards8,461 9,484 
Lease liability15,465 15,471 
Other, net1,578 543 
Gross deferred tax assets64,726 58,801 
Valuation allowance(1,199)(1,186)
Total net deferred tax assets63,527 57,615 
Intangibles(22,010)(18,941)
Depreciation and amortization(36,528)(35,941)
Prepaid expenses(15,654)(13,395)
Right-of-use assets(13,949)(14,286)
Total deferred tax liabilities(88,141)(82,563)
Net deferred tax liabilities$(24,614)$(24,948)
Change in the Balance of Gross Unrecognized Tax Benefits
The aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the three years ended December 31, 2020 was as follows:
(In thousands)
Balance as of December 31, 2017$10,741 
Increases related to tax positions taken during a prior period19 
Decreases related to tax positions taken during the prior period(1,257)
Increases related to tax positions taken during the current period870 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(412)
Balance as of December 31, 20189,961 
Increases related to tax positions taken during a prior period10 
Decreases related to tax positions taken during the prior period(6)
Increases related to tax positions taken during the current period9,282 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(2,472)
Balance as of December 31, 201916,775 
Increases related to tax positions taken during a prior period88 
Decreases related to tax positions taken during the prior period— 
Increases related to tax positions taken during the current period2,294 
Decreases related to settlements— 
Decreases related to expiration of statute of limitations(911)
Balance as of December 31, 2020$18,246 
XML 67 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring Expenses (Tables)
 12 Months Ended
Dec. 31, 2020
Restructuring and Related Activities [Abstract]  
Summary of Restructuring Expenses
The following table summarizes the total restructuring expenses recognized in the Company’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018:
Year Ended December 31,
202020192018
(In thousands)
Cost of product and service revenues$2,564 $— $186 
Research and development3,716 — — 
Selling, general, and administrative3,681 — 4,160 
Total restructuring expenses$9,961 $— $4,346 
XML 68 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies - Narrative (Details)
 12 Months Ended
Dec. 31, 2020
USD ($)
segment
reportingUnit
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Accounting Policies [Line Items]      
Number of operating segments | segment 1    
Number of reporting segments | segment 1    
Deferred revenues, net of cost of goods sold $ 105,726,000 $ 97,977,000  
Deferred revenues, net of cost of goods sold, expected to be completed within one year $ 100,053,000 90,894,000  
Recognition period five years    
Fees to GPOs $ 9,700,000 11,100,000 $ 8,700,000
Operating lease renewal terms 1 year    
Amortization period for capitalized contract costs 10 years    
Initial term and renewal service periods 10 years    
Contract cost expense $ 22,100,000 24,400,000 21,100,000
Impairment loss related to capitalized prepaid commissions 0    
Non-recourse accounts receivable transferred 58,800,000 48,300,000 46,600,000
Accounts receivable due from third-party leasing companies for transferred non-recourse accounts receivable 7,800,000 4,600,000  
Cash and cash equivalents 485,928,000 127,210,000 67,192,000
Cash equivalents 447,200,000 0  
Minimum required purchase obligation 72,800,000    
Cost of revenues 478,916,000 460,115,000 414,979,000
Amortization of capitalized software development costs $ 23,100,000 17,500,000 12,500,000
Number of reporting units | reportingUnit 1    
Accumulated impairment loss on goodwill $ 0    
Other Assets      
Accounting Policies [Line Items]      
Software development costs capitalized $ 32,000,000.0 45,800,000  
Internal Use Software and Software Development Costs      
Accounting Policies [Line Items]      
Useful life of property and equipment 5 years    
Internal Use Software and Software Development Costs | Property and Equipment      
Accounting Policies [Line Items]      
Software development costs capitalized $ 6,800,000 300,000  
Shipping Costs | Selling, general, and administrative      
Accounting Policies [Line Items]      
Cost of revenues 15,600,000 15,900,000 14,100,000
Primary Supplier      
Accounting Policies [Line Items]      
Minimum required purchase obligation $ 0    
Period for notice of termination 6 months    
Purchases from suppliers $ 76,300,000 $ 75,100,000 $ 54,800,000
Minimum      
Accounting Policies [Line Items]      
Original terms of contracts 1 year    
Estimated useful lives of intangible assets 1 year    
Maximum      
Accounting Policies [Line Items]      
Original terms of contracts 5 years    
Estimated useful life of software-related products 5 years    
Estimated useful lives of intangible assets 30 years    
Customer Concentration Risk | Revenues | Ten Largest GPOs      
Accounting Policies [Line Items]      
Concentration risk percentage 60.00%    
Customer Concentration Risk | Lease Receivable | U.S. Government Hospitals      
Accounting Policies [Line Items]      
Concentration risk percentage 67.00%    
XML 69 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accounting Policies [Abstract]    
Accounts receivable and unbilled receivables $ 4,286 $ 3,227
Long-term unbilled receivables 30 0
Net investment in sales-type leases $ 265 $ 225
XML 70 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)
 12 Months Ended
Dec. 31, 2020
Computer equipment and related software | Minimum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 3 years
Computer equipment and related software | Maximum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 5 years
Furniture and fixtures | Minimum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 5 years
Furniture and fixtures | Maximum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 7 years
Equipment | Minimum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 2 years
Equipment | Maximum  
Property, Plant and Equipment [Line Items]  
Useful life of property and equipment 12 years
XML 71 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Narrative (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Oct. 01, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]          
Goodwill   $ 499,309 $ 499,309 $ 336,539 $ 335,887
340B Link Business          
Acquired Finite-Lived Intangible Assets [Line Items]          
Purchase price $ 225,000        
Goodwill 161,117        
Goodwill expected to be deductible for tax purposes $ 93,900        
Acquisition related costs     $ 6,500    
Revenue from operations since the acquisition date   10,200      
Earnings from operations since the acquisition date   $ 1,300      
340B Link Business | Discount Rate          
Acquired Finite-Lived Intangible Assets [Line Items]          
Measurement input used in estimating the fair values of intangible assets 0.140        
340B Link Business | Acquired Technology | Royalty Rate          
Acquired Finite-Lived Intangible Assets [Line Items]          
Measurement input used in estimating the fair values of intangible assets 0.100        
340B Link Business | Trade Names | Royalty Rate          
Acquired Finite-Lived Intangible Assets [Line Items]          
Measurement input used in estimating the fair values of intangible assets 0.005        
XML 72 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Oct. 01, 2020
Dec. 31, 2019
Dec. 31, 2018
Business Acquisition [Line Items]        
Goodwill $ 499,309   $ 336,539 $ 335,887
340B Link Business        
Business Acquisition [Line Items]        
Accounts receivable and unbilled receivables   $ 8,197    
Prepaid expenses   232    
Other current assets   22,747    
Total current assets   31,176    
Property and equipment   531    
Operating lease right-of-use assets   3,138    
Goodwill   161,117    
Intangible assets   62,800    
Total assets   258,762    
Accounts payable   568    
Accrued liabilities   23,787    
Long-term deferred tax liabilities   6,818    
Long-term operating lease liabilities   2,589    
Total liabilities   33,762    
Total purchase price   $ 225,000    
XML 73 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details)
$ in Thousands
Oct. 01, 2020
USD ($)
Acquired Indefinite-lived Intangible Assets [Line Items]  
Fair value of purchased intangible assets $ 62,800
340B Link Business | Customer relationships  
Acquired Indefinite-lived Intangible Assets [Line Items]  
Fair value of purchased intangible assets $ 53,000
Useful life 21 years
340B Link Business | Acquired technology  
Acquired Indefinite-lived Intangible Assets [Line Items]  
Fair value of purchased intangible assets $ 9,000
Useful life 5 years
340B Link Business | Trade names  
Acquired Indefinite-lived Intangible Assets [Line Items]  
Fair value of purchased intangible assets $ 200
Useful life 1 year
340B Link Business | Non-compete agreements  
Acquired Indefinite-lived Intangible Assets [Line Items]  
Fair value of purchased intangible assets $ 600
Useful life 3 years
XML 74 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations - Pro Forma Financial Information (Details) - 340B Link Business - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Business Acquisition [Line Items]    
Pro forma revenues $ 920,314 $ 929,106
Pro forma net income $ 37,559 $ 56,897
XML 75 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Disaggregation of Revenues by Revenue Type (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Disaggregation of Revenue [Line Items]      
Revenues $ 892,208 $ 897,027 $ 787,309
Connected devices, software licenses, and other      
Disaggregation of Revenue [Line Items]      
Revenues 560,368 573,844 483,414
Technical services      
Disaggregation of Revenue [Line Items]      
Revenues 202,383 194,183 183,202
Consumables      
Disaggregation of Revenue [Line Items]      
Revenues 75,663 85,758 86,182
SaaS, subscription software, and technology-enabled services      
Disaggregation of Revenue [Line Items]      
Revenues $ 53,794 $ 43,242 $ 34,511
XML 76 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Dissagregation of Revenues by Geographic Region (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Disaggregation of Revenue [Line Items]      
Revenues $ 892,208 $ 897,027 $ 787,309
United States      
Disaggregation of Revenue [Line Items]      
Revenues 797,602 806,900 685,881
Rest of world      
Disaggregation of Revenue [Line Items]      
Revenues $ 94,606 $ 90,127 $ 101,428
XML 77 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Short-term unbilled receivables $ 13,895 $ 11,707
Long-term unbilled receivables 17,205 12,260
Total contract assets 31,100 23,967
Short-term deferred revenues, net 100,053 90,894
Long-term deferred revenues 5,673 7,083
Total contract liabilities $ 105,726 $ 97,977
XML 78 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Revenues - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]    
Short-term deferred revenues, net $ 100,053 $ 90,894
Deferred cost of sales 21,000 13,100
Deferred revenues recognized 84,000  
Gross short-term deferred revenue   104,000
Long-term deferred revenues $ 5,673 $ 7,083
XML 79 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Net income $ 32,194 $ 61,338 $ 37,729
Weighted-average shares outstanding — basic (in shares) 42,583 41,462 39,242
Weighted-average shares outstanding — diluted (in shares) 43,743 42,943 40,559
Net income per share - basic (in dollars per share) $ 0.76 $ 1.48 $ 0.96
Net income per share - diluted (in dollars per share) $ 0.74 $ 1.43 $ 0.93
Restricted Stock Awards      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Effect of dilutive securities from stock award plans (in shares) 1,160 1,481 1,317
Anti-dilutive weighted-average shares related to stock award plans (in shares) 2,054 926 1,279
Convertible Debt Securities and Warrants      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Effect of dilutive securities from stock award plans (in shares) 0 0 0
Anti-dilutive weighted-average shares related to stock award plans (in shares) 11,816 0 0
XML 80 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value of Financial Instruments - Narrative (Details) - USD ($)
Dec. 31, 2020
Sep. 25, 2020
Jun. 30, 2016
Convertible Senior Notes | Convertible Debt      
Cash and Cash Equivalents [Line Items]      
Fair value of long-term debt $ 782,300,000    
Carrying value of debt $ 467,201,000 $ 461,800,000  
Interest Rate Swap      
Cash and Cash Equivalents [Line Items]      
Notional amount     $ 100,000,000.0
Fixed interest rate     0.80%
Interest Rate Swap | LIBOR      
Cash and Cash Equivalents [Line Items]      
Variable rate floor     0.00%
XML 81 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Components - Balance Sheet Components (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Inventories:      
Raw materials $ 28,205 $ 31,331  
Work in process 7,973 7,620  
Finished goods 60,120 69,060  
Total inventories 96,298 108,011  
Other current assets:      
Funds held for customers, including restricted cash 18,164 0  
Net investment in sales-type leases, current portion 10,246 9,770  
Prepaid income taxes 10,095 4,347  
Other current assets 2,539 1,060  
Total other current assets 41,044 15,177  
Other long-term assets:      
Capitalized software, net 94,027 85,070  
Unbilled receivables, net 17,205 12,260  
Deferred debt issuance costs 4,253 4,700  
Other long-term assets 3,804 1,006  
Total other long-term assets 119,289 103,036  
Accrued liabilities:      
Operating lease liabilities, current portion 12,197 10,058  
Customer fund liabilities 18,164 0  
Advance payments from customers 6,981 4,006  
Rebates and lease buyouts 21,815 14,911  
Group purchasing organization fees 4,412 5,934  
Taxes payable 3,520 3,744  
Other accrued liabilities 13,222 16,914  
Total accrued liabilities $ 80,311 $ 55,567  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] us-gaap:AccruedLiabilitiesCurrent us-gaap:AccruedLiabilitiesCurrent  
Restricted cash $ 3,992 $ 0 $ 0
Cash and Cash Equivalents [Line Items]      
Restricted cash 3,992 $ 0 $ 0
Other Current Assets      
Accrued liabilities:      
Restricted cash 4,000    
Cash and Cash Equivalents [Line Items]      
Restricted cash $ 4,000    
XML 82 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Components - Accumulated Other Comprehensive Income (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance $ 845,254 $ 679,617 $ 554,341
Other comprehensive income (loss) before reclassifications 3,924 1,976  
Amounts reclassified from other comprehensive income (loss), net of tax 0 (568)  
Other comprehensive income (loss) 3,924 1,408 (4,741)
Balance 967,503 845,254 679,617
Foreign currency translation adjustments      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance (9,446) (11,274)  
Other comprehensive income (loss) before reclassifications 3,924 1,828  
Amounts reclassified from other comprehensive income (loss), net of tax 0 0  
Other comprehensive income (loss) 3,924 1,828  
Balance (5,522) (9,446) (11,274)
Unrealized gain (loss) on interest rate swap hedges      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance 0 420  
Other comprehensive income (loss) before reclassifications 0 148  
Amounts reclassified from other comprehensive income (loss), net of tax 0 (568)  
Other comprehensive income (loss) 0 (420)  
Balance 0 0 420
Accumulated other comprehensive income (loss)      
AOCI Attributable to Parent, Net of Tax [Roll Forward]      
Balance (9,446) (10,854) (6,113)
Other comprehensive income (loss) 3,924 1,408 (4,741)
Balance $ (5,522) $ (9,446) $ (10,854)
XML 83 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment - Property and Equipment Balances (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 165,374 $ 169,961
Accumulated depreciation and amortization (106,301) (115,715)
Total property and equipment, net 59,073 54,246
Equipment    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 81,034 88,569
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 7,498 7,925
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 19,517 18,979
Software    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 50,230 48,309
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 7,095 $ 6,179
XML 84 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Abstract]      
Depreciation and amortization expense of property and equipment $ 18.3 $ 17.2 $ 15.1
XML 85 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]    
Property and equipment, net $ 59,073 $ 54,246
United States    
Property, Plant and Equipment [Line Items]    
Property and equipment, net 53,203 48,769
Rest of world    
Property, Plant and Equipment [Line Items]    
Property and equipment, net $ 5,870 $ 5,477
XML 86 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Goodwill [Roll Forward]    
Balance $ 336,539 $ 335,887
Additions 161,117 0
Foreign currency exchange rate fluctuations 1,653 652
Balance $ 499,309 $ 336,539
XML 87 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 286,448 $ 224,393
Accumulated amortization (117,482) (98,485)
Foreign currency exchange rate fluctuations (755) (1,041)
Net carrying amount $ 168,211 124,867
Minimum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 1 year  
Maximum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 30 years  
Customer relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 187,889 135,234
Accumulated amortization (64,254) (54,860)
Foreign currency exchange rate fluctuations (777) (1,058)
Net carrying amount $ 122,858 $ 79,316
Customer relationships | Minimum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 10 years 10 years
Customer relationships | Maximum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 30 years 30 years
Acquired technology    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 86,029 $ 77,142
Accumulated amortization (44,851) (36,194)
Foreign currency exchange rate fluctuations 6 5
Net carrying amount $ 41,184 $ 40,953
Acquired technology | Minimum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 3 years 3 years
Acquired technology | Maximum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 20 years 20 years
Backlog    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 1,150 $ 1,150
Accumulated amortization (1,078) (791)
Foreign currency exchange rate fluctuations 0 0
Net carrying amount $ 72 $ 359
Useful life 4 years 4 years
Trade names    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 7,850 $ 7,650
Accumulated amortization (5,794) (5,037)
Foreign currency exchange rate fluctuations 14 11
Net carrying amount $ 2,070 $ 2,624
Trade names | Minimum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 1 year 6 years
Trade names | Maximum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 12 years 12 years
Patents    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 2,930 $ 3,217
Accumulated amortization (1,455) (1,603)
Foreign currency exchange rate fluctuations 2 1
Net carrying amount $ 1,477 $ 1,615
Patents | Minimum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 2 years 2 years
Patents | Maximum    
Acquired Finite-Lived Intangible Assets [Line Items]    
Useful life 20 years 20 years
Non-compete agreements    
Acquired Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 600  
Accumulated amortization (50)  
Foreign currency exchange rate fluctuations 0  
Net carrying amount $ 550  
Useful life 3 years  
XML 88 R62.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]      
Amortization expense of intangible assets $ 19.7 $ 18.9 $ 23.8
XML 89 R63.htm IDEA: XBRL DOCUMENT v3.20.4
Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]    
2021 $ 23,948  
2022 21,134  
2023 19,113  
2024 12,825  
2025 11,616  
Thereafter 79,575  
Total $ 168,211 $ 124,867
XML 90 R64.htm IDEA: XBRL DOCUMENT v3.20.4
Debt and Credit Agreements - Narrative (Details)
 1 Months Ended 12 Months Ended
Sep. 22, 2020
USD ($)
Nov. 15, 2019
USD ($)
Jan. 05, 2016
USD ($)
Dec. 31, 2017
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Dec. 26, 2017
USD ($)
Debt Instrument [Line Items]                
Debt issuance costs incurred and capitalized         $ 550,000 $ 2,321,000 $ 0  
Amortization of debt issuance costs         1,597,000 2,204,000 2,292,000  
Wells Fargo Bank                
Debt Instrument [Line Items]                
Debt issuance costs incurred and capitalized       $ 2,100,000        
Letter of Credit | Wells Fargo Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity     $ 10,000,000.0          
Swing Line Loan | Wells Fargo Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity     10,000,000.0          
Line of Credit                
Debt Instrument [Line Items]                
Debt issuance costs incurred and capitalized         550,000      
Amortization of debt issuance costs         997,000 2,200,000 2,300,000  
Interest expense         500,000 3,600,000 $ 7,500,000  
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank                
Debt Instrument [Line Items]                
Debt issuance costs incurred and capitalized $ 600,000 $ 2,300,000            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Minimum                
Debt Instrument [Line Items]                
Commitment fee rate on undrawn commitments   0.15%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Maximum                
Debt Instrument [Line Items]                
Commitment fee rate on undrawn commitments   0.30%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | LIBOR                
Debt Instrument [Line Items]                
Spread on variable interest rate   1.00%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | LIBOR | Minimum                
Debt Instrument [Line Items]                
Spread on variable interest rate   1.25%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | LIBOR | Maximum                
Debt Instrument [Line Items]                
Spread on variable interest rate   2.00%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Federal Funds                
Debt Instrument [Line Items]                
Spread on variable interest rate   0.50%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | LIBOR Plus 1.00% | Minimum                
Debt Instrument [Line Items]                
Spread on variable interest rate   0.25%            
Line of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | LIBOR Plus 1.00% | Maximum                
Debt Instrument [Line Items]                
Spread on variable interest rate   1.00%            
Line of Credit | Secured Credit Facility | Wells Fargo Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity     $ 400,000,000.0          
Line of Credit | Secured Credit Facility | Wells Fargo Bank | LIBOR | Interest Rate Option One | Minimum                
Debt Instrument [Line Items]                
Spread on variable interest rate     1.50%          
Line of Credit | Secured Credit Facility | Wells Fargo Bank | LIBOR | Interest Rate Option One | Maximum                
Debt Instrument [Line Items]                
Spread on variable interest rate     2.25%          
Line of Credit | Secured Credit Facility | Wells Fargo Bank | LIBOR | Interest Rate Option Two | Minimum                
Debt Instrument [Line Items]                
Spread on variable interest rate     0.50%          
Line of Credit | Secured Credit Facility | Wells Fargo Bank | LIBOR | Interest Rate Option Two | Maximum                
Debt Instrument [Line Items]                
Spread on variable interest rate     1.25%          
Line of Credit | Secured Credit Facility | Wells Fargo Bank | Federal Funds | Interest Rate Option Two                
Debt Instrument [Line Items]                
Spread on variable interest rate     0.50%          
Line of Credit | Revolving Credit Facility                
Debt Instrument [Line Items]                
Balance transfer   $ 80,000,000.0            
Outstanding balance         $ 0 $ 50,000,000    
Line of Credit | Revolving Credit Facility | Wells Fargo Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity     $ 200,000,000.0         $ 315,000,000.0
Term of debt instrument     5 years          
Line of Credit | Revolving Credit Facility | Wells Fargo Bank | Minimum                
Debt Instrument [Line Items]                
Commitment fee rate on undrawn commitments     0.20%          
Line of Credit | Revolving Credit Facility | Wells Fargo Bank | Maximum                
Debt Instrument [Line Items]                
Commitment fee rate on undrawn commitments     0.35%          
Line of Credit | Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity   $ 500,000,000.0            
Term of debt instrument   5 years            
Line of Credit | Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | For Calendar Quarters Ending September 30, 2020, December 31, 2020 and March 31, 2021                
Debt Instrument [Line Items]                
Maximum secured net leverage ratio 3.50              
Line of Credit | Revolving Credit Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank | Calendar Quarters Ending Thereafter                
Debt Instrument [Line Items]                
Maximum secured net leverage ratio 3.00              
Line of Credit | Term Loan Facility                
Debt Instrument [Line Items]                
Balance transfer   $ (80,000,000.0)            
Line of Credit | Term Loan Facility | Wells Fargo Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity     $ 200,000,000.0          
Term of debt instrument     5 years          
Line of Credit | Letter of Credit | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity   15,000,000.0            
Line of Credit | Swing Line Loan | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity   25,000,000.0            
Line of Credit | Incremental Loan Facility | Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank                
Debt Instrument [Line Items]                
Maximum borrowing capacity   $ 250,000,000.0            
XML 91 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Nov. 15, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Long-term Debt [Roll Forward]        
Repayments   $ (200,000) $ (90,000) $ (77,000)
Prior Term Loan Facility | Line of Credit        
Long-term Debt [Roll Forward]        
Balance transfer $ (80,000)      
Current Revolving Credit Facility | Line of Credit        
Long-term Debt [Roll Forward]        
Balance   50,000    
Proceeds   150,000    
Repayments   (200,000)    
Balance transfer $ 80,000      
Balance   $ 0 $ 50,000  
XML 92 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Change In Debt Issuance Costs, Net [Roll Forward]      
Balance $ 4,700    
Additions 550 $ 2,321 $ 0
Amortization (1,597) (2,204) (2,292)
Balance 4,253 4,700  
Line of Credit      
Change In Debt Issuance Costs, Net [Roll Forward]      
Balance 4,700    
Additions 550    
Amortization (997) (2,200) $ (2,300)
Balance $ 4,253 $ 4,700  
XML 93 R67.htm IDEA: XBRL DOCUMENT v3.20.4
Convertible Senior Notes - Narrative (Details)
 12 Months Ended
Sep. 25, 2020
USD ($)
day
$ / shares
shares
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Debt Instrument [Line Items]        
Proceeds from issuance of convertible senior notes, net of issuance costs   $ 559,665,000 $ 0 $ 0
Debt issuance costs incurred and capitalized   550,000 2,321,000 0
Purchase of convertible note hedge $ 100,600,000 100,625,000    
Proceeds from sale of warrants 51,300,000 51,290,000 $ 0 $ 0
Convertible Note Hedge        
Debt Instrument [Line Items]        
Deferred tax asset related to the convertible note hedge transaction $ 25,800,000      
Convertible Note Hedge Rights        
Debt Instrument [Line Items]        
Options and warrants to purchase shares (in shares) | shares 5,900,000      
Strike price (in dollars per share) | $ / shares $ 97.32      
Warrant        
Debt Instrument [Line Items]        
Options and warrants to purchase shares (in shares) | shares 5,900,000      
Strike price (in dollars per share) | $ / shares $ 141.56      
Convertible Senior Notes | Convertible Debt        
Debt Instrument [Line Items]        
Interest rate 0.25%      
Aggregate principal amount $ 575,000,000.0      
Additional principal amount subject to purchasers' option 75,000,000.0      
Proceeds from issuance of convertible senior notes, net of issuance costs 559,700,000      
Debt issuance costs incurred and capitalized $ 15,300,000      
Conversion ratio 0.0102751      
Conversion price (in dollars per share) | $ / shares $ 97.32      
Repurchase price as a percent of principal amount 100.00%      
Aggregate principal amount of Notes that must be outstanding and not subject to redemption if the Company redeems less than all of the Notes $ 150,000,000.0      
Carrying value of debt 461,800,000 467,201,000    
Equity component of convertible senior notes $ 72,700,000 $ 72,732,000    
Effective interest rate   4.18%    
Remaining life of debt discount and issuance cost accretion   4 years 8 months 12 days    
Maximum number of shares issuable upon conversion (in shares) | shares 8,100,000      
Convertible Senior Notes | Convertible Debt | Period 1        
Debt Instrument [Line Items]        
Threshold trading days | day 20      
Threshold consecutive trading days | day 30      
Threshold percentage of stock price trigger 130.00%      
Convertible Senior Notes | Convertible Debt | Period 2        
Debt Instrument [Line Items]        
Threshold trading days | day 5      
Threshold consecutive trading days | day 10      
Threshold percentage of stock price trigger 98.00%      
XML 94 R68.htm IDEA: XBRL DOCUMENT v3.20.4
Convertible Senior Notes - Convertible Debt Balances (Details) - Convertible Debt - Convertible Senior Notes - USD ($)
$ in Thousands
Dec. 31, 2020
Sep. 25, 2020
Liability:    
Principal amount $ 575,000  
Unamortized discount (95,744)  
Unamortized debt issuance costs (12,055)  
Convertible senior notes, liability component 467,201 $ 461,800
Equity:    
Embedded conversion option 100,510  
Debt issuance costs (2,680)  
Deferred tax impact (25,098)  
Convertible senior notes, equity component $ 72,732 $ 72,700
XML 95 R69.htm IDEA: XBRL DOCUMENT v3.20.4
Convertible Senior Notes - Summary of the Components of Interest Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Debt Instrument [Line Items]      
Amortization of discount on convertible senior notes $ 4,766 $ 0 $ 0
Amortization of debt issuance costs 1,597 $ 2,204 $ 2,292
Convertible Senior Notes | Convertible Debt      
Debt Instrument [Line Items]      
Contractual coupon interest 379    
Amortization of discount on convertible senior notes 4,766    
Amortization of debt issuance costs $ 600    
XML 96 R70.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Lessor, Lease, Description [Line Items]      
Property and equipment, net $ 59,073 $ 54,246  
Accumulated depreciation 106,301 115,715  
Depreciation expense 18,300 17,200 $ 15,100
Leased Equipment under Operating Leases      
Lessor, Lease, Description [Line Items]      
Property and equipment, net 1,400 2,100  
Accumulated depreciation 2,500 1,600  
Depreciation expense $ 600 $ 700 $ 500
Minimum      
Lessor, Lease, Description [Line Items]      
Term of sales-type leases 1 year    
Term of operating leases 1 year    
Maximum      
Lessor, Lease, Description [Line Items]      
Term of sales-type leases 5 years    
Term of operating leases 7 years    
XML 97 R71.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Income Recognized from Sales-Type Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Leases [Abstract]      
Sales-type lease revenues $ 26,040 $ 37,175  
Sales-type lease revenues     $ 39,167
Cost of sales-type lease revenues (10,624) (14,985)  
Cost of sales-type lease revenues     (16,185)
Selling profit on sales-type lease revenues 15,416 22,190  
Selling profit on sales-type lease revenues     22,982
Interest income on sales-type lease receivables $ 1,933 $ 1,756  
Interest income on sales-type lease receivables     $ 1,296
XML 98 R72.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Components of Sales-Type Lease Receivables (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Net minimum lease payments to be received $ 35,331 $ 32,360
Less: Unearned interest income portion (2,929) (2,840)
Net investment in sales-type leases 32,402 29,520
Less: current portion (10,246) (9,770)
Long-term investment in sales-type leases, net $ 22,156 $ 19,750
XML 99 R73.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
2021 $ 11,312  
2022 9,499  
2023 7,334  
2024 4,535  
2025 2,616  
Thereafter 35  
Total future minimum sales-type lease payments 35,331 $ 32,360
Present value adjustment (2,929) $ (2,840)
Total net investment in sales-type leases $ 32,402  
XML 100 R74.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Income Recognized from Operating Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Leases [Abstract]      
Rental income $ 11,668 $ 12,660  
Rental income     $ 12,207
XML 101 R75.htm IDEA: XBRL DOCUMENT v3.20.4
Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Leases [Abstract]  
2021 $ 8,848
2022 4,816
2023 2,910
2024 852
2025 256
Thereafter 89
Total future minimum operating lease payments $ 17,771
XML 102 R76.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Lessee, Lease, Description [Line Items]    
Operating lease cost $ 14.3 $ 14.6
Minimum    
Lessee, Lease, Description [Line Items]    
Term of operating leases 1 year  
Maximum    
Lessee, Lease, Description [Line Items]    
Term of operating leases 12 years  
XML 103 R77.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and the Reconciliation to the Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
2021 $ 15,290  
2022 14,106  
2023 10,221  
2024 8,922  
2025 6,571  
Thereafter 17,422  
Total operating lease payments 72,532  
Present value adjustment (11,438)  
Total operating lease liabilities 61,094  
Current portion of operating lease liabilities 12,197 $ 10,058
Long-term portion of operating lease liabilities $ 48,897 $ 50,669
XML 104 R78.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Cash paid for amounts included in the measurement of lease liabilities $ 14,490 $ 14,636
Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions $ 10,025 $ 1,204
XML 105 R79.htm IDEA: XBRL DOCUMENT v3.20.4
Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details)
Dec. 31, 2020
Dec. 31, 2019
Leases [Abstract]    
Weighted-average remaining lease term 5 years 10 months 24 days 6 years 4 months 24 days
Weighted-average discount rate 5.80% 6.40%
XML 106 R80.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments and Contingencies (Details)
$ in Millions
 12 Months Ended
Dec. 31, 2020
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Non-cancelable purchase commitments $ 72.8
Non-cancelable purchase commitments expected to be paid within the next twelve months $ 69.9
Standard warranty period (up to) 30 days
Limited warranty period (up to) 6 months
XML 107 R81.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Narrative (Details) - USD ($)
 12 Months Ended
Mar. 03, 2020
Feb. 13, 2020
Mar. 05, 2019
Feb. 13, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares reserved for future issuance (in shares)         7,144,000    
Share-based compensation expense         $ 44,697,000 $ 34,049,000 $ 28,885,000
Omnicell Plan | Other Postretirement Benefit Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Employer matching contribution, percent of employee contribution         50.00%    
Maximum amount of employer contribution         $ 3,000    
401(k) contributions         $ 5,700,000 5,100,000 4,600,000
Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares reserved for future issuance (in shares)         3,932,000    
Tax benefit realized from stock options exercised         $ (7,100,000) $ (6,300,000) (3,600,000)
ESPP              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares reserved for future issuance (in shares)         1,206,000    
PSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Trading days used for stock price appreciation calculation   20 days   20 days      
PSUs | Officer              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Awards granted (in shares)         62,759 61,098  
1997 Plan | ESPP              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Maximum percentage of earnings allowed for purchase of shares         15.00%    
Maximum fair market value of shares         $ 25,000    
Purchase price of common stock, percent         85.00%    
Offering period         24 months    
Purchasing period         6 months    
Shares reserved for future issuance (in shares)         1,200,000    
Weighted average period of compensation cost recognized         1 year 3 months 18 days    
Shares purchased under ESPP (in shares)         333,000 374,000  
Weighted-average price (in dollars per share)         $ 48.77 $ 41.44  
Unrecognized compensation cost         $ 4,100,000    
2009 Plan              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Shares reserved for future issuance (in shares)         5,900,000    
Income tax benefit from share-based compensation         $ 10,300,000 $ 11,000,000.0 $ 6,500,000
2009 Plan | Stock Options              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         4 years    
Unrecognized compensation cost of unvested stock options         $ 52,700,000    
Remaining weighted-average vesting period         7 years 8 months 12 days    
Weighted-average fair value per share (in dollars per share)         $ 26.48 $ 23.54 $ 17.22
Intrinsic value of options exercised         $ 39,800,000 $ 32,800,000 $ 20,100,000
Weighted average period of compensation cost recognized         2 years 9 months 18 days    
2009 Plan | Stock Options | Vesting One Year from Commencement Date              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         1 year    
Percentage of award vesting         25.00%    
2009 Plan | Stock Options | Vesting in Equal Monthly Installments              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         36 months    
2009 Plan | RSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         4 years    
Weighted average period of compensation cost recognized         3 years 1 month 6 days    
Weighted-average grant date fair value per award granted (in dollars per share)         $ 74.52 $ 78.49 $ 59.52
Fair value of awards vested         $ 11,200,000 $ 10,600,000 $ 7,900,000
Total unrecognized compensation cost         $ 40,500,000    
Awards granted (in shares)         343,000    
2009 Plan | RSUs | Vesting One Year from Commencement Date              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         1 year    
Percentage of award vesting         25.00%    
2009 Plan | RSUs | Vesting in Equal Monthly Installments              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)         3 years    
2009 Plan | RSAs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Weighted average period of compensation cost recognized         4 months 24 days    
Weighted-average grant date fair value per award granted (in dollars per share)         $ 68.11 $ 81.86 $ 46.60
Fair value of awards vested         $ 1,400,000 $ 1,000,000.0 $ 1,000,000.0
Total unrecognized compensation cost         $ 500,000    
Awards granted (in shares)         21,000    
2009 Plan | PSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Weighted average period of compensation cost recognized         1 year 4 months 24 days    
Weighted-average grant date fair value per award granted (in dollars per share)         $ 82.17 $ 73.38 $ 38.03
Total unrecognized compensation cost         $ 5,600,000    
Awards granted (in shares)         99,000    
Fair value of awards vested         $ 3,700,000 $ 3,500,000 $ 3,200,000
2018 Performance Based Restricted Stock Units | PSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years)     36 months        
Percentile rank of stockholder return     90.00%        
Percentage of shares eligible for time-based vesting     100.00%        
Awards eligible for vesting (in shares)     110,432        
Percentage of award vesting     25.00%        
Awards vested by period end (in shares)         67,066    
2019 Performance Based Restricted Stock Units | PSUs              
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Vesting period (in years) 36 months            
Percentile rank of stockholder return 70.00%            
Percentage of shares eligible for time-based vesting 100.00%            
Awards eligible for vesting (in shares) 61,098            
Percentage of award vesting 25.00%            
Awards vested by period end (in shares)         30,548    
XML 108 R82.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Share-based compensation expense $ 44,697 $ 34,049 $ 28,885
Cost of product and service revenues      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Share-based compensation expense 7,469 5,648 4,634
Research and development      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Share-based compensation expense 6,497 6,604 5,746
Selling, general, and administrative      
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]      
Share-based compensation expense $ 30,731 $ 21,797 $ 18,505
XML 109 R83.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details) - Stock Options
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life 4 years 8 months 12 days 4 years 4 months 24 days 4 years 9 months 18 days
Expected volatility 39.40% 33.70% 31.10%
Risk-free interest rate 0.70% 2.00% 2.80%
Estimated forfeiture rate 5.70% 7.20% 6.90%
Dividend yield 0.00% 0.00% 0.00%
XML 110 R84.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details) - ESPP - 1997 Plan
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected volatility (minimum) 30.40% 28.20% 28.10%
Expected volatility (maximum) 53.50% 39.90% 33.80%
Risk-free interest rate (minimum) 0.10% 1.30% 0.80%
Risk-free interest rate (maximum) 2.70% 2.70% 2.70%
Dividend yield 0.00% 0.00% 0.00%
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life 6 months 6 months 6 months
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected life 2 years 2 years 2 years
XML 111 R85.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details) - Stock Options - 2009 Plan - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Number of Shares    
Outstanding at beginning of year (in shares) 3,902  
Granted (in shares) 1,351  
Exercised (in shares) (891)  
Expired (in shares) (19)  
Forfeited (in shares) (411)  
Outstanding at end of year (in shares) 3,932 3,902
Exercisable (in shares) 1,556  
Vested and expected to vest (in shares) 3,755  
Weighted-Average Exercise Price    
Outstanding at beginning of year (in dollars per share) $ 52.75  
Granted (in dollars per share) 78.83  
Exercised (in dollars per share) 42.67  
Expired (in dollars per share) 59.65  
Forfeited (in dollars per share) 66.65  
Outstanding at end of year (in dollars per share) 62.50 $ 52.75
Exercisable (in dollars per share) 45.49  
Vested and expected to vest (in dollars per share) $ 61.86  
Weighted-Average Remaining Years    
Outstanding 7 years 9 months 18 days 7 years 8 months 12 days
Exercisable 6 years 2 months 12 days  
Vested and expected to vest 7 years 8 months 12 days  
Aggregate Intrinsic Value    
Outstanding $ 226,160 $ 113,198
Exercisable 115,949  
Vested and expected to vest $ 218,379  
XML 112 R86.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) - RSUs - 2009 Plan - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of Shares      
Outstanding (in shares) 544    
Granted (Awarded) (in shares) 343    
Vested (Released) (in shares) (183)    
Forfeited (in shares) (124)    
Outstanding (in shares) 580 544  
Weighted-Average Grant Date Fair Value      
Outstanding (in dollars per share) $ 66.65    
Granted (Awarded) (in dollars per share) 74.52 $ 78.49 $ 59.52
Vested (Released) (in dollars per share) 61.30    
Forfeited (in dollars per share) 67.16    
Outstanding (in dollars per share) $ 72.87 $ 66.65  
Weighted-Average Remaining Years      
Outstanding 1 year 7 months 6 days 1 year 7 months 6 days  
Aggregate Intrinsic Value      
Outstanding $ 69,670 $ 44,492  
XML 113 R87.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details) - RSAs - 2009 Plan - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of Shares      
Outstanding (in shares) 17    
Granted (Awarded) (in shares) 21    
Vested (Released) (in shares) (17)    
Outstanding (in shares) 21 17  
Weighted-Average Grant Date Fair Value      
Outstanding (in dollars per share) $ 81.92    
Granted (Awarded) (in dollars per share) 68.11 $ 81.86 $ 46.60
Vested (Released) (in dollars per share) 81.92    
Outstanding (in dollars per share) $ 68.11 $ 81.92  
XML 114 R88.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details) - Performance-Based Restricted Stock - 2009 Plan - $ / shares
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of Shares      
Outstanding (in shares) 134    
Granted (Awarded) (in shares) 99    
Vested (Released) (in shares) (73)    
Forfeited (in shares) (5)    
Outstanding (in shares) 155 134  
Weighted-Average Grant Date Fair Value      
Outstanding (in dollars per share) $ 55.82    
Granted (Awarded) (in dollars per share) 82.17 $ 73.38 $ 38.03
Vested (Released) (in dollars per share) 50.54    
Forfeited (in dollars per share) 81.72    
Outstanding (in dollars per share) $ 74.26 $ 55.82  
XML 115 R89.htm IDEA: XBRL DOCUMENT v3.20.4
Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details)
shares in Thousands
Dec. 31, 2020
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares reserved for future issuance (in shares) 7,144
Share options outstanding  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares reserved for future issuance (in shares) 3,932
Non-vested restricted stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares reserved for future issuance (in shares) 756
Shares authorized for future issuance  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares reserved for future issuance (in shares) 1,250
ESPP shares available for future issuance  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Shares reserved for future issuance (in shares) 1,206
XML 116 R90.htm IDEA: XBRL DOCUMENT v3.20.4
Stock Repurchase Program (Details) - USD ($)
 12 Months Ended
Sep. 17, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Aug. 02, 2016
Nov. 04, 2014
Equity, Class of Treasury Stock [Line Items]            
Aggregate purchase price for repurchased shares   $ 53,035,000 $ 0 $ 0    
2016 and 2014 Share Repurchase Programs            
Equity, Class of Treasury Stock [Line Items]            
Remaining value of shares authorized for repurchase under stock repurchase programs   $ 54,900,000        
Number of shares repurchased (in shares)   0 0 0    
2016 Repurchase Program            
Equity, Class of Treasury Stock [Line Items]            
Value of shares authorized for repurchase under stock repurchase programs         $ 50,000,000.0  
2014 Share Repurchase Program            
Equity, Class of Treasury Stock [Line Items]            
Value of shares authorized for repurchase under stock repurchase programs           $ 50,000,000.0
One-Time Stock Repurchase Transaction            
Equity, Class of Treasury Stock [Line Items]            
Value of shares authorized for repurchase under stock repurchase programs $ 75,000,000.0          
Number of shares repurchased (in shares) 749,300          
Average price of repurchased shares (in dollars per share) $ 70.78          
Aggregate purchase price for repurchased shares $ 53,000,000.0          
XML 117 R91.htm IDEA: XBRL DOCUMENT v3.20.4
Equity Offerings (Details) - Distribution Agreement - USD ($)
$ / shares in Units, shares in Thousands
 12 Months Ended
Nov. 03, 2017
Dec. 31, 2019
Dec. 31, 2018
Subsidiary, Sale of Stock [Line Items]      
Maximum aggregate offering price $ 125,000,000.0    
Gross proceeds from sales of common stock   $ 38,500,000 $ 40,300,000
Issuance costs on sales of common stock   $ 700,000 $ 700,000
Number of shares sold (in shares)   460 557
Price per share sold (in dollars per share)   $ 83.81 $ 72.40
XML 118 R92.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
Domestic $ 34,714 $ 81,641 $ 46,528
Foreign (5,365) (7,708) (10,912)
Income before provision for income taxes $ 29,349 $ 73,933 $ 35,616
XML 119 R93.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Provision For (Benefit From) Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Current:      
Federal $ 1,874 $ 8,006 $ 1,404
State 1,733 4,549 1,832
Foreign 647 1,240 768
Total current income taxes 4,254 13,795 4,004
Deferred:      
Federal (3,868) (1,292) 5,455
State (2,494) (1,609) (909)
Foreign (737) 1,701 (10,663)
Total deferred income taxes (7,099) (1,200) (6,117)
Total provision for (benefit from) income taxes $ (2,845) $ 12,595 $ (2,113)
XML 120 R94.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
U.S. federal tax provision at statutory rate $ 6,163 $ 15,525 $ 7,479
State taxes (601) 2,258 651
Section 162(m) limitation 2,550 2,279 738
Non-deductible expenses 325 619 686
Uncertain tax positions (394) (2,472) (412)
Share-based compensation tax benefit (6,929) (7,892) (4,005)
Research tax credits (4,038) (3,805) (3,230)
Restructuring impact 0 7,432 (4,205)
Foreign derived intangible income deduction (204) (449) (349)
Foreign rate differential (102) (1,424) 561
Other 385 524 (27)
Total provision for (benefit from) income taxes $ (2,845) $ 12,595 $ (2,113)
XML 121 R95.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Tax Credit Carryforward [Line Items]      
Tax benefit associated with making a check-the-box election to treat Aesynt as a U.S. disregarded entity   $ 4,200  
Net tax expense on sale of intellectual property rights $ 7,400    
Valuation allowance 1,186   $ 1,199
Unrecognized tax benefits that would impact tax expense 16,800   18,200
Uncertain tax positions, interest and penalties 500 500 400
Interest and penalties accrued $ 1,000 $ 1,400 1,400
State and Local Jurisdiction      
Tax Credit Carryforward [Line Items]      
Net operating loss     6,000
State and Local Jurisdiction | Research Tax Credit Carryforward      
Tax Credit Carryforward [Line Items]      
Tax credit carryforward amount     17,000
Foreign Tax Authority      
Tax Credit Carryforward [Line Items]      
Net operating loss     29,700
Internal Revenue Service (IRS) | Research Tax Credit Carryforward      
Tax Credit Carryforward [Line Items]      
Tax credit carryforward amount     $ 1,300
XML 122 R96.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Deferred tax assets (liabilities):    
Deferred revenues $ 5,910 $ 4,129
Share-based compensation 8,094 6,483
Inventory-related items 4,953 3,507
Tax credit carryforwards 12,105 13,472
Reserves and accruals 8,160 5,712
Loss carryforwards 8,461 9,484
Lease liability 15,465 15,471
Other, net 1,578 543
Gross deferred tax assets 64,726 58,801
Valuation allowance (1,199) (1,186)
Total net deferred tax assets 63,527 57,615
Intangibles (22,010) (18,941)
Depreciation and amortization (36,528) (35,941)
Prepaid expenses (15,654) (13,395)
Right-of-use assets (13,949) (14,286)
Total deferred tax liabilities (88,141) (82,563)
Net deferred tax liabilities $ (24,614) $ (24,948)
XML 123 R97.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Beginning of the period balance $ 16,775 $ 9,961 $ 10,741
Increases related to tax positions taken during a prior period 88 10 19
Decreases related to tax positions taken during the prior period 0 (6) (1,257)
Increases related to tax positions taken during the current period 2,294 9,282 870
Decreases related to settlements 0 0 0
Decreases related to expiration of statute of limitations (911) (2,472) (412)
End of the period balance $ 18,246 $ 16,775 $ 9,961
XML 124 R98.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring Expenses - Narrative (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses $ 9,961 $ 0 $ 4,346
Q1-Q2 2020 Restructuring Plan      
Restructuring Cost and Reserve [Line Items]      
Unpaid balance related to restructuring plan 600    
Q1-Q2 2020 Restructuring Plan | Employee Severance Costs and Related Expenses      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses $ 10,000    
Q4 2018 Restructuring Plan      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses     1,300
Restructuring payments     1,300
Q1 2018 Restructuring Plan      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses     $ 3,000
XML 125 R99.htm IDEA: XBRL DOCUMENT v3.20.4
Restructuring Expenses - Summary of Restructuring Expenses (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses $ 9,961 $ 0 $ 4,346
Cost of product and service revenues      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses 2,564 0 186
Research and development      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses 3,716 0 0
Selling, general, and administrative      
Restructuring Cost and Reserve [Line Items]      
Restructuring expenses $ 3,681 $ 0 $ 4,160
XML 126 R100.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule II Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 3,452 $ 2,796 $ 5,930
Charged (Credited) to Cost and Expenses 1,135 2,499 (117)
Debited (Credited) to Other Accounts 0 0 24
Amount Written Off (535) (1,986) (3,010)
Other Adjustments 529 143 (31)
Balance at End of Period 4,581 3,452 2,796
Accounts receivable and unbilled receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 3,227 2,582 5,738
Charged (Credited) to Cost and Expenses 1,095 2,488 (127)
Debited (Credited) to Other Accounts 0 0 12
Amount Written Off (535) (1,986) (3,010)
Other Adjustments 499 143 (31)
Balance at End of Period 4,286 3,227 2,582
Long-term unbilled receivables      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 0 0 0
Charged (Credited) to Cost and Expenses 0 0 0
Debited (Credited) to Other Accounts 0 0 0
Amount Written Off 0 0 0
Other Adjustments 30 0 0
Balance at End of Period 30 0 0
Net investment in sales-type leases      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 225 214 192
Charged (Credited) to Cost and Expenses 40 11 10
Debited (Credited) to Other Accounts 0 0 12
Amount Written Off 0 0 0
Other Adjustments 0 0 0
Balance at End of Period $ 265 $ 225 $ 214
EXCEL 127 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 129 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 130 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 341 623 1 false 106 0 false 7 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.omnicell.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - Consolidated Balance Sheets Sheet http://www.omnicell.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1002003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - Consolidated Statements of Operations Sheet http://www.omnicell.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1004005 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 1005006 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 6 false false R7.htm 1006007 - Statement - Consolidated Statements of Cash Flows Sheet http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 2101101 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 8 false false R9.htm 2107102 - Disclosure - Business Combinations Sheet http://www.omnicell.com/role/BusinessCombinations Business Combinations Notes 9 false false R10.htm 2113103 - Disclosure - Revenues Sheet http://www.omnicell.com/role/Revenues Revenues Notes 10 false false R11.htm 2119104 - Disclosure - Net Income Per Share Sheet http://www.omnicell.com/role/NetIncomePerShare Net Income Per Share Notes 11 false false R12.htm 2122105 - Disclosure - Fair Value of Financial Instruments Sheet http://www.omnicell.com/role/FairValueofFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 2124106 - Disclosure - Balance Sheet Components Sheet http://www.omnicell.com/role/BalanceSheetComponents Balance Sheet Components Notes 13 false false R14.htm 2128107 - Disclosure - Property and Equipment Sheet http://www.omnicell.com/role/PropertyandEquipment Property and Equipment Notes 14 false false R15.htm 2133108 - Disclosure - Goodwill and Intangible Assets Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 15 false false R16.htm 2139109 - Disclosure - Debt and Credit Agreements Sheet http://www.omnicell.com/role/DebtandCreditAgreements Debt and Credit Agreements Notes 16 false false R17.htm 2144110 - Disclosure - Convertible Senior Notes Notes http://www.omnicell.com/role/ConvertibleSeniorNotes Convertible Senior Notes Notes 17 false false R18.htm 2149111 - Disclosure - Lessor Leases Sheet http://www.omnicell.com/role/LessorLeases Lessor Leases Notes 18 false false R19.htm 2157112 - Disclosure - Lessee Leases Sheet http://www.omnicell.com/role/LesseeLeases Lessee Leases Notes 19 false false R20.htm 2163113 - Disclosure - Commitments and Contingencies Sheet http://www.omnicell.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 20 false false R21.htm 2165114 - Disclosure - Employee Benefits and Share-Based Compensation Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensation Employee Benefits and Share-Based Compensation Notes 21 false false R22.htm 2176115 - Disclosure - Stock Repurchase Program Sheet http://www.omnicell.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 22 false false R23.htm 2178116 - Disclosure - Equity Offerings Sheet http://www.omnicell.com/role/EquityOfferings Equity Offerings Notes 23 false false R24.htm 2180117 - Disclosure - Income Taxes Sheet http://www.omnicell.com/role/IncomeTaxes Income Taxes Notes 24 false false R25.htm 2188118 - Disclosure - Restructuring Expenses Sheet http://www.omnicell.com/role/RestructuringExpenses Restructuring Expenses Notes 25 false false R26.htm 2192119 - Disclosure - Schedule II Valuation and Qualifying Accounts Sheet http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccounts Schedule II Valuation and Qualifying Accounts Notes 26 false false R27.htm 2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPolicies 27 false false R28.htm 2303301 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables) Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables Organization and Summary of Significant Accounting Policies (Tables) Tables http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPolicies 28 false false R29.htm 2308302 - Disclosure - Business Combinations (Tables) Sheet http://www.omnicell.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.omnicell.com/role/BusinessCombinations 29 false false R30.htm 2314303 - Disclosure - Revenues (Tables) Sheet http://www.omnicell.com/role/RevenuesTables Revenues (Tables) Tables http://www.omnicell.com/role/Revenues 30 false false R31.htm 2320304 - Disclosure - Net Income Per Share (Tables) Sheet http://www.omnicell.com/role/NetIncomePerShareTables Net Income Per Share (Tables) Tables http://www.omnicell.com/role/NetIncomePerShare 31 false false R32.htm 2325305 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.omnicell.com/role/BalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.omnicell.com/role/BalanceSheetComponents 32 false false R33.htm 2329306 - Disclosure - Property and Equipment (Tables) Sheet http://www.omnicell.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.omnicell.com/role/PropertyandEquipment 33 false false R34.htm 2334307 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.omnicell.com/role/GoodwillandIntangibleAssets 34 false false R35.htm 2340308 - Disclosure - Debt and Credit Agreement (Tables) Sheet http://www.omnicell.com/role/DebtandCreditAgreementTables Debt and Credit Agreement (Tables) Tables http://www.omnicell.com/role/DebtandCreditAgreements 35 false false R36.htm 2345309 - Disclosure - Convertible Senior Notes (Tables) Notes http://www.omnicell.com/role/ConvertibleSeniorNotesTables Convertible Senior Notes (Tables) Tables http://www.omnicell.com/role/ConvertibleSeniorNotes 36 false false R37.htm 2350310 - Disclosure - Lessor Leases (Tables) Sheet http://www.omnicell.com/role/LessorLeasesTables Lessor Leases (Tables) Tables http://www.omnicell.com/role/LessorLeases 37 false false R38.htm 2358311 - Disclosure - Lessee Leases (Tables) Sheet http://www.omnicell.com/role/LesseeLeasesTables Lessee Leases (Tables) Tables http://www.omnicell.com/role/LesseeLeases 38 false false R39.htm 2366312 - Disclosure - Employee Benefits and Share-Based Compensation (Tables) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables Employee Benefits and Share-Based Compensation (Tables) Tables http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensation 39 false false R40.htm 2381313 - Disclosure - Income Taxes (Tables) Sheet http://www.omnicell.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.omnicell.com/role/IncomeTaxes 40 false false R41.htm 2389314 - Disclosure - Restructuring Expenses (Tables) Sheet http://www.omnicell.com/role/RestructuringExpensesTables Restructuring Expenses (Tables) Tables http://www.omnicell.com/role/RestructuringExpenses 41 false false R42.htm 2404401 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails Organization and Summary of Significant Accounting Policies - Narrative (Details) Details http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables 42 false false R43.htm 2405402 - Disclosure - Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details) Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesSummaryofAllowanceforCreditLossesbyAssetTypeDetails Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details) Details 43 false false R44.htm 2406403 - Disclosure - Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Sheet http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details) Details 44 false false R45.htm 2409404 - Disclosure - Business Combinations - Narrative (Details) Sheet http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails Business Combinations - Narrative (Details) Details 45 false false R46.htm 2410405 - Disclosure - Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details) Sheet http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details) Details 46 false false R47.htm 2411406 - Disclosure - Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details) Sheet http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details) Details 47 false false R48.htm 2412407 - Disclosure - Business Combinations - Pro Forma Financial Information (Details) Sheet http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails Business Combinations - Pro Forma Financial Information (Details) Details 48 false false R49.htm 2415408 - Disclosure - Revenues - Disaggregation of Revenues by Revenue Type (Details) Sheet http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails Revenues - Disaggregation of Revenues by Revenue Type (Details) Details 49 false false R50.htm 2416409 - Disclosure - Revenues - Dissagregation of Revenues by Geographic Region (Details) Sheet http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails Revenues - Dissagregation of Revenues by Geographic Region (Details) Details 50 false false R51.htm 2417410 - Disclosure - Revenues - Contract Assets and Liabilities (Details) Sheet http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails Revenues - Contract Assets and Liabilities (Details) Details 51 false false R52.htm 2418411 - Disclosure - Revenues - Narrative (Details) Sheet http://www.omnicell.com/role/RevenuesNarrativeDetails Revenues - Narrative (Details) Details 52 false false R53.htm 2421412 - Disclosure - Net Income Per Share (Details) Sheet http://www.omnicell.com/role/NetIncomePerShareDetails Net Income Per Share (Details) Details http://www.omnicell.com/role/NetIncomePerShareTables 53 false false R54.htm 2423413 - Disclosure - Fair Value of Financial Instruments - Narrative (Details) Sheet http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails Fair Value of Financial Instruments - Narrative (Details) Details 54 false false R55.htm 2426414 - Disclosure - Balance Sheet Components - Balance Sheet Components (Details) Sheet http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails Balance Sheet Components - Balance Sheet Components (Details) Details 55 false false R56.htm 2427415 - Disclosure - Balance Sheet Components - Accumulated Other Comprehensive Income (Details) Sheet http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails Balance Sheet Components - Accumulated Other Comprehensive Income (Details) Details 56 false false R57.htm 2430416 - Disclosure - Property and Equipment - Property and Equipment Balances (Details) Sheet http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails Property and Equipment - Property and Equipment Balances (Details) Details 57 false false R58.htm 2431417 - Disclosure - Property and Equipment - Narrative (Details) Sheet http://www.omnicell.com/role/PropertyandEquipmentNarrativeDetails Property and Equipment - Narrative (Details) Details 58 false false R59.htm 2432418 - Disclosure - Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details) Sheet http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details) Details 59 false false R60.htm 2435419 - Disclosure - Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details) Details 60 false false R61.htm 2436420 - Disclosure - Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details) Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details) Details 61 false false R62.htm 2437421 - Disclosure - Goodwill and Intangible Assets - Narrative (Details) Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssetsNarrativeDetails Goodwill and Intangible Assets - Narrative (Details) Details 62 false false R63.htm 2438422 - Disclosure - Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) Sheet http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details) Details 63 false false R64.htm 2441423 - Disclosure - Debt and Credit Agreements - Narrative (Details) Sheet http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails Debt and Credit Agreements - Narrative (Details) Details 64 false false R65.htm 2442424 - Disclosure - Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details) Sheet http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details) Details 65 false false R66.htm 2443425 - Disclosure - Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details) Sheet http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details) Details 66 false false R67.htm 2446426 - Disclosure - Convertible Senior Notes - Narrative (Details) Notes http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails Convertible Senior Notes - Narrative (Details) Details 67 false false R68.htm 2447427 - Disclosure - Convertible Senior Notes - Convertible Debt Balances (Details) Notes http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails Convertible Senior Notes - Convertible Debt Balances (Details) Details 68 false false R69.htm 2448428 - Disclosure - Convertible Senior Notes - Summary of the Components of Interest Expense (Details) Notes http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails Convertible Senior Notes - Summary of the Components of Interest Expense (Details) Details 69 false false R70.htm 2451429 - Disclosure - Lessor Leases - Narrative (Details) Sheet http://www.omnicell.com/role/LessorLeasesNarrativeDetails Lessor Leases - Narrative (Details) Details 70 false false R71.htm 2452430 - Disclosure - Lessor Leases - Income Recognized from Sales-Type Leases (Details) Sheet http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails Lessor Leases - Income Recognized from Sales-Type Leases (Details) Details 71 false false R72.htm 2453431 - Disclosure - Lessor Leases - Components of Sales-Type Lease Receivables (Details) Sheet http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails Lessor Leases - Components of Sales-Type Lease Receivables (Details) Details 72 false false R73.htm 2454432 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) Sheet http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details) Details 73 false false R74.htm 2455433 - Disclosure - Lessor Leases - Income Recognized from Operating Leases (Details) Sheet http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromOperatingLeasesDetails Lessor Leases - Income Recognized from Operating Leases (Details) Details 74 false false R75.htm 2456434 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details) Sheet http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details) Details 75 false false R76.htm 2459435 - Disclosure - Lessee Leases - Narrative (Details) Sheet http://www.omnicell.com/role/LesseeLeasesNarrativeDetails Lessee Leases - Narrative (Details) Details 76 false false R77.htm 2460436 - Disclosure - Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and??the Reconciliation to the Operating Lease Liabilities (Details) Sheet http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and??the Reconciliation to the Operating Lease Liabilities (Details) Details 77 false false R78.htm 2461437 - Disclosure - Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) Sheet http://www.omnicell.com/role/LesseeLeasesSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details) Details 78 false false R79.htm 2462438 - Disclosure - Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details) Sheet http://www.omnicell.com/role/LesseeLeasesWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details) Details 79 false false R80.htm 2464439 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.omnicell.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.omnicell.com/role/CommitmentsandContingencies 80 false false R81.htm 2467440 - Disclosure - Employee Benefits and Share-Based Compensation - Narrative (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails Employee Benefits and Share-Based Compensation - Narrative (Details) Details 81 false false R82.htm 2468441 - Disclosure - Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details) Details 82 false false R83.htm 2469442 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details) Details 83 false false R84.htm 2470443 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details) Details 84 false false R85.htm 2471444 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details) Details 85 false false R86.htm 2472445 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details) Details 86 false false R87.htm 2473446 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details) Details 87 false false R88.htm 2474447 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details) Details 88 false false R89.htm 2475448 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details) Sheet http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details) Details 89 false false R90.htm 2477449 - Disclosure - Stock Repurchase Program (Details) Sheet http://www.omnicell.com/role/StockRepurchaseProgramDetails Stock Repurchase Program (Details) Details http://www.omnicell.com/role/StockRepurchaseProgram 90 false false R91.htm 2479450 - Disclosure - Equity Offerings (Details) Sheet http://www.omnicell.com/role/EquityOfferingsDetails Equity Offerings (Details) Details http://www.omnicell.com/role/EquityOfferings 91 false false R92.htm 2482451 - Disclosure - Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details) Sheet http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details) Details 92 false false R93.htm 2483452 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details) Sheet http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails Income Taxes - Provision For (Benefit From) Income Taxes (Details) Details 93 false false R94.htm 2484453 - Disclosure - Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details) Sheet http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details) Details 94 false false R95.htm 2485454 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.omnicell.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 95 false false R96.htm 2486455 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details) Sheet http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details) Details 96 false false R97.htm 2487456 - Disclosure - Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details) Sheet http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details) Details 97 false false R98.htm 2490457 - Disclosure - Restructuring Expenses - Narrative (Details) Sheet http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails Restructuring Expenses - Narrative (Details) Details 98 false false R99.htm 2491458 - Disclosure - Restructuring Expenses - Summary of Restructuring Expenses (Details) Sheet http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails Restructuring Expenses - Summary of Restructuring Expenses (Details) Details 99 false false R100.htm 2493459 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details) Sheet http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails Schedule II Valuation and Qualifying Accounts (Details) Details http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccounts 100 false false All Reports Book All Reports omcl-20201231.htm exhibit1010q4-20.htm exhibit1022q4-20.htm exhibit1024q4-20.htm exhibit1025q4-20.htm exhibit1026q4-20.htm exhibit1027q4-20.htm exhibit109q4-20.htm exhibit211q4-20.htm exhibit231q4-20.htm exhibit311q4-20.htm exhibit312q4-20.htm exhibit321q4-20.htm omcl-20201231.xsd omcl-20201231_cal.xml omcl-20201231_def.xml omcl-20201231_lab.xml omcl-20201231_pre.xml omcl-20201231_g1.jpg omcl-20201231_g2.jpg omcl-20201231_g3.jpg omcl-20201231_g4.jpg omcl-20201231_g5.jpg omcl-20201231_g6.jpg omcl-20201231_g7.jpg http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/srt/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 true true JSON 133 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "omcl-20201231.htm": { "axisCustom": 1, "axisStandard": 37, "contextCount": 341, "dts": { "calculationLink": { "local": [ "omcl-20201231_cal.xml" ] }, "definitionLink": { "local": [ "omcl-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "omcl-20201231.htm" ] }, "labelLink": { "local": [ "omcl-20201231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "omcl-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "omcl-20201231.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 846, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 11, "http://www.omnicell.com/20201231": 1, "http://xbrl.sec.gov/dei/2020-01-31": 4, "total": 16 }, "keyCustom": 72, "keyStandard": 551, "memberCustom": 40, "memberStandard": 65, "nsprefix": "omcl", "nsuri": "http://www.omnicell.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.omnicell.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2113103 - Disclosure - Revenues", "role": "http://www.omnicell.com/role/Revenues", "shortName": "Revenues", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ibcf159018c2c436bb7ac4daabe3f4f40_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2493459 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)", "role": "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails", "shortName": "Schedule II Valuation and Qualifying Accounts (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ide23b2ae7ba346b598b742de4d4fb6c9_I20171231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ValuationAllowancesAndReservesBalance", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119104 - Disclosure - Net Income Per Share", "role": "http://www.omnicell.com/role/NetIncomePerShare", "shortName": "Net Income Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122105 - Disclosure - Fair Value of Financial Instruments", "role": "http://www.omnicell.com/role/FairValueofFinancialInstruments", "shortName": "Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124106 - Disclosure - Balance Sheet Components", "role": "http://www.omnicell.com/role/BalanceSheetComponents", "shortName": "Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128107 - Disclosure - Property and Equipment", "role": "http://www.omnicell.com/role/PropertyandEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2133108 - Disclosure - Goodwill and Intangible Assets", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssets", "shortName": "Goodwill and Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2139109 - Disclosure - Debt and Credit Agreements", "role": "http://www.omnicell.com/role/DebtandCreditAgreements", "shortName": "Debt and Credit Agreements", "subGroupType": "", "uniqueAnchor": null }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2144110 - Disclosure - Convertible Senior Notes", "role": "http://www.omnicell.com/role/ConvertibleSeniorNotes", "shortName": "Convertible Senior Notes", "subGroupType": "", "uniqueAnchor": null }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2149111 - Disclosure - Lessor Leases", "role": "http://www.omnicell.com/role/LessorLeases", "shortName": "Lessor Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LessorSalesTypeLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2157112 - Disclosure - Lessee Leases", "role": "http://www.omnicell.com/role/LesseeLeases", "shortName": "Lessee Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Consolidated Balance Sheets", "role": "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ReceivablesNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2163113 - Disclosure - Commitments and Contingencies", "role": "http://www.omnicell.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2165114 - Disclosure - Employee Benefits and Share-Based Compensation", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensation", "shortName": "Employee Benefits and Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2176115 - Disclosure - Stock Repurchase Program", "role": "http://www.omnicell.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TreasuryStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2178116 - Disclosure - Equity Offerings", "role": "http://www.omnicell.com/role/EquityOfferings", "shortName": "Equity Offerings", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2180117 - Disclosure - Income Taxes", "role": "http://www.omnicell.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2188118 - Disclosure - Restructuring Expenses", "role": "http://www.omnicell.com/role/RestructuringExpenses", "shortName": "Restructuring Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2192119 - Disclosure - Schedule II Valuation and Qualifying Accounts", "role": "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccounts", "shortName": "Schedule II Valuation and Qualifying Accounts", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies", "shortName": "Organization and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "omcl:CreditLossFinancialInstrumentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables", "shortName": "Organization and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "omcl:CreditLossFinancialInstrumentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308302 - Disclosure - Business Combinations (Tables)", "role": "http://www.omnicell.com/role/BusinessCombinationsTables", "shortName": "Business Combinations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314303 - Disclosure - Revenues (Tables)", "role": "http://www.omnicell.com/role/RevenuesTables", "shortName": "Revenues (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320304 - Disclosure - Net Income Per Share (Tables)", "role": "http://www.omnicell.com/role/NetIncomePerShareTables", "shortName": "Net Income Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2325305 - Disclosure - Balance Sheet Components (Tables)", "role": "http://www.omnicell.com/role/BalanceSheetComponentsTables", "shortName": "Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329306 - Disclosure - Property and Equipment (Tables)", "role": "http://www.omnicell.com/role/PropertyandEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2334307 - Disclosure - Goodwill and Intangible Assets (Tables)", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssetsTables", "shortName": "Goodwill and Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2340308 - Disclosure - Debt and Credit Agreement (Tables)", "role": "http://www.omnicell.com/role/DebtandCreditAgreementTables", "shortName": "Debt and Credit Agreement (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2345309 - Disclosure - Convertible Senior Notes (Tables)", "role": "http://www.omnicell.com/role/ConvertibleSeniorNotesTables", "shortName": "Convertible Senior Notes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2350310 - Disclosure - Lessor Leases (Tables)", "role": "http://www.omnicell.com/role/LessorLeasesTables", "shortName": "Lessor Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseLeaseIncomeTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2358311 - Disclosure - Lessee Leases (Tables)", "role": "http://www.omnicell.com/role/LesseeLeasesTables", "shortName": "Lessee Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2366312 - Disclosure - Employee Benefits and Share-Based Compensation (Tables)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables", "shortName": "Employee Benefits and Share-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - Consolidated Statements of Operations", "role": "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2381313 - Disclosure - Income Taxes (Tables)", "role": "http://www.omnicell.com/role/IncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2389314 - Disclosure - Restructuring Expenses (Tables)", "role": "http://www.omnicell.com/role/RestructuringExpensesTables", "shortName": "Restructuring Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404401 - Disclosure - Organization and Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Organization and Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details)", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesSummaryofAllowanceforCreditLossesbyAssetTypeDetails", "shortName": "Organization and Summary of Significant Accounting Policies - Summary of Allowance for Credit Losses by Asset Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:CreditLossFinancialInstrumentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i3014c2f5c94d4510bfaad42a86192688_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "shortName": "Organization and Summary of Significant Accounting Policies - Estimated Useful Lives of Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "ix:continuation", "div", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i3014c2f5c94d4510bfaad42a86192688_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - Business Combinations - Narrative (Details)", "role": "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "shortName": "Business Combinations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i497022c3cfb64b5d9fd140f3f56e2acd_D20201001-20201001", "decimals": "-5", "lang": "en-US", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410405 - Disclosure - Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details)", "role": "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "shortName": "Business Combinations - Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i559f4519d1db45c9a13c65f72e29fa69_I20201001", "decimals": "-3", "lang": "en-US", "name": "omcl:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsReceivableAndUnbilledReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i28cf3e4ca9dc4259994453bc8e777944_D20201001-20201001", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IndefinitelivedIntangibleAssetsAcquired", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411406 - Disclosure - Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details)", "role": "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "shortName": "Business Combinations - Summary of Identifiable Intangible Assets Acquired (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i28cf3e4ca9dc4259994453bc8e777944_D20201001-20201001", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IndefinitelivedIntangibleAssetsAcquired", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "if36ecf21da3b46438da9f2255e3a1d3e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412407 - Disclosure - Business Combinations - Pro Forma Financial Information (Details)", "role": "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails", "shortName": "Business Combinations - Pro Forma Financial Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "if36ecf21da3b46438da9f2255e3a1d3e_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2415408 - Disclosure - Revenues - Disaggregation of Revenues by Revenue Type (Details)", "role": "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails", "shortName": "Revenues - Disaggregation of Revenues by Revenue Type (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ia35d7a0d5d90459896ac0bcc1449861a_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income", "role": "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2416409 - Disclosure - Revenues - Dissagregation of Revenues by Geographic Region (Details)", "role": "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails", "shortName": "Revenues - Dissagregation of Revenues by Geographic Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i3f1527f7201c468988dbf0904bcbdbbf_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417410 - Disclosure - Revenues - Contract Assets and Liabilities (Details)", "role": "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails", "shortName": "Revenues - Contract Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerLiabilityCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418411 - Disclosure - Revenues - Narrative (Details)", "role": "http://www.omnicell.com/role/RevenuesNarrativeDetails", "shortName": "Revenues - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-5", "lang": "en-US", "name": "omcl:ContractWithCustomerAssetCurrentDeferredCostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421412 - Disclosure - Net Income Per Share (Details)", "role": "http://www.omnicell.com/role/NetIncomePerShareDetails", "shortName": "Net Income Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ic6f70f23d5154a7b9fbcf59640c12d1a_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7b5fcae4b6fe4dba96f3332d9cd4269b_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423413 - Disclosure - Fair Value of Financial Instruments - Narrative (Details)", "role": "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value of Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7b5fcae4b6fe4dba96f3332d9cd4269b_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426414 - Disclosure - Balance Sheet Components - Balance Sheet Components (Details)", "role": "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "shortName": "Balance Sheet Components - Balance Sheet Components (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ibcf159018c2c436bb7ac4daabe3f4f40_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427415 - Disclosure - Balance Sheet Components - Accumulated Other Comprehensive Income (Details)", "role": "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "shortName": "Balance Sheet Components - Accumulated Other Comprehensive Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430416 - Disclosure - Property and Equipment - Property and Equipment Balances (Details)", "role": "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails", "shortName": "Property and Equipment - Property and Equipment Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431417 - Disclosure - Property and Equipment - Narrative (Details)", "role": "http://www.omnicell.com/role/PropertyandEquipmentNarrativeDetails", "shortName": "Property and Equipment - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432418 - Disclosure - Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details)", "role": "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails", "shortName": "Property and Equipment - Summary of Geographic Information for Property and Equipment, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i318437b4f7274f22b7c3c804199caaf3_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i80774085e7c64fa5a0887df2b24e8c2c_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - Consolidated Statements of Stockholders' Equity", "role": "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i80774085e7c64fa5a0887df2b24e8c2c_I20171231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ibcf159018c2c436bb7ac4daabe3f4f40_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435419 - Disclosure - Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails", "shortName": "Goodwill and Intangible Assets - Changes in the Carrying Amount of Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436420 - Disclosure - Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details)", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Carrying Amounts and Useful Lives of Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437421 - Disclosure - Goodwill and Intangible Assets - Narrative (Details)", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssetsNarrativeDetails", "shortName": "Goodwill and Intangible Assets - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438422 - Disclosure - Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)", "role": "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails", "shortName": "Goodwill and Intangible Assets - Estimated Future Amortization Expense for Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsOfDebtIssuanceCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2441423 - Disclosure - Debt and Credit Agreements - Narrative (Details)", "role": "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "shortName": "Debt and Credit Agreements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i74908bb6ee5a4ee3a083749817b2fd4c_D20171201-20171231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PaymentsOfDebtIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RepaymentsOfLongTermDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442424 - Disclosure - Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details)", "role": "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "shortName": "Debt and Credit Agreements - Changes in the Carrying Amount of Debt Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "id4a7a421aab14fc7b6354ba80a2f67e0_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ProceedsFromDebtNetOfIssuanceCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "srt:ScheduleOfCondensedBalanceSheetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ibcf159018c2c436bb7ac4daabe3f4f40_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2443425 - Disclosure - Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details)", "role": "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "shortName": "Debt and Credit Agreements - Changes in the Balance of Deferred Debt Issuance Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:ScheduleOfDebtIssuanceCostsNetTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i1c20acf59445490ca20bbb96c77858cc_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProceedsFromConvertibleDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446426 - Disclosure - Convertible Senior Notes - Narrative (Details)", "role": "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "shortName": "Convertible Senior Notes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i8b1c95e3454f40d5ac5dbfd99c3d9d09_D20200925-20200925", "decimals": "-5", "lang": "en-US", "name": "omcl:AdjustmentsToAdditionalPaidInCapitalConvertibleNoteHedge", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7b5fcae4b6fe4dba96f3332d9cd4269b_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2447427 - Disclosure - Convertible Senior Notes - Convertible Debt Balances (Details)", "role": "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "shortName": "Convertible Senior Notes - Convertible Debt Balances (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7b5fcae4b6fe4dba96f3332d9cd4269b_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AmortizationOfDebtDiscountPremium", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2448428 - Disclosure - Convertible Senior Notes - Summary of the Components of Interest Expense (Details)", "role": "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "shortName": "Convertible Senior Notes - Summary of the Components of Interest Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:ScheduleOfInterestExpenseDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "id8c5dfc6341a44d9bd3e0ed7cb005e54_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2451429 - Disclosure - Lessor Leases - Narrative (Details)", "role": "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "shortName": "Lessor Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ib6c811486b41477b84a950c8b88be3a5_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2452430 - Disclosure - Lessor Leases - Income Recognized from Sales-Type Leases (Details)", "role": "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails", "shortName": "Lessor Leases - Income Recognized from Sales-Type Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeLeaseRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfReceivablesWithImputedInterestTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2453431 - Disclosure - Lessor Leases - Components of Sales-Type Lease Receivables (Details)", "role": "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails", "shortName": "Lessor Leases - Components of Sales-Type Lease Receivables (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfReceivablesWithImputedInterestTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:NetInvestmentInLease", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2454432 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details)", "role": "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails", "shortName": "Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2455433 - Disclosure - Lessor Leases - Income Recognized from Operating Leases (Details)", "role": "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromOperatingLeasesDetails", "shortName": "Lessor Leases - Income Recognized from Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseLeaseIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2456434 - Disclosure - Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details)", "role": "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails", "shortName": "Lessor Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2459435 - Disclosure - Lessee Leases - Narrative (Details)", "role": "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails", "shortName": "Lessee Leases - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2460436 - Disclosure - Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and\u00a0the Reconciliation to the Operating Lease Liabilities (Details)", "role": "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails", "shortName": "Lessee Leases - Maturity Schedule of Future Minimum Lease Payments under Operating Leases and\u00a0the Reconciliation to the Operating Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2461437 - Disclosure - Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details)", "role": "http://www.omnicell.com/role/LesseeLeasesSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails", "shortName": "Lessee Leases - Supplemental Cash Flow Information Related to Operating Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:LesseeOperatingLeaseLeaseAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2462438 - Disclosure - Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details)", "role": "http://www.omnicell.com/role/LesseeLeasesWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails", "shortName": "Lessee Leases - Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:LesseeOperatingLeaseLeaseAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Organization and Summary of Significant Accounting Policies", "role": "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPolicies", "shortName": "Organization and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2464439 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.omnicell.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:ScheduleofSharebasedCompensationFutureIssuanceofSharesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2467440 - Disclosure - Employee Benefits and Share-Based Compensation - Narrative (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "shortName": "Employee Benefits and Share-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i1d184cc9bb4947dfb98054dd89018291_D20200101-20201231", "decimals": "INF", "lang": "en-US", "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2468441 - Disclosure - Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "shortName": "Employee Benefits and Share-Based Compensation - Shared-based Compensation Expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i861df8f8ca4a4c7a98d5e8e519071c39_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i20ac03ab07c04d43b67303a7b74f30d4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2469442 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "shortName": "Employee Benefits and Share-Based Compensation - Assumptions Used to Value Stock Options Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i20ac03ab07c04d43b67303a7b74f30d4_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ifc9d67fb09904358b8105a3e02be5e8c_D20200101-20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2470443 - Disclosure - Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "shortName": "Employee Benefits and Share-Based Compensation - Assumptions Used to Value ESPP Shares Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ifc9d67fb09904358b8105a3e02be5e8c_D20200101-20201231", "decimals": "3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i3c397ccf66744d6d99fd856a77e729ff_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2471444 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "shortName": "Employee Benefits and Share-Based Compensation - Summary of Share Option Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i156836942f264eedbf17fd5ed29e578a_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ia86716763c6f4ccf874f1465382350ad_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2472445 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "shortName": "Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Unit Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaf570770eba4efbb5e09adb325327e8_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i2ff01ea571ef44908063e1396486e425_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2473446 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "shortName": "Employee Benefits and Share-Based Compensation - Summary of Restricted Stock Award Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ic96f910e7f93432a9d9dcda653323572_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "icb84608218d04079823d7beee32ddd8b_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2474447 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "shortName": "Employee Benefits and Share-Based Compensation - Summary of Performance-Based Restricted Stock Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ie00f3430923e4fb081f72416a9c6c181_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:ScheduleofSharebasedCompensationFutureIssuanceofSharesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2475448 - Disclosure - Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details)", "role": "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails", "shortName": "Employee Benefits and Share-Based Compensation - Summary of Shares Reserved for Future Issuance Under Equity Incentive Plans (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "omcl:ScheduleofSharebasedCompensationFutureIssuanceofSharesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i162899333e5149618d2063f420cc1799_I20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107102 - Disclosure - Business Combinations", "role": "http://www.omnicell.com/role/BusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PaymentsForRepurchaseOfCommonStock", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2477449 - Disclosure - Stock Repurchase Program (Details)", "role": "http://www.omnicell.com/role/StockRepurchaseProgramDetails", "shortName": "Stock Repurchase Program (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i3402218717d14f0a8db9fe0a99b87432_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i5042edd9ef9e41abbecc4a779337b0b3_D20171103-20171103", "decimals": "INF", "first": true, "lang": "en-US", "name": "omcl:SaleofStockAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2479450 - Disclosure - Equity Offerings (Details)", "role": "http://www.omnicell.com/role/EquityOfferingsDetails", "shortName": "Equity Offerings (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i5042edd9ef9e41abbecc4a779337b0b3_D20171103-20171103", "decimals": "INF", "first": true, "lang": "en-US", "name": "omcl:SaleofStockAuthorizedAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2482451 - Disclosure - Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails", "shortName": "Income Taxes - Geographical Breakdown of Income (Loss) before the Provision for Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2483452 - Disclosure - Income Taxes - Provision For (Benefit From) Income Taxes (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails", "shortName": "Income Taxes - Provision For (Benefit From) Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2484453 - Disclosure - Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails", "shortName": "Income Taxes - Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ib4041ace776a4c5084360d0d4d7f39d4_D20180101-20181231", "decimals": "-5", "first": true, "lang": "en-US", "name": "omcl:IncomeTaxExpenseBenefitElectionOfUSDisregardedEntityTreatment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2485454 - Disclosure - Income Taxes - Narrative (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ib4041ace776a4c5084360d0d4d7f39d4_D20180101-20181231", "decimals": "-5", "first": true, "lang": "en-US", "name": "omcl:IncomeTaxExpenseBenefitElectionOfUSDisregardedEntityTreatment", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsDeferredIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2486455 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails", "shortName": "Income Taxes - Significant Components of Deferred Tax Assets (Liabilities) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ieaacf5f9a5dc47ce9783b9d041eec922_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredTaxAssetsDeferredIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ibcf159018c2c436bb7ac4daabe3f4f40_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2487456 - Disclosure - Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details)", "role": "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Change in the Balance of Gross Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ide23b2ae7ba346b598b742de4d4fb6c9_I20171231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2490457 - Disclosure - Restructuring Expenses - Narrative (Details)", "role": "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails", "shortName": "Restructuring Expenses - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "ia4564b8d00014c5aa81766c0cb04a88d_I20201231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i7f4ea7dddf28451a8a8404f215762c3d_D20200101-20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2491458 - Disclosure - Restructuring Expenses - Summary of Restructuring Expenses (Details)", "role": "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails", "shortName": "Restructuring Expenses - Summary of Restructuring Expenses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "omcl-20201231.htm", "contextRef": "i861df8f8ca4a4c7a98d5e8e519071c39_D20200101-20201231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RestructuringCosts", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } } }, "segmentCount": 106, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r730", "r731", "r732" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r733" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r728" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r734" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r730", "r731", "r732" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r729" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "omcl_A1997EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "1997 Employee Stock Purchase Plan [Member]", "label": "1997 Employee Stock Purchase Plan [Member]", "terseLabel": "1997 Plan" } } }, "localname": "A1997EmployeeStockPurchasePlanMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_A2009PlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2009 Plan [Member]", "label": "2009 Plan [Member]", "terseLabel": "2009 Plan" } } }, "localname": "A2009PlanMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "domainItemType" }, "omcl_A2014ShareRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2014 Share Repurchase Program", "label": "2014 Share Repurchase Program [Member]", "terseLabel": "2014 Share Repurchase Program" } } }, "localname": "A2014ShareRepurchaseProgramMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "domainItemType" }, "omcl_A2016RepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The 2016 Repurchase Program [Member]", "label": "2016 Repurchase Program [Member]", "terseLabel": "2016 Repurchase Program" } } }, "localname": "A2016RepurchaseProgramMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "domainItemType" }, "omcl_A2016and2014ShareRepurchaseProgramsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2016 and 2014 Share Repurchase Programs [Member]", "label": "2016 and 2014 Share Repurchase Programs [Member]", "terseLabel": "2016 and 2014 Share Repurchase Programs" } } }, "localname": "A2016and2014ShareRepurchaseProgramsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "domainItemType" }, "omcl_A2018PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2018 Performance Based Restricted Stock Units", "label": "2018 Performance Based Restricted Stock Units [Member]", "terseLabel": "2018 Performance Based Restricted Stock Units" } } }, "localname": "A2018PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_A2019PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2019 Performance Based Restricted Stock Units", "label": "2019 Performance Based Restricted Stock Units [Member]", "terseLabel": "2019 Performance Based Restricted Stock Units" } } }, "localname": "A2019PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_A340BLinkBusinessMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "340B Link Business", "label": "340B Link Business [Member]", "terseLabel": "340B Link Business" } } }, "localname": "A340BLinkBusinessMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "omcl_AccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Accounting Policies [Table]", "label": "Accounting Policies [Line Items]", "terseLabel": "Accounting Policies [Line Items]" } } }, "localname": "AccountingPoliciesLineItems", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "omcl_AccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Policies [Table]", "label": "Accounting Policies [Table]", "terseLabel": "Accounting Policies [Table]" } } }, "localname": "AccountingPoliciesTable", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "omcl_AccruedGroupPurchasingOrganizationFees": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Group Purchasing Organization Fees", "label": "Accrued Group Purchasing Organization Fees", "terseLabel": "Group purchasing organization fees" } } }, "localname": "AccruedGroupPurchasingOrganizationFees", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "omcl_AccruedLiabilitiesRebatesandLeaseBuyoutsCurrent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Liabilities, Rebates and Lease Buyouts, Current", "label": "Accrued Liabilities, Rebates and Lease Buyouts, Current", "verboseLabel": "Rebates and lease buyouts" } } }, "localname": "AccruedLiabilitiesRebatesandLeaseBuyoutsCurrent", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "omcl_AdjustmentsToAdditionalPaidInCapitalConvertibleNoteHedge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Convertible Note Hedge", "label": "Adjustments To Additional Paid In Capital, Convertible Note Hedge", "negatedTerseLabel": "Purchase of convertible note hedge", "terseLabel": "Purchase of convertible note hedge" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleNoteHedge", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_AdjustmentsToAdditionalPaidInCapitalTaxBenefitsRelatedToConvertibleDebtAndHedge": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments To Additional Paid In Capital, Tax Benefits Related To Convertible Debt And Hedge", "label": "Adjustments To Additional Paid In Capital, Tax Benefits Related To Convertible Debt And Hedge", "terseLabel": "Tax benefits related to convertible senior notes and convertible note hedge" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalTaxBenefitsRelatedToConvertibleDebtAndHedge", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "omcl_AmortizationOfOperatingLeaseROUAsset": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization Of Operating Lease ROU Asset", "label": "Amortization Of Operating Lease ROU Asset", "terseLabel": "Amortization of operating lease right-of-use assets" } } }, "localname": "AmortizationOfOperatingLeaseROUAsset", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_BusinessCombinationAcquiredIntangibleAssetsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business Combination, Acquired Intangible Assets, Measurement Input", "label": "Business Combination, Acquired Intangible Assets, Measurement Input", "terseLabel": "Measurement input used in estimating the fair values of intangible assets" } } }, "localname": "BusinessCombinationAcquiredIntangibleAssetsMeasurementInput", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "pureItemType" }, "omcl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsReceivableAndUnbilledReceivables": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivable And Unbilled Receivables", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Receivable And Unbilled Receivables", "terseLabel": "Accounts receivable and unbilled receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsReceivableAndUnbilledReceivables", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "omcl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpense": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Prepaid Expense", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Assets, Prepaid Expense", "terseLabel": "Prepaid expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpense", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "omcl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Current Liabilities, Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedLiabilities", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "omcl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Liabilities", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Liabilities", "terseLabel": "Long-term operating lease liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "omcl_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Operating Lease Right-Of-Use Assets", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "omcl_CapitalLeasesIncomeStatementCostOfGoodsSoldSalesTypeLease": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": 2.0, "parentTag": "omcl_CapitalLeasesIncomeStatementSellingProfitLossSalesTypeLease", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capital Leases, Income Statement, Cost Of Goods Sold, Sales Type Lease", "label": "Capital Leases, Income Statement, Cost Of Goods Sold, Sales Type Lease", "negatedLabel": "Cost of sales-type lease revenues" } } }, "localname": "CapitalLeasesIncomeStatementCostOfGoodsSoldSalesTypeLease", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_CapitalLeasesIncomeStatementInterestIncomeSalesTypeLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Leases, Income Statement, Interest Income, Sales Type Lease", "label": "Capital Leases, Income Statement, Interest Income, Sales Type Lease", "terseLabel": "Interest income on sales-type lease receivables" } } }, "localname": "CapitalLeasesIncomeStatementInterestIncomeSalesTypeLease", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_CapitalLeasesIncomeStatementSellingProfitLossSalesTypeLease": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capital Leases, Income Statement, Selling Profit (Loss), Sales Type Lease", "label": "Capital Leases, Income Statement, Selling Profit (Loss), Sales Type Lease", "totalLabel": "Selling profit on sales-type lease revenues" } } }, "localname": "CapitalLeasesIncomeStatementSellingProfitLossSalesTypeLease", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_CapitalizedComputerSoftwareEstimatedUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Computer Software, Estimated Useful Life", "label": "Capitalized Computer Software, Estimated Useful Life", "terseLabel": "Estimated useful life of software-related products" } } }, "localname": "CapitalizedComputerSoftwareEstimatedUsefulLife", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_CapitalizedContractCostInitialTermAndRenewalServicePeriods": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Cost, Initial Term And Renewal Service Periods", "label": "Capitalized Contract Cost, Initial Term And Renewal Service Periods", "terseLabel": "Initial term and renewal service periods" } } }, "localname": "CapitalizedContractCostInitialTermAndRenewalServicePeriods", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_CapitalizedContractCostOriginalTermOfContract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Cost, Original Term Of Contract", "label": "Capitalized Contract Cost, Original Term Of Contract", "terseLabel": "Original terms of contracts" } } }, "localname": "CapitalizedContractCostOriginalTermOfContract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_CapitalizedContractCostsRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Capitalized Contract Costs Recognized", "label": "Capitalized Contract Costs Recognized", "terseLabel": "Contract cost expense" } } }, "localname": "CapitalizedContractCostsRecognized", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ChangeInDebtIssuanceCostsNetRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change In Debt Issuance Costs, Net", "label": "Change In Debt Issuance Costs, Net [Roll Forward]", "terseLabel": "Change In Debt Issuance Costs, Net [Roll Forward]" } } }, "localname": "ChangeInDebtIssuanceCostsNetRollForward", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails" ], "xbrltype": "stringItemType" }, "omcl_ConnectedDevicesSoftwareLicensesAndOtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Connected Devices, Software Licenses, And Other", "label": "Connected Devices, Software Licenses, And Other [Member]", "terseLabel": "Connected devices, software licenses, and other" } } }, "localname": "ConnectedDevicesSoftwareLicensesAndOtherMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "omcl_ConsumablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumables", "label": "Consumables [Member]", "terseLabel": "Consumables" } } }, "localname": "ConsumablesMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "omcl_ContractTerminationRequirementPeriodofNotification": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract Termination Requirement, Period of Notification", "label": "Contract Termination Requirement, Period of Notification", "terseLabel": "Period for notice of termination" } } }, "localname": "ContractTerminationRequirementPeriodofNotification", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_ContractWithCustomerAssetCurrentDeferredCostOfGoodsAndServicesSold": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Asset, Current, Deferred Cost Of Goods And Services Sold", "label": "Contract With Customer, Asset, Current, Deferred Cost Of Goods And Services Sold", "terseLabel": "Deferred cost of sales" } } }, "localname": "ContractWithCustomerAssetCurrentDeferredCostOfGoodsAndServicesSold", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Asset, Unbilled Receivables, Noncurrent", "label": "Contract with Customer, Asset, Unbilled Receivables, Noncurrent [Member]", "terseLabel": "Long-term unbilled receivables" } } }, "localname": "ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "omcl_ContractWithCustomerLiabilityCustomerAdvancesAndDepositsCurrent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Liability, Customer Advances and Deposits, Current", "label": "Contract with Customer, Liability, Customer Advances and Deposits, Current", "terseLabel": "Advance payments from customers" } } }, "localname": "ContractWithCustomerLiabilityCustomerAdvancesAndDepositsCurrent", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ContractwithCustomerLiabilityCurrentGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Liability, Current, Gross", "label": "Contract with Customer, Liability, Current, Gross", "terseLabel": "Gross short-term deferred revenue" } } }, "localname": "ContractwithCustomerLiabilityCurrentGross", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ConvertibleDebtSecuritiesAndWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debt Securities And Warrants", "label": "Convertible Debt Securities And Warrants [Member]", "terseLabel": "Convertible Debt Securities and Warrants" } } }, "localname": "ConvertibleDebtSecuritiesAndWarrantsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "domainItemType" }, "omcl_ConvertibleNoteHedgeRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Note Hedge Rights", "label": "Convertible Note Hedge Rights [Member]", "terseLabel": "Convertible Note Hedge Rights" } } }, "localname": "ConvertibleNoteHedgeRightsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_ConvertibleSeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Senior Notes", "label": "Convertible Senior Notes [Member]", "terseLabel": "Convertible Senior Notes" } } }, "localname": "ConvertibleSeniorNotesMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_CreditAgreementInterestRateOptionOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement, Interest Rate Option One [Member]", "label": "Credit Agreement, Interest Rate Option One [Member]", "terseLabel": "Interest Rate Option One" } } }, "localname": "CreditAgreementInterestRateOptionOneMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_CreditAgreementInterestRateOptionTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement, Interest Rate Option Two [Member]", "label": "Credit Agreement, Interest Rate Option Two [Member]", "terseLabel": "Interest Rate Option Two" } } }, "localname": "CreditAgreementInterestRateOptionTwoMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_CreditLossFinancialInstrumentTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Loss, Financial Instrument", "label": "Credit Loss, Financial Instrument [Table Text Block]", "terseLabel": "Summary of Allowance for Credit Losses by Asset Type" } } }, "localname": "CreditLossFinancialInstrumentTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "omcl_CustomerFundLiabilityCurrent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer Fund Liability, Current", "label": "Customer Fund Liability, Current", "terseLabel": "Customer fund liabilities" } } }, "localname": "CustomerFundLiabilityCurrent", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DebtInstrumentAccordionFeatureIncreaseLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Accordion Feature, Increase Limit", "label": "Debt Instrument, Accordion Feature, Increase Limit", "terseLabel": "Additional principal amount subject to purchasers' option" } } }, "localname": "DebtInstrumentAccordionFeatureIncreaseLimit", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DebtInstrumentConvertibleEmbeddedConversionOption": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 3.0, "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Embedded Conversion Option", "label": "Debt Instrument, Convertible, Embedded Conversion Option", "terseLabel": "Embedded conversion option" } } }, "localname": "DebtInstrumentConvertibleEmbeddedConversionOption", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DebtInstrumentConvertibleEquityComponentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Equity Component", "label": "Debt Instrument, Convertible, Equity Component [Abstract]", "terseLabel": "Equity:" } } }, "localname": "DebtInstrumentConvertibleEquityComponentAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "stringItemType" }, "omcl_DebtInstrumentConvertibleLiabilityComponentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Liability Component", "label": "Debt Instrument, Convertible, Liability Component [Abstract]", "terseLabel": "Liability:" } } }, "localname": "DebtInstrumentConvertibleLiabilityComponentAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "stringItemType" }, "omcl_DebtInstrumentConvertibleNumberOfSharesIssuable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Number Of Shares Issuable", "label": "Debt Instrument, Convertible, Number Of Shares Issuable", "terseLabel": "Maximum number of shares issuable upon conversion (in shares)" } } }, "localname": "DebtInstrumentConvertibleNumberOfSharesIssuable", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "omcl_DebtInstrumentConvertibleTaxEffectOfEquityComponentOfConvertibleDebt": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Convertible, Tax Effect Of Equity Component Of Convertible Debt", "label": "Debt Instrument, Convertible, Tax Effect Of Equity Component Of Convertible Debt", "negatedTerseLabel": "Deferred tax impact" } } }, "localname": "DebtInstrumentConvertibleTaxEffectOfEquityComponentOfConvertibleDebt", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DebtInstrumentCovenantMaximumSecuredNetLeverageRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant, Maximum Secured Net Leverage Ratio", "label": "Debt Instrument, Covenant, Maximum Secured Net Leverage Ratio", "terseLabel": "Maximum secured net leverage ratio" } } }, "localname": "DebtInstrumentCovenantMaximumSecuredNetLeverageRatio", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "pureItemType" }, "omcl_DebtInstrumentCovenantPeriod1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant Period 1", "label": "Debt Instrument, Covenant Period 1 [Member]", "terseLabel": "For Calendar Quarters Ending September 30, 2020, December 31, 2020 and March 31, 2021" } } }, "localname": "DebtInstrumentCovenantPeriod1Member", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_DebtInstrumentCovenantPeriod2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant Period 2", "label": "Debt Instrument, Covenant Period 2 [Member]", "terseLabel": "Calendar Quarters Ending Thereafter" } } }, "localname": "DebtInstrumentCovenantPeriod2Member", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_DebtInstrumentCovenantTermsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant Terms", "label": "Debt Instrument, Covenant Terms [Axis]", "terseLabel": "Debt Instrument, Covenant Terms [Axis]" } } }, "localname": "DebtInstrumentCovenantTermsAxis", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "omcl_DebtInstrumentCovenantTermsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Covenant Terms", "label": "Debt Instrument, Covenant Terms [Domain]", "terseLabel": "Debt Instrument, Covenant Terms [Domain]" } } }, "localname": "DebtInstrumentCovenantTermsDomain", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_DebtInstrumentRedemptionFaceAmountOfNotesThatMustBeOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Redemption, Face Amount Of Notes That Must Be Outstanding", "label": "Debt Instrument, Redemption, Face Amount Of Notes That Must Be Outstanding", "terseLabel": "Aggregate principal amount of Notes that must be outstanding and not subject to redemption if the Company redeems less than all of the Notes" } } }, "localname": "DebtInstrumentRedemptionFaceAmountOfNotesThatMustBeOutstanding", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DebtIssuanceCostsNetEquityComponent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt Issuance Costs, Net, Equity Component", "label": "Debt Issuance Costs, Net, Equity Component", "negatedTerseLabel": "Debt issuance costs" } } }, "localname": "DebtIssuanceCostsNetEquityComponent", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DeferredTaxAssetConvertibleDebtHedge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Asset, Convertible Debt Hedge", "label": "Deferred Tax Asset, Convertible Debt Hedge", "terseLabel": "Deferred tax asset related to the convertible note hedge transaction" } } }, "localname": "DeferredTaxAssetConvertibleDebtHedge", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DeferredTaxAssetsLeasingArrangements": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets, Leasing Arrangements", "label": "Deferred Tax Assets, Leasing Arrangements", "terseLabel": "Lease liability" } } }, "localname": "DeferredTaxAssetsLeasingArrangements", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DefinedContributionPlanEmployerMatchingContributionMaximumContribution": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Defined Contribution Plan, Employer Matching Contribution, Maximum Contribution", "label": "Defined Contribution Plan, Employer Matching Contribution, Maximum Contribution", "terseLabel": "Maximum amount of employer contribution" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionMaximumContribution", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_DistributionAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Distribution Agreement [Member]", "label": "Distribution Agreement [Member]", "terseLabel": "Distribution Agreement" } } }, "localname": "DistributionAgreementMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "domainItemType" }, "omcl_EffectiveIncomeTaxRateReconciliationGainOnInvestment": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 3.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Gain On Investment", "label": "Effective Income Tax Rate Reconciliation, Gain On Investment", "negatedTerseLabel": "Restructuring impact" } } }, "localname": "EffectiveIncomeTaxRateReconciliationGainOnInvestment", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "omcl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessCompensationUnderSection162mAmount": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 8.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Excess Compensation Under Section 162(m), Amount", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Excess Compensation Under Section 162(m), Amount", "terseLabel": "Section 162(m) limitation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseExcessCompensationUnderSection162mAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "omcl_EffectiveIncomeTaxRateReconciliationNondeductibleExpenselessShareBasedCompensationandAcquisitionCostAmount": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 9.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, less Share-Based Compensation and Acquisition Cost, Amount", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, less Share-Based Compensation and Acquisition Cost, Amount", "terseLabel": "Non-deductible expenses" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenselessShareBasedCompensationandAcquisitionCostAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "omcl_FundsHeldForCustomersAndCustomerFundLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Funds Held For Customers And Customer Fund Liabilities", "label": "Funds Held For Customers And Customer Fund Liabilities [Policy Text Block]", "terseLabel": "Funds Held for Customers and Customer Fund Liabilities" } } }, "localname": "FundsHeldForCustomersAndCustomerFundLiabilitiesPolicyTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "omcl_FuturegrantsandawardsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "future grants and awards [Member]", "label": "future grants and awards [Member]", "terseLabel": "Shares authorized for future issuance" } } }, "localname": "FuturegrantsandawardsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "omcl_GroupPurchasingOrganizationFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Group Purchasing Organization Fees", "label": "Group Purchasing Organization Fees", "terseLabel": "Fees to GPOs" } } }, "localname": "GroupPurchasingOrganizationFees", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_HardwareAndSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hardware And Software", "label": "Hardware And Software [Member]", "terseLabel": "SaaS, subscription software, and technology-enabled services" } } }, "localname": "HardwareAndSoftwareMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "omcl_IncomeTaxExpenseBenefitAwardsExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income Tax Expense (Benefit), Awards Exercised", "label": "Income Tax Expense (Benefit), Awards Exercised", "negatedLabel": "Tax benefit realized from stock options exercised" } } }, "localname": "IncomeTaxExpenseBenefitAwardsExercised", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_IncomeTaxExpenseBenefitElectionOfUSDisregardedEntityTreatment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income Tax Expense (Benefit), Election Of U.S. Disregarded Entity Treatment", "label": "Income Tax Expense (Benefit), Election Of U.S. Disregarded Entity Treatment", "negatedLabel": "Tax benefit associated with making a check-the-box election to treat Aesynt as a U.S. disregarded entity" } } }, "localname": "IncomeTaxExpenseBenefitElectionOfUSDisregardedEntityTreatment", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_IncomeTaxExpenseBenefitSaleOfIntellectualPropertyRights": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income Tax Expense (Benefit), Sale Of Intellectual Property Rights", "label": "Income Tax Expense (Benefit), Sale Of Intellectual Property Rights", "terseLabel": "Net tax expense on sale of intellectual property rights" } } }, "localname": "IncomeTaxExpenseBenefitSaleOfIntellectualPropertyRights", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_IncreaseDecreaseInOperatingLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Operating Lease Liabilities", "label": "Increase (Decrease) In Operating Lease Liabilities", "terseLabel": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiabilities", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_IncreaseDecreaseinPrepaidCommissions": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Prepaid Commissions", "label": "Increase (Decrease) in Prepaid Commissions", "negatedTerseLabel": "Prepaid commissions" } } }, "localname": "IncreaseDecreaseinPrepaidCommissions", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_IncrementalLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Incremental Loan Facility", "label": "Incremental Loan Facility [Member]", "terseLabel": "Incremental Loan Facility" } } }, "localname": "IncrementalLoanFacilityMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_InternalUseSoftwareandSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internal Use Software and Software Development Costs [Member]", "label": "Internal Use Software and Software Development Costs [Member]", "terseLabel": "Internal Use Software and Software Development Costs" } } }, "localname": "InternalUseSoftwareandSoftwareDevelopmentCostsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_InventoryTransferredtoPropertyandEquipment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory Transferred to Property and Equipment", "label": "Inventory Transferred to Property and Equipment", "terseLabel": "Transfers between inventory and property and equipment, net" } } }, "localname": "InventoryTransferredtoPropertyandEquipment", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_LeaseReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Receivable [Member]", "label": "Lease Receivable [Member]", "terseLabel": "Lease Receivable" } } }, "localname": "LeaseReceivableMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_LesseeOperatingLeaseLeaseAssumptionsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Lease Assumptions", "label": "Lessee, Operating Lease, Lease Assumptions [Table Text Block]", "terseLabel": "Weighted-Average Remaining Lease Term and Weighted-Average Discount Rate" } } }, "localname": "LesseeOperatingLeaseLeaseAssumptionsTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesTables" ], "xbrltype": "textBlockItemType" }, "omcl_LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Supplemental Cash Flow Information", "label": "Lessee, Operating Lease, Supplemental Cash Flow Information [Table Text Block]", "terseLabel": "Supplemental Cash Flow Information Related to Operating Leases" } } }, "localname": "LesseeOperatingLeaseSupplementalCashFlowInformationTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesTables" ], "xbrltype": "textBlockItemType" }, "omcl_LondonInterbankOfferingRateLIBORPlus100Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "London Interbank Offering Rate (LIBOR) Plus 1.00%", "label": "London Interbank Offering Rate (LIBOR) Plus 1.00% [Member]", "terseLabel": "LIBOR Plus 1.00%" } } }, "localname": "LondonInterbankOfferingRateLIBORPlus100Member", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_LongTermDebtTransfer": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt, Transfer", "label": "Long-Term Debt, Transfer", "terseLabel": "Balance transfer", "verboseLabel": "Balance transfer" } } }, "localname": "LongTermDebtTransfer", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_LongtermDebtRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-term Debt [Roll Forward]", "label": "Long-term Debt [Roll Forward]", "terseLabel": "Long-term Debt [Roll Forward]" } } }, "localname": "LongtermDebtRollForward", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails" ], "xbrltype": "stringItemType" }, "omcl_MeasurementInputRoyaltyRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement Input, Royalty Rate", "label": "Measurement Input, Royalty Rate [Member]", "terseLabel": "Royalty Rate" } } }, "localname": "MeasurementInputRoyaltyRateMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_NetInvestmentInSalesTypeLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Investment in Sales-Type Leases [Member]", "label": "Net Investment in Sales-Type Leases [Member]", "terseLabel": "Net investment in sales-type leases" } } }, "localname": "NetInvestmentInSalesTypeLeasesMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "omcl_OmnicellPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Omnicell Plan [Member]", "label": "Omnicell Plan [Member]", "terseLabel": "Omnicell Plan" } } }, "localname": "OmnicellPlanMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_OneTimeStockRepurchaseSeptember2020Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One-Time Stock Repurchase - September 2020", "label": "One-Time Stock Repurchase - September 2020 [Member]", "terseLabel": "One-Time Stock Repurchase Transaction" } } }, "localname": "OneTimeStockRepurchaseSeptember2020Member", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "domainItemType" }, "omcl_OtherAssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Assets, Current", "label": "Other Assets, Current [Abstract]", "terseLabel": "Other current assets:" } } }, "localname": "OtherAssetsCurrentAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "stringItemType" }, "omcl_OtherNoncashInvestingAndFinancingItemsLoanAmountTransferred": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Noncash Investing And Financing Items, Loan Amount Transferred", "label": "Other Noncash Investing And Financing Items, Loan Amount Transferred", "terseLabel": "Balance transfer from term loan to revolving credit facility" } } }, "localname": "OtherNoncashInvestingAndFinancingItemsLoanAmountTransferred", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_PaymentsforSoftwareForExternalUse": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for Software, For External Use", "label": "Payments for Software, For External Use", "negatedLabel": "Software development for external use" } } }, "localname": "PaymentsforSoftwareForExternalUse", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_PrimarySupplierMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary Supplier [Member]", "label": "Primary Supplier [Member]", "terseLabel": "Primary Supplier" } } }, "localname": "PrimarySupplierMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_ProceedsFromPaymentsForCustomerFundsNet": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From (Payments For) Customer Funds, Net", "label": "Proceeds From (Payments For) Customer Funds, Net", "terseLabel": "Change in customer funds, net" } } }, "localname": "ProceedsFromPaymentsForCustomerFundsNet", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_Q12018RestructuringPlanMemberMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Q1 2018 Restructuring Plan [Member] [Member]", "label": "Q1 2018 Restructuring Plan [Member] [Member]", "terseLabel": "Q1 2018 Restructuring Plan" } } }, "localname": "Q12018RestructuringPlanMemberMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_Q1Q22020RestructuringPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Q1-Q2 2020 Restructuring Plan", "label": "Q1-Q2 2020 Restructuring Plan [Member]", "terseLabel": "Q1-Q2 2020 Restructuring Plan" } } }, "localname": "Q1Q22020RestructuringPlanMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_Q42018RestructuringPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Q4 2018 Restructuring Plan [Member]", "label": "Q4 2018 Restructuring Plan [Member]", "terseLabel": "Q4 2018 Restructuring Plan" } } }, "localname": "Q42018RestructuringPlanMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_RestrictedStockAwardsRSAsAndRestrictedStockUnitsRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock Awards (RSAs) And Restricted Stock Units (RSUs)", "label": "Restricted Stock Awards (RSAs) And Restricted Stock Units (RSUs) [Member]", "verboseLabel": "Non-vested restricted stock awards" } } }, "localname": "RestrictedStockAwardsRSAsAndRestrictedStockUnitsRSUsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "omcl_SaleofStockAuthorizedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of Stock, Authorized Amount", "label": "Sale of Stock, Authorized Amount", "terseLabel": "Maximum aggregate offering price" } } }, "localname": "SaleofStockAuthorizedAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ScheduleOfDebtIssuanceCostsNetTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Debt Issuance Costs, Net", "label": "Schedule Of Debt Issuance Costs, Net [Table Text Block]", "terseLabel": "Changes in the Balance of Deferred Debt Issuance Costs" } } }, "localname": "ScheduleOfDebtIssuanceCostsNetTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementTables" ], "xbrltype": "textBlockItemType" }, "omcl_ScheduleOfInterestExpenseDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Interest Expense, Debt", "label": "Schedule Of Interest Expense, Debt [Table Text Block]", "terseLabel": "Summary of the Components of Interest Expense" } } }, "localname": "ScheduleOfInterestExpenseDebtTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesTables" ], "xbrltype": "textBlockItemType" }, "omcl_ScheduleofSharebasedCompensationFutureIssuanceofSharesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Share-based Compensation, Future Issuance of Shares", "label": "Schedule of Share-based Compensation, Future Issuance of Shares [Table Text Block]", "terseLabel": "Ordinary Shares Reserved for Future Issuance Under Equity Incentive Plans" } } }, "localname": "ScheduleofSharebasedCompensationFutureIssuanceofSharesTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageRemainingTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Remaining Term", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted-Average Remaining Term [Abstract]", "terseLabel": "Weighted-Average Remaining Years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageRemainingTermAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested", "terseLabel": "Awards vested by period end (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVested", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount", "terseLabel": "Maximum fair market value of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPurchased": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Purchased", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Purchased", "terseLabel": "Shares purchased under ESPP (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsPurchased", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregateIntrinsicValueAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "stringItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Term", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Term [Abstract]", "terseLabel": "Weighted-Average Remaining Years" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingTermAbstract", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "stringItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockOfferingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Offering Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Offering Period", "terseLabel": "Offering period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockOfferingPeriod", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockPurchasingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Purchasing Period", "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Purchase Price Of Common Stock, Purchasing Period", "terseLabel": "Purchasing period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePriceOfCommonStockPurchasingPeriod", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_ShareBasedCompensationArrangementbySharebasedPaymentDeterminationofPerformanceBasedAward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement by Share-based Payment, Determination of Performance Based Award", "label": "Share Based Compensation Arrangement by Share-based Payment, Determination of Performance Based Award", "terseLabel": "Percentile rank of stockholder return" } } }, "localname": "ShareBasedCompensationArrangementbySharebasedPaymentDeterminationofPerformanceBasedAward", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "omcl_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsPurchasedInPeriodWeightedAveragePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Purchased In Period, Weighted Average Price", "label": "Share-Based Compensation Arrangements By Share-Based Payment Award, Options, Purchased In Period, Weighted Average Price", "terseLabel": "Weighted-average price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsPurchasedInPeriodWeightedAveragePrice", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "omcl_ShareBasedPaymentArrangementAwardExcludingOptionCostNotYetRecognizedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Award, Excluding Option, Cost Not Yet Recognized, Amount", "label": "Share-Based Payment Arrangement, Award, Excluding Option, Cost Not Yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost" } } }, "localname": "ShareBasedPaymentArrangementAwardExcludingOptionCostNotYetRecognizedAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsEligibleforVesting": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Eligible for Vesting", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Eligible for Vesting", "terseLabel": "Awards eligible for vesting (in shares)" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsEligibleforVesting", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "omcl_SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPercentEligibleforTimebasedVesting": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Percent Eligible for Time-based Vesting", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Percent Eligible for Time-based Vesting", "terseLabel": "Percentage of shares eligible for time-based vesting" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsPercentEligibleforTimebasedVesting", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "omcl_SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsEstimatedForfeitureRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Estimated Forfeiture Rate", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Estimated Forfeiture Rate", "terseLabel": "Estimated forfeiture rate" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardFairValueAssumptionsEstimatedForfeitureRate", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "omcl_SharebasedCompensationArrangementbySharebasedPaymentAwardTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Trading Days", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Trading Days", "terseLabel": "Trading days used for stock price appreciation calculation" } } }, "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardTradingDays", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "omcl_StandardProductWarrantDescriptionDurationFollowingInstallation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard Product Warrant Description, Duration Following Installation", "label": "Standard Product Warrant Description, Duration Following Installation", "terseLabel": "Standard warranty period (up to)" } } }, "localname": "StandardProductWarrantDescriptionDurationFollowingInstallation", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "durationItemType" }, "omcl_StandardProductWarrantDurationofLimitedWarranty": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard Product Warrant, Duration of Limited Warranty", "label": "Standard Product Warrant, Duration of Limited Warranty", "terseLabel": "Limited warranty period (up to)" } } }, "localname": "StandardProductWarrantDurationofLimitedWarranty", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "durationItemType" }, "omcl_SummaryOfRevenueCategoriesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary Of Revenue Categories", "label": "Summary Of Revenue Categories [Table Text Block]", "terseLabel": "Summary of Revenue Recognition for Revenue Category" } } }, "localname": "SummaryOfRevenueCategoriesTableTextBlock", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "omcl_TechnicalServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Technical Services", "label": "Technical Services [Member]", "terseLabel": "Technical services" } } }, "localname": "TechnicalServicesMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "omcl_TenLargestGroupPurchasingOrganizationsGPOsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten Largest Group Purchasing Organizations (GPOs) [Member]", "label": "Ten Largest Group Purchasing Organizations (GPOs) [Member]", "terseLabel": "Ten Largest GPOs" } } }, "localname": "TenLargestGroupPurchasingOrganizationsGPOsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_TermLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan Facility [Member]", "label": "Term Loan Facility [Member]", "terseLabel": "Term Loan Facility", "verboseLabel": "Prior Term Loan Facility" } } }, "localname": "TermLoanFacilityMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_TransferofFinancialAssetsAccountedforasSalesReceivablefromThirdPartyLeasingCompanyAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer of Financial Assets Accounted for as Sales, Receivable from Third-Party Leasing Company, Amount", "label": "Transfer of Financial Assets Accounted for as Sales, Receivable from Third-Party Leasing Company, Amount", "terseLabel": "Accounts receivable due from third-party leasing companies for transferred non-recourse accounts receivable" } } }, "localname": "TransferofFinancialAssetsAccountedforasSalesReceivablefromThirdPartyLeasingCompanyAmount", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "omcl_TransfersBetweenPrepaidExpensesToPPE": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transfers Between Prepaid Expenses to PP&E", "label": "Transfers Between Prepaid Expenses to PP&E", "terseLabel": "Transfers from prepaid expenses to property and equipment" } } }, "localname": "TransfersBetweenPrepaidExpensesToPPE", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "omcl_U.S.GovernmentHospitalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. Government Hospitals [Member]", "label": "U.S. Government Hospitals [Member]", "terseLabel": "U.S. Government Hospitals" } } }, "localname": "U.S.GovernmentHospitalsMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_WellsFargoBankNationalAssociationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wells Fargo Bank, National Association [Member]", "label": "Wells Fargo Bank, National Association [Member]", "terseLabel": "Wells Fargo Bank" } } }, "localname": "WellsFargoBankNationalAssociationMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "omcl_WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wells Fargo Securities, LLC, Citizens Bank, N.A. And JPMorgan Chase Bank, N.A", "label": "Wells Fargo Securities, LLC, Citizens Bank, N.A. And JPMorgan Chase Bank, N.A [Member]", "terseLabel": "Wells Fargo Securities, Citizens Bank and JP Morgan Chase Bank" } } }, "localname": "WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember", "nsuri": "http://www.omnicell.com/20201231", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r139", "r146", "r216", "r480", "r481", "r482", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect of a Change in Accounting Principle" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r139", "r146", "r216", "r480", "r481", "r482", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r139", "r146", "r216", "r480", "r481", "r482", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r208", "r338", "r344", "r691" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r427", "r437", "r642", "r643", "r644", "r646", "r647", "r648", "r650", "r688", "r692" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails", "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r427", "r437", "r642", "r643", "r644", "r646", "r647", "r648", "r650", "r688", "r692" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails", "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r208", "r338", "r344", "r691" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_OfficerMember": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Person with designation of officer.", "label": "Officer [Member]", "terseLabel": "Officer" } } }, "localname": "OfficerMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r205", "r338", "r342", "r652", "r687", "r689" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r205", "r338", "r342", "r652", "r687", "r689" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r376", "r427", "r437", "r642", "r643", "r644", "r646", "r647", "r648", "r650", "r688", "r692" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails", "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r376", "r427", "r437", "r642", "r643", "r644", "r646", "r647", "r648", "r650", "r688", "r692" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails", "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": { "auth_ref": [ "r739" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.", "label": "Condensed Balance Sheet [Table Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": { "auth_ref": [ "r134", "r738" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]", "terseLabel": "Schedule II Valuation and Qualifying Accounts" } } }, "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccounts" ], "xbrltype": "textBlockItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r206", "r207", "r338", "r343", "r690", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r206", "r207", "r338", "r343", "r690", "r707", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r736", "r737" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r209", "r640" ], "lang": { "en-us": { "role": { "documentation": "Information by title of individual or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Axis]", "terseLabel": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Title of individual, or nature of relationship to individual or group of individuals.", "label": "Title of Individual [Domain]", "terseLabel": "Relationship to Entity [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ValuationAndQualifyingAccountsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]" } } }, "localname": "ValuationAndQualifyingAccountsAbstract", "nsuri": "http://fasb.org/srt/2020-01-31", "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "srt_ValuationAndQualifyingAccountsDisclosureTable": { "auth_ref": [ "r134", "r738" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]", "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]" } } }, "localname": "ValuationAndQualifyingAccountsDisclosureTable", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdateExtensibleList": { "auth_ref": [ "r140", "r141", "r142", "r143", "r213", "r214", "r215", "r216", "r217", "r218", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r524", "r525", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r702", "r703", "r704" ], "lang": { "en-us": { "role": { "documentation": "Indicates amendment to accounting standards.", "label": "Accounting Standards Update [Extensible List]", "terseLabel": "Accounting Standards Update [Extensible List]" } } }, "localname": "AccountingStandardsUpdateExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "extensibleListItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts receivable and unbilled receivables" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accrued Liabilities, Current [Abstract]", "terseLabel": "Accrued liabilities:" } } }, "localname": "AccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r275" ], "calculation": { "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedTerseLabel": "Accumulated depreciation and amortization", "verboseLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r64", "r65", "r66", "r70", "r71" ], "lang": { "en-us": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]", "terseLabel": "Unrealized gain (loss) on interest rate swap hedges" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r26", "r68", "r69", "r70", "r676", "r700", "r704" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r593", "r594", "r595", "r596", "r597", "r599" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r67", "r70", "r71", "r136", "r137", "r138", "r565", "r695", "r696" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "verboseLabel": "Accumulated other comprehensive income (loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r62", "r70", "r71", "r565", "r594", "r595", "r596", "r597", "r599" ], "lang": { "en-us": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Indefinite-lived Intangible Assets [Line Items]", "terseLabel": "Acquired Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of non-cash activities" } } }, "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r24", "r483" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r136", "r137", "r138", "r480", "r481", "r482" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Tax payments related to restricted stock units" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r304", "r310", "r523" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature", "terseLabel": "Equity component of convertible senior note issuance, net of issuance costs" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r439", "r441", "r486", "r487" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r295", "r304", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Sale of warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r441", "r472", "r485" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r30", "r210", "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable and unbilled receivables, net of allowance", "verboseLabel": "Accounts receivable and unbilled receivables" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesSummaryofAllowanceforCreditLossesbyAssetTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r89", "r108", "r601" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of discount on convertible senior notes" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r84", "r108", "r603" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "negatedLabel": "Amortization", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r108", "r258", "r267" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive weighted-average shares related to stock award plans (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r120", "r188", "r197", "r203", "r212", "r561", "r566", "r591", "r658", "r673" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r59", "r120", "r212", "r561", "r566", "r591" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsLeasedToOthersMember": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable property, plant or equipment held for lease to others under contractual agreements meeting the criteria for operating lease classification.", "label": "Assets Leased to Others [Member]", "terseLabel": "Leased Equipment under Operating Leases" } } }, "localname": "AssetsLeasedToOthersMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r443", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r575", "r578" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BridgeLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing which is expected to be replaced by a medium to long-term loan. The loan \"bridges\" the gap in time when otherwise no financing would be in place.", "label": "Bridge Loan [Member]", "terseLabel": "Swing Line Loan" } } }, "localname": "BridgeLoanMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r420", "r433" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r420", "r433", "r542", "r543" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Pro Forma Financial Information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r557" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Goodwill expected to be deductible for tax purposes" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r540", "r541" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Pro forma net income" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r540", "r541" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Pro forma revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Business Combination, Acquisition Related Costs", "terseLabel": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r554", "r555", "r556" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r558" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r539" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of earnings or loss of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual", "verboseLabel": "Earnings from operations since the acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "auth_ref": [ "r539" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the amount of revenue of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual", "terseLabel": "Revenue from operations since the acquisition date" } } }, "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "totalLabel": "Total current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other", "terseLabel": "Other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "terseLabel": "Long-term deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r544", "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total purchase price" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r544", "r545" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Property and equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r117", "r537" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy [Policy Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r113", "r114", "r115" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Unpaid purchases of property and equipment" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalLeasesIncomeStatementSalesTypeLeaseRevenue": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": 1.0, "parentTag": "omcl_CapitalLeasesIncomeStatementSellingProfitLossSalesTypeLease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue realized in the period on sales type leases.", "label": "Capital Leases, Income Statement, Sales Type Lease Revenue", "terseLabel": "Sales-type lease revenues" } } }, "localname": "CapitalLeasesIncomeStatementSalesTypeLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "auth_ref": [ "r724", "r726" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for amortization of capitalized computer software costs.", "label": "Capitalized Computer Software, Amortization", "terseLabel": "Amortization of capitalized software development costs" } } }, "localname": "CapitalizedComputerSoftwareAmortization1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r723" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Computer Software, Net", "terseLabel": "Capitalized software, net" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwarePeriodIncreaseDecrease": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in capitalized computer software costs.", "label": "Capitalized Computer Software, Period Increase (Decrease)", "verboseLabel": "Software development costs capitalized" } } }, "localname": "CapitalizedComputerSoftwarePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostAmortizationPeriod": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Capitalized Contract Cost, Amortization Period", "terseLabel": "Amortization period for capitalized contract costs" } } }, "localname": "CapitalizedContractCostAmortizationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_CapitalizedContractCostImpairmentLoss": { "auth_ref": [ "r248" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.", "label": "Capitalized Contract Cost, Impairment Loss", "terseLabel": "Impairment loss related to capitalized prepaid commissions" } } }, "localname": "CapitalizedContractCostImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedContractCostNetNoncurrent": { "auth_ref": [ "r247" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.", "label": "Capitalized Contract Cost, Net, Noncurrent", "terseLabel": "Prepaid commissions" } } }, "localname": "CapitalizedContractCostNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r35", "r110" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Cash and Cash Equivalents [Line Items]", "terseLabel": "Cash and Cash Equivalents [Line Items]" } } }, "localname": "CashAndCashEquivalentsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r13", "r111", "r117" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r103", "r110", "r116" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Cash, cash equivalents, and restricted cash at end of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]", "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets:" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r103", "r592" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r35" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r311", "r312", "r313", "r314" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r316", "r440" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Strike price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Options and warrants to purchase shares (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r51", "r286", "r663", "r681" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 13)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r117", "r288", "r708", "r709" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": { "auth_ref": [ "r285", "r287", "r289" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments, contingencies, and guarantees.", "label": "Commitments Contingencies and Guarantees [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsContingenciesAndGuaranteesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Shares reserved for future issuance (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r304" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balance (in shares)", "periodStartLabel": "Balance (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.001 par value, 100,000 shares authorized; 52,677 and 51,277 shares issued; 42,783 and 42,132 shares outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r350", "r353", "r438", "r488" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefits and Share-Based Compensation" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components of Deferred Tax Assets and Liabilities [Abstract]", "terseLabel": "Deferred tax assets (liabilities):" } } }, "localname": "ComponentsOfDeferredTaxAssetsAndLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r74", "r76", "r77", "r82", "r666", "r683" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and related software" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r177", "r178", "r208", "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r177", "r178", "r208", "r589", "r590", "r705" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r177", "r178", "r208", "r589", "r590", "r705" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r177", "r178", "r208", "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r177", "r178", "r208", "r589", "r590" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r117", "r563" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent": { "auth_ref": [ "r222", "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, Allowance for Credit Loss, Noncurrent", "terseLabel": "Long-term unbilled receivables" } } }, "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLossNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesSummaryofAllowanceforCreditLossesbyAssetTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Contract Assets and Liabilities" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNet": { "auth_ref": [ "r318", "r320", "r339" ], "calculation": { "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "totalLabel": "Total contract assets" } } }, "localname": "ContractWithCustomerAssetNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r318", "r320", "r339" ], "calculation": { "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Short-term unbilled receivables" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetNetNoncurrent": { "auth_ref": [ "r318", "r320", "r339" ], "calculation": { "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerAssetNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as noncurrent.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent", "terseLabel": "Long-term unbilled receivables" } } }, "localname": "ContractWithCustomerAssetNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r318", "r319", "r339" ], "calculation": { "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Deferred revenues, net of cost of goods sold", "totalLabel": "Total contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r318", "r319", "r339" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "netLabel": "Deferred revenues, net of cost of goods sold, expected to be completed within one year", "terseLabel": "Deferred revenues, net", "verboseLabel": "Short-term deferred revenues, net" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails", "http://www.omnicell.com/role/RevenuesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "auth_ref": [ "r318", "r319", "r339" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_ContractWithCustomerLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.", "label": "Contract with Customer, Liability, Noncurrent", "terseLabel": "Long-term deferred revenues", "verboseLabel": "Long-term deferred revenues" } } }, "localname": "ContractWithCustomerLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/RevenuesContractAssetsandLiabilitiesDetails", "http://www.omnicell.com/role/RevenuesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Deferred revenues recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]", "terseLabel": "Convertible Debt" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Convertible Debt [Table Text Block]", "terseLabel": "Convertible Debt Balances" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r49" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "terseLabel": "Convertible senior notes, net" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r86", "r652" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of revenues" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsSoldSalesTypeLease": { "auth_ref": [ "r170", "r634" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeLeaseSellingProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of goods sold for sales-type financing lease.", "label": "Cost of Goods Sold, Sales-type Lease", "negatedLabel": "Cost of sales-type lease revenues" } } }, "localname": "CostOfGoodsSoldSalesTypeLease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of product and service revenues" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossFinancialInstrumentPolicyTextBlock": { "auth_ref": [ "r219", "r220", "r221", "r223", "r224", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security. Includes, but is not limited to, methodology used to estimate allowance for credit loss, how writeoff of uncollectible amount is recognized, and determination of past due status and nonaccrual status.", "label": "Credit Loss, Financial Instrument [Policy Text Block]", "terseLabel": "Allowance for Credit Losses" } } }, "localname": "CreditLossFinancialInstrumentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r121", "r519", "r528" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r125", "r519" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r519", "r528", "r530" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Total current income taxes" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r121", "r519", "r528" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State and Local Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r176", "r208" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r552" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt and Credit Agreement", "verboseLabel": "Convertible Senior Notes" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotes", "http://www.omnicell.com/role/DebtandCreditAgreements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r16", "r17", "r18", "r659", "r661", "r672" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Spread on variable interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r18", "r297", "r661", "r672" ], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 3.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r296" ], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component", "terseLabel": "Equity component of convertible senior notes", "totalLabel": "Convertible senior notes, equity component" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r48", "r305", "r306", "r308" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument, Convertible, Conversion Ratio", "terseLabel": "Conversion ratio" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period", "terseLabel": "Remaining life of debt discount and issuance cost accretion" } } }, "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days", "terseLabel": "Threshold consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "terseLabel": "Threshold percentage of stock price trigger" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument, Convertible, Threshold Trading Days", "terseLabel": "Threshold trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r602", "r604" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Aggregate principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r47", "r301", "r602" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period [Axis]" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument, Redemption, Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period [Domain]" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period One [Member]", "terseLabel": "Period 1" } } }, "localname": "DebtInstrumentRedemptionPeriodOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument, Redemption, Period Two [Member]", "terseLabel": "Period 2" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r669" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Repurchase price as a percent of principal amount" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r49", "r122", "r305", "r307", "r308", "r309", "r601", "r602", "r604", "r670" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Term of debt instrument" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r601", "r604" ], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "negatedTerseLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r117", "r292" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt, Policy [Policy Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r520", "r528" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r40", "r603" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "verboseLabel": "Deferred debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r520", "r528" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r493", "r494" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Long-term deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r108", "r121", "r520", "r528", "r529", "r530" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "totalLabel": "Total deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r19", "r20", "r509", "r660", "r671" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r493", "r494" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Long-term deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r109" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes and Tax Credits", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r520", "r528" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "terseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred revenues" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r510" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets, Inventory", "terseLabel": "Inventory-related items" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r512" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Total net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "terseLabel": "Loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets, Other", "terseLabel": "Other, net" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r515", "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets, Tax Credit Carryforwards", "terseLabel": "Tax credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "terseLabel": "Share-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals", "terseLabel": "Reserves and accruals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r511" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedTerseLabel": "Valuation allowance", "terseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails", "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r494", "r512" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedTotalLabel": "Net deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.", "label": "Deferred Tax Liabilities, Leasing Arrangements", "negatedLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesLeasingArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities, Other", "negatedLabel": "Prepaid expenses" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r517", "r518" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedTerseLabel": "Depreciation and amortization" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesSignificantComponentsofDeferredTaxAssetsLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r418" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Defined Contribution Plan, Cost", "terseLabel": "401(k) contributions" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage employer matches of the employee's percentage contribution matched.", "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match", "terseLabel": "Employer matching contribution, percent of employee contribution" } } }, "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r108", "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation and amortization expense of property and equipment", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/PropertyandEquipmentNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r108", "r186" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeBasisSpreadOnVariableRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.", "label": "Derivative, Basis Spread on Variable Rate", "terseLabel": "Variable rate floor" } } }, "localname": "DerivativeBasisSpreadOnVariableRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Fixed interest rate" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r576", "r577", "r579", "r581" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r570", "r572" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative, Notional Amount", "terseLabel": "Notional amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r117", "r126", "r569", "r571", "r573", "r574", "r582" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "terseLabel": "Interest Rate Swap Agreements" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r338", "r342", "r343", "r344", "r345", "r346", "r347", "r348" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenues by Revenue Type and Geographic Region" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RevenuesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]", "terseLabel": "Internal Revenue Service (IRS)" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r83", "r144", "r145", "r146", "r147", "r148", "r153", "r155", "r160", "r161", "r162", "r166", "r167", "r667", "r684" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)", "verboseLabel": "Net income per share - basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Net income per share:" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]", "terseLabel": "Weighted-average shares outstanding:" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r83", "r144", "r145", "r146", "r147", "r148", "r155", "r160", "r161", "r162", "r166", "r167", "r667", "r684" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Net income per share - diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r117", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r163", "r164", "r165", "r168" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Income Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r592" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r45" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Weighted average period of compensation cost recognized" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "terseLabel": "Total unrecognized compensation cost" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized compensation cost of unvested stock options" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r472" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Expense, Tax Benefit", "terseLabel": "Income tax benefit from share-based compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Severance Costs and Related Expenses" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP", "verboseLabel": "ESPP shares available for future issuance" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-based Payment Arrangement, Option [Member]", "terseLabel": "Stock Options", "verboseLabel": "Share options outstanding" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Equipment" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]", "terseLabel": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r136", "r137", "r138", "r141", "r149", "r151", "r171", "r216", "r304", "r310", "r480", "r481", "r482", "r524", "r525", "r593", "r594", "r595", "r596", "r597", "r599", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r586" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Hierarchy" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r117", "r587", "r588" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r584" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "terseLabel": "Federal Funds" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated useful lives of intangible assets", "verboseLabel": "Useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "terseLabel": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r268" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r268" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r268" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r268" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r268" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r259", "r262", "r266", "r269", "r653", "r654" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency exchange rate fluctuations" } } }, "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r266", "r654" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r259", "r265" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r266", "r653" ], "calculation": { "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total", "verboseLabel": "Net carrying amount" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsEstimatedFutureAmortizationExpenseforIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]", "terseLabel": "Foreign Tax Authority" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r117", "r600" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation and Remeasurement" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FundsHeldForClients": { "auth_ref": [ "r58" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the funds held on behalf of others and that are expected to be liquidated within one year or the normal operating cycle, if longer. This does not include funds held under reinsurance agreements.", "label": "Funds Held for Clients", "terseLabel": "Funds held for customers, including restricted cash" } } }, "localname": "FundsHeldForClients", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and fixtures" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r108" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedTerseLabel": "Loss on disposal of property and equipment" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r249", "r250", "r657" ], "calculation": { "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 }, "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r252" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill, Acquired During Period", "terseLabel": "Additions" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r117", "r255", "r263" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill and Acquired Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r253" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Foreign Currency Translation Gain (Loss)", "terseLabel": "Foreign currency exchange rate fluctuations" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r251", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "terseLabel": "Accumulated impairment loss on goodwill" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]", "terseLabel": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsChangesintheCarryingAmountofGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r85", "r120", "r188", "r196", "r199", "r202", "r204", "r212", "r591" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "auth_ref": [ "r117", "r288" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.", "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]", "terseLabel": "Guarantees" } } }, "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r124", "r531" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r80", "r188", "r196", "r199", "r202", "r204", "r655", "r664", "r668", "r685" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r124", "r531" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesGeographicalBreakdownofIncomeLossbeforetheProvisionforIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r277" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r497", "r507", "r514", "r526", "r532", "r534", "r535", "r536" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.", "label": "Income Tax Examination, Penalties and Interest Accrued", "terseLabel": "Interest and penalties accrued" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r121", "r150", "r151", "r187", "r495", "r527", "r533", "r686" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for (benefit from) income taxes", "totalLabel": "Total provision for (benefit from) income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails", "http://www.omnicell.com/role/IncomeTaxesProvisionForBenefitFromIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r78", "r117", "r491", "r492", "r507", "r508", "r513", "r521", "r710" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Accounting for Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 11.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for extraterritorial income exclusion.", "label": "Effective Income Tax Rate Reconciliation, Deduction, Extraterritorial Income Exclusion, Amount", "negatedTerseLabel": "Foreign derived intangible income deduction" } } }, "localname": "IncomeTaxReconciliationDeductionsExtraterritorialIncomeExclusion", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount", "terseLabel": "Foreign rate differential" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 10.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "terseLabel": "U.S. federal tax provision at statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 7.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount", "terseLabel": "Share-based compensation tax benefit" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherReconcilingItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 5.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "terseLabel": "State taxes" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxContingencies": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 6.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.", "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount", "terseLabel": "Uncertain tax positions" } } }, "localname": "IncomeTaxReconciliationTaxContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "auth_ref": [ "r496" ], "calculation": { "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails": { "order": 4.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount", "negatedTerseLabel": "Research tax credits" } } }, "localname": "IncomeTaxReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesDifferencebetweentheProvisionForBenefitFromIncomeTaxesComparedtoIncomeTaxesComputedattheStatutoryFederalTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes, net of refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable and unbilled receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenues" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase (Decrease) in Employee Related Liabilities", "terseLabel": "Accrued compensation" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInLeasingReceivables": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from lessees arising from lease agreements.", "label": "Increase (Decrease) in Leasing Receivables", "negatedLabel": "Investment in sales-type leases" } } }, "localname": "IncreaseDecreaseInLeasingReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentAssets": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current assets classified as other.", "label": "Increase (Decrease) in Other Current Assets", "negatedLabel": "Other current assets" } } }, "localname": "IncreaseDecreaseInOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.", "label": "Increase (Decrease) in Other Noncurrent Assets", "negatedLabel": "Other long-term assets" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r156", "r157", "r158", "r162" ], "calculation": { "http://www.omnicell.com/role/NetIncomePerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Effect of dilutive securities from stock award plans (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r261", "r547" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed information about the characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.", "label": "Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table]", "terseLabel": "Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "IndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Indefinite-lived Intangible Assets Acquired", "terseLabel": "Fair value of purchased intangible assets" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r257", "r264" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r89", "r302" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r90" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "terseLabel": "Contractual coupon interest" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r101", "r104", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r32", "r241" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "verboseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r56" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Total inventories", "verboseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetItemsNetOfReserveAlternativeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory, Net, Items Net of Reserve Alternative [Abstract]", "terseLabel": "Inventories:" } } }, "localname": "InventoryNetItemsNetOfReserveAlternativeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r12", "r57", "r117", "r169", "r239", "r240", "r242" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "terseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r34", "r241" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "verboseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r33", "r241" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "verboseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r614" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r612" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Lessee Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r620" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Maturity Schedule of Future Minimum Lease Payments under Operating Leases and\u00a0the Reconciliation to the Operating Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total operating lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r620" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Present value adjustment" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r613" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Term of Contract", "terseLabel": "Term of operating leases" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r622" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Lessee Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessor, Lease, Description [Line Items]", "terseLabel": "Lessor, Lease, Description [Line Items]" } } }, "localname": "LessorLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeaseDescriptionTable": { "auth_ref": [ "r631" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessor's leases.", "label": "Lessor, Lease, Description [Table]", "terseLabel": "Lessor, Lease, Description [Table]" } } }, "localname": "LessorLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LessorLeasesPolicyTextBlock": { "auth_ref": [ "r626", "r632", "r633", "r638" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor.", "label": "Lessor, Leases [Policy Text Block]", "terseLabel": "Lessor Leases" } } }, "localname": "LessorLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceived": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payments to be received by lessor for operating lease.", "label": "Lessor, Operating Lease, Payments to be Received", "totalLabel": "Total future minimum operating lease payments" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Five", "terseLabel": "2025" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Four", "terseLabel": "2024" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": { "auth_ref": [ "r628" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.", "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Maturity Schedule of Future Minimum Lease Payments under Operating Leases" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year One", "terseLabel": "2021" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Three", "terseLabel": "2023" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r628" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessor, Operating Lease, Payment to be Received, Year Two", "terseLabel": "2022" } } }, "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseRenewalTerm": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Renewal Term", "terseLabel": "Operating lease renewal terms" } } }, "localname": "LessorOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Term of operating leases" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorSalesTypeLeaseTermOfContract1": { "auth_ref": [ "r630" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's sales-type lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Sales-type Lease, Term of Contract", "terseLabel": "Term of sales-type leases" } } }, "localname": "LessorSalesTypeLeaseTermOfContract1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LessorSalesTypeLeasesTextBlock": { "auth_ref": [ "r639" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of lessor's sales-type leases.", "label": "Lessor, Sales-type Leases [Text Block]", "terseLabel": "Lessor Leases" } } }, "localname": "LessorSalesTypeLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r44", "r120", "r198", "r212", "r562", "r566", "r567", "r591" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r120", "r212", "r591", "r662", "r678" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r46", "r120", "r212", "r562", "r566", "r567", "r591" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r42", "r122" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]", "terseLabel": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]", "terseLabel": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Commitment fee rate on undrawn commitments" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]", "terseLabel": "LIBOR" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r18", "r298", "r661", "r674" ], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "netLabel": "Outstanding balance", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "terseLabel": "Carrying value of debt", "totalLabel": "Convertible senior notes, liability component" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Fair value of long-term debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLineOfCredit": { "auth_ref": [ "r49", "r290", "r291" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit, Noncurrent", "terseLabel": "Revolving credit facility" } } }, "localname": "LongTermLineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r49", "r293" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/ConvertibleSeniorNotesSummaryoftheComponentsofInterestExpenseDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]", "terseLabel": "Discount Rate" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r585" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInValuationAllowancesAndReservesRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]", "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]" } } }, "localname": "MovementInValuationAllowancesAndReservesRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r103" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r103" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r103", "r105", "r109" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r72", "r75", "r81", "r109", "r120", "r140", "r144", "r145", "r146", "r147", "r150", "r151", "r159", "r188", "r196", "r199", "r202", "r204", "r212", "r591", "r665", "r682" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r623" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease.", "label": "Net Investment in Lease", "totalLabel": "Net investment in sales-type leases" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseCurrent": { "auth_ref": [ "r623", "r624" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 }, "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease, classified as current.", "label": "Net Investment in Lease, Current", "negatedLabel": "Less: current portion", "terseLabel": "Net investment in sales-type leases, current portion" } } }, "localname": "NetInvestmentInLeaseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseNoncurrent": { "auth_ref": [ "r623", "r624" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentInLease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net investment in sales-type and direct financing lease, classified as noncurrent.", "label": "Net Investment in Lease, Noncurrent", "terseLabel": "Long-term investment in sales-type leases, net", "verboseLabel": "Long-term investment in sales-type leases, net" } } }, "localname": "NetInvestmentInLeaseNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Authoritative and Recently Issued Authoritative Guidance" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "Rest of world" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r88" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Interest and other income (expense), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.", "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Awards Activity" } } }, "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reporting segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number of Reporting Units", "terseLabel": "Number of reporting units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "auth_ref": [ "r70", "r79" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent.", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "terseLabel": "Other comprehensive income (loss) before reclassifications" } } }, "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r188", "r196", "r199", "r202", "r204" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r615", "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncome": { "auth_ref": [ "r170", "r625", "r636" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income", "terseLabel": "Rental income" } } }, "localname": "OperatingLeaseLeaseIncome", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r170", "r636" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from operating lease.", "label": "Operating Lease, Lease Income [Table Text Block]", "terseLabel": "Income Recognized from Operating Leases" } } }, "localname": "OperatingLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r609" ], "calculation": { "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "totalLabel": "Total operating lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r609" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 }, "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current portion", "verboseLabel": "Current portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r610" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r609" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term operating lease liabilities", "verboseLabel": "Long-term portion of operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/LesseeLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderOperatingLeasesandtheReconciliationtotheOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r611", "r616" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r608" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r619", "r621" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r618", "r621" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesWeightedAverageRemainingLeaseTermandWeightedAverageDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesIncomeStatementLeaseRevenue": { "auth_ref": [ "r607" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of revenue recognized for the period from operating leases, including minimum lease revenue, contingent revenue, percentage revenue and sublease revenue.", "label": "Operating Leases, Income Statement, Lease Revenue", "terseLabel": "Rental income" } } }, "localname": "OperatingLeasesIncomeStatementLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": { "auth_ref": [ "r605", "r606", "r639" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for lessor's operating leases.", "label": "Lessor, Operating Leases [Text Block]", "terseLabel": "Lessor Leases" } } }, "localname": "OperatingLeasesOfLessorDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeases" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r515" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrderOrProductionBacklogMember": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Orders, production or production backlog arising from contracts such as purchase or sales orders acquired in a business combination.", "label": "Order or Production Backlog [Member]", "verboseLabel": "Backlog" } } }, "localname": "OrderOrProductionBacklogMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r135", "r152", "r182", "r568" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Organization and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r11", "r45" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "verboseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r58" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Other current assets", "totalLabel": "Total other current assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r575", "r583" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Other Assets" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherAssetsMiscellaneousCurrent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.", "label": "Other Assets, Miscellaneous, Current", "terseLabel": "Other current assets" } } }, "localname": "OtherAssetsMiscellaneousCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMiscellaneousNoncurrent": { "auth_ref": [], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.", "label": "Other Assets, Miscellaneous, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsMiscellaneousNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets", "totalLabel": "Total other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets, Noncurrent [Abstract]", "terseLabel": "Other long-term assets:" } } }, "localname": "OtherAssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": { "auth_ref": [ "r63", "r68" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax", "terseLabel": "Unrealized loss on interest rate swap contracts, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r61" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of reclassification adjustments:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r73", "r76", "r559", "r560", "r564" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "totalLabel": "Other comprehensive income (loss)", "verboseLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "http://www.omnicell.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r575", "r583" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other Current Assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r403", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423" ], "lang": { "en-us": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Postretirement Benefit Plan" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PatentsMember": { "auth_ref": [ "r553" ], "lang": { "en-us": { "role": { "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.", "label": "Patents [Member]", "terseLabel": "Patents" } } }, "localname": "PatentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForHedgeFinancingActivities": { "auth_ref": [ "r98", "r106" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.", "label": "Payments for Hedge, Financing Activities", "negatedTerseLabel": "Purchase of convertible note hedge" } } }, "localname": "PaymentsForHedgeFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r95" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Stock repurchases", "terseLabel": "Aggregate purchase price for repurchased shares" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r102", "r279" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "terseLabel": "Restructuring payments" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r97" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payments for debt issuance costs for revolving credit facility", "terseLabel": "Additions", "verboseLabel": "Debt issuance costs incurred and capitalized" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheBalanceofDeferredDebtIssuanceCostsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r98" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "terseLabel": "Issuance costs on sales of common stock" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r95" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedLabel": "Employees\u2019 taxes paid related to restricted stock units" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r91" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Business acquisition" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r92" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToSuppliers": { "auth_ref": [ "r99", "r100" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of cash to suppliers for goods and services during the current period.", "label": "Payments to Suppliers", "terseLabel": "Purchases from suppliers" } } }, "localname": "PaymentsToSuppliers", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "netLabel": "PSUs", "verboseLabel": "Performance-Based Restricted Stock" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r443", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValueOutstanding": { "auth_ref": [ "r21" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.", "label": "Preferred Stock, Value, Outstanding", "terseLabel": "Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued" } } }, "localname": "PreferredStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r7", "r244", "r245" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r5", "r7", "r243", "r245" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid income taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification, Comparability Adjustment [Policy Text Block]", "terseLabel": "Reclassifications and Adjustments" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r94" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from Convertible Debt", "terseLabel": "Proceeds from issuance of convertible senior notes, net of issuance costs" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r93" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from Issuance of Common Stock", "terseLabel": "At the market equity offering, net of offering costs" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r93", "r475" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised", "terseLabel": "Proceeds from issuances under stock-based compensation plans" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r93" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from sale of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r94", "r123" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from revolving credit facility" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product revenues" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r38", "r276" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Property, Plant and Equipment, Type [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r278", "r711", "r712", "r713" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r37", "r274" ], "calculation": { "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "verboseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails", "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment [Member]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r14", "r15", "r276", "r680" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "netLabel": "Property and equipment, net", "totalLabel": "Total property and equipment, net", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails", "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r36", "r117", "r276", "r711", "r712" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r14", "r276" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "netLabel": "Estimated Useful Lives of Assets", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesTables", "http://www.omnicell.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r14", "r274" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Property, Plant and Equipment, Type [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "terseLabel": "Useful life of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Non-cancelable purchase commitments", "verboseLabel": "Minimum required purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CommitmentsandContingenciesDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year One", "terseLabel": "Non-cancelable purchase commitments expected to be paid within the next twelve months" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r23", "r31", "r679", "r706" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables, Net, Current", "terseLabel": "Accounts receivable and unbilled receivables, net of allowances of $4,286 and $3,227, respectively" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "auth_ref": [ "r70", "r79" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent.", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "negatedTerseLabel": "Amounts reclassified from other comprehensive income (loss), net of tax" } } }, "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]", "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r96" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedLabel": "Repayments", "negatedTerseLabel": "Repayment of debt and revolving credit facility" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows", "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r489", "r725" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research and Development Expense [Member]", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": { "auth_ref": [ "r39", "r117", "r270", "r271", "r725" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.", "label": "Research, Development, and Computer Software, Policy [Policy Text Block]", "terseLabel": "Software Development Costs" } } }, "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research Tax Credit Carryforward [Member]", "terseLabel": "Research Tax Credit Carryforward" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCash": { "auth_ref": [ "r116", "r656", "r675" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Stock Awards", "verboseLabel": "RSAs" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "netLabel": "RSUs" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]", "terseLabel": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring Expenses" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCosts": { "auth_ref": [ "r108" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Costs", "terseLabel": "Restructuring expenses" } } }, "localname": "RestructuringCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]", "terseLabel": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]", "terseLabel": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r279", "r282" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "terseLabel": "Unpaid balance related to restructuring plan" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r310", "r483", "r677", "r699", "r704" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r136", "r137", "r138", "r141", "r149", "r151", "r216", "r480", "r481", "r482", "r524", "r525", "r695", "r697" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanNameAxis": { "auth_ref": [ "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r437" ], "lang": { "en-us": { "role": { "documentation": "Information by name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Axis]", "terseLabel": "Retirement Plan Name [Axis]" } } }, "localname": "RetirementPlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanNameDomain": { "auth_ref": [ "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r437" ], "lang": { "en-us": { "role": { "documentation": "Name of plan designed to provide retirement benefits. Includes, but is not limited to, legal name of defined benefit and defined contribution plans.", "label": "Retirement Plan Name [Domain]", "terseLabel": "Retirement Plan Name [Domain]" } } }, "localname": "RetirementPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r403", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r433", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397", "r399", "r400", "r401", "r402", "r403", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r433", "r434", "r435", "r436" ], "lang": { "en-us": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r184", "r185", "r195", "r200", "r201", "r205", "r206", "r208", "r337", "r338", "r652" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenues", "verboseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/RevenuesDisaggregationofRevenuesbyRevenueTypeDetails", "http://www.omnicell.com/role/RevenuesDissagregationofRevenuesbyGeographicRegionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r118", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition and Shipping Costs" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r341", "r349" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenues" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/Revenues" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.", "label": "Revenue, Performance Obligation, Description of Timing", "terseLabel": "Recognition period" } } }, "localname": "RevenuePerformanceObligationDescriptionOfTiming", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "verboseLabel": "Current Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsChangesintheCarryingAmountofDebtObligationsDetails", "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r617", "r621" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LesseeLeasesSupplementalCashFlowInformationRelatedtoOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Gross proceeds from sales of common stock" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Number of shares sold (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Price per share sold (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r177", "r208" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenues" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivable": { "auth_ref": [ "r627", "r637" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails_1": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Present value of lease payments not yet received by lessor and amount expected to be derived from underlying asset, following end of lease term guaranteed by lessee or other third party unrelated to lessor, from sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable", "verboseLabel": "Total net investment in sales-type leases" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock": { "auth_ref": [ "r627" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received on annual basis for sales-type and direct financing leases receivable. Includes, but is not limited to, reconciliation to lease receivable recognized in statement of financial position.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Maturity [Table Text Block]", "terseLabel": "Maturity Schedule of Future Minimum Lease Payments under Sales-Type Leases" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Payments to be Received", "terseLabel": "Net minimum lease payments to be received", "totalLabel": "Total future minimum sales-type lease payments" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails", "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Five", "terseLabel": "2025" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFiveYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Four", "terseLabel": "2024" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year One", "terseLabel": "2021" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, after Year Five", "terseLabel": "Thereafter" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThereafter", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Three", "terseLabel": "2023" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted cash flows to be received by lessor for sales-type and direct financing leases in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Sales-Type and Direct Financing Leases, Lease Receivable, to be Received, Year Two", "terseLabel": "2022" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount": { "auth_ref": [ "r627" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails_1": { "order": 1.0, "parentTag": "us-gaap_SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of undiscounted lease receivable in excess of discounted receivable for sales-type and direct financing leases.", "label": "Sales-type and Direct Financing Leases, Lease Receivable, Undiscounted Excess Amount", "negatedLabel": "Less: Unearned interest income portion", "negatedTerseLabel": "Present value adjustment" } } }, "localname": "SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesComponentsofSalesTypeLeaseReceivablesDetails", "http://www.omnicell.com/role/LessorLeasesMaturityScheduleofFutureMinimumLeasePaymentsunderSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable": { "auth_ref": [ "r170", "r635" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income from lease receivable of sales-type lease.", "label": "Sales-type Lease, Interest Income, Lease Receivable", "terseLabel": "Interest income on sales-type lease receivables" } } }, "localname": "SalesTypeLeaseInterestIncomeLeaseReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseLeaseIncomeTableTextBlock": { "auth_ref": [ "r170", "r636" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of components of income from sales-type lease.", "label": "Sales-type Lease, Lease Income [Table Text Block]", "terseLabel": "Income Recognized from Sales-Type Leases" } } }, "localname": "SalesTypeLeaseLeaseIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss": { "auth_ref": [ "r222", "r225", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on net investment in sales-type lease.", "label": "Sales-type Lease, Net Investment in Lease, Allowance for Credit Loss", "terseLabel": "Net investment in sales-type leases" } } }, "localname": "SalesTypeLeaseNetInvestmentInLeaseAllowanceForCreditLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesSummaryofAllowanceforCreditLossesbyAssetTypeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseRevenue": { "auth_ref": [ "r170", "r634" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_SalesTypeLeaseSellingProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sales-type lease revenue.", "label": "Sales-type Lease, Revenue", "terseLabel": "Sales-type lease revenues" } } }, "localname": "SalesTypeLeaseRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesTypeLeaseSellingProfitLoss": { "auth_ref": [ "r170", "r634" ], "calculation": { "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of profit (loss) recognized at commencement from sales-type lease.", "label": "Sales-type Lease, Selling Profit (Loss)", "totalLabel": "Selling profit on sales-type lease revenues" } } }, "localname": "SalesTypeLeaseSellingProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesIncomeRecognizedfromSalesTypeLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r70", "r598", "r599" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Summary of changes in accumulated balances of other comprehensive income (loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "terseLabel": "Carrying Amounts and Useful Lives of Intangible Assets" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r542", "r543" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsPreliminaryAllocationofthePurchasePricetotheAssetsAcquiredandtheLiabilitiesAssumedBytheCompanyDetails", "http://www.omnicell.com/role/BusinessCombinationsProFormaFinancialInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.", "label": "Schedule of Cash and Cash Equivalents [Table]", "terseLabel": "Schedule of Cash and Cash Equivalents [Table]" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "terseLabel": "Provision For (Benefit From) Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r49", "r122", "r305", "r307", "r308", "r309", "r601", "r602", "r604", "r670" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Changes in the Carrying Amount of Debt Obligations" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r512" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "terseLabel": "Significant Components of Deferred Tax Assets (Liabilities)" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Calculation of Basic and Diluted Net Income Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/NetIncomePerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "terseLabel": "Difference between the Provision For (Benefit From) Income Taxes Compared to Income Taxes Computed at the Statutory Federal Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r441", "r471", "r485" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r441", "r471", "r485" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Share-Based Compensation Expense" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r255", "r256" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Changes in the Carrying Amount of Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]", "terseLabel": "Geographical Breakdown of Income (Loss) before the Provision for Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r261", "r547" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of characteristics and cost, by total and major class, of indefinite-lived intangible assets acquired as part of a business combination. Indefinite-lived intangible assets are assets that have no physical form, but have expected future economic benefit. The future benefit is not expected to diminish over a stated period of time. Acquired indefinite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the entity) and in total.", "label": "Schedule of Indefinite-lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Summary of Identifiable Intangible Assets Acquired" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "terseLabel": "Summary of Restricted Stock Unit Activity" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r38", "r276" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesEstimatedUsefulLivesofAssetsDetails", "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails", "http://www.omnicell.com/role/PropertyandEquipmentSummaryofGeographicInformationforPropertyandEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfReceivablesWithImputedInterestTextBlock": { "auth_ref": [ "r601", "r602", "r603", "r604" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivables or notes with discounts or premiums resulting from the determination of present value in cash or noncash transactions, including description of the receivable, the effective interest rate, the face amount, amortization period and method.", "label": "Schedule of Receivables with Imputed Interest [Table Text Block]", "terseLabel": "Components of Sales-Type Lease Receivables" } } }, "localname": "ScheduleOfReceivablesWithImputedInterestTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/LessorLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r546" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Preliminary Allocation of the Purchase Price to the Assets Acquired and the Liabilities Assumed By the Company" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r280", "r281", "r283" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r280", "r281", "r283" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Summary of Restructuring Expenses" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r443", "r474" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r448", "r459", "r462" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Summary of Share Option Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "terseLabel": "Assumptions Used to Value ESPP Shares Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Assumptions Used to Value Stock Options Granted" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r506", "r522" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]", "terseLabel": "Change in the Balance of Gross Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Estimated Future Amortization Expense for Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/GoodwillandIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.", "label": "Secured Debt [Member]", "terseLabel": "Secured Credit Facility" } } }, "localname": "SecuredDebtMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r117", "r189", "r190", "r191", "r192", "r193", "r194", "r206" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting, Policy [Policy Text Block]", "terseLabel": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r87" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general, and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, general, and administrative", "verboseLabel": "Selling, general, and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSharedbasedCompensationExpenseDetails", "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails", "http://www.omnicell.com/role/RestructuringExpensesSummaryofRestructuringExpensesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Services and other revenues" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r107" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "terseLabel": "Vesting period (in years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Awards granted (in shares)", "verboseLabel": "Granted (Awarded) (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant date fair value per award granted (in dollars per share)", "verboseLabel": "Granted (Awarded) (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding (in shares)", "periodStartLabel": "Outstanding (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding (in dollars per share)", "periodStartLabel": "Outstanding (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]", "terseLabel": "Weighted-Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "terseLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (Released) (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r461" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Fair value of awards vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (Released) (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Expected volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "terseLabel": "Expected volatility (maximum)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "terseLabel": "Expected volatility (minimum)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk-free interest rate (maximum)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk-free interest rate (minimum)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate", "terseLabel": "Maximum percentage of earnings allowed for purchase of shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r461" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value", "terseLabel": "Intrinsic value of options exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period", "negatedTerseLabel": "Expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedTerseLabel": "Forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average fair value per share (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r450", "r474" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding at end of year (in shares)", "periodStartLabel": "Outstanding at beginning of year (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Shares" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding at end of year (in dollars per share)", "periodStartLabel": "Outstanding at beginning of year (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted-Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r464" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r462" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "terseLabel": "Vested and expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "terseLabel": "Vested and expected to vest (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "terseLabel": "Vested and expected to vest (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r440", "r445" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofPerformanceBasedRestrictedStockActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockAwardActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofSharesReservedforFutureIssuanceUnderEquityIncentivePlansDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche One [Member]", "terseLabel": "Vesting One Year from Commencement Date" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-based Payment Arrangement, Tranche Two [Member]", "terseLabel": "Vesting in Equal Monthly Installments" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r117", "r443", "r446" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "terseLabel": "Share-Based Awards" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.", "label": "Share-based Payment Arrangement, Performance Shares, Activity [Table Text Block]", "terseLabel": "Summary of Performance-Based Restricted Stock Activity" } } }, "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]", "terseLabel": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]", "terseLabel": "Share-based Goods and Nonemployee Services Transaction, Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage of award vesting" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "terseLabel": "Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofRestrictedStockUnitActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r466", "r484" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueESPPSharesGrantedDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationAssumptionsUsedtoValueStockOptionsGrantedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Vested and expected to vest", "verboseLabel": "Remaining weighted-average vesting period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails", "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r447" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Fair value of awards vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent", "terseLabel": "Purchase price of common stock, percent" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping Costs" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.", "label": "Software and Software Development Costs [Member]", "terseLabel": "Software" } } }, "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/PropertyandEquipmentPropertyandEquipmentBalancesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r54", "r136", "r137", "r138", "r141", "r149", "r151", "r171", "r216", "r304", "r310", "r480", "r481", "r482", "r524", "r525", "r593", "r594", "r595", "r596", "r597", "r599", "r695", "r696", "r697" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]", "terseLabel": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r136", "r137", "r138", "r171", "r652" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r304", "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "At the market offering, net of offering costs (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r304", "r310" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock under employee stock plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r21", "r22", "r304", "r310", "r451" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedTerseLabel": "Exercised (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationSummaryofShareOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r21", "r22", "r304", "r310" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "At the market equity offering, net of costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r310", "r442", "r460" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of common stock under employee stock plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]", "terseLabel": "Convertible Note Hedge" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Value of shares authorized for repurchase under stock repurchase programs" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Remaining value of shares authorized for repurchase under stock repurchase programs" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r21", "r22", "r304", "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Stock repurchases (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r21", "r22", "r304", "r310" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Stock repurchases" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r27", "r28", "r120", "r211", "r212", "r591" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsAccumulatedOtherComprehensiveIncomeDetails", "http://www.omnicell.com/role/ConsolidatedBalanceSheets", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r119", "r310", "r317" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity Offerings" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferings" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]", "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]", "terseLabel": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EquityOfferingsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r515" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward, Amount", "terseLabel": "Tax credit carryforward amount" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward [Axis]" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Tax Credit Carryforward [Line Items]", "terseLabel": "Tax Credit Carryforward [Line Items]" } } }, "localname": "TaxCreditCarryforwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward, Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name [Domain]" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TaxCreditCarryforwardTable": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.", "label": "Tax Credit Carryforward [Table]", "terseLabel": "Tax Credit Carryforward [Table]" } } }, "localname": "TaxCreditCarryforwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable, Current", "verboseLabel": "Taxes payable" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.", "label": "Technology-Based Intangible Assets [Member]", "terseLabel": "Acquired technology", "verboseLabel": "Acquired Technology" } } }, "localname": "TechnologyBasedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r549" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade names", "verboseLabel": "Trade Names" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BusinessCombinationsNarrativeDetails", "http://www.omnicell.com/role/BusinessCombinationsSummaryofIdentifiableIntangibleAssetsAcquiredDetails", "http://www.omnicell.com/role/GoodwillandIntangibleAssetsCarryingAmountsandUsefulLivesofIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets": { "auth_ref": [ "r649" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.", "label": "Transfer of Financial Assets Accounted for as Sales, Fair Value of Derecognized Assets", "terseLabel": "Non-recourse accounts receivable transferred" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesFairValueOfDerecognizedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialAssetsTransfersOfFinancialAssetsSalesPolicy": { "auth_ref": [ "r117", "r641", "r645" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing whether a transfer of a financial asset qualifies for sale treatment, and its initial and subsequent accounting for a sale transaction. If an entity has securitized financial assets during any period presented and accounts for that transfer as a sale, for each major asset type (for example, mortgage loans, credit card receivables, and automobile loans), the entity generally discloses its accounting policies for initially and subsequently measuring any interests that it obtains and sells, or those it continues to hold in the transaction, including the methodology (for example, quoted market prices) and significant assumptions used to value such interests, and the gains and losses resulting from the sale.", "label": "Transfers and Servicing of Financial Assets, Transfers of Financial Assets, Sales, Policy [Policy Text Block]", "terseLabel": "Sales of Accounts Receivable" } } }, "localname": "TransfersAndServicingOfFinancialAssetsTransfersOfFinancialAssetsSalesPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "terseLabel": "Average price of repurchased shares (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r53", "r311" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r53", "r311" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "negatedPeriodEndLabel": "Balance (in shares)", "negatedPeriodStartLabel": "Balance (in shares)", "terseLabel": "Treasury stock, shares outstanding (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.omnicell.com/role/ConsolidatedStatementsofStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r22", "r304", "r310" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "terseLabel": "Number of shares repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgramDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockTextBlock": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Treasury Stock [Text Block]", "terseLabel": "Stock Repurchase Program" } } }, "localname": "TreasuryStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r53", "r311", "r314" ], "calculation": { "http://www.omnicell.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury stock at cost, 9,894 and 9,145 shares outstanding, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/RestructuringExpensesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedTerseLabel": "Unamortized debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesConvertibleDebtBalancesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnbilledContractsReceivable": { "auth_ref": [ "r55", "r651" ], "calculation": { "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.", "label": "Unbilled Contracts Receivable", "terseLabel": "Unbilled receivables, net" } } }, "localname": "UnbilledContractsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/BalanceSheetComponentsBalanceSheetComponentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r490", "r500" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "End of the period balance", "periodStartLabel": "Beginning of the period balance" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r501" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions", "negatedTerseLabel": "Decreases related to tax positions taken during the prior period" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r503" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities", "negatedTerseLabel": "Decreases related to settlements" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Uncertain tax positions, interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r502" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions", "terseLabel": "Increases related to tax positions taken during the current period" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions", "terseLabel": "Increases related to tax positions taken during a prior period" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r504" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations", "negatedTerseLabel": "Decreases related to expiration of statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesChangeintheBalanceofGrossUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r505" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact tax expense" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r172", "r173", "r174", "r175", "r179", "r180", "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowancesAndReservesAdjustments": { "auth_ref": [ "r134" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment", "terseLabel": "Other Adjustments" } } }, "localname": "ValuationAllowancesAndReservesAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesBalance": { "auth_ref": [ "r127", "r133" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount", "periodEndLabel": "Balance at End of Period", "periodStartLabel": "Balance at Beginning of Period" } } }, "localname": "ValuationAllowancesAndReservesBalance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": { "auth_ref": [ "r130" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense", "terseLabel": "Charged (Credited) to Cost and Expenses" } } }, "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesChargedToOtherAccounts": { "auth_ref": [ "r131" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to accounts other than cost and expense.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account", "terseLabel": "Debited (Credited) to Other Accounts" } } }, "localname": "ValuationAllowancesAndReservesChargedToOtherAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDeductions": { "auth_ref": [ "r132" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction", "negatedLabel": "Amount Written Off" } } }, "localname": "ValuationAllowancesAndReservesDeductions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowancesAndReservesDomain": { "auth_ref": [ "r127", "r128", "r129", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]" } } }, "localname": "ValuationAllowancesAndReservesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationAllowancesAndReservesTypeAxis": { "auth_ref": [ "r127", "r128", "r129", "r132", "r133" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation and qualifying accounts and reserves.", "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]", "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]" } } }, "localname": "ValuationAllowancesAndReservesTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ScheduleIIValuationandQualifyingAccountsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/DebtandCreditAgreementsNarrativeDetails", "http://www.omnicell.com/role/FairValueofFinancialInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/EmployeeBenefitsandShareBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConvertibleSeniorNotesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r154", "r162" ], "calculation": { "http://www.omnicell.com/role/NetIncomePerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted-average shares outstanding \u2014 diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r153", "r162" ], "calculation": { "http://www.omnicell.com/role/NetIncomePerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted-average shares outstanding \u2014 basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.omnicell.com/role/ConsolidatedStatementsofOperations", "http://www.omnicell.com/role/NetIncomePerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3581-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column B))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(1)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C(2)))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column C)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column D))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09(Column E))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-09)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r168": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=121640914&loc=SL77927221-108306" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r182": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120269210-210444" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "30", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121647444&loc=SL120254536-210444" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "8A", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121648281&loc=SL120267834-210445" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL120267845-210446" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919260-210447" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919272-210447" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267966-210447" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL120267969-210447" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121614247&loc=SL120267897-210452" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120267917-210453" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121565518&loc=SL120269220-210453" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267853-210455" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "3C", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267859-210455" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL120267862-210455" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131251-203054" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68051541&loc=SL49131252-203054" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r278": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r285": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r289": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "http://asc.fasb.org/topic&trid=2155896" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1314-112600" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1336-112600" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r303": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r315": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/subtopic&trid=2208821" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r349": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r353": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=109237824&loc=d3e1703-114919" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.15)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2919-114920" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4587-114921" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(e)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(1)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(2)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(c)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(b)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r438": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r488": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r536": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116868678&loc=d3e1043-128460" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4922-128472" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5227-128473" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(c)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r558": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r568": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r600": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "Note 1", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "Note 3", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e39896-112707" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r622": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919306-209978" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919308-209978" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121561866&loc=SL77919311-209978" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919352-209981" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919391-209981" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919396-209981" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919398-209981" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919359-209981" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL117410129-209981" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919372-209981" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121576215&loc=SL77919379-209981" }, "r638": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "14", "Topic": "842", "URI": "http://asc.fasb.org/section&trid=77888298" }, "r639": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888252" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109221007&loc=SL6226446-111709" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "912", "URI": "http://asc.fasb.org/extlink&oid=118261985&loc=d3e55302-109406" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756" }, "r727": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r728": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r729": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r730": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r731": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r732": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r733": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r734": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r735": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r736": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r737": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r738": { "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "09" }, "r739": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "i", "Publisher": "SEC", "Section": "3", "Subsection": "10" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" } }, "version": "2.1" } ZIP 134 0000926326-21-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000926326-21-000007-xbrl.zip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

DY[ML&?R!-7'2_1QD;(08MN.P6ZR]!YV@#&P0%DB.E3?NJ",J]0(T M0C\2&W?1?)T7'J2+XKTB9^6T4"M,@!-_KBB/MQ6$?>FR:VDOH5XD2C_$>K2E M8!\Z!/72L"^3?KBYSN^V(TL>#RP&,9?+(%0KL_#;JTI-(_WJ3&Q%9Z'?E M!."9 &(-PL1JG2AF-%UEBUX/80%^[";YUZ=*T1 8^ MZ-JAZX%E9T190%%M*2D>O*Z(M4NODOH<&ZU6U;<>OWH%!Z BSFXIS4K13_DR M7/-G>!G.?)$RO)J&YGH;5&3X75+9BL=!I0GDIJ_C-1:Y>:8804O;:>E7YOK6 MNV.^*XQB3=IE/T+DD-7M!6[8>:4"9$6+Q4KEAV&\X+2NW%G0ZA1^>W);0'*L MCEI$.LIP S%GTK@DT[DL7JRBZD/9SO,N5OB"A:;CIUH+']UX5U;1RW+[6;5PGFJR-_."O ?6!OJ=P7G_ZN;\;7S=O-$]J1Y\T1JI52']WM?+WOEYOWO1Z_;/ MR7#4&?6N!J0S'%Z=]3JC[A#DOW]6*_C(+4>D7N.16#%%IJ*4W0)+4HD53ER8 MC)=-EV(%$N*&-]"^!WLLYEAKZMYC'FA.9A'U@?IYKTW[TZ50F?)P_"%$(6*C M1R#^DE,_ G-]&OG?J6_OJA_[U+^%M;X4[1#O$ S 9Y$\2E'@'8R\%\H*R*2S M=LZ&8JG(\[,*753%C#P5>V#23X"(Y^V1W-;G-]I=\%3S/.H..H/1.S'.SPK5 M2B3\WM>KRT'OK-OOUTAO<*84LL-:U@Z+G::E6^&-:M<_;G>?48O^PTH^VTK> M>&,R9'SV2QK(N)A-N,?_'^5#0 M@6D\ZL T-]>5W\.CAZ.Q9R_A8QK.G*__#U!+ P04 " "1@%A2JAGI4JU- M #HJP( % &5X:&EB:70Q,#(T<30M,C N:'1M[7U;<]M(DN[[^158S^Z8 MC$/1!'AWSW:$),O=VK$MAZT9QSR= ,FBB&D08 .@9.ZO/YE95;@62) F59"L MC=AI"\2E+EEYSR__]A_O;BYO__7YREA$2]?X_(^+#]>7QJNS-V^^=2_?O'EW M^\[X_?;C!Z/7[IC&;6![H1,YOF>[;]YKMFS MW'YY@Z_JO7%]/V3M631[]>O?\ K\+[-GO_Z?O_W'V9GQSI^NE\R+C&G [(C- MC'7H>'?&MQD+_S#.SL1=E_YJ$SAWB\BP.I9I?/.#/YQ[F_\>.9'+?I7O^=L; M_O??WM!'_C;Q9YM?_S9S[@UG]M^OG'Z_-S7-7K?#1N.>.9^.AI.QU9^/.]V> MU1FQV?\S89!OX';^3!AM7/;?KY:.=[9@^/VWP]XJ^N7!F46+MV:G\U^OZ+Y? M_S;WO0@^%L##_)^%=T3L>W1FN\Z=]Y9F\HH_)'^>^JX?O/U+A_[O%_SE;&XO M'7?S]O6MLV2A\8D]&%_\I>V];H6P^F]-4T8&/WY($8*[W$= MC\F1FQ8.]^K[PIDXD6%VVE8O.]CBM.W@#F8>^:NWG7:WOY)CWC[1S%,=>.J7 ME3V;P::>T;S?6E8;U_#DZ]')K4>O9#W8=(V43#16F-2>$^ZU!ZGYNFP.T^U8 M;2M9N]/-3[7??)5G;.H'-D[R[=J;L0#O>O7K^^LO7V^-\X]7G][!_]\:MS?& MAZOSKU?'F>?V)RUS2*9=+,T\N]U&#GS#;_DP"P\N(4H20/A](!P;A=. M:,@)/O;.X@!V[9^.13$:$2[+7_\RLJS.+_I&LI7NG2",C',0%C,N,/0M%ZV3 M^4O3@#6#H; Y)_C1;YAAX8_?R3JJK1^=$.T"/SUW0*6D$V"M1ULM)+:B3]. M;WSK1,!^IA6&<[X*'+=68]IV!O[Z%W/0^:7XO\;(:&G=5*O3Z;>,R<:PO9DQ M8=$#8YX1+9A63OMQ[4;.V=5RY?H;%AB? W_%@F@#:C ()9W+U3)L(\)!&*!P MVQX\"?HS[K)A6L9E^WW[2]OXRJ:DWHS;YLAH",[\ 987ACB+&1 NM]8EGOZ= MA2$,\WP=P=MHQ-?>5.?BMG%U/S//"S?N/2RN;Z>:&6N4^QHP"CVW.VKWAD5M55Q-::Q3DNA: MS)IMI/'M^O;3U=>O5[>_ZR*/#I%'?_1+-1-2;1L<8&9TV^-#S8RN-C/CV^]7 M7T"K;QFWE\8G/X#C8 .[_\BBP&\AAVPC)^KVZLJ'+O7R(%B8)K+Q=\RU'^R MI5EXB_@+YY19[3M:V)'Q 18:> WYI-ZQ*5M.0*Q:;@M5%!/M'&;0^^D^^:75 M.@C7^#YXR\/"F2[D^UV\:V8@N\*=M%>KP/_N@*!C[L8(G>_1YLSW&'S97XQ'!$S\%SSB9UUZ^AYT*F=JN^(D M3F#!.!$%,YU$Q'6CN;^&LVD]O^:*%WN6;N[X?A/+$U%AINO9@=4$C^1RP MI1.RL [J$QYB4#QA;T$S,B9KQT799;C^E!@3\*E^IV-/P+DG=U 7JP*"[W"LMW6T]*-GU1E@8/? ;N&^QW80+!T8]/G,FU>Q/+E-WZS'^R2 M9FG9DY",>'R#A*06:69!I,EG^!=W4\EIU#5+36U/A"(NC7 ]"=F?:Q@3B'@[ M#&' >&)=%[<"K1F:4LN@>!4)&8>4$%#O\J2#/\8;20H*_"),^))]/ZJ#YXV[:N3J ]2E[T0 M K"5TW.S^C00+QR4,\]):]3TEU2HYV!)@3[M?(@B=.> MW]ONFAA+Q@O*14< LM=9<1$=KN=S9^HP;TK*&GR. MZXT3'PQ2!77Q-Z]LX.F^VRX)JF^ J,:IL(^<*F&%"$'>\-?WG'YN2 OV7! M\I%$B6J\KWYMZSJ_]/5;.")PAMF=C_I%(%8H.2_R)..1\4AMOPMLE\XG.-5/1),$]*ZFKF$B[;Q#\\%B]< _L6"!P<9T0J6>([J)WI#(S)+P(:I MUQI&CY?P4VD=6V1+3NT5S0!#OQ&>6EPX&FKN=D&]Y(6@\!NS/:3N.P>=RF14 M^FBT).\08J)M7/._T/M,]&U[&SP"D9) 8"0Q\ M]]B!O?H_M2MW\EB"M=/N/XHY/:RD+EW<_(]A]@>C87--_Y%1^Y:]X.98ZC^7%R[$\ M_%AJ7;S7KYOMQ/4J<*CP-#6(1C>8Y;*_HD6C#.P<,82]NAG 7Q,_J/=QIOM3RB1TL9[N@YD&@W-Z85#N1N#>B@$XDZ MS/9D5DQ$3?2:L=D:=]1$K3M M;8"7H<[&[7R*&MG!)E5(EHYC827:U%W3HY-U9'A^9+C.TL%@([Q!UDFZ+<-C M#E*(6O_R?.4/%TK:@5_AT^N Q8F8G#ARLL[WR96!'V4H44,><^83D .S&G;3 M$'[5):',PQ!)8@R10#:2Z>L\>DFCT*[,IC$S6*1'2?6"1"S6T. MR,$^D!3TP7)L"1W<"C;,/?P!PZP#.J5;[*RID$&&7]%J*W4;\APO>BG[OD(E M5KS2Q8*^F;V)W8H@NYDWLP-C";-=B$0P)\P8NV#/-OGO((_H.Q5MRGKZMV(Y MC N@MZ+>J1JV@1U)(D1B_^SXXCG=W(=]0K9#R\SPN'7HP7R'6-?=?GN@T([%U7K @+SZ]TF0 M4R?('6$W]SDF_;8"-$9I2VD@E2ZL'@?9F2*W60MYBOP). VO1R$W6$"YO^CJ M#YQ4PKM2EVV0FPTU>H_<8L0+WZ\#SXG68/U<>\#=7)?X.6>3^$GZUT?_GIU= M\ZN@&MRFREE213")8+J%T\PXL^=OPL_MQSY1FS]?WR&4%J^"[;?2ZD1QT2(DA9[J>$&IQT#%Q'$=&F12OGN.L9%[*K+%"-BGJ^EX5LN9KAG%E%9* MJ1%K*[4X8C[V=(IU-&7.!.2"JW4 @IH1 U'S7N)$@N-RGSB]$[FVB-1B++?1 M-9OHA\#R5,+5SQ# 9"# 5$R)U9>[+A!P?%#.K%V_@^O/>%CG9S M11$'">.,2!39B4S!6 $+/)GU0CH)CVYAO&+FL#BV)7>AX5#QC\C')&MF/D<1 M6=4[VI(1&5Y+M"=Q$%T !:)/3%)?F&(O]L2_SX1YA"\OM)?DKINM>7HXJ# 9 M&Q?UFO=^ .+WH_UO!@>D#=\O!@O9]Q6(^A X6LSH'*^%#R?WP+=YS@(3A[15 M4@I%>1'\(^(LL>_T$!Y!>P5*QI1"1"6'NU4XW?29V&]"DR2IQFT]6/:L6\6M MYE818R,.+[].?[0JZ[V'Y>R<=31%(&1T3DZ0^M1X#G76R<9KIO;M$-UQ RK'8K.'\A%Q?/'XPTQI=?:NVYM/;6[MT;?N ]SK[OHO,+M:7S_ 7_[!14D;9J@,6X, MLT\NHT'L@]]S3<[1F?:#)Q2]_CJWHFK$P3BRG_'B2?D9+] ,29/,BY>Q$ANJ MB_) I%YO1]>36LAC.+HN'L/1E4@-^OFH7J^+E->+%[I:6;DB65-4+U?8$Z*T MQW>%5"K_6\5)-2Y"9PNL M+UT)6H7\+([L972V)VB=/H&J&M&<=5\2J"IU!SZD]&=8+/$>*["PK%X%YZC9 MUA,MZFVOMX[=H_D,%6#M1"H))E6^_0AJ:0(U@TEGIKAUNW.3BS>4I%FEIZ#) M*)^6.)'P('>U(E"D4(6%"-X]!",4792BP^>OQC_@D]OB7-[;%7R$'-AAIDU< MW.:ZTZ] N!:R; V$:VXOMKR.D/ZDD?LZ))1;3\(JA[:2P*T/\99N;^%Q:QL)_ ),I:*%Y0/6?A<:!@A*X048DF'CN#G': MV6'6MR-3RKI@-LB2S .J4_EHJ>0H<81,%P[,+MQWB!EO17ZZ9/15F$2+.S/L MB$RFR,&GB >$Z^FB;$3"?%S:P*=<80&C)\4/N&\,+%6;6]EH;TZG<%. ZL8 M^RYW&QR&80+/:'V>S&BE+>FCC?P?!GNB#BBN+)B M!=)H J3)EA6"VZ*%K8"SSMFT,=;^%,P_Y!1@6,'1@@5-38R[;1@'H_37HE!= M- [ 2%92%#YMEJ:UYH\.SL*^ XJZPQW8L09I)K!U/5J\Y"1.LVU;F7TAU#TY MZ50Z;GDV;CI:2JXMC/4Z\J3S2(R,:7Q=P("Y\Z A.B:DQBU5&;GVO'^L;24^1C-!/\15 MQJ92A1?47OIKSB@N<$1?\(:5O:%92G", ME$MO!PNOBI][&+K3@" %$OB[$RPE[5?$=B-:.)_ABKD1I5'36>%[ W'9,[1G;2F=]&GH Z* MR7+/2J6VMUF=5$5 U&#&\X6)25_9RR=WZ&\*5;*OB)\,3M'4[I#PR3'3"N/O MER;(JT=T?9JC7FTY*D6.LA&&_&YV1\I^=>+J#T2=MBWVN%JHJ?<2:JK2S.9( M>[I'G&I0X DC:I"9KU?2!GHF^'Z 4G!;[ZT=DJ!55114+9@XS"P?J6* HP(D M8-?49()W!K#DO;HA L*HMB,"ICUF^L;XZM>6WH53;V>,_FGDW)>I*&Q*C0$S M*E'19#L2Y"Z472UA/'F)2!@YT9IN!JT:,[E%3A/IU]AL%7[:H]UJ[Y S97;& MJCK,OD6\;8>O2Q=GBZ$%LK2;6"D(B"I]BBMXOS_+H+G1=;6GDO$8G;B'\GF= M)29ZWAWGKOS*/-V8W'WSXR*3X DL[XS((I(4STS?;(_*^FT7#: MK-TR!F9K-!KRV[B7N)F/4:2;R$0B$,4?4_J-$T^:]!RG'W2%*UKUI+!()KL7 M]EQNW%;6%0O1.J@I",^!^V&AS(M6A,D!W3G<8J;K%]KOM095 F=GNZ2M<)H[" MEQKWB!(4@-\J$=CI!]OST Z2+"S7WD=DSR&+GJT#W!<>T:NF_;*>$.&-!38OK241# <3Z#77'M5 MRG_\,G/"E6MOWCH>K2T]]$OV=0JL7]I__G-B]+<[W/"/8*#13'Y9_-RFG]Y$ ML^)OP)X'_5'IST#5I;]M?6VOW1E:1W^M":1&!L617]MKC[N]X[]VU!YVRW]. MO_8-[1O?.R"/$-20_WYE]E_E2(ASC!4<=-]U9H8\X>)7$6$O^QG)NOBC8#MO MK=5WP\PR'/Q:@?C\U:NM>D.NV<"HVU; W,>73YZ(OJM%]ACW()\;F_.7I39( MX3%\E=VTP7Y[IF-3>M1VZ]&;D5-\YCP)N'Q.N#_G_*B<*Y8^O;K=5T;@/_!_ M6T_M=(SR&S%0-:'OHW*<=WX^!@AP<<-0^?J"0AWL&S)BODC!_O7/MO$^XA4G MYRC4G_.^685"BOXILLIW[@?%,7"U@545S(+GN/ #Q<*?HDW-[I. 4N)C2@.M MIMOW\<@__F"13) T2HL/>-G^UGZNN7D,="UZ@]/[_S5,JUE=+%L%L=P]@5@V M\+\#;KU5HO.CKM^H$KNXD$[&>/$4'.*QN8)8N)Z>A:O&9Z_(S9I9-:62?@K" M^A&NV55P34NCO/IH!V"]6UW"VNCNEE:U6DQ+L9CF(*^>F01>]^C+.S2%;VQ' M#$"5&/S8^V#UVO+T6MUAFL]7M=EI]K)_O')<:=>NM7573Q4Y[6(2EE%=KLR=FIS4: :&,RE6M M'5LCW):EJZ_=&](YS$NO1P6VI"K_H_S[F6Y+_R31CXH*8J6V;\]F@ZP]]RIUA:VQA>M7C[IMN)>+0JLLGLJ_F ML-6UANU>KTS1>$-^YL-+#3KMIQ.^'8_;7?/0Z.UX7"W"N&?TMF<=_[6@1'5Z M_5.\UC+'QW_ML#VRJL6:GTGTMACG,(=FVU2P$WE9.S\9#4D3*T+=5/<5]Y] M"+=@X^MQZ'6&I1'&TV%V=TH!T57/Q M%$V/=E*IB:GV/&+>YB%S/<1*XWCVT7H5M9ZBDNDE7%]EY4]QX*H1^B'A^A-4 MXE0+O-GR!<7XU=U#E<7YD_Z'#&/M%H/57"Y./+A5K< ML<:LIYU%:4\LI-_-5K,+AMDOYBB+B]I-7$[@V^/\U0M4"GJ\:N*]6DQ\-!"- MK^J0P+ /U1T0)ND6T(RUQ$EHR7,9$,]B@NUN;]>U:9FN,0(A/.?'A@#WH MMWNUV0-KT!I9@_9 E9'V3#(=#H,RZ&LI#AE+(^C9)SH\H3P'VI2?+,UA[ZAK MG.>0+]?5PMQHRYYIGL.!6P.B/Y]HKG%KNKU.:]#M/_K^Z/<.=@_;" &=<= M9LHK!4C=,)]]=J)N5[OA$@B"L/\"05BEVU5E1E^#U!W@!XK5#\R090?W>3P2\8!91.\UAIVVI,G?$Y4?W[N6!A0@= M1 6)7CEL9'6?0.9.,28Z('WF\7,G!C\U^D(A@RI=?JH;9\')Y3@-+ZSGJU; ^C]MD4P[95 ME?Z.N\P5BWGKFTXQU):'4G'IGFI&A:70A=6=R"R*=&2X0D]+6C7QA-T(M'6. MR"H3+8I"W1RDG'F2$X_UH.0\(?2$'[9"?J!50[ZZ3&54ZK(I*R$X/)4].JS< MK]>V%/"*XFI=-N19)#RH"W/V=%4FQ>X%QMA5[*.X6I=]?/9)$U;1GH ]T.(4 M^%F@'U3YF ,M>$J=GR[=H02IIJN2\-T?XT.5NJ651JN:VW2!$X?F=D;#,_8!M F""4[X$T06JD> M"-CO1E7^;JBO7Q@-;!@:1X%2/8GL@"#0Z0O8#X.W7J@XX^ET'81)%X95@(U, MV*QM?/(C;,4:1K876]3P27;GPU^MI-TQS#S")J7OV-Q>NY'!OCMA5.AVFNI^ MS+]E3Z@KDIORU:=;ND:^>G'DI/DRS['S4:,':[&&%V77.LPT#LIT;(I;2%=; M(^T-U8&(M_6942[4.:XOS>$SM5'2-_2XB7)CLHYXE]R0MTS.TV[#P=YPF^9A M1-RLVAWD2*PPFYXE6&&O -6HY(7622+)%;?C'$XG-K+"%CN.QQM@UIB\MUE2 MVJA9<+$E [://7$"-D=^XB>=W3@!@YP EA5M@$MUFI(Q[<%\6KK:-^W8E S[ MU[D;+<.I*MV%S-[L*;++7,F)T"R\!"]D7Y-Q4Z?:&AV76BIRP .40:7GJZ/N M@L'=+A5XX"F\,Q6:S6/6VE;MAKI@&>%TP69KEX5$8J*3\#U,: 9;R+ZS8$JB M%ML"8Z,RT'G@,?8 TLQ?\8[O(.="1IH>5\RH_[!0A[**(&]\R)_&-EB-L)F0 M5_XULB5KOV/P+FG[] >LNO>YG>Z?)+6@XAD?U*WQWP[F2'O[+V8';7WC0SE5 MJV["/#0]GR/QWA-1^VK&'2NQ!?:V1T>_RB4+.WCE#/C5W2W^3I$) M59'%->QF&0E(#C+.]W1.=>.#99_%O1JICQ]9>KJ517-[S\V;%<.+P,,O?31# MXZ.H;[A9C7&2T@PV,"[LK="/90#O_LQ.U!<&1'<%BA)HJ;?V]Y<3M>5$ MY=UBPC2)^STO0.JA V3"F$<^JPW(07@0K?%$(,)4\)_%2;5$VVD?F!P8"9G= M4%DC$=Q #V?\*?%HT-K(C*&J^7!0OL/04OA+K%$EU[&N5KD$[3NLF_9I;M<^ MP;1QI@RLU5F NQKJ&Z7&[M/T]9@KMT=9IJQL1IUI*YWM/FS+M22V(CW9:G5T M_X-A:@%]VU'3:70JUW1NCS#OL1+=?C9&)TI!^X4"?;VUH(.76M JM:"')%CU ME&D-X[8^WP-I&AA ]+/GODPF?%R[D7-VM5RY_H8%*6$=@&"K=IH47> ZO4QZ MDS@8N73^KAUXNP5C.[#V!#@>XOEI(K*OS(XBE[6,;^?&>&0.S&JS*%3&X2QZ M"@Y:(!0MGE>KBY3RWIZ&#KR7>W.,AM49-(W!R#KK#0=CXQE/'/W-QM1?.0S# MGWOZLHK3/04P4V!T()=[SNN!'%PP[YU/C.\/JC,R*JKR"M:H,=P5GU<)8+85$Z79,D"C]P=FXVQT_VUFC.^I0 M%RS.KA)OT3$]SEJVRIB*:L*3G+B4,5^?;S%S[[,=!<[T#^.F#<)E,V%!L"DGA\+F M%_>>KX4F+CWJC,[,(>B%7S_ +G\#2P;_>._Z?E#1D%&0N)F&87KL&7VSPP6, M)?*]EO&N?=FFYN&=P5EWG.\8MP,R\!\P$6%E M>YNJ7*93K$X_$3Y-19$RZG1@(K;'F>4WWY^%QKO N8\U6VM0[C>I^^22B=WZ M#QXPGU7+^'QNF(/.8'#RQ*AAKUTL^+'ZQ5+YKJE)I<#6+J/:1;!Z6R-8G^W- MDB=<4MA%5Q85K5W-LJAH3$E<:WR4N!9%M59\T<."I_LXV*?JO,+Q6*/7E9B# M<.4D*N99GE56%-X*^=51.^TU^3;Z95*@JGI2^QF^!_W+^$NWTQT.*F\9[H+$INM!:QN6Y,>X!M]Q' M#J>6?[_LDGY14[:*/A:2!9!6<>U$\W#K:)9I,%?+S'1B?RZ^L0SKI^V M_)*AHH@ ;(1H05*6UP%-X0V!#!2#%=+= T5@'Z6,0@=]?- MQ)EE=S"8P./?UK?NV\CS7*@]5]\7SL2)C$N=Y $;.3G"1EY4W,@*5/&B5&M 6F'^Z=%5*32L=,._'*]YJRC*TL K=0:2 MKNY^A+M*"EHOGES>F M30)%X"6J&;E1(C&0]2ND1I(.#M0?\?SRXWH(_4N"QCS\X MS!FOF\]M_,.5BRUQ8%^'"'GQ!QD+KNM/.3Y968%O;U!22P1V0X!7Z) B L'2 M7\.7V)^(?0XG>X[C;/2;\O,GBX,LP6K981P?\",.8./PX<""5T/ M%VV\H+(J.)MBBM4H+8LY^7+,,1,4V:6V9;EH&U^QH$LQ&[@%3+\0W;#_AHG@ M..P$2$#8@^P>__ )_@2>F*WYC&%<;B'NP > MPM(_7[Z @V"E\!HR_(MS!CRS!%\%7&C*4MR5_HG#XP @"(ZUD6I;OJH1KGF& MRWE?\OFMM8[ES%W%WYK%^L3T:PEC2]9'M2*(OK]9!N$XISIPU&EE$))I( MVE'7T@N/M)T;I+= YZGC);D)O6X#2%H1)%D6E*V:+Y*.!_>VBF>VP[XBX<%6 MBA-5#L(#)#==1[%X=4(Q%C(1\?,5;9Y2&7@(0'A7U1!%D;MWUNWI*?TA?Y!I M_<0P)_M"PR2TS:6WKNI<6KKJ@'F'D_0N, @5H&A%K=$\1?>)BD1? 5RE;[7- MMEDA06/&7!8G9[@V%NX_^$;#:H(9! J%-^7B#/44(9:<0,B[:$,<<4N*1_Q M&#%[GX2.(S*RSCB;IUK.R'1E(5L]*<&PKTB8MV3Y6>4 VXO*TIFIJ4*2DTBQB&8;8.Y+9)69ZT]6N1-Q"$V-)'DY3@ M&M1@8%:[VP*)"ML.ZM4"U50G*)L#U[2 G#A.!,CF=0B?S8[]WIZ2CE9EX%]N MWG\10*.$4\L5*:X(S-@<0Y_-?:;2DU/9(W'@A]A4GBD5:S\4Y*H-EX*SH'(X MFMN*#"=-/&D6@V!VY0Q&W$ ,)B)Z MGL^X10Q\X)/O)1PNST'V (DYFOSH*1"C5.>QKRF;$*4';FW;+%4*4MX_+A,< MUQ&'BT+[%,FGF64<"=)M@=9K;(#''!B?E@["E'\1[T%/!X_JD',P) ^%M&UD M7*=O24]LBE'$7U\PM;#3CX>](ZR74'*>>'4&^#@*=DMZ-TC,)IX).R(ZB."+ M*HV ZP*PM^32X+>BAR.O8#30X(Y=VPFL+*).)?XA6V@'"+_-:7"N*#BJ05)( MOXC4 ,+Y%!7/5?%RKM-X.23]V>@E3>:H,$%Y1&(M47WT='*F&@<,"-2/.3P"&89K M8+$>RG(V9;";(-Z!\49H")%N'5&@3T0BP@5C4=/(&U;:!:RYW>5\'@N=KRAE M] TR;BTQIPQ)6$@N+6EQ:[^**C5%HQ<_O9Y3W_&F#A$C%7?B4DYLU_9 IU"$ M?G(!G3A^@_=MT<:$+0JGA/0=VW@('(2$0FT%"\!3E4A/.&5C[6%"A3-W@+DQ5[@0TF&['=O>@M?">V(Z&^', ?\)D+" ._F(5+^HCRV+SR+=Y&CA.G']3V 8.O!SPT?^0P% M?M-[Y5 ,&1,BR8LEMZDI,B<=)"K17"J*,)W'1ML7E"6$6R:*60$'2_IF"7J3 MU%6Z'D;HQ^-(1Y/;A9Y6?'3)24F/'CXC(M88$<443S55P\=<'[EAF.&Z/%F MV"0/K^97)Z&\$,[PC*T8.47<#7D"4Q] _ZSPR::]KF;;;,R:L8N W(=-[DJF M#B7KE2]1A.-I"^8=PEH2A'"UY4P2%,0)3K(QL%"&+6&;<*%SV1/H7[&$7[B% MQ$ AY8"?.QFY#Y_DL=/8TB@Y=7M$N _1UPNH.DZH+XUMN=AOF/28&:%[$+D-/I^,:>19PB5=DZ0'9!* M8. 37/3MF1AQMX%B#;ID!+(*,/G25;[E1A4]NJ$@!5]+TG)8 MQ8R1T$]2O,J_(B>249L\G\R>*!B> +;H6 M\5J^Z%PTQ@3[=8&D$+]SZ<^X+I=[:RH:"*2!OA3[CA5=T)3I*D*&U09SWXP= MT&-:$+.36[FRI@DGYI'5'6[$099KU(Q# _\+YS345A.)@X'5%UG &3WXP8&% M7-D;W L&"BQ"4E*.-&

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ʩ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�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�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

  •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ã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

    L)1Q/ID0 B/V$0A5)"$H6*(5(94!+J3*W4KE39&2DV;_LT M)I??_3DQDW[P/78> M?^E]EPXI?G6V3$AGH49?]Y=T%VH/!=%GSQ_(:[G$,49AG 90I@A#%$=<+98$ MUF&&010QX?O"*&_=F49S\RP:U0!7NH%MV52]JN-JZEU^\O)2"%9W6 >,K-AV MU1_2,=)0]K/2FPS0_'?"VN'5EDT]8#:EKB8>N*E*74TT@):EKQR"W5_ZRH6@ M"4M?.<3EL/25RP?;S:1<9,N/ZXU:KM]QKE[M\KMZY\5]\;7(?V0*DF44,T$H M#: O/5W<-_8@">($2N$SR1,4$_44@PGRFJ"YS7NUKJ!1=@$J=16DH%78C"VO MXML_:[E$;>3):#A@QNQDBL;>P2Y;#[L4[&^/^8]_48^HG6OUP[%/??7QDU"- MJ9$M@QA?/_&YH$V_9-&/ET>XR!_1_C[^\*$^^L;WJ8;I3]H %@ 9K71KTJLSD<'SALLS@X MM]7]?\:A^L 1<7;@/E3^X&[4=;_&;T(#FZWJ'8_=KS_^U+J+=V(M9+:YVWP2 MZMEDI6?CK?HD7O?W*^Y?LHA&1"04QH1[$'GJ9<.IQV&*<>CA*!4\#2S;5;O3 M;FZ^^!]_^_XW(&N-JXZP+]JW*37SD0TH6QM H72W;G#M<%#-)JXW&ZJQ%P!2 M"E85N^^TGZT*'AT:JL>LL0GLC#J^9P'NGO.MRPWY46!WW&7;H8)3M^%VC^V9 M/MTC"!F8UGM (U,BCMLQCMI[,? :2[K>4G3IJGV6GN2@=I_]< ")DV7 MW$]Y(;+'=?U0]JJ3OFXDT6@,6*,R$#_9D_;P*Z\-R-66;;9#VE=:C(89IXR#\<@\TRJ] M "W0K=Z@HSC0FCOO@VD/F-.2)>;2IZU68HW*2:$2^R?<6N?R/2F?=+DG]9=> M7?\@*[VNKHLFQKX72H0H9)B'$)&$01PF"")?(N;Y28BH58E_(ZESH[%N846M M;UVM3/_0T?S6*I9]HV"X.>H:V[%W-IW >D.-2@.8QBE,V2?XC:I1&F!QN02E MR_T!97"MF%&TXQZ/Z_. M>"SG?^:T.U7J + %]\/\&<+@U7SQ>E>%=NXM=F],O]SHMLL7QV7 7"3CMKU M,+EIU)DXF&Y2C$]#[J85/VQM]DULU")/\(^D6"MAY1U3W^ZV*J;V06IAQF.:0*0<%$@D(U"7XD8A0JG@5@F_UT7.S==H-0:B4=ENY66 L=FR MRRUR(\_L.]!:;<$O'7U!H[##?2)S=%PNM0RD3KK.,D?A>)%E<>L*J:$ROM+DQS#[' MO8JC X56%^82;M4_2-7@T8YS^K$VHQMG"([,-"<% KZUZ"EEZPZ-[EC&"!27 M!-,O<%)N,;+]F%;,;AK8*X243T=;0=]VU9F;K:+#7W2NW"^X&!;2"QD,D$[2 MT]7U4BH]2!)?(!\%L7* K+J*N-!J;@QU%&23RZJSXJ+Z$XB]_G7?TZ,&C+I. MQ^9)Z+X;9;[*>.4!O",KW6I=K<^$HK=_M>QR77]](L6^AXA)KI\U6G"@V;5L6EUB>-'!Q^O!A]*_[DN_C M<_]0[WQ>;++_5OYJ5E:!&4LODK&(9013A)4KB;&$E D/RBCD,28B]!D9D/5Q M5;#1USY]ND9'4\ ;5>UX]SKD9ISJ!L%I^%+KVDEI6( NC!^NP6A-@<;0N*2W MZT(GI2YC#(YIR?S&H90C15&HKY7\;"M1Z68N1:Z\W,WK5_7>Z ;@FNI>M ++ M0,K81UX$?9D214#2AZF?()C&DN! HC02WB "LE)CIG3T071*.VAOHQDMB_H. M0\?%E*7_:3UKW#?6>"2Q09!YY;3[%28F.$&X7/* M=\,>,R!&8I> <1#I?K@NU!%C]^O/ZQ^B;LRR% E.*.,AQ+XG(0I###$E'O33 ME,0^IZGT$PO^&ZS(3!FP\I!U:&I1]45Y5I<9.F3#A\0@%&$TA.>5*K2H U;O MUV!OQMCH6YSNCST*$YW3CS(:=B?NMR#9>W8^Z,'3G8+?8O?!>?9-#QHPU]PQ M5FP%_ZW(MR]?ZW8'BB#OBT>R;MS#3T*42P^IQ7S("8P8ISK_@4 280K]T/=U M058_$KYQ+)V9S+GMRU;JMIU1]"22=Q0&TKB/JPWL!C.(>S!'GC,:A4&-YUYE MT-49?!H%3XLYP3VN$\T"#O"UXWP[I'I9WO!1T_&ZG6T'3&YYZ\!SN5S- FHE M3U=";\A4X=FZIW'5TGB)PB01GEH3<"JQ6A,D#)(T)C 1& ?"#V5*C6I^&4F; M&U]WE 75QF)S#&9YOM^/L.&YEBO;%6-O-DPZ72_J?1O%)IY%)Q^)X.II6^,"$:%W>7+ G_U\U7VU>+4/0'(^B MV;3T=F,S\OS3->Q_-W4D%V!G'&BL UWS=%CAH8&@M7"4X+1QP'>:^.U6PVDS MQ$=!]R25?!PI=A-!66R6?R?_D1?OM^4F?U:JW/W,RF484DE])J!D,H7(BP1, M48"@2"B+8D9#/S#*M#K_^+D1<:N<^E25=H;)N!>0ZR?/V_$8>X?#$ ICQNJW MN(=QU(T=ME'_.F::"T^>A"GZK6J_]"M7#3B->D]>L@U950D,97T"5E5!UZ[@ M=U$1@W(59;;1Q7*^DY4H'Y24ZO)EDB0RE#Z#H1 >1-*3D(HXA-)7?ADF@?!] MNMSD^O'73U5N4,3JZ]^I,^)\7ZNK:ZTJ?8&:V4NM+]22VB0H\4.LMU8'+K>, ME,&IUD3XC\TVM15UME2Y:(_E=Y8L0#LXM3%-12_U:VT1T";5]TXT,!;'8Q,- MT$1G9N,/E-V1F@-T>\_9;GG^=(=O#E X.)%S\;R!O6ZS=;817[(?NHKY1KUY MV6Y?Q*#<80("EQ(G#D"V+5#O<6;>;FW(Y6C_*V M,3/;9)AL)$:>Z&H[0&4(V%O2[%Z_12U+)\@Z;>Q[DT+3]OYU@=U)>V G#[VQ MY\HI#@DAD%6]BF*NF#7V(BAB#[.8,#].K XD+PF:&VDVY92U M0Z.[@.[#16VC(RXB:\9_+O :F=KVV"Q K27XL_E[E+"(:Y",TJG@6-;;-!VX M8/'%_@&7KA_:"J ^H.HAJB_96GQ6_F*Y3$*JN"&1,/6I;D).0YC&@?+08E]@ M[!/EDUDV"# 7/C\R:U;8"%_XFX&]LB<]C@8\(R!7,?_8UOG#I0/^1WGF7:VR.HKR93(9IE\ MOIGM-WV"6RK]OHOB1\9$W9*K.?C7%U0U\Y8)3G&28@I%&BE^U&"-S<]?/[]?G"^$NB])6>TO M%M7.N_:^W^?E!G1L6&B$3B92Z:2.RSEK%E\5@Y\)IJ. M""@)_ AS"GF0ZKX4G*M/B'HP1E&"A/00D4;;G'U"YL;SG85XJZ==TXE>1 T. MVAS@-+K+.R9$=AEAMT(U70J8-636.5]]6%Q+\CI[[Z1977W:'Z=Q]5X[),I! MASD1MOEGMGEJ0R'"=^;,R2MV@R-RK]DJ\?H1+T#+:-\J#8:V]S@G[+ M\)C$-DP$^MC!#8T9X"]E!V@-6=0[$+IT5S,('6L68&\/^+.VR(;$;QH9F^"& MB49HJNB&VT;*54R# U#[@QIN$3!A5(,#' [#&EP\<, T]D4H(>*PZO#W[:U6N<_5.WZ4/>NE 4:Z9EM(/*&/WSQ(L)]"CU,1A1Y" MH3"J!^Q&G;E-:%WEZYJP6GW0T5]]L76-_TT.CFISVTQXMP^DP:PWZ?",//75 MMBR.,5\ @R&S2*D>8Z0L9L%)1VRBJ?"&D7,T#3I#M7*J?ZD;#TW07_\V>3"Z)E:_:?K"BX]3-) %^C <2@A8I[Z22(!$YGR M@+(D)L0JT&^ #G.;!+]9A:;? GZ**9$>81#SA$$4)0I\%!+HA3C@7ACXZN_E M#U'0?";P=W7YOV$ S Z31@9U9,^AT1YH"@27UF4[&T!KA X_GP3B=MGP:_JAA\X\.%;B7[PO!L\TGHFL';EZK#+XD#-(D"6+=?X5# M%+!$33<^@C%)DUCPU MI:#/)7!(TMYGDBU@K],#OZA*K1,BK@)KQE@N81E_6 M&"-DS3G7S'=)+!=E3URP^IHBKU]]6V:F*+BJK$]SJK:4!B>-0^9J4I(H& M*(UA&F$,<>!1)&/A)X%5+Z8+"_9>*K%SZ7+[6@C?Q:->_OXF\L>"O#QEC*P^Y,\D6R^9 MGZ*081]*%@F(0HP@02&'U&>)8(3*,#6*V.N5,C7[$4U2R,)$,0 F$F))B%HBA'X2$1Q[Q*JZE;'DN;'"7C^=0YKEMS3NZ@/< MS%48!<:1B>.DD5='[?8?%;[?>O&]L:.7 5;C=?;J$_Z&';X,,.GO]&7R@ &' MR;NDKH\_=2BJ>"?60F8;G85_+W4QJ-5*Z$3N55LJL.IO6R5B$4\@ GD4IA#Y M*8.4$PIQZG$>HXB)T*B2TRU*S(V_?A<;L"$_@:BM:$N^Z%:R6<<(71&FKB1; M-<&V.3$>.EH&Y\03C,'(Y-=IOM+8 'YIK&@JAH![";JF[(JWU@VUIQ@)BW/@ M"49DHM/?$4?&[A#X1DA[CWZ'/GNZ ]\;K3\XYKWU6;UF;R"L*D+[1JWT?WG MIJED6SBEC[GQ@/?23%.EL_EE]%465S MO2-EQN[6_$.VVFX$WY4\CCU/)QS$^VM]L1%!?9\N-ZDVU>_Y&OMLJQ+UX_92OUB2^3&$<\ ME!1&$NL8-WWNB'@,*>*$)$G@$\I,J.BBA+F13JTDV&D):C7-:.FC/.]D[H0MQDQ[WLA=M'UZ I:([?$7*7@5L..SB DN$8S]@.N@R !2 MIGO\$!;@$ O&$+:AJHN2YL9,>C.AUA1T51T4#7497C,V<@+:R.0S$"]KKKF* MA4MJN2QL4B:Y:O,Q<5R_P7FE[KMGW;:F;MW;[.+<2?6A_KL@Q2=UPS(@211P MC"&2@?HC33#$B8=@) )"/)R*2%H%4-R@R^RXYDD4@F@-G17AOCH<9LPS$<@C MA57&0S7=^6=3=IJ#4JB[J0Z829)6VX)=L MW?SF\K&M+=AF7. &PI$Y88_>]QJ]6D]0*^J.&ZZ#X9(C>J1-RA77K3[F#(,[ M!F:GBK+,B\/J#$VEW/(A?R?JDD7JY8Z$8"$F!(:>D!!1$4-*$D4G2:Q^'7/B M1ZE)5S];P5:\,D$7OPM@58B^K"]A=#3MZ< MC;09?;[%^(U,KQV3-)'NC0+:*J!/>ZOZ29@>[T*<4GDA55$?T[ MQ4K/+U5KRG:#]A^Y;GRG%^C?R$;\O?;SECXA,48X@%PD*40!$9 ($< T]7G( MHR2)8JMML^E4G]TLTFZ$_]AI"WYIW&G+%?F$XV\V<\QS5$>>6[JM5KIF=_NM M /IZOB6+-GX!M/F@LA]T .@[R87RB M,(P\"K$7Z1.A6$#,D(0\#<,T]D0<^E:Q,<:2YT80!XI723-MR.I>=Y/\F1O' MPXQ/1D%Y9))Q!?" LJJ68+DMIFHJ?.(2JI:8G!9.M7V L]R&#GF))$@Y]Z#P MU:H;T9A"ZE,&!=,5NRG")(QNS&:8+5^="[D?3E"],)MQDBOP1J:AP;BYR$T8 ME6IZY;UU_L%50C&Z9Z@WM,F*:EGV5;T*NHQN4PT0,TI1P"CT8Z860E$@(4[3 M" :2BH"$*4VQ52^;IO#B>Z9L M[:1&?5!>T%U5V&:)DA S3!7ZH?05NW@1Q D)(?.C5-=TI+X0=HTKQE+5YFN; MIKO%KIQ!U9"AB:?1$W6IC0";)P%()[N0*U-N=GCVYT?6M'T2GB M!DZF6WG#IJ#/:U;H>*@/HO[[\[J*ZWS*5^H991UA\RU?K3[5Z71+C+TDCEB@ M8Y,81"&-8)KX OI1D,22A1&-C6IU#)0_-W>V51_\TAKPJPY>Z=KPOT$3I_2G MM@,TAECZNK;#9#85C C^R P_ N[6G#T0/9=4;*O"I P[$)]CXASZF&%\^(=Z MZZH4.,&K(L=-E&"3"[>4'"48Q0%$"/NZ##J#)$T\*)+(4X08^S&GR[5XU!N2 M#^8LV"_5Z+O#]7=W(GN\;["C-. Z,.^6D,HKN)OQF0,8IZ&O+G1U8?06ND97 M=RQEAHE+4KHB<5(.,K/^F'(,[QJ8 UN'(^J'MWW?=#63;N;M5U%D.5^&2'*2 M> $D@0PA2F---I+ *, I(BGE(;%+C365/#.A48 >F9(Z.N^[4&JM%P<5 D"MN,.<7%NLG*;J&@N?-H/7%I.3 MQ%[K!PS-]\V9$+S432Q;EKR7:HG[G-=>VM)C/A-$^4I^5,4I,P*)SV/(4QSZ M+$EIF%JM%Z]*G!UW;:HMPV=2_*?8 %$O27(IA3Z]WF6CM+\8PE[7!\&,M9Q" M.S);M;K6F[0[[TDA6>M;KP1=9@<;8N,V2?B:T(ESA0TQ.$T9-KUQ& L=9O9] MJ1>)=6WM;O?VI60A"J5:O#%?N5(HY1BF.LV.1EZ"!&(RL.MF92AW;HS4%([_ M)EC^N*[F^^HC.LITM20ATS$PHZ(1D!V9D$[RA*N_VB+]?U9Z ZTXJ#1WN UE MB95+@C(5/2E-6>)Q3%:VM[MHP?=-<%%'Y-=>V?U:-#'>L>^)%"<(AK%'(8IY M""E5*\(@I+$O?$2Y9U6)TE#NW"BK5@_XM[3=NPRR&2>- -W(G'32BH!'RKD1/DQ#$L$4A5'D!802NS7P0#WF MQACOR8IM5_6A7"[/=%S3K>V:_:==9S9+GV?@B!EZ/^./P]A^4&.!QM^P"]Z( M&X$WXNG401JHRK2NTFUXG3A--S[.CE3;3L=U5@I9?VNHKA=%_4>;/L9SBUB M(Y/81;"NK]QL4;/K,.\&O>GZR%N^LJ [J,THGK@P(O%1(E$/%4!P@+ M!DD2!S!,61()R3RIBU,/<5:=Z#UT6V.%J_\*_W[CNV@,1Z\>ZW^ERZ51=:619=^[L@ MY;;)),]7&7NM_]R3A!]Z"=.125ZX8ZS8BBXI?A.4;$2I)N0J(NK=]C7?;LKWVZ)0\IBKZ5M0R@3VXL"G5OLC%L+GYN(V^H)*X6J/ MHFIC8QEY;P6_X1[$2*".O<'041L<@MO1'/PYSK[! ,R<;@K8R)]VQ3\ F9/E M_)!G#*.SW\7F/2F?OA;YCXP+_N[UCU+W2=[E!>SKS"X#Q5F<>Q'DE(80D32" M.,481CP6.$8QIXS8="(T%VU%91/T(M2Q!DRI#EX:W76#C7TO0K)3W([;+,;" MC-G&07AD7M/@:JW!UPZXOVC-0;;^M9.X=7<=9FM>LT?,):M92)^4T^Q1.6:T M 4^PXS,NLN7']2;;O+X7.@5\]7G-Q<__(UZ7L4 !DZD/<SG'"?PC$PMUL@8\\=5Z_VN*4#\<,\/EYTY" %?-:K_SZQ<.=$^V^M1;'VN\Z&(. MZ\<_UMFF7'IQ1#&E$K* !1#AE,%4,J+659A'7*81]ZS2<FC]<9#^J9(Q.7F!6_N?=SZQ<(H(\XFLNB'P"D8<\7:1._10G ON8AC*T M:K+5)VQNC+#7M9/Y"O[4JEHF4_1";$8-KH ;F2 &838@)_@Z&&X3@7OD39S] M>]WRTY1?@WL&!B-DBH#$%]WQ_/-ZHUX$W1*WCHAX]_IW\A]Y\7Y%RK)ZSRF3 MC)$X@3Q))424,HA3Q" 589H&81K%=N5^+63/C5EJU6&E.]@KWP8MJ25YI3^H M#!C$.#8#8T9 (\$],A\Y1=H^;,$>,Z>!"Q;BIPU=L,?E)'AAP",&A"\/(CBN6PZQ$A!<"H] H5VCA +!<2)1#!%B8\2PBE.N'%JQ%5Q? M,EW(@+%%!T$"YG?947!9;);?U:M2G=;])O+'@KP\98RL*K\EC2G%# F(4LHA M"L,04NQAF# 1AP&-_, W8MY>*7,CW*Y^5IYA/Y;]E.H,H9&9U 8 MMTW=WW'9U+^.W;5^ 9-\^T8VMI^\V<7#%I0Z'K7N0K]:Y7_IL_FR:LM:BN*' M*-\_D>)1\(?\?O,DBCO&=+/I2E@A#,HMAJ MPWJ($G/C"47)F=\U2I#%J=[9:4@X;&;&TY-N CT\[WC^]! MFR2R 'X /;P .YO WJBF7W1MU@+<<5YU8-)ACI6-)T/D;BEZ"\0NUZ2#])AT M<7H+4L>KU)N>-6"Y6C^H6@4W 9F[]L>>6HXBYGDP2()8>4O,AVF D>Z[%1-* M$)+$J,OT%3ESX\'ZB=V'9<_MT*\KK-APL)0TN'QA:WGJL]U('2WU2 M?+SO#9\@D:012: 7R02B.-9G$Y+ U(NC**1!A(E5E;@^87-CR)VN5>P/M?703.;N6EF"K&V.<<01:%#"*F M*T4D7/T11'[L83\586I7\_NZ4)LO:YI4ZU;GX2VS+L!KQDEN(1N9C Z;9FEU M%Q4!*4=HUT'K?6__L9OZ9O7C,U;CK M2WZQS5C\*?:VSKMPYC&@^2BF8>N;' MG^Q)O2OBF_+![M?:_[I;<_V7;K#\@ZQT7NH2A9Y@/D4P%KY0*RX6ZM:DBH%B MD1#)_=!/K(K3V B?FW]4ZZZ_'=%H#PJE/JA_+D&^KA/B].YQ]8/8VV)'5E9# M9$9;8P$_,H'M,6\5!UISC?7[%NOJAX\&6%MSV1#07+*:E?Q)^6T(,L=,-^@9 MPSBO]M)VR\TO3=7!ZDP]BEC,O01#YG,?(L_#D KE9&&/<8)P$O/0JMAXCZRY M,5JS#MEOD+3*#@IF[0/9C*0<03_R?KLI-VKJR=:/RY0*&?-$0B\.(XC"6*I%&5-$DI @35.*HM"H MO(F9N+DQ2)M-VFG!NZAKX9>@HS;X)5N#LOKUY?V.(>CW\XI[3,=V=\S@=)JK M:X#,[8F[?4*FSN(U,/A,2J_)70-" 3YMU[S\-['BG_+B_;;<*!(K=/!!^[/^ M_YVJ3L=U+!F-I?!Q!"F. H@4_4#J13%$$<5^*D5"S1+_'.@R-VJJK ':'+VK M#78&U6N&YE] 7]6M(@=,/1(X:PV-]L&.LL8$1$))J"DS-/5+0)(9,(@#C'E%/$XQ-)F56XJ>&ZS6*,B M>*GZ(=1E+YH>";SQJ"OGFN>K%5$?Z(OZ+JM?&_K9U@-CMI(? ^Z1YZA6Y=KM MWK4D6(!V"+3>!GW5K%?YMEBY7/(;RYYT_6^+R/%F@/7]P\BLB7S[)+ANFOI M?C9M4M^)M9#99NG[*16,$RAED"H.0P@2C@2,4Y^2R&<8L="&PZ[(FQMU-7K: M\= U3,WHQR%2([-.&\?;J J4KFTC9?!+HZ[#$!%#8%Q2S#61DS*+H?W'A&)Z MVZVE?7[/M5]/5G?/.L=@*1F+?<$(]"66$(D$01S(!'IIY"'E"(5):)4Q=4G0 MW)BCU0Z0Y][T&CLTS:C#!48C<\9>Q0780777#]4-Q7O.XS!.X9XC66]4M.>\ MQ9<+]ERXWD$AB[5R6C:Z9D9;4ZS>?*SB0=1OE]P7:2I" N.88XA"#T$:^"GD M1(14A@*GL5'SN2'"Y\8:?R<_L^?M,UCOJM\UZZ.L41AL7W2,1F57J<_KK$\E M!HV1P4;?B,B/SD4G%1QVRBMVJH?B7K:'&*T%(\)]0\D,A["_70&-F^"_K;"& M(7Y693:N/?/MBFX86MM;@L/T&<,<2S4?J:?_=_4.WLOC DS+A%(92)Q"(G5- MI(0D,)7$@P0EDM#8YS&QZLS1+VYNTT576R":)9>:-+)]^;$Z#]7._;R"N9D3 MZ@[)D>G_ $0=57Q/W%FP*EEISD 9ZX9F$^M_8EW^K3H MMSSG^ISO]WPMGE]6^:L0WT7Q(V.B?"C(NM0=6_)UU78G$T53?RXE(A6(A- / MN2[>E8208)I GP8!"[&( \_J&.XV=>9&!)4UD%9G<94]56Q)QR+0F@0Z-BU M:Y5ES4!'8VK&-].-U,@,90ZV?;:W$XR-.T#O)*7?SU*$[^1>6 M=P]JD,NG?,6_"O5:*S_L4:BUGCZ>_*H/]A^*[/%1%$N?)8%0SA.D6(<0BX1 M'(L$,H:"U ](&@26=?QOTF=N?+O36H#8:H#*RJ3P,.581IP7N$$7+?'&K>I-/'IAQ/\3@])W#QV M2$]S]1HG'UOFKY[<1$Y]52_SWX7><%LR(B,9$ \&*67*P455%R4$F0@8E50* M;A9G9BQQ;IRJ509:/9O6V2;(&AQ[N,9K9-:KH/JX<^UK-FL4KB $?]8ZVT0I M&V%ITWO<,:83'60XP-:RQ[@%3OV-Q4T>-&$W<0N[#EN(V]PXM+B;>JH^VQ#\ MP[;(UH^*^[.%@/61J?BKOL#A9J853&ZKPYD(GKA,G 46I_7B;&X> MQE'?!!/9#WWX6NJ&O77@WU)@)C$/%,(B"2 BB$/,F'(8*1-(>K$N&V?#26>E MS(Z#FE+'H-AI6VUP;M*!1RB-HSA"IC4" MCA\^-]*HE-*?OA_\0G\%K;KF6?\GZ/5_X+=B,O)W;0N'50;_);MOR-<_>>1D MV?F7C.GFXE^\9L#VT'ORDFW(*OMOP=_GSR];]7%\S^7F+U*(C^4F>R8;P?\H MA=RNOF12+&G$*"(\@A$/)$1I0"#U_!#B) Y#+R+<8T:UIP?(GMLGOE,1;"L= MP4HI6>W#-S; 0JRJ__]2Y'S+3)'RO*1T^U5#;/U8-=JX",&S!?[@V4M M2*S+NL!44>C:=?J=?/>ZO^0K>=6_NE-Z\(_5YLW^$*2LFB<\/)'U_4M53O@? MHE1:+E.?$\9C#Q*LPW&YIR87XC$HTR@-!4N](#1O43JVMG.;DRK=2_"C4DXW M#'ZIM@: 4"O/86D>HX^WP=0UIU$<>V].VP$J0T#76-"Q%KQ[!=WK&HM!93*H M;>X<2Y=-ERYM-FCL!K7AU^N]BLY2$T821!/HR#B%*4@HQ$Q@RF?HLB#%*8FS7+*!? MH UU3-,H0!>Z9Z0H7O4QSY!,\BL(!V&(*8H(C)3C!A'&'-(P2'4D"?7B.)$I M3Y>;7'FG4^.[%SKBQI:6X11/LXU\=RB-[-#4BL)*T].\J&J3W]W>OADJ+C?Y MKTB<=+??S/KC;7_#NV[-N["GS:Z&4?4_/ZBE M[2>2%=7IYS*D- @#'L,PB@.(TJI>FJBZN-VBSWFBN.UAO+-HEQ0+4 M* #UEK11)BT2NZ)RU25 @P$T&G48RA@9*I..XS@I+=.8\$8Y,)..S^6DF6G5 M&#:W?A%EF1?WBG&5FNO'+T+'*-9*E0_Y.U&?YPO^\%?^[T)Q\S(004P#YD,/ M4>6IHZ$?8V%51\M6@;G-;NI+"^QF*6O(S::9,8$<>9ZH5==D MWR@/*NT7N\E@DP,J0&O! F@#@#+$';D/1<\E.UOK,"F]#D7HF!\'/V<8P>G] M(26FR=>- L(%"CA,,<7*M<<8XE!O.X3($Y[/9&C'7@=/GQLU-7'GVRUU3VDZM*QI5I ;]2)AY&D2BI%GF]F\#T/R>B89),]_FZS'BU-YJOVZW0^W6GR-H2L8 %*:%04)TU':8(ICP* M8!3SR.=<)$%@U63=2OK1[R4TC3",4QKI=I48DE0$$,>8 M(TI\YA&C/BPV0N=&:UV=JXH/I*.L;3U& \S-&,PUDB,35U?=!=@I7.%Y9X+G M@,*)Y@"YK8YH('?B$HCF2)S6.;2X=Z#'Q9X$WVKBTT$Z^;K*+)"?JR+T)RWI M'G0YBWTS:YI0$2:"PQ K)PSYZH\420^*)/04=T4RB>W"0X?K,C?:^EKD/[*J M'91N==WV7 2?U.OQ*Z@MNE+=WOEH&?IFTXS!V)Y:8X7VUO9VU+U$6NQ/.V*" M/RN#C#K#V[MOMP/KU)F[09UI7;O;<3MQ]!P\THYMRV*S_%J7K;@OFGKA=S^S MD>'"-(_2"!1%).8Y\@(8RZ^5X2,$->U#I6GD>C)OA3*VIX ME'$1R'YV-\Q[ M^GC8 N!\Q//ONCZUSLVLRPE4.6[=_Z^;A_^>;_Y=;+[M-MKKF&?E.S2_TM?Y MRUA$)) *?L&4FX7"U(/4\Q+HQ4@D'H^01(&-PS6M^G/CHEW:1)N.TU1WJ/?+ M]CD:NAXJV)^!V'EL$[\A9D[>?,=];+_P7'[-/B%!=SYNC&[3;K25NA\R>!4; ML#=TT23? *G<^XZQ[OS%MQDCER[FQ!9,ZI6^S>@<.[)OI,6PN5+I\4?9'#6& M*-&E;V,H683U62V&6)_/;=9YIO"7D\I?^7%RG+NZ")F M1NP#<1B9=956ZN\1SE_/F.N2P+J/GY1=SMAU_.F?NV1(K+DH2R$.)C)\U"&8*F[<>"A<19(/1JT_SMS^L1-&H0^V^3!&??ACACF! M[_/UIB!L\\]L\_1^6V[R9U%\R0C-5MGF]9OX(=9;L7=#EP&AODAQ!&4<^!#) MA$"2^!'D)$V9B$-*D%6G6#OQE; ALZQNSSP*<-([O.: M%9I$/XCZ[\_KMNG)5_*JV70I)*,TB#$D0B@?6OH$TE@-C4P"IC"B$?-]&UZ[ M*G%N5+;K O-2ZV='7]8NY-C(1Z5SI^5?Y:MRXQ5M;SNMYMR0]8ZO6S) H^AF$G(2(@@BHB M5/@"QI(P1+#G^V;[C7,P9FYN6$>U 04FW^J-,&/=_RGC/.&1]\#2DQ=KW6\Z MM>X78 <+V.'2-D U><^&E:%\XP%V7I/RK>R9OD#E&X_K0L8BY365:PPY%6465]@!I M-M?.6P[_MNO90!S&D:Z)@'GLL03'5MN)UP3.[=OOZ@OV M"JLEJ[II8-7'JZ";,8-+*$?FB1M1M.8-4VA[)J@ MN?'+W\G/['G[#,ANA9-+*0H=V_!29,PF=JTV;RE:. M\++I<><&MZG:TPW%S[*AW'50^GO!]=P_81NWZU8<=F SN'[@.BPK6X:H*F]S&&=2; 5O(UN44[CD 498\0V,19! %/@1Q"FF,)$R8H+%) JL"N29")T; M[S0:@M5>10-5N7XAE?N$$^TT M\0!*+R9A& 0RM6UC/Y'FLZ/"NJ6]:!2M\E=_-$U!;FAI/]5[8+)$GNGH_E]S MSONQ^^XT0,SU?;'9(ICI>S/5GL,\WQ_+'8TW&,/^+9(I%9IPS^4-<#[ M-%('K95#R_.Y'&JS=>6;#^#8_DVGI-_>0KBJ:BY?'D! =&I$444NMY:"CJD3 MU?P;84S&J0;H4M$WJA,X M:7*PB.(6S8///'6JWJ5WI"K%/=RKIN=94.)75E M0<12B$-/S18ACB#F<0Q][%,AB.026\T6/;+FQOFMJCI7ME%1^:!K87@(:8*N M&4$[PFQDFMW!M5,3[/5TQXP&8+CDMSYQD[*4@=W'7&-RR\"X,OX?VW+3]!MN MV_Z(W\6F+H7Z)2_5[]^3\JFJ9LP%?_?Z1ZDY;E_UOYBR5'?YJ$S5Z_%\5V;C_^?N79L;QY4TX;_"B#=BMSO".,L+" *SG^K: M4Q%URK55[CDQT1\4N-J_ $A*LBX40($T>V-B^KALDFLO,W^J/U.&11WH 3$K20;P@[QRW^&Q#IHX+!(QYWH_"[O>]BJ M%F&ZHS_K)?[V]/4,)PF&,J$@$:;%/,4*X (S0-*44TEBF3.O8QCGAYH:.VT- M RLYIT8^N33U3;ZGK\XBZ\8\8? :F&RV(EZF!4EMYDVT-33DJ:Q+8(0]G75V MM)%/:5WR^OBTUL4K>E?GU?U$7C;4_;[6S\>;A?BL9W"^_8RL9@4B*<=%GZJ;8$=$&6"O MV_1OX%O=Z6OUK=^7*_W%^U@NJ!ZV$1>M['_W!X0[Z'WE'> &M:KK8^VYM>*Q56K7#S$/DA?\$+W]?6R8?36OGT0.M7= MM]=]^J:WZK;H9C2]+ITOG\Q3W+26FZ699(F@"L2%Z7^!J&GDQ#%(>"Q5@G&6 MY%[[L9VC32VR:XVUSYS8F>N;M.H"V#55%0BVP1-4>XCM6=JVL R9DG) )&PB MJFO D=-/#KX?)YU<+NJ9:M)!6;4N^3L3>*^>FTXP,H%Y)@C3B-K>.2D$C& . MI$PSBIG@-//:8#TYRM0XX]-"C[+045&;JVU;)/[RZ=MWQ],*W; ZIIBN!6OH M[%)C7YU=JH\WKY\':+W3"430S-+)@<9-*G7Y>I1/ZOQP/R+XNBJ7J[HGEPY0 MYK2J2E7RNN1YN[/W7E9\53[5!QTRR9&,,Y @B0!,H 18ZO45(8AFD,A$".C# M$;X&3(T^#HVN[)MT;U?4CT&\Y\.-7(9$>? (Y:6]-_8,"5TU"OM[4$=_?%W. M2_X\3,5M7PA#,I:W#:.265^$#GFN]WUZ-X[ATFSJF7M]*ZL_WS[;Q9S1Z,LR M6BC$"* I,K(:,@84(0@*$:=%7N1,Q%X14<=84R.V%Z9&QM;(F-I+_; +8C<" M"P3TCL/LUYM^'ICU+J^ZN]! MH]XG54ZX@ APPG( 99$!6L0("$@)0\C\%7EF8$Z-,S6^>&%F9.SL*8]X#E?G MQ,NU: V?NQ]483?9'<<>>7?=#Y'C;77/Z_N1U6^:[TQU]NWB?5D]+:NR%A*K*Y62 MF2PPP5E1 )PC$\4H!C!G&*1*\C26$F/&9@LK62KNW)FJ>U2GYXG4S]/1V,,] M6\;@2'.3L"9KKEHJ2=%@ M[EEK\*SM#<=+;K"$9*,+(X[*06[>'S*/XU7]^.:@%7#;(?.+=FBS6NEG9U9@ M)7-AEDLRUU%1DD- N=!0LS0N8I@B+#*?J.CBB%,+ASXO%_=@;9JZ[X[>V7*< M_O*"EU''&*4I+1A(69Z;1LA24SZA "&!L Y-C8ZC7YE44-S'J8O:(?]D7K U M)8TX"6Y4'Q38@=G^N$?[KN7QSN!P?.^,34C*OSSHJ*SOC,$A\;M?V(_[/W;( M6.Q%M$W$^Y^2KC[J+^+,%'#&#.8 <8T]3'"J7P@Z!L4PAC"+%!'9BI:@? YY-R/S=V/_9&QN#(6AS5)GM(@EY$ MN9OD@F,W_ ;D>=@NUVKUP,]#!C4DCB-)E_;[&OHIB[K"TJD&>O$FXREXNOKS M0G73^:)^ >@=_?EN)46Y?D=7JV>U7!G!SL_;1AY)G#(I( 9%JB" /,D!5C$! MJF 9%#*#*E$^@6;W<%/C6E/069L;[=M[1>>4"W"[!9;A0!R8=*_"SSM*=(,E M9#1X8<11HSXW[P^C.\>K>FJ=V2CQ7;U0WBJ:R(2I+&<)4'%2 "ABO6QEB(#" MJ,L@27@JO<1E3HXR-29IS(NH-=97*^PDCFY<<34Z U-$J\;0 C2(OE87!D$% MLDX.-*["59>O1Q)5G1_N]]"W:JM6A;7>*/FJORP/M))?3=_&-W,[8?K7ORV7 MXJ]R/F_S")J+WDNQX3;6:=H-FCW5Q!Q59B1' "(3?W"9 )CG"J8,0\:]R"*H M=5,CF=;D2+:9F?4R8C(26[NM_/]:OY6?-JNGI?=IYK!SZT9@KS9C Q/?5AA[ MS[&;J/5A+[MF@JB='\$E(0;!-R2IAC5P5#(>!-M#$A]FD!!;V56M<6%E+TQ* MHCGM;0\3SG*9Y6D10X"S6(>!B@I 2"I 0C*LFJT_=>/?92 V%XK@[JE;;RZKH; W?R4E8VX?:7'7!:[A=UL[17W&[U065 M[GU7ISOT%,\Q/8F_R:/>9FBF36<[C/(:I IP) M"F#*"6!F.Y8SA'-&%,LH\6H'T]N4Z3%:8W/T@\XWMGU(W>,NHKNVVB8476T] MB38+/6E193#8__53C8*O[$[_677CR7'F:F#>M$Y$.PNCQHV;:#>!>WW0]SX8 M.@B]'LZ@XCS]K1E7IN=JU(X$>ZZ_8^^CIL?BL28[\8;SS>/&ZIN:0/8OJI'Y MN%S524M3DKE7*P8+BA1/.> %D@ *K F9*0FX0A@S* 547LF"$$9-C9IW]7R; M$TU:O ^O7C]I;GP[]E0,OQM]0O#ZIJVLV7IB7Y+-#HIQ9I@*P9#@!CY=>[U= M8Q_##8;DB?.ZX>[=EZ4?GU;R02ZJ\H>L8_(OZ;V6L=W >M*D$'@&ISW M]I%ZT8SEQO9GT2L%;;%FP/5Z5;+-VO8)7"]-.\' E'<1KK!,=GZXD0GJHM_' MO'/YDIYK;[,F?-O14/;M\^XC^PUE/])R]1]F9:GY;_/8])!MDIKO2]-,92&, MVO*,9QQG(L,@HU(!F%,)J%Z;@P21+%8R1H5R:F$_FL53"Q=;VZ+G4LY].[,. M/KV.:_4I3=K02_KK.XH;KR/K=K3G]]Z&U/8[87P/F ,8:YJ"I@H&-WK!AMX)YJ@/H6BVUIKZ1*)C3/09(AHE\KF0*,$PH4-KM:)(<)2;VD_O;O M/K570&.+HW"@-S:F/7 (*>)ST.*HOW8H!Q->].^78D:'?R0SW. MC!@MB$\+(UUCF8%S?:6F@H^2KCQQ)&0CID4ZG!$3<[\A*#]@Z3Z_XW&^\@RP]O'QQIJ7/]7U5G)M68W9GZRM= MW:YL%8&P,>-7N;)1Y4P62:X*3H!@*0-0Y010F@J]0$IH#"7'A'DI$[H-.[47 MPM;J>AO^)GJBJV8'_Y=R$8GE?$Y75?1D]NF-_9X:\(YSX1@L!D=XZ"AR"^[W M&EQML_XJUS5*HEEP:[OKI7E(=68?H,)J,CN-/+(2LP\:Q_K+7E?[49:0Y>Q] M\WJT!4^KI^7*W/SM\SK4"&MK>+1ONLR770[OS)[=[F%),ZI('#.0(D1U:,4$( 4B(*$$N+!J%-PX?ZH,_1 M'S;F\:5K>TOSFMJ8!KMZ_:,G7B_TVXZDGGLZUWP5'+=K1IK@H7=B&C?,EK9K M.UC-KW;#>Y V'2%P#;IU-+41__R_N%[B8Q46^EMY6AU9N%, TT5S]DU9S^ M7"ZJ&2URFA8)!#*1&, L*X"F]PQ(6"2)P"I+)&Q5S=T"==>AG9Z=E]+F0V^, MU7M@_UJ5Z[4.R6^5\@N2G4%W"XB# CE2\/OA7=1&.#=1DH*8W$1;/W;U[75/ MP-:5FVCK3+BPUQ>]D"&N\]BCAK.^B!R&KM[7]PA3VSV@][+^WT^+TTJ\I:QF M.(YSDO$"<$HH@#"6 &>B 7A64%RG"2%4RLZWX&G%JC>7JO*[8V\0[ Z$)X# M\]=V;_B7UFZ3>(D.#II'GP='V"-:'0CID<+5@(C[1:L]8.L,5WWN-UZ\VL/+ M%P%KG^M[2HCP\JU4RY4\ZA_3#N.>>KL,RJ'9)/TO&U3&Y"JTC39/K[N9?3?"N7#^_ MT73];BGD#.9<4IXCO<#G.DK&B&B"3(E>F:D$28%8RIVBY,,;3XWRWMG6Y]JX MR%CGOOW_ JS+._Q](1@ZS>KFO=<6_2E7K]B%?W&[T3;:3SFQOY=^\N]]FYTV M^SB-7(:^L6GGS7!**.<)P 64^@%D!:"*IR!!C)-8_QMQKXWPT\-,[7'7O<6[3ST_U+^;[* M5;D4'Q;BO3FQFC)&4)(4H,B,^#6!6--!BD &]>L7R2Q+N=,RY>P(4WO^6R.C MVLI(FQF]=RX[.0_DY3?TU? ,_,A[(].KKNZD]P%JZ%[>=_1ZN9-NG:J-._W! MD%J!.U&L5D).2,65C'- D)$V91 "@HD$M) %3CC/5>%TP,QSW*D]^O\Q)>V_ MXUERBQP&P'[HO;>SJGY[6G[C"/B=A6EXM;[CH2<@S7<6#S<=OO.7!VT\W/0# MV*JMWJJ/Y8(N>$GG7YO6QQ]^KDTVD!^_+BM[?KTR-E2E! M4XW"]D$5?R&A2(A"($8H U!JQL>9(B!1--%O 580O_Y-3J-.C\<;L MJCXP97^.[O2XML+I-VE>X$\/)==_NW>64/";&#="#@[WT,ODEC""Z60 M!.DV\*CLYX7%(;7Y7=R/MS[+JI+R)8G>R=7CK6HU4V>0<&FH"4"BN"8M% .* M8P9HGN184)0SOR7YY2&GQEC&.O/T+%]6B7DNKAV@=J.AL .S$&UL3>'U4@W M40MJ:W,X G+')R3[.(PZ*O6XHW#(.QY7]I&;TL&6W:DW5;!M%7_;G3RC4,HL M!8HS 6""*" $Z<5PAKA"LJ ,N1^;ZAAH:@2S;^KNV(F/DE$'J-VD$A*JX<.9 M$RCU.?/4!9>/T%,8V,82=NH)GZ>*TV5,NE6;.JX?4:7ILAFH<@L1DE!")0 4ZB9,BZD9DHN@5 I(T:,3\#,*R@[.'+7@5,O$O^H;?7,Y9W!U3$"NQJMH:.N7D#Y1UJ=. 2-KDZ/-&Y$U>GM M4135_>F0LN^S6$B9IP4"198F ,(D!T1* 6@JA(HY09SQZ[7:I\8&^T+D@I1;B_6:E5W%U,8>M*Y@A'*=%G%% $XH %#(&!!&N5UTIQ(CE MJ<*B/;!\U[O6XGA@I^?AY7'ENS%XY*!XXKJBB1-X.W)($/A>IU!"1+6U34%6 M?6 Y)(FX8C-@=<2)05^S+N(\!A=%0 MN2@X2F*<@#1/(8 D)@!#O82!.4YXS C#RJN>V]N"R84RQDA@[ML<0%XU6V*> MO;"\9\*-F@;%=V"J:FSOZ&]M/:B72 .UNNZ-7]!&6MY&C-M>JR]&1TVW>M^H M'_W91H*5O:&X6]ICHVWS#B5@5K!4!UJ2I JD0)*D ))#O,449A[%G>='VIJ MA%;;&'WX[TWY9!<;=9WJ8;MY/WKK0-J-Q\+@-S!AU49+K953;.4 /E0$EXMJ\VA[!S=?XLQ4>V9$\P.41*_+T@3@!$O M<<(R#EF*BMA=-?#P]E.CB#T#?>3JCE!SV-^Z"HNAXY.=;;WD^X[P\%'INP:7 ML<3X'+XFGB)[Y[SNUM([NFI$R;QS%K]4QCO[J1[GWY<_Y.H-J^JZ%"[S#+*X M #E,C9QIG *",@@2GB58$9GGU/T _/Z=I\=)VKCHB=[+?W@G9$UM-G1['$8 M_BRV;DN($(@-_!SW \M[]7 )B9!KA[-CC;IRN.3QX;KAXN=[K!H^;DR?K_L5 M7:PKNA#4-'+=]E8E!4RYD$#%. .0\!@P+#%(),Y)G#.*B5-1R*6!IL8.WT\> MDE76@:BLJ@UU[F9S$6.'U48@Y 9FB0:>VDQ[TJ(VM,\BI LPC^5((.!&6ICT M!]!ON>* 2N?"I>OZ\98P#EZ\6,RX?+Y?D8<;\P MS/%)Z"].J4JSBJK3/F_X?V_*E11O%F)/J=&VS):B.6:V_P?.S?GBZBM]-O>8 MT:0H\D2':(@P';%I$@8$9P)@SEFLJ,PROZVN4:V?&M&WYND5FK7/+_(;=^+= MPLG)3N? ;Y_6[VC/\9MHYWJT[WO4I,1;[RW9[KD9-0!LSQ#O_[%N8&N_-5\O M?&N\0^!7F;V0[I.VH1Q" M&$JF"!"*Y *I #+5 9DJK(D99+'U+W[N\N(4WO_&+G9$L6'[]>K%V\+NQ9Y+OM@5=7N-3JR%LEQO?Z?ZIUR?6+Y*/^?7E_V$\R M*X2,$9,@QE9GK8@!3:4 BFF.1T(2D?9L+=K+GJD1_4YT@LZCMRM)_Q3+OZR" M0E,^]LOG?0GXEYU'3?)IOZ-HWS:A_6;6;=TQXGP-_#K9;Q;:H-[,RFX.;J+6 M(;MT:%P:J67H50 /TS6TGTFOU#CT*OS.]PZ][K8]58(DT^^#:KVRD<"[I7Y) MK-9&@>B;-(?#RL7]^[*R,?V;QZ7^R_^UP4)=J9W,A&*YHD( P4VSII@(0&*& M <(YDC%.4T*]^G1<9[;K8"(+RO]&\Y7LK-A MV@!SZ,;.H\W,P-QL_(AVCMQ$>ZZ8;$\[9:TWT;X[S5F2@,)$(5 -*EATE4'C M"AF%P.Y(X"C(3?N?J[]KCN?.9)YCB@L*",P%@&FJ *.8@2PF$".-%U74]S1] M>_.I$>4[NEH]FX?N1ZLQ;(C2__#\%CP:QS'.8@1D01.@%P\Y8&D,01R+/*.S)_M5_[ZFJZ'0:[YXAP,-F/B_&CE$L( MJZ+ &M'9>FD.S@Q+<=LA!J2XW9LDJN2BU.OQQ7)MMH+:OI[/5C!@N7!663J) MJ5LPUQ>I@6.SEQ(A835!#MT-K02RO?_H^A^'GIU2_3CZ3+\(Y;AO9"N_]J]R M_?!N4ZWU8G6U5;R=$892@O(<%%*F $(< XR3 A "BYSE@F32J4B[Y_A3BW/> M2R579K.XWU%:7_3=N&! 3 >FBU--9LO%5KTQ^DO;'[4.[.EZ!VW!U >[P+V9 MO$P8NVE3'WQ.='/J=9MP^K/5+IF=,D01(1P(A'34$G-#9PG1L1ZE.E+F.$^2 M:[5GJ\GN0M36]CHJ>P%7Q\@E&%I#QS*G16:KZ(]!S7L7 M4=D35_5CD6]R7=9U]E_U]^*+_J;8$QTPPTIFI *Q6D1-?/)-SNO^T _E4UO\0R1E)J$+J&0$P"R+ >5*$P,G^BNB MF8%1Z*4Z='ZLJ7%":ZI>#.W9ZBDNU &M&R<$ FQ@8MAB]<+, >0W'. (JO_3 M,=RX2C^7_3[2]'&XI"=A&)O-^L;6YI;5GV^?W\H%?WBDJS_MZRZ),X1D;'+T M)G&:2@)8GF>@R"%'B: TI5Y+D$L#3HXZ]NV-C,'1UMY>8<5%Q!W))"".0S/* M%1#ZLXHC+D&IY=*8X_*+(P)').-Z75^FJ=:WZK?E4E1O%N*[7/THN:R^+^=B MEG*),DH$H,JJN:<,T 0A(',N)8QI$1,O_>;S0TV/72K;YJ^GWN%Y2%U)) 10 M@]-'C9$UTQ8RM89&QM*0U'$)C;"D<7:TD>GBDM?'1''QBK[2S8U.H='-6S^_ M:_++#F 5@PD&>F&U5445%PE"'!O/:20QHW-6;Z?;&2=&X/+<^UY9$. M\;#G)C+>1<:]R/IW$QD/MW^EQLWHT$\;F]UU3*M_/^H!\ _:DSJD?>/V MI1X V:/>U$.,$>+DB4FV-PVO3.3(!$L!)"D"D%$"*(]3D#&14:Q_2E.O]-:Y M@:;&VD='$^K]GUZ]Q,Z"ZT:R(2 ;F#![HG7E$8UC*(8[?;$WUBL>K#CVN/O, MQ(G/]^6'NEI.,TTM1?';2O/1+,GB F4Y!X0B>G_6B@6JUG_RP7Y>/FL=G1U8\ZIB8NX SK M)S]."H 9*4 J,(FA25:G3BGIHSM/+1!HC'-[M(]QZGZ:K_)^X >XL2O@QO99 M;SN>5'W-WE.J_W7XA![?=)2'\JPO[7-X_@.O+TM8?V0F>"Y5S A ,8P!Y*;/ M7THR@(402!.G]N:_,V/T>MD/,'UN@<+K3LK '#603.";[@E^ M51W EW,P5;&_QLJ_K:+?2Y2'E.T[&*GGRZ$^__G]0'Q:;Y\EK*I3CC=:?K+TLK4 M:9*R\MHV^MG_NRET^+)<_Z=<[^AO=Z?Z(IODOGN@B]LG6YDYRQ.I$,\)*&)N MF@4QF;&LJ8+89Y%?Z; ^LO%FM]$>:]K5;_R/KRTWTX2>?;ZQ,2>V-D5VJ MUOISZ^A9L_X.A1NCM[3ID$#PIOU7G["0;Y77HAH&WW M91I].3-V]44>5OG,6%XD!4<,B"*3 "*$ 6$B WG.N(2H0 (GLX6\I]JM.T<9 M;8=QGXHO)/E\Q+-=\.Y^R02%;\QMV!8R:Z_F?ZE? H?%?H&1 M]-#-#HSH2++9 9#U$\WV@*E3,]OE/N-)9GMX]4(QV^>ZWN>\CD0L;&I&CZ3? M);QNKF"VO2@NF 148+UX2:G1Q8X+D"G(LR*/#L-.;:6QTX;:+%@Y MGUL5'2[+'Q[=FCV!=UL0A(=S8,8^IX]CC6[K"-_,Y\N_+/$8Z?!W*RE*DYRI M*AO<-TX%/2'F 6+@7;"XHNUSY^U'ZP+MXN1^4VBGS_=:;1X4 M_Q@]G7)QOY<8JF89RI*42 F$PIH=5(H!S;,4H"S%$/(4,>E4VNL\XM1HPHH, M[30_O=9$#O@Z+2_#HC;X^O)$35]C\G[2T6^A[@"EU_HR+*2C+3"OA=9W?>D. MTX4%IL.-QEQANOMUL,3TN-"/DJU$_>IY]OOWF80%12S-@3#'^2&",2 BRT$F M%2D0Q1G,G<&JG^OBC-7H,]RNC( WOX='-F/Z\')L7?OWRZ^_ ^^G[W MYN[#]^N?SF,?.Z*BYL-U9-3\XS ZVKOA*(_AL0/M\_J6^? M=Y]I=L5L3K_)Y'_X*5>\K&3UJ6D7\2]9WC^8W8(?.A*[E^W?OZY*+F=)DL=( MR@+P).$ QC$'-.4$Q#B5"=6$2#.G9=3KF#\U@FB-$]$OY2(2R_F)_7&_"FYIJ.E.\(B;T?NNOXA@(O8G&PC,/G4#@A&2KF&X MB5H@H@:)[:C"NO,*KS,Z17L/K6-'OI?E%KLVA8MN' M4DCQ]OEW;=.GQ59R]XU)0-25J:RR2WGM%*1WMOJ]L'I,@]M+9UAP!WYQF+;$5E*A-=^\)'XQ'FCR M_S4Z!7OT1^M'P+K4_B"&9.X>5HS*OOU1.F30*^[45T)KR?]\6,[U%56]@_QE MN9:FC]Q\66U6>XUR"ZZ107D"!*3F=!2&@&8\!4F6%$FJ"IFGL9^ L:AP^(]F_]G6S%BS(YV=@_4B\ ;KK!Z7*Z# MCZS-Y8G)L4Z7[PWZ%J6T F"WZB@_>7":J T6:"8*5; 8<($0@ E)S,D?3S MRU;M,T4+SM*T -2$=GH]BP&E60IDG*(BHPH)X=74]WJ3IL:;WS>/CW3U;!YF MZU*3FFO78(X;Y@&GS#%"''4B1LRHGCS>TY[A:3W1<:0][#Y,-!D,VJ!AYO56 MC1M_!D/Q*# -=^=^O/Q5?^\?]*BW;%[>U]4:3,8)1##3%,LE@!1A@)420.0, MTH) (I)T]D.NV-*5:8\'\7E@]X<:[KEMU7-6LA&;>&J,CI9;J_WX\P2TF$(B MNP&OBMT1H7W5[^LGF_!,Y['I+43XPR*DF?]_*0=#L^&;*\ MH:9M'4U_LFU(RA_2]$6KOB[G)7^>Z76^+#(I !.* I@5IIA3Y'KM+V"N*,72 M;]G?PX:I<44=.ED?ZKUEW\QECVFXICX@&+BO&Y)&?]06#Q2!]H=N^+WU;C,F ML$'NA)/;+K?;K?H1X#^7/^Q7Z=/B/^A\4V^JMV>@3#[AFZSDZH>LOBWG\X_+ ME7FV9P+1(I$X!2(UV@=,ANUYSJ[X]<.WY(GTS6=XO[NC/#S\-J\NW1,F/Z/Q(#TP!7+]V)S& ,,[WB].N#VSG>U%BSL=.W^6TWIH[;/^&0&GJK MI[8T:DRU>SR-L=$OC;GG*WE[M,)U B9L.]SN(4=NB>OD_W%;7+?+>O((?2K7 M=6>C]IBST6;X]/A$RY6A-'-$?8:9!CC/%)"TR#2',-.[DFDV40DL.$T3F/GU MKG09=6JEEQ'?^1$\KJ3\GZFQ659DLK2<-.4V)(QF%!GIH M2MH#K;Z;4NM%PS057,",<\!1:71<"J/XW8 1+KO\/%L1K,[ACK*EQDS75[/$V MQFI,(VMN3Z7<+I@=F2<,>$/S37_<_'GF,B)!V:5CN'$YY;+?1TSB<,F5W7=O MU7$!X*[^+B[2),L+@/52"4!1$( 5DJ 02:HX2V"._!+Q+J-.C5.V1MO:D5/5 MKPZ57U=,@F,:/C2T0R>.0J#:OXNO"TJ#=//M'/AUNOJZ8'&VNZ_3Q=?6Q;5- M!SZ6YD#^Y_*'.5>QUE^G6,??JXG)*BX3'@)*,Z@6;B@%A M,@&6C@IUGE]J) M##61CB0XZO0,S9"-,V8"MFU>:G^ =>AX6LQ!,^M45 =TXY3/78OU,.5SO:UZ MI?*Y:U$\7SYW]9VO:[-9]P&^HS_W*J=G1"29BE,,,D2A:;F' >.(@ 02C!(I M$X[RK3RT?\_-4V,Z/=H'TM"CM>%ZT8!S[SA'ORZ<)R%WH]"K$7P%]:X]$P=K MR]F%QQ#-.4^.]RHM.KL\/]>HL_.:'AJ O__C^S]^6_Z0JX6).?]]6=D,6]7T MI41$ZF@.8I#0#)ER"048%@BP%,-40,92[M06ZO)04XO>C+'1SMIH:ZZ':%TW MMMVL$1:Q@3GC+%B7VX+ZHN:A\1<,O9'$_:Y T4_5SPF83CF_[CN,I^/GY,D+ M 3^W*WIJIVS,36[5-_FT7*W- N&[O*^E*7-,)2$* T5S B#*"H"3+ &49Z@H M<)QFN?#22#D[U-2(M+;4++56UE:S(JX:6STU4<[#ZQ:!A0%M8"[=X;4S,_I^ M"3!_"9.+6 25*CD_VKB2)!>]/I(>N7Q%/[+X)M=ZZ6CN9"IB[_1-VE:<<4)2 MD7&0*YP R/("$/VE 1R2/(VA_M;$J0]5G!MH:D2QLS,RAD;&TIZ;BV>Q=>.) M$(@-S!+]P/)FB4M(A.2(LV.-RA"7/#[DAXN?[\<.W56>[Q[HZMXD44SU@_Y] M4[ U2T2\8B_>;'C7X&1WWH]/JIRO6+U>HWT1NAIZ<6]:R=/#5/X;CM M*IA#$E\_0T9EQ:NP.J3,ZV[6-V7.UI\6U7JUJ:OH-?'(:OV-KN4'I:1MJO%5 MKLP1)7HO9T4NF-3T"03.,@"YT#R:)P+0+,O23$&%F%?_+J_1I\:?6Q.CLC$\ M6FG+??/G/OB[)M0'0G7P#+OI$K@U_"9J38^,[3?1#O"=^2'3[CU0"YN']S%@ MY,1\#VR.,_5];M)W$5E)?=&#YLGW\H><+Y_,F UE-AG3O(@)57HJ4AHS %.D M ,N,3*5FL52S69P3IP8^'F-.C<):DVT@(79&^ZXJ+X/MNL ,"N'@:\T]]/;L MW1[E"9>>[@%0V"7HY6%'7HTZXW"\,'6_M!_Y?)95)>56A-?VR6IW)9^;(__5 M^XV<<2D22',$,,EU.,6*3(=3$H*$*06%2@J(X&SM7HO@.K 7#8U6D+#QI\9@/S)R!M^-D8: =&!:JDV^V5/]ME;?;(L6GF_, I+I,(J6(APW^4(5 MDJ"2Y;S(B7.U@\. 4PN3_D\2&9NC%T;;_++']KT+T-V< M- 1\ W/1>>2VP5&?4@@7+#T*(@)C.E)91!!L_0HD/(#J+)-PN<]XQ1(>7KTH MF?"Y[KJ"UJT:\.WZP?!Q(@7*B 0J3?7*-AJ$(6I1#T9ZE2K4T]Z>JS\] M\^D06?EWR\4/N5J;VOD[#79E3C[=K:C0?/.>/EM^%]I5)>4?4ADO*7S+@%9/RCMAT)^5=;S)0W]ES[?X^TG)E-D?-T:'- M8ZV__:VL_ORXDG)_'Z%1C9XQ*6B>808R&"L 8V&4* @&<4.9_3+8VUOZ&:SH>;?C9&G.*L#D[E+@]D+_66-\[9HQ9X M;=V_B0P D4'@<->V06'$UK*!YVW4IK*A;)^ 6NYP,^+=2#;T^/W>?P>)7/.? M^M3:C) 4)SB#0&1<+^,I3 !#4 *2*4EB'$OLEF"].-+DWC F3::1LL;YO4W. MH^E&_T$P&IBOC[=P[,[8IVZXO!GU(A0A*?#\8*-RUD6?#TGF\@4AUOK?I) U M$=4=K9OZ?!0KR 7%($7"1+1)"C#-."G7H.+"C+.3,=[PL*(%(4$).8A#Q+ MJ. P(:E7I7!O2Z;&8JWD<^M)M&=[4_?_J-\MF_KLC!^/]9\N-W(;91(&9KS3 M^#=>V G8]R-JFK$,VI3E:EA#Q94M\<]!%0#/_2MB9$RHMC[ M1@9L0WD!AJ#-*,^--6Y+R@L>'S6FO/3Y'M6V.XG$-KW<'#PPB[F#=MU%3GAL MM0KU4@KH%1,%3$$&; M+AV#OFXNNJEE2(2'WA%L)5]OC[&\B6QZR$/2]3J0/2IV!P)[I,K=RZ 'JM?M M 5-GW:[/_<:KW^WAY8LZWC[7^W&_D.7L??/=LDM)J^=02R?-4$)03(A>[B52 MQX*,4H EU_^$*$\2E/+$G *[S/-=@TR-TUL[HYVAC:R7&[=T MI-UJ%@&CHS M[X^0,S>X0+"+_ZHV *PD_\?]\L?_TI?7L9_^X3#DZ[SU*)3@XES[^#M]=HAM MO3<_RVJ&("&*0 ID4F BS0!1# ,\@RF>9X0B>(KZG9/#3DY&G#9?C*&!]W0 ML^"'V,[SA70*FWG=: ;>RML':+R-/#OJA+;Q]E'PV\1[<:4?#U7Z17A7KNNH M1I0_2K&A<_O-EPI"FL,$Y'$7L7*JCCT[PM18QAI9 M+Q9;,[U8Y3R4W202!*"!.:,'-LX<<='_#DK0U^[1@?[7(16]"?,\<2=RMBNYO%@(9Y1E1\;,4YWI,$F M9YBV2>'-?:5^2H/A?K[1TG!#!NK ]+)ENFE.7"XVY>*^J:8UU17;UI^8H@*1 M',"<)@#RW,KU)H G,5>I)*K(O-XZ5]@RM;=*Z\J_7=FVP4MVW<_U6N']YMJK4>>V7U!>H"M75KEJE2N56_+9?"E*E]EZL?)9?5]^5< MS CD,,:, *IBH]H$,: QUXM]';VK!!%$N-.^0B![ILJI$3=*VCK6J^C8L MU!0Y;"N/"_S 1-LZ$QEOHM:=FUJWY*:IR5V;+=!F;JS*^:V*K%^1=BQJ/8N, M:^/.EL?^]+BS-M*V]6BSY[?)'0[KSKWO ,.,MR4>#I,7.^4!;]NS_8>LS!$\ MFWR-$:,4(@B8-'EL(A0@+-7_Q*1(($]S09A74X_=O:?VKFI,Z[47M@^96U#? M$XB!WQV.&/BWNSCV-F@3B[W;C]N:XMBOHX83)S[2[[ELGO\^"\U"(*7_7X!$ MQ06 &6& 0=.J!^#&I*TKK!F5(Z['K5#2@QPQY[[>6;U:=JD&5WZ"@Y4]K_? M))?E#Y.Q;:O3[Y9OF]]*\5'_YS\E754S4O 4"2J!@L@T/"LH8 D6^I^8PA2E MB0Z9O';P0EHW-9[5#T'NN147=+(<-]]>:PJ&WFXS?@';I]'VT;"N15O?:LF3 MJI4^V?G7BMBWOMU$QK/(N!AP4VT(T(-NHP4U<-R-LR&P/=HJ&V20'@G=MYNJ M7,BJ>K=\9-J"NLZ4+^\7Y?^5XI/08Y:J-!;4*K)O^']OM+E"F]TJ_I>RLMMV M4KR4HOE6WC_HU?;O57/I3+"<4I0G(,T* F"1F,1OC@%.($6(,<:Y4Z/V> MVFMA)[Y4]R-9&7O!4H&-_@>U)GOD'T>L\C1G=> W3>MTM.>U*9)M_8[V M'6^TM*/6=9N^W',^:KP_ZK,2603 K0(:@^8NT_R>>.2SI_E]&2GO/<'OC5^& M?/S9Z\RDCVC.>!GW\3%^D9E_A>'[ZIW\D(N-Z?2HEJM'T^3VELW+>VOQ>UGQ M56G+DF[57?EH#O4G%!9"(@5R7$@ 29X# M,$Q"*E"<9(QSC<3PS%:_RI!27- MI-K*PB=[1L!7)<4/?K>UZ8"@#AP3-);;\S&M[='.>+.9N37?% G4#H248.F% M7%A]%C\31A9OZ87/L;)+O]OTK8)%VS[/.XNA%5(+0&)J6=E3=1#=H+ M3?60=887X0A;1WA^N)'K!"_Z?5P'>/D2_Q-Z[S:/F[F]:]T#NS[V=ZO>B*4E M)+MKGZHD+T1, ,\0!E! :4KZ8I 13C,8Z__/A.N!/9ETW MV_K0B*D[!PK(8\OM\" MQQW."<[MT)N?US?DN6T[\.Q]13[L?47,K_6G=B#<1#4,$^C(TW/B)M&1Q]?V MOT='GIXS$JPC3]_Q>Y8MKJ0HUQ\IMQW5FT8/1!">02R!S#,(((FA4>9"().J M$)R3.(Z]7EFG!IG:ZZ6V,6J-[-E'XR2<;MQ_+4A#A\V^^/@7 '8 $+2T[]0X MXQ;M=7AZ5([7]=G O77K'RLCOK,JN4QFG!2*XR(%*F49@!)S0!@K=.R:2\&3 M0JC%\\B38X>M?=&3,=!&G&(YG]-5978AZNC3,_ATGP?7U-X Z Z>Z.MJ MKKL'N[5\A+:ZY[ :I:7NT>#3:*=[#A/G5KIG;]"/P#[0U4('0-57N6ICJ)+/ MA*(QEDP 9<4$81P#&BL.)&>(H90PE7I5_)X<96K$9(T*PD:G064T0SS#$.2T M0 "*0@#]/A @Y28BQ% P"F=Z;MER-%CW1QL.V"]RW31EW"$:@8@-C+<;TU^- MX<"LWMIG,JOUROTFLC:&(_!."$*2]>F!1B7F3E\/2;C[P_T(]_?%:EM*][$:WISX@U?D1K[4CTE_$D*JTK]L_21]?_RAESHY_A MYV%@?GHQ!>;DV]L74V"=B&HOHJT;]H-A=Y^O S(DR_6T9%0:O ZM0YZ\\FY7 M[#JQRUE!YM*G>YL9E*O'9":S3!&,,T 14P 2DNJU.L^ 2%%&*64DU@M)WWVF M04R=&B%O]PKFI?*DV0'GTV/'Z-5G:?I[1,;=1H9TS^&;W3Z1\3GP?M"@TQ)\ M!V@8:\??\QD4]9.[/,..Z-]GY<-B7:Z?/Y9SV6P^YXDJ8)H6 '&9 \@)!D3F M!*2B2)(\RV*%G'1B3MU\2\#U\W!U\(Q]"+<'0FOOBGG7+ZB M7\K1+4?KDW+.F?W^*&<_\SJ51YHFRD9YX5/3)6&6(!+KI78"XIQ# '.U;MU2J)3LVJ1PCX M"I/TMXG];O>"O=;32,_SU^[30Z,7 75,Q)3J?4Z9^;G .7053]=0_=X> M+X\F_DN:LXE2O/FA?WLOOTE3'M#^L5Y'0@(Q(A("(2 "D*@$D (F0&4J(S%) M12R]DK"^!DPM0&PM!K0V.5JU-CZD#SK;<.H)-H7H4.&['V??O3W65;55 +,B,R*IHJ P9BCV$DGUMF!J!*B_KM"/W_Q!=R.X0:$< MF.%JVX\T+&ZVP>=I;2X]?CB6ZXU?2)KS-V)4GNN-T2'1];_1I XH??@I5[RL MK!#&_?W*KK _+=:K:)U.L8@!C:)J?(04RE"J:\I20V"MB M?#5/IL:\>Q9/XIB2PW=AG!3$*#/\-TI4=!YDVD/E)MKB$FV!J;>YII/6N'IR MIY3\Z._,WRI%1HSITY#?L-.[?VV3VU\GP)[E; Y0N_VA@H/Z(BOD^UK8O>X MW+1B[>%XW@^BD*3L./*H#.J'QB'=>5[=DYLXKW42I/@BUZ:>CJOD2:L%Q)-4?47?8H>I+AW[8[6>X8FM3>W[S[I MJ'7G0/2;1=X8^ZO1FF/KZ+ODFY658]2?_$'+N7F] [5< =.@SF18;..*/VKG M IY [8MK4"[TM6%<5NR)T!$_]KU/GT:2]*E9[ER?C(8DG9NDM XK MO\F%_(O.FT9=]4Y=-4-"BE3I>-,4^HPTH3X=(D<96+&Z@XYX 1Y-H2\&M;N1I#];S]B \BK,7C9^/'Z MV_6+\M_2N5%K_?X@Y?JSF?96F:^@"J<08I ;=3&8DP10"B5 !4D+J K)N9>. MZKF!IO;V:>R,K*%1:VFOSI!GL76+PT,@-O!+HQ]8WI'S)21"1LAGQQHU$K[D M\6'$>_'S :40;*>?^48'U[?K![EZ7U9<(RP5.0(8D!+#(, M&$4"Y*DA^UPF."-7BR5R69S/*OA/DQD CP#XP09V5 M"FAZH5D_;B+K2;3GRB ]**^$LO M&H6Z&^8L00CG>98!'JO*_E$2[NU M\UA61LW',QWJA+0;\87&[_76[MID_9^MT0'U]#P@"JJOYS+NN'I['D@_Y M7-N/@'Y;+L5?Y7RNF>[30D<9]^6V2]&.[;:!@10%UT$;!2(SW<))SO2R+Y8 M8HGR0O&"^$5N7J-/C9):XVVPL#._;4&V<\ E7 @P.6[D-1CD [-84+2]^:P7 M:B&)S<^ 41FN%S:'5-?O)O[GT]\WZ=@WB\6&SK_)I^5J/BXBV4QU\\LG?6UUA;Q( MCSESH^.!9V(,[JVBVOZ;>@.ANCE]R&:?DJG27Y'HXW*E9+G6RYJ QV7ZXQGT MH$L/,\8]HM(?IZ/#)5?<*D0+C3M3H#H322X2;$Y^9 0"&&!W_B#%9FXI\/-R<0]L1>!!3X%O4PK]C%XH6?W?TJ7GZTISQ%N9"WZF7/GL_2Q --+Z@4 MQRA!*@%Y1KB.HP@%1, ,%!DC&>:<)=CK",:E :?&&,9>\\T_:"=U$]5&]VR[ M=1%V-^((">; +'(UCOYB$X[@!-66N#3FN%(2C@@<*4>X7M>S0'13Z0&J2HR>\5I&9@;6\^B/==NHIUST;YW[>9EZY_=V]SS,&I?.I MV#NAR"N !E:-SHM46%W[O]8 [12R:HQV*MXG%&;M1R(#U5[WEPG(8@TU_Y.0 MR0KNW-]#-FNH.0TFHS68@?TB51WKOJ/5P]?5\D>IWR!OGW^OC/A#+?]0+N[? MF)YK=7#8:?UKK(]:\\TKZQ?C@7[?_!J=@GV0@N?^((9\%?2P M8E3.[H_2(;E><:?^N\A?E_.2/]_)G^NWVJL_9P7E19;H13/-L=(T)U) B@(" ME,:*QES$@@C?7>2#,:;&8\9$_[WA0^#<]X:O@&-@YC'6W42U?=$?S?\:0R-K M:>#=X#,XA-X-/AQF]-W@,WZ>V@T^]]&^S[>2JY5M+[N7[K.1UXR21"F($8!, M4@ A@X!(G ,L>9+B@L=8TK9CE^N3?G8TIZ_XRZ9; S_S[5G21AG4,V[I M:5 M!ZX#:RP^J*VTA<-[=C;GX4/2P44XPM+"^>%&IH>+?A_3Q.5+>JC4U07^^J9- MC6]3 ?QA;MI/+Q>WZO?O[\O**!R;E-L'VY+P;B6I%F.F1S9W>Z6F5)_\JUP_1(_W3A/(TX@^2 M_PGT- *V_!G)QE4CN[XVGD5O9/6\,-?KS_[^C^__B,0.@4A:"#SDU:Z;[FZ. M&VD*QZ' YN"+F<+&D^B7QI=?;Z+6G>A6U9.RYU-4.Q5MO1IM>CP$\$:;II$T M\,:8+C\MO" (=\KA73?">(IX09!X(8H7YHX!9%L>GS9ZI?I]J=9_T94T13"V M\VVJ5\^8ZM :)I(#%BZ<+NX::VI-[7&ZD:,V^B14<%2Q^, MW4+M<,@-_*IY*=)26QI]WZ(7M/['#93!9%F.1WP]09:SWG=*L9R_JA^=:"I; MF99>[V7]OY\6;SA?;A;KJF[L51_Q8#G&2&0:6ZE)13 %"$UTP(T2BI(8D;1( M_1;M+L-.+Z!N;8Q66R-MW=QFH==#:!C?>"0;M:(&N-3/ZI37X M5[.]O85Z9W0X%O*!*"07.8T[*B/Y(''(2U[7]CVRJY]J$S3=JCKF>K.P'+B2 M#SKN*G_(YK?M+EW&)8)QD@$2C?B7&CK@'A'IC%@B#=X\QM+[S"GK?U,V'DL[:]\#D^9]OO M-OTXKVVN>JNVYWO-<7NCOE?-)(QEFN<02"AR %-J'[*+TS4]:0]HE-6?=_H^S=%0FC"<806!D#@% M,#?"U,2IC% M),^ 2DBB0Q&) 8%)#*ADF&&94"JXSWG92P-ZLT-W5_5QM.JT&K#SX=_5F];M-[[ZTN(]C)C._J MNC$S[0XX @73W 9)@0#%F #.$JXDP4H0ZL-R78--C=)VU30]]M'.0^J\?Q8$ MJ.'WS=J*H_T&!(-4S;M $GB?[/QX8^^/7?3\Q+[8Y6OZ,8;I&-W*;.SD7J:E]SLQIE$]F:M?_6Y?"SKDKAJ)AB* M.9(0<$5B'4ZE$)C"61!KXBEXFN0PWV[NW[GSS0"F]B@(N!OE'$^]_VG* NH@ M8;TT!?YEDRK1L4!5>V-^G._\\:.V(>;>C1%?:RK'(=)][_:5RBNCG=1X&&T] MK.7GK8]F-G=>1M]W<_S988Z]27C 60C)W4.8.2KE#XCSX9MBR*'ZO6!NGZ1A MK<7]9\-H9@]BEF8IS5!"0(*AT.\'2$U-!05$*AQCBA 17BT CX>86OBYM3": MV\HDL]_HQ]4G8'2CVNO &9@I=[A8ZV[LOF$X@COO>TA^.C'*J/1RWLM#=NCX MY.LK9N[]9H9XP1CA"4@25@"H$@8T)V0@RY(,QS"-&9*OI9RY]YO);R"\GGSF M_FRZ$=4$YFA@MAM(3O.SPWR_JJSFB=F8JKSFOJE_6YG-$W@/*;=Y:K@KTY98JGEJ[(UI;VS/MZ3@5GIG0\ "/EQS=L_TF^KJ#N6[E M6L_ FPN8]T^8^B$W2 [5T8372:OZX7,VT^IYFY[[U)IF13G?K,L?\KODFY4E MT0\_^7PCI&A[EFWJA?BM^D!7"QV\5U_ERFK3O7DT9R-F@J19GB &"JFY#PI< M (*%CIA)S@7G5"#F=4 SB%53XT;C%&B]BOXZ%/NM6XGMIUOK9F.UU.^5+/]'.H:CUJ,Z>[OEDLJ6M5T;2M)9(O8EJSP+NGX<$.NBN M>A##QMUK#XGET0Y\T)OW$*3YOGE\I*OG6_5-_I"+C7RG*>9^N=)&V$9)N]UD M&4N1YG$.4F7SHD(!)O,$2'-85B8(9=BI@-IKU*D1=6.W>8P;R]L5LGVZU7*U M_7WCDH]:C/-<=+/M8 @/S*8MN+?J$$0KO6GM=I+)NP)9#TV7(1 >2;ZE$^E M@BR^\'1JKSC?;#R9%5__7BBJ>%_<\T#,9K72WZ8S^BTSBHL8XC@#D"0*0,41 MP) I4!"%\TQ@GB?")Y'=/=PT\]&\MCDJMYW7?1/3%T!VBXS#03&1B]2 M#@<*4 &/QCC!$O1T3/>(XQZ01'.X3=JONBO:G'G&4P M+IA*]!H_U3P".8* 82I RF&2P"0E4C.*5X.6[@%]'HQQNJ;L>KV66[.-P(<] MNPO,>/4N>]5#I^D"^%1)ED&L^9MF,8 PP4#_&X$XSD469ZFBPJMY>SCH1VDY M^GK NU%\.#@'IGA3T/_I!89-_:RO95.HB.V)IF,1;-^[ MCT#R7_7@JQ,L@(M<(94@(#-, :2* T88 H2F2@E4%(E;1CBD47]W@J>FL_1R M-3RYGYO4 :@]P%1-C]BM4U.B]0LHOQJIG[-KNI1^ :QRK6(3<#.8V%*48S#?8R"IB>8I;@&-',Y]2;\\!.#_GX M9]C:OC1\9ZE?VX#+B#OLT04#\%6E:ULLWPV'I5^GA:"8CM=0X5ILO?LE..-T MJ2W"Y1N-VOW V:_#)@?N%_:+NC^6BW(M/Y<_3+_!M9[^LJUA_KV2:C/_7"HY MRXE419H(0!$N#%-C@%G. 84IBO5?!,H2GZC:9="I12WR_BB[+31"(S?P*[(V%UA[HYW!]7&9FZA!]',7HMZK!!^(0JX" MG,8=-(PBO>ZMA_]U^IAIIYON= 112M,&J>H8$P E1<*0(H5H"070%") M%<8BHP3Y\/W)429'\-;(:&ME3RW2TXBZ,3-')P0AJ>+T0*-R M0Z>OAV30_>%^3_]OJV55?5TM34U0DJ0D$2G7#WEFNE8I'6$(H8#(F(2$JSR3 MB4_AU=Z]IU9E94V+GJQM?@_W/F!NCW1/& 9^D&L$OG8CX/WLGO UY!.[?_M1 MG],3?AT^G:<^TK/WP&KY)%?KYZ]ZPM9O%L(\]T]FM6_:GA6X((0I#J!"^B&5 M>0X8PCF(%85Z?1!SQF._94#7<-,+_UMK[=E!V9K:HWJF$V7):,8@*4",B#0= M'B0@""> D4(EF<)QEL<^5!@*X_$J4)]&P3G+ 2"5*&8 MYUF1)$+-]) CH;Q-^:[_G_@6N[V?0GTW!WYAM6;>1-;0K3IU@US0!HDND 3M MG=$UWKB],QP\/^J=X7*-WZM0R'+6=&RE/UMM!6ZSW5\VCTRN9D;WGM$<@X0( M"F!>,(!%@@&7A,2"$:3_ZK) O3C2Y!:I3:=B^C-Z:6Y4V^O&'YM 72>^8VYQ4]$UI=,+O%&(' &Y@HKL#-OQ'&942"]L#H&&[< M]A>7_3[J?.%PR17GAEH]^9G $ O*]*(O(69]76" )16 %EE>0)Z(A&"?1=^+ MNT]ME6>.4]2G"WL<.ME"AJ2.PC*9 VT[-++5$N T30 AM(@+#A&-68^357U M&R?]$ 8VA1AD16%:XF89@+%)X@B$ 4M35.@7D^0">I^)ZO5-&^%M% 8RM_=, M;R &?K/4AY?V&I1$;];K5A#O47V#IIL;V5AW]&G4K/UML>RI 6+4X) 2C5FD!(*]"HU!S01!2<<)B3U M*C]W'WIJS_V[!_TO69F"L>56L[@NC[')FSW-U7_S%MISG0XWVA@&Y($YY4QQ MWDX?NC%]D*;7_H@%EM5S'7UL13U/5$Z(Z?G>H1^EO9=,\Z.^E:TC?;=!Y[ MA2]7V#(UTFOJ(_BV/L+VQ=XZ%%5R84YH+)9K7T&/:R:L0"F2-"X RH@ ^AV4 M TQS!23G18**E.MEC\_*9JP)&V$=].[,Y-PT#4-W4SG>=+F]M$::A('?8L:+ M:.>&:6>P=43_HW&ED2*T0H4'%4CAWFD! WYDKO&G%'?>@%P.WP-AKAESY3R M_OMG])NCJ D51PB @0M*( 9I(#AA((8 MYRF!4J82^26774:=VKO.FN:9279"US&G'!JSH;/+UMYH:W#46!P9DZ-?K-&_ M1G_4=H?,-/O@%#3G[#3PN-EG'RR.\M!>%_>CG[L5%?*+^18UST(LJ2PX)8 J MJ&-M(BD@65X "(5@N?X#9ZE?AO5PB.DE6:V%D371CUZ.T..2*864 4X1O5*) M4[U201Q@F(H")I QY96-N0:[,2BY1FX1 #DW#KX&CX'I=N]+- "IGG,\)'\> MC3$J59[S\) 5SWZNUZ%Q_9 LZ/SW2GY?JO5?="7I0K0_OI<_Y'SY5$>$U7K[ MC&>(Q (20(3$^AE/,D"(RD&19TA*F*$\+9PEH/M8,#42:'TP![NBUG2;N/^F5B"@2_UU'U8:=AM*/K0TR'[VGV_E!> M.-W>X\9CGG;O[_?!Z?U^ M(80":F#.[X615U7I)1"N*"@]>^O1:DDO.;=?1GKQLU>V6F[TJ*OMSG%*'6EJ#_YN UDVEGINSY_'U&U1&02I M@9_\'4BMD8-LLU^$8I"FS$>#O4YOYG,^GVW1?/:"/AV(3",C1BMIE';,;6V\ M^F:U,D4M)N1@S[N/?*7/YE=O3.>S>CMBMWE1W:X?Y&K]0!>WMF[5=$GB^OQD8[]ME+36'@#K0O2C]L&GH<]K?FD1^(: ^)B#U'^Y]KT(@L'#?M+O0>(I&%)#*81 THIM6IA27ZL/\5N]M] MQ?[C[_45\^E#]3?YJHW5V^IO\Y7S[*1=_Y@Q0; M4_B6Z"\1N8FVCD0[3VP2N_5E3PI\KPQ\YV&XI:@WIB&7INZ#C[I4]<;D<.GJ M?X,>2]D[S;F5TBSP5J[_DK)5D&U7RW?+KU\_S HI< )Q A*6(@!%SH'^MP28 MQB0A<8P@9\Y+3I<1IT9A6YMK)?VG1N.XS8&9,UJG-7$\@G>GF7!8QX7&=_A2 MC ;:QMZM@O2'/72_?OT?]/'I?W\(C:?'HB4TKB,M+@+AZQ?Y^V#5&:$[W6B\ M2-K'KQ<1K]>%/6C\G7X7+!_EZN-F(3XW9^>>FVV1F<)""J/=B&/. (P3#BC+ M\:P:Z2IT79K:Z0V+\\4>M!()[(.=!P*K\%W*QNHC)W1UM"; MMAU8*,0\"#<4 M+1]9N;#?DV_;!CFM-!%MU;6K-UR'=RLIWNP,T9RB_Z:_9H=2W'6&XNZ!+GY; M+L5?Y7P^8WF&89(((&.1 9A) 0A.],J&PI06A>*".JF3O8KU4Z/X3]=U5QAW MYMT2%).=SX%?0:W?T9[C-]'.]6C?][H_016UWMMEUY[_40/ S5%/@^IF/S7> MXA N%_(JTQ-;0-I;VWR]2OYH!F5]?8U8&KO MISW[&]IYX<&!\,\?QH_(.N(IP^<]46[OHB'A'_AU,@#RWN^"OO"%I'-O&T9E MY+X('9)J[_OT54A14J\\3$?,FGCU#^_TO\NU/82NEBNS75G-I,I4#+,$H((+ M $4& 5$9 RFB>8XAI+'P:I7C..[46-#(ZW)K9L3W[?25S7 #W8W:!H!R8$9K M+;9JQ6TL:WZNS8[>.4';0_K""ZBP,A=N0X\L:>&%Q[%\A=_E_0C*UD^\[2BQ M>/N\^\A^B4532'&[65\Y& M?QAWH\;?@"'EL!,2DKP'LG14KA\6[<-7P\"C]7R3;%A5BI*NGK_3N;Q5W]=+ M_N=N'2EDGN<*<4"10@#FM*B//Z)"Q+"@)%'4*\+M'FYJS+ZS]B8R]EJ.-Q9? ML92_ +@C;P>#<6C^O0Y!?_YT B8H#W:/."Z?.7E_Q$MN5_7CEW?+A3V0]:]R M_=#N\6WW][YHMYJ=8T8IS J1 YP;.7F8YH DB(&$9IIP$I$JW^9VCB/[/"SC M:"!]7B[N@::WQTBT2\*5_"$7&]_0TA7[ DE)4P8UJR<,0/TCH"HG@&.A*!4R MEKF7I-T R(\B:C;-!9'?VF3H];FF_VJB9W=X;C?$ZB0+P'7 MH4=]&WCBT9]-I=Q;N9"JK(/>ZL-/N>*E#H5G4F8ZSDP4 M@"HQ&L:FGU-*8T $9Q+GB'.)9@MY;]+#W0SE,:K3\[3M&KD;>]@T*ZMMU<1$ MYW;7W%8L5S:B6M;+A$BV+GA)"SG-1#=CA49W-#%]LU-DT&U,CGYIC/[UIDX" M5-&'X3#U$F@*C>UHDDQ!,/;58/)!ZX+JDM.MQM19\O'M0%G)Z]*^:86GI[E- M:M#Y.UH]?)PO__JT4,O58YWTV/9,X4G,8D0 AA !&/,<4"D2@/1BH(A3DG,I M_?(+3N-.+?3<-SOBVNY(:<.CY;Y+!#7[7;$-P4 =/.^SA:4R.C,W1GM&# M:+9X A4V#>$V],CY""\\CA,3?I=?5QYL*[&JTMZY+LJ2[Y>/M%S,",M0G" . M$#<]VWB2 )(D!%">8J4*<\S":UOLXHA3HZ=M[>:>Q3=M<::,_JBM]DR$7L;= MC9V"HCDP+UT+9.]RU8O@#%%B>G[05RD+O8C!N5+.RQ?V8YZSW=-WVP$Y5#++ M) 6J2*1>^L82,&;TS#."T@2Q).%>IPDN#SDU[FDMOHFLS;82?&OU%?LP#N"[ M\4]82 G.0.T A2^P&-"4OE5[@M3K?'Y>K#S^W M0N S01*F5$H!PE(!6.BXB#(-.TI%42"<$ZY\-@(N#CB]/8"M@KW84[ W,F^R ML3K:5(X:W8Z8.Z3\P^ X4@#4V&I!:ZV],95\46NPZ1L0%$*/#']0*$=*[E\+ MJ5]6WQFASH3^Y;N,E\MW]NA%&M_]JI%+S#_2H@J[7IG/9/^K-\W#S.JQC ')XSBF.$ERO\AR+,.G M%IX:4X$R::2R,39:V?:"C[6]OXY4E^X[_XY[$!.VY M?Q,9 "*#0-1"8%M1WD0-"A,H:.\Y;Y,HU_>]1]-YS1H*5P?<=OW?A:MMY MV+0D;KIIL82C1'"L%Q^D !!3 5A!,Y#DF4P$2ADC7OO5)T>9VIMEOU&ZL=*[ M&O($D&ZL?S4\ U/T(3(#M)OLA"!P#>.)@<:N6#SOZXGZQ(X/A\Z$ZO7U6VWJ MG[-<4 Z3# &EPU9S1C(#A#$,E,AP7* T1Y+-%G)];1JT'= O![$>F H^5.OR MT8HNZ!6&VLPCD[VKS*F.-SWTF5S@)BB#,9QGL?3J MQ10(\%=(.[_,-P<'^MK\SZ\XJ31G#(VOY*,GF0YC&R35O1YU(JOD0 M!?=,\]&5/1+-;](X0=_DD_Z>/>@@4P]VOZ*/36"B\J*(%=2$D\4"0"HA^/^[ M^[;>N'$MW??Y%03F8- ;*,[1A92HV< [G32"*839Q+W'@SZH)4XFC%T>: M&L\84<%.5M )Z^$)O8BK@Q\Y%%H#T\H9H/IT]+V(F(?;.!1R8U6MOI>@-XI^ M[F(79"YZBB_>8#PGL:%-N(HU1MF%BF5QWF1.O45\!MV:K1ZLP(K_;@_ MT/KO2X15AAA4J9(0)?H'57JW3T24<54D*!*Y#VF]-.#4Z,H*U99Q M,R\1?5BN?3>;+V+L1D(AD1N8?EI1NTBF$Q6)K;SA6,<5F9!\\^*8HS*-*P*' M'.-\73]V^4TVS;+^S73B^D4VO"[M(<5ONVHZ FN2^5D*V9Z&OM-/S(U=L&_5Q^5*-G?W=/5A MW:Q^EGNUP^8YRA*6)AAB)A.(*(NUB:-)*>9%FK"$)"J+G#U&H> MF#[M*>UN)J8#Q68N)ER&:Z.MU??M1M]F1L!,"?PL]VM CJ'H:R54X M@K[\'(IA$+[H.:V#'3+?O;[MH_?326^R/JIY/J>MTKO&JA> M#.BBJ^B\^=;1_YCZ>QE-3+ MD1!0MJFMNE8T&T/ N=%P8]H"R?+)G,_Z;09"*M!MX_!*:AEXE=RU%35&S79> M1D=;^7;I>&&*+G MZ5;7B?U6[5BH,47PWC\\KE?6<61#37>A,Y'(9)Q)#!,I*$0DY9!B26 :,67R M]PN1^Y7-]Y5@:H1N-CG+RN8$F7J_1C70IL?:[? >N_O6RO=6C>-YUY" #WWT MUG9;UO='6KN%_D8RTU M\QJS7/^]D#9^OQ+:/*]7Y3_LYV<#N.;:HA=8H@@619QJLN0",IZG4##$XAQ1 MSG&RR>&]Z]5)[BKYG-[LYRF_=V,XIO;:G8F]^5G[C.Y-K'=?N>NTBF.]UJ64 M0Y5CO=LA&8.4ISF,(Y'D"F6QRJE?^>Y1%3IJ?>]SNGPEU;DMD:^ACH%7SGT] M[,_)'*ITL[*OU_Z\9N @J'CF&)9]37/!(( /U'3P.ME>JQEA$$0O-"D,<_]P M'1?L'NFC7'4-U><9Q[2@)(&$9L@T+HSU1U$.TPYM3V*%_N MM2K: &?@&[K^_^&PKU[[_PP.+G7_SUW:-\NNZZ]A0_YL2N_^ M<5?!,*,DEE"*PF38&7<*(05DD9!8<)22V*OGU.7AIL9+6VG;JOXS\'^B?XVB M&#S2&CP9V6< SZ(HZL*$ 5VO-).97@!_!=5R\VEIXRA]D\0NJL6-O\*!/3!U M[7#^TN+\MQ;&?JB$S06[..+(>6 NLS_. 7.ZZG4:J/Y--MK,,U;;]T?) MC1-@:3[:$W ;2O)>TVE9-26W4YACSJ@FL0QJ>ZN *,9$&V&*PBA+9$X$U7MG MI_RR5Y_)U(BSG8C=CLEN*B8$YTE_/&Y'UO[/AJ.W^L^@\:&]W@'[NNX].&_W M'ASS\;/E0)NUV_"P+3#MLC&!>CFAE#N) CI73^;/45$GE,Y"=YJ]7J#^\?-2 MWC[*6@M297DIY@2'"6&\4LIA#18H( MJRRE@@C?F'I/&::V$FZD!/MG@^_6^D,)/I25*8[4G<1N2S>N*ZTEL)UU^]\V M^N-?_CG.HK^:J-3/TKP/&H>6:35%FD\/KMDV^2M]?2A]E.^V8 ZLTH&7NE;Z MV2'0S]HI;C4^Y/GN%3"&3@[P%6/TA(&>.)U*(NA[JY[=<&A3-K>JB\0S69@V MIJ;]N7OQ4I:23"8<\IA2B!A+(8T2"G&D6,HRKD3BQ;INPTZ-:*W4AESU7K79 MQ$)[=L%QP]N-Z,*C.#"W;0'"PA MRJ0V5N,D@R2)L(P5TN8J\@M.&PS[<2+0-N)#VLJ_.376V@ R&_L!+R49NT D.6LEMC'RK@&?>9BM^N"6E%VHA%Q<_ 49=9GIA<[C@ M]+M)OZ7G>9JDM<"_/.HU3MQ6?Z-U:3P"IA1Z/(]SDO(DHY";7$0D8@*+ L>0 MLXQRG"B$)A'8X"ST MGR. P5<'H_<"&GK1:EZ(I'BWK)4LS;!/>?I)KOC,>#+%<+&C=@$>] MZ;;>C- ]\4(_#H&6NE=4\@16OL8U$' /!FT!;0M('[EM-F B\:(2^% >AQU M90P]AVDME -IR'O='$J.G@D_^IW]J-_BKI6]*I!,E4IABF(%48(X)"J-(8]0 M3EB:<2Z].KX^O_W4EB C'3#BO=S4W@4\MR6A/R0#$[8'&OY9-B5#P?Y9/LEK+=UK"4VG#>U'Z/,]Q5$2FZ'T&4X;&.\/L9AP, =[ '-*)#,R[ $Y7'0!_#!(IZ@M6 M2'/#>>Q1#1%?1 Y-%._K>W*3V<[ YV) MK)\7D4IIRB7,$J+I*N(($JX4I!*K2#$69[&7&^X*62;'8&8J<*G@NI& VMJ; M8-G-QWA-9#3+*U3O2*'C*'1H5MWH4L^CK=D";O=4^79?E>?RO'X$I-KK00W* MOE>(,RXA7X_;$4<'N&7/'-!E]?5.U@\F+&%[RC/'21%%0C,P%XF""%,):4XB M&&R=J:+R9$<*%%;NM5"2VT9V[E25#=J.YJJ 8F ML=^VN!@)]T^R Z8^7L(@:'+CR8'&35^\-->C!,6+7^Y9P(XV]S>5,+],#+]^ M 8Q#^S CCN<%TV1 (**9_B%P#%G""IA3E"=$QAEBL5<).Y=1I\801EJP)ZYG MU3HGH-U8(CA\ [.&1$8?G!IH:[6SE]..; MLSBZ44P(= 9FE:V(X[#(2XB$)(ZS8XW*%2_-^) >7OQ^7T;@RP=Y1[^; CE5 M(W^6E53E:DX44GG&- W@F&FC1.B_3#/I#!-)-1\HD7H2PLEQIL8'G^KE4]F8 ML!OC*?B)M5):9\Y?C+-'SP&LZ'=?M_)\M5S1Q7@H;T<;#N4[,P9X'!=K5VJ^&L'!F=DBHT4$G8S@IT[*\T& M/0CY(@YA^?CT4"/3\<7Y'K/QY:_WWR\>V'^?9;.J2U.YK+,/GW^P]\VYRM.$ MLSB')%*Y)A."8"&8@BQ6F"B<9SF-YH\V0NK+BM8K]]UD;YE\7IM#R8;=,CN5]@O4-,?]6E95US2NE=)_=]I?K9(529:E @HD8JA7!ZU@ M3F+(*&5)A+C6,^W4^K82DU3J1J[)J%3JCU]%F041$8XH@84T/8,R3B%+]((? MXR2)B4@PY\AGP1]-D6.8!7\6);K[D491S0C^I=D)Y]).=K!U01U^YN+0Z^5Q MNAK8T)ZH_@*-[J&Z&KM3GJOK;]JW \.9WC.'GAD9R30M--_JGP5$% N]C%*A M[20A(Z2W7B+SBMMR'7B".UPKMV.WI^M =V/*(: F<]!W,%[?OS;T8 ^ W,2JVD M)PHL=^("(V_8,LH.P(0NF7QIR-'+(SO,_U0I9)?+_-BEJ5?SNW)E^NB^KT3Y M5(HU79AHU,]R87/JFOOR\6[9QM!OTM=8RCDU>] B8A!%>0Z+B#(H$BHESFD2 M8:=VWSW&GAKK[$MJ"L)WJ1Y^B6Y]='"9@P9&=F ^LI*;/?I.]H#)&HJZYA7]BWF]:M8M/]\NJJS WSS J]+L@%WU1/=\NR/@+I/(M7 ,;;6X M(^&51G=NRE=DSAW=]H'=([Y;U WU? M*?/+?+3;[,>QC!*F#,VDH,]T6U'\P[R/?$'[233$\&@;1@\ M11BW'T,_?(X:,_2\C?\6ZDW;^+Q\DF^5DGS55A2Y53=B:>N-=%:[3+C0?,=@ M+%,*458HR'(9:=:C61Y'M,#$R9OL/N34Z&TG-6C%GG5EAFP3E$[T'OLG1P6\ MO&T*#^O0!VUA$/7:/_F!=.VVR7&TT79+?K/?WR1Y7AFT9I\I?G17:XOB7MY6 M\H.T.P">:CZ*1&3:6&6:AHH(DISG,")II'*)8QFC .7V3HT]-68R#1Z-[U,+ M"/Y;TGJ3:O_P(/438>NE_1*J&.Q)7;@97P,A/#!)G:P^MZO6-0.=[!;]/UKQ M ]I;/4 ;H2;&G4,[M$BZ.E=@NWN)U6I9O"KIM"[[9>.*##M2$D2@GJ(!9 M)B5$*B*0,83UEE0RF0J1I7ZEV<80>FI,NNL-OW!LAN.IZ!5Z.H_BK^ M?36%CDC2>PBHSB"9"=P+W&MMO75L^\,7\ MC2TF\;ZR32B:9JU73/EFV:R:CW+U>;E8O%O61IJY,K5!$98P3A-MJ!/31DV* M'*8RIPBG*2/8J8V-SZ!36U=:L35C@+;Y2B_&'$!YW\CNX#+SU< M7B2&0G=H%\($@!5+;ONOV/=S=("?C?Z:0%^__O6!J%V_S)5V58J3;DWRNMY*P1G6@?_S[JLI?Q2:FGVO-7&X7##5VNZ MF*LDRH1IYEM$!8.()A@6/*60Q9+DG.@E 'D5 HNX=16BV<5$Y=MV)39@C1F M!F!U+_?KJP'A[=H)KV*_T[=74=Q8YW-[DSMS/F>B$UL%V^[I[20[Y>Y-T_KL M9J"=:?@#O.!*&.*(+YR0KW((&!SC<\>$X0<*T=OR#:WK'V7U]>;!=)>?,Y*K MV(1Y,V2"+Q,909)A_1=F>1[''.6Y5X6%2X--C=(_Z4T7+Q_I E KWS4]*P]@ M=>/>4& -3*.'%>%^K9=-P$PZ%Q2&:SMY,-XKMIH\/?/+[27/7-./*'ZO:LF7 M7ZOR'U+]=-8'F%\EK6U;VLVS6"W.H94H-ZY=G67<^#/K]T[(K+#LO,I4F M&3:&92),J=\$4L(+2"DO<"HI(0F=5_*K9C=QY\XK(61S>J6*]I4ZDG"XUVL[ M!U";^%8I3.3WBGX'CQO!];_^+K51N:[-B:*Q-1_-#'LE'0=1LAN]C::S<6AP M?SJV\,EF0C.PF1+83JG=)]A);>(GS"7;>86CSY HAZ39('*-2L+ ]<*S$?Z[IHE36]N?< M&/_-+V7#%\MF7:R FD49X1J?E>F=)^;A'"5\@Q M-;[?3 6\?P^VD['E$W;3 9OYN$<-7Z.IRSPU(OY#1X"\?0,V,YF!.(%1,=M^ M8%;:%_4!=A,,W*,H$,K7!BA?(\)H4YB36;(:\*HX]N_O4*,D*!XQTX \CGV=KZ.?(N5%- M;SP&YA)W*+R9XN240U+!\P%&?==/SNWP93[]I9'3$$Q=L-6/W5%0<[NZE_7= M/:VZ6-./R^I)-BMYV(G^5WWKE3E=WC88>AX9F@C"]3X1XSR&B!$)*6<49E(F M*HTR0I'7@?#$YCAIFX=-[Z4SQ2;D0Z,:DG1.4!DB9:C, > M2,"B!%8:IEU*Q1:I&=A@!2X^F'IM88WU>@V?7O?:3\(DLC(&FN*?(X%C6/T& MR_486,RIV1E_LU-YEM"RZXD9\4+R'.GM!U:I_I$*R%040:IB+%&6$Z*R:9@3 MEZ8Q-:OA>2=3:N;7@/:1FHJI&V+()2N_]8(T93"E&42DD AS[INR*$T50@A[;6,N-*^3FA5C88I:/W2PT83\\E*O6O)3?'R7OHMB9_@XMA8U6T[:EB5RO3,#& MRLX1/-A)>G9]<=28&SD-H(>!>6HC,=B)/.N@_J2AGK7%QFZK@&:[)TA!6[PX M#CUNAQ<_/(X:O'A>WJ,,R$&2T/)):L[LR@/&77VX.,EXQG .94H3B)"F-*9, MZ]^"QRJ+4IQ+IPQPUP&GQF7OEC5X8[I_"?V^_.>:UF90\+82)KSBBWX,K-0@ MC6; /)PVR:/[*&X_L@%J'[1F[C!4$"0SI2,9"7H0U4#,0#GHN%0%SN,UX1$(]9/2L XG-=/QOU M>=/".14,%:*(8433%**4,$@C@J' &#',%$T+I_84IV\_-9;>Z^5I.J[ZV8H' MR+F9A/WQ&)@[#]J:AK/O3L\XI!EW,,*HUMKIV1T:96>^U?>-7=&RDN(MK4W' M[J9;@A3&.,D0AS0ERK1&I^;-C6$B,DJ3F)"$>Q4#/3W,U-[@&\[;,M7ZN=U( MZOL:GX33]76^%J3!7^M6P"TX Q0LO@Q"V#?]Y$@CO_&79GO\YE_\=C\&^"A7 MAD<^U^]MTAE7Y9',=YP7.\Y0K!%/*S#ZL8'H?)@64 M6491KA=SJ>_KD0/J/K074XR0$&H* ]JVZNNF/8LL-S(#NA7:CSH\].!&)\.@ M.S#%&&!M)_2-V.;0^*??6Y3_ K;"@YN78?;F'G_$0O*1Q^BC\U>,. M5T0.L9=/7MF9FK>WZU6SHM:O+!MB#(W ;YU?49?# H)&G,7Y4T.OHZ61(T"N)TG,II0O9V,2A2OQ2 MUI*OMJ?9M@%WT[7AYK)\,B>LG=#-W?+G[E,IYHC',5>BT*]T+"!2-(*$IWK_ MP/(X*S 5+/)KLA1 J*DM=L;B?= :-$FS"UN9Z[&3NCLKK3O!/9?"$/H3C-'" M=#D7&"F(M#D#:9%&$$>(I0)%(I?89\,WNOY&JPVDUBM3Y&&CR,9,%)K!#G3Z M"DIT-%!&5LW0%L=. >;HLYT1V$X)M'.:M;_!;EJSC=VQ>?L^O_3V^9L/ 9$. M:@^$D&OL#&BLBE&+,M)J. M(,(DAC3!*91IE!28TXPBKZ;30P@YM25Z/T'=JS_KH)KTV'B^HGX&YGD?U81/ M KD"NU%3//K(.:T$CBN0]D[/N&:LGH6=9-,LZ]NV54>WP)Q:4#Y0;666JQ^V M0?NN()NB,N=IGL TSS6G1RJ&180+TR:E*&2,Z<:;&WALIGY5N>]?: MZQ\Z>[TU [>FW[K2N@-; #IKT;-6U'4Z=6/W\30U,(^W$YD=8KXUQP^L\9DV MY1NN]UTVA'BKX3_L_$#02GMAH0Y:ANHZB<8M3!4$O:-256'N&CAL.>FB/C#" M(B.T@"I&.41(YK! --6TS!*$\Y@*3(*$+2?3#*K7X8"WVE+7635?UH!CM9=1JK1!&1046(Z2X;*4BHR"')"<9"\$1BKQ,* MG\&GQM<;V:W'="NX9\Z;#_AN-NY0D Y,W1NQM0EK!'\.ZG"%H:]!+6@ZG,_X MX^;$]4#F*#&NSSW"%7W^O3)QAYLBK&^V*:WOI-1,RLWB^57.(Y:27,H,YCG7 MW)8B!0N)$L@Q(C&G!1?(R?Z\6I*I$=U.3*"D!+4I%+>LS*Z_IM^J_13AZ\M# MNZG*<;<_A@*&WNB?*QS=3F1;+=K88ULMZC05:7=A'GU$M-> MF+G4F_:[8=\F4]O7W,3.Z(VIK'@I&TWGO^H-JR9V*9N=L9+GF&8(84AYC#6; MYBED.&&0130ILBBC<>IU<.8W_'0IM+&6S;,I^#9%\M*#&U4.A^[ _+@/[#/) M+E7G?IX:6\,>6;C(W:.7425O"$\QA2 M*@1$+)>P0!&'6*9"9$+_F[@74CBX^=08RDAGMUX>CK%#O!S\B5>@,#"3; 'H MXR(\1,+#'7@%(B.Y_CR0\7/UG9GZ1;?>X37CN?#.2/O,77?N._U,KCO3071= M__BRTL36UE=568:S),&PR%0$4:PRR!2.H=ZXLDQ)1$B2]&C"?#R2TW,X?DOE MC:"@,9("NK(E!6>@F)$"V36_F,4(@\9$)#1@N9_]H#\P!:S*)[GP;&1T0A%N M=E5/7,=AO"V65KI9Z)JPY^<>TOXY,^V<-6&;^&^39UPN1+ M;)H#S&,2RU1%!&)6V'R^&!:LT(0D"HX*)$66.G4AFM*DIF:;';42V:5MF8 . MQPWDE!!V,14G(NJ$"/M5VX6<>/@,3"Y]0J;[&'K8Z1,1>8+[@RD^EH%V*!-3 M^L6=T51D'6]'-I49G]H)3DVV?CO03>F<3[*VTN[\R@6BB<21-OE,EUQ$40J+ M6!M_>9%E64(R2AGV\>^?'6EJQIA)0'U?\>6#/6-K25+=-91"H!C95 MMB6OMA@-Y(%_$8R0F\WS@XVZYWQQSH=;SY0P53Q*"A$5D7 Z#?0=>&KD\67]\$#K'^9$_V:Q M6'ZS+0B4J5?,]4+IH,_O<;SR[ML?:[O&VU'F8E M*67S9EW7QH;=.@81(P)' C)FBF$P'FAK)=^*! MQ4[B?_.-C#L+JYN)& :L@8EZ3\@9V( V1-O9E]$(&YAV=K21(\]>FO5Q:-F+ M5XS81R68B,=SM3HKNLP:]SL$&1\%^*FL@%@N%K1NP*/>"=IC MV;^,U,DTS,/C1KA_GD=B^F<4A[U+;2K(WI-E/GZIL.$&'F#QF4"CTZ!ZGD3# MTS SFE;=C%&T%ZP!:EBIKBQ\:+/)WU=ZQ=%CMP[2@YI/\S0E/"M$ 3F6>AVF M3,$"B1C&^BMY)H7*"K]B2NYC3VW1W @+RM:5K GRJ A>O96^;QT\!YTX+F_# M(#WT6K1#M"N/L86]%?VXH-T =>O<(1ND/)W#\*]3A5CWZM%R4_$?[<^?QPURB+,\S&.O$??^'5= M"N,E]^T.X:DW-QH<4AL#QD!\^%GX%6I>0X%**YIV>T&]E)9M-?N(\C87@!".("8XA*KC>\BFBH."( M%#DF5"9>%M_9D:;&>QM!@5&RMN2>EHLG\][Q]J!$=8F;WM4BSN#L1E]!T!N8 MIYX#9Z78:C".JC10<:2.%ZBT<+4@>)W&22^;E MEG(8=&ILLY795GO=!G!LQ/:.\O=2@*,/*C"L0SN?KD?4W^?D 5%09Y/+N.-Z MF3R0.'(O^5Q[CI?VE:IMI[__^S]M/M$_S+'7O__3_P=02P,$% @ D8!8 M4HS^!< __P Y"0, !4 !O;6-L+3(P,C Q,C,Q7W!R92YX;6SOR)OSNN-RMB7LNX>TUHM&Y4DDY1=,_<%%HL'A2X0T "@4NQ??ST. I< M=0B

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end

    •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omcl-20201231_g6.jpg begin 644 omcl-20201231_g6.jpg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omcl-20201231_g7.jpg begin 644 omcl-20201231_g7.jpg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end XML 26 omcl-20201231_htm.xml IDEA: XBRL DOCUMENT 0000926326 2020-01-01 2020-12-31 0000926326 2020-06-30 0000926326 2021-02-17 0000926326 2020-12-31 0000926326 2019-12-31 0000926326 us-gaap:ProductMember 2020-01-01 2020-12-31 0000926326 us-gaap:ProductMember 2019-01-01 2019-12-31 0000926326 us-gaap:ProductMember 2018-01-01 2018-12-31 0000926326 us-gaap:ServiceMember 2020-01-01 2020-12-31 0000926326 us-gaap:ServiceMember 2019-01-01 2019-12-31 0000926326 us-gaap:ServiceMember 2018-01-01 2018-12-31 0000926326 2019-01-01 2019-12-31 0000926326 2018-01-01 2018-12-31 0000926326 us-gaap:CommonStockMember 2017-12-31 0000926326 us-gaap:TreasuryStockMember 2017-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000926326 us-gaap:RetainedEarningsMember 2017-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000926326 2017-12-31 0000926326 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0000926326 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0000926326 us-gaap:CommonStockMember 2018-12-31 0000926326 us-gaap:TreasuryStockMember 2018-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000926326 us-gaap:RetainedEarningsMember 2018-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000926326 2018-12-31 0000926326 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0000926326 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0000926326 us-gaap:CommonStockMember 2019-12-31 0000926326 us-gaap:TreasuryStockMember 2019-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000926326 us-gaap:RetainedEarningsMember 2019-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000926326 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0000926326 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0000926326 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0000926326 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0000926326 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000926326 us-gaap:CommonStockMember 2020-12-31 0000926326 us-gaap:TreasuryStockMember 2020-12-31 0000926326 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000926326 us-gaap:RetainedEarningsMember 2020-12-31 0000926326 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000926326 omcl:TenLargestGroupPurchasingOrganizationsGPOsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember 2020-01-01 2020-12-31 0000926326 omcl:U.S.GovernmentHospitalsMember omcl:LeaseReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0000926326 omcl:PrimarySupplierMember 2020-12-31 0000926326 omcl:PrimarySupplierMember 2020-01-01 2020-12-31 0000926326 omcl:PrimarySupplierMember 2019-01-01 2019-12-31 0000926326 omcl:PrimarySupplierMember 2018-01-01 2018-12-31 0000926326 us-gaap:ShippingAndHandlingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000926326 us-gaap:ShippingAndHandlingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000926326 us-gaap:ShippingAndHandlingMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0000926326 srt:MinimumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:EquipmentMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:EquipmentMember 2020-01-01 2020-12-31 0000926326 omcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0000926326 us-gaap:PropertyPlantAndEquipmentMember omcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember 2020-01-01 2020-12-31 0000926326 us-gaap:PropertyPlantAndEquipmentMember omcl:InternalUseSoftwareandSoftwareDevelopmentCostsMember 2019-01-01 2019-12-31 0000926326 us-gaap:OtherAssetsMember 2020-01-01 2020-12-31 0000926326 us-gaap:OtherAssetsMember 2019-01-01 2019-12-31 0000926326 omcl:A340BLinkBusinessMember 2020-10-01 2020-10-01 0000926326 omcl:A340BLinkBusinessMember 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:CustomerRelationshipsMember 2020-10-01 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-10-01 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:TradeNamesMember 2020-10-01 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:NoncompeteAgreementsMember 2020-10-01 2020-10-01 0000926326 2020-10-01 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:TechnologyBasedIntangibleAssetsMember omcl:MeasurementInputRoyaltyRateMember 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:TradeNamesMember omcl:MeasurementInputRoyaltyRateMember 2020-10-01 0000926326 omcl:A340BLinkBusinessMember us-gaap:MeasurementInputDiscountRateMember 2020-10-01 0000926326 omcl:A340BLinkBusinessMember 2020-01-01 2020-12-31 0000926326 omcl:A340BLinkBusinessMember 2020-10-01 2020-12-31 0000926326 omcl:A340BLinkBusinessMember 2019-01-01 2019-12-31 0000926326 omcl:ConnectedDevicesSoftwareLicensesAndOtherMember 2020-01-01 2020-12-31 0000926326 omcl:ConnectedDevicesSoftwareLicensesAndOtherMember 2019-01-01 2019-12-31 0000926326 omcl:ConnectedDevicesSoftwareLicensesAndOtherMember 2018-01-01 2018-12-31 0000926326 omcl:TechnicalServicesMember 2020-01-01 2020-12-31 0000926326 omcl:TechnicalServicesMember 2019-01-01 2019-12-31 0000926326 omcl:TechnicalServicesMember 2018-01-01 2018-12-31 0000926326 omcl:ConsumablesMember 2020-01-01 2020-12-31 0000926326 omcl:ConsumablesMember 2019-01-01 2019-12-31 0000926326 omcl:ConsumablesMember 2018-01-01 2018-12-31 0000926326 omcl:HardwareAndSoftwareMember 2020-01-01 2020-12-31 0000926326 omcl:HardwareAndSoftwareMember 2019-01-01 2019-12-31 0000926326 omcl:HardwareAndSoftwareMember 2018-01-01 2018-12-31 0000926326 country:US 2020-01-01 2020-12-31 0000926326 country:US 2019-01-01 2019-12-31 0000926326 country:US 2018-01-01 2018-12-31 0000926326 us-gaap:NonUsMember 2020-01-01 2020-12-31 0000926326 us-gaap:NonUsMember 2019-01-01 2019-12-31 0000926326 us-gaap:NonUsMember 2018-01-01 2018-12-31 0000926326 us-gaap:RestrictedStockMember 2020-01-01 2020-12-31 0000926326 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0000926326 us-gaap:RestrictedStockMember 2018-01-01 2018-12-31 0000926326 omcl:ConvertibleDebtSecuritiesAndWarrantsMember 2020-01-01 2020-12-31 0000926326 omcl:ConvertibleDebtSecuritiesAndWarrantsMember 2019-01-01 2019-12-31 0000926326 omcl:ConvertibleDebtSecuritiesAndWarrantsMember 2018-01-01 2018-12-31 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-12-31 0000926326 us-gaap:InterestRateSwapMember 2016-06-30 0000926326 us-gaap:InterestRateSwapMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-06-30 0000926326 us-gaap:OtherCurrentAssetsMember 2020-12-31 0000926326 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000926326 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000926326 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0000926326 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0000926326 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000926326 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000926326 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-12-31 0000926326 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-12-31 0000926326 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000926326 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-12-31 0000926326 us-gaap:EquipmentMember 2020-12-31 0000926326 us-gaap:EquipmentMember 2019-12-31 0000926326 us-gaap:FurnitureAndFixturesMember 2020-12-31 0000926326 us-gaap:FurnitureAndFixturesMember 2019-12-31 0000926326 us-gaap:LeaseholdImprovementsMember 2020-12-31 0000926326 us-gaap:LeaseholdImprovementsMember 2019-12-31 0000926326 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2020-12-31 0000926326 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2019-12-31 0000926326 us-gaap:ConstructionInProgressMember 2020-12-31 0000926326 us-gaap:ConstructionInProgressMember 2019-12-31 0000926326 country:US 2020-12-31 0000926326 country:US 2019-12-31 0000926326 us-gaap:NonUsMember 2020-12-31 0000926326 us-gaap:NonUsMember 2019-12-31 0000926326 us-gaap:CustomerRelationshipsMember 2020-12-31 0000926326 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0000926326 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-12-31 0000926326 us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2020-01-01 2020-12-31 0000926326 us-gaap:OrderOrProductionBacklogMember 2020-12-31 0000926326 us-gaap:OrderOrProductionBacklogMember 2020-01-01 2020-12-31 0000926326 us-gaap:TradeNamesMember 2020-12-31 0000926326 us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:TradeNamesMember 2020-01-01 2020-12-31 0000926326 us-gaap:PatentsMember 2020-12-31 0000926326 us-gaap:PatentsMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:PatentsMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:PatentsMember 2020-01-01 2020-12-31 0000926326 us-gaap:NoncompeteAgreementsMember 2020-12-31 0000926326 us-gaap:NoncompeteAgreementsMember 2020-01-01 2020-12-31 0000926326 us-gaap:CustomerRelationshipsMember 2019-12-31 0000926326 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000926326 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000926326 srt:MaximumMember us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0000926326 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-12-31 0000926326 us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-01 2019-12-31 0000926326 srt:MinimumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-01 2019-12-31 0000926326 srt:MaximumMember us-gaap:TechnologyBasedIntangibleAssetsMember 2019-01-01 2019-12-31 0000926326 us-gaap:OrderOrProductionBacklogMember 2019-12-31 0000926326 us-gaap:OrderOrProductionBacklogMember 2019-01-01 2019-12-31 0000926326 us-gaap:TradeNamesMember 2019-12-31 0000926326 us-gaap:TradeNamesMember 2019-01-01 2019-12-31 0000926326 srt:MinimumMember us-gaap:TradeNamesMember 2019-01-01 2019-12-31 0000926326 srt:MaximumMember us-gaap:TradeNamesMember 2019-01-01 2019-12-31 0000926326 us-gaap:PatentsMember 2019-12-31 0000926326 us-gaap:PatentsMember 2019-01-01 2019-12-31 0000926326 srt:MinimumMember us-gaap:PatentsMember 2019-01-01 2019-12-31 0000926326 srt:MaximumMember us-gaap:PatentsMember 2019-01-01 2019-12-31 0000926326 us-gaap:SecuredDebtMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 2016-01-05 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 0000926326 omcl:TermLoanFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 2016-01-05 0000926326 omcl:TermLoanFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 0000926326 us-gaap:LetterOfCreditMember omcl:WellsFargoBankNationalAssociationMember 2016-01-05 0000926326 us-gaap:BridgeLoanMember omcl:WellsFargoBankNationalAssociationMember 2016-01-05 0000926326 srt:MinimumMember us-gaap:SecuredDebtMember omcl:CreditAgreementInterestRateOptionOneMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-05 2016-01-05 0000926326 srt:MaximumMember us-gaap:SecuredDebtMember omcl:CreditAgreementInterestRateOptionOneMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-05 2016-01-05 0000926326 us-gaap:SecuredDebtMember omcl:CreditAgreementInterestRateOptionTwoMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2016-01-05 2016-01-05 0000926326 srt:MinimumMember us-gaap:SecuredDebtMember omcl:CreditAgreementInterestRateOptionTwoMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-05 2016-01-05 0000926326 srt:MaximumMember us-gaap:SecuredDebtMember omcl:CreditAgreementInterestRateOptionTwoMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2016-01-05 2016-01-05 0000926326 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 2016-01-05 0000926326 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2016-01-05 2016-01-05 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2017-12-26 0000926326 omcl:WellsFargoBankNationalAssociationMember 2017-12-01 2017-12-31 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 0000926326 omcl:IncrementalLoanFacilityMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 0000926326 us-gaap:LetterOfCreditMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 0000926326 us-gaap:BridgeLoanMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 0000926326 omcl:TermLoanFacilityMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 srt:MinimumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-11-15 2019-11-15 0000926326 srt:MaximumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-11-15 2019-11-15 0000926326 omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-11-15 2019-11-15 0000926326 omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-11-15 2019-11-15 0000926326 srt:MinimumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember omcl:LondonInterbankOfferingRateLIBORPlus100Member 2019-11-15 2019-11-15 0000926326 srt:MaximumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember omcl:LondonInterbankOfferingRateLIBORPlus100Member 2019-11-15 2019-11-15 0000926326 srt:MinimumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 srt:MaximumMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember omcl:DebtInstrumentCovenantPeriod1Member 2020-09-22 0000926326 us-gaap:RevolvingCreditFacilityMember omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember omcl:DebtInstrumentCovenantPeriod2Member 2020-09-22 0000926326 omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2019-11-15 2019-11-15 0000926326 omcl:WellsFargoSecuritiesLLCCitizensBankNAAndJPMorganChaseBankNAMember us-gaap:LineOfCreditMember 2020-09-22 2020-09-22 0000926326 us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0000926326 us-gaap:LineOfCreditMember 2019-01-01 2019-12-31 0000926326 us-gaap:LineOfCreditMember 2018-01-01 2018-12-31 0000926326 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2019-12-31 0000926326 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-01-01 2020-12-31 0000926326 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-31 0000926326 us-gaap:LineOfCreditMember 2019-12-31 0000926326 us-gaap:LineOfCreditMember 2020-12-31 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-09-25 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-09-25 2020-09-25 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:DebtInstrumentRedemptionPeriodOneMember us-gaap:ConvertibleDebtMember 2020-09-25 2020-09-25 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:ConvertibleDebtMember 2020-09-25 2020-09-25 0000926326 omcl:ConvertibleSeniorNotesMember us-gaap:ConvertibleDebtMember 2020-01-01 2020-12-31 0000926326 omcl:ConvertibleNoteHedgeRightsMember 2020-09-25 0000926326 2020-09-25 2020-09-25 0000926326 us-gaap:StockOptionMember 2020-09-25 0000926326 us-gaap:WarrantMember 2020-09-25 0000926326 srt:MinimumMember 2020-12-31 0000926326 srt:MaximumMember 2020-12-31 0000926326 us-gaap:AssetsLeasedToOthersMember 2020-12-31 0000926326 us-gaap:AssetsLeasedToOthersMember 2019-12-31 0000926326 us-gaap:AssetsLeasedToOthersMember 2020-01-01 2020-12-31 0000926326 us-gaap:AssetsLeasedToOthersMember 2019-01-01 2019-12-31 0000926326 us-gaap:AssetsLeasedToOthersMember 2018-01-01 2018-12-31 0000926326 us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2020-12-31 0000926326 us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0000926326 omcl:A2009PlanMember 2020-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember 2020-01-01 2020-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-01-01 2020-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember 2020-01-01 2020-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-01-01 2020-12-31 0000926326 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0000926326 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0000926326 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0000926326 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0000926326 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0000926326 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0000926326 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0000926326 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0000926326 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0000926326 omcl:A2009PlanMember 2020-01-01 2020-12-31 0000926326 omcl:A2009PlanMember 2019-01-01 2019-12-31 0000926326 omcl:A2009PlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0000926326 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0000926326 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0000926326 srt:MinimumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0000926326 srt:MaximumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2020-01-01 2020-12-31 0000926326 srt:MinimumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0000926326 srt:MaximumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0000926326 srt:MinimumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2018-01-01 2018-12-31 0000926326 srt:MaximumMember us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0000926326 us-gaap:EmployeeStockMember omcl:A1997EmployeeStockPurchasePlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember 2019-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember 2019-01-01 2019-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember 2020-12-31 0000926326 us-gaap:EmployeeStockOptionMember omcl:A2009PlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember 2019-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember 2019-01-01 2019-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember 2020-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:RestrictedStockMember omcl:A2009PlanMember 2019-12-31 0000926326 us-gaap:RestrictedStockMember omcl:A2009PlanMember 2020-01-01 2020-12-31 0000926326 us-gaap:RestrictedStockMember omcl:A2009PlanMember 2020-12-31 0000926326 us-gaap:RestrictedStockMember omcl:A2009PlanMember 2019-01-01 2019-12-31 0000926326 us-gaap:RestrictedStockMember omcl:A2009PlanMember 2018-01-01 2018-12-31 0000926326 srt:OfficerMember us-gaap:PerformanceSharesMember 2019-01-01 2019-12-31 0000926326 srt:OfficerMember us-gaap:PerformanceSharesMember 2020-01-01 2020-12-31 0000926326 us-gaap:PerformanceSharesMember 2020-02-13 2020-02-13 0000926326 us-gaap:PerformanceSharesMember 2019-02-13 2019-02-13 0000926326 us-gaap:PerformanceSharesMember omcl:A2018PerformanceBasedRestrictedStockUnitsMember 2019-03-05 2019-03-05 0000926326 us-gaap:PerformanceSharesMember omcl:A2018PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2019PerformanceBasedRestrictedStockUnitsMember 2020-03-03 2020-03-03 0000926326 us-gaap:PerformanceSharesMember omcl:A2019PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2009PlanMember 2019-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2009PlanMember 2020-01-01 2020-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2009PlanMember 2020-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2009PlanMember 2019-01-01 2019-12-31 0000926326 us-gaap:PerformanceSharesMember omcl:A2009PlanMember 2018-01-01 2018-12-31 0000926326 us-gaap:EmployeeStockOptionMember 2020-12-31 0000926326 omcl:RestrictedStockAwardsRSAsAndRestrictedStockUnitsRSUsMember 2020-12-31 0000926326 omcl:FuturegrantsandawardsMember 2020-12-31 0000926326 us-gaap:EmployeeStockMember 2020-12-31 0000926326 omcl:OmnicellPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-12-31 0000926326 omcl:OmnicellPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0000926326 omcl:OmnicellPlanMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0000926326 us-gaap:RestrictedStockUnitsRSUMember omcl:A2009PlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2020-01-01 2020-12-31 0000926326 omcl:A2016RepurchaseProgramMember 2016-08-02 0000926326 omcl:A2014ShareRepurchaseProgramMember 2014-11-04 0000926326 omcl:A2016and2014ShareRepurchaseProgramsMember 2020-12-31 0000926326 omcl:OneTimeStockRepurchaseSeptember2020Member 2020-09-17 0000926326 omcl:OneTimeStockRepurchaseSeptember2020Member 2020-09-17 2020-09-17 0000926326 omcl:A2016and2014ShareRepurchaseProgramsMember 2018-01-01 2018-12-31 0000926326 omcl:A2016and2014ShareRepurchaseProgramsMember 2020-01-01 2020-12-31 0000926326 omcl:A2016and2014ShareRepurchaseProgramsMember 2019-01-01 2019-12-31 0000926326 omcl:DistributionAgreementMember 2017-11-03 2017-11-03 0000926326 omcl:DistributionAgreementMember 2018-01-01 2018-12-31 0000926326 omcl:DistributionAgreementMember 2018-12-31 0000926326 omcl:DistributionAgreementMember 2019-01-01 2019-12-31 0000926326 omcl:DistributionAgreementMember 2019-12-31 0000926326 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0000926326 us-gaap:ForeignCountryMember 2020-12-31 0000926326 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-12-31 0000926326 us-gaap:StateAndLocalJurisdictionMember us-gaap:ResearchMember 2020-12-31 0000926326 us-gaap:EmployeeSeveranceMember omcl:Q1Q22020RestructuringPlanMember 2020-01-01 2020-12-31 0000926326 omcl:Q1Q22020RestructuringPlanMember 2020-12-31 0000926326 omcl:Q42018RestructuringPlanMember 2018-01-01 2018-12-31 0000926326 omcl:Q12018RestructuringPlanMemberMember 2018-01-01 2018-12-31 0000926326 us-gaap:AccountsReceivableMember 2017-12-31 0000926326 us-gaap:AccountsReceivableMember 2018-01-01 2018-12-31 0000926326 us-gaap:AccountsReceivableMember 2018-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2017-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2018-01-01 2018-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2018-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2017-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2018-01-01 2018-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2018-12-31 0000926326 us-gaap:AccountsReceivableMember 2019-01-01 2019-12-31 0000926326 us-gaap:AccountsReceivableMember 2019-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2019-01-01 2019-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2019-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2019-01-01 2019-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2019-12-31 0000926326 us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0000926326 us-gaap:AccountsReceivableMember 2020-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2020-01-01 2020-12-31 0000926326 omcl:ContractWithCustomerAssetUnbilledReceivablesNoncurrentMember 2020-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2020-01-01 2020-12-31 0000926326 omcl:NetInvestmentInSalesTypeLeasesMember 2020-12-31 iso4217:USD shares iso4217:USD shares omcl:segment pure omcl:reportingUnit omcl:day FY false 2020 0000926326 us-gaap:AccountingStandardsUpdate201613Member P1Y P1Y us-gaap:AccruedLiabilitiesCurrent us-gaap:AccruedLiabilitiesCurrent 0.0102751 P1Y P1Y P1Y P3Y 0.25 0.25 10-K true 2020-12-31 --12-31 false 000-33043 OMNICELL, INC. DE 94-3166458 590 East Middlefield Road Mountain View CA 94043 650 251-6100 Common Stock, $0.001 par value OMCL NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 3000000000.0 43041554 Portions of the registrant’s definitive Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the United States Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Form 10-K are incorporated by reference in Part III, Items 10-14 of this Form 10-K. 485928000 127210000 4286000 3227000 190117000 218362000 96298000 108011000 16027000 14478000 41044000 15177000 829414000 483238000 59073000 54246000 22156000 19750000 55114000 56130000 499309000 336539000 168211000 124867000 15019000 14142000 56919000 48862000 119289000 103036000 1824504000 1240810000 40309000 46380000 55750000 44155000 80311000 55567000 100053000 90894000 276423000 236996000 5673000 7083000 39633000 39090000 48897000 50669000 19174000 11718000 0 50000000 467201000 0 857001000 395556000 0.001 0.001 5000000 5000000 0 0 0 0 0.001 0.001 100000000 100000000 52677000 51277000 42783000 42132000 53000 51000 9894000 9145000 238109000 185074000 920359000 780931000 290722000 258792000 -5522000 -9446000 967503000 845254000 1824504000 1240810000 636031000 659602000 569595000 256177000 237425000 217714000 892208000 897027000 787309000 354004000 344914000 312360000 124912000 115201000 102619000 478916000 460115000 414979000 413292000 436912000 372330000 70161000 68644000 64843000 307605000 289916000 263095000 377766000 358560000 327938000 35526000 78352000 44392000 -6177000 -4419000 -8776000 29349000 73933000 35616000 -2845000 12595000 -2113000 32194000 61338000 37729000 0.76 1.48 0.96 0.74 1.43 0.93 42583000 41462000 39242000 43743000 42943000 40559000 32194000 61338000 37729000 0 -420000 -421000 3924000 1828000 -4320000 3924000 1408000 -4741000 36118000 62746000 32988000 47577000 48000 9145000 -185074000 585755000 159725000 -6113000 554341000 37729000 37729000 -4741000 -4741000 557000 1000 39566000 39567000 28885000 28885000 1346000 1000 30610000 30611000 6775000 6775000 49480000 50000 9145000 -185074000 678041000 197454000 -10854000 679617000 61338000 61338000 1408000 1408000 460000 0 37806000 37806000 34049000 34049000 1337000 1000 40705000 40706000 9670000 9670000 51277000 51000 9145000 -185074000 780931000 258792000 -9446000 845254000 32194000 32194000 3924000 3924000 44697000 44697000 1400000 2000 54268000 54270000 8738000 8738000 749000 53035000 53035000 97830000 97830000 100625000 100625000 51290000 51290000 706000 706000 -264000 -264000 52677000 53000 9894000 -238109000 920359000 290722000 -5522000 967503000 32194000 61338000 37729000 61067000 53559000 51350000 -267000 -445000 -133000 44697000 34049000 28885000 -6546000 -1339000 -5705000 10528000 10562000 0 1597000 2204000 2292000 4766000 0 0 -36842000 21540000 6192000 -12359000 8123000 6763000 2081000 -2909000 308000 6408000 2010000 -1170000 2882000 3699000 1680000 8057000 2719000 4711000 7675000 -4528000 7077000 -6300000 7893000 -9154000 11595000 2495000 14419000 4374000 3045000 8223000 7620000 5445000 3020000 -9543000 -10040000 0 7456000 6006000 -1665000 185870000 145008000 103966000 32024000 45770000 30677000 22842000 15894000 23697000 225000000 0 0 -279866000 -61664000 -54374000 150000000 0 0 200000000 90000000 77000000 550000 2321000 0 559665000 0 0 100625000 0 0 51290000 0 0 0 37806000 39567000 54270000 40706000 30611000 8738000 9670000 6775000 53035000 0 0 3992000 0 0 456269000 -23479000 -13597000 437000 153000 -1227000 362710000 60018000 34768000 127210000 67192000 32424000 489920000 127210000 67192000 485928000 127210000 67192000 3992000 0 0 489920000 127210000 67192000 522000 3582000 7487000 10343000 7761000 3489000 405000 913000 1123000 0 1552000 2032000 0 3313000 0 0 80000000 0 Organization and Summary of Significant Accounting Policies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omnicell, Inc. was incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company’s major products are medication management automation solutions and adherence tools for healthcare systems and pharmacies, which are sold in its principal market, the healthcare industry. The Company’s market is primarily located in the United States and Europe. “Omnicell” or the “Company” collectively refer to Omnicell, Inc. and its subsidiaries.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, the Company completed its acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The Consolidated Financial Statements include the results of operations of this recently acquired company, commencing as of the acquisition date. The significant accounting policies of the acquired business have been aligned to conform to the accounting policies of Omnicell.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications and Adjustments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior-year amounts have been reclassified to conform with current-period presentation. These reclassifications include (i) a change in the presentation of certain items in the disaggregation of revenues for the years ended December 31, 2020, 2019, and 2018 in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (ii) a change in the presentation of certain items in the reconciliation of the provision for (benefit from) income taxes for the years ended December 31, 2019 and 2018 in Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These changes were not deemed material and were included to conform with current-period classification and presentation. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts from the COVID-19 pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. Those policies are revenue recognition; accounts receivable, unbilled receivables, and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill; purchased intangibles and long-lived assets; fair value of assets acquired and liabilities assumed in business combinations; convertible senior notes; share-based compensation; and accounting for income taxes. As of December 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the ongoing uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation and Remeasurement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s foreign subsidiaries use the local currency of their respective countries as their functional currency. The Company translates the assets and liabilities of such non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recorded as foreign currency translation adjustments and included in accumulated other comprehensive income (loss) in stockholders’ equity.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities denominated in a currency other than the functional currency are remeasured into the respective entity’s functional currency. Monetary assets and liabilities are remeasured at exchange rates in effect at the end of each period, and non-monetary assets and liabilities are remeasured at historical rates. Gains and losses from foreign currency remeasurement of monetary assets and liabilities are recorded in interest and other income (expense), net.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Connected devices, software licenses, and other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements with multi-year co-development plans. Solutions in this category include, but are not limited to, XT Series automated dispensing systems, the XR2 Automated Central Pharmacy system, and IV compounding automation solutions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technical services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software-as-a-service (“SaaS”), subscription software, and technology-enabled services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth (formerly Population Health Solutions), 340B solutions, and services associated with Omnicell One (formerly Performance Center), Central Pharmacy Compounding Services, including the XR2 Automated Central Pharmacy system, and Central Pharmacy Compounding Services, including IV compounding automation solutions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue recognition for each revenue category which is further discussed below: </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Revenue Category</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Timing of Revenue Recognition</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Income Statement Classification</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Connected devices, software licenses, and other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Technical services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided, typically ratably over the service term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Consumables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">SaaS, subscription software, and technology-enabled services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to recognizing revenue, the Company identifies the contract, performance obligations, and transaction price, and allocates the transaction price to the performance obligations. All identified contracts meet the following required criteria:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Parties to the contract have approved the contract </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of the Company’s contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Entity can identify each party’s rights regarding the goods or services to be transferred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following the Company’s standard business process and terms. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The entity can identify the payment terms for the goods or services to be transferred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, the Company’s standard payment terms are net 30 day terms. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The contract has commercial substance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). The Company’s agreements are an exchange of cash for a combination of products and services which result in changes in the amount of the Company’s future cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company performs a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, the Company combines the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify its performance obligations, the Company considers all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, the Company considers an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of the Company’s sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of the Company’s commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as the Company provides a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations recorded as deferred revenues, net of deferred cost of goods sold, at December 31, 2020 and 2019 were $105.7 million and $98.0 million, respectively, of which $100.1 million and $90.9 million, respectively, are expected to be completed within one year and are presented as current deferred revenues, net on the Consolidated Balance Sheets. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, contract assets, and contract liabilities are recorded net of associated taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements are generally periodic and are billed on a monthly, quarterly, or annual basis. In certain circumstances, multiple years are billed at one time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues, net. The Company typically recognizes product revenue, and correspondingly reduces deferred revenues, net, for equipment and software upon written customer acceptance of installation. Consumables are recorded as revenue upon shipment to or receipt by the customer, depending upon contract terms. The portion of deferred revenues, net, not expected to be recognized as revenue within twelve months of the balance sheet date are included in long-term deferred revenues on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often enters into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. The Company’s change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company typically does not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. The Company establishes provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to the Consolidated Financial Statements for any periods presented.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. The Company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease the Company's products. Pursuant to the terms of GPO agreements and the GSA Contract, each member or agency contracts directly with Omnicell and can purchase the Company’s products at pre-negotiated contract terms and pricing. GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee ("IFF") to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $9.7 million, $11.1 million, and $8.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During the year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Contract Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract asset is a right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration. A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from the customer. Contract liabilities include customer deposits under non-cancelable contracts, and current and non-current deferred revenue balances. The Company’s contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant changes in the contract assets and the contract liabilities balances during the period are the result of the issuance of invoices and recognition of deferred revenues in the normal course of business. As a result of the right to invoice for the transaction consideration becoming unconditional, unbilled contract assets as of December 31, 2019 which were invoiced during the year ended December 31, 2020 were not material. The contract modifications entered into during the year ended December 31, 2020 did not have a significant impact on the Company’s contract assets or deferred revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has determined that certain incentive portions of its sales commission plans require capitalization since these payments are directly related to sales achieved during a time period. These commissions are earned on the basis of the total purchase order value of new product bookings. Since there are no commensurate commissions earned on renewal of the service bookings, the Company concluded that the capitalized asset is related to services provided under both the initial contract and renewal periods. The Company applies a practical expedient to account for the incremental costs of obtaining a contract as part of a portfolio of contracts with similar characteristics as the Company expects the effect on the financial statements of applying the practical expedient would not differ materially from applying the accounting guidance to the individual contracts within the portfolio. A pool of contracts is defined as all contracts booked in a particular quarter. The amortization for the capitalized asset is an estimate of the pool’s original contract term, generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xMjQvZnJhZzoyNmM5ZmE5NTA5MTE0NjExYjM1YjkwOGU4NGFkNGU2Yi90ZXh0cmVnaW9uOjI2YzlmYTk1MDkxMTQ2MTFiMzViOTA4ZTg0YWQ0ZTZiXzIwNDUx_167aff03-38d2-405a-b79a-ef3dc61bed55">one</span> to five years, plus an estimate of future customer renewal periods resulting in a total amortization period of ten years. Costs to obtain a contract are allocated amongst performance obligations and recognized as sales and marketing expense consistent with the pattern of revenue recognition. Capitalized costs are periodically reviewed for impairment. In accordance with U.S. GAAP, while certain compensation elements are expensed as incurred, a portion of the pool’s capitalized asset is recorded as an expense over the first two quarters after booking, which represents the estimated period during which the product revenue associated with the contract is recorded. The remaining capitalized contract costs are recorded as expense ratably over the ten year estimated initial and renewal service periods. The Company recognized contract cost expense of $22.1 million, $24.4 million, and $21.1 million during the years </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended December 31, 2020, 2019, and 2018, respectively. The commission expenses paid or due to be paid as of the consolidated balance sheet date to be recognized in future periods are recorded in long-term prepaid commissions on the Consolidated Balance Sheets. There was no impairment loss recorded related to capitalized prepaid commissions as of and for the year ended December 31, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. The Company’s sales-type lease agreements do not contain any material residual value guarantees. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sales-type leases, the Company recognizes revenues for its hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. The Company recognizes service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. The Company recognizes interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company optimizes cash flows by selling a majority of its non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. The Company has no obligation to the leasing company once the lease has been sold. Some of the Company's sales-type leases, mostly those relating to U.S. government hospitals which comprise approximately 67% of the lease receivable balance, are retained in-house.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of Accounting Standards Codification ("ASC") 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Those agreements in place prior to January 1, 2019 continue to be treated as operating leases, however, any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements entered into prior to January 1, 2019 are non-cancelable, and most automatically renew for successive one year periods at the end of each lease term absent written notice from the customer. The Company’s operating lease agreements do not contain any material residual value guarantees. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, rental income is generally recognized on a straight-line basis over the term of the associated lease, and recorded in services and other revenues in the Consolidated Statements of Operations. Leased assets under operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the Consolidated Balance Sheets. The depreciation expense of the leased assets is recognized on a straight-line basis over the contractual term of the associated lease, and recorded in cost of revenues in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is presented in the Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:</span></div><div style="margin-bottom:4pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in other long-term assets in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funds Held for Customers and Customer Fund Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the 340B Link Business, the Company now offers certain products and services in which it is customary for pharmacies to owe funds to the Company which are collected on behalf of, and, after a short holding period, disbursed to, the Company’s customers. The Company presents amounts due from pharmacies and amounts due to be disbursed to customers on a gross basis within other current assets and accrued liabilities, respectively, in the Consolidated Balance Sheets, as such amounts are expected to be settled within one year. Any funds received from the pharmacies that are held by the Company are segregated from its other corporate cash accounts. These funds are classified as restricted cash as the Company is contractually obligated to disburse these amounts to customers.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales of Accounts Receivable</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the sale of its accounts receivables in accordance with accounting guidance for transfers and servicing of financial assets. The Company transferred non-recourse accounts receivable totaling $58.8 million, $48.3 million, and $46.6 million during the years ended December 31, 2020, 2019, and 2018, respectively, which approximated fair value, to leasing companies on a non-recourse basis. Accounts receivable balance included approximately $7.8 million and $4.6 million due from third-party leasing companies for transferred non-recourse accounts receivable as of December 31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies all highly-liquid investments with original maturities of three months or less as cash equivalents. The Company’s cash and cash equivalent balances include bank accounts and highly-liquid U.S. Government money market funds held in sweep accounts with financial institutions of high credit quality. The Company continuously monitors the credit worthiness of the financial institutions in which it invests. The Company has not experienced any credit losses from its cash equivalents. Cash and cash equivalents were $485.9 million and $127.2 million as of December 31, 2020 and 2019, respectively. As of December 31, 2020, cash equivalents were $447.2 million, which consisted of money market funds held in sweep accounts, and as of December 31, 2019, the Company had no cash equivalents.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities measured at fair value, the amounts are based on an expected exit price representing the amount that would be received from the sale of an asset or paid to transfer a liability in a transaction between market participants. The fair value may be based on assumptions that market participants would use in pricing an asset or liability. ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs used in valuation techniques are assigned a hierarchical level, as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Observable inputs, such as quoted prices in active markets for identical instruments;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Quoted prices for similar instruments in active markets, or quoted prices for identical instruments in inactive markets; and</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs for financial instruments reflecting Company’s assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap Agreements </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swap agreements qualify as cash flow hedging instruments in accordance with ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company records its interest rate swap agreements on its Consolidated Balance Sheets at fair value. The effective portion of changes in fair value are recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Any ineffective portion is recognized in earnings. On a quarterly basis, the Company performs a qualitative assessment to determine effectiveness. For further information, refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before the Company receives them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to the Company.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a supply agreement with one primary supplier for construction and supply of several sub-assemblies and inventory management of sub-assemblies used in its hardware products. There are no minimum purchase requirements. The contract with the Company’s supplier may be terminated by either the supplier or by the Company without cause and at any time upon delivery of six months’ notice. Purchases from this supplier were $76.3 million, $75.1 million, and $54.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shipping Costs</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outbound freight billed to customers is recorded as product revenue. The related shipping and handling costs are expensed as part of selling, general, and administrative expense. Shipping and handling expenses were $15.6 million, $15.9 million, and $14.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment less accumulated depreciation are stated at historical cost. The Company’s expenditures for property and equipment are primarily for computer equipment and software used in the administration of its business, and for leasehold improvements to its leased facilities. The Company also develops molds and dies used in long-term manufacturing arrangements with suppliers and for production automation equipment used in the manufacturing of consumable blister card components. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and related software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the lease term or the estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 12 years</span></div></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs related to computer software developed or obtained for internal use in accordance with ASC 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Software obtained for internal use includes enterprise-level business and finance software that the Company customizes to meet its specific operational needs, as well as certain costs for the development of its subscription and cloud-based offerings sold to its customers. Costs incurred in the application development phase are capitalized and amortized over their useful lives, which is generally five years. Costs recognized in the preliminary project phase and the post-implementation phase are expensed as incurred. The Company capitalized $6.8 million and $0.3 million of </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs related to the application development of enterprise-level software and its subscription and cloud-based offerings that were included in property and equipment during the years ended December 31, 2020 and 2019, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Development Costs </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain software development costs in accordance with ASC 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of Software to Be Sold, Leased, or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. The Company establishes technological feasibility when it completes a detail program design or a working model. The Company amortizes development costs over the estimated lives of the related products, which is generally five years. The Company capitalized software development costs of $32.0 million and $45.8 million, which are included in other long-term assets as of December 31, 2020 and 2019, respectively. The Company recorded $23.1 million, $17.5 million, and $12.5 million to cost of revenues for amortization of capitalized software development costs for the years ended December 31, 2020, 2019, and 2018, respectively. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of its lease contracts do not provide an implicit rate, the Company uses its incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The Company does not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. The Company elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company’s operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that the Company operates. The Company reviews each of its lease options at a time required by the terms of the lease contract, and notifies the lessor if it chooses to exercise the lease renewal option. Until the Company is reasonably certain that it will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When the Company has made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating lease agreements do not contain any material residual value guarantees, restrictions, or restriction covenants.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting under ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each acquired company’s operating results are included in the Company's Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Acquired Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. The Company has one reporting unit, which is the same as its operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if the Company decides to bypass this option, it proceeds to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of the Company’s reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, the Company will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the reporting unit’s fair value under the quantitative approach, the Company uses a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. The Company also considers its market capitalization on the date of the analysis to ensure the reasonableness of its reporting unit's fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed a qualitative impairment assessment analysis as of October 1, 2020 for its reporting unit taking into consideration past, current, and projected future earnings, recent trends, and market conditions, and valuation metrics involving similar companies that are publicly-traded. Based on the result of this analysis, an impairment does not exist as of December 31, 2020, and there were no accumulated impairment losses.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisitions, the Company generally recognizes assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xMjQvZnJhZzoyNmM5ZmE5NTA5MTE0NjExYjM1YjkwOGU4NGFkNGU2Yi90ZXh0cmVnaW9uOjI2YzlmYTk1MDkxMTQ2MTFiMzViOTA4ZTg0YWQ0ZTZiXzQxMjE0_1a56bc6f-8012-4f15-82af-ea8e73f48d0c">one</span> to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. The Company’s cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of the Company’s intangible assets are subjective and are affected by changes to its business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of the Company’s assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on the Company’s operating results and financial condition. For the years ended December 31, 2020 and 2019, there were no events or changes in circumstances to indicate that intangible assets carrying amounts may not be recoverable.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Debt</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for convertible debt and related transactions in accordance with ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation of Share-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company recognizes compensation expense related to share-based compensation based on the grant date estimated fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of its common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on the Company’s historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeiture rates are estimated based on the Company's historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, the Company will incur a benefit or detriment on its income tax expense in the period of change. If the Company were to determine that all or part of the net deferred tax assets are not realizable in the future, it will record a valuation allowance that would be charged to earnings in the period such determination is made.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, the Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Authoritative Guidance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Authoritative Guidance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, as well as improves consistent application of and simplifies the guidance for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 will be effective for the Company beginning January 1, 2021. The Company does not expect ASU 2019-12 to have a material impact on its Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. This update permits the use of either the modified retrospective or fully retrospective method of transition. ASU 2020-06 will be effective for the Company beginning January 1, 2022. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Consolidated Financial Statements through the reporting date.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Consolidated Financial Statements have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) and include all adjustments necessary for the fair presentation of the Company’s consolidated financial position, results of operations, and cash flows for the periods presented.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, the Company completed its acquisition of the 340B Link business (the “340B Link Business”) of Pharmaceutical Strategies Group, LLC. The Consolidated Financial Statements include the results of operations of this recently acquired company, commencing as of the acquisition date. The significant accounting policies of the acquired business have been aligned to conform to the accounting policies of Omnicell.</span></div> Reclassifications and Adjustments<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior-year amounts have been reclassified to conform with current-period presentation. These reclassifications include (i) a change in the presentation of certain items in the disaggregation of revenues for the years ended December 31, 2020, 2019, and 2018 in Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (ii) a change in the presentation of certain items in the reconciliation of the provision for (benefit from) income taxes for the years ended December 31, 2019 and 2018 in Note 17, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span>. These changes were not deemed material and were included to conform with current-period classification and presentation. <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s Consolidated Financial Statements and accompanying Notes. Management bases its estimates on historical experience and various other assumptions believed to be reasonable, including any potential impacts from the COVID-19 pandemic. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results may be different from the estimates. The Company’s critical accounting policies are those that affect its financial statements materially and involve difficult, subjective, or complex judgments by management. Those policies are revenue recognition; accounts receivable, unbilled receivables, and notes receivable from investment in sales-type leases; operating lease right-of-use assets and liabilities; inventory valuation; capitalized software development costs; impairment of goodwill; purchased intangibles and long-lived assets; fair value of assets acquired and liabilities assumed in business combinations; convertible senior notes; share-based compensation; and accounting for income taxes. As of December 31, 2020, the Company is not aware of any events or circumstances that would require an update to its estimates, judgments, or revisions to the carrying value of its assets or liabilities. Given the ongoing uncertainty surrounding the COVID-19 pandemic, events or circumstances may arise that could result in a change in estimates, judgments, or revisions to the carrying value of the Company’s assets or liabilities.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions. The Company's Chief Operating Decision Maker ("CODM") is its Chief Executive Officer. The CODM allocates resources and evaluates the performance of the Company at the consolidated level using information about its revenues, gross profit, income from operations, and other key financial data. All significant operating decisions are based upon an analysis of the Company as one operating segment, which is the same as its reporting segment.</span></div> 1 1 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Translation and Remeasurement</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of the Company’s foreign subsidiaries use the local currency of their respective countries as their functional currency. The Company translates the assets and liabilities of such non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recorded as foreign currency translation adjustments and included in accumulated other comprehensive income (loss) in stockholders’ equity.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities denominated in a currency other than the functional currency are remeasured into the respective entity’s functional currency. Monetary assets and liabilities are remeasured at exchange rates in effect at the end of each period, and non-monetary assets and liabilities are remeasured at historical rates. Gains and losses from foreign currency remeasurement of monetary assets and liabilities are recorded in interest and other income (expense), net.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company earns revenues from sales of its products and related services, which are sold in the healthcare industry, its principal market. The Company’s customer arrangements typically include one or more of the following revenue categories:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Connected devices, software licenses, and other. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software-enabled connected devices and software licenses that manage and regulate the storage and dispensing of pharmaceuticals, consumables blister cards, and packaging equipment and other supplies. This revenue category is often sold through long-term, sole-source agreements with multi-year co-development plans. Solutions in this category include, but are not limited to, XT Series automated dispensing systems, the XR2 Automated Central Pharmacy system, and IV compounding automation solutions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Technical services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Post-installation technical support and other related services, including phone support, on-site service, parts, and access to unspecified software updates and enhancements, if and when available. This revenue category is often supported by multi-year or annual contractual agreements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consumables. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medication adherence packaging, labeling, and other one-time use packaging including multimed adherence packaging and single dose blister cards which are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve patient engagement and adherence to prescriptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Software-as-a-service (“SaaS”), subscription software, and technology-enabled services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Emerging software and service solutions which are offered on a subscription basis with fees typically based either on transaction volume or a fee over a specified period of time. Solutions in this category include, but are not limited to, EnlivenHealth (formerly Population Health Solutions), 340B solutions, and services associated with Omnicell One (formerly Performance Center), Central Pharmacy Compounding Services, including the XR2 Automated Central Pharmacy system, and Central Pharmacy Compounding Services, including IV compounding automation solutions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue recognition for each revenue category which is further discussed below: </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Revenue Category</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Timing of Revenue Recognition</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Income Statement Classification</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Connected devices, software licenses, and other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Technical services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided, typically ratably over the service term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Consumables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">SaaS, subscription software, and technology-enabled services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to recognizing revenue, the Company identifies the contract, performance obligations, and transaction price, and allocates the transaction price to the performance obligations. All identified contracts meet the following required criteria:</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Parties to the contract have approved the contract </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in writing, orally, or in accordance with other customary business practices) and are committed to perform their respective obligations. A majority of the Company’s contracts are evidenced by a non-cancelable written agreement. Contracts for consumable products are generally evidenced by an order placed via phone or a purchase order. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Entity can identify each party’s rights regarding the goods or services to be transferred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Contract terms are documented within the written agreements. Where a written contract does not exist, such as for consumable products, the rights of each party are understood as following the Company’s standard business process and terms. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The entity can identify the payment terms for the goods or services to be transferred</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment terms are documented within the agreement and are generally net 30 to 60 days from shipment of tangible product or services performed for customers in the United States. Where a written contract does not exist, the Company’s standard payment terms are net 30 day terms. </span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The contract has commercial substance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (that is the risk, timing, or amount of the entity’s future cash flows is expected to change as a result of the contract). The Company’s agreements are an exchange of cash for a combination of products and services which result in changes in the amount of the Company’s future cash flows.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">It is probable the entity will collect the consideration to which it will be entitled in exchange for the goods or services that will be transferred to the customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company performs a credit check for all significant customers or transactions and where collectability is not probable, payment in full or a substantial down payment is typically required to help assure the full agreed upon contract price will be collected. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distinct goods or services are identified as performance obligations. A series of distinct goods or services that are substantially the same and that have the same pattern of transfer to the customer are considered a single performance obligation. Where a good or service is determined not to be distinct, the Company combines the good or service with other promised goods or services until a bundle of goods or services that is distinct is identified. To identify its performance obligations, the Company considers all of the products or services promised in the contract regardless of whether they are explicitly stated or are implied by customary business practices. When performance obligations are included in separate contracts, the Company considers an entire customer arrangement to determine if separate contracts should be considered combined for the purposes of revenue recognition. Most of the Company’s sales, other than renewals of support and maintenance, contain multiple performance obligations, with a combination of hardware systems, consumables and software products, support and maintenance, and professional services. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price of a contract is determined based on the fixed consideration, net of an estimate for variable consideration such as various discounts or rebates provided to customers. As a result of the Company’s commercial selling practices, contract prices are generally fixed with minimal, if any, variable consideration.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is allocated to separate performance obligations proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when the performance obligation has been satisfied by transferring a promised good or service to a customer. The good or service is transferred when or as the customer obtains control of the good or service. Determining when control transfers requires management to make judgments that affect the timing of revenues recognized. Generally, for products requiring a complex implementation, control passes when the product is installed and ready for use. For all other products, control generally passes when product has been shipped and title has passed. For maintenance contracts and certain other services provided on a subscription basis, control passes to the customer over time, generally ratably over the service term as the Company provides a stand-ready service to service the customer’s equipment. Time and material services transfer control to the customer at the time the services are provided. The portion of the transaction price allocated to the Company’s unsatisfied performance obligations recorded as deferred revenues, net of deferred cost of goods sold, at December 31, 2020 and 2019 were $105.7 million and $98.0 million, respectively, of which $100.1 million and $90.9 million, respectively, are expected to be completed within one year and are presented as current deferred revenues, net on the Consolidated Balance Sheets. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, contract assets, and contract liabilities are recorded net of associated taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally invoices customers for products upon shipment. Invoicing associated with the service portion of agreements are generally periodic and are billed on a monthly, quarterly, or annual basis. In certain circumstances, multiple years are billed at one time.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount invoiced for equipment and software is typically reflected in both accounts receivable and deferred revenues, net. The Company typically recognizes product revenue, and correspondingly reduces deferred revenues, net, for equipment and software upon written customer acceptance of installation. Consumables are recorded as revenue upon shipment to or receipt by the customer, depending upon contract terms. The portion of deferred revenues, net, not expected to be recognized as revenue within twelve months of the balance sheet date are included in long-term deferred revenues on the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company often enters into change orders which modify the product to be received by the customer pursuant to certain contracts. Changes to any contract are accounted for as a modification of the existing contract to the extent the goods and services to be delivered as part of the contract are generally consistent with the nature and type of those to be provided under the terms of the original contract. Examples of such change orders include the addition or removal of units of equipment or changes to the configuration of the equipment where the overall nature of the contract remains intact. The Company’s change orders generally result in the change being accounted for as modifications of existing contracts given the nature of the impacted orders.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company typically does not accept product returns unless the item is defective as manufactured or the configuration of the product is incorrect. The Company establishes provisions for estimated returns based on historical product returns. The allowance for sales returns is not material to the Consolidated Financial Statements for any periods presented.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company contracts with Group Purchasing Organizations (“GPOs”), each of which functions as a purchasing agent on behalf of member hospitals and other healthcare providers. The Company also has a Federal Supply Schedule contract with the Department of Veterans Affairs (the "GSA Contract"), allowing the Department of Veterans Affairs, the Department of Defense, and other Federal government customers to purchase or lease the Company's products. Pursuant to the terms of GPO agreements and the GSA Contract, each member or agency contracts directly with Omnicell and can purchase the Company’s products at pre-negotiated contract terms and pricing. GPOs are often owned fully or in part by the Company’s customers, and the Company pays fees to the GPO on completed contracts. The Company also pays the Industrial Funding Fee ("IFF") to the Department of Veterans Affairs under the GSA Contract. The Company considers these fees consideration paid to customers and records them as reductions to revenue. Fees to GPOs and the IFF were $9.7 million, $11.1 million, and $8.7 million for the years ended December 31, 2020, 2019, and 2018, respectively. The accounts receivable balances are with individual members of the GPOs and Federal agencies that purchase under the GSA Contract, and therefore no significant concentration of credit risk exists. During the year ended December 31, 2020, sales to members of the ten largest GPOs and Federal agencies that purchase under the GSA Contract accounted for approximately 60% of total consolidated revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Contract Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract asset is a right to consideration in exchange for goods or services that the Company has transferred to a customer when that right is conditional and is not just subject to the passage of time. A receivable will be recorded on the balance sheet when the Company has unconditional rights to consideration. A contract liability is an obligation to transfer goods or services for which the Company has received consideration, or for which an amount of consideration is due from the customer. Contract liabilities include customer deposits under non-cancelable contracts, and current and non-current deferred revenue balances. The Company’s contract balances are reported in a net contract asset or liability position on a contract-by-contract basis at the end of each reporting period.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant changes in the contract assets and the contract liabilities balances during the period are the result of the issuance of invoices and recognition of deferred revenues in the normal course of business. As a result of the right to invoice for the transaction consideration becoming unconditional, unbilled contract assets as of December 31, 2019 which were invoiced during the year ended December 31, 2020 were not material. The contract modifications entered into during the year ended December 31, 2020 did not have a significant impact on the Company’s contract assets or deferred revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Costs</span></div>The Company has determined that certain incentive portions of its sales commission plans require capitalization since these payments are directly related to sales achieved during a time period. These commissions are earned on the basis of the total purchase order value of new product bookings. Since there are no commensurate commissions earned on renewal of the service bookings, the Company concluded that the capitalized asset is related to services provided under both the initial contract and renewal periods. The Company applies a practical expedient to account for the incremental costs of obtaining a contract as part of a portfolio of contracts with similar characteristics as the Company expects the effect on the financial statements of applying the practical expedient would not differ materially from applying the accounting guidance to the individual contracts within the portfolio. A pool of contracts is defined as all contracts booked in a particular quarter. The amortization for the capitalized asset is an estimate of the pool’s original contract term, generally <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xMjQvZnJhZzoyNmM5ZmE5NTA5MTE0NjExYjM1YjkwOGU4NGFkNGU2Yi90ZXh0cmVnaW9uOjI2YzlmYTk1MDkxMTQ2MTFiMzViOTA4ZTg0YWQ0ZTZiXzIwNDUx_167aff03-38d2-405a-b79a-ef3dc61bed55">one</span> to five years, plus an estimate of future customer renewal periods resulting in a total amortization period of ten years. Costs to obtain a contract are allocated amongst performance obligations and recognized as sales and marketing expense consistent with the pattern of revenue recognition. Capitalized costs are periodically reviewed for impairment. In accordance with U.S. GAAP, while certain compensation elements are expensed as incurred, a portion of the pool’s capitalized asset is recorded as an expense over the first two quarters after booking, which represents the estimated period during which the product revenue associated with the contract is recorded. The remaining capitalized contract costs are recorded as expense ratably over the ten year estimated initial and renewal service periodsShipping CostsOutbound freight billed to customers is recorded as product revenue. The related shipping and handling costs are expensed as part of selling, general, and administrative expense. <div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue recognition for each revenue category which is further discussed below: </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.379%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:45.098%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.055%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Revenue Category</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Timing of Revenue Recognition</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:83%">Income Statement Classification</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Connected devices, software licenses, and other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon installation and acceptance by the customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Technical services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided, typically ratably over the service term</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Consumables</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Point in time, as transfer of control occurs, generally upon shipment to or receipt by customer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Product</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:2.09pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">SaaS, subscription software, and technology-enabled services</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Over time, as services are provided</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:83%">Service</span></div></td></tr></table></div> 105700000 98000000.0 100100000 90900000 five years 9700000 11100000 8700000 0.60 P5Y P10Y P10Y 22100000 24400000 21100000 0 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessor Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. The transaction price is allocated to separate performance obligations, generally consisting of hardware and software products, installation, and post-installation technical support, proportionally based on the standalone selling price of each performance obligation. Standalone selling price is best evidenced by the price the Company charges for the good or service when selling it separately in similar circumstances to similar customers. Other than for the renewal of annual support services contracts, the Company’s products and services are not generally sold separately. The Company uses an amount discounted from the list price as a best estimated selling price.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into non-cancelable sales-type lease arrangements, most of which do not have an option to extend the lease term. At the end of the lease term, the customer must either return the equipment or negotiate a new agreement, resulting in a new purchase or lease transaction. Failure of the customer to either return the equipment or negotiate a new agreement results in the contract becoming a month-to-month rental. Certain sales-type leases automatically renew for successive one year periods at the end of each lease term with written notice from the customer. The Company’s sales-type lease agreements do not contain any material residual value guarantees. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sales-type leases, the Company recognizes revenues for its hardware and software products, net of lease execution costs, post-installation product maintenance, and technical support, at the net present value of the lease payment stream upon customer acceptance. The Company recognizes service revenues associated with sales-type leases ratably over the term of the agreement in service revenues in the Consolidated Statements of Operations. The Company recognizes interest income from sales-type leases using the effective interest method. Both hardware and software revenues, and interest income from sales-types leases are recorded in product revenues in the Consolidated Statements of Operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company optimizes cash flows by selling a majority of its non-U.S. government sales-type leases to third-party leasing finance companies on a non-recourse basis. The Company has no obligation to the leasing company once the lease has been sold. Some of the Company's sales-type leases, mostly those relating to U.S. government hospitals which comprise approximately 67% of the lease receivable balance, are retained in-house.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of Accounting Standards Codification ("ASC") 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Those agreements in place prior to January 1, 2019 continue to be treated as operating leases, however, any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements entered into prior to January 1, 2019 are non-cancelable, and most automatically renew for successive one year periods at the end of each lease term absent written notice from the customer. The Company’s operating lease agreements do not contain any material residual value guarantees. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, rental income is generally recognized on a straight-line basis over the term of the associated lease, and recorded in services and other revenues in the Consolidated Statements of Operations. Leased assets under operating leases are carried at amortized cost net of accumulated depreciation in property and equipment, net on the Consolidated Balance Sheets. The depreciation expense of the leased assets is recognized on a straight-line basis over the contractual term of the associated lease, and recorded in cost of revenues in the Consolidated Statements of Operations.</span></div> 0.67 P1Y <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for Credit Losses</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to credit losses primarily through sales of its products and services, as well as its sales-type leasing arrangements. The Company performs credit evaluations of its customers’ financial condition in order to assess each customer’s ability to pay. These evaluations require significant judgment and are based on a variety of factors including, but not limited to, current economic trends, payment history, and a financial review of the customer. The Company continues to monitor customers’ creditworthiness on an ongoing basis.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains an allowance for credit losses for accounts receivable, unbilled receivables, and net investment in sales-type leases based on expected credit losses resulting from the inability of its customers to make required payments. The allowance for credit losses is measured using a loss rate method, considering factors such as customers’ credit risk, historical loss experience, current conditions, and forecasts. The allowance for credit losses is measured on a collective </span></div>(pool) basis by aggregating customer balances with similar risk characteristics. The Company also records a specific allowance based on an analysis of individual past due balances or customer-specific information, such as a decline in creditworthiness or bankruptcy. Actual collection losses may differ from management’s estimates, and such differences could be material to the Company’s financial position and results of operations. <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance for credit losses is presented in the Consolidated Balance Sheets as a deduction from the respective asset balance. The following table summarizes the Company’s allowance for credit losses by asset type:</span></div><div style="margin-bottom:4pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for credit losses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in other long-term assets in the Consolidated Balance Sheets.</span></div>(2)    Includes both current and long-term portions presented in other current assets and long-term investment in sales-type leases, net, respectively. 4286000 3227000 30000 0 265000 225000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Funds Held for Customers and Customer Fund Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the acquisition of the 340B Link Business, the Company now offers certain products and services in which it is customary for pharmacies to owe funds to the Company which are collected on behalf of, and, after a short holding period, disbursed to, the Company’s customers. The Company presents amounts due from pharmacies and amounts due to be disbursed to customers on a gross basis within other current assets and accrued liabilities, respectively, in the Consolidated Balance Sheets, as such amounts are expected to be settled within one year. Any funds received from the pharmacies that are held by the Company are segregated from its other corporate cash accounts. These funds are classified as restricted cash as the Company is contractually obligated to disburse these amounts to customers.</span></div> Sales of Accounts ReceivableThe Company records the sale of its accounts receivables in accordance with accounting guidance for transfers and servicing of financial assets. 58800000 48300000 46600000 7800000 4600000 Cash and Cash EquivalentsThe Company classifies all highly-liquid investments with original maturities of three months or less as cash equivalents. The Company’s cash and cash equivalent balances include bank accounts and highly-liquid U.S. Government money market funds held in sweep accounts with financial institutions of high credit quality. The Company continuously monitors the credit worthiness of the financial institutions in which it invests. The Company has not experienced any credit losses from its cash equivalents. 485900000 127200000 447200000 0 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Instruments</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For assets and liabilities measured at fair value, the amounts are based on an expected exit price representing the amount that would be received from the sale of an asset or paid to transfer a liability in a transaction between market participants. The fair value may be based on assumptions that market participants would use in pricing an asset or liability. ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs used in valuation techniques are assigned a hierarchical level, as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Observable inputs, such as quoted prices in active markets for identical instruments;</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Quoted prices for similar instruments in active markets, or quoted prices for identical instruments in inactive markets; and</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs for financial instruments reflecting Company’s assumptions.</span> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap Agreements </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses interest rate swap agreements to protect the Company against adverse fluctuations in interest rates by reducing its exposure to variability in cash flows relating to interest payments on a portion of its outstanding debt. The Company does not hold or issue any derivative financial instruments for speculative trading purposes.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swap agreements qualify as cash flow hedging instruments in accordance with ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company records its interest rate swap agreements on its Consolidated Balance Sheets at fair value. The effective portion of changes in fair value are recorded in accumulated other comprehensive loss and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. Any ineffective portion is recognized in earnings. On a quarterly basis, the Company performs a qualitative assessment to determine effectiveness. For further information, refer to Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments</span>. <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost, computed using the first-in, first-out method, and net realizable value. Inbound shipping costs are included in cost of inventory. The Company regularly monitors inventory quantities on hand and records write-downs for excess and obsolete inventories based on the Company’s estimate of demand for its products, potential obsolescence of technology, product life cycles, and whether pricing trends or forecasts indicate that the carrying value of inventory exceeds its estimated selling price. These factors are impacted by market and economic conditions, technology changes, and new product introductions and require estimates that may include elements that are uncertain. Actual demand may differ from forecasted demand and may have a material effect on gross margins. If inventory is written down, a new cost basis is established that cannot be increased in future periods. Shipments from suppliers or contract manufacturers before the Company receives them are recorded as in-transit inventory when title and the significant risks and rewards of ownership have passed to the Company.</span></div>The Company has a supply agreement with one primary supplier for construction and supply of several sub-assemblies and inventory management of sub-assemblies used in its hardware products. There are no minimum purchase requirements. The contract with the Company’s supplier may be terminated by either the supplier or by the Company without cause and at any time upon delivery of six months’ notice. 0 P6M 76300000 75100000 54800000 15600000 15900000 14100000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment less accumulated depreciation are stated at historical cost. The Company’s expenditures for property and equipment are primarily for computer equipment and software used in the administration of its business, and for leasehold improvements to its leased facilities. The Company also develops molds and dies used in long-term manufacturing arrangements with suppliers and for production automation equipment used in the manufacturing of consumable blister card components. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and related software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the lease term or the estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 12 years</span></div></td></tr></table></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes costs related to computer software developed or obtained for internal use in accordance with ASC 350-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal-Use Software</span>. Software obtained for internal use includes enterprise-level business and finance software that the Company customizes to meet its specific operational needs, as well as certain costs for the development of its subscription and cloud-based offerings sold to its customers. Costs incurred in the application development phase are capitalized and amortized over their useful lives, which is generally five years. Costs recognized in the preliminary project phase and the post-implementation phase are expensed as incurred. Depreciation and amortization is computed by use of the straight-line method over the estimated useful lives of the assets as stated below:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment and related software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold and building improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the lease term or the estimated useful life</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 7 years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 12 years</span></div></td></tr></table><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the property and equipment balances as of December 31, 2020 and 2019:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,498 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,517 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,374 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,961 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,073 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,246 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.</span></div>The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:<div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,073 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,246 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No individual country represented more than 10% of the total property and equipment, net.</span></div> P3Y P5Y P5Y P7Y P2Y P12Y P5Y 6800000 300000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Software Development Costs </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain software development costs in accordance with ASC 985-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs of Software to Be Sold, Leased, or Marketed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, under which those costs incurred subsequent to the establishment of technological feasibility may be capitalized and amortized over the estimated lives of the related products. The Company establishes technological feasibility when it completes a detail program design or a working model. The Company amortizes development costs over the estimated lives of the related products, which is generally five years. The Company capitalized software development costs of $32.0 million and $45.8 million, which are included in other long-term assets as of December 31, 2020 and 2019, respectively. The Company recorded $23.1 million, $17.5 million, and $12.5 million to cost of revenues for amortization of capitalized software development costs for the years ended December 31, 2020, 2019, and 2018, respectively. All development costs prior to the completion of a detail program design or a working model are recognized as research and development expense.</span></div> P5Y 32000000.0 45800000 23100000 17500000 12500000 <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lessee Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease at inception. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of its lease contracts do not provide an implicit rate, the Company uses its incremental borrowing rate based on information available at the commencement date in determining the present value of the lease payments. Lease expense is recognized on a straight-line basis over the lease term. The Company does not recognize a right-of-use asset and a lease liability for leases with an initial term of 12 months or less. The Company elected the practical expedient to not separate lease components from nonlease components and applied that practical expedient to all material classes of leased assets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the Company’s operating leases include an option to extend the lease. The specific terms and conditions of the extension options vary from lease to lease, but are consistent with standard industry practices in each area that the Company operates. The Company reviews each of its lease options at a time required by the terms of the lease contract, and notifies the lessor if it chooses to exercise the lease renewal option. Until the Company is reasonably certain that it will extend the lease contract, the renewal option periods will not be recognized as right-of-use assets or lease liabilities.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain leases include provisions for early termination, which allow the contract parties to terminate their obligations under the lease contract. The terms and conditions of the termination options vary by contract. When the Company has made a decision to exercise an early termination option, the right-of-use assets and associated lease liabilities are remeasured in accordance with the present value of the remaining cash flows under the lease contract.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain building lease agreements include rental payments subject to change annually based on fluctuations in various indexes (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consumer Price Index (“CPI”), Retail Price Index, and other international indexes). Certain data center lease agreements include rental payments subject to change based on usage and CPI fluctuations. The changes based on usage and indexes are treated as variable lease costs and recognized in the period in which the obligation for those payments was incurred. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s operating lease agreements do not contain any material residual value guarantees, restrictions, or restriction covenants.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the acquisition method of accounting under ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each acquired company’s operating results are included in the Company's Consolidated Financial Statements starting on the date of acquisition. The purchase price is equivalent to the fair value of consideration transferred. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Goodwill is recognized for the excess of purchase price over the net fair value of assets acquired and liabilities assumed. </span></div>Amounts allocated to assets and liabilities are based upon fair values. Such valuations require management to make significant estimates and assumptions, especially with respect to the identifiable intangible assets. Management makes estimates of fair value based upon assumptions believed to be reasonable and that of a market participant. These estimates are based on historical experience and information obtained from the management of the acquired companies and the estimates are inherently uncertain. The separately identifiable intangible assets generally include customer relationships, acquired technology, backlog, trade names, and non-compete agreements. <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill and Acquired Intangible Assets</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment on an annual basis on the first day of the fourth quarter of each year at the reporting unit level. This assessment is also performed whenever there is a change in circumstances that indicates the carrying value of goodwill may be impaired. The Company has one reporting unit, which is the same as its operating segment. A qualitative assessment is initially made to determine whether it is necessary to perform quantitative testing. A qualitative assessment includes, among others, consideration of: (i) past, current, and projected future earnings and equity; (ii) recent trends and market conditions; and (iii) valuation metrics involving similar companies that are publicly-traded and acquisitions of similar companies, if available. If this qualitative assessment indicates that it is more likely than not that impairment exists, or if the Company decides to bypass this option, it proceeds to the quantitative assessment. The quantitative assessment involves a comparison between the estimated fair value of the Company’s reporting unit with its carrying amount including goodwill. If the carrying value exceeds estimated fair value, the Company will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine the reporting unit’s fair value under the quantitative approach, the Company uses a combination of income and market approaches, equally weighting the two approaches, such as estimated discounted future cash flows of the reporting unit, multiples of earnings or revenues, and analysis of recent sales or offerings of comparable entities. The Company also considers its market capitalization on the date of the analysis to ensure the reasonableness of its reporting unit's fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performed a qualitative impairment assessment analysis as of October 1, 2020 for its reporting unit taking into consideration past, current, and projected future earnings, recent trends, and market conditions, and valuation metrics involving similar companies that are publicly-traded. Based on the result of this analysis, an impairment does not exist as of December 31, 2020, and there were no accumulated impairment losses.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with its acquisitions, the Company generally recognizes assets for customer relationships, acquired technology, backlog, trade names, and non-compete agreements. Intangible assets are carried at cost less accumulated amortization. Such amortization is provided on a straight-line basis or on an accelerated basis based on a pattern of economic benefit that is expected to be obtained over the estimated useful lives of the respective assets, generally from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xMjQvZnJhZzoyNmM5ZmE5NTA5MTE0NjExYjM1YjkwOGU4NGFkNGU2Yi90ZXh0cmVnaW9uOjI2YzlmYTk1MDkxMTQ2MTFiMzViOTA4ZTg0YWQ0ZTZiXzQxMjE0_1a56bc6f-8012-4f15-82af-ea8e73f48d0c">one</span> to 30 years. Amortization for acquired technology and backlog is recognized in cost of revenues, and amortization for customer relationships, trade names, non-compete agreements, and patents is recognized in selling, general, and administrative expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the impairment of identifiable intangible assets whenever events or changes in circumstances indicate that an asset’s carrying amount may not be recoverable. Recoverability of an asset is measured by the comparison of the carrying amount to the sum of the undiscounted estimated future cash flows the asset is expected to generate, offset by estimated future costs to dispose of the product to which the asset relates. If an asset is considered to be impaired, the amount of such impairment would be measured as the difference between the carrying amount of the asset and its fair value. The Company’s cash flow assumptions are based on historical and forecasted future revenue, operating costs, and other relevant factors. Assumptions and estimates about the remaining useful lives of the Company’s intangible assets are subjective and are affected by changes to its business strategies. If management’s estimates of future operating results change, or if there are changes to other assumptions, the estimate of the fair value of the Company’s assets could change significantly. Such change could result in impairment charges in future periods, which could have a significant impact on the Company’s operating results and financial condition. For the years ended December 31, 2020 and 2019, there were no events or changes in circumstances to indicate that intangible assets carrying amounts may not be recoverable.</span></div> 1 0 P30Y <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Debt</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for convertible debt and related transactions in accordance with ASC 470-20, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates convertible debt instruments and related transactions at inception to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for. Convertible debt instruments that may be settled in cash are separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. The difference between the principal amount of the convertible debt instruments and the liability component, inclusive of issuance costs, represents the debt discount, which is amortized to interest expense over the term of instruments. The determination of the discount rate requires certain estimates and assumptions.</span></div>Convertible note hedge and warrant transactions associated with convertible debt instruments are accounted for as equity instruments, and are recorded in additional paid-in capital in the Consolidated Balance Sheet<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modifications and Extinguishments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&amp;R Credit Agreement.</span>Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation of Share-Based Compensation</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for share-based compensation in accordance with ASC 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company recognizes compensation expense related to share-based compensation based on the grant date estimated fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options (“options”) on the grant date is estimated using the Black-Scholes option pricing model, which requires the following inputs: expected life, expected volatility, risk-free interest rate, expected dividend yield rate, exercise price, and closing price of its common stock on the date of grant. The expected volatility is based on a combination of historical and market-based implied volatility, and the expected life of the awards is based on the Company’s historical experience of employee stock option exercises, including forfeitures. Expense is recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock units (“RSUs”) is based on the stock price on the grant date. The fair value of restricted stock awards (“RSAs”) is their intrinsic value, which is the difference between the fair value of the underlying stock at the measurement date and the purchase price. The RSUs and RSAs are subject to a service vesting condition and are recognized on a straight-line basis over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of performance-based stock unit awards (“PSUs”) with service and market conditions is estimated using a Monte Carlo simulation model applying multiple awards approach. Expense is recognized when it is probable that the performance condition will be met using the accelerated attribution method over the requisite service period. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeiture rates are estimated based on the Company's historical experience with equity awards that were granted and forfeited prior to vesting. The valuation assumptions used in estimating the fair value of employee share-based awards may change in future periods.</span></div>Awards of restricted stock to non-employee directors are granted on the date of the annual meeting of stockholders and vest in full on the date of the next annual meeting of stockholders, provided such non-employee director remains a director on such date. The fair value of the awards on the date of issuance is amortized to expense from the date of grant to the date of vesting and are expensed ratably on a straight-line basis over the vesting period. PSUs granted to the Company’s executives might include performance and market conditions. PSUs become eligible for vesting when certain market or performance conditions are met. <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounting for Income Taxes</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records an income tax provision for (benefit from) the anticipated tax consequences of the reported results of operations. In accordance with ASC 740,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the provision for (benefit from) income taxes is computed using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax bases of assets and liabilities and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the enacted tax rates in effect for the periods in which those tax assets and liabilities are expected to be realized or settled. In the event that these tax rates change, the Company will incur a benefit or detriment on its income tax expense in the period of change. If the Company were to determine that all or part of the net deferred tax assets are not realizable in the future, it will record a valuation allowance that would be charged to earnings in the period such determination is made.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, the Company recognizes the tax benefit from an uncertain tax position if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. The calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of ASC 740 and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material impact on the Company’s financial condition and operating results.</span></div> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Authoritative Guidance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2018-15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to align the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted ASU 2018-15 on January 1, 2020 on a prospective basis. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments-Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that modifies or replaces existing models for trade and other receivables, debt securities, loans, and certain other financial instruments. For instruments measured at amortized cost, including trade and lease receivables, loans, and held-to-maturity debt securities, the standard replaced the current “incurred loss” approach with an </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“expected loss” model. Entities are required to estimate expected credit losses over the life of the instrument, considering available relevant information about the collectibility of cash flows, including information about past events, current conditions, and reasonable and supportable forecasts. The Company adopted the new standard on January 1, 2020 using the modified retrospective transition method, which resulted in the recognition of an immaterial cumulative-effect adjustment to retained earnings.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Authoritative Guidance</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update simplifies the accounting for income taxes by removing certain exceptions to the general principles in ASC 740, as well as improves consistent application of and simplifies the guidance for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 will be effective for the Company beginning January 1, 2021. The Company does not expect ASU 2019-12 to have a material impact on its Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The update simplifies the accounting for convertible debt instruments by reducing the number of accounting models and the number of embedded conversion features that could be recognized separately from the primary contract. ASU 2020-06 also enhances transparency and improves disclosures for convertible instruments and earnings per share guidance. This update permits the use of either the modified retrospective or fully retrospective method of transition. ASU 2020-06 will be effective for the Company beginning January 1, 2022. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact ASU 2020-06 will have on its Consolidated Financial Statements.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no other recently issued and effective authoritative guidance that is expected to have a material impact on the Company’s Consolidated Financial Statements through the reporting date.</span></div> Business Combinations<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">340B Link Business Acquisition</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2020, the Company completed the acquisition of all of the outstanding equity of the 340B Link Business pursuant to the terms and conditions of the Equity Purchase Agreement, dated August 11, 2020, as amended, by and among the Company, PSGH, LLC, BW Apothecary Holdings, LLC, the sellers identified therein and the sellers’ representative for total cash consideration of $225.0 million. The 340B Link Business acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner. The results of the 340B Link Business' operations have been included in the Company's consolidated results of operations, commencing as of the acquisition date.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the acquisition of the 340B Link Business in accordance with ASC 805. The tangible and intangible assets acquired and liabilities assumed were recorded at fair value on the acquisition date. The preliminary fair values assume management's best estimates based on information available at the acquisition date and may change over the measurement period, which will end no later than one year form the acquisition date, as additional information is received. The following table represents the preliminary allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of the acquisition reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheets:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">340B Link Business<br/>(Preliminary)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,176 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,762 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,762 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $161.1 million of goodwill arising from the 340B Link Business acquisition is primarily attributed to sales of future software-enabled services and solutions and the 340B Link Business’ assembled workforce. Goodwill that is expected to be deductible for tax purposes is approximately $93.9 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets eligible for recognition separate from goodwill were those that satisfied either the contractual/legal criterion or the separability criterion in the accounting guidance. The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">304B Link Business</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchased intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,800 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The customer relationships intangible asset represents the fair value of the underlying relationships and agreements with the 340B Link Business’ customers. The acquired technology intangible asset represents the fair value of the 340B Link Business' portfolio of software and solutions that have reached technological feasibility and were part of the 340B Link Business’ offerings at the date of acquisition. The trade names intangible asset represents the fair value of brand and name recognition associated with the marketing of the 340B Link Business' software-enabled services and solutions. The non-compete agreements intangible asset represents the fair value of non-compete agreements with former key members of the 340B Link Business' management.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the customer relationships intangible asset was determined based on the excess earnings method; the fair values of the acquired technology and trade names intangible assets were determined based on the relief-from-royalty </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">method; and the fair value of the non-compete agreements intangible asset was determined based on the lost profits method. The key assumptions used in estimating the fair values of intangible assets included forecasted financial information; customer attrition rates; royalty rates of 10.0% and 0.5% for the acquired technology and trade names intangible assets, respectively; discount rate of 14.0% for all intangible assets; and certain other assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The customer relationships and acquired technology intangible assets are being amortized using a double-declining method of amortization as such method better represents the economic benefits to be obtained. The trade names and non-compete agreements are being amortized over their estimated useful lives using the straight-line method of amortization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that the fair value assigned to the assets acquired and liabilities assumed are based on reasonable assumptions and estimates that market participants would use. Actual results may differ from these estimates and assumptions.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company incurred approximately $6.5 million in acquisition-related costs related to the 340B Link Business acquisition during the year ended December 31, 2020. These costs were expensed as incurred, and are included in selling, general, and administrative expenses in the Company's Consolidated Statements of Operations.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues and earnings from the 340B Link Business operations since the acquisition date through December 31, 2020 were $10.2 million and $1.3 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pro Forma Financial Information</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain unaudited pro forma information for illustrative purposes only, for the years ended December 31, 2020 and 2019 as if this acquisition had been completed on January 1, 2019. The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2019. The unaudited pro forma information combines the historical results of the acquisition with the Company’s consolidated historical results and includes certain adjustments including, but not limited to, amortization and depreciation of intangible assets and property and equipment acquired; imputed interest, interest expense, and amortization of debt issuance costs for the indebtedness incurred to complete the acquisition; and acquisition-related costs incurred.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,559 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 225000000.0 The following table represents the preliminary allocation of the purchase price to the assets acquired and the liabilities assumed by the Company as part of the acquisition reconciled to the purchase price transferred included in the Company's Consolidated Balance Sheets:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">340B Link Business<br/>(Preliminary)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,747 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,176 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,762 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,762 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225,000 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 8197000 232000 22747000 31176000 531000 3138000 161117000 62800000 258762000 568000 23787000 6818000 2589000 33762000 225000000 161100000 93900000 The identifiable intangible assets acquired and their estimated useful lives for amortization are as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">304B Link Business</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchased intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,800 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table> 53000000 P21Y 9000000 P5Y 200000 P1Y 600000 P3Y 62800000 0.100 0.005 0.140 6500000 10200000 1300000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain unaudited pro forma information for illustrative purposes only, for the years ended December 31, 2020 and 2019 as if this acquisition had been completed on January 1, 2019. The pro forma information is not indicative of what would have occurred had the acquisition taken place on January 1, 2019. The unaudited pro forma information combines the historical results of the acquisition with the Company’s consolidated historical results and includes certain adjustments including, but not limited to, amortization and depreciation of intangible assets and property and equipment acquired; imputed interest, interest expense, and amortization of debt issuance costs for the indebtedness incurred to complete the acquisition; and acquisition-related costs incurred.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,314 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pro forma net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,559 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,897 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 920314000 929106000 37559000 56897000 Revenues<div style="margin-bottom:8pt;margin-top:8pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenues</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s revenues disaggregated by revenue type for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connected devices, software licenses, and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,844 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,663 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS, subscription software, and technology-enabled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,208 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,027 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797,602</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,881</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,428</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,208</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,309</span></td></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No individual country represented more than 10% of total revenues.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Contract Liabilities</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the Company’s contract assets and contract liabilities:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term unbilled receivables, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term deferred revenues, net</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,726 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,977 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in accounts receivable and unbilled receivables in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Included in other long-term assets in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term deferred revenues of $100.1 million and $90.9 million include deferred revenues from product sales and service contracts, net of deferred cost of sales of $21.0 million and $13.1 million, as of December 31, 2020 and 2019, respectively. The short-term deferred revenues from product sales relate to delivered and invoiced products, pending installation and acceptance, expected to occur within the next twelve months. During the year ended December 31, 2020, the Company recognized revenues of $84.0 million that were included in the corresponding gross short-term deferred revenue balance of $104.0 million as of December 31, 2019.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term deferred revenues include deferred revenues from service contracts of $5.7 million and $7.1 million as of December 31, 2020 and 2019, respectively. Remaining performance obligations primarily relate to maintenance contracts and are recognized ratably over the remaining term of the contract, generally not more than five years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Customers</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no customers that accounted for more than 10% of the Company’s total revenues for the years ended December 31, 2020, 2019, and 2018. Also, there were no customers that accounted for more than 10% of the Company’s accounts receivable balance as of December 31, 2020 and 2019.</span></div> <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s revenues disaggregated by revenue type for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connected devices, software licenses, and other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,844 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,414 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technical services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,202 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consumables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,663 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,758 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,182 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS, subscription software, and technology-enabled services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,794 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,242 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,511 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,208 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,027 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company’s revenues disaggregated by geographic region, which is determined based on customer location, for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797,602</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806,900</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">685,881</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,127</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,428</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">892,208</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">897,027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,309</span></td></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No individual country represented more than 10% of total revenues.</span></div> 560368000 573844000 483414000 202383000 194183000 183202000 75663000 85758000 86182000 53794000 43242000 34511000 892208000 897027000 787309000 797602000 806900000 685881000 94606000 90127000 101428000 892208000 897027000 787309000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the Company’s contract assets and contract liabilities:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term unbilled receivables, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,895 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,707 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,205 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,100 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term deferred revenues, net</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,053 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,894 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term deferred revenues</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contract liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,726 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,977 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in accounts receivable and unbilled receivables in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Included in other long-term assets in the Consolidated Balance Sheets.</span></div> 13895000 11707000 17205000 12260000 31100000 23967000 100053000 90894000 5673000 7083000 105726000 97977000 100100000 90900000 21000000.0 13100000 84000000.0 104000000.0 5700000 7100000 Net Income Per Share<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period, using the treasury stock method. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units, as well as shares the Company could be obligated to issue from its convertible senior notes and warrants, as described in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any anti-dilutive weighted-average dilutive shares related to stock award plans, convertible senior notes, and warrants are excluded from the computation of the diluted net income per share.</span><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The basic and diluted net income per share calculations for the years ended December 31, 2020, 2019, and 2018 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,729 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,583 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,462 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,242 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities from stock award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of convertible senior notes and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,559 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average shares related to stock award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average shares related to convertible senior notes and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing net income for the period by the weighted-average number of shares outstanding during the period. In periods of net loss, all potential common shares are anti-dilutive, so diluted net loss per share equals the basic net loss per share. In periods of net income, diluted net income per share is computed by dividing net income for the period by the basic weighted-average number of shares plus any dilutive potential common stock outstanding during the period, using the treasury stock method. Potential common stock includes the effect of outstanding dilutive stock options, restricted stock awards, and restricted stock units, as well as shares the Company could be obligated to issue from its convertible senior notes and warrants, as described in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any anti-dilutive weighted-average dilutive shares related to stock award plans, convertible senior notes, and warrants are excluded from the computation of the diluted net income per share.</span> <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The basic and diluted net income per share calculations for the years ended December 31, 2020, 2019, and 2018 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,194 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,338 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,729 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding - basic</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,583 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,462 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,242 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities from stock award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,317 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of convertible senior notes and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,743 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,559 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - basic</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.76 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.48 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per share - diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average shares related to stock award plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,054 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">926 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive weighted-average shares related to convertible senior notes and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 32194000 61338000 37729000 42583000 41462000 39242000 1160000 1481000 1317000 0 0 0 43743000 42943000 40559000 0.76 1.48 0.96 0.74 1.43 0.93 2054000 926000 1279000 11816000 0 0 Fair Value of Financial Instruments<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Hierarchy</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and credit facilities are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company's convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period. As of December 31, 2020, the fair value of the convertible senior notes was $782.3 million, compared to their carrying value of $467.2 million, which is net of unamortized discount and debt issuance costs and excludes amounts classified within additional paid-in capital. Refer to Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt and Credit Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information regarding the Company’s credit facilities and Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for further information regarding the Company’s convertible senior notes.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Swap Contracts</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2016, the Company entered into an interest rate swap agreement with a combined notional amount of $100.0 million with one counterparty that became effective on June 30, 2016 and matured on April 30, 2019. The swap agreement required the Company to pay a fixed rate of 0.8% and provided that the Company receive a variable rate based on the one month LIBOR rate subject to a LIBOR floor of 0.0%. Amounts payable by or due to the Company were net settled with the respective counterparty on the last business day of each month, commencing July 31, 2016. The Company’s interest rate swap agreement matured during the second quarter of 2019, and, as of December 31, 2020, the Company did not have any outstanding interest rate swap agreements.</span></div> Fair Value HierarchyThe Company measures its financial instruments at fair value. The Company’s cash, cash equivalents, and restricted cash are classified within Level 1 of the fair value hierarchy as they are valued primarily using quoted market prices utilizing market observable inputs. The Company's interest rate swap contracts and credit facilities are classified within Level 2 as the valuation inputs are based on quoted prices or market observable data of similar instruments. The Company's convertible senior notes are classified within Level 2 as the valuation inputs are based on quoted prices in an inactive market on the last day in the reporting period. 782300000 467200000 100000000.0 0.008 0.000 Balance Sheet Components<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance sheet details as of December 31, 2020 and 2019 are presented in the tables below:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,011 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funds held for customers, including restricted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,347 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,289 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,036 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer fund liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payments from customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and lease buyouts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,815 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group purchasing organization fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,567 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Includes $4.0 million of restricted cash. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain (loss) on interest rate swap hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,446)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,446)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance sheet details as of December 31, 2020 and 2019 are presented in the tables below:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,973 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,620 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,120 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,060 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,298 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,011 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Funds held for customers, including restricted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,770 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,347 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,060 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,044 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,177 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other long-term assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,205 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,804 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other long-term assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,289 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,036 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current portion</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,197 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,058 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer fund liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advance payments from customers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,981 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and lease buyouts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,815 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,911 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group purchasing organization fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,412 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,914 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,311 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,567 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div>(1)    Includes $4.0 million of restricted cash. 28205000 31331000 7973000 7620000 60120000 69060000 96298000 108011000 18164000 0 10246000 9770000 10095000 4347000 2539000 1060000 41044000 15177000 94027000 85070000 17205000 12260000 4253000 4700000 3804000 1006000 119289000 103036000 12197000 10058000 18164000 0 6981000 4006000 21815000 14911000 4412000 5934000 3520000 3744000 13222000 16914000 80311000 55567000 4000000.0 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in accumulated balances of other comprehensive income (loss) for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.744%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized gain (loss) on interest rate swap hedges</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,854)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(568)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(420)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,446)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,446)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified from other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current-period other comprehensive income (loss), net of tax</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,924 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,522)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div> -11274000 420000 -10854000 1828000 148000 1976000 0 568000 568000 1828000 -420000 1408000 -9446000 0 -9446000 3924000 0 3924000 0 0 0 3924000 0 3924000 -5522000 0 -5522000 Property and Equipment<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the property and equipment balances as of December 31, 2020 and 2019:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,034 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,569 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,498 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,925 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,517 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,979 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,230 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,179 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,374 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,961 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,301)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,073 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,246 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The change in balances between periods is primarily due to the disposal of certain fully depreciated property and equipment, partially offset by additions, and depreciation and amortization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense of property and equipment was $18.3 million, $17.2 million, and $15.1 million for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The geographic location of the Company's property and equipment, net, is based on the physical location in which it is located. The following table summarizes the geographic information for property and equipment, net, as of December 31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,203 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,769 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,477 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,073 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,246 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No individual country represented more than 10% of the total property and equipment, net.</span></div> 81034000 88569000 7498000 7925000 19517000 18979000 50230000 48309000 7095000 6179000 165374000 169961000 106301000 115715000 59073000 54246000 18300000 17200000 15100000 53203000 48769000 5870000 5477000 59073000 54246000 Goodwill and Intangible Assets<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the carrying amount of goodwill:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,887 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate fluctuations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate fluctuations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions represent the preliminary value assigned to goodwill in connection with the 340B Link Business acquisition in October 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intangible Assets, Net</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and useful lives of intangible assets as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency exchange <br/>rate fluctuations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 - 30</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 - 12</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,448 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Foreign currency exchange <br/>rate fluctuations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 - 30</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,037)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 - 12</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 20</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,393 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,485)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,041)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,867 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The differences in gross carrying amounts between periods are primarily due to additions of intangible assets in connection with the 340B Link Business acquisition, partially offset by the write-off of certain fully amortized intangible assets. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of intangible assets was $19.7 million, $18.9 million, and $23.8 million for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expenses for amortizable intangible assets were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the carrying amount of goodwill:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,887 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate fluctuations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,539 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,117 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange rate fluctuations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,309 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions represent the preliminary value assigned to goodwill in connection with the 340B Link Business acquisition in October 2020.</span></div> 335887000 0 652000 336539000 161117000 1653000 499309000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts and useful lives of intangible assets as of December 31, 2020 and 2019 were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">amount </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign currency exchange <br/>rate fluctuations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,889 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(777)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,858 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 - 30</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,029 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,851)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,184 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,070 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 - 12</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,477 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,448 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117,482)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(755)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">amount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"> Foreign currency exchange <br/>rate fluctuations</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net carrying<br/>amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful life<br/>(years)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except for years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,234 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,860)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,058)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 - 30</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,142 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,953 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 20</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backlog</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,650 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,037)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,624 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 - 12</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,217 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,603)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 - 20</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangibles assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,393 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,485)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,041)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,867 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div>(1)     The differences in gross carrying amounts between periods are primarily due to additions of intangible assets in connection with the 340B Link Business acquisition, partially offset by the write-off of certain fully amortized intangible assets. 187889000 64254000 -777000 122858000 P10Y P30Y 86029000 44851000 6000 41184000 P3Y P20Y 1150000 1078000 0 72000 P4Y 7850000 5794000 14000 2070000 P1Y P12Y 2930000 1455000 2000 1477000 P2Y P20Y 600000 50000 0 550000 P3Y 286448000 117482000 -755000 168211000 135234000 54860000 -1058000 79316000 P10Y P30Y 77142000 36194000 5000 40953000 P3Y P20Y 1150000 791000 0 359000 P4Y 7650000 5037000 11000 2624000 P6Y P12Y 3217000 1603000 1000 1615000 P2Y P20Y 224393000 98485000 -1041000 124867000 19700000 18900000 23800000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated future amortization expenses for amortizable intangible assets were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,134 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,113 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,825 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,575 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,211 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23948000 21134000 19113000 12825000 11616000 79575000 168211000 Debt and Credit Agreements <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2016 Senior Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 5, 2016, the Company entered into a $400.0 million senior secured credit facility pursuant to a credit agreement with certain lenders, Wells Fargo Securities, LLC as sole lead arranger, and Wells Fargo Bank, National Association as administrative agent (as subsequently amended as discussed below, the “Prior Credit Agreement”). The Prior Credit Agreement provided for (a) a five-year revolving credit facility of $200.0 million, which was subsequently increased pursuant to the amendment discussed below (the “Prior Revolving Credit Facility”) and (b) a five-year $200.0 million term loan facility (the “Prior Term Loan Facility” and, together with the Prior Revolving Credit Facility, the “Prior Facilities”). In addition, the Prior Credit Agreement included a letter of credit sub-limit of up to $10.0 million and a swing line loan sub-limit of up to $10.0 million. The Prior Credit Agreement had an expiration date of January 5, 2021, upon which date all remaining outstanding borrowings were due and payable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Prior Facilities bore interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.50% to 2.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month, plus an applicable margin ranging from 0.50% to 1.25% per annum based on the Company’s consolidated total net leverage ratio (as defined in the Prior Credit Agreement). Undrawn commitments under the Prior Revolving Credit Facility were subject to a commitment fee ranging from 0.20% to 0.35% per annum based on the Company’s consolidated total net leverage ratio on the average daily unused portion of the Prior Revolving Credit Facility. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On each of April 11, 2017 and December 26, 2017, the parties entered into amendments to the Prior Credit Agreement. Under these amendments, the Prior Revolving Credit Facility was increased from $200.0 million to $315.0 million and certain other modifications were made. In connection with the December 2017 amendment, the Company incurred and capitalized an additional $2.1 million of debt issuance costs. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2019 Revolving Credit Facility</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2019, the Company refinanced the Prior Credit Agreement and entered into an Amended and Restated Credit Agreement (the “A&amp;R Credit Agreement”) with the lenders from time to time party thereto, Wells Fargo Securities, LLC, Citizens Bank, N.A., and JPMorgan Chase Bank, N.A., as joint lead arrangers and Wells Fargo Bank, National Association, as administrative agent. The A&amp;R Credit Agreement replaced the Prior Credit Agreement and provides for (a) a five-year revolving credit facility of $500.0 million (the “Current Revolving Credit Facility”) and (b) an uncommitted incremental loan facility of up to $250.0 million (the “Incremental Facility”). In addition, the A&amp;R Credit Agreement includes a letter of credit sub-limit of up to $15.0 million and a swing line loan sub-limit of up to $25.0 million. The A&amp;R Credit Agreement has an expiration date of November 15, 2024, upon which date all remaining outstanding borrowings will be due and payable.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 15, 2019, the $80.0 million outstanding term loan balance under the Prior Facilities was transferred to the Current Revolving Credit Facility.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans under the Current Revolving Credit Facility bear interest, at the Company’s option, at a rate equal to either (a) the LIBOR Rate, plus an applicable margin ranging from 1.25% to 2.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio (as defined in the A&amp;R Credit Agreement), or (b) an alternate base rate equal to the highest of (i) the </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prime rate, (ii) the federal funds rate plus 0.50%, and (iii) LIBOR for an interest period of one month plus 1.00%, plus an applicable margin ranging from 0.25% to 1.00% per annum based on the Company’s Consolidated Total Net Leverage Ratio. Undrawn commitments under the Current Revolving Credit Facility are subject to a commitment fee ranging from 0.15% to 0.30% per annum based on the Company’s Consolidated Total Net Leverage Ratio on the average daily unused portion of the Current Revolving Credit Facility. The applicable margin for and certain other terms of any term loans under the Incremental Facility will be determined prior to the incurrence of such loans. The Company is permitted to make voluntary prepayments at any time without payment of a premium or penalty.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22, 2020, the parties entered into an amendment (the “Amendment”) to the A&amp;R Credit Agreement to, among other changes, permit the issuance of the convertible senior notes and the purchase of the convertible note hedge transactions as described in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, expand the Company’s flexibility to repurchase its common stock and make other restricted payments, and replace the total net leverage covenant with a new secured net leverage covenant that requires the Company to maintain a consolidated secured net leverage ratio not to exceed 3.50:1 for the calendar quarters ending September 30, 2020, December 31, 2020, and March 31, 2021 and 3.00:1 for the calendar quarters ending thereafter.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The A&amp;R Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the Company and its subsidiaries, including, among other things, restrictions on indebtedness, liens, investments, mergers, dispositions, dividends, and other distributions. The A&amp;R Credit Agreement contains financial covenants that require the Company and its subsidiaries to not exceed a maximum consolidated total net leverage ratio and maintain a minimum interest coverage ratio. In addition, the A&amp;R Credit Agreement contains certain customary events of default including, but not limited to, failure to pay interest, principal, and fees or other amounts when due, material misrepresentations or misstatements in any representation or warranty, covenant defaults, certain cross defaults to other material indebtedness, certain judgment defaults, and events of bankruptcy. The Company’s obligations under the A&amp;R Credit Agreement and any swap obligations and banking services obligations owing to a lender (or an affiliate of a lender) are guaranteed by certain of its domestic subsidiaries and secured by substantially all of its and such subsidiary guarantors’ assets. In connection with entering into the A&amp;R Credit Agreement, and as a condition precedent to borrowing loans thereunder, the Company and certain of the Company’s other direct and indirect subsidiaries have entered into certain ancillary agreements, including, but not limited to, a reaffirmation agreement, which amends certain terms of the existing collateral agreement and reaffirms their obligations under the existing guaranty agreement. The Company was in full compliance with all covenants as of December 31, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The refinancing of the Prior Credit Agreement was evaluated in accordance with ASC 470-50, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modifications and Extinguishments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining whether the refinancing was to be accounted for as a debt extinguishment or a debt modification, the Company considered whether lenders within the syndicate remained the same or changed and whether the changes in debt terms were substantial. This assessment was performed on an individual lender basis within the syndicate. As a result, the refinancing was accounted for as a modification with the exception of certain lenders that exited the syndicate. The exit of certain lenders resulted in an immaterial write-off of existing unamortized debt issuance costs. The remaining unamortized debt issuance costs related to debt modification, along with the new deferred costs, will be amortized over the remaining term of the A&amp;R Credit Agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the A&amp;R Credit Agreement, the Company incurred and capitalized an additional $2.3 million of debt issuance costs. In connection with the Amendment on September 22, 2020, the Company incurred and capitalized an additional $0.6 million of debt issuance costs. The debt issuance costs are being amortized to interest expense using the straight-line method through 2024. Amortization expense related to debt issuance costs was approximately $1.0 million, $2.2 million, and $2.3 million for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense (exclusive of fees and debt issuance cost amortization) was approximately $0.5 million, $3.6 million, and $7.5 million for the years ended December 31, 2020, 2019, and 2018, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the carrying amount of the Company's debt obligations:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Revolving Credit Facility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the balance of the Company's deferred debt issuance costs:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Convertible Senior Notes<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.25% Convertible Senior Notes due 2025</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2020, the Company completed a private offering of $575.0 million aggregate principal amount of 0.25% convertible senior notes (the “Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $75.0 million principal amount of the Notes. The Company received proceeds from the issuance of the Notes of $559.7 million, net of $15.3 million of transaction fees and other debt issuance costs. The Notes bear interest at a rate of 0.25% per year, payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Notes were issued pursuant to an indenture, dated September 25, 2020 (the “Indenture”), between the Company and U.S. Bank National Association, as trustee. The Notes are general senior, unsecured obligations of the Company and will mature on September 15, 2025, unless earlier redeemed, repurchased, or converted. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding May 15, 2025, only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ended on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price for the Notes on each applicable trading day; (ii) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined in the Indenture) per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate for the Notes on each such trading day; (iii) if the Company calls such Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the Notes called (or deemed called) for redemption; and (iv) upon the occurrence of specified corporate events, as specified in the Indenture. On or after May 15, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the Notes may convert all or any portion of their Notes at any time, regardless of the foregoing conditions. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of its common stock, or a combination of cash and shares of its common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. The initial conversion rate for the Notes is 10.2751 shares of the Company’s common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $97.32 per share of the Company’s common stock, subject to adjustment under certain circumstances in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the Notes or if the Company delivers a notice of redemption in respect of the Notes, the Company will, under certain circumstances, increase the conversion rate of the Notes for a holder who elects to convert its Notes (or any portion thereof) in connection with such a corporate event or convert its Notes called (or deemed called) for redemption during the related redemption period (as defined in the Indenture), as the case may be.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a fundamental change, holders may require, subject to certain exceptions, the Company to repurchase for cash all or any portion of their Notes at a fundamental change repurchase price equal to 100% of the principal amount of the Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. As of December 31, 2020, none of the criteria for a fundamental change or a conversion rate adjustment had been met. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may not redeem the Notes prior to September 20, 2023. The Company may redeem for cash all or any portion of the Notes, at its option, on or after September 20, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price for the Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. If the Company redeems less than all the outstanding Notes, at least $150.0 million aggregate </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">principal amount of Notes must be outstanding and not subject to redemption as of the date of the relevant notice of redemption. No sinking fund is provided for in the Notes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt instruments that may be settled in cash are required to be separated into liability and equity components. The allocation to the liability component is based on the fair value of a similar instrument that does not contain an equity conversion option. Based on this debt-to-equity ratio, debt issuance costs are then allocated to the liability and equity components in a similar manner. Accordingly, at issuance, the Company allocated $461.8 million to the debt liability and $72.7 million to additional paid in capital, net of applicable issuance costs and deferred taxes. The difference between the principal amount of the Notes and the liability component, inclusive of issuance costs, represents the debt discount, which the Company will amortize to interest expense over the term of the Notes using an effective interest rate of 4.18%. The determination of the discount rate required certain estimates and assumptions. As of December 31, 2020, the remaining life of the Notes and the related debt discount and issuance cost accretion is approximately 4.7 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum number of shares issuable upon conversion, including the effect of a fundamental change and subject to other conversion rate adjustments, would be 8.1 million shares.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, liability component</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467,201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embedded conversion option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, equity component </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,732 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)    </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Included in additional paid-in capital in the Consolidated Balance Sheets. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, <br/>2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of discount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Note Hedge and Warrant Transactions</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the Notes, the Company entered into convertible note hedge and warrant transactions with an affiliate of one of the initial purchasers of the Notes and certain other financial institutions (the “option counterparties”) with respect to the Company’s common stock.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The convertible note hedge consists of an option for the Company to purchase up to approximately 5.9 million shares of the Company’s common stock, which is equal to the number of shares of the Company’s common stock underlying the Notes, at an initial strike price of approximately $97.32 per share. The convertible note hedge will expire upon the maturity of the Notes, if not earlier exercised or terminated. The cost of the convertible note hedge was approximately $100.6 million and was accounted for as an equity instrument, which was recorded in additional paid-in capital in the Consolidated Balance Sheets. The Company recorded a deferred tax asset of $25.8 million at issuance related to the convertible note hedge transaction. The </span></div>convertible note hedge is expected generally to reduce the potential dilution to the Company’s common stock upon any conversion of Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Notes.Separately from the convertible note hedge, the Company entered into warrant transactions to sell to the option counterparties warrants to acquire, subject to customary anti-dilution adjustments, up to approximately 5.9 million shares of its common stock in the aggregate at an initial strike price of $141.56 per share. The warrants require net share or net cash settlement upon the Company’s election. The Company received aggregate proceeds of approximately $51.3 million for the issuance of the warrants, which was recorded in additional paid in capital at issuance in the Consolidated Balance Sheets. The warrants could separately have a dilutive effect to the Company’s common stock to the extent that the market price per share of its common stock exceeds the strike price of the warrants. 400000000.0 P5Y 200000000.0 P5Y 200000000.0 10000000.0 10000000.0 0.0150 0.0225 0.0050 0.0050 0.0125 0.0020 0.0035 200000000.0 315000000.0 2100000 P5Y 500000000.0 250000000.0 15000000.0 25000000.0 -80000000.0 80000000.0 0.0125 0.0200 0.0050 0.0100 0.0025 0.0100 0.0015 0.0030 3.50 3.00 2300000 600000 1000000.0 2200000 2300000 500000 3600000 7500000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the carrying amount of the Company's debt obligations:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Current Revolving Credit Facility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 50000000 150000000 200000000 0 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents changes in the balance of the Company's deferred debt issuance costs:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,700 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(997)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,253 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 4700000 550000 997000 4253000 0.0025 575000000.0 0.0025 75000000.0 559700000 15300000 0.0025 20 30 1.30 5 10 0.98 97.32 1 1.30 20 30 1 150000000.0 461800000 72700000 0.0418 P4Y8M12D 8100000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notes consisted of the following balances reported in the Consolidated Balance Sheets as of December 31, 2020:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,744)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, liability component</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467,201 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Embedded conversion option</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,510 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,098)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible senior notes, equity component </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,732 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div>(1)    Included in additional paid-in capital in the Consolidated Balance Sheets. 575000000 95744000 12055000 467201000 100510000 2680000 25098000 72732000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense resulting from the Notes recognized in interest and other income (expense), net in the Consolidated Statements of Operations for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended<br/>December 31, <br/>2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contractual coupon interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">379 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of discount</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 379000 4766000 600000 5900000 97.32 100600000 25800000 5900000 141.56 51300000 Lessor Leases<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company enters into multi-year, sales-type lease agreements with the majority varying in length from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xNTEvZnJhZzpkYmY0NjVjZDljOWU0OGNjYmJmZmYwNjQ2ZDMyNmFkMS90ZXh0cmVnaW9uOmRiZjQ2NWNkOWM5ZTQ4Y2NiYmZmZjA2NDZkMzI2YWQxXzE1OA_d22129fc-5788-4ea1-98be-c43d63a6cfb7">one</span> to five years. The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales-type lease revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling profit on sales-type lease revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,982 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on sales-type lease receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,770)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investment in sales-type leases, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,156 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum sales-type lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These agreements in place prior to January 1, 2019 continue to be treated as operating leases, however any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements generally have initial terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xNTEvZnJhZzpkYmY0NjVjZDljOWU0OGNjYmJmZmYwNjQ2ZDMyNmFkMS90ZXh0cmVnaW9uOmRiZjQ2NWNkOWM5ZTQ4Y2NiYmZmZjA2NDZkMzI2YWQxXzE2NzA_f2a837e6-1b2f-4241-8589-0ff0ef6e8f1c">one</span> to seven years. The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying value of the leased equipment under operating leases was $1.4 million and $2.1 million, which includes accumulated depreciation of $2.5 million and $1.6 million, as of December 31, 2020 and 2019, respectively. Depreciation expense of the leased equipment for the years ended December 31, 2020, 2019, and 2018 was $0.6 million, $0.7 million, and $0.5 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under operating leases was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,848 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum operating lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,771 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> Lessor Leases<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales-Type Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a recurring basis, the Company enters into multi-year, sales-type lease agreements with the majority varying in length from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xNTEvZnJhZzpkYmY0NjVjZDljOWU0OGNjYmJmZmYwNjQ2ZDMyNmFkMS90ZXh0cmVnaW9uOmRiZjQ2NWNkOWM5ZTQ4Y2NiYmZmZjA2NDZkMzI2YWQxXzE1OA_d22129fc-5788-4ea1-98be-c43d63a6cfb7">one</span> to five years. The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales-type lease revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling profit on sales-type lease revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,982 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on sales-type lease receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,770)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investment in sales-type leases, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,156 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s sales-type lease receivables is a reasonable estimate of fair value.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum sales-type lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into certain leasing agreements that were classified as operating leases prior to the adoption of ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These agreements in place prior to January 1, 2019 continue to be treated as operating leases, however any leasing agreements entered into on or after January 1, 2019 under these programs are classified and accounted for as sales-type leases in accordance with ASC 842. The operating lease arrangements generally have initial terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xNTEvZnJhZzpkYmY0NjVjZDljOWU0OGNjYmJmZmYwNjQ2ZDMyNmFkMS90ZXh0cmVnaW9uOmRiZjQ2NWNkOWM5ZTQ4Y2NiYmZmZjA2NDZkMzI2YWQxXzE2NzA_f2a837e6-1b2f-4241-8589-0ff0ef6e8f1c">one</span> to seven years. The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net carrying value of the leased equipment under operating leases was $1.4 million and $2.1 million, which includes accumulated depreciation of $2.5 million and $1.6 million, as of December 31, 2020 and 2019, respectively. Depreciation expense of the leased equipment for the years ended December 31, 2020, 2019, and 2018 was $0.6 million, $0.7 million, and $0.5 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under operating leases was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,848 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum operating lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,771 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P5Y The following table presents the Company’s income recognized from sales-type leases for the years ended December 31, 2020, 2019, and 2018:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales-type lease revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,040 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,175 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales-type lease revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,624)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,985)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling profit on sales-type lease revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,416 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,982 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income on sales-type lease receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,933 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,756 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,296 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 26040000 37175000 39167000 10624000 14985000 16185000 15416000 22190000 22982000 1933000 1756000 1296000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The receivables as a result of these types of transactions are collateralized by the underlying equipment leased and consist of the following components at December 31, 2020 and 2019:</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net minimum lease payments to be received</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Unearned interest income portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,520 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,246)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,770)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investment in sales-type leases, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,156 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,750 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    The current portion of the net investment in sales-type leases is included in other current assets in the Consolidated Balance Sheets.</span></div> 35331000 32360000 2929000 2840000 32402000 29520000 10246000 9770000 22156000 19750000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under sales-type leases retained in-house and the reconciliation to the net investment in sales-type leases reported on the Consolidated Balance Sheets was as follows:</span></div><div style="margin-bottom:6pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,312 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,499 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,334 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,535 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum sales-type lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,331 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net investment in sales-type leases</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,402 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 11312000 9499000 7334000 4535000 2616000 35000 35331000 2929000 32402000 P7Y The following table represents the Company’s income recognized from operating leases for the years ended December 31, 2020, 2019, and 2018:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,668 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,660 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,207 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 11668000 12660000 12207000 1400000 2100000 2500000 1600000 600000 700000 500000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under operating leases was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,848 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,816 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum operating lease payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,771 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8848000 4816000 2910000 852000 256000 89000 17771000 Lessee LeasesThe Company has operating leases for office buildings, data centers, office equipment, and vehicles. The Company’s leases have initial terms of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjYwMjI2ZmQzZGUzOTQ5OTRhYmIzYjMzMDUzM2E4ZWI2L3NlYzo2MDIyNmZkM2RlMzk0OTk0YWJiM2IzMzA1MzNhOGViNl8xNTQvZnJhZzo2MjBlYTE5MzYxOGE0OGY3YmM0OTA1ZDA0ZmMyYjEyZC90ZXh0cmVnaW9uOjYyMGVhMTkzNjE4YTQ4ZjdiYzQ5MDVkMDRmYzJiMTJkXzE1Ng_9a1ef3af-3df2-4a47-97f2-cf0668e63a6f">one</span> to 12 years. As of December 31, 2020, the Company did not have any additional material operating leases that were entered into, but not yet commenced. <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Consolidated Balance Sheets was as follows:</span></div><div style="margin-bottom:4pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,922 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,094 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Amount consists of a current and long-term portion of operating lease liabilities of $12.2 million and $48.9 million, respectively. The short-term portion of the operating lease liabilities is included in accrued liabilities in the Consolidated Balance Sheets.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease costs were $14.3 million and $14.6 million for the years ended December 31, 2020 and 2019, respectively. Short-term lease costs and variable lease costs were immaterial for the years ended December 31, 2020 and 2019, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes supplemental cash flow information related to the Company’s operating leases for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term, years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> P12Y <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maturity schedule of future minimum lease payments under operating leases and the reconciliation to the operating lease liabilities reported on the Consolidated Balance Sheets was as follows:</span></div><div style="margin-bottom:4pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,106 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,221 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,922 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,571 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,422 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,532 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,438)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,094 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________________________________________</span></div><div style="margin-bottom:8pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    Amount consists of a current and long-term portion of operating lease liabilities of $12.2 million and $48.9 million, respectively. The short-term portion of the operating lease liabilities is included in accrued liabilities in the Consolidated Balance Sheets.</span></div> 15290000 14106000 10221000 8922000 6571000 17422000 72532000 11438000 61094000 12200000 48900000 14300000 14600000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes supplemental cash flow information related to the Company’s operating leases for the years ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,490 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,636 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new lease liabilities, including leases obtained from recent acquisitions</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 14490000 14636000 10025000 1204000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the weighted-average remaining lease term and weighted-average discount rate related to the Company’s operating leases as of December 31, 2020 and 2019:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term, years</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> P5Y10M24D P6Y4M24D 0.058 0.064 Commitments and Contingencies<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company issues purchase orders based on its current manufacturing needs. As of December 31, 2020, the Company had non-cancelable purchase commitments of $72.8 million, of which $69.9 million are expected to be paid within the next twelve months. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is currently involved in various legal proceedings.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A class action lawsuit was filed against the Company, on June 5, 2019, in the Circuit Court of Cook County, Illinois, Chancery Division, captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corey Heard, individually and on behalf of all others similarly situated, v. Omnicell, Inc., Case No. 2019-CH-06817</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The complaint seeks class certification, monetary damages in the form of statutory damages for willful and/or reckless or, in the alternative, negligent violation of the Illinois Biometric Information Privacy Act (“BIPA”), and certain declaratory, injunctive, and other relief based on causes of action directed to allegations of violation of BIPA by the Company. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The complaint was served on the Company on June 13, 2019. On July 31, 2019, the Company filed a motion to stay or consolidate the case with the action </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yana Mazya, et al. v. Northwestern Lake Forest Hospital, et al., Case No. 2018-CH-07161, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pending in the Circuit Court of Cook County, Illinois, Chancery Division (the “Mazya Action”). The Court subsequently, on October 10, 2019, denied the motion, without prejudice, as being moot in view of the Company’s dismissal from the Mazya Action. The Company filed a motion to dismiss the complaint on October 31, 2019. The hearing on the Company’s motion to dismiss was held on September 2, 2020. The Court ruled from the bench and dismissed the complaint without prejudice giving plaintiff leave to file an amended complaint by September 30, 2020. Plaintiff filed an amended complaint on September 30, 2020 and the Company subsequently filed a motion to dismiss the complaint on October 28, 2020. The Company's motion to dismiss is now fully briefed and the Court has scheduled oral argument on the motion for June 4, 2021. The Company intends to defend the lawsuit vigorously.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 21, 2020, Becton, Dickinson and Company (“BD”) filed a complaint against the Company in the United States District Court for the Middle District of North Carolina, asserting claims of misappropriation under the Defend Trade Secrets Act, misappropriation under the North Carolina Trade Secrets Protection Act, unfair competition, and unfair/deceptive trade practices in violation of North Carolina law (the “Omnicell Complaint”). This action was commenced in relation to another action brought by BD, in the same Court, (the “Related Matter”) against a former BD employee who is also a former Company employee (the “Former Employee”) alleging that the Former Employee had violated the Former Employee’s legal obligations to BD regarding BD’s confidential and trade secret information when the Former Employee allegedly downloaded certain documents from BD’s information technology system following the end of the Former Employee’s employment with BD. In connection with the Related Matter, BD, the Former Employee, and the Company entered into a protocol to facilitate the return to BD of any BD documents that may have been resident, as a result of the Former Employee’s actions, on any devices belonging to the Former Employee or the Company. The Omnicell Complaint seeks injunctive relief and monetary damages in the form of compensatory, punitive, and exemplary damages, attorneys’ fees and costs, and pre-judgment and post-judgment interest. BD has not yet served the Omnicell Complaint on the Company, and, therefore, there are no response dates pending. The Company intends to defend the lawsuit vigorously.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with the legal proceedings described above based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time or is not deemed material. The Company believes that it has valid defenses with respect to these legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of any of these legal proceedings or because of the diversion of management’s attention and the creation of significant expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company’s certificate of incorporation and bylaws, the Company has agreed to indemnify its directors and executive officers to the fullest extent not prohibited by Delaware and other applicable law, subject to certain exceptions. The Company has entered into individual indemnification agreements with its directors and officers. The term of the indemnification period is for the entirety of the director’s or officer’s service to the Company and continues so long as the director or officer may be subject to any claim, action, or proceeding, and there is no limit on the potential amount of future payments that the Company could be required to make under these indemnification agreements. The Company has purchased a directors’ and officers’ liability insurance policy that may enable it to recover a portion of any future payments that it may be required to make under these indemnification agreements. Assuming the applicability of coverage and the willingness of the insurer to assume coverage and subject to certain retention, loss limits, and other policy provisions, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations. However, no assurances can be given that the insurers will not attempt to dispute the validity, applicability, or amount of coverage without expensive and time-consuming litigation against the insurers.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company undertakes indemnification obligations in its ordinary course of business in connection with, among other things, the licensing of its products and the provision of its support services. In the ordinary course of the Company’s business, the Company has in the past and may in the future agree to indemnify another party, generally its business affiliates or customers, against certain losses suffered or incurred by the indemnified party in connection with various types of claims, which may include, without limitation, claims of intellectual property infringement, certain tax liabilities, its gross negligence or intentional acts in the performance of support services, and violations of laws. The term of these indemnification obligations is generally perpetual. In general, the Company attempts to limit the maximum potential amount of future payments that it may be required to make under these indemnification obligations to the amounts paid to it by a customer, but in some cases the obligation may not be so limited. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has in the past and may in the future warrant to its customers that its products will conform to functional specifications for a limited period of time following the date of installation (generally not exceeding 30 days) or that its software media is free from material defects. Sales contracts for certain of the Company’s medication packaging systems often include limited warranties for up to six months, but the periodic activity and ending warranty balances the Company records have historically been immaterial.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may also warrant that its professional services will be performed in a good and workmanlike manner or in a professional manner consistent with industry standards. The Company generally seeks to disclaim most warranties, including any implied or statutory warranties such as warranties of merchantability, fitness for a particular purpose, title, quality, and non-infringement, as well as any liability with respect to incidental, consequential, special, exemplary, punitive, or similar damages. In some states, such disclaimers may not be enforceable. If necessary, the Company would provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. The Company has not been subject to any significant claims for such losses and has not incurred any material costs in defending or settling claims related to these indemnification obligations. Accordingly, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations or potential warranty claims and, therefore, no material liabilities have been recorded for such indemnification obligations as of December 31, 2020 and 2019.</span></div> 72800000 69900000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required under ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company accrues for contingencies when it believes that a loss is probable and that it can reasonably estimate the amount of any such loss. The Company has not recorded any material accrual for contingent liabilities associated with the legal proceedings described above based on its belief that any potential loss, while reasonably possible, is not probable. Further, any possible range of loss in these matters cannot be reasonably estimated at this time or is not deemed material. The Company believes that it has valid defenses with respect to these legal proceedings pending against it. However, litigation is inherently unpredictable, and it is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of any of these legal proceedings or because of the diversion of management’s attention and the creation of significant expenses.</span> <div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Company’s certificate of incorporation and bylaws, the Company has agreed to indemnify its directors and executive officers to the fullest extent not prohibited by Delaware and other applicable law, subject to certain exceptions. The Company has entered into individual indemnification agreements with its directors and officers. The term of the indemnification period is for the entirety of the director’s or officer’s service to the Company and continues so long as the director or officer may be subject to any claim, action, or proceeding, and there is no limit on the potential amount of future payments that the Company could be required to make under these indemnification agreements. The Company has purchased a directors’ and officers’ liability insurance policy that may enable it to recover a portion of any future payments that it may be required to make under these indemnification agreements. Assuming the applicability of coverage and the willingness of the insurer to assume coverage and subject to certain retention, loss limits, and other policy provisions, the Company believes it is unlikely that the Company will be required to pay any material amounts pursuant to these indemnification obligations. However, no assurances can be given that the insurers will not attempt to dispute the validity, applicability, or amount of coverage without expensive and time-consuming litigation against the insurers.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company undertakes indemnification obligations in its ordinary course of business in connection with, among other things, the licensing of its products and the provision of its support services. In the ordinary course of the Company’s business, the Company has in the past and may in the future agree to indemnify another party, generally its business affiliates or customers, against certain losses suffered or incurred by the indemnified party in connection with various types of claims, which may include, without limitation, claims of intellectual property infringement, certain tax liabilities, its gross negligence or intentional acts in the performance of support services, and violations of laws. The term of these indemnification obligations is generally perpetual. In general, the Company attempts to limit the maximum potential amount of future payments that it may be required to make under these indemnification obligations to the amounts paid to it by a customer, but in some cases the obligation may not be so limited. </span></div>In addition, the Company has in the past and may in the future warrant to its customers that its products will conform to functional specifications for a limited period of time following the date of installation (generally not exceeding 30 days) or that its software media is free from material defects. Sales contracts for certain of the Company’s medication packaging systems often include limited warranties for up to six months, but the periodic activity and ending warranty balances the Company records have historically been immaterial.From time to time, the Company may also warrant that its professional services will be performed in a good and workmanlike manner or in a professional manner consistent with industry standards. The Company generally seeks to disclaim most warranties, including any implied or statutory warranties such as warranties of merchantability, fitness for a particular purpose, title, quality, and non-infringement, as well as any liability with respect to incidental, consequential, special, exemplary, punitive, or similar damages. In some states, such disclaimers may not be enforceable. If necessary, the Company would provide for the estimated cost of product and service warranties based on specific warranty claims and claim history. The Company has not been subject to any significant claims for such losses and has not incurred any material costs in defending or settling claims related to these indemnification obligations. P30D P6M Employee Benefits and Share-Based Compensation<div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1997 Employee Stock Purchase Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has an Employee Stock Purchase Plan (“ESPP”), under which employees can purchase shares of its common stock based on a percentage of their compensation, but not greater than 15% of their earnings; provided, however, an eligible employee’s right to purchase shares of the Company’s common stock may not accrue at a rate which exceeds $25,000 of the fair market value of such shares for each calendar year in which such rights are outstanding. The purchase price per share must be equal to the lower of 85% of the fair value of the common stock at the beginning of a 24-month offering period or the end of each six-month purchasing period.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was a total of 1.2 million shares reserved for future issuance under the ESPP as of December 31, 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Award Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2009 Equity Incentive Plan</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2009 Equity Incentive Plan (“2009 Plan”), as amended, provides for the issuance of incentive stock options, RSAs, RSUs, PSUs, and other stock awards to the Company’s employees, directors, and consultants. There were 5.9 million shares of common stock reserved for future issuance under the 2009 Plan as of December 31, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted under the 2009 Plan generally become exercisable over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 36 equal monthly installments thereafter. The exercise prices of the options is the fair market value of common stock on the date of grant. RSUs generally vest over periods of up to four years, with one-fourth of the shares vesting one year from the vesting commencement date with respect to initial grants, and the remaining shares vesting in 12 equal quarterly installments thereafter. Awards of restricted stock to non-employee directors are granted on the date of the annual meeting of stockholders and vest in full on the date of the next annual meeting of stockholders, provided such non-employee director remains a director on such date. The fair value of the awards on the date of issuance is amortized to expense from the date of grant to the date of vesting and are expensed ratably on a straight-line basis over the vesting period. PSUs granted to the Company’s executives might include performance and market conditions. PSUs become eligible for vesting when certain market or performance conditions are met. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation Expense</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total share-based compensation expense recognized in the Company’s Consolidated Statements of Operations:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,505 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,697 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,049 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,885 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not capitalize any share-based compensation as inventory as such amounts were not material for the years ended December 31, 2020 and 2019. Income tax benefits realized from share-based compensation were $10.3 million, $11.0 million, and $6.5 million, for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options and ESPP Shares</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to value stock options and ESPP shares granted pursuant to the Company’s equity incentive plans for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life, years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate, %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated forfeiture rate, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield, %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life, years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility, %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4% - 53.5%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2% - 39.9%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1% - 33.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate, %</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1% - 2.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 2.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8% - 2.7%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options Activity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the share option activity under the Company’s 2009 Plan during the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2020 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value per share of options granted during the years ended December 31, 2020, 2019, and 2018 was $26.48, $23.54, and $17.22, respectively. The intrinsic value of options exercised during the years ended December 31, 2020, 2019, and 2018 was $39.8 million, $32.8 million, and $20.1 million, respectively. The tax benefit realized from stock options exercised was $7.1 million, $6.3 million, and $3.6 million, for the years ended December 31, 2020, 2019, and 2018, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, total unrecognized compensation cost related to unvested stock options was $52.7 million, which is expected to be recognized over a weighted-average vesting period of 2.8 years. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Plan Activity</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020 and 2019, employees purchased approximately 333,000 and 374,000 shares of common stock, respectively, under the ESPP at a weighted-average price of $48.77 and $41.44, respectively. As of December 31, 2020, the unrecognized compensation cost related to the shares to be purchased under the ESPP was approximately $4.1 million and is expected to be recognized over a weighted-average period of 1.3 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock Units (RSUs) and Restricted Stock Awards (RSAs)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summaries of the restricted stock activity under the 2009 Plan are presented below for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted stock units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (Awarded)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested (Released)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share of RSUs granted during the years ended December 31, 2020, 2019, and 2018 was $74.52, $78.49, and $59.52, respectively. The total fair value of RSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $11.2 million, $10.6 million, and $7.9 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, total unrecognized compensation cost related to RSUs was $40.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 3.1 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (Awarded)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested (Released)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share of RSAs granted during the years ended December 31, 2020, 2019, and 2018 was $68.11, $81.86, and $46.60, respectively. The total fair value of RSAs that vested in the years ended December 31, 2020, 2019, and 2018 was $1.4 million, $1.0 million, and $1.0 million, respectively.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, total unrecognized compensation cost related to RSAs was $0.5 million, which is expected to be recognized over the remaining weighted-average vesting period of 0.4 years. </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units (PSUs)</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, the Company granted 61,098 PSUs to its executive officers, all of which became eligible for vesting upon the achievement of a certain level of shareholder return. In 2020, the Company granted 62,759 PSUs to its executive officers, all, none, or a portion of which may become eligible for vesting depending on the level of shareholder return for the period from March 1, 2020 through March 1, 2021.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of PSU awards to executive officers is determined using a Monte Carlo simulation model. The number of shares that vest at the end of the performance period depends on the percentile ranking of the total shareholder return for Omnicell stock over the performance period relative to the total shareholder return of each of the other companies in the NASDAQ Healthcare Index (the “Index”).</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For PSUs granted on February 13, 2020, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2020, compared to the trailing 20-day average stock price just prior to the first trading day of March 2021. For PSUs granted on February 13, 2019, stock price appreciation is calculated based on the trailing 20-day average stock price just prior to the first trading day of March 2019, compared to the trailing 20-day average stock price just prior to the first trading day of March 2020. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 5, 2019, the Compensation Committee confirmed the Company's total stockholder return at the 90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile rank of the Index. This resulted in 100% of the 2018 PSUs, or 110,432 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 5, 2019 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2019. Vesting is contingent upon continued service. Of the 110,432 shares eligible for time-based vesting under the 2018 PSUs, 67,066 shares, net of forfeitures, have vested as of December 31, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 3, 2020, the Compensation Committee confirmed the Company's total stockholder return at the 70</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile rank of the Index. This resulted in 100% of the 2019 PSUs, or 61,098 shares, as eligible for further time-based vesting. The eligible PSUs will vest as follows: 25% of the shares vested immediately on March 3, 2020 with the remaining shares vesting on a semi-annual basis period of 36 months commencing on June 15, 2020. Vesting is contingent upon continued service. Of the 61,098 shares eligible for time-based vesting under the 2019 PSUs, 30,548 shares, net of forfeitures, have vested as of December 31, 2020.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to executive officers' PSU awards, from time to time, the Company may grant PSUs with specific performance and service conditions to certain employees on an ad hoc basis. Historically such grants have not been material.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value Per Unit</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value per share of PSUs granted during the years ended December 31, 2020, 2019, and 2018 was $82.17, $73.38, and $38.03, respectively. The total fair value of PSUs that vested in the years ended December 31, 2020, 2019, and 2018 was $3.7 million, $3.5 million, and $3.2 million, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, total unrecognized compensation cost related to PSUs was approximately $5.6 million, which is expected to be recognized over the remaining weighted-average period of 1.4 years.</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Shares Reserved for Future Issuance under Equity Incentive Plans</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of December 31, 2020: </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares authorized for future issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP shares available for future issuance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares reserved for future issuance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">401(k) Plan</span></div>The Company has established a pre-tax savings plan under Section 401(k) of the Internal Revenue Code of 1986, as amended. The 401(k) Plan allows eligible employees in the United States to voluntarily contribute a portion of their pre-tax salary, subject to a maximum limit specified in the Internal Revenue Code. The Company matches 50% of employee contributions up to $3,000, annually. The Company’s contributions under this plan were $5.7 million, $5.1 million, and $4.6 million in the years ended December 31, 2020, 2019, and 2018, respectively. 0.15 25000 0.85 P24M P6M 1200000 5900000 P4Y P1Y P36M P4Y P1Y <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the total share-based compensation expense recognized in the Company’s Consolidated Statements of Operations:</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,648 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,634 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,497 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,604 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,746 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,797 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,505 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,697 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,049 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,885 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 7469000 5648000 4634000 6497000 6604000 5746000 30731000 21797000 18505000 44697000 34049000 28885000 10300000 11000000.0 6500000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to value stock options and ESPP shares granted pursuant to the Company’s equity incentive plans for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life, years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate, %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Estimated forfeiture rate, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield, %</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> P4Y8M12D P4Y4M24D P4Y9M18D 0.394 0.337 0.311 0.007 0.020 0.028 0.057 0.072 0.069 0 0 0 <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Employee stock purchase plan shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life, years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 - 2.0</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility, %</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4% - 53.5%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.2% - 39.9%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.1% - 33.8%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate, %</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1% - 2.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 2.7%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8% - 2.7%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield, %</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table> P0Y6M P2Y P0Y6M P2Y P0Y6M P2Y 0.304 0.535 0.282 0.399 0.281 0.338 0.001 0.027 0.013 0.027 0.008 0.027 0 0 0 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the share option activity under the Company’s 2009 Plan during the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.75 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,198 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,351 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.83 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.65 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.50 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,160 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,556 </span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,949 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at December 31, 2020 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,755 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.86 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3902000 52.75 P7Y8M12D 113198000 1351000 78.83 891000 42.67 19000 59.65 411000 66.65 3932000 62.50 P7Y9M18D 226160000 1556000 45.49 P6Y2M12D 115949000 3755000 61.86 P7Y8M12D 218379000 26.48 23.54 17.22 39800000 32800000 20100000 7100000 6300000 3600000 52700000 P2Y9M18D 333000 374000 48.77 41.44 4100000 P1Y3M18D <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summaries of the restricted stock activity under the 2009 Plan are presented below for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Years</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Intrinsic Value</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted stock units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.65 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,492 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (Awarded)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.52 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested (Released)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.30 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">580 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.87 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,670 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 544000 66.65 P1Y7M6D 44492000 343000 74.52 183000 61.30 124000 67.16 580000 72.87 P1Y7M6D 69670000 74.52 78.49 59.52 11200000 10600000 7900000 40500000 P3Y1M6D <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted stock awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (Awarded)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested (Released)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 17000 81.92 21000 68.11 17000 81.92 21000 68.11 68.11 81.86 46.60 1400000 1000000.0 1000000.0 500000 P0Y4M24D 61098 62759 P20D P20D P20D P20D 0.90 1 110432 0.25 P36M 110432 67066 0.70 1 61098 0.25 P36M 61098 30548 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the performance-based restricted stock activity under the 2009 Plan is presented below for the year ended December 31, 2020:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Grant Date Fair Value Per Unit</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.82 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.54 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.72 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.26 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 134000 55.82 99000 82.17 73000 50.54 5000 81.72 155000 74.26 82.17 73.38 38.03 3700000 3500000 3200000 5600000 P1Y4M24D <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had the following ordinary shares reserved for future issuance under its equity incentive plans as of December 31, 2020: </span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,932 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-vested restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares authorized for future issuance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP shares available for future issuance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,206 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares reserved for future issuance</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,144 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3932000 756000 1250000 1206000 7144000 0.50 3000 5700000 5100000 4600000 Stock Repurchase Program<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2016, the Company’s Board of Directors (the “Board”) authorized a stock repurchase program providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2016 Repurchase Program”). The 2016 Repurchase Program is in addition to the stock repurchase program approved by the Board on November 4, 2014 providing for the repurchase of up to $50.0 million of the Company’s common stock (the “2014 Repurchase Program”). As of December 31, 2020, the maximum dollar value of shares that may yet be purchased under the two repurchase programs was $54.9 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing, price, and volume of repurchases are to be based on market conditions, relevant securities laws, and other factors. The stock repurchases may be made from time to time on the open market, in privately negotiated transactions, or pursuant to a Rule 10b-18 plan, subject to the terms and conditions of that certain A&amp;R Credit Agreement, as amended. The stock repurchase programs do not obligate the Company to repurchase any specific number of shares, and the Company may terminate or suspend the repurchase programs at any time. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 17, 2020, the Board authorized a one-time stock repurchase transaction providing for the repurchase of up to $75.0 million of the Company’s common stock in privately negotiated transactions concurrently with the issuance of the Notes, described in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, the Company repurchased 749,300 shares of its common stock from purchasers of the Notes in the offering in privately negotiated transactions effected through one of the </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">initial purchasers or its affiliate at an average price of $70.78 per share for an aggregate purchase price of approximately $53.0 million. There will be no further repurchases under this one-time authorization.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2020, 2019, and 2018, the Company did not repurchase any of its outstanding common stock, including under the 2014 Repurchase Program or the 2016 Repurchase Program, other than the separately-authorized one-time stock repurchase concurrent with the offering of the Notes in September 2020.</span></div> 50000000.0 50000000.0 54900000 75000000.0 749300 70.78 53000000.0 0 0 0 Equity Offerings<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2017, the Company entered into a Distribution Agreement (the “Distribution Agreement”) with J.P. Morgan Securities LLC, Wells Fargo Securities, LLC, and HSBC Securities (USA) Inc., as its sales agents, pursuant to which the Company was able to offer and sell from time to time through the sales agents up to $125.0 million maximum aggregate offering price of the Company’s common stock. Sales of the common stock pursuant to the Distribution Agreement may be made in negotiated transactions or transactions that are deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, including sales made directly on the Nasdaq Stock Market, or sales made to or through a market maker other than on an exchange.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2018, the Company received gross proceeds of $40.3 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 557,000 shares of its common stock at an average price of approximately $72.40 per share.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2019, the Company received gross proceeds of $38.5 million from sales of its common stock under the Distribution Agreement and incurred issuance costs of $0.7 million on sales of approximately 460,000 shares of its common stock at an average price of approximately $83.81 per share.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, the Company did not sell any of its common stock under the Distribution Agreement.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement under which the shares that could have been sold pursuant to the Distribution Agreement expired on November 3, 2020, and, accordingly, no additional sales will be made pursuant to the Distribution Agreement.</span></div> 125000000.0 40300000 700000 557000 72.40 38500000 700000 460000 83.81 Income Taxes<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a geographical breakdown of income (loss) before the provision for income taxes:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,349 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,933 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,616 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes consisted of the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,795 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes differs from the amount computed by applying the statutory federal tax rate as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal tax provision at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,432 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of global operational centralization activities during the year ended December 31, 2018, the Company recognized $4.2 million of tax benefit associated with making a check-the-box election to treat Aesynt Holding Coöperatief U.A. (Netherlands) as the U.S. disregarded entity beginning in the first quarter of 2018. Subsequently, during the year ended December 31, 2019, the Company recognized gain on the sale of certain intellectual property rights by Aesynt B.V. to Omnicell, Inc. and by Mach4 Automatisierungstechnik GmbH ("Mach4") to Omnicell, Inc., which resulted in a tax expense, net of tax benefit, of $7.4 million. As the Company continued with global operational centralization activities during the year ended December 31, 2020, Aesynt B.V. merged with and into Aesynt Holding B.V., with Aesynt Holding B.V. surviving and changing its name to Omnicell B.V., Aesynt Holding Coöperatief U.A. liquidated into Omnicell, Inc., and Omnicell GmbH merged with and into Mach4, with Mach4 surviving and changing its name to Omnicell GmbH. During the year ended December 31, 2020, the Company also recognized a gain on Omnicell Limited’s transferring shares of Omnicell GmbH to Omnicell International, LLC, which resulted in an immaterial tax expense.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was signed into law in response to the COVID-19 pandemic. The CARES Act, among other provisions, includes provisions related to refundable payroll tax credits, deferment of the employer portion of certain payroll taxes, net operating losses carryback periods, alternative minimum tax credit refunds, modification to the net interest expense deduction limitation, and technical amendments to tax depreciation methods for qualified improvement property placed in service after December 31, 2017. The provisions of the CARES Act did not have a material impact on the Company’s income taxes.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company’s deferred tax assets (liabilities) were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory-related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,461 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,484 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,726 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,801 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,141)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,563)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,948)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax assets (liabilities) are provided for temporary differences that will result in future tax deductions or future taxable income, as well as the future benefit of tax credit carryforwards. The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies, and results of recent operations. On the basis of this evaluation, as of December 31, 2020, $1.2 million of valuation allowance was recorded on certain foreign net operating losses carried forward, as the Company believes that such deferred tax assets are not more likely than not to be realized.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had $6.0 million of state net operating loss carryforwards expiring at various dates beginning in 2024, and $29.7 million of foreign net operating losses carried forward indefinitely. For income tax purposes, the Company has federal and California research tax credits carryforwards of $1.3 million and $17.0 million, respectively. Federal research tax credit carryforwards from prior years will begin to expire in 2035. California credits are available indefinitely to reduce cash taxes payable. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is the Company's practice and intention to reinvest the earnings of its non-U.S. subsidiaries in those operations. As of December 31, 2020, the Company has not made a provision for U.S. federal income, withholding, and state income taxes on the outside basis difference related to certain foreign subsidiaries because earnings are intended to be indefinitely reinvested in operations outside the U.S.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the United States and various state and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities, including major jurisdictions such as the United States, Germany, Italy, Netherlands, and the United Kingdom. With few exceptions, as of December 31, 2020, the Company was no longer subject to U.S., state, and foreign examination for years before 2017, 2016, and 2016, respectively. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the three years ended December 31, 2020 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,741 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,246 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total amounts of gross unrecognized tax benefit that, if realized, would favorably affect the Company's effective income tax rate in future periods, was $18.2 million and $16.8 million as of December 31, 2020 and 2019, respectively. The Company recognizes interest and/or penalties related to uncertain tax positions in interest and other income (expense), net in the Consolidated Statements of Operations, accruing $0.4 million, $0.5 million, and $0.5 million for the years ended December 31, 2020, 2019, and 2018, respectively. Accrued interest and penalties are included within other long-term liabilities on the Consolidated Balance Sheets. The combined amount of cumulative accrued interest and penalties was approximately $1.4 million, $1.0 million, and $1.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The Company does not believe there will be any significant changes in its unrecognized tax positions over the next twelve months.</span></div> <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a geographical breakdown of income (loss) before the provision for income taxes:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Domestic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,714 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,641 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,528 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,365)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) before provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,349 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,933 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,616 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 34714000 81641000 46528000 -5365000 -7708000 -10912000 29349000 73933000 35616000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes consisted of the following:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,006 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,733 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,549 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,832 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,254 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,795 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,004 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,868)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,455 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,494)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,609)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(737)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,701 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,663)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,099)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,200)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,117)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1874000 8006000 1404000 1733000 4549000 1832000 647000 1240000 768000 4254000 13795000 4004000 -3868000 -1292000 5455000 -2494000 -1609000 -909000 -737000 1701000 -10663000 -7099000 -1200000 -6117000 -2845000 12595000 -2113000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes differs from the amount computed by applying the statutory federal tax rate as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal tax provision at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,163 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,525 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(601)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,279 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(394)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,892)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,038)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,805)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,432 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,205)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign derived intangible income deduction</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(349)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,424)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,845)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,113)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6163000 15525000 7479000 -601000 2258000 651000 2550000 2279000 738000 325000 619000 686000 -394000 -2472000 -412000 -6929000 -7892000 -4005000 4038000 3805000 3230000 0 -7432000 4205000 204000 449000 349000 -102000 -1424000 561000 385000 524000 -27000 -2845000 12595000 -2113000 -4200000 7400000 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the Company’s deferred tax assets (liabilities) were as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,910 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,094 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,483 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory-related items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,953 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,507 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,105 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserves and accruals</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,712 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,461 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,484 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,471 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,578 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">543 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,726 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,801 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,199)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,186)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,527 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,941)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,941)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,141)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82,563)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,614)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,948)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5910000 4129000 8094000 6483000 4953000 3507000 12105000 13472000 8160000 5712000 8461000 9484000 15465000 15471000 1578000 543000 64726000 58801000 1199000 1186000 63527000 57615000 22010000 18941000 36528000 35941000 15654000 13395000 13949000 14286000 88141000 82563000 24614000 24948000 1200000 6000000.0 29700000 1300000 17000000.0 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate change in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the three years ended December 31, 2020 was as follows:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:85.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2017</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,741 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,257)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">870 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(412)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,472)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during a prior period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to tax positions taken during the prior period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to tax positions taken during the current period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,294 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decreases related to expiration of statute of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,246 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10741000 19000 1257000 870000 0 412000 9961000 10000 6000 9282000 0 2472000 16775000 88000 0 2294000 0 911000 18246000 18200000 16800000 400000 500000 500000 1400000 1000000.0 1400000 Restructuring Expenses<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2020, the Company announced a company-wide organizational realignment initiative in order to more effectively align its organizational infrastructure and operations with the strategic vision of the autonomous pharmacy. In the second quarter of 2020, the Company continued its organizational realignment initiative, as well as initiated a restructuring plan to help mitigate the adverse impact of the COVID-19 pandemic on its business and financial results. During the year ended December 31, 2020, the Company incurred and accrued $10.0 million of employee severance costs and related expenses. As of December 31, 2020, the unpaid balance related to this restructuring plan was $0.6 million.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, the Company announced a company-wide organizational realignment initiative in order to align its organizational infrastructure for future expected growth. During the year ended December 31, 2018, the Company accrued and paid out $1.3 million of restructuring expenses, which includes severance and consulting-related expenses.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2018, the Company initiated the realignment of its Automation and Analytics commercial group in North America and France. During the year ended December 31, 2018, the Company accrued and paid out $3.0 million of employee severance costs and related expenses. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total restructuring expenses recognized in the Company’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,716 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,346 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 10000000.0 600000 1300000 1300000 3000000.0 3000000.0 <div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total restructuring expenses recognized in the Company’s Consolidated Statements of Operations for the years ended December 31, 2020, 2019, and 2018:</span></div><div style="margin-bottom:8pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of product and service revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,564 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,716 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,681 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,160 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total restructuring expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,346 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 2564000 0 186000 3716000 0 0 3681000 0 4160000 9961000 0 4346000 <div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE II</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div><div style="margin-bottom:4pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.818%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.432%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beginning of Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Charged (Credited) to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Costs and Expenses </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Debited (Credited) to</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Accounts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amounts</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Written Off </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Adjustments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">End of Period </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,738 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,010)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,930 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,010)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,796 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,582 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,488 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,796 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,499 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,986)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable and unbilled receivables</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,227 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,095 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,286 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term unbilled receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net investment in sales-type leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total allowances deducted from assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,135 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(535)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,581 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:4pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________________________</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Allowance for credit losses.</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Represents amounts charged and credited for provisions for credit losses. </span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Represents amounts debited to receivables as recoveries, increasing the allowance.</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Represents amounts written off from the allowance and receivable.</span></div><div style="margin-bottom:4pt;margin-top:4pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">Represents other adjustments, such as foreign currency translation, adoption of new accounting guidance, and purchase price accounting adjustments in connection with acquisitions.</span></div> 5738000 -127000 12000 3010000 -31000 2582000 0 0 0 0 0 0 192000 10000 12000 0 0 214000 5930000 -117000 24000 3010000 -31000 2796000 2582000 2488000 0 1986000 143000 3227000 0 0 0 0 0 0 214000 11000 0 0 0 225000 2796000 2499000 0 1986000 143000 3452000 3227000 1095000 0 535000 499000 4286000 0 0 0 0 30000 30000 225000 40000 0 0 0 265000 3452000 1135000 0 535000 529000 4581000 XML 27 R1.htm IDEA: XBRL DOCUMENT v3.20.4
    Cover Page - USD ($)
    $ in Billions
    		 12 Months Ended
    Dec. 31, 2020
    Feb. 17, 2021
    Jun. 30, 2020
    Cover [Abstract]      
    Document Type 10-K    
    Document Annual Report true    
    Document Period End Date Dec. 31, 2020    
    Current Fiscal Year End Date --12-31    
    Document Transition Report false    
    Entity File Number 000-33043    
    Entity Registrant Name OMNICELL, INC.    
    Entity Incorporation, State or Country Code DE    
    Entity Tax Identification Number 94-3166458    
    Entity Address, Address Line One 590 East Middlefield Road    
    Entity Address, City or Town Mountain View    
    Entity Address, State or Province CA    
    Entity Address, Postal Zip Code 94043    
    City Area Code 650    
    Local Phone Number 251-6100    
    Title of 12(b) Security Common Stock, $0.001 par value    
    Trading Symbol OMCL    
    Security Exchange Name NASDAQ    
    Entity Well-known Seasoned Issuer Yes    
    Entity Voluntary Filers No    
    Entity Current Reporting Status Yes    
    Entity Interactive Data Current Yes    
    Entity Filer Category Large Accelerated Filer    
    Entity Small Business false    
    Entity Emerging Growth Company false    
    ICFR Auditor Attestation Flag true    
    Entity Shell Company false    
    Entity Public Float     $ 3.0
    Entity Common Stock, Shares Outstanding (in shares)   43,041,554  
    Documents Incorporated by Reference Portions of the registrant’s definitive Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the United States Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Form 10-K are incorporated by reference in Part III, Items 10-14 of this Form 10-K.    
    Document Fiscal Period Focus FY    
    Amendment Flag false    
    Document Fiscal Year Focus 2020    
    Entity Central Index Key 0000926326